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Julia Berghäuser, Wiebke Bensmann, Nicolas Zink, Tanja Endrass, Christian Beste and
Ann-Kathrin Stock
Alcohol Hangover Does Not Alter the Application of Model-Based and Model-Free
Learning Strategies
Reprinted from: J. Clin. Med. 2020, 9, 1453, doi:10.3390/jcm9051453 . . . . . . . . . . . . . . . . . 281
Lydia E. Devenney, Kieran B. Coyle, Thomas Roth and Joris C. Verster
Sleep after Heavy Alcohol Consumption and Physical Activity Levels during Alcohol Hangover
Reprinted from: J. Clin. Med. 2019, 8, 752, doi:10.3390/jcm8050752 . . . . . . . . . . . . . . . . . 301
Joris C Verster, Aikaterini Anogeianaki, Darren Kruisselbrink, Chris Alford and
Ann-Kathrin Stock
Relationship between Alcohol Hangover and Physical Endurance Performance: Walking the
Samaria Gorge
Reprinted from: J. Clin. Med. 2020, 9, 114, doi:10.3390/jcm9010114 . . . . . . . . . . . . . . . . . . 315
Joris C Verster, Thomas A Dahl, Andrew Scholey and Jacqueline M Iversen
The Effects of SJP-001 on Alcohol Hangover Severity: A Pilot Study
Reprinted from: J. Clin. Med. 2020, 9, 932, doi:10.3390/jcm9040932 . . . . . . . . . . . . . . . . . 331
Andrew Scholey, Elizabeth Ayre, Ann-Kathrin Stock, Joris C Verster and Sarah Benson
Effects of Rapid Recovery on Alcohol Hangover Severity: A Double-Blind, Placebo-Controlled,
Randomized, Balanced Crossover Trial




Joris C Verster (1970) studied psychology and obtained his Ph.D. at the Utrecht Institute for
Pharmaceutical Sciences in 2002. Verster is Associate Professor at the Division of Pharmacology
at Utrecht University, The Netherlands, and Adjunct Professor of Human Psychopharmacology at
the Centre for Human Psychopharmacology of Swinburne University of Technology, Melbourne,
Australia. Dr. Verster investigates the impact of exposome pressure (e.g., lifestyle factors) on
health, immune fitness, and behavior. The aim of this multidisciplinary research is to develop and
implement tools and methods (biomarkers, clinical assessments, and questionnaires), and to collect
real world evidence on how a wide range of environmental factors may impact health outcomes and
quality of life. Dr. Verster has a track record of clinical trials examining the effects of CNS drugs
and psychoactive substances on cognitive and psychomotor functioning, mood, sleep, and daily
activities, such as driving a car. He conducts extensive research into the effects of alcohol use as risk
factor in health and disease, and the causes, consequences, and treatments of an alcohol hangover.
Verster is the founder of the Alcohol Hangover Research Group, and his research is regularly
covered by international media. Joris serves as scientific advisor for both industry and governmental
organizations.
Lizanne Arnoldy is a Ph.D. candidate from the Centre for Human Psychopharmacology at
Swinburne University, where she explores the role of diet on aging brains, as indexed by diffusion
weighted imaging. Arnoldy has a background in pharmacy, and previously worked for Utrecht
University where she conducted research for the World Health Organization.
Sarah Benson is a Postdoctoral Research Fellow at the Centre for Human Psychopharmacology,
Swinburne University. She completed her Ph.D. in 2016, where she explored the cognitive and
behavioral effects of alcohol and caffeine. Her research portfolio has focused primarily on cognitive
impairment and enhancement, alcohol hangover, and drug use and functional outcomes. Sarah aims
to disentangle the neurocognitive effects of licit and illicit substances in order to identify relationships
between their behavioral effects and pharmacological properties, as well as to reduce dangerous
behaviors and harm.
Andrew Scholey is Professor of Human Psychopharmacology based in Melbourne, Australia.
He is a leading international researcher for the neurocognitive effects of nutritional interventions,
recreational drugs, supplements, and food components. He has published >250 peer-reviewed
journal articles, as well as over 25 books and book chapters. He has attracted around $25 million
in research funding. Andrew has been a lead investigator on a series of studies regarding human
biobehavioral effects of nutritional interventions, focusing on potential neurocognition-enhancing
and anti-stress/anxiolytic properties (including first-into-human neurocognitive assessment of
ginseng, sage, curcumin, and lemon balm amongst others). His current research focuses on
neuroimaging and biomarker techniques to better understand the mechanisms of cognitive
enhancement. Andrew works closely with the industry to allow for the rapid translation of research
into evidence-based end-user health benefits.
ix
Ann-Kathrin Stock (1987) studied psychology and obtained her doctorate at the University of
Bochum in 2014, where she focused on dopaminergic modulation of action control. She is currently a
senior researcher at the Faculty of Medicine/Chair of Cognitive Neurophysiology and at the Faculty
of Psychology/Chair of Biopsychology at TU Dresden, Germany. Dr. Stock’s research focuses on
neurobiochemical modulators of action control and executive functions. With respect to drugs of





The Alcohol Hangover Research Group: Ten Years of
Progress in Research on the Causes, Consequences,
and Treatment of the Alcohol Hangover
Joris C. Verster 1,2,*, Lizanne Arnoldy 1,2, Sarah Benson 2, Andrew Scholey 2
and Ann-Kathrin Stock 3,4
1 Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS),
Utrecht University, 3584CG Utrecht, The Netherlands; larnoldy@swin.edu.au
2 Centre for Human Psychopharmacology, Swinburne University, Melbourne VIC 3122, Australia;
sarahmichellebenson@gmail.com (S.B.); andrew@scholeylab.com (A.S.)
3 Cognitive Neurophysiology, Department of Child and Adolescent Psychiatry, Faculty of Medicine,
TU Dresden, Fetscherstr. 74, 01,307 Dresden, Germany; Ann-Kathrin.Stock@uniklinikum-dresden.de
4 Biopsychology, Department of Psychology, School of Science, TU Dresden, Zellescher Weg 19,
01,069 Dresden, Germany
* Correspondence: j.c.verster@uu.nl
Received: 2 November 2020; Accepted: 2 November 2020; Published: 16 November 2020
Abstract: The alcohol hangover is defined as the combination of negative mental and physical
symptoms, which can be experienced after a single episode of alcohol consumption, starting when
blood alcohol concentration (BAC) approaches zero. Here, we present the book “The alcohol
hangover: causes, consequences, and treatment”, written to celebrate the 10th anniversary of the
Alcohol Hangover Research Group (AHRG), summarizing recent advances in the field of alcohol
hangover research.
Keywords: alcohol; hangover; causes; consequences; treatments
The alcohol hangover is defined as the combination of negative mental and physical symptoms,
which can be experienced after a single episode of alcohol consumption, starting when blood alcohol
concentration (BAC) approaches zero [1,2]. Despite the fact that the alcohol hangover is the most
commonly reported negative consequence of alcohol consumption [3], a relatively small amount of
research has been devoted to this topic. The latter is surprising as the alcohol hangover is associated
with negative mood, cognitive impairment, and physical effects [4]. Here, we present the book
“The alcohol hangover: causes, consequences, and treatment”, written to celebrate the 10th anniversary
of the Alcohol Hangover Research Group (AHRG).
In 2010, the AHRG was founded to raise the profile of alcohol hangover research [5]. The AHRG
scientific meetings aim to bring together active and internationally diverse alcohol hangover researchers
to generate discussion on recent developments in hangover research. The objectives of these meetings
are to discuss recent findings and future research directions, to raise the profile of alcohol hangover
research, and to start new research collaborations. Over the past 10 years, 11 successful AHRG
meetings have been held across the world [5–11]. In 2010, the first AHRG meeting was held as a
satellite symposium of the Research Society on Alcoholism conference in San Antonio, Texas, USA.
Subsequent AHRG meetings were held in Paris in 2010 (France), Utrecht in 2011 (The Netherlands),
Wolfville in 2012 (Canada), Keele in 2013 (UK), Bellevue in 2014 (USA), Perth in 2015 (Australia),
New Orleans in 2016 (USA), Utrecht in 2017 (The Netherlands), Utrecht in 2018 (The Netherlands),
and Wailoaloa Beach, Nadi in 2019 (Fiji). Proceedings of most of the AHRG meetings have been
published [5–11].
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In the decade since its inception, the AHRG has moved the field forward significantly.
The inaugural meeting resulted in the publication of a consensus paper on best practice in hangover
research, and an evaluation of the gaps in knowledge that should be addressed by future research [12].
Among the key accomplishments was the development of a definition for the alcohol hangover [1].
In addition, international research collaborations resulted in a significant increase in the number of
published articles on the alcohol hangover (see Figure 1).
Figure 1. Published articles on the alcohol hangover. Number of publications taken from PubMed
(https://pubmed.ncbi.nlm.nih.gov, assessed on 13 October 2020), searching for “alcohol hangover”.
In 2010 (red bar), the Alcohol Hangover Research Group (AHRG) was founded.
In conjunction with its 10th anniversary, a Special Issue of the Journal of Clinical Medicine on
the alcohol hangover was curated by members of the AHRG. After peer-review, twenty-five articles
were accepted for the Special Issue, and this collection is combined in this book, entitled “The alcohol
hangover: causes, consequences, and treatment”.
The first five articles discuss significant methodological advances. In the first article, an update of
the definition of the alcohol hangover is discussed [2]. The update of the definition was necessary,
as current thinking about the traditional threshold for experiencing hangovers (a BAC of at least
0.11%) had changed. The new consensus, which is discussed in article two, reflects observations that
hangovers can be experienced at any BAC [13].
Article three discusses the advantages and limitations of naturalistic study designs and their
implementation in alcohol hangover research [14]. In contrast to traditional, controlled clinical trials,
hangover research often applies a naturalistic study design in which investigators do not interfere
with the drinking session. The article explains why this is important in terms of ecological validity
(i.e., a real-life drinking session at a venue of choice, with corresponding behaviors and real-life
alcohol consumption levels), and to what extent the naturalistic design has an impact on reliability and
validity of study outcomes in comparison to highly controlled clinical trials. Article four discusses the
assessment of overall hangover severity [15]. Traditional research has used composite symptom scales
to assess hangover severity. The advantage of this approach is that information is gathered about the
presence and severity of individual hangover symptoms. However, the research discussed in article
four demonstrates that there are several disadvantages to this approach (e.g., the choice of included
individual symptoms in a scale determines the overall hangover severity score, which therefore differs
between currently used scales). The findings suggest that a one-item hangover severity assessment
has advantages over composite symptom scale scores. In the final part of this section, article five
discusses the prevalence of hangover resistance according to two methods for calculating estimated
2
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BAC [16]. The findings discussed show that different equations used to calculate estimated BAC yield
different outcomes. The latter is an important finding, and future consensus is warranted among
AHRG members to ensure harmonization in reporting estimated BAC to allow direct comparisons of
research from different groups.
The next two articles discuss the “causes” of alcohol hangover, and articles review the current
knowledge on the pathology of the alcohol hangover. Whereas previous reviews on the causes
of the alcohol hangover relied heavily on research data from the 1970s by the Finnish group
Ylikhari et al., [17–19], the articles in this book provide major advances in the understanding of
the pathology of the alcohol hangover. Article six reviews the role of alcohol metabolism in the
pathology of the alcohol hangover [20], and article seven presents new data on the inflammatory
response to alcohol consumption and its contribution to the alcohol hangover [21]. The data reveal that
the rate of ethanol metabolism is an important predictor of next day hangover severity. In addition,
the impact of oxidative stress and the balance between free radicals and antioxidants is discussed, as
well as the role of acetaldehyde in eliciting an inflammatory response to alcohol (e.g., the release of
cytokines), which ultimately elicits the alcohol hangover.
The following six articles discussing a variety of factors (‘correlates’) that may exacerbate or
attenuate hangover symptoms. Article eight presents data on the effect of dietary nutrient intake on
alcohol hangover severity [22]. Dietary nutrients are frequently included as ingredients in hangover
treatments. Therefore, it is of interest to verify which of these, taken as part of daily diet, are
associated with experiencing less severe hangovers. The results indicate that drinkers who consume
food rich in zinc and nicotinic acid report less severe hangovers. Both nutrients are involved in the
breakdown of ethanol and acetaldehyde, which may explain these findings. Article nine discusses
the fact that different drinking levels are associated with experiencing differential levels of hangover
severity [23]. The data confirm previous findings that hangover symptom severity is most severe
among heavy and chronic drinkers. Article 10 discusses the interesting finding that when individuals
experience hangovers more frequently, their severity increases [24]. Contrary to the common notion
that drinkers get used to the amount of alcohol they consume and become “immune” to the adverse
effects of drinking at this level, this observation suggests that reverse tolerance develops. Article 11
discusses the finding that hangover symptom severity is to some extent determined by the level of
pain catastrophizing of drinkers [25]. Reporting higher levels of pain catastrophizing, in particular
rumination, was associated with experiencing more severe hangovers. This finding is important, as it
may have implications for the percentage of drinkers reporting being hangover resistant, and illustrates
that the psychological perception of “what is pain?” and “what is mild, moderate, or severe?” differs
between individuals, and thus impacts the reporting of the presence and rating of the severity of
hangover symptoms. The latter is important as to date, no objective assessments for alcohol hangover
(symptom) severity are available, and researchers have to rely on subjective reporting. Article 12
reviews possible sex differences in the presence and severity of hangover symptoms [26]. In contrast to
acute alcohol effects (e.g., greater ratings of subjective intoxication in women), sex differences in the
next-day effects of alcohol consumption appear to be limited. Finally, article 13 discusses the impact of
mood and subjective intoxication on hangover severity [27]. Whereas baseline mood and mood while
drinking had no relevant impact on next-day hangover severity, subjective intoxication (i.e., the level
of drunkenness) showed to be a strong determinant of hangover severity.
Eleven subsequent articles discuss various aspects of cognitive, psychomotor, and physical
performance during the hangover state (‘consequences’). Article 14 describes the results of a
study that assessed cognitive functioning and mood, applying a naturalistic study design [28].
The study demonstrates that participants can be tested at home using mobile technology to collect
data. This methodology has clear advantages for participants (they do not have to come to the research
center) and logistics for researchers (no lab space needed). Article 15 describes an investigation
in which participants were approached on premise after consuming alcohol [29]. Both objective
(breathalyzer) and subjective assessments (interview) of alcohol consumption and intoxication were
3
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made, and subjects were invited to complete online assessments of hangover severity and cognitive
performance the next morning. Articles 14 and 15 demonstrate the utility of mobile/online assessments
for hangover research. Future direct comparisons should investigate if validity and reliability of at
home testing are equal to that of testing in controlled laboratory environments. Driving a car is one
of the common daily activities that are potentially dangerous, as the use of alcohol can significantly
impair driving performance and increase the chances of having an accident. Numerous studies have
demonstrated that driving a car or bicycle while intoxicated is unsafe [30,31]. Previous research has also
shown that simulated highway driving whilst experiencing a hangover is significantly impaired [32].
Despite this knowledge, a substantial number of both private and professional drivers continue to
drive a car while experiencing a hangover [33]. Article 16 discusses the impact of alcohol hangover on
simulated driving performance during a “commute to work” [34]. The study also revealed that during
a relatively short drive, driving performance was significantly impaired while hungover. Driving is
also a clear example of multitasking. In article 17, Benson et al. investigate alcohol hangover effects on
another behavior, which can be translated to everyday workload, namely multitasking [35]. A hangover
was associated with worse mood (reduced alertness and contentment, and increased anxiety and
mental fatigue), and poorer multitasking performance, with greater effort needed to complete the tasks
compared to the non-hangover condition. Interestingly, stress reactivity was not differentially affected
by the hangover. The effects of alcohol hangover on executive functions are discussed in article 18.
The investigation by Gunn et al. found that the alcohol hangover impairs core executive function
processes that are important for everyday behaviors, such as decision-making and planning [36].
Affected daily behaviors and cognitive functioning during the hangover may ultimately be related
to impaired information processing during the hangover. Three articles from Stock and colleagues
investigated this in more detail. In article 19, they demonstrate that the alcohol hangover differentially
modulates the processing of relevant and irrelevant information [37], and article 20 discusses findings
showing that the alcohol hangover slightly impairs response selection but not response inhibition [38].
Finally, article 21 shows that the alcohol hangover does not alter the application of model-based and
model-free learning strategies [39]. Together, these three articles provide further insights into the
nature of slowed and impaired information processing during a hangover.
Whereas much research is devoted to cognitive aspects of the alcohol hangover, our understanding
of the effects on physical state and sports performance has been limited. In article 22, Devenney et al. [40]
report on physical activity level assessments comparing hangover and alcohol-free days. Using mobile
technology, the continuous assessments of activity levels showed that during hangover subjects
performed at lower activity levels, and vigorous activities were absent. Additionally, the assessments
revealed that sleep quality was significantly poorer after the evening of alcohol consumption. Article 23
discusses the results of a study investigating the effects of alcohol consumption and hangover on
endurance performance. Subjects on holiday walking the 18 km Samariá Gorge on the island of Crete
in Greece were surveyed before and after they completed the walk. The analysis revealed that a variety
of factors may predict walking performance and effort required to perform the walk, ranging from
baseline physical state, immune fitness, to past night sleep quality, and also alcohol consumption and
hangover severity [41].
Two articles discuss the outcomes of recent clinical trials that evaluated potential new hangover
treatments. Despite a clear demand from drinkers who experience hangovers [42], currently there are
no hangover treatments where the effectiveness has been demonstrated in independent double-blind,
placebo-controlled clinical trials [43–45]. The increasing knowledge on the pathology of the alcohol
hangover has resulted in focusing treatment development on products that aim to reduce the
inflammatory response to alcohol and/or to enhance alcohol metabolism. In article 24, results of a
pilot study are presented examining the effectiveness of SJP-005, a combination product of naproxen
and fexofenadine, aiming to prevent hangovers by reducing the inflammatory response to alcohol
consumption [46]. In article 25, the effects of Rapid Recovery are discussed—a hangover treatment
aiming to reduce oxidative stress—and thereby preventing hangovers or reducing their severity [47].
4
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Taken together, “The alcohol hangover: causes, consequences, and treatment” provides a
comprehensive overview of current insights and research into many aspects of the alcohol hangover.
The book highlights the advances in the field over the past decade, fueled by successful collaborations
of researchers of the Alcohol Hangover Research Group and others investigating the interesting yet
sometimes puzzling phenomenon of the alcohol hangover.
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Abstract: In 2016, the Alcohol Hangover Research Group defined the alcohol hangover as
“the combination of mental and physical symptoms experienced the day after a single episode
of heavy drinking, starting when blood alcohol concentration (BAC) approaches zero”. In the light of
new findings and evidence, we carefully reviewed the different components of that definition. Several
studies demonstrated that alcohol hangovers are not limited to heavy drinking occasions. Instead,
data from both student and non-student samples revealed that at a group level, alcohol hangover
may occur at much lower BAC levels than previously thought. Regression analysis further revealed
that for individual drinkers, the occurrence of hangovers is more likely when subjects consume more
alcohol than they usually do. However, hangovers may also occur at a drinker’s usual BAC, and in
some cases even at lower BAC (e.g. in case of illness). We also carefully reviewed and modified other
parts of the definition. Finally, hangovers are not necessarily limited to the ‘next day’. They can start
at any time of day or night, whenever BAC approaches zero after a single dinking occasion. This may
also be on the same day as the drinking occasion (e.g. when drinking in, or until the morning and
subsequently having a hangover in the afternoon or evening). To better reflect the new insights and
sharpen the description of the concept, we hereby propose to update the definition of the alcohol
hangover as follows: “The alcohol hangover refers to the combination of negative mental and physical
symptoms which can be experienced after a single episode of alcohol consumption, starting when
blood alcohol concentration (BAC) approaches zero”, and recommend to use this new definition in
future hangover research.
Keywords: alcohol; hangover; definition
1. Introduction
In 2016, the Alcohol Hangover Research Group defined the alcohol hangover as “the combination
of mental and physical symptoms experienced the day after a single episode of heavy drinking, starting
when blood alcohol concentration (BAC) approaches zero” [1]. The development of this definition
was a welcome and necessary addition to the substance abuse and addiction research field. Since
then, ongoing research has generated new insights and there have been continuous discussions among
researchers about how to further improve the definition of the alcohol hangover. Updating the current
definition is necessary to describe the alcohol hangover more precisely against the background of
new findings in the field. These specifications address recently discussed issues and further remove
ambiguity from the previous wording.
J. Clin. Med. 2020, 9, 823; doi:10.3390/jcm9030823 www.mdpi.com/journal/jcm9
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2. Heavy Drinking
The most important discussion pertains to the amount of alcohol consumption that is required to
elicit a hangover. Given this discussion, there is controversy about the word ‘heavy’ in the definition of
alcohol hangover. First, the word ‘heavy’ is unspecific, as it does not define what exact amount of
alcohol should actually be consumed to elicit a hangover. Second, it suggests that hangovers occur
only when large amounts of alcohol are consumed. However, the Alcohol Hangover Research Group
recently reached a consensus to abandon the criterion that a BAC of 0.11% or higher is needed to
provoke a hangover [2]. This conclusion was drawn based on an increasing body of evidence showing
that drinkers also report hangovers at BACs that are much lower than both the suggested threshold of
0.11%, as well as the binge drinking threshold of 0.08% issued by the National Institute on Alcohol
Abuse and Alcoholism (NIAAA) [3].
For example, Verster et al. [4] found that non-student subjects (N = 176) who consumed a mean
(SD) of 3.0 (1.8) alcoholic drinks (10 g ethanol each) reported considerable next-morning hangover
severity, i.e., a mean (SD) overall hangover severity score of 4.6 (2.4) on a 0–10 scale. Despite this, their
peak estimated BAC was 0.03%. In another student sample, Kruisselbrink et al. [5] found significant
hangover symptoms in subjects having consumed as few as two beers, with a mean maximum BAC of
0.036%. These observations are neither consistent with ‘heavy drinking’ in the definition of the alcohol
hangover, nor with the binge drinking threshold suggested by the NIAAA. Surveys completed by
large student samples from Canada (N = 5540) and The Netherlands (N = 6002) further confirmed
that alcohol hangovers are reported across all BAC levels [6,7]. Thus, hangovers may occur at any
reasonable BAC level, and are not limited to ‘heavy’ drinking only. Given this, we need to modify the
current definition of the alcohol hangover and omit the referral to heavy drinking.
3. The Concept of Alcohol Hangover Versus Risk Factors and Possible Causes
When developing a definition, it is vital to accurately describe the concept (i.e., alcohol hangover).
Furthermore, a proper definition of a phenomenon should not contain potential risk factors for its
occurrence. There are many risk factors for hangover including, but not limited to, the amount of
consumed alcohol (compared to normal), peak BAC, congener content of drinks, smoking, activities
during drinking (e.g. dancing or sitting in a bar), or the emotional state during drinking. While these
risk factors are of course important to investigate and mention in relation to alcohol hangover, they
should not be included in a definition of the concept itself, as the observation/diagnosis of a condition
should be separate from the risk/likelihood that it will occur. It is however important to still refer to
‘alcohol consumption’ in the definition of alcohol hangover as this behavior is mandatory to elicit the
condition (rather than a mere risk factor).
Evaluating hangover experiences from individual drinkers has shown that developing a useful,
short, and accurate description of the relevant amount of alcohol intake to elicit a hangover is not
straightforward. First of all, the presence and severity of alcohol hangovers may vary from day to
day [8], even when the same amount of alcohol is consumed and the same BAC is reached. In line with
this, regression analyses revealed that neither the amount of consumed alcohol, nor BAC, were strong
predictors of hangover severity [2]. Instead, the relative increase in alcohol consumption, as compared
to what subjects normally consume on a typical drinking occasion, was the best predictor of overall
hangover severity [2]. Thus, the chances of having a hangover are significantly increased when drinking
more alcohol than usual, whatever the usual amount consumed. However, including the phrase
‘relatively elevated amounts of alcohol consumption’ into the definition would exclude a substantial
amount of drinkers who also experience hangovers, but do not fulfill this criterion. For example, there
are drinkers who almost always experience a hangover, also when only drinking their usual amount of
alcohol. One of the many potential reasons for this could be deficient metabolization of alcohol and/or
its metabolite acetaldehyde in the liver. Genetic variation in alleles for alcohol dehydrogenase (ADH)
and aldehyde dehydrogenase (ALDH), which are the enzymes necessary for metabolizing ethanol
into acetaldehyde and further into acetate, may account for this. Twin studies showed that heritability
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of this genetic variation is related to about 45% of the reported hangover severity [9,10]. In this
context, in populations of Asian descent, subjects with ALDH2*2 alleles, i.e., those who breakdown
acetaldehyde more slowly, usually report significantly worse hangovers [11,12], and are more likely to
experience hangovers at lower alcohol consumption levels than others. In such hangover-sensitive
drinkers, the amount of alcohol does not need to be elevated to elicit a hangover. Aside from this,
hangovers may also occur when drinking less alcohol than usual on a given occasion. This might
for example be the case if subjects experience illness or reduced immune fitness [13,14], or in case of
elevated negative mood while drinking [15,16]. It is hence challenging to encompass the different
scenarios that may result in a hangover in a modified definition, without making it very lengthy.
We therefore propose to substitute ‘heavy drinking’ with ‘alcohol consumption’ without any further
reference to the amount consumed. Further, to more accurately reflect the day-to-day variability in the
likelihood of developing a hangover despite more or less equal circumstances [8], we further propose to
change ‘experienced’ into ‘which can be experienced’. This also acknowledges the fact that about 10%
to 20% of drinkers report not having a hangover, even after consuming large amounts of alcohol [6,7].
4. Alcohol Hangover Symptoms
The definition refers to a ‘combination of mental and physical symptoms’. Hangover symptoms are
generally perceived to be negative, but the original wording does not specify whether these symptoms
are expected to be negative or positive. Therefore, we suggest to modify this as a ‘combination of
negative mental and physical symptoms’. In line with previous discussions [1], hangover symptoms
are not listed as part of the definition. Symptoms vary between drinkers and between drinking
occasions, even when same amounts of alcohol are consumed [8,17]. Including specific symptoms
instead of the general description ‘combination of negative mental and physical symptoms’ would
thus significantly limit the applicability of the definition.
5. Timing of Drinking
The previous definition states that hangover is ‘experienced the day after . . . ’, which was included
to clearly differentiate the intoxication phase from the hangover phase. In the vast majority of cases,
the hangover starts when waking up after an afternoon, evening, or night of drinking, followed by a
period of sleep. Yet, this definition would not properly match cases where an individual drinks past
midnight, in the morning, or during the day [18]. For example, a UK study revealed that almost 20%
of all ‘drinking occasions’ took place before 5:00 p.m. [19]. In these instances, drinkers may experience
a hangover in the afternoon or evening of the same day. We therefore decided to omit the next day
criterion and changed the definition to ‘experienced after’.
6. Differentiating between Alcohol Hangover and Withdrawal
The definition refers to ‘a single episode . . . ’. This was included to differentiate hangovers in
social drinkers from withdrawal symptoms experienced by individuals with alcohol use disorders
(i.e., alcoholism), who tend to not only engage in alcohol binges but also maintain a rather steady baseline
level of alcohol consumption with continuous drinking for several days, or even longer. This leads to
extensive homeostatic adaptations in the regulation of many vital parameters as well as neuroadaptive
processes [20], which foster the development of alcohol tolerance. These counter-regulatory mechanisms
require clinical treatment as they may cause life-threatening complications when the BAC approaches
zero. In contrast to individuals with alcohol use disorder, social drinkers lack such extensive tolerance,
as they do by definition not engage in such continuous drinking. Given the functional differences
in the symptom-associated drinking patterns as well as the underlying physiological mechanisms,
we therefore decided not to alter this part of the definition.
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7. Differentiating between Alcohol Hangover and Intoxication
The definition states that hangover is ‘starting when blood alcohol concentration (BAC) approaches
zero’. This is crucial in order to clearly distinguish between alcohol intoxication and alcohol hangover
on the basis of timing. We did therefore not alter this part of the definition.
8. Conclusions
We hereby propose to update the definition of alcohol hangover as follows: “The alcohol hangover
refers to the combination of negative mental and physical symptoms which can be experienced
after a single episode of alcohol consumption, starting when blood alcohol concentration (BAC)
approaches zero”.
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Abstract: The 2010 Alcohol Hangover Research Group consensus paper defined a cutoff blood alcohol
concentration (BAC) of 0.11% as a toxicological threshold indicating that sufficient alcohol had been
consumed to develop a hangover. The cutoffwas based on previous research and applied mostly in
studies comprising student samples. Previously, we showed that sensitivity to hangovers depends
on (estimated) BAC during acute intoxication, with a greater percentage of drinkers reporting
hangovers at higher BAC levels. However, a substantial number of participants also reported
hangovers at comparatively lower BAC levels. This calls the suitability of the 0.11% threshold into
question. Recent research has shown that subjective intoxication, i.e., the level of severity of reported
drunkenness, and not BAC, is the most important determinant of hangover severity. Non-student
samples often have a much lower alcohol intake compared to student samples, and overall BACs
often remain below 0.11%. Despite these lower BACs, many non-student participants report having
a hangover, especially when their subjective intoxication levels are high. This may be the case
when alcohol consumption on the drinking occasion that results in a hangover significantly exceeds
their “normal” drinking level, irrespective of whether they meet the 0.11% threshold in any of these
conditions. Whereas consumers may have relative tolerance to the adverse effects at their “regular”
drinking level, considerably higher alcohol intake—irrespective of the absolute amount—may
consequentially result in a next-day hangover. Taken together, these findings suggest that the 0.11%
threshold value as a criterion for having a hangover should be abandoned.
Keywords: alcohol; hangover; sensitivity; subjective intoxication; blood alcohol concentration
Alcohol hangover is defined as the combination of mental and physical symptoms experienced
the day after a single episode of heavy drinking, starting when blood alcohol concentration (BAC)
approaches zero [1]. The hangover state can comprise a variety of symptoms which differ in presence
and severity among drinkers [2,3]. These symptoms include, but are not limited to, nausea, sleepiness,
concentration problems, and headache. In the 2010 consensus paper of the Alcohol Hangover Research
Group [4], it was stated that in order to experience a hangover per se, a minimum BAC of 0.11% should
be reached. In the current consensus paper, we discuss why the 0.11% threshold value as a criterion for
having a hangover should be abandoned.
BAC varies depending on the combination of the amount of alcohol consumed and drinking
duration. A smaller impact is also evident for other factors such as sex and body weight. For example,
a BAC of 0.11% roughly equates to consuming about 6 US standard drinks (14 g of alcohol each) or
8.4 European standard drinks (10 g of alcohol each) over a period of 2 hours [5]. This threshold was
based on a study by Chapman et al. [6] in which participants experienced hangovers at this BAC level.
At first glance, observing drinking levels of student samples and corresponding average BACs [3,7–9],
the threshold seems well selected. However, a closer look at the data revealed that this threshold could
well be an arbitrary one. Research on large Dutch and Canadian student samples [7,8] revealed that
a substantial number of drinkers who did not reach the consensus BAC level of 0.11% still reported
having a hangover. Other studies also confirmed this observation. For example, the data of van
Schrojenstein Lantman et al. [3] identified that 19.4% of N = 1833 students who had a hangover after
their past month’s heaviest drinking occasion had an estimated BAC below 0.11%. Data from another
16
J. Clin. Med. 2020, 9, 179
survey [9] revealed that 22.5% of N = 989 students had an estimated BAC below 0.11% at their past
month’s heaviest drinking occasion that resulted in a hangover. Aggregating the data of these two
studies [3,9] revealed that 20.5% of N = 2822 students who reported a hangover had an estimated
BAC well below 0.11% the night before (see Figure 1). In each of these studies [3,7–9], BAC was
(retrospectively) estimated using a modified Widmark formula [10] based on self-reported alcohol
consumption, and taking into account sex and body weight.
Figure 1. Percentage of students reporting a hangover at different blood alcohol concentrations.
Aggregated data from N = 2822 students who reported a hangover after their past month’s heaviest
drinking occasion. Data from references [3,9]. Abbreviation: BAC = blood alcohol concentration.
In non-student samples, alcohol consumption levels are often considerably lower. Nevertheless,
these drinkers report having hangovers as well. An illustrative example for this was provided by a
recent study conducted among N = 307 adults in Crete, Greece [11]. Among them, N = 176 reported
having had a hangover. These individuals were on average 39.0 (10.3) years old (59.7% men) and had
consumed a mean (SD) of 3.0 (1.8) alcoholic drinks the previous evening over a drinking period from
17:40 (1.8 h) to 20:13 (1.9 h). Their mean (SD) BAC, estimated via a modified Widmark formula [10],
equaled 0.03% (0.03). While the amount of alcohol consumed was low in comparison to student
samples, it is still likely that they consumed significantly more alcohol than they usually do at home
(i.e., as compared to their usual weekly alcohol intake of 5.9 alcoholic drinks). As a consequence,
they reported a mean (SD) being drunk/ intoxicated score of 4.7 (2.6) rated on a scale ranging from
0 (absent) to 10 (extreme) [12,13]. Their mean (SD) overall hangover severity, rated on an 11-point
scale ranging from 0 (absent) to 10 (extreme) [14], was 4.6 (2.1). In line with other studies [15,16],
both subjective intoxication and estimated BAC correlated significantly with overall hangover severity.
The correlations between hangover severity and past evening’s drinking behavior (see Figure 2)
revealed that subjective intoxication yielded the strongest correlation with overall hangover severity
(Figure 2B), followed by the number of alcoholic drinks consumed (Figure 2A). Although significant,
the correlations between hangover severity and estimated BAC (Figure 2C) and drinking duration
(Figure 2D) were smaller in magnitude. Figure 2C further shows that participants also reported having
hangovers of moderate to high severity at lower BAC levels. In fact, the estimated BAC level of almost
all participants (98.3%) fell below 0.11%.
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Figure 2. Correlations between overall hangover severity and drinking variables. Depicted are the
correlations between overall hangover severity and (A) number of alcoholic drinks consumed the
previous evening, (B) subjective intoxication while drinking, (C) estimated blood alcohol concentration
(eBAC) on the previous evening, and (D) hours of drinking alcohol on the previous evening. Dotted lines
represent Spearman’s rho correlations. Data from Reference [11].
A stepwise regression analysis revealed that four variables accounted for 58% of the variance
in overall hangover severity. When looking at their unique contributions to the variance explained,
the strongest predictor was subjective intoxication (48.5%), followed by sleep quality (7.2%),
estimated BAC (1.2%), and body mass index (BMI; 1.1%). These findings are in line with two
other recent regression analyses [17,18]. Both studies showed that subjective intoxication (perceived
drunkenness), and not BAC, was the strongest predictor of hangover severity.
It is important to have an understanding as to why people experience hangovers at low BAC
levels. An explanation could be found through a closer examination of the participants’ weekly alcohol
consumption. If participants usually consume one or two alcoholic drinks per drinking occasion,
and then consume two or three times as much while on holiday, this “higher than usual” drinking level
may cause a hangover. This could potentially occur even if the absolute number of alcoholic drinks is
still low as compared to some student samples [14]. The increase in the number of consumed alcoholic
drinks, as compared to “regular” drinking occasions, and the corresponding increase in subjective
intoxication, highly correlates with experiencing a hangover the next day. Importantly, this increase
is independent of the absolute BAC levels. In other words, hangovers may occur at any BAC level,
and their occurrence is more likely if individuals drink substantially more alcohol than they usually
do on occasions that do not result in a hangover.
The impact of an increase in alcohol consumption relative to a regular drinking occasion was also
demonstrated in a recent study [19]. This naturalistic study comprised an alcohol test day resulting
in a hangover, and an alcohol-free control day. Various demographic data (e.g., age, sex, height, and
weight) and data on drinking variables (including number of drinks, drinking duration, and the
number of additional drinks they had consumed on the hangover drinking occasion as compared
to a regular non-hangover drinking occasion) were collected in students aged 18 to 30 years. BAC
was estimated using a modified Widmark equation [10]. Overall hangover severity was rated on
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an 11-point scale ranging from 0 (absent) to 10 (extreme) [14]. The number of hangover episodes
that participants had experienced during the past year was also assessed. Dancing frequency during
the drinking occasion was rated as “none”, “sometimes”, “often”, or “almost all the time” and the
number of cigarettes smoked, drug use, and total sleep time were also recorded. The Five-Shot
questionnaire alcohol screening test was used to analyze general drinking behavior [20]. Personality
(i.e., somatization, obsession-compulsion, interpersonal sensitivity, depression, anxiety, hostility,
phobic anxiety, paranoid ideation, and psychoticism) was assessed with the Brief Symptom Inventory
(BSI) [21]. Risk taking was assessed with the RT18 questionnaire [22]. N = 93 participants were
included in this study with a mean (SD) age of 21.0 (2.9) years old, and 41.9% were male. On the
alcohol test day, participants consumed 9.2 (4.6) alcoholic drinks over a time period of 6.3 (2.2) hours.
They reported consuming 6.5 (4.2) more alcoholic drinks than they would normally consume on a
regular non-hangover drinking occasion. Although not assessed in this study, assuming the alcohol
was consumed within a similar time frame on both occasions, the increase in alcohol consumption
likely corresponded to a significant rise in BAC relative to a regular drinking occasion. Mean (SD)
next-day hangover severity was 3.5 (2.5). Although the average estimated BAC was relatively high,
i.e., 0.16% (0.09), about one-third of the hungover participants (30.4%) had had an estimated BAC
below the 0.11% cutoff level. A stepwise linear regression analysis including all the assessed variables
revealed that four variables accounted for 31.7% of the variance in overall hangover severity (See
Table 1). The analysis showed that with regard to the unique contribution to variance explained of
individual variables, the increase in alcohol consumption relative to a regular drinking occasion was
the strongest predictor of hangover severity.
Table 1. Summary of the regression analysis.
Variables Model Contribution
Increase in alcohol consumption relative to a “regular” drinking occasion 17.8% 17.8%
Body mass index (kg/m2) 24.0% 6.2%
Dancing frequency on the drinking occasion 28.5% 4.5%
Number of past year’s hangovers 31.7% 3.2%
Variables were included if they significantly (p < 0.05) contributed to the model. Significant Spearman’s rho
correlations were found between hangover severity and increase in alcohol consumption relative to a regular
drinking occasion (r = 0.435, p < 0.0001), dancing frequency on the drinking occasion (r = 0.288, p = 0.005), and the
number of hangovers in the past year (r = 0.529, p < 0.0001). The correlation between hangover severity and body
mass index did not reach statistical significance (r = −0.144, p = 0.168). Data from Reference [18].
The findings discussed above do not imply that calculating estimated BAC serves no relevant
purpose in future hangover research. Quite the opposite, BAC is a valuable measure that must be
implemented in experimental studies. Calculating the estimated BAC enables researchers to administer
individual amounts of alcohol that have been adjusted for sex and body weight, in order to achieve
comparable BAC levels across study participants who undergo experimentally induced intoxication.
BAC assessment also serves an important purpose during the process of recruitment of participants.
Whenever a certain dose of alcohol is administered in an experimental study, researchers require a
prior estimate of whether a participant will experience a next-day hangover at the designated BAC
level. For this purpose, the estimated BAC can be calculated for a regular drinking occasion that
usually results in a hangover. Preferably, this estimated BAC should be evaluated for more than one
drinking occasion, as a recent analysis of data from an experimental study showed that there is a
subset of approximately 20% of study participants for whom there was a substantial intra-individual
hangover severity difference between the test days, even when the administered amount of alcohol
and achieved BAC where the same [23]. With this prior understanding, the researcher can identify a
group of drinkers who are resistant to developing hangovers at the (estimated) BAC level that will
be achieved in their experimental study, and exclude these individuals. One could also consider
excluding participants who report great intra-individual differences. Alternatively, one could identify
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individuals who are very sensitive to acute alcohol effects, or already develop hangovers at much
lower BAC levels than the designated study BAC. It would be ethically inappropriate to include these
individuals and they should be excluded in order to reduce drop-out rate due to anticipated adverse
events such as vomiting. Finally, future experiments could also use actual BAC measures to avoid recall
bias which may emerge with retrospective recall [24]. Similarly, subjective intoxication ratings could
be measured in real time rather than retrospectively. However, research has shown that subjective
intoxication, either assessed in real time (while drinking) [25] or the next morning (retrospectively,
as in the presented survey data discussed in this paper) both highly correlate with hangover severity.
Research on predictors of hangover severity and possible tolerance to hangovers is relatively new [19],
and future research should explore the spectrum of additional factors, such as genetics, environment,
drinking behaviors, and alcohol metabolism to further understand how variations in BAC (e.g., as a
result of drinking more alcohol than usual) influence the presence and severity of alcohol hangovers.
Taken together, the research reviewed here suggests that the level of subjective intoxication and
the increase in alcohol consumption relative to a regular drinking occasion are stronger predictors
of next-day hangover severity than (estimated) BAC. Furthermore, a substantial number of alcohol
drinkers experience hangovers at BAC levels well below 0.11%. Therefore, we argue that the current
consensus regarding the BAC 0.11% threshold value as a criterion for having a hangover should
be abandoned.
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Abstract: In alcohol hangover research, both naturalistic designs and randomized controlled trials
(RCTs) are successfully employed to study the causes, consequences, and treatments of hangovers.
Although increasingly applied in both social sciences and medical research, the suitability of
naturalistic study designs remains a topic of debate. In both types of study design, screening
participants and conducting assessments on-site (e.g., psychometric tests, questionnaires, and
biomarker assessments) are usually equally rigorous and follow the same standard operating
procedures. However, they differ in the levels of monitoring and restrictions imposed on behaviors of
participants before the assessments are conducted (e.g., drinking behaviors resulting in the next day
hangover). These behaviors are highly controlled in RCTs and uncontrolled in naturalistic studies.
As a result, the largest difference between naturalistic studies and RCTs is their ecological validity,
which is usually significantly lower for RCTs and (related to that) the degree of standardization of
experimental intervention, which is usually significantly higher for RCTs. In this paper, we specifically
discuss the application of naturalistic study designs and RCTs in hangover research. It is debated
whether it is necessary to control certain behaviors that precede the hangover state when the aim of a
study is to examine the effects of the hangover state itself. If the preceding factors and behaviors are
not in the focus of the research question, a naturalistic study design should be preferred whenever
one aims to better mimic or understand real-life situations in experimental/intervention studies.
Furthermore, to improve the level of control in naturalistic studies, mobile technology can be applied
to provide more continuous and objective real-time data, without investigators interfering with
participant behaviors or the lab environment impacting on the subjective state. However, for other
studies, it may be essential that certain behaviors are strictly controlled. It is, for example, vital that
both test days are comparable in terms of consumed alcohol and achieved hangover severity levels
when comparing the efficacy and safety of a hangover treatment with a placebo treatment day. This is
best accomplished with the help of a highly controlled RCT design.
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1. Introduction
The alcohol hangover is defined as a combination of mental and physical symptoms, experienced
the day after a single episode of heavy drinking, starting when the blood alcohol concentration
approaches 0 [1]. Studies in this research area examine the causes, functional consequences, and
potential treatments of the next day (i.e., post-intoxication) effects of alcohol consumption. The alcohol
hangover is associated with cognitive and psychomotor impairment [2] and mood changes [3], and may
negatively affect daily activities, such as driving a car [4,5] or job performance [6]. The World Health
Organization (WHO) estimates that 5.1% of the global burden of disease and injury is attributable
to alcohol use and its consequences [7], and a recent UK study rated the economic costs of having
hangovers in terms of absenteeism and presenteeism at 4 billion GBP per year [8]. Despite this, the
pathology of the alcohol hangover is poorly understood [9,10], and although there is great market
demand [11], there are currently no effective hangover treatments available [12].
Both randomized controlled trials (RCTs) and naturalistic study designs are commonly applied in
hangover research. Although increasingly applied in social sciences and medical research, the suitability
of using naturalistic study designs remains a topic of debate. To examine this, our paper compares
the naturalistic study design with the traditional controlled experimental design, in particular RCTs.
It discusses the advantages and disadvantages of both designs and suggests solutions for issues of concern.
Traditionally, medical science has been based on clinical observations of patients and control
samples. In the fields of psychiatry and psychology, for example, participants either self-report their
mood or an investigator observes their behavior. This was common practice before the introduction of
RCTs. However, since their introduction, the quality, methodology, and reporting of medical science has
been continuously optimized [13], and the RCT is, therefore, currently often viewed as the gold standard
that allows for the most precise and systematic investigations. RCTs are, for example, commonly used
to investigate the efficacy and safety of a medicinal drug in a specific patient population. The RCT
design is characterized by having several inclusions, exclusion, and discontinuation criteria that apply
to participants, including lifestyle rules with regard to, for example, alcohol and drug use and smoking.
RCTs are ideally double or triple blind to avoid influencing the study outcome, and participants are
randomly allocated to treatment conditions. The treatment order is varied (cross-over) to account for
any learning or order effects. All study-related activities are highly standardized and conducted per
protocol, with the aim to have all test days as identical to each other as possible. In theory, the only
methodological difference between the test days is the administered treatment or intervention. This
way, it is thought that the study gathers ‘clean’ data about the effect of the treatment or intervention.
However, this level of control comes at the cost of RCTs creating highly artificial situations, which lack
ecological validity and/or potentially differ from the effects observed in the participants’ everyday life.
On the other hand, the aim of the naturalistic study design is to mimic real-life as closely as
possible, and as such is characterized by a minimum of lifestyle rules for participants, in which the
investigators do not (actively) interfere with their activities. Hence, several behaviors and activities of
the participants are not standardized and not regulated by a study protocol. Participants continue their
normal lives and may visit the testing site for assessments or bio-sample collection or may even be able
to undertake these assessments whilst remaining in their usual environment. Commonly, the only
instruction is to behave normally (e.g., take their medication as prescribed or drink alcohol as they
would on a normal night out), complete scheduled assessments (e.g., a sleep diary or online scales),
and visit the testing site at set times.
The naturalistic design is increasingly utilized in various research areas and has been successfully
applied in phase III studies and pharmacovigilance research, e.g., to investigate the efficacy of
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antipsychotics in schizophrenia patients [14] or breast cancer patients [15]. The following sections will
discuss the commonalities and differences between RCTs and naturalistic study designs, advantages
and disadvantages, and possible solutions to common pitfalls.
2. Recruitment, Screening, and Test Days
Both RCTs and naturalistic studies have highly controlled data collection on test days. This includes
conducting standardized and validated tests according to good clinical practice (GCP) and utilizing
standard operating procedures at pre-set times specified in the study protocol. Furthermore, both
study designs can have various lifestyle rules (e.g., no alcohol or drug use, no smoking), which can be
verified by objective assessments on the test day. In this respect, naturalistic studies do usually not
differ from RCTs.
Recruitment, screening, selecting, and training of participants can also be equally rigorous in
RCTs and naturalistic studies. Both study designs can apply the same inclusion and exclusion criteria.
Objective assessments can be conducted to verify the criteria (e.g., blood chemistry, urinalysis, and
electrocardiography), and participants can be familiarized with and trained in completing psychometric
tests, treatment administration, and completing mood scales. The main reason that rigorous screening
and selection of study participants in RCTs is common is that it ensures a more homogenous study
sample. It is expected that there will be more variability between study participants in responsiveness
to the administered treatments when the eligibility criteria are loosened. Loosening eligibility criteria
may then decrease the chances of successfully demonstrating efficacy or safety. To demonstrate the true
drug effect, assessments should not be obscured by various external uncontrolled factors. Unfortunately,
applying a large number of eligibility criteria usually results in a considerable number of screening
failures (i.e., participants not meeting all criteria for participation) or drop-outs and compliance failures
(i.e., participants discontinuing or failing to adhere to the study protocol). This is commonly seen in
RCTs [16–18]. In addition, a number of people may not participate in the first place when they are
informed about the strict lifestyle rules and the hassle of screening procedures (e.g., blood drawings and
medical examinations). Unfortunately, this may induce a (self-)selection bias in the study sample.
The extent to which RCT participants in drug development are representative for the patient
population can therefore be questioned [17,18]. While some ‘safety-related’ eligibility criteria are
obviously necessary, other eligibility criteria (e.g., cut off values for body weight ranges) are often
not strongly justified by supporting scientific evidence [16]. Not applying or loosening unjustified
eligibility criteria will increase recruitment speed and result in a study sample that better reflects the entire
patient population. Some recent RCTs have, therefore, included a ‘real life’ arm in their study, including
participants who did not meet the stringent eligibility criteria of the RCT [19]. As naturalistic studies aim
to mimic real life, eligibility criteria are often less strict than those applied in RCTs. This may significantly
increase the ecological validity of the study, which is usually low in RCTs [14].
3. Level of Control, Supervision, and Monitoring
All RCT study-related activities are closely monitored at the testing site (e.g., clinic or lab).
However, this is not always the case in naturalistic study designs, in which researchers are not
necessarily present.
One issue is not reporting behavior. As participation in research studies is typically confidential,
and sometimes anonymous, there should be no objective reason for participants not to report certain
behaviors. However, if these behaviors are restricted by discontinuation criteria, participants may
decide not to report them in order to prevent themselves from being excluded from further study
participation. Another reason could be social desirability, as participants may be less likely to report
behaviors or incidents that they either perceived to be detrimental to their self-image or that they fear
may result in negative judgement from others. Another issue may be misreporting. Participants may
not report certain behaviors simply because they were not asked about them (e.g., a researcher refrains
from questioning participants about drug use, because an inclusion criterion to participate in the study
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was not using drugs), or they view these behaviors as irrelevant to the study (e.g., a participant being
unaware that drinking a cup of coffee can improve subsequent cognitive test performance). Fortunately,
there are several ways to retrospectively and objectively verify the occurrence of study-relevant
behaviors, including assessments for residual alcohol use (breathalyzer), drug use (urine tests), and
recent smoking (exhaled carbon monoxide), or monitor activity and sleep episodes (actigraphy).
In both naturalistic studies and RCTs, it is also increasingly common to implement ambulatory
assessments in the study design, for example cognitive tests or questionnaires completed online/at
home. The advantage of not having to schedule visits to the testing site makes it easier to participate
in the study and thus reduces chances of dropouts. It also allows for repeated testing at fixed time
intervals, which may help to reduce the risk of study-relevant events not being recalled correctly.
At home, testing has been successfully implemented in numerous phase III studies, using the same tests
that would have been conducted in the clinic (e.g., online cognitive tests, blood pressure assessment,
or self-administered blood glucose tests). In short, the use of mobile technologies enable compliance
monitoring. Furthermore, mobile technology, home testing, and the internet provide various ways
to ensure valid and reliable real-time assessments of cognitive and physical functioning, mood, and
biomarkers [20–23].
However, in naturalistic studies, assessments are often limited to retrospective and subjective
self-reports. When relying entirely on self-reports, recall bias and memory loss may have a significant
impact on the accuracy of the collected data. For example, research has shown that people under- or
over-estimate the amount of alcohol consumed [22,23] and that subjective and objective assessment of
sleep parameters are not always in concordance with each other [23]. The latter should be taken into
account when interpreting the data obtained in naturalistic studies.
To prevent the presence of observers/researchers from influencing the behaviors of study
participants, one could consider monitoring the subject’s behaviors in real time via video streaming,
without the awareness of study participants that they are being filmed. However, this approach would
raise ethical, privacy, and data security concerns. A better alternative to this would be to apply mobile
technology to objectively measure behaviors, including parallel objective measures to help triangulate
data obtained from other measures.
Activity, sleep, and physiological parameters, such as heartrate and body temperature, can,
for example, all be measured in real time using activity watches or ‘wearables’. Behavioral and
mood data can be collected by real-time self-reports via smartphone apps (e.g., entering every drink
they consumed). Alternatively, wearable technology (watches) that may record transdermal alcohol
concentrations are currently being developed. In the future, these devices could be used to complement
or partly replace self-reports. Moreover, they could help to reduce drop-out rates as a number
of “passive” measurements could be conducted without requiring any effort from the participants.
Importantly, this would also help to obtain a more complete picture in studies that investigate aversive
effects, such as a hangover, which might lead to systematic drop-outs on the more severe end of
the symptom scale. Taken together, mobile technology would not only reduce the strain on study
participants, but potentially also make the measurements more objective. In addition, test batteries
used in RCTs are often administered as single assessments or, at best infrequently. These can therefore
easily miss critical events or periods. Mobile data collection can include participant actioned recording
of events and more regular testing, or continuous psychophysiological assessments, including wearable
devices, which can all provide a better picture of participant behavior and subjective state.
As part of mobile testing, conducting an online survey is another common way to collect data
from participants. This is effective if the subject sample is large or if it is not necessary or possible for
participants to visit the research facility (e.g., due to obstacles, such as bad weather, large distances,
or physiological constraints). While online methodologies are an easy way to collect data, there are
several disadvantages. For example, the researcher cannot be certain whether the scheduled participant
is completing the survey or whether someone else is doing it in their place. Furthermore, the condition
of the participant cannot be verified by the researcher (e.g., they might be drunk or drugged while
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completing the survey or may not be giving the assessment their full attention), which may reduce
the accuracy and validity of the resulting data. Further enhancing this methodology can increase
reliability of the collected data, for example by video streaming. Video streaming can confirm if
the scheduled participant is actually present and can verify how the participant conducts a test or
completes questionnaires. It further enables the researcher to observe the general health and makes it
possible to record real-time observer-rated adverse effects.
4. Level of Standardization of Tests and Procedures
While the scrutiny of recruitment, screening, and test day assessments can have comparable levels
of control and standardization in RCTs and naturalistic studies, the designs differ significantly with
regard to the standardization and activities of participants during the intervention phase. In RCTs,
every activity of the participant takes place in the testing facility. Activities are scheduled at pre-set
times and conducted according to standard procedures. This includes treatment administration,
meals, activities, time going to bed, or the environment where participants spend time (i.e., the
testing site). Moreover, all assessments and activities are standardized and precisely monitored and
recorded by the researchers. The rationale to conduct an RCT in this way is clear: By minimizing the
non-intervention-related variability (i.e., the uncontrolled “noise”) in all potentially study-relevant
parameters, the chance of observing a true treatment effect increases.
In contrast, in naturalistic studies, participants continue with their usual activities and researchers
do not observe them or provide instructions on how to behave. Thus, the researchers do not interfere
with the participants’ activities. Consequently, behaviors are unstandardized and self-initiated.
The rationale for this approach is to closely mimic real life, i.e., to maximize ecological validity.
This ecological validity is important because it best reflects the way in which phenomena, such as
hangovers, emerge, and medicinal treatments will be actually used when marketed. Additionally,
eligibility criteria in naturalistic studies may be less strict compared to those of RCTs to ensure the
study sample better reflects the heterogeneous population who will use a treatment or intervention
in clinical practice and provide a better picture of efficacy. Thus, rather than a limitation, the lack of
standardization can be considered to be a benefit of the naturalistic study design.
A related discussion is the use of subjective versus objective assessments and the quest for the
inclusion of biomarker assessments in a study. Cytokine concentrations, for example, can vary in
cases of depression [24] or during the hangover state [25]. It can thus be interesting to assess cytokine
changes in blood or saliva. The alcohol hangover state is a subjective experience which, up till now,
cannot be objectively measured. Although this can be viewed as a significant limitation of this research
area, it should be underlined that biomarkers are per definition (at best) proxy-measures if one aims to
measure mood or how the participant feels. Clinical observations may be an alternative, but these
usually do not substitute for subjective assessments of the severity or nature of mood states. To date,
the best way to rate mood levels is by asking participants to report how they feel [26]. Interestingly,
in this regard, the outcome of these subjective assessments is not always in correspondence with the
outcome of objective biomarker assessments. Participants can, for example, report feeling perfectly
fine while having a clinically relevant increase in blood pressure. Alternatively, participants can report
sleep complaints and poor sleep quality while their polysomnographic outcomes are within normal
ranges. Together, these findings advocate to include both subjective and objective assessments in
future studies, irrespective of whether the study design is RCT or naturalistic.
5. Implications for Hangover Research
To provoke the hangover state, an evening of supervised alcohol consumption is typically
scheduled in RCTs. The amount and type of alcoholic drink (and placebo) and the pace of drinking are
usually pre-defined, and drinking is conducted within a pre-set time frame. This is typically conducted
in a clinical setting, often accompanied by other participants who do not know each other. Food and
other beverage intake (e.g., water) are prohibited or controlled, as are the cognitive and physical
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activities of the participants. All activities are closely monitored and recorded by the researchers,
including blood alcohol concentration (BAC) assessments to verify alcohol consumption levels and
adverse event recording. The evening activities are often concluded by a night of supervised sleep in
the clinic, with a pre-set bed-time and wake-up time. Sleep quality and duration can be monitored
with polysomnography or study personnel.
In contrast, in naturalistic studies, participants drink in a familiar setting (e.g., a bar or at home)
with people they know, engaging in their usual activities. These normally differ from activities
employed in RCTs (e.g., dancing in a club versus reading a magazine in the laboratory). In naturalistic
studies, participants can eat food when they feel hungry and smoke and are exposed to external stimuli
which are not replicated in the RCT setting (e.g., visiting multiple bars, walking outside in the rain,
waiting for a bus to travel home). They can go to bed when feeling sleepy without being restricted by
study procedures, which often dictate a much earlier time-to-bed than people have in real life after an
evening out. As they sleep in their own beds, they will not experience the sleep problems that are
common in RCTs, in which participants sleep in a new and unknown clinical environment (e.g., the
first night effect) [27,28]. In addition, participants can apply their personal sleep habits, sleep hygiene
activities, and wake-up rituals in naturalistic studies. Finally, socializing, expectancies, and motives
for alcohol consumption most likely differ between real-life situations and RCTs and may impact
assessment outcomes. Thus, in naturalistic studies, participants can either drink alone or have an
evening with friends in a setting of their own choice. Bedtime is self-initiated, and participants sleep at
home in their own bed. The next morning, participants come to the testing site for the assessments
on the test day. Past evening behaviors are recorded retrospectively (e.g., via questionnaires or an
interview), and in case of mobile technology use, objective data read-outs are obtained from the devices.
Whether or not it is important to monitor the drinking session depends entirely on the aim of
individual research projects. For some studies, it may be essential that certain behaviors are strictly
controlled. For example, when comparing the efficacy and safety of a hangover treatment with a
placebo treatment, it is vital that both test days are comparable, in terms of consumed alcohol and
achieved hangover severity levels. In this case, a strictly controlled RCT design would be favorable.
If one chooses to use a naturalistic study design in efficacy studies, a statistical analysis should account
for differences between the test days (e.g., in the form of co-variates or propensity scores). However,
it is not always possible to accurately account for all variables. This could, for example, be because
they depend on subjective self-reports (e.g., alcohol intake), because certain information is lacking
(e.g., congener content of drinks), or because a certain factor has not (yet) been recognized as relevant
(e.g., a certain genotype or developmental factors). In summary, several important factors that differ
between test days (e.g., certain behaviors) that may bias the comparison between treatment and placebo
will likely remain unknown or unrecognized and, therefore, not properly accounted for.
On the other hand, if one is primarily interested in the effects of the (subjective) alcohol hangover
itself on cognitive performance, mood, or other variables, then the behaviors that provoked the
hangover state are of limited importance. In this case, there is no clear need to monitor the amount and
type of alcohol consumed, estimated peak BAC, and the setting and behaviors during the drinking
session. In extremis, participants could then be recruited in the morning after an evening out and
allocated to a hangover or control group, or groups that consumed alcohol or not. This would be
the ultimate way of not interfering with participant drinking behavior, as participants were unaware
that they were going to participate in a research study at the time they displayed the study-relevant
behavior (e.g., drinking or staying sober). This design was successfully applied by Devenney et al. [29],
who recruited participants at university venues in the morning, i.e., on the day following the drinking
session. However, if one is interested in how drinking variables and behaviors during the drinking
session cause or relate to hangover variables, it is essential that these are accurately measured. Statistical
analysis can then take into account the observed interindividual differences in naturalistic studies.
There are obvious advantages of applying a naturalistic study design in alcohol hangover research,
as the drinking session reflects what people do in normal life. In contrast to RCTs, they are not forced
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to adapt to a drinking regime, including consuming alcoholic beverages that are not their regular
choice during a pre-set drinking time period that may differ from a normal night out. In fact, research
consistently shows that in real life situations, most people consume much larger quantities of alcohol
over a longer period of time, as compared to the pre-set dosages of alcohol that are administered in
clinical studies to provoke a hangover. This results in significantly higher (and more realistic) BAC
levels in naturalistic studies, as compared to many RCTs [30].
Assessments during the hangover state can then take place in the clinic, following a highly
standardized and controlled protocol, similar to RCTs. Alternatively, Scholey et al. [31] utilized online
cognitive testing in a naturalistic hangover study and demonstrated that this was an effective way
to collect objective data in real time during the hangover state. This study also addressed the issue
of participant drop out. It has been argued that participants who experience severe events may not
continue participation in naturalistic studies. This would of course bias the study outcome in favor of
a treatment. Scholey et al. [31] compared their study participants with their dropouts. For both groups,
peak BAC was assessed in real time the evening before the (hangover) test day, and no significant BAC
difference was observed between participants who did and did not complete the test day assessments.
Hence, there are presumably other reasons than mere degree of intoxication that determine whether
participants discontinue study participation or not. A different approach has been the use of mobile
technology, including screen-based tests, to enable participants to be assessed within the privacy and safety
of their own homes, without the need to travel to the test center when hungover, avoiding dropouts [32].
Finally, studies comprising alcohol administration to humans usually require ethics approval.
For many ethics committees, it appears that a noteworthy difference is made based on whether the
alcohol is actually administered to participants by the experimenters (RCTs) or whether they administer
it themselves in an unsupervised setting (naturalistic studies). Ethics committees often limit the
amount of alcohol researchers are allowed to administer to participants of RCTs to a blood alcohol
concentration (BAC) below 0.12%, while in study protocols for naturalistic studies it is unknown how
much alcohol participants will consume. Naturalistic studies consistently demonstrate that actual
drinking levels are associated with much higher BACs. For example, Hogewoning et al. [30] reported
an estimated BAC of 0.2%. When interviewing naturalistic study participants, they attest that they had
a ‘normal’ night out, including their usual drinking behavior. This is an odd situation considering
that, in RCTs, alcohol consumption is closely monitored with a physician and study personnel present,
while participants can drink alcohol freely and unsupervised in naturalistic studies. Monitoring the
level of alcohol consumed will also aid in evaluating hangover treatments. True symptom levels may
not be assessed in the laboratory due to alcohol dosing restrictions, where effectively only ‘sub-clinical’
hangover symptom levels are evaluated.
Of note, viewpoints and safety concerns of ethics committee members are not always in
agreement with those of study participants. For example, Petrie et al. [33] investigated the stress and
pressure/imposition experienced by RCT participants for a variety of study-related handlings (e.g.,
blood pressure assessment, blood drawing) and compared their ratings to those of ethics committee
members. The study revealed that several commonly applied procedures, such as taking a saliva
sample or completing a questionnaire or mood scale, were rated as significantly less stressful by RCT
participants compared to the ratings anticipated by ethics board members.
Petrie et al. [33] also compared the experienced stress levels in RCT procedures with those
experienced in daily life and found that many relatively harmless experiences (e.g., stress when ‘asked
to donate to a charity in the street’ or being ‘caught in the rain’) were rated as more stressful by study
participants than completing a mood scale or delivering a saliva or urine sample. The overall conclusion
of the study was that study-related stress and the impact of procedures in the standardized data collection
may be overestimated by some ethics committees. Unfortunately, the restrictions that ethics committees
feel inclined to impose upon proposed research projects (especially RCTs) can have a significant impact
on the ecological validity of these studies and the consequential validity of the findings.
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6. Concluding Remarks
The commonalities and differences between RCT designs and naturalistic studies are summarized
in Table 1.
Table 1. Commonalities and differences between randomized controlled trial (RCT) and naturalistic
study designs.
Study Design RCT Naturalistic Study Design
Ecological validity Low to medium High
External validity Low to medium High
Internal validity High Low to medium
Criterion validity High High
Construct validity High High
Screening Controlled, per protocol Controlled, per protocol
Inclusion, exclusion criteria Yes Yes
Familiarize with procedures and tests Yes Yes
Drinking session Per protocol, supervised Uncontrolled, not supervised
Instructions Per protocol None, or minimal
Amount, type of drink Pre-set, standardized Self-initiated
Start and stop time of drinking Pre-set, per protocol Self-initiated
Behaviors during drinking Restricted, per protocol Free (as normal)
Drinking environment Research unit Free (e.g., bar(s), at home)
Social aspects of drinking (if not alone) With strangers With friends or strangers
Real time assessments (e.g., BAC) Yes Possible via mobile technology
Food and water intake Restricted, per protocol Free (as normal)
Smoking Restricted, per protocol Free (as normal)
Sleep Controlled and supervised Uncontrolled, not supervised
Time to bed, wake up time Restricted, per protocol Self-initiated
Sleep hygiene and related behaviors Restricted, per protocol Self-initiated
Monitoring, real time assessments Yes Possible via mobile technology
Sleep environment Sleep unit At home or elsewhere
Test days Controlled and standardized Controlled and standardized
Psychometric tests, mood assessments Standardized and validated Standardized and validated
Time of testing Per protocol at pre-set time Per protocol at pre-set time
Conductance of study procedures Per protocol Per protocol
Supervision, monitoring Yes Yes
Description of validity types: Ecological validity = to what extend the study reflects a realistic hangover drinking
occasion; external validity = to what extent can findings be generalized to the population as a whole; internal
validity = to what extent can the design demonstrate causal effects; criterion validity = to what extent are measures
related to study outcomes; construct validity = the degree to which the administered tests measure what they claim
or purport to be measuring. Abbreviation: Blood alcohol concentration (BAC). Please note that this table is intended
to contrast the RCT and naturalistic study design. Some studies might incorporate features of both designs (e.g.,
supervised and standardized alcohol administration, but unsupervised sleep at home). Additionally, studies with
the same design type may differ significantly in the levels of control, standardization, and quality.
RCT designs are preferred for studies that require strictly-controlled study procedures. Treatment
efficacy and safety studies, for example, require controlled treatment administration and the variability
in participants’ behaviors (e.g., alcohol intake, physical activity, food intake, and sleep) should be
kept to a minimum. However, RCTs, per definition, modify and structure participant behaviors
in a standardized and, therefore, often “unnatural” way. Therefore, a naturalistic study design is
preferred if one aims to better understand or mimic real-life interventions. The lack of standardization
of naturalistic studies should, therefore, be considered as a benefit of the study design.
Additionally, free drinking in naturalistic studies often exceeds the intoxication limits deemed safe
and ethically approved for RCT studies, which further increases the ecological validity of naturalistic
hangover studies compared to RCT hangover studies. To improve the level of control in naturalistic
studies, mobile technology can be used to assess objective real-time data and control the quality of
assessment, without investigators interfering with participant behaviors.
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Abstract: The aim of this study was to critically evaluate and compare the different methods to assess
overall hangover severity. Currently, there are three multi-item hangover scales that are commonly
used for this purpose. All of them comprise a number of hangover symptoms for which an average
score is calculated. These scales were compared to a single, 1-item scale assessing overall hangover
severity. The results showed that the hangover symptom scales significantly underestimate (subjective)
hangover severity, as assessed with a 1-item overall hangover severity scale. A possible reason for this
could be that overall hangover severity varies, depending on the frequency of occurrence of individual
symptoms included in the respective scale. In contrast, it can be assumed that, when completing
a 1-item overall hangover scale, the rating includes all possible hangover symptoms and their impact
on cognitive and physical functioning and mood, thus better reflecting the actually experienced
hangover severity. On the other hand, solely relying on hangover symptom scales may yield false
positives in subjects who report not having a hangover. When the average symptom score is greater
than zero, this may lead to non-hungover subjects being categorized as having a hangover, as many
of the somatic and psychological hangover symptoms may also be experienced without consuming
alcohol (e.g., having a headache). Taken together, the current analyses suggest that a 1-item overall
hangover score is superior to hangover symptom scales in accurately assessing overall hangover
severity. We therefore recommend using a 1-item overall hangover rating as primary endpoint in
future hangover studies that aim to assess overall hangover severity.
Keywords: alcohol; hangover; symptoms; severity; measurement; scale; single item assessment
1. Introduction
The alcohol hangover is defined as the combination of negative mental and physical symptoms
which may be experienced the day after a single episode of alcohol consumption, starting when blood
alcohol concentration (BAC) approaches zero [1,2]. Alcohol hangovers are typically characterized
by a combination of symptoms affecting subjective mood, cognition and physical functioning [3–6].
These symptoms have been shown to negatively impact daily activities such as job performance [7]
and driving [8–10]. The annual economic costs of alcohol hangover in terms of absenteeism and
presenteeism have been estimated to be 173 billion USD for the USA [11] and 4 billion GBP for the
UK [12]. Since the foundation of the Alcohol Hangover Research Group in 2010, the amount of research
on the causes, consequences, treatment, and prevention of hangovers has been growing rapidly.
Accurate measurement tools are essential to assess hangover severity, for example in experimental
J. Clin. Med. 2020, 9, 786; doi:10.3390/jcm9030786 www.mdpi.com/journal/jcm33
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and naturalistic studies, in intervention studies examining treatment efficacy, and in survey research.
Generally, they may be filled in by any drinker of all (adult) ages and in any drinking-related (research)
context. There is, however, ongoing debate about which measure of hangover severity is most suitable.
In this paper, we compare the three most widely used hangover symptom scales with a 1-item overall
hangover severity rating, and discusses why the latter is a more reliable and useful measure to be
included in future hangover research.
2. Characteristics of an Effective Patient-Reported Outcome Measure (PROM)
Currently, there are no biomarkers that accurately and objectively assess hangover severity.
Therefore, one has to rely on Patient-Reported Outcome Measures (PROMs). A PRO instrument is often
a questionnaire/scale or single item that is directly answered by the patient, capturing the patient’s
experience without interpretation of the patient’s response by a clinician or anyone else [13]. To the
ensure the validity of a PRO, it is fundamental that it reliably measures the concept it is intended to
measure (i.e., hangover). In the case of a multi-item scale, it is furthermore important that all of the
individual items adequately contribute to the final conceptual framework of the instrument [13]. Any
given scale can only be considered to have sufficient validity as a measuring tool when these conditions
are fulfilled. The complex nature of alcohol hangover severity, which includes multidomain facets
associated with the presence and severity of variable symptoms, and their impact on cognitive and
physical functioning and mood, makes it quite challenging to develop multi-item scales that accurately
assess the concept of hangover severity. Nevertheless, there are currently three hangover symptom
scales available for this purpose, and they are commonly used in hangover research [14–16].
Slutske et al. [14] developed the Hangover Symptoms Scale (HSS) to assess the frequency with
which drinkers experienced hangover symptoms in the last year. The scale consists of 13 items including
“felt extremely thirsty or dehydrated”, “felt more tired than usual”, “experienced a headache”, “felt
very nauseous”, “vomited”, “felt very weak”, “had difficulty concentrating”, “more sensitive to light
and sound than usual”, “sweated more than usual”, “had a lot of trouble sleeping”, “was anxious”,
“felt depressed”, and “experienced trembling or shaking”. Items can be scored either dichotomously
(experienced the symptom, or not), or on a 5-point scale from “never”, “2 times or less” (once or twice
per year), “3–11 times” (more than once or twice, but less than once per week), “12–51 times” (more
than once a month, but not every week), and “52 times or more” (once per week or more frequently).
It is important to underline that the original HSS outcome is a frequency measure. The scale has,
however, been modified and used to assess hangover severity, for example by using the same items
but changing the item scoring into a symptom rating ranging from 0 (absent) to 10 (extreme) [3].
Rohsenow et al. [15] developed the Acute Hangover Scale (AHS) to assess hangover severity. The
scale consists of nine items including “hangover”, “thirsty”, “tired”, “headache”, “dizziness/faintness”,
“loss of appetite”, “stomachache”, “nausea”, and “heart racing”, which are rated on a scale ranging
from 0 to 7. The anchors of the scale are “none” (score of 0), “mild” (score of 1), “moderate” (score of
4), and “incapacitating” (score of 7). Overall hangover severity is computed by calculating the average
score across the AHS nine items.
The third scale, developed by Penning et al. [16], is the Alcohol Hangover Severity Scale
(AHSS). It consists of 12 items, including “fatigue (being tired)”, “clumsiness”, “dizziness”, “apathy”,
“sweating”, “shivering”, “confusion”, “stomach pain”, “nausea”, “concentration problems”, “heart
pounding”, and “thirst”. Symptom severity for each item can be rated on a scale ranging from 0 (absent)
to 10 (extreme). Overall hangover severity is the average score across the 12 items.
The three hangover symptom scales each present with some shortcomings, and their limitations
are discussed in detail elsewhere [16]. For example, scales do not always include true hangover
symptoms (e.g., the HSS includes the item “trouble sleeping”, which is experienced before the start of
the hangover state). The AHS includes the item “hangover”, but it is usually not advised to include
an item that is identical to the overall concept that one aims to measure with a multi-item scale. Finally,
the AHSS does not include the item headache, even though this is a frequently reported hangover
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symptom. Notwithstanding these limitations, the three hangover symptom scales are currently the
most frequently used scales to assess hangover severity. Other researchers such as Hogewoning
et al. [17] have been using an extended symptom listing, including all symptoms of the three hangover
symptom scales.
Alternatively, overall hangover severity may be assessed with a single item rated on a scale
ranging from absent (0) to extreme (10). This 1-item score is hypothesized to encompass all symptoms
experienced by the drinker, including their relative impact on daily activities and mood.
3. Comparing Overall Hangover Severity Outcomes of the Different Assessment Methods
When using multi-item instruments, it is important that all items are relevant to the concept
under investigation (i.e., alcohol hangover). If irrelevant items were included (e.g., symptoms that
are seldomly reported), this would result in an overall hangover severity score that would be biased
towards zero, and would therefore tend to underestimate, or even not show, the effects of treatment in
intervention studies. In extreme cases, this might even lead to the wrong conclusion that a treatment is
ineffective [13].
Penning et al. [3] examined the scientific literature and identified 47 hangover symptoms. However,
the AHSS, HSS and AHS each comprise a different selection of these symptoms. This selection of
symptoms may have a significant, and potentially biasing effect on the aggregate rating of overall
hangover severity. The discrepancy between aggregate symptom scores and 1-item overall hangover
severity assessments has been demonstrated previously by Penning et al. [16]. In that study, 947 subjects
(Mean (SD) age of 21.1 (2.3) years old, 46 % men) rated the presence and severity of 23 hangover
symptoms on a scale ranging from 0 (absent) to 10 (extreme). In addition, overall hangover severity
was assessed. Further evaluation of the data showed that mean (SD) scores on a modified HSS and the
AHSS were 3.6 (1.4) and 3.7 (1.7), respectively. Of note, the mean (SD) severity score on the 1-item
hangover scale, i.e., 5.7 (2.2), was significantly higher (p < 0.0001) than both the modified HSS and the
AHSS hangover score. These observations suggest that hangover severity scores based on aggregate
symptom scores significantly underestimate the true hangover severity assessed with a single overall
severity item.
There are three important reasons why aggregate symptom scores may deviate from the true
hangover effect. These are related to (1) the relative presence and severity of hangover symptoms,
(2) the impact of the experienced symptoms on cognitive functioning, physical activities, and mood,
and (3) the fact that several assessed symptoms are also experienced without having a hangover,
or even without consuming alcohol at all. These issues are discussed further in the next sections.
4. Presence and Severity of Hangover Symptoms
The occurrence and severity may differ significantly between symptoms experienced in the
hangover state. This is illustrated by evaluating the data by Van Schrojenstein Lantman et al. [4],
which is depicted in Figure 1. This study surveyed n = 1837 social drinkers who reported overall
hangover severity and the presence and severity of individual hangover symptoms experienced in
their last hangover in the past month, and rated this on a scale ranging from 0 (absent) to 10 (extreme).
On this occasion, they reported consuming a mean (SD) of 12.6 (5.5) alcoholic drinks, corresponding
to an estimated peak BAC of 0.19 (0.1) %. Figure 1 shows that both the frequency of occurrence and
severity differed considerably between individual hangover symptoms. Most individual symptom
scores are lower than the 1-item overall hangover severity score, suggesting that a symptom average
score will underestimate overall hangover severity. As the three hangover scales comprise different
hangover symptoms, it is understandable that the aggregate symptom scores of these scales differ from
each other. Several symptoms, such as depression and anxiety (both low frequency/low severity), have
a limited contribution to the aggregate scale score, whereas other symptoms, such as concentration
problems and being tired (both high frequency/high severity symptoms), have a large contribution to
the aggregate score. Including low frequency/low severity symptoms or excluding high frequency/high
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severity symptoms results in an underestimation of the “true” overall hangover severity. It is evident
from Figure 1 that the HSS, especially, contains several low frequency/low presence items. Therefore,
HSS scores likely underestimate the true hangover severity to a greater extent than the AHS and AHSS.
Figure 1. Presence and severity of symptoms included in hangover symptom scales. Data from n = 1837
social drinkers who reported on their latest past month hangover [4]. Note: “sensitivity to sound” was
not assessed. Abbreviations: HSS =Hangover Symptoms Scale, AHSS = Alcohol Hangover Severity
Scale, AHS = Acute Hangover Scale.
A similar variability in the presence and severity of hangover symptoms was recently reported by
Van Lawick van Pabst et al. [18]. Omitting relevant items from a scale can have a significant impact on
the overall rating of hangover severity. An example from the dataset of Van Schrojenstein Lantman
is the item “sleepiness”, which is not included in any of the three hangover scales. Sleepiness was
reported by 97.1% of participants and its severity was rated as 6.5 out of 10 (extreme). It can be
assumed that when completing a single item overall hangover severity item, the subject’s rating is
influenced by all symptoms and feelings the subject experiences during the hangover state. Therefore,
aggregate scale scores of a limited number of symptoms are very likely to underestimate the true
overall hangover severity.
5. Negative Impact of Hangover Symptoms
When judging overall hangover severity, it is likely that drinkers will take into account to what
extent all experienced individual hangover symptoms negatively affect their cognitive functioning,
physical activities, and mood. Symptoms with the largest negative impact on these domains are not
necessarily those symptoms that have the highest severity scores. There is also no relationship between
the impact symptoms may have and the relative frequency of occurrence in the overall drinking
population. For example, heart racing can be a very disturbing effect and have a significant impact
on mood. However, the symptom is not frequently reported. Alternatively, severity scores and the
presence of ratings of being thirsty are usually high, while effects on cognitive functioning, physical
activities, and mood are virtually absent.
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Van Schrojenstein Lantman et al. [4] also examined the impact of experiencing hangover symptoms
on cognitive and physical functioning, and mood in n = 1837 social drinkers who reported on their last
hangover experience in the past month. Negative impact of hangover symptoms on cognitive and
physical functioning, and mood was rated on scales ranging from 0 (absent) to 5 (extreme). The results
are summarized in Figure 2.
Figure 2. Impact of hangover symptoms on cognitive and physical functioning and mood. Negative
impact of hangover symptoms cognitive functioning (A), physical functioning (B), and mood (C) was
rated on scales ranging from 0 (absent) to 5 (extreme). Note: “sensitivity to sound” was not assessed
and “trouble sleeping” was excluded as not being a true hangover symptom. Data from reference [4].
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It is evident from Figure 2, that there are clear differences regarding the extent that hangover
symptoms have an impact on cognition, physical activities, and mood. Therefore, the specific items
that are included in a hangover symptom scale determine to what degree the true overall hangover
effect is accurately reflected in an aggregate score (especially if no item weights are used during the
formation of the composite score). As the hangover symptom scales do not include all imaginable
hangover symptoms, while at the same time providing items that may not apply to a given participant,
they will likely underestimate the “true” overall impact of hangover symptoms on cognition, physical
activities, and mood. This can again be illustrated by considering the hangover symptom “sleepiness”.
Although not included in any of the three hangover symptom scales, Van Schrojenstein Lantman
et al. [4] found that sleepiness was reported by 97.1% of drinkers. The mean (SD) impact scores for
sleepiness were 2.7 (1.7) for cognitive functioning, 2.5 (1.7) for physical functioning, and 2.4 (1.6) for
mood. If this symptom was incorporated in a scale, it would very likely have influenced the aggregate
impact score.
6. Symptoms May also be Present without a Hangover or Alcohol Consumption
Hangover symptoms are also experienced when no alcohol is consumed. As a result, aggregate
symptom scores may be greater than zero, even when no alcohol has been consumed. A recent study [19]
compared hangover symptoms between subjects with and without a hangover and demonstrated that
several symptoms are not unique to the hangover state but are also present without having a hangover
or consuming alcohol. In this study, n = 299 subjects who were on holiday in Greece (mean (SD) age of
38.9 (11.0) years old) completed the AHS in the morning before walking the Samaria Gorge. n = 47
subjects consumed alcohol the evening before but reported having no hangover, n = 176 consumed
alcohol and reported a hangover, and n = 76 consumed no alcohol and reported no hangover. Reported
hangover symptoms from the three groups are depicted in Figure 3.
Figure 3. Presence and severity of symptoms related to alcohol hangover. Note: In contrast to the
original AHS, scores range from 0 (absent) to 10 (extreme). Data from reference [19].
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First of all, these data again demonstrate that the mean (SD) AHS score of 2.9 (1.3) significantly
underestimated the true hangover severity of 4.6 (2.1) among subjects with a hangover (p < 0.0001).
Statistical comparisons of the individual hangover symptom scores between subjects who consumed
no alcohol, those who consumed alcohol but reported no hangover, and drinkers with a hangover
revealed that no significant differences between the groups were found for nausea and loss of appetite.
Severity scores for headache did not significantly differ between drinkers with and without a hangover.
The data in Figure 3 suggest that most symptoms that are attributed to the hangover state are always
present, irrespective of alcohol consumption or having a hangover. It can be assumed that, when
rating overall hangover severity via a 1-item scale, drinkers take into account that some symptoms
may already be present on non-drinking days as well. For example, they may usually feel somewhat
tired (although perhaps to a lesser extent than during the hangover state). This knowledge is then
incorporated in their rating of hangover severity, which is more likely to reflect the difference/changes
in symptom severity relative to a normal non-drinking day. Although the latter cannot be proven with
the data at hand, we deem it to be a plausible hypothesis. Yet, hangover scales aggregate symptom
scores without taking baseline symptom scores into account. As a result, a positive AHS hangover
severity score can be obtained in subjects who reported to have no hangover after drinking alcohol (0.9)
as well as in subjects who did not consume alcohol at all (1.0). In fact, their 1-item overall hangover
severity score was zero. When relying solely on AHS scores, it would incorrectly be assumed that
these subjects had a hangover. In this study, 95% of subjects who report no hangover via the 1-item
overall hangover severity rating had an AHS score greater than zero and would be incorrectly labelled
as having a hangover. When including these subjects in the dataset for statistical analysis, their AHS
scores are, however, higher than those assessed with a 1-item severity score (i.e., zero), meaning that
the AHS score overestimates the true overall hangover severity, producing false positives. When taken
together, the findings that the severity of a true hangover tends to be underestimated (due the fact
that not all of the items usually apply), while severity tends to be overestimated in the absence of
a hangover, it seems that composite scores might be worse than 1-item overall ratings in differentiating
between individuals with severe versus light hangover symptoms, by producing a tendency towards
the middle. While it could theoretically be possible to try to identify false positives by the ratio of
single-scale scores to overall ratings (even though this currently still remains to be tested), it would
likely be impractical in most cases to have participants fill in an entire questionnaire, when a single-item
overall hangover rating already provides the required information to a good, if not even better, degree.
7. Day to Day Variability in the Presence and Severity of Hangover Symptoms
Van Wijk et al. [20] examined hangover severity of n = 22 students who were on a skiing holiday
in Italy. The students experienced multiple hangovers during this period. Each morning at breakfast,
subjects completed a modified AHS. The AHS included all nine symptoms, including a 1-item overall
hangover severity score, but the severity scoring of items was modified to a range from 0 (absent) to
10 (extreme) In addition, past evening alcohol consumption was recorded and the level of subjective
intoxication (i.e., drunkenness) was rated on a scale from 0 (absent) to 10 (extreme). For n = 13 subjects,
it was possible to match two test days with identical hangover scores, as assessed with a 1-item overall
hangover severity score. Several important observations were made when evaluating the data: First of
all, the 1-item overall hangover severity score was different between subjects, but identical on the two
test days (see Figure 4A). However, the AHS scores of the two test days showed considerable variability
for some of the subjects (see Figure 4B), as the severity scores of individual hangover symptoms
contributing to the aggregate AHS score differed between the two test days (see Figure 4C–J). In other
words, despite having identical 1-item overall hangover severity scores, subjects reported considerable
variability in individual symptom scores and overall AHS scores on the two test days. Finally, the data
showed that having an identical 1-item overall hangover severity score does not necessarily imply that
the same amount of alcohol was consumed, or that the corresponding level of reported intoxication was
similar on the evening preceding the test day. Instead, subjects consumed different amounts of alcohol
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on both test days (see Figure 4K) and reported different levels of subjective intoxication (see Figure 4L).
Notwithstanding this, their 1-item overall hangover severity scores on each test day were identical.
Figure 4. Level of subjective intoxication and alcohol consumption and corresponding next day
hangover symptom severity reported on two different test days by the same subjects. Individual subject
ratings for 1-item overall hangover severity (A), the AHS score (B), individual symptom scores (C–J),
the amount of alcohol consumed the evening before having the hangover (K), and the corresponding
level of subjective intoxication (L) are shown.
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Figure 5 shows the test–retest reliability of the AHS and its items. While the test–retest reliability
of the 1-item overall hangover severity score was 1.0 (maximal, as test days had been selected to
fulfil this criterion), the AHS test–retest reliability (0.69) was below the generally acceptable level of
test–retest reliability of 0.7 [21]. The variability in individual hangover severity scores was greatest
for headache, thirst and nausea, and none of the symptoms reached the acceptable limit of 0.7 for
test–retest reliability, except for dizziness. Applying the more stringent Bland-Altman 95% limits of
agreement method [22]—in which 95% of difference scores of day 1 and day 2 item or scale ratings
should lie within the range of two standard deviations of the mean difference score to demonstrate
agreement between the two assessments—revealed that no agreement was found for the symptoms of
headache, heart racing, and loss of appetite.
Figure 5. Test–retest reliability. Spearman’s correlations are shown. Higher scores suggest a better
test–retest reliability. Bootstrapping (n = 10.000 samples, bias corrected 95% confidence interval)
was applied to adjust correlations for the small sample size. An acceptable test–retest reliability is
demonstrated if Spearman’s correlation > 0.7 [21].
An alternative way to look at the data is to select test days on which subjects consumed an identical
amount of alcohol and then compare the presence and severity of AHS symptom scores. For n = 18
subjects, it was possible to match two test days with an identical amount of alcohol consumption. They
consumed a mean (SD) of 11.6 (5.7) alcoholic drinks on these test days (range: 2 to 20 alcoholic drinks).
Their AHS scores and individual symptom scores are summarized in Table 1 and Figure 6. Despite the
fact that subjects consumed the same amount of alcohol on both test days, the data show considerable
variability within subjects in both the presence and severity ratings on individual hangover symptoms,
including the 1-item hangover severity score.
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1 20 3.78 2.67 7 6
2 17 1.00 1.33 3 2
3 20 1.89 1.78 3 4
4 12 2.33 1.56 4 0
5 10 2.33 4.11 3 5
6 20 1.44 1.89 2 4
7 2 0.78 0.78 0 0
8 5 0.89 0.33 0 0
9 6 1.00 1.11 0 0
10 10 0.56 0.56 0 0
11 20 1.44 1.00 1 1
12 10 1.00 0.67 2 1
13 10 0.78 0.56 1 0
14 10 1.89 0.56 3 0
15 8 0.56 0.22 0 0
16 14 3.11 0.78 4 0
17 6 1.11 1.00 1 0
18 8 0.56 0.33 0 0
Figure 6. AHS and symptom severity scores for two days on which an equal amount of alcohol was
consumed within subjects. Significant differences (p < 0.05) between the two days are indicated by
an asterisk (*). Abbreviation: AHS = acute hangover scale.
Test-retest reliability for the AHS (r = 0.731, p = 0.001) was acceptable. With regard to individual
symptoms, an acceptable test–retest reliability was, however, only found for the symptom of being tired
(r = 0.775, p < 0.0001). No acceptable test–retest reliability was found for the ratings of overall hangover
(r = 0.537, p = 0.022), and stomach pain (r = 0.569, p = 0.014). A poor test–retest reliability was found
for being thirsty (r = 0.365, p = 0.136), dizziness (r = 0.351, p = 0.153), heart racing (r = 0.240, p = 0.337),
headache (r = 0.186, p = 0.460), and nausea (r = 0.090, p = 0.723). The low test–retest reliabilities
again confirm the fact that the presence and severity of hangover symptoms considerably varies
between drinking occasions. In line with this, a recent study showed that there is great intraindividual
variability in hangover severity scores between drinking occasions, even when the same amount of
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alcohol is consumed [23], and regression analyses demonstrated that the amount of consumed alcohol
is usually not a strong predictor of hangover severity [24].
Table 1 further shows that the AHS scores on day 1 and day 2 are greater than zero for each subject.
This could suggest that all of them experienced a hangover on both days. However, the 1-item overall
hangover severity score demonstrated this to be incorrect, as six out of 18 subjects (33.3%) did not
report having a hangover on day 1, and eleven subjects (61.1%) reported having no hangover on day
2. Taken together, relying solely on hangover symptom scales to assess the presence and severity of
alcohol hangover will likely result in inaccurate results.
8. Should We Abandon the Use of Hangover Symptom Scales?
The fact that the outcomes of composite hangover scales do not appear to accurately reflect overall
hangover severity does not imply that we should abandon their use altogether. In many cases, it is
very relevant to assess the presence and severity of individual hangover symptoms. For example,
if a company claims that treatment X is effective in reducing hangover headaches, it is highly relevant
to assess “headache” severity, in addition to an assessment of overall hangover severity. As is evident
from Section 2, there is a great variability in the presence and severity of individual hangover symptoms.
It is also important to identify those symptoms that are most bothersome and impairing to subjects.
For future research, it is therefore recommended to also assess individual hangover symptoms. This
can be done by using one of the existing hangover scales, or simply by assessing individual symptoms
of interest via symptom-specific 1-item severity scores. However, the judgement of the overall efficacy
of a hangover treatment should preferably be based on a 1-item overall hangover severity rating,
as this most likely incorporates all experienced symptoms and circumstances of the hangover state.
As discussed in Section 5, symptoms experienced during hangover may also be experienced on
non-hangover days. Therefore, is advisable to use difference scores for these individual symptoms
when comparing their severity on a hangover day versus a no-hangover day to capture the “true”
hangover effect. The latter does not apply for intervention studies, where a direct comparison of
symptom scores between treatment and placebo should be made to evaluate a possible difference
between the two hangover conditions.
Finally, it should be acknowledged that subjective ratings have sometimes been argued to
be unreliable per se, thus mandating the assessment of biomarkers in order to have an objective
assessment of hangover severity. Indeed, it would be very useful if such a biomarker would be
discovered. Biomarkers related to alcohol metabolism and immune function may be promising
candidates, but several lines of research have unfortunately not yet been able identified a suitable
biomarker. Biomarkers can be assessed in various samples, including blood, saliva, hair, sweat,
and stool, but, for practical use, volatiles in expired air would be ideal. However, the traditional
breathalyzer readings reflecting ethanol concentrations are not useful, as BAC readings are often zero
in the hangover state [25]. Alas, chemical compounds other than ethanol, which should ideally relate
to hangover severity and/or functional impairments, would need to be detected by a breathalyzer in
order to reliably indicate alcohol hangover. Notwithstanding this, the alcohol hangover is a complex
state with many symptoms that may be experienced alone or in combination and may have differential
severity and impact on daytime functioning. Given the currently available knowledge on the potential
underlying mechanisms, it is still unclear whether a complex concept such as alcohol hangover can be
accurately represented by a single biomarker. Further research investigating the suitability of potential
volatile biomarkers in order to develop a breathalyzer for the hangover state is currently in progress.
9. Conclusions
Hangover symptoms can vary in their presence and severity between different drinking events
in the same individual, and not all symptoms have equal impact in terms of impairment or being
bothersome, regardless of their severity. Therefore, researchers should not rely solely on hangover
symptom scales to assess overall hangover severity. Based on our reasoning, it is evident that composite,
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multi-item hangover symptom scales will likely underestimate severe hangovers and, at the same time,
overestimate light hangovers, thus partly masking the true hangover effect. The resulting reduction
in variance could hamper the ability to assess changes across study appointments or interventions
and may thus have serious implications for the interpretation of study outcomes. Furthermore,
the use of hangover symptom scales may also contribute to false positives, i.e., misidentifying subjects
without a hangover as supposedly suffering from one. We propose that the most important, clinically
meaningful endpoint for rating hangovers and the prevention or mitigation of hangovers by an effective
product is the 1-item overall hangover severity score. This measurement allows the subject to assess
the effect the condition is having on him or her, taking into account the symptoms being experienced,
the severity of the symptoms being experienced and, most importantly, how the condition is impacting
them in their activities of daily living and interactions with others, regardless of what the individual
symptoms comprising his or her condition may be at the moment. The single greatest strength of the
1-item global assessment as a primary outcome measure is that it incorporates the subjects’ evaluation
of the impact the specific subset of symptoms being experienced at that time, in place of and with
greater subject-focused information value than the specific symptom-based sum score can provide.
Thus, this single-score approach evaluates the entire constellation of the hangover state, regardless of
the individual components contributing to it, in terms of presence, severity, and impact.
Thus, the 1-item overall hangover severity rating represents a self-reported outcome instrument
capable of measuring the severity of a condition (i.e., hangover) or the effect of a treatment in
concordance with and incorporating all three concepts of an effective Patient-Reported Outcome
Measure, namely, assessing the presence of symptoms, their effects on function, and their severity [13].
In addition, as secondary outcome measures (of efficacy), individual symptom presence and severity
(or their impact) can be assessed using either hangover symptom scales, or individually. This will
identify which individual symptoms are described by subjects as being the most bothersome during
the alcohol hangover state.
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Abstract: Hangover resistance may be linked to an increased risk of continuing harmful drinking
behaviours as well as involvement in potentially dangerous daily activities such as driving while
hungover, mainly due to the absence of negative consequences (i.e., hangover symptoms) the
day after alcohol consumption. The aim of this study was to examine the occurrence of claimed
alcohol hangover resistance relative to estimated blood alcohol concentration (eBAC). A total of
1198 participants completed an online survey by answering questions regarding their demographics,
alcohol consumption and occurrence of hangover. Two methods were used to calculate eBAC,
one based on the modified Widmark Equation (N = 955) and the other from an equation averaging
the total body water (TBW) estimates of Forrest, Watson, Seidl, Widmark and Ulrich (males only)
(N = 942). The percentage of participants who claimed to be hangover resistant decreased rapidly
with increasing eBAC and only a small number of hangover resistant drinkers remained at higher
eBACs. Comparisons of the eBACs calculated by the two methods revealed significantly higher
BACs when using the modified Widmark equation. These findings suggest that additional research
for eBAC calculations is needed to improve accuracy and comprehensiveness of these equations for
future alcohol hangover research.
Keywords: hangover; alcohol; BAC; hangover resistance
1. Introduction
Alcohol hangovers are often the result of a night of heavy drinking and are a familiar phenomenon
worldwide. The alcohol hangover refers to the combination of negative mental and physical symptoms,
which can be experienced after a single episode of alcohol consumption, starting when blood
alcohol concentration (BAC) approaches zero [1]. Historical definitions suggested that a blood alcohol
concentration level equivalent to 0.11% was required to experience a next day hangover, with a greater
percentage of drinkers reporting hangovers at higher BAC levels [2]. However, recent research shows
that a considerable number of participants also reported hangover occurrence at moderately lower BAC
levels [3]. The most reported hangover symptoms typically include fatigue [4,5], thirst [5], drowsiness [5],
headache [5,6], dry mouth [5], nausea [7], reduced alertness [5], weakness [5], and concentration
problems [5,8,9]. Other symptoms include vomiting, regret, heart racing, and apathy [5,10].
A hangover can result in impairment in both cognitive and psychomotor functioning [11].
This potential impairment can have repercussions when it comes to daily activities, such as driving a
car, studying, or working [12]. A hangover can result in reduced productivity as individuals may be
more likely to call in sick for work or study, or work at a reduced level of productivity. Employees with
J. Clin. Med. 2020, 9, 2823; doi:10.3390/jcm9092823 www.mdpi.com/journal/jcm47
J. Clin. Med. 2020, 9, 2823
an alcohol hangover reported having significantly more conflicts with supervisors and co-workers,
feeling miserable, or falling asleep on the job [13,14]. According to a large survey in The Netherlands,
University students are less productive, and half of the students reported not being able to study while
hungover. On average, students experience a hangover 2.7 days per month, which adds up to a total
study loss of one month per year [15].
Because of the substantial impact of alcohol hangovers on health, economy, and society, it is
important to determine the causes of alcohol hangover as well as factors that contribute to symptom
severity. Recent research showed that hangover-resistant drinkers may be at increased risk of continuing
harmful drinking behaviours as well as involvement in potentially dangerous daily activities, such as
driving, mainly because of absence of negative consequences (i.e., severe hangover symptoms) the day
after drinking [16,17]. Lower perceptions of hangover severity (thus experiencing less severe hangover
symptoms) are associated with stronger beliefs that it is safe to drive the morning after drinking [18].
Despite the belief that one is safe to drive, research showed significant impairment in driving abilities
while experiencing a hangover [19].
Identifying how hangover-resistant drinkers differ from non-hangover resistant drinkers may
help to unfold the pathology of alcohol hangovers. Thus far, several theories exist as to why hangovers
occur and what factors might influence severity, but this phenomenon remains largely unclear [20].
Previous research showed that the presence and severity of alcohol hangovers can differ between and
within drinkers since the alcohol hangover is influenced by several other factors other than the amount
of alcohol consumed. These factors include, but are not limited to, gender, age, personality, genetics,
and health-related behaviours such as smoking, illicit drug use, sleep quality and duration as well as
the type of drink consumed [21].
Quantity of alcohol consumed directly impacts the severity of hangovers and associated
impairments [22]. As such, it is essential that studies assessing the effects of hangover collect and report
data describing alcohol intake. Objective measures of alcohol concentration—such as those collected
in blood, breath, saliva, and urine samples—can be obtained relatively easily in laboratory studies.
However, when using a naturalistic design this is seldom accessible, as typically the researchers are
not present during the drinking session. The naturalistic design in alcohol hangover research describes
a methodology where participants consume alcohol on a typical night out and attend the laboratory
for testing the following morning. The results are then compared to a non-hangover visit. Participants
are questioned regarding their alcohol consumption from the night before, after which estimated blood
alcohol concentration (eBAC) is calculated. While forgoing some of the experimental control inherent
in laboratory testing, the naturalistic design allows an environment of less interference and free alcohol
consumption compared to the typically smaller doses of alcohol approved for controlled studies [23].
Naturalistic studies are likely the most optimum to study hangovers, but it is also necessary to
control several intervening factors that complicate the comparison of results among hangover studies.
For example, in naturalistic designs, it is difficult to determine when BAC returns to 0. As alcohol
hangover commonly utilizes naturalistic designs to ensure ecological validity, it is imperative that
methodology to assess (naturalistic) hangovers adapts and develops according to existing information
about hangovers [24]. Of relevance to the current study is the fact that the data needed to reconstruct
BAC typically involves the number of alcoholic drinks consumed, duration of alcohol consumption,
along with morphometric and demographic information such as gender, age, height, and weight [25].
The most widely used eBAC calculation was developed by Widmark [26,27]. This equation is
dependent on the amount of alcohol consumed, the relative body water (set value for males (0.68) and
females (0.55)), body mass (weight in kg), degradation rate in g/l (0.15), duration of alcohol consumption,
and a set value for absorption time of 0.5 h. Please see Appendix A for additional information.
This equation has been modified as research has shown that the original Widmark formula had a
tendency to overestimate BAC [25]. Specifically, the modified formula optimised the calculation of
total amount of body water and included height and age [28]. The updated equations are found to be
reasonably accurate for eBACs under controlled laboratory environments [28–30] and are frequently
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used in present alcohol hangover research to estimate BACs [3,31–33]. Please refer to Appendix B for
additional information.
However, the use of eBAC has limitations when applied to real world drinking experiences. It is
likely to introduce more variability of BAC and the accuracy of eBAC equations in naturalistic settings
is relatively unknown [25]. Additionally, when reliant on self-report data from intoxicated participants,
or retrospectively when remembering intoxication, accuracy of eBAC could be compromised due to
poor recall [34]. Furthermore, eBAC calculations based on self-report data are less accurate when
estimating higher BACs [35]. Therefore, it is important to compare eBAC calculations to examine
whether different calculations are consistent or whether they may differentially affect results.
Approximately 20–25% of alcohol consumers are classed as ‘hangover resistant’, in that they report
no hangover symptoms after a night of heavy drinking [36]. Previous research shows that hangover
resistance is tightly coupled to eBAC levels [37,38]. Clearly, the number of hangover resistance claims
is highly dependent on the amount of alcohol consumed; as the more drinks are consumed (and the
higher the eBAC), the less likely drinkers are to claim hangover resistance. For example, with an eBAC
level above 0.20%, only 8.1% of alcohol consumers claim hangover resistance [37].
Another factor that needs to be considered when investigating hangover resistance is the definition
that is being used. A Canadian study used two definitions to describe hangover resistance. The first
definition stated ‘Never having had a hangover during one’s lifetime’ and the second definition stated
‘Never having had a hangover during a certain time period (e.g., 1, 3, 5 years)’ [39]. A recent study
showed that lifetime hangover resistance amongst heavier drinkers (eBAC 80 mg/dL, heaviest drinking
occasion of the past month) occurs in 5–6% of participants [38]. Among people who claim hangover
resistance, the symptoms reported by this group of heavy drinkers were limited to sleepiness and
tiredness which were rated as less severe than the same items in the hangover sensitive group [40].
Even though hangover resistance seems to be rare and decreases with eBAC, a small number of people
persist in claiming hangover resistance.
Due to the frequent use of eBAC in alcohol hangover research, it is vital to explore accuracy,
comprehensiveness, and possible improvements for currently used formulas. This study aimed to
assess whether the previously discussed calculations differ and explores the use of an additional and
more comprehensive eBAC evaluation when assessing hangover resistance to explore similarities and
differences in eBAC outcomes within an Australian population when compared with a previously
used calculation in international research. This additional and more comprehensive method calculates
eBAC by averaging the total body water (TBW) estimates of Forrest [41], Watson [28], Seidl [42],
Widmark [26], and Ulrich [43] (males only) calculations. The mean TBW was then used in the following
eBAC formula
BAC = (G/(TBW) − β × t (1)
where G is the amount of alcohol consumed in grams; β is the metabolic rate in grams per hour; and t
is time in hours [44].
In line with previous research, it was predicted that around 50% of the participants would have
relatively low eBACs (e.g., <0.08%) [37]. It was further predicted that higher eBACs will lead to a
decrease of hangover resistance claims. Despite the decrease of hangover resistance prevalence with
higher eBACs, we hypothesised that a small number of hangover resistance would persist. Additionally,
the primary aim of the study was to evaluate, for the first time, the use of a more comprehensive eBAC
methodology in the context of hangover resistance, and in particular to examine whether it produced
different values to previous research.
2. Experimental Section
2.1. Method
The study was approved by the Swinburne University Human Research Ethics Committee
(Reference 2012/045) and was conducted in accordance with the Declaration of Helsinki.
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2.2. Design
This was an online survey assessing alcohol consumption behaviours and hangover resistance
occurrence amongst an Australian population with the use of a commonly used method to calculate
eBAC as well as an additional and more comprehensive calculation for eBAC.
2.3. Participants
Overall, 1748 respondents opened the online anonymous questionnaire. Data provided by
non-drinkers were removed from the dataset. In total, 1198 participants completed the online survey
(N = 444 male and N = 754 female), mostly consisting of students (65.3%). The mean age of the
participants was 23.10 years old (SD = 4.68, range = 18–40 years old).
2.4. Measures
2.4.1. Demographics
Participants answered questions regarding demographics (gender, age, weight, height), use of
medications, tobacco, and illicit drugs.
2.4.2. Alcohol Consumption Questions
Participants were questioned on their alcohol intake (e.g., in the past 30 days and the past 12 months).
Alcohol consumption was defined using standardized Australian alcohol units (one standard drink =
10 g of pure alcohol). The consumption questions assessed frequency and quantity of alcohol consumed
across various timescales (i.e., one occasion, 30 days, and 12 months) for each type of drink (beer, wine,
spirits, and alcohol mixed with energy drink). Specifically, participants were asked the number of
standard drinks and the number of hours that they had spent drinking.
2.4.3. Estimated BAC (eBAC)
Responses to alcohol consumption questions regarding the heaviest drinking session within the
previous 30 days were used to calculate eBAC with two different methods. Both methods computed
the eBAC separately for males and females. Method 1 is the most frequently used method in previous
research and is a modified Widmark equation [26]. The modified Widmark equation considers the
number of alcoholic drinks, relative body water volume, weight, gender, and time needed to clear
alcohol through metabolism [27], please see Appendix B for additional information [26]. Method
2 calculates eBAC by averaging the total body water (TBW) estimates of Forrest [41], Watson [28]
Seidl [42], Widmark [26], and Ulrich [43] (males only) calculations. The mean TBW was then used in
the following eBAC formula (1) in Section 1.
2.4.4. Single Item Hangover Sensitivity/Resistance
Two groups were created, depending on the answer to the question: “I have had a hangover
(headache, sick stomach) the morning after I had been drinking” over the past year. If the answer
was ‘yes’, the participant was assigned to the hangover sensitive group. If the answer was ‘no’,
the participant was assigned to the hangover resistant group.
2.5. Procedure
Participants were recruited via word of mouth, flyers, and advertisements on social media.
Participation was voluntary and anonymous. Participants provided informed consent by agreeing
to the survey terms online, after which they completed the online questionnaire. On completion of
the survey, participants could choose to go into the draw to win one of two iPads by entering their
email address.
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2.6. Statistical Analysis
Data were collected online using SurveyMonkey and analysed using the Statistical Package for
the Social Sciences version 25 (SPSS Inc., Chicago, IL, USA). Initially, the data were screened for any
participants who did not meet the criteria, i.e., surveys completed between 2:00 a.m. and 7:00 a.m.,
and surveys submitted from the same IP address. Finally, any participant who answered ‘no’ to
the final question, whether they had honestly and correctly answered all questions, were excluded.
The mean, standard deviation and frequency distributions were calculated for the hangover sensitive
group and the hangover resistant group. Comparisons between the two methods to calculate eBAC
were made using nonparametric tests, since the eBAC data were skewed. Pearson’s Chi square test
was used to measure associations between the different eBAC levels of the two methods and hangover
resistance. Effects were regarded as statistically significant if p < 0.05.
3. Results
Two methods were used to calculate eBAC. First, the most commonly used method in previous
alcohol hangover research was used and described, Method 1 [26,27]. Second, a more comprehensive
method based on TBW was calculated (Method 2). Since results differed slightly depending on the
eBAC method used, data are described separately.
Participants aged 36 years and older were excluded, since this question was assessed in a
multiple-choice format and the exact age was needed in the eBAC calculation. This resulted in
the removal of 100 participants, leaving 1098 participants. Participants with an estimated eBAC
of 0.00% were excluded in both methods used because this suggests either no or extremely low
alcohol consumption. Participants with an estimated eBAC of 0.40% and higher were also excluded in
both methods, as this is an unreliably high estimation which suggests overestimation of the alcohol
consumption and thus eBAC. This resulted in 20.3% of participant exclusion in Method 1 (leaving
955/1198) and 21.4% in Method 2 (leaving 942/1198). A general description of the typical drinking
pattern is provided in Table 1.
Table 1. Participant morphometrics, demographics, and drinking characteristics. Numbers are means
with standard deviations in parentheses. * p < 0.05 between hangover resistant and hangover sensitive
group of participants.
Full Sample Hangover Resistant Hangover Sensitive
Age 23.10(4.7) 22.95(5.1) 23.14(4.6)
Height (m) 1.71(0.1) 1.69(0.1) * 1.71(0.1) *
Weight (kg) 70.57(15.6) 69.93(17.7) 70.77(15.0)
Standard drinks per occasion 5.25(3.9) 3.40(2.6) * 5.83(4.1) *
Days used alcohol (30 days) 6.97(6.7) 4.93(6.1) * 7.60(6.8) *
Days drunk (30 days) 2.43(3.5) 0.95(2.4) * 2.90(3.6) *
Days binge (30 days) 3.22(4.3) 1.50(3.5) * 3.76(4.4) *
Greatest number of drinks (30 days) 7.87(6.1) 4.72(4.8) * 8.85(6.1) *
Consumption duration (hours) 5.16(3.5) 3.68(3.0) * 5.62(3.5) *
Alcohol consumed (grams) 78.67(61.1) 47.23(48.1) * 88.54(61.4) *
eBAC (Method 1) (N = 955)








Of N = 955 remaining participants, 196 (20.5%) reported no hangover the day after drinking while
759 (79.5%) reported experiencing a hangover.
Consistent with previous research [37], participants were divided into seven groups, based on
eBAC, to examine the occurrence of reported hangover resistance the day after drinking (Table 2).
These eBAC values include those corresponding to the two most common internationally recognized
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legal driving limits (i.e., 0.05% and 0.08%) and the highest eBAC value (i.e., 0.20% and higher) as
described in previous research [37].
Table 2. Percentage of participants who report no hangover symptoms following alcohol consumption







Group 1 0 ≤ BAC < 0.02% 48.0 (36/75) 36.1 (53/147) 2.95 0.09
Group 2 0.02% ≤ BAC < 0.05% 37.1 (62/167) 29.1 (53/182) 2.53 0.11
Group 3 0.05% ≤ BAC < 0.08% 22.6 (33/146) 21.9 (30/137) 0.02 0.89
Group 4 0.08% ≤ BAC < 0.11% 17.9 (22/123) 10.8 (13/120) 2.45 0.12
Group 5 0.11 ≤ BAC < 0.20% 8.0 (22/275) 8.9 (22/246) 0.15 0.70
Group 6 0.20 ≤ BAC < 0.30% 11.5 (15/131) 15.7 (14/89) 0.85 0.36
Group 7 0.30 ≤ BAC < 0.40% 16.2 (6/37) 9.5 (2/21) 0.50 0.48
Note. This table also shows results of a chi-square test of independence to investigate associations between the two
methods and hangover resistance.
The data show that 39.9 of drinkers fell within an eBAC below 0.08%. When considering only
the subset of drinkers with eBACs above 0.08% the proportion of this subset who claimed hangover
resistance was 11.5% (65/567). When the smaller subset of drinkers with eBACs above 0.20% was
considered, the prevalence of hangover resistance was 12.5% (21/168), respectively.
3.2. Method 2
Of N = 942 remaining participants, 19.9% reported no hangover symptoms the day after drinking
(N = 187) and 755 (80.1%) reported experiencing hangover symptoms. The participants were divided
into seven groups to examine the occurrence of hangover resistance the day after drinking within
different eBAC ranges, which are shown in Table 2. This is consistent with previous research [37] to be
able to compare our findings. These eBAC values correspond to the two most common internationally
recognized legal driving limits (i.e., 0.05% and 0.08%) and the highest eBAC value (i.e., 0.20% and
higher) [37]. The frequency distributions for hangover resistant drinkers across the eBAC continuum
of Method 2 are also shown in Figure 1.
 
Figure 1. Prevalence of hangover resistance after alcohol consumption at different eBAC levels for
Method 1 [26] and Method 2 [44]. p < 0.05 with Chi Square test of independence.
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The data shows that 49.4% of drinkers fell within an eBAC below 0.08%. When considering only
the subset of drinkers with eBACs above 0.08% the proportion of this subset who claimed no next day
adverse effects after drinking was 10.7% (51/476). When the smaller subset of drinkers with eBACs
above 0.20% was considered, the prevalence of no adverse effects the day after drinking was 14.5%
(16/110), respectively.
3.3. Comparison of Two Methods
eBAC data was skewed for both eBAC methods, since most people are distributed along the lower
eBAC ranges. Therefore, a Wilcoxon signed-rank test, which evaluated the difference between medians
for eBAC Method 1 and eBAC Method 2 was conducted. The results indicated that eBAC levels of
Method 1 were statistically significantly higher than eBAC levels of Method 2, z = −11.07, p < 0.001.
A chi-square test of independence showed that there were no significant differences in reported
hangover resistance in the two eBAC methods and across the 7 BAC groups [45]. Results of the
chi-square test can be found in Table 2.
4. Discussion
The current study assessed the occurrence of hangover resistance amongst an Australian population
and compared two eBAC equations. Several of our hypotheses were supported. Both eBAC methods
showed that almost half of the drinkers were distributed at eBAC levels below 0.08% (Method 1: 39.9%
and Method 2: 49.4%), which supports the findings of previous research [37,38]. Previous research
found that only a small percentage of 8.1% of participants who did not have a hangover in the past
year were distributed at an eBAC level of 0.20% and higher [37]. A Canadian study found an even
lower level of 4–5% of hangover resistance at an eBAC level of 0.20% and higher [38].
The present study confirms that the percentage of people who claim to be hangover resistant
decreases with increasing eBACs, independent of eBAC method. However, contrary to previous
research, a slight increase of hangover resistance claims occurred above 0.20% in the present study
for both eBAC methods. This is likely a chance fluctuation due to smaller numbers of participants
claiming hangover resistance at higher eBACs [36,37,40].
When comparing the two methods to calculate eBAC, several similarities were found.
Both methods were able to show a decrease in hangover resistance prevalence with higher eBACs.
Both methods showed that between 22–25% of the drinkers reported no hangover, however almost
half of these drinkers were distributed at eBAC levels below 0.08%, which is a threshold to determine
impaired driving in several countries [37].
The differences between the two methods are found in the mean eBACs, with a significantly
higher mean eBAC for Method 1 than for Method 2. Interestingly, hangover resistance prevalence
in several eBAC increments was observed to be slightly, but not significantly, lower with the use of
Method 2. An explanation for this could possibly be found in the notion that previous research found
that Method 1 (based on a modified Widmark formula) [26,27] might lead to an overestimation of
eBAC when used in naturalistic settings with the help of self-report measures [29].
Differences found between the two eBAC methods used in this study suggest that additional
research exploring the accuracy and comprehensiveness of eBAC equations is needed for future
(naturalistic) hangover research. As illustrated earlier, previous alcohol hangover research most
commonly uses the modified Widmark calculations for BAC [3,31–33]. Previous research suggests
that higher levels of BAC (0.11%) were needed to develop a next day hangover. However, a recent
study suggests that hangover prevalence and severity occur at lower BACs [3]. This may mean that
previous alcohol hangover research overestimated BACs and that hangover occurrence and severity
occur at lower BACs. Interestingly, a significant difference was found between the hangover resistant
and hangover sensitive group on all questions related to alcohol consumption with numerically higher
means in the hangover sensitive group. This suggests that even though hangover occurs at lower
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BACs [3], BAC is a relevant indicator for hangover occurrence. Based on this study only, there appear
to be no clinically relevant differences between the two methods of eBAC calculation.
Limitations of this study include relying on self-reported alcohol intake and eBAC calculations
to estimate BAC obtained during the drinking episode. Heavy drinking often results in memory
impairment, which may lead to less accuracy and recall-bias [46]. This limitation is often observed in
(semi) naturalistic hangover research. However, it can be argued that the naturalistic design of this
study relates to a representative alcohol consumption in real life situations.
Objective measures of ethanol assessments are absent in this study, which could pose the question
whether the calculations for both BAC methods are accurate. It is unclear whether similar results would
be found in controlled settings based on these study findings. However, the main purpose of this
study was to assess whether the two methods to calculate eBAC differ rather than assess the accuracy
of the two methods. An objective measure of ethanol assessment, such as blood and saliva, should
be utilized for future research purposes. A controlled setting would allow equal quantity of alcohol
consumption in both groups of drinkers. This ensures valid comparison of hangover-resistant and
non-hangover-resistant drinkers in a controlled setting, which could then be translated to naturalistic
designs. Including measures on hangover frequency and severity in future research will enhance our
understanding of differences between hangover-resistant and non-hangover resistant drinkers.
5. Conclusions
The findings presented here show that almost half of drinkers had an eBAC below 0.08%,
irrespective of applying Method 1 or Method 2 to calculate estimated BAC. The present results support
previous findings and show that the percentage of people who claim to be hangover resistant decreases
rapidly with increasing eBACs. However, a small number of hangover resistant drinkers persists,
independently of higher eBACs. Differences between the two eBAC methods are found in the mean
eBACs, with a significantly higher mean eBAC for Method 1. Future research should assess influences
of eBAC on hangover resistance prevalence with the use of an objective and more extensive assessment
of hangover (severity) and should further explore research on eBAC calculations to improve their
accuracy and comprehensiveness for future research. Notwithstanding the absence of significant
findings, this study highlights the importance of continuing assessment of the methodology used to
assess hangovers to increase knowledge of alcohol hangover resistance and pathology.
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Appendix A
BAC = A/(r*G) − B* (t − 0.5),
For males rw = Total Body Water = 2.447 − 0.09515(y) + 0.1074(h) + 0.3362(W)
For females rw = Total Body Water = −2.097 + 0.1069(h) + 0.04666(W)
BAC = blood alcohol concentration in g/l, A = number of standard drinks consumed in grams,
r = relative amount of body water (l/kg), G =weight of subject in kg, B = degradation rate in g/l of 0.15,
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t = elapsed time during alcohol consumption in hours, r = a set value for males (0.68) and females
(0.55), the absorption time is 0.5 h.
Appendix B
BAC = A/(W*rw) − (β60*t),
For males rw = Total Body Water = 2.447 − 0.09515(y) + 0.1074(h) + 0.3362(W)
For females rw = Total Body Water = −2.097 + 0.1069(h) + 0.04666(W)
BAC= blood alcohol concentration in g/dL, c= number of standard drinks consumed GC = gender
constant (9.0 for females and 7.5 for males), w = weight in pounds, β60 = the metabolism rate of
alcohol per hour (e.g., 0.017 g/dL), t = time in hours since the first sip of alcohol to the time of
assessment, A = total volume (in mL) of drinks consumed multiplied by the percent of alcohol of the
drink multiplied by the density of alcohol (0.79 g/mL) divided by 10, W = weight of participant in kg,
H = height in meters, y = the age of the participant in years, h = height measured in cm.
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Abstract: The limited number of available studies that examined the pathology of alcohol hangover
focused on biomarkers of alcohol metabolism, oxidative stress and the inflammatory response to
alcohol as potentially important determinants of hangover severity. The available literature on
alcohol metabolism and oxidative stress is reviewed in this article. The current body of evidence
suggests a direct relationship between blood ethanol concentration and hangover severity, whereas this
association is not significant for acetaldehyde. The rate of alcohol metabolism seems to be an important
determinant of hangover severity. That is, fast elimination of ethanol is associated with experiencing
less severe hangovers. An explanation for this observation may be the fact that ethanol—in contrast
to acetaldehyde—is capable of crossing the blood–brain barrier. With slower ethanol metabolism,
more ethanol is able to reach the brain and elicit hangover symptoms. Hangover severity was also
significantly associated with biomarkers of oxidative stress. More oxidative stress in the first hours
after alcohol consumption was associated with less severe next-day hangovers (i.e., a significant
negative correlation was found between hangover severity and malondialdehyde). On the contrary,
more oxidative stress at a later stage after alcohol consumption was associated with having more
severe next-day hangovers (i.e., a significant positive correlation was found between hangover
severity and 8-isoprostane). In conclusion, assessment of biomarkers of alcohol metabolism suggests
that fast elimination of ethanol is associated with experiencing less severe hangovers. More research
is needed to further examine the complex interrelationship between alcohol metabolism, the role of
acetaldehyde and oxidative stress and antioxidants, and the pathology of the alcohol hangover.
Keywords: alcohol; hangover; ethanol; acetaldehyde; acetate; oxidative stress; malondialdehyde;
8-isoprostane
1. Introduction
The alcohol hangover refers to the combination of negative mental and physical symptoms
which can be experienced after a single episode of alcohol consumption, starting when blood alcohol
concentration (BAC) approaches zero [1,2]. An increasing body of the scientific literature is addressing
the negative consequences of having hangovers for cognitive functioning including memory [3–6],
and potentially endangering daily activities such as driving a car [7,8]. In contrast, research on the
pathology of the alcohol hangover remains limited. Reviews on this topic suggest a variety of possible
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causes of the alcohol hangover [9–11], such as the role of the presence of ethanol and its metabolites
in the blood, oxidative stress, and the immune response to alcohol consumption. However, the data
presented in these reviews to support these hypotheses are limited. In this article, the current scientific
evidence is reviewed and hypotheses are formulated on how alcohol metabolism and oxidative stress
are related to the development of the alcohol hangover.
1.1. Alcohol Metabolism and Hangover Severity
The majority of ethanol is eliminated via oxidative processes in the liver [12–14]. Metabolism of
ethanol is a two-step process, driven by the action of two enzymes, alcohol dehydrogenase (ADH),
which oxidizes ethanol to acetaldehyde, and aldehyde dehydrogenase (ALDH), which oxidizes
acetaldehyde to acetate. In both cases, the speed of both conversions is determined by the presence of
the co-factor nicotinamide adenine dinucleotide (NAD+). A second pathway for alcohol breakdown,
which is especially active in subjects who consume alcohol chronically, or in others after consuming
large amounts of alcohol, is the microsomal ethanol oxidizing system (MEOS) [15]. This reaction
is catalyzed by CYP2E1 and requires the co-factor nicotinamide adenine dinucleotide phosphate
(NADP+), rather than NAD+, to convert ethanol into acetaldehyde. A third, relatively minor pathway
involves the activity of catalase in liver peroxisomes in which ethanol functions as an electron donor
for the reduction of hydrogen peroxide to water. Together, these oxidative pathways account for over
90% of alcohol elimination. The other 10% of ethanol is metabolized via non-oxidative pathways [16].
Irrespective of the pathway of alcohol metabolism, ethanol and acetaldehyde are the key
compounds researched in relation to alcohol hangover. There is, however, ongoing debate about
their role in the pathology of the alcohol hangover [9–11], and given the paucity of empirical data,
theoretically both ethanol and acetaldehyde concentrations could have a direct influence on hangover
severity. Many core hangover symptoms (e.g., headache, nausea, apathy, and concentration problems)
likely involve central processes. While systemic processes clearly play a role in aspects of alcohol
hangover, exposure of the brain to ethanol or its metabolites may ultimately determine the pathogenesis
of alcohol hangover (symptoms). Given this, it is important to investigate the capability of peripheral
ethanol and acetaldehyde to enter the brain and exert central effects, including a hangover.
Ethanol’s molecular structure allows it to freely cross the blood–brain barrier (BBB), and peripheral
blood ethanol concentrations correlate significantly with brain ethanol concentrations [17]. This is
not the case for acetaldehyde. Although original studies claimed that acetaldehyde can cross the
BBB [18–21], these studies have been criticized for methodological shortcomings [22,23], and the
current consensus is that acetaldehyde does not readily cross the BBB [23,24]. This is primarily due to
the abundance of ALDH in the BBB which rapidly converts acetaldehyde into acetate and water before
it can pass the membrane [23,25]. Theoretically small amounts of acetaldehyde may enter the brain
via the circumventricular organs (CVOs), where no BBB exists [26]. However, under normal drinking
circumstances, most acetaldehyde is metabolized systemically (i.e., before it reaches these areas),
meaning negligible amounts of acetaldehyde will enter the brain via this pathway [27,28]. As a result,
unlike ethanol and acetate, acetaldehyde is physiologically compartmentalized, with independent
and different concentrations in the periphery and centrally [29–31]. As such, in theory, peripheral
acetaldehyde should have no direct influence on hangover severity. However, it is important to note
that acetaldehyde may also be produced centrally, via catalase from ethanol that entered the brain,
where it can exert direct effects or be further metabolized and be involved in producing oxidative
stress [32].
Only a few studies have reported correlations between hangover severity and acetaldehyde
concentrations. This may be because of the fact that acetaldehyde is quickly converted into acetate and
water, or because its blood concentration during the hangover state often falls below the detection
limit [33,34]. This makes it difficult to accurately detect acetaldehyde.
Ylikahri et al. [35] examined the physiological correlates of a hangover in 23 healthy men.
The morning following alcohol consumption (1.5 g/kg), no significant correlations were found between
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peak blood ethanol, acetaldehyde concentrations, and hangover severity. In a subsequent study,
Ylikhari et al. [36] confirmed that blood acetaldehyde concentration was not significantly correlated
with hangover severity. In a naturalistic study, Van de Loo et al. [37] found that urine ethanol
concentrations assessed the morning following drinking were significantly lower in drinkers who
reported no hangover compared to hangover-sensitive drinkers (p = 0.027). Overall hangover severity
was positively and significantly associated with the amount of urine ethanol in those who reported
having a hangover (r = 0.571, p = 0.013). Finally, using a mixed field and Internet methodology,
Scholey et al. [38] found that hangover severity was significantly associated with the previous night’s
breath alcohol concentration (r = 0.228, p = 0.019). Together, the majority of these studies suggested a
relationship between ethanol concentration and hangover severity.
The end products of ethanol metabolism, acetate (acetic acid) and water, both readily cross the
BBB [24,39]. Water is an ‘inactive’ metabolite of ethanol, while acetate has received very little research
attention in the context of alcohol hangovers. One study assessed urine acetate and acetone levels
during alcohol hangover and reported significantly increased concentrations [40]. Unfortunately, in the
report of this study, no data were presented on the correlations of the concentrations of acetate and
acetone with hangover severity. The findings from an animal study do suggest a possible relationship
between blood acetate levels and hangover headache [41]. Using a headache model in rats, it was
demonstrated that administering acetate contributed to the development of trigeminal pain in rats,
whereas a similar correlation was not found for acetaldehyde. On the other hand, acetate is a common
additive in food preservation [42] and is, for example, the main acid in vinegar. As such, acetate
consumption as food constituent is considered safe and has not been associated with significant adverse
effects when consumed at dietary levels. Taken together, the possible role of acetate in the pathology of
the alcohol hangover deserves further investigation. Figure 1 summarizes the current hypothesis on
how alcohol metabolism may be related to hangover severity.
Figure 1. Alcohol metabolites and their hypothesized impact on the presence and severity of alcohol
hangover. Abbreviations: BBB = blood brain barrier, ADH = alcohol dehydrogenase, ALDH =
aldehyde dehydrogenase.
As summarized in Figure 1, it is hypothesized that the concentration of peripheral ethanol may be
the important correlate of hangover severity, as it can freely pass the BBB. In contrast, it is hypothesized
that peripheral acetaldehyde does not play a direct role in the development of the alcohol hangover in
the brain. However, as discussed elsewhere [43] and in this review, blood acetaldehyde concentrations
are suggested to have indirect effects on hangover severity via oxidative stress or via the inflammatory
response elicited by alcohol consumption.
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1.2. Accelerating Ethanol or Acetaldehyde Breakdown in Reducing Hangover Severity
It has been hypothesized that accelerating alcohol metabolism will reduce hangover severity as
ethanol and acetaldehyde are then quickly removed from the body. To further evaluate the literature
on alcohol metabolism rate, it is important to take into account the fact that the alcohol breakdown rate
is largely determined by the presence of two enzymes vital in catalyzing the alcohol metabolism, ADH
and ALDH (see Figure 1), together with their co-factor NAD+.
There is evidence supporting the hypothesis that accelerating alcohol metabolism may reduce
hangover symptom severity. For example, in Korea, red ginseng has been used for medical purposes for
thousands of years, and research in rats and dogs revealed that red ginseng extract had short-term effects
on ethanol metabolism in that it helped to reduce blood ethanol concentration [44,45]. Findings by
Lee et al. [46] in human volunteers suggest that increasing the rate of alcohol metabolism may
reduce hangover severity. Lee et al. [46] examined the effects of red ginseng on alcohol hangover
severity. Higher blood ethanol concentrations (observed in the placebo condition vs. red ginseng
condition at peak concentration, and first 60 min) were associated with significantly more severe
hangovers (See Figure 2A). They further observed a rise in blood acetaldehyde levels 120 min after
alcohol consumption, which was significantly greater after red ginseng than placebo (See Figure 2B).
The reduction in ethanol and increase in acetaldehyde observed after red ginseng administration were
followed by a significant reduction in next day hangover severity.
Figure 2. Effects of red ginseng on blood ethanol and acetaldehyde concentration. Alcohol and
acetaldehyde levels over 240 min following alcohol intake in placebo () and test (•) with red ginseng
groups. (A) Alcohol levels in plasma; (B) acetaldehyde levels in plasma. Values are expressed as
means ± SEM. p-values are from nonparametric paired t-tests. * p < 0.05, ** p < 0.01. Reproduced from
reference [46], with permission from the Royal Society of Chemistry.
Dihydromyricetin (DHM), the active constituent of Hovenia dulcis, has been found to induce the
expression of ethanol-metabolizing enzymes and reduce ethanol and acetaldehyde concentrations in
rats [47]. Kim et al. [48] examined the effects of the fruit of Hovenia dulcis versus placebo on hangover
severity in N = 26 healthy Asian men with heterozygous ALDH2. Blood samples were taken 1, 4
and 12 h after alcohol consumption and ethanol and acetaldehyde concentrations were determined.
Hangover severity was assessed the next morning, 12 h after alcohol consumption. The authors reported
a positive, significant relationship (r = 0.410, p = 0.003) between blood acetaldehyde concentration
assessed 4 h after alcohol consumption and hangover severity. This finding suggests that higher
acetaldehyde concentrations in the first hours after drinking are associated with having a more severe
hangover the next day. However, critical further analysis of the same data by Van de Loo et al. [43]
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revealed a different outcome. Van de Loo et al. [43] examined data from the placebo condition of the
study. It appeared that N = 10 subjects did not report a hangover and these were omitted from the
analysis. Data from the remaining N = 16 subjects were analyzed, and it appeared that there were no
significant correlations between blood acetaldehyde concentration assessed 1, 2 or 4 h after alcohol
consumption and next-day hangover severity. In addition, no significant correlations were found
between blood ethanol concentration and hangover severity. However, an indirect relationship between
the presence of ethanol and hangover severity was found. The presence of ethanol was associated
with increased levels of cytokines in the blood (interleukin (IL)-6 and tumor necrosis factor - alpha
(TNF-α), of which the concentration was significantly and positively related to next-day hangover
severity. This observation provides further evidence that a fast conversion of ethanol into acetaldehyde
could be associated with experiencing less severe hangovers.
Finally, disulfiram is an ALDH2 inhibitor used in the treatment of alcoholism to prevent alcoholic
patients from consuming alcohol. Its effects are established by inhibiting the breakdown of acetaldehyde
into acetate and water, which results in accumulation of acetaldehyde. The effects of disulfiram start
approximately 10 min after alcohol consumption and last for 1 h or more. Its effects include experiencing
acute intoxication symptoms such as flushing, headache, nausea, vomiting, and sweating. Up to now,
no studies have investigated the possible effects of disulfiram in the treatment of alcohol hangover.
Preclinical findings in animal studies and cell lines investigating natural compounds that enhance
the activity of ADH and ALDH suggest that these products may possess properties which reduce or
prevent alcohol hangovers [49,50]. In this context, recent research in social drinkers revealed that the
dietary intake of two essential nutrients for the activation of ADH and ALDH was associated with
hangover severity [51]. That is, there was a significant relationship between higher dietary intake of
zinc and nicotinic acid and reporting less severe hangovers. Alternatively, acetaldehyde production
can be influenced by modifying acetaldehyde producing microbiota [52]. High abundance of several
microbiota such as Rothia is associated with increased production of acetaldehyde from ethanol [53].
A recent study [54] examined changes in the oral (saliva) microbiome of 15 young drinkers after an
evening of heavy alcohol consumption. Compared to an alcohol-free day, the relative abundance of
Rothia, Streptococcus, and Veillonella was significantly increased during the hangover state, whereas
the relative abundance of Prevotella, Fusobacterium, Campylobacter, and Leptotrichia was significantly
decreased. The largest change in saliva microbiome after heavy alcohol consumption was an increase
in Rothia, which correlated significantly and negatively with reported hangover severity (r = −0.564,
p = 0.036). Changes in other microbiota did not correlate significantly with hangover severity.
Genetic variety in ADH and ALDH also plays a role in alcohol metabolism [55], and this may
affect the presence and severity of alcohol hangover. The ADH variants, of which ADH1B (subvariants
*1, *2, and *3) and ADH1C (subvariants *1 and *2) are the most important in this context, differentially
influence the breakdown rate of ethanol into acetaldehyde [56]. A relatively quick conversion from
ethanol into acetaldehyde is observed in people possessing ADH1B*2, ADH1B*3 and ADH1C*1 alleles,
whereas ethanol metabolism is relative slow in in people possessing the ADH1B*1 and ADH1C*2
allele [57]. The ADH1B*2 (common in people of Asian descent) and ADH1B*3 alleles (prevalent in
people of African American decent) result in relative high blood concentrations of acetaldehyde
(and thus lower blood ethanol concentrations) [58,59]. Additionally, subjects with an ALDH2*2 allele
have a slower breakdown of acetaldehyde into acetate and water. Whereas acetaldehyde is usually
quickly broken down, possession of the ALDH2*2 allele makes alcohol consumption unpleasant,
because due to persistent elevated acetaldehyde concentrations in the blood, adverse effects such
as flushing are frequently experienced [58]. Unfortunately, research into the genetics of alcohol
hangover is limited. Two studies did report that subjects with Asian descent, possessing the ALDH2*2
allele, typically report significantly worse hangovers, and are more likely to experience hangovers at
relatively lower alcohol consumption levels. [58,59]. Twin study by Slutske et al. [60] and Wu et al. [61]
revealed that 45% [60] to 55% [61] of the frequency of experiencing hangovers. Forty-three percent of
being hangover resistant could be explained by genetic variability [60]. These findings warrant further
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investigation into the impact of possessing different ADH and ALDH variants on the presence and
severity of alcohol hangover.
In conclusion, these studies support the hypothesis that a quick conversion of ethanol into
acetaldehyde is associated with having less severe hangovers (see Figure 3). Contrary to popular belief,
there is no published scientific evidence showing that any hangover product that claims to enhance the
elimination of acetaldehyde is actually effective in reducing hangover severity. This, however, does
not rule out the possibility that acetaldehyde may have indirect effects on the presence and severity of
alcohol hangover. The fact that possessing the ALDH2*2 allele is associated with experiencing worse
hangovers supports this possibility.
Figure 3. The impact of alcohol metabolism rate on hangover severity. Abbreviations: E = ethanol,
A = acetaldehyde, BBB = blood brain barrier, ALDH = aldehyde dehydrogenase.
Up to now, one study directly associated alcohol elimination rate with hangover severity [62].
Data from N = 8 healthy volunteers who participated in both an acute study to investigate alcohol
metabolism after alcohol consumption to achieve a BAC of 0.05% [63] and a naturalistic hangover
study [64] were combined. In the acute alcohol study, breath alcohol content was assessed with a
breathalyzer. Assessments were made every 5 min until subjects reached a BAC of zero. Using these
data, the ethanol elimination rate was computed. These data were related to hangover severity reported
in the hangover study, applying partial correlations correcting for estimated BAC. Hangover severity
was assessed hourly from 09.30 to 15.30, using a one-item hangover severity scale ranging from 0 (absent)
to 10 (severe) [65]. The analysis revealed significant negative correlations between hangover severity
and ethanol elimination rate. In other words, those with a higher ethanol elimination rate (i.e., a faster
conversion from ethanol into acetaldehyde) reported significantly lower hangover severity scores.
1.3. Oxidative Stress
Whereas in the liver the primary pathway of ethanol elimination is via ADH and ALDH activity,
there exist alternative pathways for ethanol breakdown via the liver of which the microsomal ethanol
oxidizing system (MEOS) is suggested to be the most important (See Figure 4).
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Figure 4. Oxidative stress and the inflammatory response to alcohol consumption. Arrows in red
represent the relationship between alcohol metabolism and oxidative stress. Other arrows illustrate
the pathways from oxidative stress to an inflammatory response and eliciting the alcohol hangover.
Abbreviations: ADH = alcohol dehydrogenase, ALDH = aldehyde dehydrogenase, CRP = C-reactive
protein, HER = hydroxyethyl radical, HNE = 4-hydroxy-2-nonenal, MAA = malondialdehyde
– acetaldehyde, MDA = malondialdehyde (MDA), NAD+ = nicotinamide adenine dinucleotide,
NADH = nicotinamide adenine dinucleotide (NAD) + hydrogen (H), NADP+ = nicotinamide adenine
dinucleotide phosphate, NADPH = nicotinamide adenine dinucleotide phosphate + hydrogen (H),
RNS = reactive nitrogen species, ROS = reactive oxygen species. Pathways contributing to ROS
production are indicated by red dashed lines. * = free radicals are scavenged by antioxidants such
as superoxide dismutase (SOD), catalase, and glutathione peroxidase, which may counteract lipid
peroxidation and oxidative stress, and mitigate a subsequent inflammatory response.
The MEOS is more active after chronic alcohol use, as well as after drinking large quantities of
alcohol. In addition, the MEOS is known to play a role in the link between alcohol metabolism and the
inflammatory response consequent to alcohol consumption [43].
Ethanol is catalyzed by CYP2E1 into acetaldehyde, but in addition the MEOS also produces
free (oxygen) radicals [66,67]. Free radicals are oxygen-containing molecules with unpaired electrons
which allow them to easily react with other molecules. Free radicals, i.e., reactive oxygen species
(ROS), are usually scavenged by antioxidants such as glutathione or superoxide dismutase (SOD).
However, consuming large quantities of alcohol causes an imbalance between the amount of free
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radicals and antioxidants, i.e., excess levels of ROS such as hydroxyethyl radical (HER), called
oxidative stress [66,67]. The abundance of free radicals elicits a process called lipid peroxidation,
in which various byproducts of alcohol breakdown, called adducts, are formed [68,69]. Adducts are
a combination of acetaldehyde or other aldehydes with a protein. Most notable in this regard are
the aldehydes malondialdehyde (MDA) and 4-hydroxy-2-nonenal (HNE). Similar to acetaldehyde,
these highly reactive aldehydes cannot pass through the blood brain barrier. In the presence of
acetaldehyde, MDA can react with various proteins to form malondialdehyde–acetaldehyde adducts
(MAA adducts). MAA adducts are known to have proinflammatory properties [70]. The MAA adducts
are recognized by the body as foreign substances, and as a result an immune response is elicited [71–73],
including increased secretion of cytokines and chemokines, as discussed elsewhere [43].
To counteract oxidative stress, various antioxidants (e.g., glutathione) and enzymes (e.g., catalase
and superoxide dismutase) are produced endogenously. Cysteine is one of the precursors of glutathione,
functioning as a semi-essential amino acid that binds acetaldehyde [74]. It has therefore been
hypothesized that products increasing levels of antioxidants (e.g., glutathione, vitamin C, or vitamin E)
may be effective as products to prevent hangovers [53]. However, most data to support these claims are
indirect and comes from preclinical studies including animal research. For example, it has been shown
that treatments that slowly release L-cysteine in the oral cavity significantly reduce saliva acetaldehyde
concentration during alcohol consumption [75]. In rats, it was shown that a preparation of combined
glutathione-enriched yeast (GEY) and rice embryo/soybean (RES) extracts significantly reduced both
blood alcohol and acetaldehyde concentrations after an alcohol challenge [76]. Other research in rats
revealed that administering electrolyzed-reduced water (ERW) was accompanied by activation of
glutathione, and a significant increase in ADH and ALDH in the liver [77]. In the context of such
preclinical findings, L-cysteine, its precursor N-acetyl-L-cysteine (NAC), and glutathione have been
proposed as hangover treatments and are included as ingredients in various marketed hangover
treatments. However, supportive peer-reviewed scientific data from clinical trials in humans on the
efficacy of antioxidants in reducing or preventing hangovers are currently lacking [78–81]. Indeed, two
recent double blind placebo controlled studies found no significant effect of a hangover treatment
consisting of L-cysteine. Scholey et al. found no significant improvement of hangover severity
after administering L-cysteine (650 mg) and B- and C-vitamins [82], and Eriksson et al. also did not
demonstrate a significant reduction in hangover severity after administering L-cysteine (600 mg and
1200 mg) [83,84]. The reported data from a clinical trial on www.clinicaltrials.gov showed that NAC
had no significant effects on reducing hangover severity but did produce more adverse effects than
placebo (clinicaltrials.gov identifier NCT02541422). Another study examining NAC and hangover was
terminated before completion (clinicaltrials.gov identifier NCT03104959), and the results from a third
hangover study with glutathione are not reported (clinicaltrials.gov identifier NCT00127309).
To date, only one study has investigated both the biomarkers of oxidative stress and antioxidants
in relationship to hangover severity [85]. Mammen et al. [85] examined the effect of a polyphenolic
extract of clove buds (Clovinol) versus placebo on hangover severity in N = 16 healthy men, aged 25
to 55 years old. Blood ethanol and acetaldehyde concentration were determined before and at 0.5, 2,
4, and 12 h after alcohol consumption (240 mL of 42.8% McDowell’s V.S.O.P. Brandy; United Spirits
Limited, Bangalore, India), and a hangover scale was completed 14 h after drinking. To assess oxidative
stress, two biomarkers (8-isoprostane and malondialdehyde) were assessed, as well as two antioxidants,
glutathione and superoxide dismutase (SOD). No significant difference in ethanol concentrations was
found between placebo and Clovinol at any time point. After intake of alcohol alone (i.e., the placebo
condition), biomarkers of oxidative stress increased over time, whereas antioxidant concentrations
decreased. Mammen et al. [85] observed a significant reduction in hangover severity after Clovinol,
which was associated with a significant reduction in acetaldehyde, 8-isoprostane and malondialdehyde
concentration and a significant increase in glutathione and SOD. Van de Loo et al. [43] further evaluated
the placebo data of the study by Mammen et al. This evaluation revealed no significant correlations
between hangover severity and blood ethanol or acetaldehyde concentrations at any time point after
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alcohol consumption. In addition, concentrations of the antioxidants glutathione and SOD did not
significantly correlate with hangover severity at any timepoint after alcohol consumption.
A significant negative correlation was found between hangover severity and blood
malondialdehyde concentration at 0.5 h after alcohol consumption (rB = −0.707, BCa 95%CIB = −0.96,
−0.16). Correlations between hangover severity and 8-isoprostane in the first hours after drinking were
also negative, but did not reach statistical significance. At a later stage after drinking, a significant
positive correlation was found between hangover severity and 8-isoprostane at 12 h (rB = 0.475,
BCa 95%CIB = 0.06, 0.78), and the association between malondialdehyde at 12 h and hangover severity
was also positive, but did not reach significance.
Together, these findings suggest that higher levels of oxidative stress in the first hours after alcohol
consumption (i.e., quick metabolism of ethanol) are associated with less severe hangovers (a negative
correlation was found), whereas high levels of oxidative stress and inflammation during hangover are
associated with more severe hangovers (a positive correlation was found).
2. Conclusions
The data summarized in this review suggest that the ethanol elimination rate is a critical
determinant of hangover severity for a number of reasons. First, significant correlations have been
found between ethanol concentration (but not acetaldehyde) and hangover severity. Second, nutrients,
microbiota, and hangover treatments that speed up the conversion of ethanol into acetaldehyde are
associated with less severe hangovers. Taken together, the data suggest that a more rapid conversion
of ethanol to acetaldehyde and other aldehydes is associated with less severe hangovers. Based on the
currently available data, the hypothesized relationship between alcohol metabolism and the presence
and severity of alcohol hangover is schematized in Figure 5.
Figure 5. Schematic representation of the hypothesized relationship between alcohol metabolism and
hangover severity.
The association between blood ethanol content and hangover severity is physiologically plausible,
because unlike acetaldehyde, ethanol can freely pass the BBB. Compared to fast metabolizers of alcohol,
slow metabolizers will have relatively large amounts of circulating ethanol that can cross the BBB over
a longer time period, increasing the relative probability of a more severe hangover.
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Figure 5 also includes oxidative stress, suggesting that high levels of oxidative stress in the
first hours after drinking are associated with less severe hangovers, whereas high levels of oxidative
stress during hangover are associated with more severe hangovers. It should be taken into account,
however, that at this moment limited data are available on the role of oxidative stress and antioxidants
in the pathogenesis of alcohol hangover, and this observation was based on only one study [43,85].
Therefore, much more research attention is needed to confirm these findings and elucidate the
exact relationship between oxidative stress and alcohol hangover. Additionally, more research is
needed to investigate to what extent antioxidants can prevent or reduce alcohol hangover, oxidative
stress and the inflammatory response to alcohol consumption are interrelated and may impact
hangover severity. Finally, although no direct effects of acetaldehyde on hangover severity have been
demonstrated, acetaldehyde does play a role in oxidative stress resulting in hangovers. It has also
been shown that subjects with an ALDH2*2 allele report more severe hangovers than other drinkers.
Therefore, more research is also needed in the role of acetaldehyde in the development of alcohol
hangover. Notwithstanding the limited amount of research, it is evident that alcohol metabolism and
ethanol elimination rate play a critical role in the presence and severity of the alcohol hangover.
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Abstract: An increasing number of studies are focusing on the inflammatory response to alcohol as a
potentially important determinant of hangover severity. In this article, data from two studies were
re-evaluated to investigate the relationship between hangover severity and relevant biomarkers of
alcohol metabolism, oxidative stress and the inflammatory response to alcohol. Hangover severity was
significantly and positively correlated with blood concentrations of biomarkers of the inflammatory
response to alcohol, in particular, Interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α) and
C-reactive protein (CRP). At 4 h after alcohol consumption, blood ethanol concentration (but not
acetaldehyde) was significantly and positively associated with elevated levels of IL-6, suggesting a
direct inflammatory effect of ethanol. In addition, biomarkers of oxidative stress, i.e., malondialdehyde
and 8-isoprostrane, were significantly correlated with hangover severity, suggesting that oxidative
stress also contributes to the inflammatory response. The timing of the assessments suggests initial
slow elimination of ethanol in the first hours after alcohol consumption. As a consequence, more
ethanol is present in the second half of the night and the next morning, which will elicit more
oxidative stress and a more profound inflammatory response. Together, these processes result in
more severe hangovers.
Keywords: alcohol; hangover; ethanol; acetaldehyde; acetate; oxidative stress; malondialdehyde;
8-isoprostane; cytokines; C-reactive protein
1. Introduction
The alcohol hangover refers to the combination of negative mental and physical symptoms,
which can be experienced after a single episode of alcohol consumption, starting when blood alcohol
concentration (BAC) approaches zero [1,2]. Reviews on the pathology of alcohol hangover [3–5] suggest
that, although research is limited, both alcohol metabolism and the immune system play an important
role in the development of alcohol hangover. The role of alcohol metabolism and oxidative stress are
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discussed elsewhere in detail [6]. These analyses revealed that higher blood concentrations of ethanol
(but not acetaldehyde) and oxidative stress (a combination between depletion of antioxidants and an
increase in free radicals, originating in the liver) were associated with having more severe hangovers.
These processes are determined by the ethanol elimination rate. In other words, fast elimination of
ethanol was associated with experiencing less severe hangovers [7]. The current analysis aimed to
further elaborate the role of immune responses elicited by alcohol consumption in the development of
the alcohol hangover.
A possible role of the immune system in the pathology of alcohol hangover was first hypothesized
in the 1980s [8,9]. Kaivola et al. [8] examined the effects of tolfenamic acid on alcohol hangover in n = 30
social drinkers. Tolfenamic acid is a non-steroidal anti-inflammatory drug (NSAID), and prostaglandin
(PG) is an inhibitor used for the treatment of pain, and as such, it could be hypothesized that the drug
would be helpful in mitigating related hangover symptoms. From n = 10 subjects, blood samples
were also taken, and prostaglandin PGE2, PGF2α, thromboxane B2 (TXB2) and 6-keto PGF1α were
determined at 0, 5, 10 and 20 h after drinking. Subjects rated the efficacy of the drug on an 11-point scale
ranging from “very ineffective” to “very effective”, with subjects rating the treatment as significantly
more effective than placebo. The same study further showed a significant reduction in the severity of
several hangover symptoms after drug administration, with headache, dry mouth and thirst being the
most drug-sensitive items. Alcohol consumption significantly increased PGE2 and TXB2 concentrations
(the placebo condition). Administering tolfenamic acid partly counteracted the observed increments.
No significant changes in PGF2α and 6-keto PGF1α were observed over time, and tolfenamic acid had
no significant effect on these assessments.
Paratainen [9] reviewed the evidence for the role of prostaglandins in hangover, which at that
time was limited to the study by Kaiviola et al. [8]. The review concluded that alcohol has an effect on
prostaglandin synthesis, which can be counteracted by a prostaglandin inhibitor such as tolfenamic
acid. It took 20 years for other studies to confirm that alcohol consumption is accompanied by an
immune response, and that elevated levels of cytokines in blood and saliva may be related to the
presence and severity of the alcohol hangover.
Kim et al. [10] demonstrated an inflammatory response accompanying alcohol consumption
that was significantly associated with next-day hangover severity. In their study, twenty male Asian
subjects had an evening of alcohol consumption (soju, a distilled beverage of Korean origin), which
was compared to an alcohol-free control day. The following morning, blood samples were collected for
determination of cytokine concentrations. The hangover scale consisted of two subscales, computing
sum scores of ratings of subjective hangover symptoms (i.e., thirst, tension, depression and general
discomfort, rated by the participant) or somatic hangover symptoms (i.e., paleness, tremor, perspiration,
nystagmus, vomiting and general appearance, rated by two psychiatrists). On the hangover day,
compared to the alcohol-free control day, significantly increased blood concentrations were found
for interleukin (IL)-10, IL-12 and interferon-gamma (IFN-γ), whereas no significant changes were
observed for IL-1β, IL-4, IL-6 or tumor necrosis factor-alpha (TNF-α). Furthermore, the increase in
IL-12 and IFN-γ correlated significantly with overall hangover severity. Significant correlations with
subjective hangover scale scores were found for difference scores (Δ, alcohol-control day) Δ IFN-γ,
and significant correlations with somatic hangover scale scores were found for Δ TNF-α and Δ IL-12.
Wiese et al. [11] examined the effects of Opuntia ficus indica (OFI) (prickly pear) on alcohol hangover,
administered 5 h before alcohol consumption. OFI is used as a dietary supplement for its antioxidant
and anti-inflammatory properties [12]. The authors concluded that the alcohol hangover is mediated
by an inflammatory response, as they observed significant correlations between blood C-reactive
protein (CRP) concentration and hangover severity. After placebo treatment, CRP levels rose by 50%,
accompanied by experiencing an alcohol hangover. After administering OFI, no inflammatory response
was seen (CRP levels did not differ from placebo) and several hangover symptoms were alleviated.
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George et al. [13] examined the effects of a new hangover treatment (Phyllanthus amarus,
PHYLLPROTM, 750 mg/day, administered for 10 days) on hangover severity. Phyllanthus amarus is
traditionally used in India for the treatment of hepatitis and jaundice, and for general liver health, and
its reported effectiveness is most likely due to its antioxidant properties [14]. George et al. assessed a
variety of blood cytokines the day following alcohol consumption, and hangover severity reported 10 h
after drinking. In this study, IL-8, IL-10 and IL-12p70 levels were increased significantly in the active
group, denoting an anti-inflammatory effect of the treatment compared to the placebo treatment alcohol
challenge. Unfortunately, the authors did not report correlations between inflammatory markers and
the presence or severity of alcohol hangover.
Van de Loo et al. [15] examined cytokine concentration in saliva. n = 36 healthy social drinkers
(18 to 30 years old) participated in a naturalistic study. Based on lifetime self-report, at screening,
subjects were allocated to a hangover-sensitive group (those who reported having hangovers), or the
hangover-resistant group (those reporting never having hangovers despite consuming large quantities
of alcohol). The morning following an evening of alcohol consumption and an alcohol-free control day,
saliva samples were collected, and cytokine concentrations were assessed. Significant increases in IL-6
and IL-10 concentrations were observed the morning after heavy drinking. No significant changes
were found for IL-1β, IL-8 and TNF-α. Interestingly, no significant differences were observed between
the hangover-sensitive group and the drinkers that claimed to be hangover-resistant. The elevation
in saliva IL-6 and IL-10 concentration did not significantly correlate with overall hangover severity.
However, the correlations between IL-6 and headache (r = 0.572, p = 0.017) and between IL-6 and
concentration problems (r = 0.536, p = 0.027) showed a trend towards significance (taking into account
multiple comparisons, a conservative p-value cut-offwas applied for statistical significance, which was
set at p < 0.002).
Ethanol may elicit an inflammatory response directly, or indirectly via its breakdown products and
oxidative stress [6]. The conversion of ethanol into acetaldehyde involves the production of reactive
oxygen species (ROS) and reactive nitrogen species (RNS), which are both harmful for the body and
thus elicit an immune response [16]. The free radicals are usually neutralized by antioxidants such as
superoxide dismutase or glutathione. Oxidative stress refers to the situation when the amount of ROS
and RNS is much larger than the present antioxidants. The free radicals are highly reactive. For example,
malondialdehyde–acetaldehyde adducts (MAA adducts) are formed, which have proinflammatory
properties [17]. The MAA adducts are recognized by the body as foreign substances, and as a result,
an immune response is elicited [18–20], including increased secretion of cytokines and chemokines.
Other important biomarkers of oxidative stress are isoprostanes, i.e., prostaglandin-like compounds
formed via non-enzymatic free radical-initiated lipid peroxidation of arachidonic acid, and other
polyunsaturated fatty acids (PUFAs), including α-linolenic acid, eicosapentaenoic acid (EPA), adrenic
acid and docosahexaenoic acid (DHA) [21]. However, studies that have examined oxidative stress in
human subjects in the context of alcohol hangover are scarce [6].
Together, previous studies demonstrated that alcohol consumption is followed by an inflammatory
response. However, the precise mechanism of how the inflammatory response is elicited is unclear,
and there are mixed results on which specific cytokines play a key role in this process. Further, it is
uncertain to what extent changes in cytokine concentrations correlate significantly to self-reported
hangover severity. Finally, the previous studies also do not provide insight into how cytokine changes
are related to biomarkers of alcohol metabolism and oxidative stress. This knowledge is, however,
vital to better understand the pathology of the alcohol hangover. Therefore, the aim of the current
article was to further investigate and integrate data on alcohol metabolism, oxidative stress and the
inflammatory response to alcohol consumption in relation to alcohol hangover. To this extent, we
re-evaluated data from the two available studies that collected this combined data in the same subjects,
enabling a direct investigation into their interrelationships [22,23].
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2. Methods
Data from two studies were re-evaluated (see original articles for details on methodology) [22,23].
In the first double-blind crossover study, Kim et al. [22] examined the effects of the fruit of
Hovenia dulcis versus placebo on hangover severity in n = 26 healthy men (mean ± standard deviation
(SD) age of 23.7 ± 0.3 years old), with heterozygous ALDH2. Subjects consumed 360 mL of Korean
Soju (50 g alcohol) together with Hovenia dulcis extract (2460 mg) or matched placebo. Blood samples
were taken 1, 4 and 12 h after alcohol consumption and ethanol and acetaldehyde concentrations
were determined. Blood cytokine concentrations of IL-6, IL-10, IL-12 and TNF-α were assessed at 4
and 12 h after drinking alcohol. Hangover severity was assessed the next morning, 12 h after alcohol
consumption, using a 14-item scale on which symptoms could be scored on a 5-point likers scale, which
was developed for this study. The sum score of the 14 items was used as the overall hangover severity
score. The study was conducted in accordance with the Declaration of Helsinki and was approved by
the Institutional Review Board of Chonbuk National University Hospital (World Health Organization
International Clinical Trials Registry Platform identification number: KCT0001626).
In a second double-blind crossover study, Mammen et al. [23] examined the effect of a polyphenolic
extract of clove buds (Clovinol) versus placebo on hangover severity in n = 16 healthy men (mean
± SD age of 29.5 ± 6.2 years old). The study was conducted in India, and genetic polymorphisms in
alcohol metabolic enzymes were not considered. Blood ethanol and acetaldehyde concentration were
determined before and at 0.5, 2, 4 and 12 h after alcohol consumption (240 mL of 42.8% McDowell’s
Very Superior Old Pale (V.S.O.P.) Brandy; United Spirits Limited, Bangalore, India). To investigate
the inflammatory response, IL-6 and CRP were also assessed at the same time points. Finally, two
antioxidants (glutathione and superoxide dismutase (SOD)), and two biomarkers of oxidative stress
(8-isoprostane and malondialdehyde) were measured. A hangover scale was completed 14 h after
drinking. Hangover severity was measured using a 15-item scale on which symptoms could be scored
on scales ranging from 1 (absent) to 10 (extreme). The scale was composed by the authors. The average
score of the 15 items was computed and used as overall hangover severity score.
The study was carried out in accordance with the clinical research guidelines established by the
Government of India, and protocol was approved by an independent ethical committee (Clinical trial
Reg. No. ECR/64/Indt/KA/2013).
Statistical Analysis
Statistical analyses were conducted with SPSS, version 25 (Armonk, IBM Corp, New York, NY,
USA). Subjects were only included in the current analysis if they had hangover severity scores greater
than zero. Regarding individual data, outliers (mean ± 3 interquartile ranges) were omitted from
the analysis. Only data from the placebo condition (i.e., alcohol-only, without treatment) were used.
Means and standard deviation (SD) were computed for each variable. Non-parametric Spearman’s
correlations were used to account for a non-normal distribution.
Due to the relatively small sample size, a bootstrapping technique was applied [24,25] to simulate
the population distributions of the partial correlations (rP). To obtain an adequate resampling
size [26], B = 10,000 bootstrapped samples (of n = 8 subjects each) were created by randomly
drawing cases (resampling), with replacement, from the original sample. For each of the bootstrap
samples, the bootstrapped partial correlation, denoted as rPB, was calculated. The standard error (SE)
represents how much the rPBs vary across the bootstrap samples, and the reported ‘bias’ measure
represents the deviation of the overall rPB from the rP that was obtained from the original sample [27].
The bias-corrected and accelerated bootstrapped 95% confidence interval (BCa 95% CIB) was computed
for each correlation [28]. The lower and upper limit of the BCa 95% CIB can range from −1 to +1,
with narrower BCa 95% CIB’s implying greater precision. Bootstrapping does not provide p-values,
but significance is determined by the BCa 95% CIB. If the BCa 95% CIB does not include zero, the rPB is
considered statistically significant (corresponding to a significance level of α = 5%).
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3. Results
3.1. Study 1
Only data from the placebo condition (i.e., alcohol-only, without treatment) were considered.
Analysis of the raw data revealed that n = 10 subjects did not report any hangover symptoms. Data
from these n = 10 subjects were omitted. The results from the remaining n = 16 subjects are summarized
in Table 1 and Figure 1.
Table 1. Biomarkers of alcohol metabolism, the inflammatory response to alcohol consumption and
their relation to hangover severity.
Biomarker
Time After Alcohol Consumption
0 h 1 h 4 h 12 h
Ethanol (mg/dL) 0.0 (0.0) 56.8 (10.0) 38.9 (7.2) 1.1 (0.4)
Acetaldehyde (mg/dL) 0.0 (0.0) 0.13 (0.07) 0.04 (0.02) 0.01 (0.01)
Interleukin (IL)-6 (pg/mL) 0.50 (1.2) – 0.97 (1.7) 1.03 (1.7) *
Interleukin (IL)-10 (pg/mL) 0.35 (0.5) – 0.29 (0.4) 0.28 (0.4)
Interleukin (IL)-12 (pg/mL) 0.04 (0.07) – 0.01 (0.006) 0.01 (0.006)
Interferon-gamma (IFN-γ) (pg/mL) 0.09 (0.2) – 0.02 (0.01) 0.04 (0.07)
Tumor necrosis factor-alpha (TNF-α) (pg/mL) 3.56 (1.9) – 3.31 (1.4) * 4.00 (2.0) *
Biomarker assessments after consumption of alcohol to reach a desired breath alcohol concentration (BrAC) of
0.06%. Mean and standard deviation (SD) (between brackets) are shown. Significant correlations with hangover
severity (p < 0.05), after bootstrapping (B = 10,000 bootstrapped samples), are indicated by *. – = not assessed. Data
from Kim et al. [22].
Figure 1. Relationship of hangover severity with blood ethanol concentration and the inflammatory
response to alcohol. Note: Arrows represent significant correlations after bootstrapping. Abbreviations:
Il = interleukin, TNF = tumor necrosis factor, h = hours after alcohol consumption. Data from
Kim et al. [22].
Mean (SD) hangover severity, assessed 12 h after alcohol consumption, was 16.2 (1.8). The analysis
revealed no significant correlations between blood ethanol and overall hangover severity at any
timepoint. Also, no significant correlations were found between blood acetaldehyde and overall
hangover severity at any timepoint. Significant correlations were found between hangover severity and
TNF-α at 4 h (rB = 0.679, BCa 95%CIB = 0.440, 0.835) and TNF-α at 12 h (rB = 0.625, BCa 95%CIB = 0.252,
0.889). A significant correlation was also found between IL-6 at 12 h and hangover severity (rB = 0.459,
BCa 95%CI = 0.036, 0.796).
On the contrary, the inflammatory response seems to be directly related to blood ethanol
concentrations. That is, significant positive correlations were found between blood ethanol at 4 h and
IL-6 at 4 h (rB = 0.482, BCa 95%CIB = 0.038, 0.803) and between blood ethanol at 4 h and IL-6 at 12 h
(rB = 0.573, BCa 95%CIB = 0.216, 0.835). Correlations between IL-6 and TNF-α did not reach statistical
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significance for any timepoint combination. In contrast to ethanol, the inflammatory response was not
significantly associated with acetaldehyde concentrations.
3.2. Study 2
Data on hangover severity of three subjects were not collected. Raw data from the remaining
n = 13 subjects were used for the statistical analysis. Their mean (SD) hangover severity, assessed 14 h
after alcohol consumption, was 4.4 (0.5). The results of the assessments in the alcohol-only condition
are summarized in Table 2.
Table 2. Biomarkers of alcohol metabolism, oxidative stress and the inflammatory response to alcohol
consumption and their relation to hangover severity.
Biomarker
Time After Alcohol Consumption
0 h 0.5 h 2 h 4 h 12 h
Ethanol (mg/dL) – 26.2 (4.5) 14.8 (3.5) 6.8 (1.0) 2.7 (0.4)
Acetaldehyde (mg/dL) – 0.42 (0.03) 0.28 (0.05) 0.17 (0.02) –
Interleukin (IL)-6 (pg/mL) 4.2 (0.0) 4.3 (0.8) 5.1 (1.0) 5.8 (1.0) 6.1 (1.0)
C-reactive protein (mg/L) 2.2 (0.6) 2.6 (0.7) 3.3 (0.8) 3.8 (0.7) * 3.8 (1.2)
8-isoprostane (pg/mL) 22.6 (4.5) 25.3 (3.5) 26.2 (4.8) 29.8 (7.1) 30.6 (6.5) *
Malondialdehyde (nmol/dL) 72.0 (7.3) 83.4 (7.2) * 94.4 (7.0) 95.5 (7.0) 92.6 (13.3)
Glutathione (nmol/mg Hb) 23.9 (3.4) 21.7 (3.1) 21.6 (3.9) 23.0 (2.4) 21.7 (3.5)
Superoxide dismutase (U/mL) 0.42 (0.1) 0.35 (0.1) 0.30 (0.1) 0.28 (0.1) 0.27 (0.1)
Biomarker assessments after consumption of alcohol to reach a desired BrAC of 0.03%. Mean and standard deviation
(between brackets) are shown. Significant correlations with hangover severity (p < 0.05), assessed 14 h after alcohol
consumption, are indicated by *. – = ethanol and acetaldehyde were not assessed at 0 h, and acetaldehyde could not
be detected 12 h after alcohol consumption. Data from Mammen et al. [23].
Acetaldehyde levels significantly increased directly after alcohol consumption (p < 0.0001),
but declined steadily thereafter, and at 12 h after drinking, acetaldehyde could no longer be detected,
whereas ethanol concentrations were still detectible after this time period. No significant correlations
were found between hangover severity and blood ethanol or acetaldehyde concentrations at any time
point after alcohol consumption.
CRP concentration at 4 h was significantly associated with hangover severity at 14 h (rB = 0.534,
BCa 95%CIB = 0.120, 0.825). No significant correlations between IL-6 and hangover severity were
found at any time point, and the associations between blood ethanol and acetaldehyde concentrations
and IL-6 were also not significant at any timepoint. A significant correlation was found between IL-6
at 2 h and CRP at 4 h (rB = 0.587, BCa 95%CIB = −0.874, −0.130). CRP concentrations did not correlate
significantly with blood ethanol or acetaldehyde concentrations at any timepoint.
With regard to antioxidants, the assessments revealed that both glutathione and SOD
concentrations showed a decrease after alcohol consumption, but at no timepoint did their
concentrations correlate significantly with hangover severity. The concentration of 8-isoprostane
increased over time and reached its highest point 12 h after alcohol consumption (p < 0.0001).
A significant correlation was found between hangover severity and 8-isoprostane at 12 h (rB = 0.475,
BCa 95%CIB = 0.06, 0.78). Also, the blood malondialdehyde concentration at 0.5 h correlated significantly
with hangover severity at 14 h (rB = −0.707, BCa 95%CIB = −0.96, −0.16). The negative correlation
suggests that higher malondialdehyde concentrations directly after drinking are associated with
experiencing less severe hangovers. 8-isoprostane at 2 h after alcohol consumption correlated
significantly, and negatively, with acetaldehyde assessed 0.5 h (rB = −0.612, BCa 95%CIB = −0.884,
−0.192) and 2 h (rB = −0.613, BCa 95%CIB = −0.881, −0.191) after alcohol consumption, while ethanol
concentrations revealed non-significant positive associations at these timepoints. Assessments at 2 h
after alcohol consumption revealed a significant negative association (rB = −0.541, BCa 95%CIB = 0.113,
0.833) between oxidative stress (8-isoprostane) and antioxidant depletion (glutathione). The results are
summarized in Figures 2 and 3.
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Figure 2. Markers of oxidative stress and inflammatory responses in the first four hours after
alcohol consumption. Percentage changes between assessments made in the first 4 h after alcohol
consumption relative to T0 (the assessment made before alcohol consumption) are shown. Abbreviations:
CRP = C-reactive protein, IL-6 = interleukin-6, SOD = superoxide dismutase.
 
Figure 3. Oxidative stress and the inflammatory response during alcohol hangover. Percentage changes
between assessments made 12 h after alcohol consumption relative to T0 (the assessment made before
alcohol consumption) are shown. Abbreviations: CRP = C-reactive protein, IL-6 = interleukin-6,
SOD = superoxide dismutase.
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4. Discussion
Multiple lines of evidence, as summarized elsewhere [6], suggest that the amount of ethanol
present in the blood is an important determinant of hangover severity. Specifically, faster conversion of
ethanol into acetaldehyde and other aldehydes is associated with having less severe hangovers [7].
Data from the two studies evaluated here confirm and extend previous findings. For example, the data
support previously reported relationships between oxidative stress and inflammatory responses to
alcohol consumption (i.e., increases in IL-6 and CRP). Blood malondialdehyde concentration at 0.5 h
correlated negatively with hangover severity at 14 h. Thus, higher oxidative stress in the first hours
after drinking was associated with less severe next-day hangovers. The significant positive correlation
between hangover severity and 8-isoprostane at 12 h after alcohol consumption suggests that more
oxidative stress, experienced at a later stage after alcohol consumption, is associated with having
more severe hangovers. In other words, a quick ethanol metabolism results in more oxidative stress
in the first hours of drinking. This is associated with having less severe next-day hangovers. On the
other hand, if ethanol metabolism is relatively slow, there will be more oxidative stress the following
morning, which is associated with having more severe hangovers. Increased ethanol concentration,
but not acetaldehyde, was associated with elevated IL-6 levels. The magnitude of the inflammatory
response correlated significantly with hangover severity.
Low-grade inflammation, i.e., relative minor elevations in proinflammatory cytokine
concentrations, is a common underlying condition in many diseases [29]. Alcohol consumption is one
of the many factors that can provoke such an elevation of proinflammatory cytokines. The studies
reviewed in the introduction, and the data from the two studies presented here, demonstrate significant
and robust elevations in cytokine concentrations, including IL-6, IL-10, IL-12, IFN-γ and TNF-α,
after alcohol consumption and during the hangover state. The relationship between CRP and cytokine
production is complex and bi-directional, and CRP production is usually followed in time by cytokine
production, particularly IL-6 and TNF-α are induced by the presence of CRP [30].
Results of the two studies were in agreement that an inflammatory response follows alcohol
consumption. However, there were also differences. For example, whereas Kim et al. [22] found a
significant correlation between Il-6 and hangover severity, this correlation did not reach significance in
the study by Mammen et al. [23]. Other studies also reported no significant correlation between IL-6
concentration and hangover severity [10,14]. The finding by Mammen et al. [23] that CRP concentration
did correlate significantly with hangover severity is in line with previous findings [11]. In contrast to
other studies [10,15], we did not find significant correlations between hangover severity and blood
ethanol concentration. The observed differences between the outcomes of the two studies and available
literature can be explained by differences in the study designs. For example, with regards to subject
recruitment, one study took genetic polymorphism into account [22] whereas the other study did
not [23]. The administered type and amount of alcohol differed between the two studies, which resulted
in different blood alcohol concentrations. At 4h after alcohol consumption, the difference in blood
alcohol levels was roughly 32.1 mg/dL (~0.03%) between the two studies, which might explain why
some associations with overall hangover severity were only significant in one study. Further, different
hangover assessment scales were used, and the assessments of hangover severity were made at
different points in time after drinking (12 versus 14 h after drinking). Similarly, the biomarkers of
alcohol metabolism and oxidative stress were assessed at various points in time after alcohol intake,
and the timing of the assessments differed between the two studies. Of note, the expression of various
cytokines is interrelated and time-dependent. Therefore, different timing of assessments may explain
why in some study designs, a relationship of a biomarker of alcohol metabolism or specific cytokines
significantly correlated with hangover severity, while in another study, the same correlation does not
reach statistical significance. Notwithstanding this, it is clear from all studies that alcohol consumption
is followed by oxidative stress and an inflammatory response.
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There are several issues that deserve attention when interpreting the results of the two studies we
re-analyzed here. First, participants of the studies were young males only. Therefore, it is unclear to
what extent the results can be generalized to females and other age groups. Research has shown that age
and sex differentially impact both alcohol elimination rate [31] and inflammatory responsiveness [32].
Other studies that did include both male and female subjects (discussed in the introduction section of
this article) did not report any sex or age differences in aspects of the pathology of the alcohol hangover.
However, these aspects may not have been reported as the investigated samples were not powered to
conduct such comparisons. Future research should therefore be conducted in samples comprising both
men and women, and also investigate other age groups. These studies should have sufficient sample
size to allow comparisons among groups.
Second, the subjects in the re-evaluated studies were of Asian descent. There are differences
reported in ethanol metabolism between different ethnic groups. For example, it has been found
that in populations of Asian descent, subjects with ALDH2*2 alleles, i.e., those who breakdown
acetaldehyde more slowly, typically report significantly worse hangovers, and are more likely to
experience hangovers at relatively lower alcohol consumption levels. [33,34]. Therefore, future studies
should confirm the current observations in subjects of non-Asian descent.
Third, the administered amount of alcohol consumed was relatively low in the re-evaluated
studies. It would be interesting to further investigate the observed effects when higher amounts of
alcohol are consumed that may better reflect real-life alcohol consumption. On the other hand, also
with the currently applied consumption levels, inflammatory effects were evident. Moreover, recent
studies have demonstrated that consuming large amounts of alcohol is not a necessity for having
hangovers [35]. In fact, a recent large sample study revealed an average estimated BAC of 0.03% of
subjects that reported a hangover [36], which is lower that the achieved BACs in the re-evaluated
studies here.
Fourth, both studies assessed hangover severity using a composite scale of hangover symptoms.
Recent examinations revealed that the magnitude of hangover severity of composite scales ultimately
depends on which symptoms are included in such scales [37]. This may have had an impact on the
correlational analyses. Future research should also use single-item hangover severity assessments
as these better reflect overall hangover severity, and its impact. It is also important to thoroughly
investigate whether potential participants of hangover studies will likely have a hangover when a
certain amount of alcohol is consumed. In the study by Kim et al. [22], n = 10 subjects were excluded
after participation because they reported no hangover during the study. Instead of excluding them
after participation, it is more ideal to identify them during screening, and screening tools for this
purpose are currently under development.
To conclude, it should be noted that the current body of data examining the pathology of the
alcohol hangover is limited, and much more research is needed to further elucidate the exact nature of
how ethanol metabolism, oxidative stress and the immune response are interrelated and may impact
hangover severity. In this context, it is important to note that the two studies in this article comprised
only male participants. As it is known that ethanol elimination rate is influenced by sex, future studies
should be conducted to further investigate the role of the immune system on hangover in samples
comprising both men and women, of different ethnicity and age.
Taken together, the timing of the observed assessments (see Figures 2 and 3) suggests that initial
slow elimination of ethanol in the first hours after drinking results in more ethanol present in the
second half of the night and the next morning, which will elicit more oxidative stress and a stronger
inflammatory response. Together, these processes result in having more severe next-morning hangovers
(See Figure 4).
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Figure 4. The relationship of alcohol metabolism, oxidative stress and the inflammatory response
with hangover severity. Note: The rate of alcohol metabolism, i.e., the conversion of ethanol into
acetaldehyde and other aldehydes, seems to be the primary determinant of hangover severity.
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Abstract: Several dietary components have been shown to influence alcohol metabolism and thereby
potentially affect the development of a hangover. From the literature, it is evident that dietary
nicotinic acid and zinc play a pivotal role in the oxidation of ethanol into acetaldehyde. The aim of
the current study was to associate dietary intake of nicotinic acid and zinc with hangover severity.
To this end, data from n = 23 healthy social drinkers who participated in a naturalistic hangover study
were analyzed. n = 10 of them reported to be hangover-resistant (the control group), whereas n = 13
reported to have regular hangovers (the hangover-sensitive group). Two 24 h dietary recall records
were completed, one for the day of alcohol consumption and another one for an alcohol-free control
day. Dietary nutrient intake was averaged and did not significantly differ between hangover-sensitive
and hangover-resistant drinkers. For the hangover-sensitive drinkers, partial correlations with
overall hangover severity were computed, controlling for estimated blood alcohol concentration.
A bootstrapping technique was applied to account for the relatively small sample size. The results
showed that dietary intake of nicotinic acid (rPB = −0.521) and zinc (rPB = −0.341) were significantly
and negatively associated (p < 0.002) with overall hangover severity. Dietary zinc intake was
also significantly and negatively associated with severity of vomiting (rPB = −0.577, p < 0.002).
No significant associations with hangover severity were found for other nutrients, such as fat and
fibers. In conclusion, this study suggests that social drinkers who have a higher dietary intake
of nicotinic acid and zinc report significantly less severe hangovers. As hangover-resistant and
hangover-sensitive drinkers had a similar dietary nutrient intake, the claim of being hangover-resistant
must be based on other unknown biopsychosocial factors. These findings should be replicated in a
larger sample and include more elaborate food frequency questionnaires or nutrient-specific dietary
intake records for zinc and nicotinic acid, and preferably accompanied by nutrient assessments in
urine and/or blood.
Keywords: alcohol; hangover; nutrients; zinc; nicotinic acid; bootstrapping
1. Introduction
The alcohol hangover refers to the combination of mental and physical symptoms, experienced
the day after a single episode of heavy drinking, starting when blood alcohol concentration (BAC)
approaches zero [1]. The pathology underlying alcohol hangover is not well understood [2,3],
and increasingly the subject of scientific investigation. In parallel, research has also been directed at
the development of alcohol hangover treatments. This has led to the study of compounds that can
influence the immune response to heavy alcohol consumption (which is assumed to contribute to alcohol
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hangover). Several hangover treatments have been reported to attenuate the rise in blood cytokines
concentrations seen after heavy drinking, as well as reducing selective next day hangover symptoms.
For example, Kim et al. [4] showed that Hovenia dulcis Thunb fruit extract (containing dihydromyricetin
and heteropolysaccharides) significantly reduced blood cytokine concentrations that were increased
due to heavy drinking. This was accompanied by a significant reduction in overall hangover severity.
Interestingly, Hovenia dulcis Thunb fruit extract had no effect on alcohol metabolism (i.e., blood ethanol
and acetaldehyde concentrations were not different from the alcohol only condition).
A different approach is to develop compounds that accelerate alcohol metabolism. The rationale
for this approach is that more rapid elimination of ethanol and acetaldehyde could reduce the presence
and severity of alcohol hangover symptoms. This hypothesis is supported by recent research showing
that urine ethanol concentration was significantly lower in drinkers claiming to have no hangover
after heavy alcohol consumption compared to drinkers who reported a hangover [5]. Although overall
hangover severity was positively associated with the amount of ethanol found in urine of those who
reported having a hangover, the partial correlation controlling for eBAC was not statistically significant.
Nevertheless, this finding suggests that drinkers with slower alcohol metabolism, i.e., those with more
ethanol in their urine, report significantly more frequent, and more severe hangovers. In other words,
speeding up alcohol metabolism may have a beneficial effect on reducing hangover severity.
Another approach to the development of hangover treatments is to examine whether dietary
nutrient intake has an effect on hangover severity. Two review papers have addressed this [6,7].
Firstly, Min et al. [6] argued that various minerals, including selenium, zinc, copper, vanadium, iron,
and magnesium, may have a direct effect on either alcohol metabolism, on glutamatergic activity, or may
influence the presence and severity of alcohol hangover via their antioxidant and/or anti-inflammatory
properties. Secondly, Wang et al. [7] described the proposed mechanism of action of a number of
natural products that might alleviate alcohol hangover symptoms. Both authors stressed that their
hypotheses were based on limited animal research, and that research in humans is necessary to
investigate the actual efficacy of minerals and herbal supplements in reducing or preventing alcohol
hangover symptoms.
The scientific literature indicates that food intake can indeed have a significant effect on
alcohol metabolism, both quantitatively and qualitatively. For example, relative to fasting,
the consumption of foods before or together with alcohol reduces peak blood alcohol concentration
(BAC), decreases absorption and slows metabolism [8–10]. In particular, ‘high-energy’ meals may
slow down alcohol metabolism and reduce subjective intoxication [11–13]. Specific food products or
nutrients have also been investigated. However, mixed results have been reported in relation to alcohol
metabolism. For example, Kim et al. [14] found that consuming a mixed fruit and vegetable juice
(Angelica keiskei/green grape/pear juice) significantly reduced peak BAC. In another study, Hong [15]
examined the effect of a purported hangover treatment (DTS20, a mixture that consists of Viscum album L.,
Lycium chinense L., Inonotus obliquus, and Acanthopanax senticosus H.). The proposed active ingredients of
DTS20 are sugar, uronic acid, and polyphenols. Relative to placebo, DTS20 significantly reduced BAC
at 2 h after drinking alcohol in the form of Soju. The reduction in blood acetaldehyde levels, however,
did not reach statistical significance. Taken together, there is limited evidence to date to support the
notion that acute intake of specific nutrients can alter alcohol metabolism. Thus, further research into
nutrients that can accelerate alcohol metabolism is warranted. Research on the possible impact of
regular nutrient intake on hangover susceptibility to hangovers or relating nutrient intake to hangover
symptom severity is currently lacking.
Alcohol is metabolized primarily in the liver via a two-step reaction (see Figure 1) [16,17].
First, ethanol is oxidized into acetaldehyde, which is highly toxic. Although the first step in alcohol
metabolism is reversible, acetaldehyde is usually metabolized rapidly. In this second step, acetaldehyde
enters the mitochondria where it is oxidized into acetate and water. This process is facilitated by
mitochondrial aldehyde dehydrogenase (ALDH). For both steps, nicotinamide adenine dinucleotide
86
J. Clin. Med. 2019, 8, 1316
(NAD+) is essential to provide the necessary energy for the conversion, which becomes available when
NAD+ is converted into NADH + H+.
Figure 1. Pathways involved in alcohol metabolism. In the major metabolic pathway (A) ethanol is
oxidized into acetaldehyde. This oxidative process is facilitated by alcohol dehydrogenase (ADH),
which is present in high concentration in the cytosol of hepatocytes. In this second step, acetaldehyde
enters the mitochondria where it is oxidized into acetate and water. This process is facilitated by
mitochondrial aldehyde dehydrogenase (ALDH). For both steps, nicotinamide adenine dinucleotide
(NAD+) is essential to provide the necessary energy for the conversion, which becomes available when
NAD+ is converted into NADH+H+. A second major pathway for alcohol breakdown, especially active
in subjects who chronically drink alcohol, is the microsomal ethanol oxidizing system (MEOS, see (B)).
The reaction is catalyzed by CYP2E1 and requires nicotinamide adenine dinucleotide phosphate
(NADP+) instead of NAD+ to convert ethanol into acetaldehyde.
NADP+ can be formed from NAD+, and differs from NAD+ in the presence of an additional
phosphate group [18]. The conversion of acetaldehyde into acetate and water is similar to that
overserved in the major alcohol metabolism pathway and requires NAD+. A third minor pathway
oxidizes ethanol into acetaldehyde via catalase (not shown in Figure 1) [17]. Together, the oxidative
pathways account for over 90% of alcohol elimination [19]. Thus, ADH thus plays a vital role in
alcohol metabolism.
Two nutrients are known to play an important role in alcohol metabolism, namely nicotinic
acid and zinc [20,21]. Dietary intake of these micronutrients is necessary, as the body is unable to
synthesize them itself [22,23]. Other nutrients do not seem to have an important direct influence on
alcohol metabolism.
Zinc (Zn2+) is absorbed from the small intestine. Most zinc can be found in tissue, with only 0.1%
of total bodily zinc present in blood, where most (~70%) is bound to serum albumin [24]. From here
zinc is transported as needed to body tissues. Since zinc is essential in the conversion of ethanol into
acetaldehyde [20,21], we hypothesize that drinkers who consume abundant amounts of dietary zinc
metabolize alcohol faster than those who consume relatively lower levels.
Niacin and its equivalents are the main dietary source of NAD+. Tryptophan is also a source of
NAD+, and its relative contribution is estimated as 60 mg of tryptophan equaling 1 mg of nicotinic acid
and other niacin equivalents, although a 30% individual variability in the conversion from tryptophan
into nicotinic acid has been observed [25]. For the MEOS alcohol metabolism pathway (see Figure 1),
NADP+ is required. Nicotinic acid and its equivalents are the dietary sources of both NAD+ and
NADP+, which together catalyze alcohol metabolism.
We hypothesize that when abundant amounts of nicotinic acid are present in the daily diet of
a drinker, alcohol is metabolized faster than in drinkers who have lower levels of dietary nicotinic
acid intake. To investigate the hypothesis that higher levels of dietary nicotinic acid and zinc may
be protective against alcohol hangover of healthy social drinkers, dietary food intake was recorded
during an experimental hangover study. Dietary nicotinic acid and zinc intake were computed and
related to hangover severity.
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2. Materials and Methods
A naturalistic study was conducted, including a ‘control day’ (no alcohol consumed) and
a ‘hangover day’ (alcohol consumed the evening before), separated by approximately one week.
Written informed consent was obtained from each participant, and The University of Groningen
Psychology Ethics Committee approved the study.
2.1. Subjects
n = 23 subjects participated in the study. Of them, n = 13 subjects (n = 7 men and n = 6 women)
regularly have hangovers when they consume alcohol and n = 10 (n = 4 men and n = 6 women)
drinkers claimed to be hangover-resistant. They were recruited by local advertisement at Utrecht
University. After indicating interest, participants were contacted over the phone and underwent an
initial screening. Subjects were included if they were between 18–30 years old, mentally and physically
healthy, social drinkers. Recreational drug users and smokers were excluded from participation.
Further exclusion criteria comprised a positive urine drug or pregnancy screen, the use of medicinal
drugs (including over-the-counter pain killers), and alcohol consumption within 24 h before the start of
the control test day. To maximize the likelihood that subjects would actually have a hangover during
the study, subjects were included only if it was demonstrated that they consume sufficient amounts
of alcohol that can produce a hangover per se. To check this, estimated blood alcohol concentration
(eBAC) was calculated for the alcohol consumption they reported for ‘a regular night out’. This was
done by applying a modified Widmark equation [26], taking into account gender and body weight.
To be enrolled in the study, an eBAC of 0.08% or higher was required, based on hangover susceptibility
likelihood calculations by Verster et al. [27] and Kruisselbrink et al. [28].
2.2. Procedures
The naturalistic design was chosen to closely mimic a realistic real-life hangover experience which
has relatively higher ecological validity compared with other methodologies [29]. Researchers were
not present during alcohol consumption, and thus had no influence on the participants’ (drinking)
behavior. Participants, therefore, dictated their own time period of drinking, types of alcoholic
beverages consumed, and their activities during drinking (e.g., staying at home, going to a bar, dancing,
etc.). Subjects were asked not to change their lifestyle while participating in the study. They were
asked to refrain from consuming any alcohol three days prior to the control day. Both test days
started at 9 a.m. Subjects completed a 24 h dietary recall diary [30] and the presence and severity of
hangover symptoms were assessed. A urine drug screen (Instant-View, determining the presence of
amphetamines, barbiturates, cannabinoids, benzodiazepines, cocaine, and opiates) was conducted
according to the manufacturer’s instructions (Alfa Scientific Designs, Inc., Poway, CA, USA).
2.3. Alcohol Consumption and Hangover Severity
At 09:45 a.m., previous night alcohol consumption was recorded (number of units), including the
times at which drinking commenced and ceased. The adjusted Widmark formula [26] was used to
calculate eBAC. Overall hangover severity was assessed with a single one-item rating on an 11-point
scale ranging from 0 (absent) to 10 (extreme) [31]. In addition, using the same scale, severity of
23 hangover symptoms was assessed, including headache, nausea, concentration problems, regret,
sleepiness, heart pounding, vomiting, being tired, shaking/shivering, clumsiness, weakness, dizziness,
apathy, sweating, stomach pain, confusion, sensitivity to light, sensitivity to sound, thirst, heart racing,
anxiety, depression, and reduced appetite.
2.4. Dietary Recall
The participants were asked to complete a 24-h dietary recall diary [31]. This assessed the 24 h
dietary intake before both test days. Participants wrote down the amount and type of food as precisely
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as possible. Subjects were asked to record all food and beverages consumed for breakfast, lunch,
dinner, and ‘in-between’ during the past 24 h. They were instructed to write down the time of
consumption and the amount consumed (i.e., an estimate of the portion size). Examples were provided
on how to complete the diary. Participants were urged not to forget smaller, ‘less significant’ food
items, such as pieces of candy and to include details such as whether or not they buttered any bread
consumed. Nutrient calculations were performed using the ‘eetmeter’ (‘eating meter’ in English) [32],
developed by the ’Voedingscentrum’ of ‘Rijksinstituut voor Volksgezondheid en Milieu’ (RIVM).
The assessments take into account quantities, frequency, and portion sizes of consumed food and
beverages. Nutrients obtained from alcoholic and non-alcoholic beverages, consumed during the
drinking session, were included in the calculation models. The ‘eetmeter’ provided data on nutrient
intake of nicotinic acid, zinc, total fat (triglycerides, esters derived from glycerol and fatty acids,
and fatty constituents such as phosphatides and sterols), saturated fat (total of saturated fatty acids),
carbohydrates (total of mono- and disaccharides, starch, dextrin, and glycogen), proteins, fibers, water,
sugar, vitamin A (retinol), vitamin B1 (thiamine), vitamin B2 (riboflavin), vitamin B6 (pyridoxine,
including pyridoxal and pyridoxamine), vitamin B11 (folic acid), vitamin B12 (cobalamins), vitamin C
(ascorbic acid, including L-ascorbic acid and L-dehydro-ascorbic acid), vitamin D (cholecalciferol and
25-hydroxy vitamin D), vitamin E, salt, sodium, potassium, calcium, magnesium, iron, selenium, iodine,
and phosphorus [33]. Dietary intake was computed for the alcohol and the control day. The average
dietary intake of the two days was computed to better represent daily dietary nutrient intake.
2.5. Statistical Analysis
Statistical analyses were conducted with SPSS, version 25 (Armonk, IBM Corp, New York, NY,
USA). Mean and standard deviation (SD) were computed for each variable. Hangover-sensitive drinkers
were included in the analysis if they had an overall hangover score of 2 or higher. Hangover-resistant
drinkers were included in the analysis is they had an overall hangover score of 0 or 1. Firstly,
nutrient intake was computed separately for the alcohol test day and alcohol-free control day
respectively. These were combined into a two-day average score to better reflect regular nutrient intake.
Secondly, dietary nutrient intake of hangover-sensitive and hangover-resistant drinkers was compared.
Third, dietary nutrient intake of hangover-sensitive drinkers was correlated with overall hangover
severity, by computing partial correlations (rP), controlling for eBAC. This approach controlled for
the different alcohol consumption levels between participants. Thirdly, nutrient intake levels that
correlated significantly with overall hangover severity were further correlated with the 23 individual
hangover severity measures, again by computing rP, controlling for eBAC.
To further examine the data and account for the relatively small sample size, a bootstrapping
analysis [34,35] was conducted to simulate the population distributions of the partial correlations (rP).
Bootstrapping and interpretation of its results are summarized in Figure 2. In bootstrapping, data from
the original sample (Figure 2A) are used to generate B new datasets (Figure 2B). The new samples
have the same sample size as the original sample. The new samples are constructed by randomly
drawing cases (resampling), with replacement, from the original sample. In the current analysis,
B = 10.000 samples (of n = 13 subjects each) were created (Figure 2C), a recommended resampling size
for bootstrapped CI estimation [36]. For each of the bootstrap samples a new rP is then computed
(the bootstrapped partial correlation, denoted as rPB). Composing a histogram of all rPB (Figure 2D)
results in a histogram with a normal distribution that usually mimics the population distribution [36].
Subsequently, it can then be calculated how much the rPB’s vary across the bootstrap samples
(Standard Error, SE). The reported ‘Bias’ measure represents the deviation of the overall rPB from the rP
that was obtained from the original sample [37]. To compute the corresponding bootstrapped confidence
interval (CIB), a Bias Corrected and accelerated (BCa) correction was applied [38]. This correction
was applied to adjust for the observed Bias, and to account for potential skewness of the bootstrap
distribution (operationalized as SE). In the case of (partial) correlations, CIB’s can range from −1 to
+1. Narrow CIB’s imply greater precision, and if the CIB does not include zero, the rPB is considered
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statistically significant (Figure 2E). Usually, 95% CIB’s are computed (corresponding to a significance
level of α = 5%). However, to correct for the multiple comparisons in the current study, a 99.8% CIB
was computed (corresponding to a significance level of p < 0.002).
Figure 2. The bootstrapping technique. (A) original sample, (B) new datasets, (C) B = 10.000 samples,
(D) Composing a histogram of all rPB, (E) rPB is considered statistically significant. Abbreviations:
rP = partial correlation, rPB = bootstrapped partial correlation, BCa = bias-corrected and accelerated,
CIB = bootstrapped confidence interval.
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3. Results
Data from n = 13 hangover-sensitive subjects (seven men and six women) were included in the
analysis. Their mean (±SD) age was 20.8 (±1.4) years old. Their mean height and weight were 1.76
(±0.07) m and 70.8 (±7.9) kg, respectively. They consumed a mean of 11.3 (±3.8) alcoholic drinks
on the alcohol test day, resulting in an eBAC of 0.20 (±0.07)%, and a next-day overall hangover
score of 6.2 (±2.2). n = 10 hangover-resistant drinkers (four men and six women) served as control
group in this study. Demographics and drinking variable outcomes were comparable to those of the
hangover-sensitive group. Their mean (±SD) age was 21.2 (±2.4) years old. Their mean height and
weight were 1.76 (±0.11) m and 73.0 (±15.9) kg, respectively. They consumed a mean of 13.0 (±6.2)
alcoholic drinks on the alcohol test day, resulting in an eBAC of 0.22 (±0.12)%, and a next-day overall
hangover score of 0.2 (±0.4). Dietary nutrient intake of hangover-sensitive drinkers did not significantly
differ from that of hangover-resistant drinkers. Moreover, alcohol consumption and eBAC did not
significantly differ between the two groups. The next statistical analysis was, therefore, conducted
only for the hangover-sensitive group. Dietary nutrient intake on the alcohol and control day are
summarized in Table 1.
Table 1. Dietary nutrient intake.
Nutrient Control Day Alcohol Day p-Value 2-Day Average
Nicotinic acid (mg) 22.0 (17.1) 34.8 (19.4) 0.075 28.4 (14.9)
Zinc (mg) 9.7 (3.4) 12.6 (8.3) 0.134 11.2 (5.3)
Total fat (g) 83.6 (19.2) 103.1 (47.6) 0.221 93.4 (26.7)
Saturated fat (g) 27.3 (10.2) 35.5 (20.2) 0.249 31.4 (11.6)
Carbohydrates (g) 208.0 (57.8) 330.3 (86.7) 0.002 269.2 (62.2)
Proteins (g) 91.6 (38.3) 108.2 (69.0) 0.650 99.9 (45.9)
Fibers (g) 22.7 (7.5) 26.2 (5.5) 0.158 24.5 (4.8)
Salt (g) 7.5 (3.0) 10.1 (5.6) 0.055 8.8 (3.8)
Alcohol (g) 0 (0) 128.2 (45.3) 0.001 * 64.1 (22.6)
Water (ml) 942.7 (347.6) 3165.2 (933.9) 0.001 * 2053.9 (533.8)
Sodium (mg) 2989.3 (1121.5) 3843.4 (1946.8) 0.016 3416.3 (1396.2)
Potassium (mg) 2987.1 (695.6) 4228.5 (1287.1) 0.003 3607.8 (901.2)
Calcium (mg) 749.4 (356.7) 863.2 (472.4) 0.552 806.3 (285.3)
Magnesium (mg) 301.6 (86.9) 454.4 (168.3) 0.003 378.0 (111.4)
Iron (mg) 10.2 (2.2) 11.7 (4.7) 0.311 11.0 (2.9)
Selenium (mg) 52.8 (30.4) 60.8 (34.5) 0.916 56.8 (26.4)
Iodine (mg) 188.8 (51.4) 187.1 (76.6) 0.600 187.3 (52.6)
Phosphorus (mg) 1464.3 (504.9) 1622.2 (1134.5) 0.701 1543.3 (693.4)
Vitamin A (mg) 665.6 (640.6) 769.3 (521.8) 0.345 717.5 (451.8)
Vitamin B1 (mg) 0.9 (0.2) 1.2 (0.9) 0.421 1.1 (0.5)
Vitamin B2 (mg) 1.3 (0.5) 1.8 (0.9) 0.133 1.5 (0.5)
Vitamin B6 (mg) 1.7 (0.9) 2.7 (1.3) 0.011 2.2 (0.9)
Vitamin B11 (mg) 238.4 (100.8) 349.4 (129.0) 0.033 293.9 (86.3)
Vitamin B12 (mg) 7.4 (12.4) 4.3 (2.8) 0.861 5.8 (6.0)
Vitamin C (mg) 89.2 (52.6) 97.1 (95.4) 0.969 93.2 (65.4)
Vitamin D (mg) 2.0 (1.9) 3.1 (1.8) 0.084 2.5 (1.4)
Vitamin E (mg) 13.3 (5.7) 14.4 (7.0) 0.807 13.8 (4.7)
Energy (Kcal) 2003.7 (406.8) 3655.8 (1030.0) 0.001 * 2829.8 (621.1)
Related-samples Wilcoxon singed rank test. Results are significant if p < 0.0017, after Bonferroni’s correction for
multiple comparisons, indicated by *.
On the alcohol day, alcohol was consumed, and this was accompanied by significantly increased
water intake (included in the beverages). As a result, the energy intake on the alcohol day was also
significantly greater compared to the control day. However, dietary nutrient intake data show no
significant differences between the alcohol day and the control day. Therefore, the statistical analysis
that follows the two-day average nutrient intake is used. The association of dietary nutrient intake and
overall hangover severity is summarized in Table 2.
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Table 2. Association between dietary nutrient intake (two-day average) and overall hangover severity.
Original Sample Bootstrapping Results
Nutrients rP p-Value Bias SE rPB Lower CIB Limit Upper CIB Limit
Nicotinic acid * −0.512 0.089 0.009 0.185 −0.521 −0.893 −0.032
Zinc * −0.393 0.206 −0.052 0.219 −0.341 −0.829 −0.109
Total fat −0.014 0.967 0.018 0.338 −0.032 −0.993 +0.998
Saturated fat 0.021 0.948 −0.011 0.331 −0.010 −0.917 +0.910
Carbohydrates −0.223 0.485 −0.029 0.274 −0.204 −0.991 +0.940
Proteins −0.285 0.370 0.000 0.269 −0.285 −0.997 +0.939
Fibers −0.157 0.627 0.004 0.319 −0.161 −1.000 +0.999
Salt −0.059 0.855 −0.073 0.424 −0.014 −0.981 +0.973
Alcohol 0.138 0.669 −0.026 0.294 0.112 −0.858 +0.910
Water −0.103 0.749 −0.037 0.277 −0.066 −0.880 +0.764
Sodium −0.157 0.626 −0.041 0.365 −0.116 −0.973 +0.856
Potassium −0.409 0.187 0.004 0.266 −0.413 −0.985 +0.846
Calcium −0.045 0.890 0.006 0.282 −0.051 −0.933 +0.946
Magnesium −0.499 0.098 0.007 0.233 −0.506 −0.954 +0.328
Iron −0.250 0.433 0.008 0.282 −0.258 −1.000 +1.000
Selenium −0.356 0.256 0.017 0.292 −0.373 −0.971 +0.912
Iodine −0.347 0.270 0.024 0.255 −0.371 −0.967 +0.885
Phosphorus −0.355 0.258 0.034 0.247 −0.389 −1.000 +0.872
Vitamin A 0.125 0.698 0.012 0.243 0.137 −0.848 +0.962
Vitamin B1 0.019 0.952 0.017 0.272 0.036 −0.883 +0.874
Vitamin B2 −0.193 0.549 0.000 0.288 −0.193 −0.986 +0.723
Vitamin B6 −0.407 0.189 0.000 0.293 −0.407 −0.994 +0.950
Vitamin B11 −0.175 0.586 −0.014 0.354 −0.161 −0.996 +0.897
Vitamin B12 0.096 0.768 −0.046 0.279 0.050 −0.875 +0.697
Vitamin C 0.489 0.107 −0.125 0.417 0.364 −0.885 +0.947
Vitamin D −0.146 0.651 −0.023 0.341 −0.123 −0.976 +0.956
Vitamin E 0.083 0.797 −0.003 0.273 0.080 −0.770 +0.917
Energy (Kcal) −0.145 0.652 −0.009 0.259 −0.136 −0.961 +0.925
Bootstrapping was conducted with B = 10.000 samples. A BCa 99.8% CIB (corresponding to p < 0.002) was used
to correct for multiple comparisons. Partial correlations control for eBAC and are significant if the BCa 99.8%
CIB does not contain zero, indicated by *. Abbreviations: rP = partial correlation, rPB = bootstrapped partial
correlation, eBAC= estimated blood alcohol concentration, SE= standard error, BCa= bias-corrected and accelerated,
CIB = bootstrapped confidence interval.
The association between both the two-day average dietary nicotinic acid and zinc intake and
hangover severity is shown in Figure 3. It is evident from Figure 3 that higher levels of dietary
nicotinic acid and zinc are associated with less severe alcohol hangovers. After bootstrapping with
10.000 samples the rPB’s were statistically significant (p < 0.002). Increasing the bootstrap sample size
to B = 100.000 samples did not alter the results. Bootstrapping analysis of other nutrients revealed no
significant rPBs between overall hangover severity and dietary nutrient intake (see Table 2).
Figure 4 summarizes the mean (SD) severity scores on the individual hangover symptoms.
A bootstrapping analysis was conducted to investigate the rPB’s, controlling for eBAC, between
individual hangover symptom severity scores and dietary intake of nicotinic acid and zinc.
The bootstrapping results are summarized in Tables 3 and 4.
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Figure 3. The negative association of dietary nicotinic acid intake (two-day average) and dietary zinc
intake with overall hangover severity. Figure 3 shows the partial correlation (rP), controlled for eBAC,
between (A) dietary nicotinic acid and (B) zinc intake (two-day average) and overall hangover severity.
Figure 4. Hangover symptom severity. The average score across all subjects is shown for each hangover
symptom in (A). (B) shows the hangover severity reported by only those subjects that endorsed the
hangover symptom. Error bars represent the standard error.
Table 3. Association between dietary nicotinic acid intake (two-day average) and hangover
symptom severity.
Original Sample Bootstrapping Results
Hangover Symptoms rP p-Value Bias SE rPB Lower CIB Limit Upper CIB Limit
Concentration problems −0.163 0.612 0.049 0.329 −0.212 −0.940 +0.948
Sleepiness −0.248 0.437 −0.022 0.386 −0.226 −0.985 +0.885
Being tired −0.448 0.145 0.043 0.348 −0.531 −1.000 +0.998
Thirst −0.157 0.625 −0.013 0.255 −0.144 −0.897 +0.634
Nausea −0.447 0.145 0.103 0.347 −0.550 −1.000 +1.000
Clumsiness −0.272 0.392 0.029 0.302 −0.301 −0.975 +0.942
Reduced appetite −0.181 0.573 0.080 0.360 −0.261 −1.000 +0.998
Headache −0.561 0.058 0.049 0.234 −0.610 −0.987 +0.911
Weakness −0.141 0.662 0.028 0.348 −0.169 −0.998 +1.000
Dizziness −0.281 0.376 0.062 0.334 −0.343 −0.940 +0.792
Apathy −0.303 0.339 0.120 0.419 −0.423 −0.987 +0.994
Stomach pain −0.363 0.246 0.027 0.299 −0.390 −0.973 +0.813
Sensitivity to light −0.352 0.262 0.082 0.345 −0.434 −0.985 +0.919
Sensitivity to sound −0.406 0.190 0.064 0.349 −0.470 −1.000 +0.865
Shaking, shivering −0.430 0.163 0.018 0.248 −0.448 −0.999 +0.940
Confusion −0.204 0.524 0.047 0.334 −0.251 −0.999 +0.987
Depression −0.335 0.287 0.061 0.354 −0.396 −0.982 +0.961
Regret −0.324 0.304 0.078 0.365 −0.402 −0.994 +0.998
Heart pounding −0.514 0.087 0.054 0.282 −0.568 −1.000 +0.997
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Table 3. Cont.
Original Sample Bootstrapping Results
Hangover Symptoms rP p-Value Bias SE rPB Lower CIB Limit Upper CIB Limit
Sweating −0.347 0.268 0.071 0.366 −0.418 −0.994 +0.973
Vomiting −0.506 0.093 0.016 0.235 −0.522 −0.999 +0.985
Heart racing −0.439 0.154 0.066 0.325 −0.505 −1.000 +0.980
Anxiety −0.379 0.224 0.059 0.346 −0.438 −0.977 +0.842
Reported r and p-value are from the original rP, controlling for eBAC. Bootstrapping was conducted with B = 10.000
samples. A 99.8% CIB (corresponding to p < 0.002) was used to correct for multiple comparisons. None of
the correlations are significant, as their BCa 99.8% CIB contains zero. Abbreviations: rP = partial correlation,
eBAC = estimated blood alcohol concentration, SE = standard error, BCa = bias-corrected and accelerated,
CIB = bootstrapped confidence interval.
Table 4. Association between dietary zinc intake (two-day average) and hangover symptom severity.
Original Sample Bootstrapping Results
Hangover Symptoms rP p-Value Bias SE rPB Lower CIB Limit Upper CIB Limit
Concentration problems −0.128 0.691 −0.007 0.314 −0.121 −0.854 +0.887
Sleepiness −0.055 0.865 −0.072 0.326 0.023 −0.855 +0.741
Being tired −0.195 0.544 −0.020 0.305 −0.175 −0.979 +0.933
Thirst −0.045 0.888 0.000 0.224 −0.045 −0.816 +0.659
Nausea −0.077 0.813 −0.050 0.370 −0.027 −0.904 +0.806
Clumsiness −0.209 0.514 −0.054 0.275 −0.155 −0.910 +0.703
Reduced appetite 0.105 0.745 −0.048 0.404 0.057 −0.956 +0.939
Headache −0.260 0.414 −0.022 0.241 −0.238 −0.882 +0.611
Weakness −0.002 0.995 −0.128 0.473 0.126 −0.963 +0.932
Dizziness −0.005 0.988 −0.052 0.403 0.047 −0.952 +0.933
Apathy 0.060 0.853 −0.019 0.373 0.041 −0.972 +0.965
Stomach pain −0.117 0.718 −0.103 0.389 −0.014 −0.978 +0.765
Sensitivity to light −0.138 0.669 −0.031 0.292 −0.107 −0.845 +0.674
Sensitivity to sound −0.157 0.627 −0.047 0.298 −0.110 −0.851 +0.699
Shaking, shivering −0.370 0.236 −0.076 0.290 −0.294 −0.958 +0.492
Confusion −0.113 0.726 −0.071 0.390 −0.042 −0.961 +0.982
Depression −0.160 0.618 −0.085 0.425 −0.075 −0.960 +0.984
Regret −0.150 0.641 −0.061 0.431 −0.089 −0.980 +0.987
Heart pounding −0.298 0.347 −0.067 0.384 −0.231 −0.995 +0.952
Sweating −0.136 0.674 −0.061 0.479 −0.075 −0.964 +0.972
Vomiting * −0.609 0.035 −0.032 0.179 −0.577 −0.944 −0.059
Heart racing −0.211 0.511 −0.076 0.411 −0.135 −0.976 +0.962
Anxiety −0.214 0.505 −0.065 0.466 −0.149 −0.990 +0.993
Reported rP and p-value are from the original partial correlation, controlling for eBAC. Bootstrapping was conducted
with B = 10.000 samples. A 99.8% CIB (corresponding to p < 0.002) was used to correct for multiple comparisons.
The rPB’s are significant if the BCa 99.8% CIB does not contain zero, indicated by *. Abbreviations: rP = partial
correlation, eBAC= estimated blood alcohol concentration, SE= standard error, BCa= bias-corrected and accelerated,
CIB = bootstrapped confidence interval.
The rPB’s between hangover symptom severity and dietary intake of nicotinic acid were negative,
suggesting that increased dietary nicotinic acid intake is beneficial for reducing hangover symptom
severity. However, in contrast to overall hangover severity, the rPB’s with individual hangover
symptoms were not statistically significant (see Table 3).
The rPB’s between hangover symptom severity and dietary intake of zinc were also negative,
suggesting that also increased dietary nicotinic acid intake might be beneficial for reducing hangover
symptom severity. Dietary zinc intake (two-day average) was significantly associated with the severity
of vomiting (see Table 4 and Figure 5A). The negative rPB implies that higher levels of dietary zinc
are associated with less severe vomiting. Increasing the bootstrap sample size to B = 100.000 samples
did not alter the results. Figure 5B shows that the severity of vomiting is an important determinant
of overall hangover severity (rP = 0.661, p = 0.019, rPB = 0.635, significant at the p < 0.002 level).
No significant rPB’s were found between two-day average dietary zinc intake and the severity of the
other 21 hangover symptoms (see Table 4).
94
J. Clin. Med. 2019, 8, 1316
Figure 5. Severity of vomiting, dietary zinc intake, and overall hangover severity. (A) shows the partial
correlation (rP), controlled for eBAC, between dietary zinc intake (two-day average) and vomiting
severity during alcohol hangover. (B) shows the rP, controlled for eBAC, between overall hangover
severity and vomiting severity. After bootstrapping, both the corresponding rPB’s are significant at the
p < 0.002 level.
Finally, although the number of men (n = 7) and women (n = 6) did not allow for reliable sex
comparisons, we conducted some exploratory analysis. The analysis revealed that men had a higher
dietary nicotinic acid intake than women (38.0 mg and 17.2 mg, respectively, p = 0.002) as well as
a higher intake of zinc (13.8 mg and 8.1 mg, respectively, p = 0.022). The differences did not reach
significance at the p < 0.0017 level. Men reported less severe hangovers than women (scores of 5.0
and 7.5, respectively, p = 0.073), while their eBAC did not differ significantly (eBAC 0.20% and 0.19%,
respectively, p = 0.628). The partial correlations between dietary nicotinic acid and zinc intake and
hangover severity calculated for men and women separately were not statistically significant.
4. Discussion
The current study demonstrated that dietary nicotinic acid and zinc intake were significantly and
negatively associated with overall hangover severity. Both nutrients are essential in effective alcohol
metabolism and, therefore, the current findings suggest that more rapid and efficient oxidation of
ethanol into acetaldehyde, and acetaldehyde into acetate, may be associated with less severe hangovers.
There was no similar association found for the other nutrients that were examined.
Sufficient dietary intake of zinc and nicotinic acid are important to maintain health. Examples
of food rich in zinc are meat, shellfish (e.g., oysters), and legumes, such as lentils and beans.
The recommended dietary allowance for zinc is 11 mg per day for men and 8 mg per day for
women [39]. Deficiency of zinc can have serious health consequences and negatively impact immune
defense [23]. Zinc deficiency is relatively more common among the elderly. For example, a US study
found that only 42.5% of the elderly had an adequate level of dietary zinc intake [40].
Examples of food rich in nicotinic acid include those containing high levels of niacin or tryptophan
such as meat, fish and poultry, avocado, peanuts, whole grains, and mushrooms. The recommended
dietary allowance (RDA) for niacin and its equivalents is 16 mg per day for men and 14 mg per
day for women [41,42]. Pellagra (pigmented skin rash) is a common consequence of severe niacin
deficiency [43], and, although uncommon in the general population of Western countries, it is seen
among chronic alcoholics [41]. In this context, niacin supplementation has been suggested as a
treatment for alcoholism [44]. Our data suggest that this should be explored in more detail in
different types of social drinkers, given the obvious relationship between frequent heavy drinking and
hangover frequency.
The current finding may have implications for the development of effective hangover treatments.
Although there is a buoyant market for so-called hangover treatment among social drinkers [45],
currently they lack robust evidence of efficacy [46–48]. Several newly developed putative hangover
treatments are comprised of natural ingredients, such as plant extracts, herbs, minerals and
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vitamins [48]. For example, studies were conducted to investigate the effects of, Korean pear
juice [49] and red ginseng [50], which both showed some positive effects in reducing hangover
severity. However, other products, such as artichoke extract [51], showed no beneficial effects
on hangover. Kelly et al. [52] found that intravenous vitamin B complex and Vitamin C had no
significant effect on alcohol metabolism. Kahn et al. [53] reported that pyritinol (1200 mg oral
vitamin B6) significantly reduced the number of reported hangover symptoms, but unfortunately,
no assessments were conducted with regard to the severity of hangover symptoms. Laas [54]
conducted a double-blind placebo-controlled study to examine the efficacy of ‘Morning Fit’ (dried
yeast, thiamine nitrate (Vitamin B1), pyridozine hydrochloride (Vitamin B6) and riboflavin (Vitamin B2)
and found no significant differences in either blood alcohol or acetaldehyde concentrations between
the Morning Fit and placebo condition. Although significant improvements were reported for certain
individual symptoms, namely ‘uncomfortable feelings’, ‘restlessness’, and ‘impatience’, no significant
improvement was found on general wellbeing. A study conducted by Ylikahri et al. found no significant
effect of sugars such as fructose and glucose on alcohol metabolism or hangover severity [55]. A more
recent study by Bang et al. examined the effects on hangover of a polysaccharide-rich extract of
Acanthopanax senticosus (PEA) [56]. While blood sample analysis revealed no significant effect on alcohol
metabolism, PEA did, however, significantly reduce alcohol-induced next-day changes in glucose and
c-reactive protein levels (i.e., it was effective in reducing alcohol-induced hypoglycemia and inhibiting
the inflammatory response, respectively). Overall hangover severity, and the individual hangover
symptoms, such as tiredness, headache, dizziness, stomachache and nausea, significantly improved
after administering PEA.
Taken together, there is mixed evidence on acute effects of dietary nutrients on the presence and
severity of hangover symptoms. The current findings are also in contrast to anecdotal evidence that
suggests that taking fiber-rich food, consuming water, or eating fat-rich meals may reduce the severity
of alcohol hangovers.
In the current study, dietary zinc and nicotinic acid intake (or any other nutrient that was assessed)
did not significantly differ between hangover-sensitive drinkers and hangover-resistant drinkers. Thus,
it is unlikely that supplementing diet with high levels of nicotinic acid and zinc makes a hangover
sensitive drinker immune to hangovers. However, the data of hangover-sensitive drinkers clearly
show that higher dietary intake of both nutrients is associated with experiencing less severe hangovers.
The issue of drinkers claiming hangover resistance is a complex one. Data show that this claim
heavily depends on how much alcohol drinkers consume, but even at higher eBAC levels a small
proportion of drinkers claim not to have hangovers [27,28]. At the same time, other hangover research
showed no significant differences between the two groups of drinkers on several biomarkers such as
urine ethyl glucuronide (EtG) and ethyl sulfate (EtS) [57] or methanol [58], saliva cytokine levels [59],
sensitivity to acute alcohol effects [60], demographics [31], or psychological characteristics such as
mental resilience [61]. Additionally, the current study could not differentiate hangover-sensitive and
hangover-resistant drinkers based on their dietary nutrient intake. Thus, there must be different
unknown biopsychosocial factors (e.g., alexithymia) that may explain why some drinkers claim to be
hangover-resistant. Research did show that experiencing alcohol hangovers (compared to claiming to
be resistant) was associated with significantly poorer self-reported immune function [62] and having
higher urine ethanol concentrations during the hangover state [5]. Future research should further
investigate the puzzling phenomenon of hangover-resistance.
The study has several limitations. Firstly, it had a small sample size. Future research should,
therefore, aim to replicate the current findings in larger samples. The use of bootstrapping techniques
in hypothesis testing is increasingly popular [36] and was used in the current analysis to mitigate the
small sample size. Secondly, the sample size was too small to reliably assess possible gender differences.
Explorative analysis revealed that men had a higher intake of dietary nicotinic acid and zinc. Moreover,
women reported non-significantly higher hangover severity than men, and eBAC levels did not differ
significantly. These findings are in line with a recent analysis showing that the presence and severity
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of hangover symptoms experienced at the same eBAC levels show no relevant sex differences [63].
However, studies have shown sex differences in cognitive functioning and driving performance
the morning following bedtime administration of other psychoactive drugs, such as hypnotics [64].
Therefore, future replication research with larger sample size is required to further investigate possible
sex differences during the hangover state in these domains. Thirdly, eBAC assessments were based on
subjective retrospective recall of the number of alcoholic drinks consumed. These reports may to some
extent be inaccurate. In naturalistic study designs, researchers are not present during the drinking
occasion, to ensure the real-life ‘natural’ drinking setting, and retrospective assessments of alcohol
consumption are common practice. However, very recently real-time objective BAC assessment devices
have been developed that are capable of continuously recording transdermal BAC. It would be useful to
use such devices in future naturalistic studies. Fourthly, there were many statistical comparisons made
in the analysis. Although the primary aim was to investigate the association between dietary nicotinic
acid and zinc intake with overall hangover severity, we also collected data on 25 other nutrients and
23 individual hangover symptoms. A strict Bonferroni’s correction (p < 0.002) was applied to account
for this, and therefore we are confident with the reported statistical significance thresholds.
Dietary nutrient intake was collected via 24-h dietary recall records. These were completed by
the subjects the day after drinking, and thus recall bias may have resulted in underestimation or
overestimation of food portions, omitting food items or erroneously adding others. On the other
hand, there was good correspondence between the diary measures across the two collection periods.
Furthermore, the group average nutrient intake in the current study corresponds well to large scale
studies that assessed nutrient intake via elaborate food frequency questionnaires [41,42]. This provides
some confidence that recall bias played a minor role in the current study. Clearly, future research
should utilize more elaborate food frequency questionnaires, or nutrient-specific dietary records for
nicotinic acid or zinc. Additionally, assessments of nutrient status in blood or urine would provide an
objective measure of nutrient status.
It is relevant to note that dietary nutrients can impact alcohol metabolism via the gut and oral
microbiome. Dietary nutrient intake, as well as alcohol consumption, have an influence on the
composition of the microbiome. Several studies have reported the effects of alcohol consumption and
dietary intake on microbiota composition [65,66]. The effect of these on hangover is not well understood,
but a high abundance of several microbiota, including Rothia, Neisseria, and Streptococcus, is associated
with accelerated alcohol metabolism by producing relatively higher amounts of acetaldehyde [67].
Future research should investigate the relationship between the microbiome, and the presence and
severity of alcohol hangover. Moreover, there are several other factors that may influence alcohol
metabolism that were not assessed in the current study. These include, for example, various genetic
and environmental factors, sex, age, race, biological rhythms (time of day), and medicinal and
recreational drug use (e.g., compounds which inhibit ADH such as pyrazoles or isobutyramine),
Antabuse (disulfiram, which inhibits the elimination of acetaldehyde), or other alcohols that compete
with ethanol for ADH (e.g., methanol) [17]. These are also important topics for future research.
Finally, the oxidative pathways account for over 90% of alcohol elimination [19]. In addition,
there are also nonoxidative pathways for alcohol metabolism, producing metabolites such as
ethyl-glucuronide (EtG), ethyl-sulfate (EtS), phosphatidyl-ethanol (PEth) and fatty acid ethyl ester
(FAEE) [19]. As these pathways usually only process a very limited amount of alcohol, and thus the
overall impact of nutrients on alcohol metabolism via these pathways can be considered as marginal,
they were not taken into account in the current paper.
5. Conclusions
In conclusion, this study suggests that social drinkers who have a higher dietary intake of nicotinic
acid and zinc report significantly less severe hangovers.
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Abstract: Alcohol hangover is a combination of mental, sympathetic, and physical symptoms
experienced the day after a single period of heavy drinking, starting when blood alcohol concentration
approaches zero. How individual measures/domains of hangover symptomology might differ with
moderate to heavy alcohol consumption and how these symptoms correlate with the drinking markers
is unclear. We investigated the amount/patterns of drinking and hangover symptomology by the
categories of alcohol drinking. We studied males and females in three groups: 12 heavy drinkers
(HD;>15 drinks/week, 34–63 years old (y.o.)); 17 moderate drinkers (MD; 5–14 drinks/week, 21–30 y.o.);
and 12 healthy controls (social/light drinkers, SD;<5 drinks/week, 25–54 y.o.). Demographics, drinking
measures (Timeline followback past 90 days (TLFB90), Alcohol Use Disorders Identification Test
(AUDIT)), and alcohol hangover scale (AHS) were analyzed. Average drinks/day was 5.1-times
greater in HD compared to MD. Average AHS score showed moderate incapacity, and individual
measures and domains of the AHS were significantly elevated in HD compared to MD. Symptoms
of three domains of the AHS (mental, gastrointestinal, and sympathetic) showed domain-specific
significant increase in HD. A domain-specific relation was present between AUDIT and specific
measures of AHS scores in HD, specifically with the dependence symptoms. Exacerbation in hangover
symptomology could be a marker of more severe alcohol use disorder.
Keywords: alcohol hangover scale (AHS); alcohol use disorders identification test (AUDIT); dependence
symptoms of AUDIT (DS-AUDIT); hangover; heavy drinking
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1. Introduction
Excessive alcohol consumption is a leading cause of preventable mortality in the United States [1].
However, alcohol consumption continues to steadily rise in the United States; 2014 year estimates
(52.7% of people aged 12 or older drank in the past month of reporting) were higher than the estimates
in most years between 2002 and 2008 [2]. The most frequently reported consequence of excessive
alcohol consumption is experiencing a hangover. The alcohol hangover refers to the combination of
mental and physical symptoms, experienced the day after a single episode of heavy drinking, starting
when blood alcohol concentration approaches zero [3]. The number of people experiencing alcohol
hangover is high, with studies reporting 78% and higher prevalence of alcohol induced hangover [4,5]
including social/light, moderate, and heavy drinkers. Hangover symptoms can be severe enough
to impair daily routine, reduce productivity, and cause other associated complications of alcohol
consumption [6]. Thus, understanding these symptoms and how they relate to the severity of alcohol
abuse is important.
Adverse effects of excess alcohol intake manifest acutely as hangover symptoms. “Hangover”
consists of a wide array of mental, physical, and neuropsychological (including sympathetic) symptoms
that occur usually within hours of alcohol consumption and are recorded through the following day
starting when blood alcohol concentration approaches zero [7–9]. Some of the common symptoms are
fatigue, headaches, nausea, sleepiness, shakiness, weakness, excessive thirst and dry mouth, mood
disturbances, and apathy [10–12].
Although hangover has been linked to heavy alcohol consumption and binge drinking, it can
also be seen in individuals with moderate alcohol drinking [13,14]. This observation illustrates the
gaps in our knowledge of how hangover symptoms manifest differently in moderate and heavy
drinkers. Further, we do not know how hangover symptomology changes with the increased/altered
drinking volume/patterns. Recent drinking history (Timeline follow-back, TLFB), and Alcohol Use
Disorders Identification Test (AUDIT) are validated measures for assessing drinking patterns and
quantity. In recent investigations, AUDIT and TLFB were used to study hangover symptoms [12,15]
and they showed a close association with the hangover spectrum. Such associations have not been
investigated in individuals with a high level of heavy drinking (≥15 drinks/per day), nor have there
been studies of how hangover symptoms change with increased levels of alcohol drinking and altered
patterns of consumption.
The primary objective of this pilot study was to identify the domains and individual measures of
hangover symptoms that are different in individuals who consume alcohol in a moderate fashion and
those who are heavy drinkers. Another aim of this study was to identify the associations of hangover
symptoms and heavy drinking markers (derived from drinking history assessments) in heavy drinkers.
We also included some of the potential modifiers (sex, family history, comorbid conditions) contributing
to the changes in drinking patterns and hangover symptoms and assessed their interactions.
2. Study Participants and Methods
2.1. Patient Recruitment
The specific investigations reported here were conducted under two different larger protocols,
one approved by the Combined Neuroscience Institutional Review Board at the NIH and other
approved by the University of Louisville IRB. IRBs of both institutions approved the study once it
was concluded that the study objectives met the ethical standards/regulations. The study at the NIH
was indexed at ClinicalTrials.gov with identifier #NCT00713492, and the studies carried out at the
University of Louisville were indexed at ClinicalTrials.gov, with the identifier numbers: #NCT01922895;
#NCT01809132. Study participants who met diagnosis criteria for alcohol use disorder (AUD) and
alcoholic liver disease (ALD) were approached at the outpatient and inpatient settings of the University
of Louisville. Moderate drinkers and healthy volunteers were approached by advertisement using
flyers, newspaper column, and word of mouth at both sites. All participants meeting eligibility
104
J. Clin. Med. 2019, 8, 1943
criteria were enrolled after providing written informed consent. All participants’ data were available
securely to the PIs only. De-identified data were used to perform statistical analyses. Heavy drinkers
and social/light drinkers were recruited at the University of Louisville; and moderate drinkers were
recruited at NIH using cohort specific eligibility criteria as mentioned further.
A total of forty-one male and female individuals aged 21 to 64 years participated in this study.
Study participants were classified based on their alcohol consumption pattern as follows: heavy
drinkers ((HD), n = 12, aged 34–64 years); moderate drinkers ((MD), n = 17, aged 21–30 years); and
social/light drinkers (healthy volunteers (SD); n = 12, aged 25–54 years). In our study, heavy drinkers
(NIAAA guideline: ≥15 drinks/week for females; ≥20 drinks/week for males) drank around 15 drinks
per day on an average (>90 drinks/week); all participants also met criteria for alcohol use disorder
diagnosis according to DSM 5 criteria. Moderate drinkers drank in between 5–14 alcoholic drinks per
week. Social/light drinkers (SD) drank four or fewer drinks on an average per week; they were not
abstinent to alcohol drinking and were actively drinking at the time of screening. Inclusion criteria
for heavy drinkers were that the females drank 15 or more drinks/week, and males drank 20 or more
drinks/week meeting the NIAAA guidelines. Inclusion criteria for heavy drinkers also included being
age 21 years or older with reported heavy drinking for at least the past six months. Inclusion criteria
for the social/light drinkers (SD) in this study were: (a) age 21 years or older, (b) without any reported
heavy or moderate drinking for at least the past six months, (c) normal comprehensive metabolic panel
(normal liver and kidney panel, specifically serum albumin, total bilirubin, aspartate aminotransferase
(AST), and alanine aminotransferase (ALT), and (d) no ongoing inflammation/infection or occurrence
in the last three months. Exclusion criteria for heavy drinkers were: (a) unwilling or unable to provide
informed consent, (b) significant comorbid conditions (heart, kidney, lung, neurological or psychiatric
illnesses, sepsis) or active drug abuse, (c) pregnant or lactating women, (d) other known liver disease
(except alcoholic liver disease—ALD), and/or (e) prisoners or other vulnerable subjects. Exclusion
criteria for social/light drinkers included clinical diagnosis of any kind of liver disease and alcohol
consumption meeting heavy or moderate drinking classification plus the four criteria above for heavy
drinkers. Moderate drinkers (MD) had the same inclusion and exclusion as of social/light drinkers
apart from the drinking profile (clause b). All study participants had a complete history and physical
examination and laboratory evaluation upon study enrollment.
2.2. Study Paradigm
This investigation was a single time point assessment of AUD patients and healthy control
participants. All participating individuals were consented for this study prior to collection of data
and bodily samples. We collected demographic data, clinical data, medical history, and biochemical
measures of liver injury and dysfunction. We also collected drinking history information (using timeline
followback (TLFB), and Alcohol Use Disorders Identification Test (AUDIT)) from heavy drinkers and
TLFB from moderate and social/light drinkers. Hangover symptomology was assessed using the
Alcohol Hangover Scale (AHS). Participants reported on hangover after the last alcohol consumption
until 10:00 am of the following day. The following drinking markers were calculated from the TLFB
assessment for the past 90 days: total drinks past 90 days (TD90), number of drinking days past 90 days
(NDD90), average drinks per drinking day past 90 Days (AvgDPD90), and heavy drinking days past
90 Days (HDD90) [16]. We used the total AUDIT score [17] and scores for its individual domains:
hazardous alcohol use (frequency of drinking, typical quantity, and frequency of heavy drinking
(HzAU)), dependence symptoms (impaired control over drinking, increased salience of drinking,
and morning drinking (DS)) and harmful alcohol use (guilt after drinking, blackouts, alcohol-related
injuries (HAU)). AHS is one of the standardized symptom scales used to quantify intensity of hangover
symptoms based on the two publications we used as our assessment for hangover symptoms [18,19].
We used the guideline for AHS data based on our previous publication [12]. Symptoms measured
by the AHS included mental domain (“hangover”, “dizziness”, and “craving”), physical domain
measures (“thirsty”, “tired”, and “headache”), gastrointestinal domain symptoms (“nausea”, “loss of
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appetite”, and “stomach ache”) and sympathetic (“heart-racing”) that were analyzed individually and
domain-wise. Participants rated the hangover symptoms they experienced until 10 am of the following
morning after alcohol consumption on a scale from 0–7; as described in a previous publication from our
group [12]. Categories of severity for hangover scale are n = 0 as “none”, n = 1–3 as “mild”, n = 4–6 as
“moderate”, and n = 7 as “incapacitated”.
Family history of alcoholism (FHA) assessment was performed on all the subjects [20]. Subjects
were asked for a family history of alcohol use disorders. A positive history (FHP) meant having at
least one or more first degree relatives with a history of alcohol use disorder. A negative family history
(FHN) was confirmed as being without any first- or second-degree relatives with alcohol use disorder.
Liver injury markers alanine transaminase (ALT), aspartate aminotransferase (AST), the ratio
of AST:ALT, albumin, and total bilirubin were examined. All these measures were analyzed under
comprehensive metabolic panel of the standard of care order. Laboratory testing were performed by
the hospital laboratory at both the institutions.
2.3. Analysis
Demographics, drinking history and hangover data were analyzed using one-way analysis of
variance (ANOVA) along with post-hoc t-tests for group comparisons. Group means and standard
deviations were tabulated. Assessment of the association of hangover symptoms (itemized hangover
measures, their domains, and average hangover score (avgAHS)) with AUDIT scores, TLFB measures,
and family history of alcoholism were evaluated using multiple linear regression model, where sex and
age were selected as co-variables; and liver function markers using liver panel tests (serum albumin
and serum total bilirubin) were incorporated as modifying factors in multivariate linear regression
models. SPSS 25.0 (IBM, Chicago IL, USA), GraphPad Prism 7.0 (GraphPad Software, San Diego
CA, USA), and Microsoft Excel 2016 (Microsoft Corp., Redmond WA, USA) software were used for
data processing, statistical analyses, and plot/figure development. Descriptive data are presented as
mean ± standard deviation (M ± SD). Effect size is shown in Figures 2–4 as a model fit (goodness-of-fit)
of the relation (adjusted R2). Statistical significance was set at p < 0.05.
3. Results
3.1. Demographics and Drinking Profile
More females than males (almost double) were enrolled in both the moderate drinkers (MD)
group (n = 11 and n = 6, respectively) and the social/light drinkers (SD) groups (n = 7 and n = 5,
respectively). However, only approximately 1/4 of the heavy drinkers (HD) were female (n = 3 of 12;
see Table 1). HD individuals had significantly higher (p = 0.023) BMI and were significantly (p ≤ 0.001)
older. In our study, most of the HD individuals were family history positive for alcohol use disorder.
The likelihood ratio for positive family history of alcohol use disorder in HD group was considerably
higher (+30%, 6.971) at p = 0.008 (2-sided) compared to MD. By race, SD group had only one subject as
Asian, and two subjects as African American. One subject was African American in the HD group.
One individual reported multi-race background in the MD group. All study subjects but one in MD
group by ethnicity were Non-Hispanic or Latino. As anticipated, all TLFB90 markers were significantly
higher in HD group compared to SD or MD groups. The MD group showed numerically higher
levels of all the TLFB90 measures compared to SD; however, only AvgDPD90 scores were statistically
significant (Table 1). The mean AUDIT score in the HD group was >20, thus meeting criteria for
diagnosis of alcohol dependence [17]. Ten of the 12 HD subjects had an AUDIT score >20. We did not
evaluate sex differences since there were only three female heavy drinkers (Table 1).
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Heavy vs. Moderate Drinking
Group Significance
Demographics and Family History of Alcoholism
Sex (M or F) n(M) = 9, n(F) = 3 n(M) = 6, n(F) = 11 n(M) = 5, n(F) = 7 NA
Age (years.) a,b 49.8 ± 9.8 25.1± 3.1 31.6 ± 10.6 ≤0.001
BMI a 30.6 ± 7.6 25.1 ± 4.7 25.0 ± 3.1 0.023
FHA FHP, n = 11;FHN, n = 1
FHP, n = 8; FHN, n
= 9
FHP, n = 5; FHN,
n = 7 NA
Heavy Drinking Markers
TD90 a,b 1153.92 ± 765.56 74.41 ± 31.39 23.67 ± 18.14 ≤0.001
HDD90 a 67.33 ± 34.88 4.82 ± 9.47 0.58 ± 1.38 ≤0.001
NDD90 a 72.5 ± 24.4 31.47 ± 16.62 18.25 ± 18.70 ≤0.001
AvgDPD90 a,b 13.57 ± 8.1 2.5 ± 0.99 1.4 ± 0.72 ≤0.001
AUDIT Scores and Its Domains
AUDIT 23.08 ± 8.19 NC NC NA
AUDIT>20 10/12 NC NC NA
HzAU 9.92 ± 2.15 NC NC NA
DS 5.83 ± 3.86 NC NC NA
HAU 7.33 ± 4.5 NC NC NA
Abbreviations; M: male; F: female; BMI: body mass index; FHA: Family history of alcoholism; FHP: family history
positive; FHN: family history negative; TD90: total drinks past 90 days; HDD90: heavy drinking days past 90 days;
NDD90: number of drinking days past 90 days; AvDPD90: average drinks per drinking day past 90 days; AUDIT:
alcohol use disorder identification test; DS: dependence symptoms; HAU: harmful alcohol use; HzAU: hazardous
alcohol use. NA: not applicable, NC: not collected. a: between group comparisons of heavy and social/light
drinkers; all comparisons found to have p ≤ 0.001. b: between group comparison of moderate and social drinkers
(age: p = 0.023; BMI: not significant; TD90: p ≤ 0.001; HDD90: not significant; AvgDPD90: p = 0.002; NDD90:
p = 0.055).
3.2. Assessment of Hangover Symptoms
There was a stepwise pattern to the occurrence of hangover symptomology wherein almost all of
the hangover measures increased numerically from the social to moderate drinker groups and were the
highest in heavy drinkers (Table 2). We found a large variability in some of the measures (as observed
by the standard deviations) (Figure 1). This could be due to the individual variability in how the
individual measures and domains of hangover manifest.
Table 2. Scores of hangover symptoms in social, moderate, and heavy drinkers. Effects of difference
between moderate and heavy drinkers.
Symptoms
Social Drinkers
(SD) n = 12
Moderate Drinkers
(MD) n = 17
Heavy Drinkers
(HD) n = 12
MD vs. HD Effects
(Adjusted R2)
Hangover a 0.33 ± 0.89 1.12 ± 1.22 2.67 ± 2.87 p = 0.056; R2 = 0.129
Thirsty a,b 0.33 ± 0.65 2.94 ± 1.89 4.50 ± 1.93 p = 0.039; R2 = 0.149
Tired a,b 0.83 ± 1.64 3.35 ± 1.73 3.08 ± 2.54 p = 0.736; R2 = 0.004
Headache 0.33 ± 1.16 1.59 ± 1.91 1.92 ± 2.54 p = 0.693; R2 = 0.006
Dizziness a 0.00 0.18 ± 0.53 2.25 ± 0.53 p = 0.005; R2 = 0.259
Nausea a 0.00 0.59 ± 1.12 3.50 ± 2.61 p ≤ 0.001; R2 = 0.214
Stomachache a 0.00 0.35 ± 0.86 3.17 ± 2.29 p ≤ 0.001; R2 = 0.445
Heart-racing a 0.00 0.00 3.08 ± 2.78 p ≤ 0.001; R2 = 0.441
Loss of Appetite a 0.00 0.18 ± 0.73 4.50 ± 2.15 p ≤ 0.001; R2 = 0.689
Craving a 0.00 0.41 ± 1.18 4.0 ± 2.83 p ≤ 0.001; R2 = 0.451
AvgHS a,b 0.18 ± 0.41 1.14 ± 0.64 3.3 ± 1.58 p ≤ 0.001; R2 = 0.489
Abbreviations; SD: social drinkers (or light drinkers); MD: moderate drinkers; HD: heavy drinkers; AvgAHS:
average hangover score. a significant statistical difference in hangover symptoms between social and heavy
drinkers. b significant statistical difference in hangover symptoms between social and moderate drinkers. In italics:
not significant.
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Figure 1. Levels of hangover measures in social/light drinkers (SD), moderate drinkers (MD), and
heavy drinkers (HD). (a): Hangover measure “Hangover”. (b): Hangover measure “Thirsty”.
(c): Hangover measure “Tired”. (d): Hangover measure “Headache”. (e): Hangover measure
“Dizziness”. (f): Hangover measure “Nausea”. (g): Hangover measure “Stomachache”. (h): Hangover
measure “Heart-racing” (i): Hangover measure “Loss of appetite”. (j): “Craving”, “loss of appetite”,
and “thirsty” measures showed moderate level of hangover severity in heavy drinkers (Table 2). Data
are presented as mean ± standard deviation. Statistical significance was set at p ≤ 0.05. Statistical
significance is not described in comparisons when the SD group individuals reported “zero”, as in
some measures.
3.3. AUDIT Domains, and Association of Drinking Markers in Heavy Drinkers
The HzAU domain of the AUDIT was significantly higher compared to DS and HAU domains in
HD group (Figure 2a). Neither the DS nor the HAU domain exerted as great an effect as the HzAU
(Figure 2a). The AUDIT score and the recent heavy drinking marker, HDD90, showed a significant
association in the HD group (Figure 2b). Among the domains of AUDIT, only HzAU domain was
significantly associated with HDD90 marker at moderate effects in the HD group (Figure 2c), thus
suggesting overall AUDIT vs. heavy drinking relation was primarily due to the hazardous domain
of AUDIT.
Figure 2. AUDIT and its association with timeline followback measures in heavy drinkers (HD).
(a) Presentation of hazardous, dependency, and harmful domains that constitute AUDIT. (b) AUDIT
score and heavy drinking days past 90 days (HDD90) drinking marker. (c) Scores of “hazardous-domain”
of AUDIT and HDD90 (There are two points each for 11 and 12 [hazardous domain] that have
corresponding 90 units of HDD90). Statistical significance was set at p ≤ 0.05.
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3.4. Internal Consistency of Hangover Measures in Heavy Drinkers
Mental domain measures of “hangover”, “craving”, and “dizziness” together showed very strong
main effects, unadjusted R2 = 0.707 at high significance p = 0.009. Physical domain measures of
“headache”, “thirsty”, and “tired” together showed the strongest main effects, unadjusted R2 = 0.862
at very high significance p ≤ 0.001. Gastrointestinal domain measures of “stomachache”, “nausea”,
and “loss of appetite” together also showed strong main effects, unadjusted R2 = 0.842 at high
significance p = 0.001. “Stomachache” and “nausea” measures were associated at high effects adjusted
R2 = 0.642 and high significance p = 0.001. No other measures within any of the domains showed any
such association.
3.5. Association of AUDIT and Hangover Measures in Heavy Drinkers
In the HD group, the AUDIT showed a significant association with the average hangover scores
(Figure 3a) and with three hangover measures: “heart-racing” (Figure 3b), “craving” (Figure 3c), and
“thirsty” (Figure 3d). The AUDIT score showed significant high main effects with the symptoms of
mental domain (“hangover”, “dizziness”, and “craving”) (unadjusted R2 = 0.727, p ≤ 0.001), as well as
physical domain (“thirsty”, “tired”, and “headache” together) (unadjusted R2 = 0.778, p ≤ 0.001) in this
group. Gastrointestinal domain symptoms (“nausea”, “loss of appetite”, and “stomachache”) showed
significant, though moderate, main effects with AUDIT scores (unadjusted R2 = 0.685, p ≤ 0.001) in
these heavy drinkers.
Figure 3. Association of AUDIT and hangover measures in heavy drinkers. (a) AUDIT and “Average
hangover score” (AvgAHS). (b) AUDIT and “Heart-racing” (sympathetic domain) measure. (c) AUDIT
and “Craving” (mental domain) measure. (d) AUDIT and “Thirsty” (physical domain) measure.
Statistical significance was set at p ≤ 0.05.
3.6. Role of AUDIT and Heavy Drinking TLFB Markers on Hangover Symptoms
There was no direct association of hangover measures and timeline followback markers (data not
plotted). However, specific TLFB drinking markers and AUDIT scores together showed the augmented
association with hangover measures, and that effect was higher than those exhibited by the univariate
associations of AUDIT and specific hangover measures (Figure 3a,c). The average hangover score
and AUDIT score showed a strong association (adjusted R2 = 0.578) at high significance, p = 0.021,
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when adjusted for NDD90. The “craving” measure and the AUDIT showed an association (adjusted
R2 = 0.462) at a high significance (p = 0.025), when adjusted for HDD90.
We further evaluated the association of hangover measures and domains of AUDIT to identify
domain-specific relations in heavy drinkers. The hangover measure, “heart-racing”, was closely
associated with the combined effect of hazardous alcohol use (HzAU) and the “dependence symptoms”
(DS) domains of the AUDIT (Figure 4a,d). Notably, the association of “heart-racing” values and DS
scores was of very high effect (Figure 4d). DS scores also correlated with average hangover scores
(Figure 4b), for “craving” (Figure 4c), and for “stomachache” (Figure 4e) in heavy drinkers. The
association of DS and craving was likely significant (Figure 4c); when this association was tested with
HDD90 as a covariate, both the significance (p = 0.025) and effect size (Adjusted R2 = 0.462) showed
substantial augmentation. The harmful alcohol use (HAU) domain was significantly associated with
only one hangover measure, “thirsty”, in heavy drinkers (Figure 4f). Domain specific responses of the
AUDIT showed close associations with specific hangover symptoms.
Figure 4. Association of AUDIT domains (Hazardous alcohol use (HzAU), dependence score (DS), and
harmful alcohol use (HAU)) and individual hangover measures in heavy drinkers. (a) Association of
HzAU and “Heart-racing” measure. (b) Association of DS and “Average hangover score” (AvgAHS)
measure. (c) Association of DS and “Craving” measure. (d) Association of DS and “Heart-racing”
measure. (e) Association of DS and “stomachache” measure. (f) Association of HAU and “Thirsty”
measure. Statistical significance was set at p ≤ 0.05.
3.7. Role of Liver Dysfunction on Hangover Symptoms
Impaired liver health, characterized by serum total bilirubin and serum albumin (Table 3), along
with drinking profile (using AUDIT) was predictive of the average hangover score (Figure 5). However,
we did not find major effects of liver injury markers (ALT, AST, and AST:ALT ratio) in combination
with AUDIT on hangover severity.
In heavy drinking AUD patients, more severe form of ALD was a comorbid condition (with a
diagnosis of alcoholic hepatitis) (Table 3). Heavy drinkers with comorbid ALD showed signs of both
clinical range of liver injury and function markers. AUDIT scores showed significant association with
average hangover score and other hangover symptoms (Figure 3), and thus, we investigated if there is
any mediating role of liver function/ injury in the hangover symptomology (Figure 5).
One of the hypotheses for our observation is that impaired liver function contributes to suboptimal
metabolism of alcohol and alcohol metabolites. This could lead to both higher blood alcohol
concentrations and longer durations in the system. Aldehyde, a metabolite of alcohol metabolism
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primarily in liver, has toxic effects on the system that lead to pathological (oxidative stress), and this may
be related to psychiatric manifestations (withdrawal/hangover). We found that higher hangover scores
are associated with greater effects by heavy drinking (AUDIT) mediated by worsening indications of
liver function (Figure 5). Further investigation on the roles of alcohol dehydrogenase and aldehyde
dehydrogenase with respect to hangover symptomology could help define this relation.








Heavy vs. Moderate Drinking
Group Significance
ALT (U/L) 73.83 ± 61.00 18.82 ± 7.95 28.5 ± 28.77 0.001
AST (U/L) 174.75 ± 82.11 24.53 ± 6.27 28.7 ± 13.92 ≤0.001
AST:ALT ratio 3.53 ± 2.56 1.39 ± 0.48 1.03 ± 0.56 0.002
Total Bilirubin
(μmol/L) 9.72 ± 7.77 0.55 ± 0.35 0.610 ± 0.31 ≤0.001
Albumin (g/dL) 2.66 ± 0.29 4.17 ± 0.26 4.08 ± 0.24 ≤0.001
Abbreviations; ALT: alanine aminotransferase, AST: aspartate aminotransferase. All markers in social and moderate
drinkers were not clinically significant.
Figure 5. Schema of the effects of liver status (impaired liver function) and drinking severity on
hangover symptomology. Liver function markers serum albumin and serum total bilirubin showed
potential mediating roles in the effects of AUDIT on hangover symptoms.
4. Discussion
All heavy drinkers in this study reported hangover symptoms, whereas only some moderate
drinker subjects reported hangover symptoms. The average hangover score in heavy drinkers was >3
of a possible 7, which was, by definition, a moderate level of incapacity. Three measures of hangover,
“thirsty”, “craving”, and “loss of appetite”, were numerically well into the moderate range of hangover
intensity. Mental, gastrointestinal and sympathetic domains of the hangover scale were significantly
higher in heavy drinkers compared to the moderate drinkers. Almost all of the HD patients reported
a positive family history of alcoholism in our study. The AUDIT score has been shown to have a
significant association with future alcohol use disorder, with up to 61% of higher AUDIT scores linked
to alcohol use disorder in comparison to 10% with lower scores [21]. In our study, we found the
majority of the heavy drinkers scored very high (>20) on the AUDIT scale. We found a close association
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of heavy drinking days past 90 days (HDD90, a component of TLFB90) with the AUDIT score and with
its hazardous domain in particular. In our previous findings, we found a close association of recent
drinking and hangover in moderate drinkers [12]. In the heavy drinkers, hangover measures showed a
close association with AUDIT and its domains. Recent studies have linked higher hangover symptoms
to a higher risk of alcohol use disorder and delirium tremens [22]. However, there is a significant gap
in the understanding of the intensity of hangover symptoms and their association with patterns of
heavy alcohol drinking. Our previous study reported a mild level of hangover symptoms in moderate
drinkers [12]. In this study, we found that the heavy drinkers, who also exhibited remarkably heavier
alcohol intake, showed a moderate level of incapacity in overall hangover assessment.
AUDIT scores (and specifically hazardous and dependence domains of the AUDIT scale) of heavy
drinkers were most closely associated with the “heart-racing” measure of hangover. “Heart-racing” is
a measure of the sympathetic domain of hangover, and manifestations of sympathetic hyperactivity
could be related to vasoconstriction and tachycardia [23]. Stimulant and sedative use can potentiate
sympathetic nervous system hyperactivity that could be related to elevated “heart-racing” and may
result in severe withdrawal symptoms in alcohol use disorder.
In our study, the AUDIT score and its harmful domain showed a close association with the physical
(“thirsty”) domain. This association is consistent with a previous publication stating that hangover could
be an indicator of risk for physical dependence [24]. Likewise, the AUDIT score and its dependence
domain showed a significant association with the mental domain “craving” measure. Subsequent
drinking to relieve hangover could lead to heavier alcohol consumption and higher AUD symptoms [25].
Further, craving and its association with the dependence domain of AUDIT might influence subsequent
drinks and their timing, as has been reported previously [26], also suggesting increased predisposition
for alcohol use disorder (AUD). Hangover symptomology is a direct and immediate adverse effect of
alcohol intake, which we have now assessed in all categories of drinking (social, moderate, and heavy)
in this pilot study. Importantly, we have shown a stepwise relation between levels of drinking and
symptomology of hangover. However, in the alcohol use disorder spectrum, much emphasis is given
on dependence and withdrawal categories of diagnosis. In heavy drinkers, these adverse symptoms of
alcohol-associated hangover are worse than in moderate or social/light drinkers. Furthermore, the
dependence domain of the AUDIT and specific domains of the hangover scale correlate highly in heavy
drinkers. Thus, these findings provide the basis for including alcohol-associated adverse effects scales,
such as the AHS, in the diagnosis of alcohol use disorder (detailing item 3 of the “DSM-5” concerning
the aftereffects: https://pubs.niaaa.nih.gov/publications/dsmfactsheet/DSMfact.pdf). Validation of
these findings and their effects from a large study cohort of heavy and moderate drinkers may
elucidate the role of specific adverse effects of alcohol intake in the development and progression of
alcohol dependence.
Most studies report that males consumed a higher amount of alcohol in comparison to females;
thus, males are likely to show higher incapacity in the hangover symptoms scale [27]. In our study,
3/4 of the participants in HD group were males, and they exhibited numerically higher severity
both in alcohol consumption and hangover symptoms. We examined other factors that could be
associated with higher alcohol consumption. Positive family history of alcoholism was a significant
factor associated with heavy alcohol consumption and higher hangover symptom scores, as reported
previously [28–30]. Our study was consistent with those findings.
There were limitations in this study. This study was performed as a proof of principle design to
address the primary aims. Given the results showing considerable effect sizes, this study supports the
utility of these outcomes in larger populations. We acknowledge that these initial results would benefit
from further testing with a larger sample size, and we are pursuing such study presently. We did not
collect the length of time for each of the hangover symptoms. This should likely be used as another
parameter in the ongoing and future studies. There were few females in the heavy drinking group,
therefore we could not determine any sex differences. Variability in ethnicity was limited, most of the
participants were Caucasian, and few were Hispanic-Latino; thus, any meaningful race/ethnicity-based
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comparisons is not within the scope of this study. Gamma-glutamyl transferase (GGT), a marker of
liver injury was not tested in this study. Our focus in this study was on the heavy drinkers; 11 of
12 participants were positive for family history of alcoholism. Importantly, the sample size for each of
the subgroups is not large, and thus, we focused on the effect sizes for interpreting the results. There are
more factors that can modify/potentiate hangover symptoms, and assessing those was not in the scope
of this study. For example, dehydration and electrolyte imbalances can worsen significantly under the
effects of alcohol, and we did not study either of these factors. Nor did we evaluate acute withdrawal
symptoms (Clinical Institute Withdrawal Assessment for Alcohol Scale-revised (CIWA-Ar)) in heavy
drinkers for comparisons with the AHS, the AUDIT, or the TLFB measures. This is a future direction.
We found an interesting association between liver function markers (albumin and total bilirubin)
and higher hangover scale results. One of the hypotheses for our observation is that impaired liver
function contributes to slower metabolism of alcohol and alcohol metabolites. This could lead to
both higher and more persistent blood alcohol/metabolite concentrations. We did not find any direct
(or modifying) association of liver injury and higher hangover symptoms. This could inform that liver
function (not liver injury) might be a better predictor of alcohol associated adverse effects. Further study
could identify an altered mechanistic response that causes delayed and slower alcohol metabolism that
would be consequential in higher and prolonged levels of alcohol consumption.
The presence and severity of hangover symptoms varied substantially across the three drinking
groups. Hangover in heavy drinkers was debilitating, while in moderate drinkers, it was reported only
as uncomfortable. Domains of hangover symptoms corresponded with the specific markers/domains
of heavy alcohol drinking in heavy drinkers. Specific assessment of drinking measures should be used
for assessing hangover symptomology in different drinking groups; AUDIT seems to better correlate
with hangover measures in heavy drinkers. Elevated domains of symptoms assessed by the AUDIT in
heavy drinkers, and their relevance with domains of the AHS, support the potential use of the AHS
in determining severity of alcohol use disorder. Our findings point to the need for further studies
on larger groups of drinkers with regard to patterns of alcohol consumption, levels of alcohol use,
and adverse symptomology. Alcohol associated hangover, adverse effects, and liver injury are most
common immediate manifestations that are observed together very frequently. AUD characterization
based on DSM-5 criteria addresses some of the hangover symptomology in the diagnosis; however,
it does not specify the integrated role of the aforementioned measures. Available treatment options
for AUD are also limited. Shared pathology of AUD and ALD require focused treatment for both
AUD and ALD. Disulfiram and Acamprosate can be useful in AUD patients who are abstinent at the
time of treatment; and Naltrexone cannot be prescribed in AUD patients with liver injury (black box
warning identifies adverse interaction with liver health). Thus, intervention for AUD patients with
liver injury who are actively drinking heavily is limited and new drugs are under investigation, for
example, Varenicline tartrate, which does not interfere with liver [31]. Specifically, larger groups are
needed to evaluate any potential sex differences; we have reported about the differences in liver injury
and drinking patterns in AUD females in a larger study population previously [32].
5. Conclusions
Alcohol hangover symptoms increase with corresponding increases in the level of alcohol
consumption. Specific domains of hangover symptomology are exacerbated with heavy drinking.
Symptoms of hangover are associated with long term assessment of heavy drinking rather than the
recent drinking history. AUDIT (Alcohol Use Disorders Identification Test) and its hazardous domain
are associated with the heavy drinking marker, HDD90 (heavy drinking days in the past 90 days).
Dependence scores of AUDIT scale were closely associated with the presentation of adverse after-effects
of heavy drinking as characterized by the hangover scale (chiefly in the mental, sympathetic, and
gastrointestinal domains). Large population studies are needed to confirm and more precisely illustrate
the findings in this study and would also allow for analysis of differences between sexes.
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Abstract: Although hangover is a common consequence of heavy alcohol consumption, the area is
heavily under-researched. Hangover frequency is a potential predictor of future alcohol use disorder
that may be affected by hangover severity, yet the relationship between hangover frequency and
severity has not been investigated. Using different methodologies and assessment instruments,
two surveys, and one naturalistic study collected data on hangover frequency, hangover severity,
and alcohol consumption. The relationship between hangover frequency and severity was investigated
via correlational analysis, considering potentially moderating variables including alcohol intake,
estimated blood alcohol concentration, demographics, and personality characteristics. In all the three
studies, a positive and significant association between hangover frequency and severity was found,
which remained significant after correcting for alcohol intake and other moderating factors. These
findings suggest that hangover severity increases when hangovers are experienced more frequently
and may be driven by sensitization or reverse tolerance to this aspect of alcohol consumption. Future
research should further investigate the relationship between hangover frequency and severity and
alcohol use disorder and its implications for prevention.
Keywords: alcohol; hangover; frequency; severity; tolerance
1. Introduction
Alcohol hangover refers to the combination of mental and physical symptoms, experienced the
day after a single episode of heavy drinking, starting when the blood alcohol concentration (BAC)
approaches zero [1]. Although hangover is a common consequence of heavy alcohol consumption,
research investigating hangover frequency is sparse [2], and perhaps surprisingly, the relationship
between hangover frequency and hangover severity has not been investigated.
This is potentially important, as experiencing frequent hangovers has been associated with
significant health consequences and mortality. For example, there is a significant positive association
between hangover frequency and cardiovascular mortality [3]. A negative relationship has also been
identified between intelligence quotient (IQ) at age 11 and hangover frequency in middle-age [4].
Whereas childhood socioeconomic status had no relevant influence, the association between childhood
IQ and later life hangover frequency was significantly attenuated by middle age socioeconomic status.
Other reports have identified a significant relationship between hangover frequency and experiencing
depressive symptoms [5,6]. These studies did not explore the relationship between hangover frequency
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and hangover severity. The latter is important as it has been suggested that having hangovers frequently
could be a predictor of future alcohol use disorder [7].
If tolerance develops when hangovers are experienced more frequently, i.e., their severity
diminishes, this could feasibly lead to higher alcohol consumption. Alternatively, if hangover severity
remains constant or increases with greater frequency, this may have a protective effect in that drinkers
would consume less alcohol on future drinking occasions. A prospective study using the sensitivity to
the effects of alcohol (SRE) scale, showed that drinkers who have a low sensitivity to alcohol (i.e., more
drinks are needed to feel an effect), report hangovers less frequently following a given number of
drinks [8]. These findings suggest that tolerance develops to experiencing hangovers in subjects who
report frequent heavy drinking episodes. Conversely, Courtney et al. [9] found that having more
frequent hangovers was a marker for increased future numbers of alcoholic drinks per drinking day.
Importantly, neither study assessed hangover severity, which may play a pivotal role in the relationship
between hangover frequency and drinking quantity.
Recently, Köchling et al. [10] examined the impact of the sequence of consuming beer and wine on
hangover severity in 90 participants. On two test days, beer, wine, or both were consumed to reach a
BAC of 0.12%. Overall hangover severity was assessed as a composite score of eight individual items,
including thirst, fatigue, headache, dizziness, nausea, stomach ache, tachycardia, and loss of appetite.
The intensity of these symptoms was scored on a seven-point scale, with the sum score representing the
overall hangover severity ranging from 0 (absent) to 56 (extreme hangover). Hangover frequency was
assessed using five categories, including ‘rarely’, ‘once-monthly’, ‘more than once-monthly, and less
than once-weekly’, ‘once-weekly’, and ‘more than once-weekly’. The authors reported that hangover
frequency was not a significant predictor of hangover severity. These findings suggest that hangover
frequency and severity are unrelated. However, it should be considered that (1) a very crude measure
of hangover frequency was used which provides little differentiation between the subjects, and (2)
overall hangover severity was computed as a sum score from individual hangover symptoms, and
no overall hangover severity rating was obtained. It is, thus important to further investigate the
relationship between hangover frequency and severity using more precise measures.
Therefore, the current analysis investigated whether tolerance develops for experiencing alcohol
hangovers. We interrogated databases from three independent studies which utilized different
methodological approaches to evaluate hangover severity and frequency. It was hypothesized that
hangover frequency would negatively correlate with hangover severity. In other words, if hangovers
are experienced more frequently, their intensity diminishes, that is “hangover tolerance” develops.
2. Methods
The relationship between hangover frequency and severity was analyzed using data from three
independent studies. Study 1 was a survey by Penning et al. [11] among Dutch students that
retrospectively assessed hangover frequency and severity. Study 2 was an international survey
among young adults who recorded hangover severity on three different days and related these
scores to hangover frequency. The retrospective assessment for multiple days is important as it has
been suggested that hangover severity not only varies between drinkers but also within the same
individual [2,12]. Using the average hangover severity score over the three days accounts for any
intra-individual variation. Study 3 was a semi-naturalistic laboratory study with real-time assessments
of hangover severity.
Study 1 was approved by the Institutional Review Board of the Utrecht Institute for Pharmaceutical
Sciences of Utrecht University. No formal medical ethics approval was required to conduct this survey
according to the Central Committee of Research Involving Human Subjects, The Netherlands. Study 2
received ethics approval from the Ethics Committee of the Faculty of Social and Behavioral Sciences of
Utrecht University (FETC17-063). Study 3 also received ethics approval from the Ethics Committee
of the Faculty of Social and Behavioral Sciences of Utrecht University. Study 3 was registered at
www.clinicaltrials.gov (ClinicalTrials.gov Identifier: NCT01400204).
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2.1. Study 1: Dutch Students Survey
Study 1 was a survey among Dutch students [11]. The survey comprised questions about drinking
behavior, and the nature and severity of symptoms experienced during the past month latest hangover.
Demographic data were collected (e.g., age, sex, height, and weight) and questions regarding usual
drinking behavior were assessed, including a question on how many hangovers participants had
experienced during the past month. The number of alcoholic drinks consumed for the evening before
their past month latest hangover was recorded. The start and stop time of drinking alcohol was not
measured in this study; therefore, the estimated blood alcohol concentration (eBAC) could not be
computed. Subjects were asked to rate the severity of a list of 47 hangover symptoms they possibly
experienced on their most recent hangover experience within the past month. From these, three
outcome measures of overall hangover severity were computed. First, a modified version of the
Hangover Symptoms Scale (HSS) [13] was compiled. This included the following 12 items; being tired,
headache, nausea, vomiting, weakness, thirst, concentration problems, sensitivity to light, sweating,
anxiety, depression, and shaking/shivering. For this study, the HSS item ‘trouble sleeping’ was omitted.
The rationale for excluding this item was that it is not a true hangover symptom [14]. Trouble sleeping,
if anything, is part of the cause, rather than the effect of hangover. As such, it may have an impact on
the presence and severity of hangover symptoms [15]. The original HSS assessed the frequency of
occurrence of hangover symptoms. To obtain a severity score, in our modified version, the severity of
each item was rated on an 11-point scale from 0 (absent) to 10 (extremely severe). The mean score of the
12 items was used as a measure of overall hangover severity. Second, the Acute Hangover Scale (AHS)
score was computed [16]. Third, the Alcohol Hangover Severity Scale (AHSS) score was computed [14].
Data from those subjects aged 18–30 who reported a past month alcohol hangover were included in
the statistical analyses, which were conducted with SPSS (SPSS, version 25.0, SPSS Inc., Armonk, NY:
IBM Corp). The analyses included correlating past month hangover frequency with overall hangover
severity scores, using partial correlations, adjusting for the number of alcoholic drinks consumed.
2.2. Study 2: International Survey
An international survey was conducted in Nadi, Fiji among people working or on holiday. Subjects
were approached to complete the survey at Wailoaloa Beach, Nadi, Fiji. The survey was anonymous,
and participants did not receive an incentive for completing the survey. Potential participants were
approached between 8 a.m. and 4 p.m. They were asked if they had consumed alcohol during the
past three days. Those who were willing to participate and understood the English language were
handed the survey. The investigator was present to address any queries with regards to language
comprehension of the participants (who included international holidaymakers).
The survey collected demographic data such as gender, age, and country of citizenship. Usual
weekly alcohol consumption (at home, before going to Fiji) was recorded, as well as information on
how many day subjects were abroad from their home country, and how long they had been in Fiji.
Data regarding alcohol consumption and hangover severity were recorded for three consecutive
days. Both the number of alcoholic drinks and the timeframe of consumption were recorded. The
survey contained guidance about standard drinking sizes and how to convert, for example, bottles of
wine into standardized alcohol units. Estimated blood alcohol concentration (eBAC) was computed,
applying a modified Widmark formula [17]. On each test day, subjects reported their overall hangover
severity on an 11-point scale ranging from 0 (absent) to 10 (extreme). Further questions asked about
alcohol consumption when at home (before coming to Fiji), how many days per month they experienced
a hangover, and how many times they had a hangover during their stay in Fiji.
Statistical analysis was performed using the SPSS statistical program (SPSS, version 25.0, SPSS Inc.,
Armonk, NY: IBM Corp). The participants who reported they did not have a hangover were excluded.
Data from the three days were averaged to provide a more reliable average measure of alcohol intake
and hangover severity. The hangover frequency at home and in Fiji was correlated with the average
overall hangover severity score, using a partial correlation, adjusting for eBAC.
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2.3. Study 3: Naturalistic Study
Students, aged 18 to 30 years old, were recruited at different locations (university canteen and
colleges) of the university campus of Utrecht University, The Netherlands. The subjects remained
anonymous, and after finalizing the study, they were paid 20 Euros for their participation. This
naturalistic, observational study comprised two assessments: one the day after an evening of alcohol
consumption, and the second assessment was made after an alcohol-free day. The investigators took
steps to not influence the subjects’ drinking behavior or activities on the test days. There were no
lifestyle or other guidelines imposed on the subjects, except that they were asked to complete the
online survey between 2 p.m. and 10 p.m. The test days were scheduled one to three weeks apart, and
the exact dates of the test days were chosen by the subjects themselves, depending on whether they
choose to consume alcohol or not.
Demographic data were collected (e.g., age, sex, height, and weight) and questions regarding
usual drinking behavior were assessed, including a question on how many hangovers participants
had experienced during the past year. The Five-Shot questionnaire alcohol screening test was used to
analyze general drinking behavior [18]. Personality was assessed with the Brief Symptom Inventory
(BSI) [19] and the RT18 risk-taking questionnaire [20].
The BSI is a broad-used multidimensional symptom self-report inventory. It consists of 53 items;
each rated on a five-point scale of distress from 1 (not-at-all) to 5 (extremely). The instrument is
scored on nine symptom dimensions; somatization, obsession-compulsion, interpersonal sensitivity,
depression, anxiety, hostility, phobic anxiety, paranoid ideation, and psychoticism.
The RT-18 consists of 18 items that can be scored as ‘yes’ or ‘no’ [19]. Higher scores imply greater
levels of risk-taking. Two subscales can be computed, namely ‘level of risk-taking behavior’ and ‘risk
assessment’.
The Five-Shot questionnaire alcohol screening test was used to detect heavy drinking [18]. It is a
short, self-report inventory, composed of two questions from the Alcohol Use Disorders Identification
Test (AUDIT) [21,22] and three questions from the CAGE test [23]. A score of 2.5 or greater indicates
possible alcohol misuse.
The number of alcoholic drinks consumed on the night prior to the test day was recorded,
including the start and stop time of drinking alcohol. The estimated blood alcohol concentration
(eBAC) was computed using a modified Widmark equation [17]. The modified Widmark equation
takes into account the number of alcoholic drinks, relative body water volume, weight, gender, time
taken to clear alcohol through metabolism. Participants were also asked how many alcoholic drinks
they had consumed on this occasion, relative to a ‘regular’ drinking occasion. For each test day, subjects
reported their overall hangover severity on an 11-point scale ranging from 0 (absent) to 10 (extreme).
In addition, subjects rated their alcohol hangover via the modified 13-item version of the HSS [13], on
which the severity of each item was rated on an 11-point scale from 0 (absent) to 10 (extremely severe).
Statistical analysis was performed using the SPSS statistical program (SPSS, version 25.0, SPSS Inc.,
Armonk, NY: IBM Corp). Subject reporting not having a hangover were excluded from the analysis.
Past month hangover frequency was correlated with overall hangover severity scores, using partial
correlations, adjusting for eBAC.
3. Results
3.1. Study 1: Dutch Students Survey
A total of 1410 participants completed the questionnaire, of which 56.1% (n = 791) had experienced
at least one hangover during the last month. Their data were used for the analysis. The mean (SD) age
of the sample was 20.4 (3.4) years, and 68.7% of the sample were women. The results of the study are
summarized in Table 1.
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Overall hangover severity, measured using the HSS, correlated significantly and positively with
the frequency of past month hangovers (r = 0.188, p = 0.000). When adjusting for the number of
alcoholic drinks consumed, the partial correlation remained significant (r = 0.126, p = 0.001).
Overall AHS hangover severity correlated significantly and positively with the frequency of past
month hangovers (r = 0.145, p = 0.000). When adjusting for the number of alcoholic drinks consumed,
the partial correlation remained significant (r = 0.125, p = 0.001).
Overall AHSS hangover severity correlated significantly and positively with the frequency of past
month hangovers (r = 0.198, p = 0.000). When adjusting for the number of alcoholic drinks consumed,
the partial correlation remained significant (r = 0.153, p = 0.001).
Table 1. The association between drinking variables and the severity and frequency of hangovers.









alcoholic drinks 16.8 (14.6) r = 0.583, p = 0.000 r = 0.170, p = 0.000 r = 0.167, p = 0.000
number of past month
hangovers 2.4 (2.2) - - - r = 0.145, p = 0.000 r = 0.188, p = 0.000
Hangover day
number of alcoholic drinks 10.6 (5.9) r = 0.329, p = 0.000 r = 0.164, p = 0.000 r = 0.211, p = 0.000 r = 0.196, p = 0.000
HSS hangover severity 3.1 (1.5) r = 0.188, p = 0.000 r = 0.873, p = 0.000 r = 0.913, p = 0.000 - - -
AHSS hangover severity 3.0 (1.6) r = 0.153, p = 0.000 r = 0.874, p = 0.000 - - - r = 0.913, p = 0.000
AHS hangover severity 3.7 (1.7) r = 0.145, p = 0.000 - - - r = 0.188, p = 0.000 r = 0.873, p = 0.000
Note: Partial correlations, adjusting for the number of alcoholic drinks consumed before the hangover day, were
computed to relate the hangover frequency with severity. For other associations, non-parametric (Spearman’s rho)
correlations were computed.
3.2. Study 2: International Survey
The international survey was completed by n = 333 subjects (145 men and 188 women). Subjects
originated from 20 different countries, with most of them coming from the UK (34.6%), Australia (11%),
France (9.4%), USA (8.7%), and New Zealand (7.1%). Their mean (± SD) age was 23.5 (± 4.2) years old,
and they reported weekly alcohol consumption of 11.5 (± 10.9) drinks. They reported experiencing 3.9
(± 3.4) hangovers per month at home, and 4.8 (± 13.2) while at Fiji. There was no significant difference
in hangover frequency reported at home or in Fiji (t = −1.26, p = 0.208). On average they were 78
(± 102) days abroad from their home country, of which the past 26 (± 26) days were spent at Fiji. In Fiji,
alcohol consumption and hangover data were gathered for three consecutive days, and the results
are summarized in Table 2. A partial correlation, adjusting for eBAC, revealed that the associations
between hangover severity and hangover frequency at home (r = 0.197, p = 0.024) and hangover
frequency at Fiji (r = 0.276, p = 0.001) remained significant.
Table 2. The association between drinking variables, hangover severity, and hangover frequency.
Hangover (3 Day Average) Mean (SD) Frequency at Home Frequency at Fiji
Severity
(1-Item)
Number of alcoholic drinks
consumed 6.0 (5.2) r = 0.188, p = 0.001 r = 0.228, p = 0.000 r = 0.504, p = 0.000
eBAC (%) 0.11 (0.1) r = 0.216, p = 0.012 r = 0.250, p = 0.004 r = 0.454, p = 0.000
Drinking duration (h) 5.3 (3.5) r = 0.062, p = 0.443 r = 0.197, p = 0.014 r = 0.294, p = 0.000
1-item hangover severity score 1.2 (1.5) r = 0.309, p = 0.000 r = 0.468, p = 0.000 - - -
Note: data represent the average scores of three consecutive days of alcohol consumption and experiencing
hangovers. Abbreviation: eBAC = estimated blood alcohol concentration.
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3.3. Study 3: Naturalistic Study
A total of n = 99 subjects participated in the study. Subjects were excluded if they used drugs of
abuse on the test days (n = 3) or alcohol on the control day (n = 3). N = 12 other subjects were excluded
because they reported no hangover on the alcohol test day. N = 81 subjects were eligible for the present
analysis, of which 36 (44.4%) were men. The subjects had a mean (SD) age of 21.2 (2.9) years old. The
associations between drinking variables and hangover frequency and severity are summarized in
Table 3.
Table 3. Association between drinking variables and severity and frequency of hangovers.






weekly number of alcoholic drinks 8.4 (7.4) r = 0.695, p = 0.000 r = 0.324, p = 0.002 r = 0.695, p = 0.000
the Five Shot score 2.6 (1.2) r = 0.507, p = 0.000 r = 0.206, p = 0.048 r = 0.507, p = 0.000
Number of hangovers per month 1.4 (1.7) - - - r = 0.452, p = 0.000 r = 0.529, p = 0.000
Hangover day
number of alcoholic drinks
consumed 9.2 (4.6) r = 0.452, p = 0.000 r = 0.413, p = 0.000 r = 0.452, p = 0.000
eBAC (%) 0.16 (0.1) r = 0.416, p = 0.000 r = 0.421, p = 0.000 r = 0.416, p = 0.000
drinking duration (h) 6.3 (2.2) r = 0.174, p = 0.095 r = 0.236, p = 0.023 r = 0.174, p = 0.095
HSS hangover severity score 2.3 (1.4) r = 0.452, p = 0.000 - - - r = 0.718, p = 0.000
1-item hangover severity 3.5 (2.5) r = 0.529, p = 0.000 r = 0.718, p = 0.000 - - -
Note: Non-parametric (Spearman’s rho) correlations were computed. These are considered statistically significant if
p < 0.004, after Bonferroni’s correction for multiple comparisons.
As expected, hangover frequency was significantly correlated with a weekly number of alcoholic
drinks consumed, the Five-Shot score, and the number of alcoholic drinks consumed, and eBAC on the
evening before the hangover. Similarly, both HSS and the one-item hangover severity was significantly
associated with the weekly number of alcoholic drinks consumed, the Five-Shot score, and the number
of alcoholic drinks consumed, and the eBAC on the evening before the hangover. Figure 1 shows
the distribution of hangover frequencies per month (Figure 1A) and its correlation with the one-item
hangover severity (Figure 1B).
A positive and significant Spearman’s correlation was found between the hangover frequency
and HSS hangover severity (r = 0.452, p = 0.000) and between hangover frequency and the one-item
hangover severity (r = 0.529, p = 0.000). When conducting a partial correlation, adjusting for eBAC, the
correlations between the hangover frequency and the severity remained significant and positive (HSS:
r = 0.301, p = 0.004, 1-item: r = 0.297, p = 0.004).
The partial correlation between the hangover frequency and the severity also remained significant
when in addition to eBAC, was also corrected for the usual alcohol intake variables (weekly number
of alcoholic drinks consumed and the Five-Shot score) (HSS: r = 0.297, p = 0.005, 1-item: r = 0.341,
p = 0.001). When, in addition to eBAC, the correlation also adjusted for the hangover test day variables
(number of alcoholic drinks consumed on the drinking occasion and the drinking duration), the
correlation between the hangover frequency and severity also remained significant (HSS: r = 0.318,
p = 0.002, 1-item: r = 0.283, p = 0.007).
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Figure 1. Distribution of the hangover frequency scores (A) and their association with the overall
hangover severity (B). Note: a partial correlation (rP), adjusting for estimated blood alcohol
concentration, was computed between the hangover frequency and severity.
3.4. Individual Hangover Symptoms
The severity of individual hangover symptoms and their frequency of being reported are
summarized in Table 4. An exploratory analysis was conducted to identify individual hangover
symptoms of which the reported severity was associated with hangover severity. Partial correlations,
adjusting for eBAC, were computed, and a Bonferroni’s correction was applied to account for the
multiple comparisons (p-values are considered statistically significant if p < 0.004). The analysis
revealed that only the severity score of headache correlated significantly with hangover frequency
(See Table 4).
Table 4. The severity of individual hangover symptoms and past year’s hangover frequency.
Hangover Symptom Mean (SD) Frequency Reported Correlation with Hangover Frequency
Being tired 5.6 (2.6) 97.8% r = 0.059, p = 0.580
Thirst 4.7 (3.0) 90.3% r = 0.176, p = 0.095
Weakness 4.1 (3.0) 83.9% r = 0.238, p = 0.023
Concentration problems 3.6 (2.7) 81.7% r = 0.242, p = 0.021
Headache 2.8 (3.2) 58.1% r = 0.340, p = 0.001 *
Nausea 2.3 (2.8) 57.0% r = 0.212, p = 0.044
Shaking, shivering 1.3 (2.2) 40.9% r = 0.184, p = 0.081
Sleep problems 1.3 (2.1) 36.6% r = 0.025, p = 0.811
Sensitivity to light 1.3 (2.2) 37.6% r = 0.045, p = 0.672
Sweating 1.2 (2.2) 32.3% r = 0.263, p = 0.012
Depression 0.6 (1.6) 15.1% r = 0.182, p = 0.084
Anxiety 0.4 (1.3) 11.8% r = 0.219, p = 0.037
Vomiting 0.4 (1.7) 6.5% r = −0.047, p = 0.660
Note: Partial correlations, adjusted for eBAC, were computed. These are considered statistically significant if
p < 0.004, after Bonferroni’s correction for multiple comparisons. Significance is indicated by *.
3.5. Personality Characteristics
It is unlikely that the association between the hangover frequency and the severity could be
explained by personality characteristics, including somatization. In Study 3, partial correlations,
adjusting for eBAC and all BSI subscales, also revealed significant correlations between hangover
frequency and severity (HSS: r = 0.217, p = 0.050, 1-item: r = 0.361, p = 0.000). Also, partial correlations,
adjusting for eBAC and RT-18 risk-taking subscales, revealed significant correlations between hangover
frequency and severity (HSS: r = 0.277, p = 0.008, 1-item: r = 0.278, p = 0.008).
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3.6. Age
It could be argued that the hangover frequency is a proxy measure of age. As age progresses, the
lifetime number of experienced hangovers increases. Also, research has suggested that the severity of
hangover declines when age progresses [24], along with a steady reduction in the number of binge
drinking days when age progresses [25]. To investigate the possible impact of age on the association
between the hangover frequency and severity, the partial correlations in study 1, 2, and 3 were now
corrected for both eBAC and age. It should be taken into account that the age range for the three
studies, 18-30 years old, was relatively small. In study 1 the partial correlation, adjusting for the
number of drinks consumed and age, between hangover frequency and hangover severity remained
significant when assessed with either the HSS (r = 0.125, p = 0.001), AHS (r = 0.121, p = 0.002), or the
AHSS (r = 0.151, p = 0.000). In study 2, the partial correlation, adjusting for eBAC and age, between
hangover severity and hangover frequency at home or at Fiji remained significant (r = 0.195, p = 0.026,
and r = 0.274, p = 0.002, respectively). In study 3, the partial correlation, adjusting for eBAC and age,
between hangover frequency and hangover severity assessed with the HSS or the one-item hangover
rating also remained significant (r = 0.286, p = 0.006, and r = 0.300, p = 0.004, respectively).
4. Discussion
Across studies, a significant and positive correlation was found between hangover frequency and
severity, suggesting that when hangovers are experienced more frequently, their severity increases.
These findings run counter to our prediction that tolerance develops to the effects of alcohol hangover.
Therefore our hypothesis was not supported.
Our findings, are in contrast to those of the recent study by Köchling et al. [10], who reported that
hangover frequency and severity are unrelated. The studies differed, however, in the methodologies to
assess hangover frequency. Whereas Köchling et al. [10] used five relative crude frequency categories,
in the current studies, the actual number of hangovers per month was calculated, which gives a
more precise measure. Also, as opposed to our studies, Köchling et al. [10] used an unvalidated
hangover scale to assess hangover severity, and an overall hangover severity rating was not obtained.
Alternatively, one could argue that the study by Köchling et al. [10] was a controlled experiment, while
our data was gathered via survey research and a study utilizing a less controlled naturalistic design.
These methodological differences may account for the different outcomes of the study. Future research
is, therefore, necessary to elucidate the exact nature of the relationship between hangover frequency
and severity.
Our findings also contrast with the literature pertaining to acute intoxication, which suggests
that, to some extent, tolerance develops to the acute effects of alcohol. This can be conceptualized as a
rightward shift in the dose-response curve whereby repeated exposure to alcohol is manifested in two
ways. The first is by individuals becoming less sensitive to the behavioral effects of the same dose of
alcohol; the other is by requiring a greater amount of alcohol to achieve previous effects.
The physiological evidence of this effect includes data showing that more frequent drinkers
develop pharmacokinetic tolerance. This is illustrated by reports of lower breath alcohol concentration
(BAC) to the same level of alcohol compared with less frequent drinkers [26]. Consistent with this
finding, after consuming the same dose of alcohol, frequent drinkers may report fewer adverse sedative
effects [27] and feel less intoxicated [28]. In addition, behavioral tolerance to the acute effects of
alcohol may develop differentially, depending on the task domain [29]. Behavioral tolerance, i.e., the
observation that greater experience with drinking to intoxication leads to less impaired cognitive and
psychomotor performance, has been observed in several studies [29–33]. In this context, a recent study
showed that drinkers with higher levels of performance maintenance and those who experienced less
severe intoxication effects, self-administered higher dosages of intravenous alcohol and reached higher
peak BACs than drinkers who were more sensitive to the effects of alcohol [34]. Finally, research has
shown that the sensitivity to acute alcohol effects varies with age such that, across several domains,
young drinkers are less sensitive than older drinkers to alcohol intoxication effects [35].
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Taken together, there is evidence that more frequent consumption of greater alcohol quantities
results in tolerance to the acute effects of alcohol. In contrast to the assumption that alcohol hangover
would exhibit similar characteristics [7], the reduced sensitivity to acute alcohol effects is not reflected
in lower sensitivity to hangover effects. Instead, the opposite was observed: the data suggest that with
increased hangover frequency, the severity of hangovers becomes worse. In the context of the current
findings, it appears that repeated exposure to alcohol differentially affects intoxication and hangover.
That is, repeated exposure to alcohol was related to increases in the magnitude of the hangover effect.
This leftward shift in the dose-response is characteristic of sensitization or reverse tolerance.
A strength of the current paper is that the results were consistent across several studies using
different methodologies (surveys and naturalistic study). Different instruments were applied to assess
overall hangover severity (one-item score, HSS, AHS, and AHSS, and aggregate severity scores over
three days). Despite the variation in these measures, in all cases, a significant and positive association
was found between hangover frequency and severity. Additionally, the sample sizes were sufficiently
large to be confident about this outcome. This finding persists when adjusting for alcohol consumption
variables (e.g., the amount of alcohol consumed and eBAC), age, or personality characteristics.
The current findings have several implications. Firstly, as no tolerance to hangover severity
develops but rather the opposite, this may have consequences for the functional outcomes of the
alcohol hangover. That is, behavioral effects may also further deteriorate in drinkers who exhibit more
frequent hangovers. This is an important issue for further research, as reverse tolerance may have
a significant impact on the magnitude of impairments seen in the hangover state on common daily
activities such as driving a car [36,37].
Secondly, the findings suggest that alcohol hangovers do not act as a deterrent to further
alcohol consumption. In fact, even though hangovers become worse with frequency, drinkers persist
in consuming alcohol to levels that produce hangovers. Previous studies [38,39] also noted that
experiencing hangovers does not have a relevant impact on future drinking behavior. One implication
of this is that there may be value in investigating harm reduction strategies which act as ‘hangover
treatments’ [40–42].
The studies also have limitations that should be addressed. The first one is the possibility of recall
bias. The survey by Penning et al. [11] gathered data retrospectively. Therefore, hangover severity may
not have been accurately recalled. However, the naturalistic study and International survey recorded
hangover severity in real-time and showed similar results. Moreover, the observed correlation between
hangover frequency and severity in real-time was of greater magnitude in the naturalistic study than
the correlations observed when data was collected retrospectively. Secondly, hangover frequency
was recorded via a single question. In future research, it could be considered to apply alternative
methods such as the Time Line Follow Back approach [43] to reduce the possible impact of recall bias.
Thirdly, hangover severity assessment may be biased, as this is a single measurement rather than
an average over multiple drinking sessions. A single assessment may not accurately represent the
typical hangover severity experienced by drinkers. However, the Fiji survey made hangover severity
assessments on three consecutive days, and average scores were used for the analysis to account for
intrapersonal differences and day-to-day fluctuations in alcohol consumption and hangover severity.
Analysis of the Fiji dataset revealed similar results as the single timepoint survey and the naturalistic
study. Thus, the observations cannot be regarded as coincidental, depending on the unique unknown
features affecting hangover severity of one hangover occasion.
Fourthly, there is the issue of experimental control. None of the three datasets were drawn from
controlled experiments with a set amount of alcohol consumed, nor were drink types standardized or
controlled by the investigators. Therefore, hangover severity scores are influenced by several factors
such as total amount of alcohol consumed, drinking duration, congener content, and eBAC. This may
also explain in part why our findings differ from the controlled study conducted by Köchling et al. [10].
In the statistical analysis, the variability in drinking patterns was controlled by computing partial
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correlations, adjusting the observed associations between hangover frequency and severity for eBAC
or the number of alcoholic drinks consumed.
Fifthly, the assessment of hangover frequency was done by simply asking subjects how many
hangovers they had experienced per month, or during the past year. It is likely, however, that hangover
frequency varies across a lifetime, along with periods of higher and lower alcohol intake. The current
analysis did not take this variability into account as this data was not collected. There are alternative
measures that could be applied, such as lifetime number of experienced hangovers that may be more
informative in this regard and could be applied in future research.
Sixthly, the age range of study participants, 18–30 years old, was small. This may have an impact on
the relationship between hangover frequency and hangover severity. Future studies should, therefore,
also include older-aged drinkers. Although longitudinal research showed that reported past year
hangover frequency remains relatively stable from when assessed one year apart [6], Piasecki et al. [44]
also followed student drinkers for 11 years and showed a steady decline in past year hangover
frequency. Tolstrup et al. [24] also reported that during adulthood (18–65 years old) with increasing age,
the frequency of hangovers gradually ameliorates. Although the title of the paper suggests otherwise,
a closer look at the data revealed that they did not assess hangover severity. Instead, the frequency of
experiencing nine hangover symptoms was assessed. The observation that the occurrence of hangovers
declined with increasing age persisted after correction for the usual amount of alcohol intake, frequency
of binge drinking, and the proportion of alcohol consumed with meals. There are various socioeconomic
and cultural factors that may contribute to the reduction in hangover frequency when age progresses.
For example, the start of job and family life responsibilities at the transition from student to adult life
may reduce the frequency and quantity of alcohol consumption. Research has shown that the number
of binge drinking days reduces with progressing age [25]. Hence, when age progresses, given the
reduced amount of alcohol consumed per drinking session, there is a reduction of the opportunities
to have a hangover per se. As stated above, the association between hangover frequency and age is
complex, and there may be many moderating variables, which should be the subject of future research.
For example, it has also been found that infrequent drinkers (14 or fewer days per month) consumed
more alcohol on drinking days and were more frequently involved in binge drinking (13.4%) compared
to frequent drinkers (4.3%) [45]. Taken together, future research on the association between hangover
frequency and severity should take age into account as a moderating factor.
Finally, there is no validated, reliable assessment scale to determine the vulnerability and sensitivity
of alcohol hangover. It should be the aim of future research to develop such a scale, to be able to,
for example, select study subjects that are sensitive to hangover effects per se at a given number of
alcoholic drinks, or to create homogenous research samples. The current findings can then be replicated
in prospective studies or controlled experimental studies with standardized alcohol intake.
In addition to the limitations described above, future research should also elucidate the possible
reasons for variability in the presence and severity of alcohol hangover. This is important because
although a consistent positive association was shown between hangover frequency and hangover
severity, correlational analysis does not imply causality. There may be other factors than hangover
frequency that may be the actual cause of variability in hangover severity. Similarly, the regression
analysis by Kochling et al. [10] cannot prove the absence of a causal relationship between hangover
frequency and severity. The association between hangover frequency and severity is complex, and
there may be many moderating variables. Future research should address biopsychological age-related
factors that may impact the association between hangover frequency and severity, such as deterioration
of liver function, psychological changes, motives for alcohol consumption, and cognitive decline.
Slutske et al. [13] found that only 13% of 1265 students reported having experienced no hangover
symptoms during the past year. Most subjects reported 1–2 past year hangovers (27%) followed by
3–11 past year hangovers (34%). Hangover resistance is reported by around 25% of drinkers who reach
BACs around 0.10–0.12% [46], but the percentage depends on the amount of alcohol consumed and at
higher dosages significantly fewer drinkers claim to be hangover resistant [47–49].
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Studies reported that subjects with a positive family history of alcoholism reported more frequent
hangovers than drinkers with a negative family history of alcoholism [13,44,49]. In an experimental
study, Span and Earlywine [50] found that subjects with a positive family history of alcoholism reported
more severe hangovers than subjects with a negative family history of alcoholism.
Genetic profiling may elucidate why these differences exist. An Australian twin study revealed
that 43% of hangover resistance could be explained by genetic influences [51]. Genetic factors accounted
for 40% (men) to 45% (women) of variability in hangover frequency. A US twin study reported 55%
heritability of the frequency of having hangovers [52]. In both studies, a close relationship was
observed with genetic variability in the frequency of being intoxicated. The severity of hangovers
is also influenced by genetic factors, for example by variability in alleles decoding for aldehyde
dehydrogenase (ALDH2). For example, it has been found that Asian American students with ALDH2*2
alleles may experience more severe hangovers [53], and similar findings were reported for Japanese
workers [54]. Unfortunately, in both studies, a direct relationship between hangover frequency and
hangover severity was not assessed. Nevertheless, Wall et al. [53] suggested that tolerance develops to
the risk of having hangovers, as they found that higher levels of usual alcohol intake were associated
with increased hangover frequency and with reduced hangover severity. This suggestion is, however,
not supported by the current findings.
5. Conclusions
A positive and significant association between hangover frequency and severity was found, which
remained significant after correcting for alcohol intake. This finding suggests that hangovers become
worse when they are experienced more often. Future research should further investigate this, and
factors mediating the observed association, including its implications for alcohol prevention.
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Abstract: Alcohol hangover is a cause of considerable social and economic burden. Identification
of predictors of alcohol hangover severity have the potential to contribute to reductions in costs
associated with both absenteeism/presenteeism and health care. Pain catastrophising (PC) is the
tendency to ruminate and describe a pain experience in more exaggerated terms. The current study
examines the possibility that this cognitive coping strategy may influence experience of alcohol
hangover. The aims of the current study were to (1) examine the relationship between hangover
severity and PC, (2) explore and identify discreet factors within the Acute Hangover Scale (AHS) and
(3) explore whether independent factors/dimensions of acute hangover are differentially predicted
by PC. A retrospective survey (n = 86) was conducted in which participants completed the Acute
Hangover Scale (AHS); the Pain Catastrophising Scale (PCS); a questionnaire pertaining to the
amount of alcohol consumed; and a demographic information questionnaire. Regression analyses
showed a significant relationship between PC and hangover severity scores and demonstrated that
PC was, in fact, a stronger predictor of perceived hangover severity than estimated peak blood alcohol
concentrations (eBACs). Factor analysis of the AHS scale, resulted in the identification of two distinct
symptom dimensions; ‘Headache and thirst’, and ‘Gastric and cardiovascular’ symptoms. Regression
analyses showed that both eBAC and PCS score were significantly associated with ‘Headache and
thirst’. However, only PCS score was associated with ‘Gastric and cardiovascular’ symptoms. These
novel findings implicate a role for cognitive coping strategies in self-reports of alcohol hangover
severity, and may have implications for understanding behavioural response to hangover, as well as
suggesting that hangover and PC may be important factors mediating the motivation to drink and/or
abuse alcohol, with potential implications in addiction research. Furthermore, these findings suggest
that distinct alcohol hangover symptoms may be associated with different mechanisms underlying
the experience of alcohol hangover.
Keywords: hangover; catastrophising; alcohol; veisalgia; acute hangover scale
1. Introduction
1.1. Alcohol Hangover, Symptoms and Economic Burden
Alcohol hangover is a phenomenon that occurs the day after the ingestion of alcohol, once the
blood alcohol concentration (BAC) is approaching nil [1], and it is associated with a wide variety
of symptoms, such as headache, nausea, and concentration problems [2,3]. Hangover is thought to
be a considerable cause of economic loss through workplace absenteeism and lost productivity [4].
Researchers have also speculated that the severity of alcohol hangover is linked to the development of
alcohol use disorders (AUDs) [5,6], indicating that a better understanding of the individual hangover
experience and its mediators may offset the associated financial and social burden of AUD.
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A number of explanations for the variance seen in alcohol hangover presentation have been
suggested, including gene associations of alcohol metabolism [7,8], gender differences [9] inflammatory
response to alcohol consumption [10,11], immunological functioning [12], and congener content of
alcoholic drinks [13], as well as individual differences in psychosocial factors such as anxiety and
mood [14], or guilt related to the actions carried out whilst drinking [3]. There is, however, little
consensus regarding the biological mechanisms that underpin the experience of alcohol hangover [4],
and this is particularly true for psycho-social variables. Identification of mediating factors of alcohol
hangover severity may thus inform mechanistic investigations of hangover, as well as having the
potential to reduce costs associated with absenteeism/presenteeism and improve health care outcomes.
1.2. Hangover and Risk of Alcohol Abuse
Despite the lack of mechanistic explanations for the influence of predictor variables on the
experience of hangover, and mixed findings regarding relationships between familial risk for addiction
and experience of hangover [15,16], there is some evidence that alcohol hangover experience may
be a potential risk factor for alcohol use disorder (AUD) [15]. In this regard, hangover has been
conceptualised as affecting cognitive control processes that influence local drinking behaviour. Evidence
suggests that people who experience a more severe hangover will drink less, when they engage in
drinking the day of a hangover [17], and that hangover can increase the time before the next alcoholic
drink is consumed in frequent drinkers [18], with hangover occurrence predicting a 6 hour delay to next
drink when used as sole predictor in a survival model. It is notable, however, that hangover occurrence
was only associated with a delayed time to next drink in multivariate models when interacting with
the onset of financial stressors, or the presence of high levels of craving at the end of the drinking
episode (pre-hangover). This may implicate a role for the hangover in the delay of further engagement
with drinking, when experienced alongside a continued desire/motivation to drink. The investigation
of differences in factors related to motivational and inhibitive processes, such as cognitive coping
strategies, during hangover, therefore has the potential to contribute to understanding of possible
relationships between the hangover experience and propensity for development of AUDs.
1.3. Alcohol Hangover and Pain Catastrophising
Pain catastrophising (PC) has been broadly defined as an exaggerated negative orientation
towards actual or anticipated pain experiences [19] and has been described as the tendency to recall
pain experiences in more exaggerated terms, to feel helpless and ruminate over painful events. PC
appears to be moderated, to some degree, by gender [20], psychosocial and dispositional factors [19,20].
However, despite these moderating factors, PC contributes unique and significant variance to the
prediction of self-reported pain intensity, as well as to neural processing of pain [21]. Evidence has
shown that the relationship between PC and pain ratings is partially mediated by diminished diffuse
noxious inhibitory controls (a measure of endogenous pain inhibition), indicating a disruption in
pain inhibition and suggesting a relationship between PC and pain inhibition [22]. Neurological
evidence (utilising functional magnetic resonance imaging) has demonstrated that PC predicts the
experience of pain, in that, during exposure to a painful stimulus, pain specific response activation in
the dorsolateral prefrontal cortex (dlPFC) and medial prefrontal cortex (mPFC) correlate negatively
with PC [23]. The effect of PC on brain activity in the mPFC and dlPFC also seems to be mediated by
the severity of pain experienced, with reduced activity during more intense pain [24]. Additionally,
the dlPFC shows greater bilateral activation during response inhibition, in comparison to interference
monitoring and suppression [25], indicating some anatomical overlap between inhibitive processes and
PC. It has been argued that PC may heighten pain experiences by reducing the efficiency of inhibitory
pathways, though evidence for this position is indirect [26].
Alcohol hangover is characterised by pain symptoms. Indeed, the medical term for alcohol
hangover “veisalgia” comes from the Norwegian kveis, which refers to the uneasiness following
debauchery, and algia, the Greek term for pain. Cytokines, proteins produced during immune response
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that are involved in both the initiation and persistence of pathologic pain [27], are altered during
hangover. Interleukin (IL-2; IL-10) and interferon (IFN-γ) cytokines have been shown to be elevated
in blood during hangover [10]. In saliva, elevations of IL-2, IL-4, IL-5, IL-6, IL-10, IFN-γ, and TNF-α
have been observed during hangover, and in urine, elevations of IL-4 and IL-6, as well as decreases
in IL-8 have been observed in comparison to non-hangover-days [28]. These differences in cytokine
levels between hangover and non-hangover days do not, however, appear to explain variance in the
experience of hangover, with similar changes observed in both those reporting hangover, and those
reporting hangover resistance [29]. Headache, a continuous pain in the head which has also been
associated with changes in cytokine levels [29,30], represents the 3rd most common symptom of alcohol
hangover [31] and symptomatic ratings of headache severity have large statistical effects in measures
of hangover severity [32]. PC therefore presents a good candidate for potentially explaining some of
the variance in self-reported hangover severity scores. Consequently, the current study hypothesises
that greater PC will be associated with elevated hangover severity scores.
It has also been argued that hangover lacks in mechanistic explanations [4], despite the wide
variety of symptoms associated with the hangover experience [2]. Certainly, dehydration is thought to
represent one potential mechanism, with thirst being one of the most commonly reported hangover
symptoms [2,31], due to the diuretic effects of alcohol [33]. Vasopressin levels, a biological marker of
dehydration, do not, however, necessarily correlate with overall hangover severity [12]. It is possible
that this is due to dehydration representing a mechanism of hangover that explains only a particular
symptom cluster. Factor analysis of measures of hangover severity may therefore provide some
direction for investigations of the mechanisms that give rise to symptom clusters. Furthermore, certain
symptom clusters may be independently moderated by PC and may represent better predictors of
alcohol abuse risk.
The current retrospective survey was therefore designed with three main aims: (i) to examine
whether increased PC scores are associated with elevated hangover severity scores, (ii) to explore the
factor structure of the acute hangover scale (AHS), and (iii) to explore whether different dimensions of
the AHS are independently associated with PC.
2. Materials and Methods
2.1. Participants
Participants were recruited through opportunity sampling—both at a university in the north-west
United Kingdom, and online via social media. Ninety-one participants completed the survey, with
3 participants excluded from analysis because they reported a non-binary gender, which presents issues
for calculating blood alcohol concentrations. A further 2 participants were excluded from analyses
based on age, with one reporting an age of 5 years, violating exclusion criteria, and one reporting
an age of 80 years, representing an extreme outlier in the current sample (+6.24 SDs from the mean).
The remaining sample of 86 had an overall mean age of 25.93 years (SD: 6.03, range: 18–46), with
51 female respondents (59%). No incentive was provided for participation. Exclusion criteria for the
study were: below 18 years of age (not of legal drinking age for the area in which they reside); having
not experienced hangover in the last 6 months. Exclusion was based on self-report: independent
verification of these criteria was not possible with an online survey. Ethnicity was not analysed as a
variable as the majority of participants (88%) self-identified as white.
2.2. Materials
Participants were required to complete an online survey that included the Acute Aangover Scale
(AHS) [32], to measure hangover severity retrospectively, and the Pain Catastrophising Scale (PCS) [19],
to measure PC associated with the experience. The PCS consists of 13 items addressing the experience
of catastrophic thoughts related to the experience of pain, rated on a scale from 0 (not at all) to 4 (all the
time), with total score calculated as the sum of all items. The PCS has shown a high level of reliability,
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with Cronbach’s α scores typically exceeding 0.8 [19,30,31], and the PCS has been validated in a variety
of samples, including those ‘seeking treatment’ (vs. not seeking treatment) [34], pain outpatients (vs.
community participants) [35], those with back pain (Norwegian version) [36], and those with chronic
pain (Korean and Brazilian-Portuguese versions) [37,38]. The AHS consists of 9 items addressing the
severity of 8 hangover symptoms, plus an overall hangover severity rating, all given on a scale from 0
(None) to 7 (Incapacitating), with AHS total score calculated as the mean of all items. The AHS has been
validated for concurrent hangover severity measurement, but also shows very high correlations with
scales designed for measurement of the most recent (retrospective) hangover experience [39], as well
as having been utilised for recent hangover severity measurement in other research [40]. Participants
reported the drinking that led to their most recent hangover using the items from McKinney and
Coyle’s investigation, which asks about the number of a variety of standardised drinks consumed (e.g.,
pints of beer, bottles of beer, alcopops, etc.), and allows for the number of units of ethanol consumed to
be calculated [41]. Demographics were also collected, including age (which was recorded for use as a
covariable since previous evidence has suggested a role in the experience of hangover [42]), height and
weight, (for the calculation of estimated blood alcohol concentrations), and ethnicity. Estimated blood
alcohol concentrations were calculated using the method from Siedl et al. [9], resulting in the estimated
peak blood alcohol concentration assuming no elimination (eBAC), and assuming a 15% elimination
rate (eBAC15%). Both the AHS and PCS were adapted to reference how the participants felt during
their most recent hangover.
2.3. Procedure
Participants, recruited via social media (Twitter, Reddit) and posters located around a university
in the north-west, UK, completed an online survey hosted on Online Surveys by Jisc (https://www.
onlinesurveys.ac.uk/). Participants completed the survey during their own time. The total time to
complete the study was approximately 15 min. No incentives were offered for participation.
2.4. Ethics
The materials and methods utilised in this procedure were approved by the University of Salford
Health Sciences Research ethics board (HSR1617-15), and all participants provided informed consent.
The use of Online Surveys for data collection allowed for participant anonymity, and the system
adheres to high ethical standards (e.g., no use of ‘cookies’ which store files to the local PC used to
complete the survey).
3. Results
All analyses were carried out in IBM SPSS 25.0.0.1 (IBM Corp., Armonk, NY, USA).
3.1. Factor Analysis
A dimension reduction procedure was carried out on responses to the items of the AHS to establish
whether symptom clusters existed. The item ‘hangover’ was excluded from this analysis, as this is
non-symptomatic and thought to capture a broad rating of hangover severity [32]. Descriptive statistics
for the remaining items are presented in Table 1. Inter-item correlations are presented in Table 2.
As all items failed to meet at least parametric assumption of normality in univariate analyses,
principal axis factor analysis was utilised for dimension reduction [43]. Reduction was carried out using
a direct obliminal rotation with a delta of 0, given the likelihood of correlations between dimensions
of hangover, and in line with the recommendations of Costello and Osborne [43]. Factors with an
eigenvalue above 1 were retained, with results checked visually using the Scree test. Results indicated
a solution with 2 dimensions, one factor consisting of symptoms linked to dehydration, and one to
stress responses. Kaiser–Meyer–Olkin statistics indicated good sampling adequacy (KMO = 0.722),
though KMO values for individual variables indicated a potential issue with the item ‘nausea’ (KMO =
0.495; removal of this item did not result in changes to the factor structure). Bartlett’s test of sphericity
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indicated acceptable deviance from an identity matrix (× 2(28) = 138.762, p < 0.001), and 35% of
residuals between observed and reproduced correlations had absolute values above 0.05, indicating
moderate model fit. The factor model is summarized in Table 3.
Table 1. Descriptive statistics for ratings of hangover symptom severity on the acute hangover scale
(AHS).
Item. Mean SD Median Normality
95% CI
Lower Upper
Tired 5.94 1.24 6 <0.001 *** 5.68 6.21
Thirsty 5.31 1.528 5 0.001 **** 4.99 5.64
Headache 4.71 2.057 5 <0.001 **** 4.27 5.15
Nausea 3.66 2.433 3 <0.001 **** 3.14 4.18
Loss of appetite 3.33 2.078 3 <0.001 **** 2.88 3.77
Dizziness/faintness 3.22 2.008 3 <0.001 **** 2.79 3.65
Stomach ache 3.06 2.054 2 <0.001 **** 2.62 3.5
Heart racing 2.72 2.096 2 <0.001 **** 2.27 3.17
SD—standard deviation; normality—p-Value for Shapiro–Wilk analysis of normality. The n for all items was 86.
Significant results indicated by *** p < 0.01, **** p < 0.001.











0.239 0.312 0.192 0.176 0.156 0.223 0.161
(0.013) * (0.002) *** (0.038) * (0.052) (0.075) (0.020) * (0.069)
Thirsty 0.276 0.140 0.112 −0.031 0.084 0.226
(0.005) ** (0.100) (0.152) (0.390) (0.221) (0.018) *
Headache
0.208 0.344 0.241 0.182 0.183
(0.027) * (0.001) *** (0.013) * (0.047) * (0.046) *
Nausea
0.473 0.497 0.529 0.434
(<0.001) * (<0.001) **** (<0.001) **** (<0.001) ****
Loss of appetite 0.369 0.211 0.305
(<0.001) * (0.026) * (0.002) *




Significant correlations indicated by * p < 0.05, ** p < 0.01, *** p < 0.005, **** p < 0.001.
Table 3. Factor loadings of AHS items based on principal axis factoring.






Heart racing 0.088 0.535
Stomach ache 0.024 0.532
Loss of appetite 0.164 0.47
Eigenvalues 1.252 2.906
Factor correlation 0.452
Composite scores were calculated for each factor based on the mean of the items which had
their primary loadings on each factor (Headache and thirst: mean = 5.32, SD = 1.17; Gastric and
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cardiovascular symptoms: mean = 3.20, SD = 1.53) with higher scores indicating greater severity of
symptoms within the cluster. The bold indicates most relevance.
3.2. Regression Models
Three initial regression models of the AHS score were formed, with PCS score and age used
as predictor variables in all three models, and the contribution of ‘measures of drinking’ assessed
across separate models. A further two regression models were formed to assess dimensions of
the AHS identified in factor analysis. Descriptive statistics for the variables included across these
regression models are presented in Table 4. To minimize overfitting of the data, rather than utilize an
automated variable selection method, for each model, each variable was entered into the regression
concurrently [44], with a model formed for each of the three ‘measures of drinking’ obtained; units
consumed, eBAC, and eBAC15%. Gender was also entered into the model with the number of units
consumed, since this is controlled for in the calculations used to derive eBAC and eBAC15% scores and
approximates differences in the body fat composition of different genders which influences alcohol
distribution through body water during consumption.
Table 4. Descriptive statistics for variables included across the five regression models constructed.
Variable Mean SD Median Normality
95% CI
Lower Upper
Acute Hangover Scale (AHS) 4.1 1.2 4.11 0.101 3.85 4.36
Pain Catastrophizing scale (PCS) 28.81 11.64 26.5 <0.001 **** 26.32 31.31
Age 25.93 6.03 25 <0.001 **** 24.64 27.22
Total units 15.62 8.64 13.4 <0.001 **** 13.77 17.48
eBAC 0.26 0.14 0.22 <0.001**** 0.23 0.29
eBAC15% 0.18 0.13 0.14 <0.001 **** 0.15 0.21
Headache and thirst 5.32 1.17 5.33 0.06 5.07 5.57
Gastric and cardiovascular
symptoms 3.2 1.53 3 0.002 *** 2.87 3.53
Variables: AHS—acute hangover scale; PCS—pain catastrophising scale; total units—units of alcohol consumed,
calculated from self-report; eBAC—the estimated blood alcohol concentration assuming no elimination;
eBAC15%—the estimated blood alcohol concentration assuming 15% elimination rate; Headache and thirst—mean
score for items identified within dimension 1 of the factor analysis; Gastric and cardiovascular symptoms—mean
score for items identified within dimension 2 of the factor analysis; SD—standard deviation; normality—significance
of Shapiro–Wilk analysis. The n for all measures was 86, *** p < 0.005, **** p < 0.001.
Results indicated that eBAC represented the drinking measure that explained the most variance
in AHS scores (power = 0.50, calculated post-hoc), and as such the model containing this variable
was carried forward for regression analyses of factor scores calculated during factor axis analysis.
A regression model containing eBAC, PCS score, and age, as predictor variables, was therefore formed
for each of the two factor scores derived. Summaries of regression models are presented in Table 5,
with a summary of individual variable contributions presented in Table 6.
Tolerance, variance inflation factors (VIFs), and collinearity diagnostics indicated no issues
with multicollinearity. Manual examination of standardized residuals plotted against standardized
predicted values suggested no issues with heteroscedasticity in the data, and multivariate normality
was present in all models. Durbin–Watson statistics indicated independence of errors. Some issues
were identified in casewise diagnostics, with a small number of cases indicating issues with either
problematic covariance ratios or high leverage values in regression models.
Given that a number of cases presented potential issues with covariance and leverage, and in
line with recommendations made by Babyak [44], validation of the final models (those containing
the eBAC drinking measure) was carried out using bootstrap methods with 2000 random resamples
drawn. Bootstrapped models are summarised in Table 7.
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Table 7. Summary of bootstrapped regression model coefficients.













Constant 3.005 0.009 0.725 <0.001 **** 1.612 4.491
eBAC 2.262 0.027 0.959 0.022 * 0.483 4.280
PCS score 0.033 <0.001 0.009 <0.001 **** 0.015 0.051
Age −0.017 <0.001 0.020 0.401 −0.058 0.021
4 Headache
and thirst
Constant 4.288 0.046 0.658 <0.001 **** 2.975 5.840
eBAC 1.876 0.032 0.950 0.046 * 0.049 3.812
PCS score 0.022 <0.001 0.010 0.026 * 0.003 0.040





Constant 2.323 −0.002 0.922 0.014 * 0.577 4.119
eBAC 2.258 0.007 1.233 0.066 −0.060 4.654
PCS score 0.039 <0.001 0.013 0.004 *** 0.013 0.064
Age −0.032 <0.001 0.024 0.165 −0.080 0.015
DV—dependent variable; IV—independent variable; B—beta weight; SE—standard error; BCa 95%
CI—bias-corrected accelerated 95% confidence interval. Bootstrap results based on 2000 bootstrap samples.
Significant results indicated by *, * p < 0.05 = *, *** p < 0.005, **** p < 0.001.
Results of bootstrap analyses have a fairly high level of agreement with original regression models,
with significant predictor variables remaining constant. Both eBAC and total PCS score demonstrated
significant relationships with total AHS score, and a composite score based on symptoms of the AHS
related to ’Headache and thirst’. Only total PCS score demonstrated a relationship with a composite
score based on ‘Gastric and cardiovascular’ symptoms. eBAC approached significance in this model.
However, bootstrapping did indicate some bias toward significance of this variable with this sample.
4. Discussion
4.1. Summary of the Main Findings
Hangover, the mental and physical symptoms experienced the day after drinking and once BAC
is approaching 0, has previously been associated with a variety of other factors, including genetic
influences on alcohol metabolism [7,8], gender [9], inflammatory responses [10,11], immunological
function [12] and congeners [13]. However, few psychosocial predictors of hangover have been
identified so far.
The three main aims of the current study were: (i) to examine whether increased PC scores
are associated with elevated hangover severity scores, (ii) to explore the factor structure of the
acute hangover scale (AHS), and (iii) to explore whether different dimensions of the AHS were
independently associated with PC. The current study demonstrated that PC was a predictor of
perceived hangover severity and was, in fact, a stronger predictor than the estimated peak blood
alcohol concentration (eBAC). Exploration of the dimensions of the AHS revealed two distinct symptom
dimensions; ‘Headache and thirst’; and ‘Gastric and cardiovascular’ symptoms. While both eBAC and
PC were significantly associated with ‘Headache and thirst’, only PC was associated with ‘Gastric and
cardiovascular’ symptoms.
4.2. Relationships between Pain Catastrophising and Hangover Severity
Relationships between PC and AHS scores were investigated using multiple linear regression.
Initial models indicated that, of the drinking measures, a calculated blood alcohol concentration
that did not account for elimination (eBAC) was the best predictor of the AHS score. One potential
explanation is that the preferential metabolism of ethanol limits downstream action to eliminate ethanol
metabolites leading to a build-up of biologically active compounds [45]. This would be consistent
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with the time course of alcohol hangover, with symptomology extending beyond the period of acute
ethanol intoxication.
Regression models (and calculated product measures [46]) indicated PC was a better predictor
of perceived hangover severity than eBAC. Given relationships between PC and other psychosocial
variables such as depression and anxiety [20,21], PC could provide a mechanism through which
other psychosocial variables influence self-report hangover severity scores. Furthermore, given links
between PC and inhibitive processes [26], this cognitive strategy may influence motivational responses
to hangover, providing a potential link between hangover experience and local behaviour, such as
engagement with further drinking. Such effects could have implications in addiction research [15].
The results of the current investigation may also have implications for the measurement of
hangover, given its reliance on self-report measures, such as the AHS [32]. This issue has been largely
ignored in hangover research for purposes of practicality, with a lack of other approaches available.
Results from the regression models developed as part of this investigation indicate a moderate effect
of PC on AHS score, comparable to the effect observed for measures of alcohol consumption, and
support the view that self-report hangover questionnaires contain a significant subjective element.
This may reinforce the need for an objective measure of hangover. However, research into biomarkers
of hangover severity has yet to find a reliable indicator [1,28]. An alternative approach to measuring
hangover severity in a more objective manner may be to examine the cognitive effects of hangover.
A meta-analytic examination of the next-day cognitive effects of hangover published in 2018 suggested
that effects can be seen during hangover on short- and long-term memory, sustained attention, and
psychomotor speed [47]. Differences in performance on tasks examining these functions between
hangover and non-hangover days could therefore present a measure of functional hangover severity.
Questions can be raised regarding the value of any of these measurement approaches. Arguably, the
subjective experience of hangover is likely to influence the behavioural response to the experience, and
may provide value over ‘objective’ measurements of hangover, such as cognitive performance measures
or biomarkers, in particular contexts (e.g., the investigation of absenteeism/presenteeism and other
acute behaviours). In comparison, objective measures may be more useful in investigations examining
the biological correlates of alcohol hangover. Further research will need to examine the comparative
value of different measurement approaches in relation to different outcomes. However, controlling for
PC in future analyses may also aid in understanding the hangover experience, particularly with regard
to the investigation of biomarkers.
Dimensions of the AHS
A recent review of the physiology of hangover identified alcohol metabolites, neurotransmitter
alterations, inflammatory factors, and mitochondrial (metabolic) dysfunction as the most likely factors
involved in hangover symptomology [48]. PC has also been associated with alterations to immune
responses, with heightened reactivity of cytokine IL-6 related to increased levels of PC as measured
immediately after painful stimulation [49]. This relationship between PC and IL-6 also appeared
to be independent of pain ratings given during stimulation. Likewise, immune responses during
hangover have been shown to include increases in IL-6 levels [28], with IL-6 thought to have particular
importance as a messenger molecule that connects peripheral regulatory processes with the central
nervous system during responses to both physiological and psychological stress [49].
In this study, factor analysis of AHS responses resulted in two symptom dimensions; (1) Headache
and thirst (‘headache’, ‘tired’, ‘thirsty’), and (2) Gastric and cardiovascular symptoms (‘nausea’,
‘dizziness/faintness’, ‘heart racing’, ‘loss of appetite’, and ‘stomach ache’). The ‘Headache and
thirst’ symptom cluster could be related to the diuretic properties of alcohol [29], which can lead
to dehydration. Dehydration has been linked to headache [50], with tiredness and thirst being
considered common symptoms. Headache may also be the result of cytokine release prompted by
physiological stress associated with alcohol consumption [29,30], or indeed physiological stress may
be caused by dehydration. However, there is potential for overlap in the causes of symptom clusters.
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Speculation regarding the biological mechanisms underlying symptom cluster experience is, however,
not possible based on the current investigation. Future work will be needed to identify specific biological
associations with the experience of hangover symptom clusters. Penning et al.’s factor analysis also
identified dehydration (‘disturbed water balance’) as a dimension of the hangover experience [2].
However, in their investigation, the item ‘headache’ was not loaded on this dimension. Dehydration
causes physiological changes, e.g., to electrolytic balance, which have proposed associations with
hangover. However, evidence for relationships between physiological changes and hangover severity
is lacking [12], though they have not been investigated in relation to specific symptom clusters. One
potential explanation for the ‘Gastric and cardiovascular’ symptom cluster emerging is that they can
all be linked to physiological stress responses. Effects of stress response on the autonomic nervous
system are well established [51], and acute physiological stress can also induce various responses in
the gastrointestinal system [52].
An alternative explanation of the factor structure of the AHS identified in this investigation relates
to the prevalence of symptoms. Tiredness, thirst and headache, the items loaded within the ‘Headache
and thirst’ dimension, represent the three most commonly reported hangover symptoms [31]. It is
possible that these symptom clusters are thus representative of different groups that either experience
one or both of the symptom clusters. An extension of this reasoning, given the prevalence of headache
and thirst symptoms in hangover, could be that less severe hangovers consist of symptoms included
within the ’Headache and thirst’ symptom cluster, with more severe hangovers including ‘Gastric and
cardiovascular’ symptoms.
4.3. Dimensions of the AHS Independently Associated with PC
Composite scores based on ‘Headache and thirst’ symptoms, and ‘Gastric and cardiovascular’
symptoms, identified during factor analysis of AHS responses, were also assessed using regression. Both
eBAC and PCS score significantly predicted ‘Headache and thirst’ symptom scores with approximately
equal contributions. The observation of PC score as a significant predictor in this model is possibly due
to the inclusion of headache severity ratings in the construction of this score, with PC having previously
been linked with both the presence of weekly headache [53], and the severity of migraine symptoms, a
phenomenon associated with headache [54]. Given the diuretic effects of alcohol [33], it follows that
measures of alcohol consumption would be related to symptoms associated with dehydration.
Finally, only PCS score significantly predicted composite scores based on ‘Gastric and
cardiovascular’ symptoms, though eBAC was only marginally non-significant. Product measures
supported the interpretation that PC was more strongly related with ‘Gastric and cardiovascular’
symptoms than eBAC, and robust regression provided some validation of this model. PC has been
related to activity in the mPFC [24], an anatomical area that has also been shown to mediate stress
response [55]. This may provide a link through which this cognitive strategy can influence stress
responses occurring as a result of hangover. The exclusion of eBAC from this model may indicate
that these symptoms are not direct products of alcohol consumption, or that this symptom set is not
associated linearly with the volume of alcohol consumed (e.g., threshold effects). It has, however,
been previously suggested that increased levels of fatty acids seen during hangover are products of a
stress response concurrent with hangover [12], which could indicate that ‘Gastric and cardiovascular’
symptoms in hangover are somewhat independent of the amount of alcohol consumed.
4.4. Conclusions and Directions for Future Research
Hangover represents a considerable economic toll due to its influence on local behaviour, such as
lost productivity and workplace absenteeism [4]. Furthermore, the experience of hangover may be
related to downstream health consequences by promoting deviant drinking practices [12]. The current
investigation revealed, for the first time, that PC predicts alcohol hangover severity and that this effect
occurs in a symptom specific manner. PC may also provide a cognitive strategy through which other
psychosocial variables can influence hangover.
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Exploratory factor analysis provided evidence of two distinct sub-structures of the AHS, ‘Headache
and thirst’, and ‘Gastric and cardiovascular’ symptoms. Results of this investigation could be interpreted
as suggesting that dehydration and physiological stress responses represent areas that warrant further
examination, with differences in regression models based on composite hangover scores for symptom
clusters providing some evidence that symptom clusters are somewhat independent. This may provide
an explanation for why markers of dehydration have not always correlated with overall hangover
severity [12], as well as why thirst had the lowest item-total correlation during development of the
AHS [32]. Further research will be required to establish whether particular covariables correlate with
symptom clusters either derived from dimension reduction procedures or theoretical mechanistic
relationships. The AHS also measures a somewhat limited sample of hangover symptoms, and recent
research has adopted the approach of combining the symptoms identified in a number of validated
hangover measures, in order to capture the diversity of the hangover experience [56]. These measures
consist largely of different symptoms, but show high correlations, and further research will be needed
to examine whether the dimensions of the hangover experience suggested here are evident within this
broader context, as well as their relationships with PC.
As noted previously, hangover has also been associated with effects on local drinking behaviour [17,
18], with an ecological momentary assessment conducted by Epler et al. in 2014 indicating that the
presence of hangover delayed the onset of the next drinking episode when interacting with either
the onset of financial stressors, or the presence of craving at the end of the drinking episode [18].
Epler et al.’s (2014) sample consisted of participants with a reasonably low risk of alcohol problems
(average AUDIT score = 12.21), but no research has addressed this relationship in high-risk or clinical
groups. Evidence has suggested relationships between craving and AUD symptomology in a sample
containing a high proportion of participants meeting criteria for diagnosis of AUD. However, no
relationship was found between craving and drinking habits in this sample [57]. This may suggest that
interactions between craving, hangover, and local drinking behaviour do not exist in those at a high risk
for AUD. Greater craving in the high-risk sample also showed a relationship with increased impulsive
discounting (a devaluation of future reward) [57], which may provide a mechanism for observed losses
of inhibitory response control in alcohol disorders, as well as other disorders, such as depression [58].
Weaker inhibition processes have also been noted in those with a family history of AUD [59], and in
young-adult binge drinkers [60], a form of drinking associated with an increased incidence of hangover.
Inhibition is also inherently linked with impulsivity [61], which has itself been strongly associated
with AUD [58]. Given the links between PC and motivational/inhibitive processes [26,62], future
research should consider PC and hangover alongside factors related to motivation/inhibition, such as
performance on inhibition dependent tasks, and craving. Vatsalya et al.’s (2018) investigation found
no relationship between hangover severity (as measured by the AHS) and a single item measure of
craving [40]. However, this craving measurement is unlikely to capture the theoretical complexity of
the phenomenon and future research would benefit from the use of context appropriate, validated
craving measures [63].
Future research should therefore seek to elucidate the potential interaction between PC
and cognitive processing systems mediating inhibitory control and the craving response during
alcohol hangover.
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Abstract: Studies have demonstrated significant sex differences in alcohol intoxication effects.
In contrast, the majority of studies on the alcohol hangover phase did not investigate sex differences.
Therefore, the current study examined possible sex differences in the presence and severity of alcohol
hangover symptoms. Data from n= 2446 Dutch students (male= 50.7%, female= 49.3%) were analyzed.
They reported the presence and severity of 22 hangover symptoms experienced after their past month
heaviest drinking occasion. Subjects were categorized according to their estimated peak blood alcohol
concentration (eBAC) and presence and severity of the hangover symptoms were compared between
men and women. In the lowest eBAC group (0% ≤ eBAC < 0.08%), no significant sex differences were
found. In the subsequent eBAC group (0.08% ≤ eBAC < 0.11%), severity of nausea was significantly
higher in women than in men. In the third eBAC group (0.11% ≤ eBAC < 0.2%), women reported
higher severity scores on nausea, tiredness, weakness, and dizziness than men. Men reported the
presence of confusion significantly more often than women, and women reported the presence
of shivering significantly more often than men. In the fourth eBAC group (0.2% ≤ eBAC < 0.3%),
women reported higher severity scores on nausea and tiredness than men. In the highest eBAC group
(0.3% ≤ eBAC < 0.4%), no significant sex differences were found. In conclusion, across the eBAC
groups, severity scores of nausea and tiredness were higher in women than in men. However, albeit
statistically significant, the observed sex differences in presence and severity of hangover symptoms
were of small magnitude, and therefore, have little clinical relevance.
Keywords: alcohol; hangover; symptoms; sex differences; presence; severity
1. Introduction
The alcohol hangover is defined as the combination of mental and physical symptoms that
are experienced the day after an episode of heavy alcohol consumption, starting when blood
alcohol concentration (BAC) approaches zero [1]. Alcohol hangovers may negatively impact people’s
psychological and physical well-being by increasing accidents and injury [2,3] and impairing daily
activities such as driving a car [4,5] or riding a bicycle [6].
Sex differences in acute alcohol effects have been well documented. Females have more body
fat and less water than men of the same body weight [7]. Since alcohol is dispensed in body water,
women reach higher BAC levels than men despite consuming an identical number of alcohol units [7].
Moreover, women usually have increased bioavailability and faster disappearance rates than men [8].
Also, alcohol appears to impair cognitive and psychomotor functioning in women more than in
men [9,10].
Research usually shows that men consume more alcohol than women on a single drinking session
(e.g., [11]). Therefore, in most observational and naturalistic studies men have higher BACs and
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experience more negative alcohol related consequences and performance impairment then women.
However, studies employing the self-rating of the effects of alcohol (SRE) form show that at the same
BAC levels, women usually are more sensitive to alcohol effects than men [12]. Lower scores on the
SRE imply that fewer alcoholic drinks are needed to achieve a certain effect, meaning that subjects
are more sensitive to alcohol. Usually, men have significantly higher SRE scores than women [13],
suggesting that at the same BAC level men are less sensitive to (the adverse effects of) alcohol compared
to women. As sex differences in pharmacokinetics and pharmacodynamics sex have been observed
after acute alcohol intake, it is important to further investigate possible sex differences in the presence
and severity of alcohol hangover effects.
A search of the literature revealed that the majority of studies on alcohol hangovers did not
investigate possible sex differences. In fact, many older studies included men only. For example, until
2004, studies on the pathology and physiological correlates of alcohol hangover were solely conducted
in male subjects [14–28].
Also, many studies investigating cognitive impairments that may accompany the alcohol hangover
used samples that consisted of men only [29–44]. In addition, some studies have focused on women
only [45], while others did not mention the sex of their participants [46,47]. Moreover, several studies on
cognitive performance included both men and women but omitted any statistical analysis on possible
sex effects [6,48–55], leaving it unknown whether sex differences were either absent or not investigated.
Up to now, six controlled studies examining performance on a variety of cognitive, psychomotor, and
memory tests found no significant sex differences on any of the administered tests [56–61], and two
other studies reported no significant sex differences in driving performance [4,62]. In experimental
studies where sex-adjusted dosing was used, with few exceptions [58], usually no sex differences in the
presence and severity of hangover symptoms was found [60,63]. Most commonly, however, possible
sex differences were not investigated. Also, with few exceptions [64,65], survey studies usually did not
report on sex differences.
Insight into possible sex differences in the symptomatology of the alcohol hangover may help
to increase our understanding of the pathology of the alcohol hangover and be of guidance in the
development of sex-tailored alcohol hangover treatments, targeting those core symptoms that are
characteristic for the hangover state in relation to different peak eBAC levels. The aim of the current
study was, therefore, to systematically investigate possible sex differences in the presence and severity
of alcohol hangover symptoms at various estimated blood alcohol concentration (eBAC) ranges. The
latter is a novel approach compared to previous research but differentiating BAC levels is important, as
sex-effects may be differential at high or low BACs. Given the pharmacokinetic and pharmacodynamic
sex differences in acute alcohol effects, sex differences in the presence and severity of hangover
symptoms were also expected to be present during the hangover state.
2. Methods
Data from two previous surveys on alcohol hangovers were combined [66,67]. The combined
dataset consisted of n = 2446 Dutch students (male = 50.7%, female = 49.35%), with an age range
of 18 to 30 years old. For their past month’s heaviest drinking occasion, they reported the number
of alcoholic drinks they consumed and the start and stop time of drinking. The estimated peak
blood alcohol concentration (eBAC) for this drinking occasion was calculated by applying an adapted
Widmark equation [68]. As the eBAC formula includes data on weight, sex, duration of drinking, and
the amount of alcohol consumed, eBAC can be regarded as the most overall alcohol consumption
parameter. The severity of 22 individual hangover symptoms was scored on an 11 point scale ranging
from 0 (absent) to 10 (extreme) [69]. The 22 individual hangover symptoms are a combination of those
listed in the three most commonly used hangover symptom scales [70–72], and include headache,
nausea, concentration problems, regret, sleepiness, heart pounding, heart racing, vomiting, tiredness,
shivering, clumsiness, weakness, dizziness, apathy, sweating, stomach pain, confusion, sensitivity to
light, thirst, anxiety, depression, and reduced appetite.
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Statistical Analysis
Data were analyzed using SPSS version 25. Subjects who reported no hangover and those with an
eBAC of 0.40% and higher were omitted from the analysis. The presence of each of the 22 hangover
symptoms was calculated (i.e., the % of subjects with a score >0). Mean (SD) hangover symptom
severity was calculated only for those subjects reporting a particular hangover symptom (i.e., excluding
scores of 0). The presence and severity of individual hangover symptoms were compared between
men and women using the nonparametric Chi-squared test (presence, comparing percentages) and the
Mann–Whitney U test (severity, comparing means), respectively. A Bonferroni correction was applied
to adjust for multiple comparisons. Sex differences were considered statistically significant if p < 0.002.
Since alcohol consumption levels may significantly differ between men and women, as well as the
corresponding presence and severity of hangover symptoms, subjects were grouped according to their
estimated blood alcohol concentration (eBAC): (a) 0% ≤ eBAC < 0.08%, (b) 0.08% ≤ eBAC < 0.11%, (c)
0.11% ≤ eBAC < 0.2%, (d) 0.2% ≤ eBAC < 0.3% and (e) 0.3% ≤ eBAC < 0.4%. The lower cut-off values
(a) correspond to common legal limits for driving, whereas ≥0.11% (d) corresponds to the Alcohol
Hangover Research Group proposed eBAC limit needed to provoke a hangover per se [73]. For the
current study, participants with an eBAC of ≥0.4 were considered outliers (>2 SD from the mean) and
excluded from the data analysis.
3. Results
From the n = 2446 subjects that completed the survey, those who reported no past month hangover
were omitted from the analysis (n = 681, 27.6%). Thus, data on the presence and severity of hangover
symptoms from n = 1765 subjects (n = 895 men and n = 870 women) were compared. Demographics of
the sample are summarized in Table 1.
Table 1. Demographics.
Demographics Overall Men Women p-Value
(n = 1765) (n = 895) (n = 870)
Age (years) 20.9 (2.3) 21 (2.4) 20.7 (2.2) 0.003 *
Body weight (kg) 71.9 (12.2) 77.4 (11.3) 66.3 (10.5) 0.000 *
Alcoholic drinks per
week 13.2 (9.8) 16.6 (10.6) 9.7 (7.5) 0.000 *
Latest Past Month Drinking Session that Produced a Hangover
Number of alcoholic
drinks 12.1 (4.7) 14.1 (5) 10.0 (3.4) 0.000 *
Duration of the
drinking session (h) 5.8 (2.0) 6.0 (2) 5.5 (1.9) 0.000 *
eBAC (%) 0.18 (0.08) 0.18 (0.08) 0.18 (0.08) 0.321
Overall hangover
severity 6.1 (1.9) 6.1 (1.8) 6.2 (1.9) 0.367
Mean (SD) are shown. Differences are considered significant if p < 0.05 (indicated with *). Abbreviation:
eBAC = estimated blood alcohol concentration.
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Women reported consuming significantly less alcohol per week than men. Also, on the latest past
month drinking occasion that resulted in a hangover, women reported consuming significantly fewer
alcoholic drinks then men. Overall hangover severity and eBAC on the latest past month drinking
occasion that resulted in a hangover did not significantly differ between men and women.
The overall results (0 ≤ eBAC < 0.4%, see Table 2) show that women reported significantly higher
hangover symptom scores than men for nausea, sleepiness, being tired, vomiting, weakness, sensitivity
to light, and dizziness. Further, the presence of shivering was reported significantly more often by
women, whereas the presence of heat racing, confusion, and sweating were reported significantly more
frequently by men. Subjects were further categorized according to their eBAC. The results for the sex
comparisons for each eBAC range are summarized in Tables 3–7.
Table 2. Presence and severity of individual hangover symptoms after alcohol consumption and











Headache 5.7 (2.5) 91% 5.7 (2.4) 90.7% 5.8 (2.5) 91.3%
Nausea 5.6 (2.6) 86% 5.2 (2.5) 84.1% 5.9 (2.7) * 87.5%
Concentration
problems 6.0 (2.4) 91.1% 6.1 (2.4) 92.2% 5.8 (2.5) 90.1%
Regret 4.5 (2.7) 58.9% 4.4 (2.7) 57.1% 4.6 (2.7) 60.2%
Sleepiness 6.6 (2.3) 94.9% 6.4 (2.3) 94.3% 6.8 (2.2) * 95.3%
Heart
pounding 4 (2.4) 35.5% 4 (2.4) 35.7% 4.0 (2.5) 35.3%
Vomiting 5.3 (3.2) 26% 4.8 (3.1) 23.5% 5.6 (3.2) * 28.1%
Tired 6.9 (2.2) 97.7% 6.6 (2.2) 96.8% 7.1 (2.2) * 98.4%
Shivering 4.2 (2.5) 45.7% 4.2 (2.5) 41.4% 4.3 (2.5) 49.1%*
Clumsy 4.9 (2.4) 72.2% 4.8 (2.4) 72.4% 4.9 (2.4) 72.1%
Weakness 5.4 (2.4) 85.2% 5.1 (2.4) 83.4% 5.6 (2.4) * 86.7%
Dizziness 4.4 (2.6) 62.3% 4.1 (2.4) 61% 4.6 (2.7) * 63.3%
Apathy 5.8 (2.5) 80.1% 5.6 (2.5) 78.3% 5.9 (2.6) 81.5%
Sweating 4.3 (2.4) 54.8% 4.3 (2.4) 58.5% 4.3 (2.5) 51.7%*
Stomach
Pain 4.4 (2.5) 57.3% 4.3 (2.4) 54.4% 4.5 (2.5) 59.7%
Confusion 4.2 (2.4) 46.3% 4.1 (2.4) 49.9% 4.2 (4.5) 43.4%*
Light
sensitivity 4.1 (2.4) 52.2% 3.9 (2.3) 52.4% 4.3 (2.4) * 52%
Thirst 6.7 (2.4) 94.5% 6.7 (2.4) 95% 6.6 (2.4) 94.1%
Heart racing 4.2 (2.5) 41.6% 4.2 (2.5) 45.7% 4.1 (2.5) 38.3%*
Anxiety 3.2 (2.4) 18.3% 3.2 (2.4) 17.4% 3.2 (2.4) 19.1%
Depression 3.8 (2.5) 29.9% 3.9 (2.5) 28.9% 3.8 (2.5) 30.6%
Reduced
appetite 5.5 (2.6) 70.1% 5.5 (2.6) 69.9% 5.5 (2.6) 70.3%
Significant differences (p < 0.002, after Bonferroni correction) between men and women are indicated with *.
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Table 3. Presence and severity of individual hangover symptoms after alcohol consumption and











Headache 5.5 (2.3) 90.3% 5.7 (2.2) 89% 5.4 (2.5) 91.4%
Nausea 4.9 (2.6) 82.2% 4.9 (2.6) 80% 5 (2.6) 84.1%
Concentration
problems 5.3 (2.4) 85.4% 5.4 (2.2) 86% 5.3 (2.6) 84.9%
Regret 4.1 (2.8) 50.0% 4.2 (2.8) 52.9% 4.1 (2.8) 47.4%
Sleepiness 6.2 (2.3) 92.7% 5.8 (2.3) 91.1% 6.5 (2.3) 94.1%
Heart
pounding 3.8 (2.5) 30.2% 3.8 (2.7) 37.5% 3.8 (2.2) 23.7%
Vomiting 4.5 (3.1) 20.5% 4.4 (3.2) 22.1% 4.7 (3.1) 19.1%
Tired 6.3 (2.4) 97.2% 5.9 (2.3) 95.6% 6.6 (2.4) 98.7%
Shivering 3.8 (2.2) 34.4% 3.9 (2.4) 36% 3.6 (2.0) 32.9%
Clumsy 4.3 (2.3) 56.6% 4.3 (2) 56.6% 4.3 (2.5) 56.6%
Weakness 4.8 (2.4) 74.3% 4.7(2.4) 72.8% 5 (2.4) 75.7%
Dizziness 3.9 (2.4) 52.8% 3.8 (2.3) 55.9% 4 (2.6) 50.0%
Apathy 5.5 (2.6) 74.2% 5.3 (2.6) 71.9% 5.8 (2.5) 76.3%
Sweating 4.1 (2.4) 44.6% 4.4 (2.4) 48.5% 3.8 (2.5) 41.1%
Stomach
Pain 3.8 (2.2) 55.4% 3.8 (2.4) 53.7% 3.8 (2.1) 57.0%
Confusion 3.6 (2.5) 36.8% 3.8 (2.4) 41.2% 3.4 (2.6) 32.9%
Light
sensitivity 4 (2.3) 42% 3.7 (2.3) 44.1% 4.3 (2.2) 40.1%
Thirst 6 (2.5) 90.9% 5.9 (2.4) 88.9% 6.1 (2.5) 92.7%
Heart racing 4 (2.6) 30.3% 4.2 (2.8) 36.3% 3.8 (2.4) 25%
Anxiety 3.1 (2.4) 12.9% 3.5 (2.8) 14.7% 2.6 (1.8) 11.3%
Depression 3.7 (2.3) 24.6% 3.9 (2.4) 25.9% 3.4 (2.1) 23.3%
Reduced
appetite 4.6 (2.6) 60.4% 4.3 (2.5) 56.6% 4.8 (2.6) 63.8%
No significant differences (p < 0.002, after Bonferroni correction) were found between men and women.
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Table 4. Presence and severity of individual hangover symptoms after alcohol consumption and











Headache 5.6 (2.4) 88.8% 5.7 (2.3) 89.3% 5.4 (2.5) 88.4%
Nausea 5.3 (2.6) 83% 4.7 (2.5) 83.5% 5.8 (2.6) * 82.6%
Concentration
problems 5.4 (2.4) 88.4% 5.9 (2.2) 87.6% 5.1 (2.5) 89%
Regret 4.4 (2.6) 59.8% 4.5 (2.7) 57% 4.3 (2.6) 61.9%
Sleepiness 6.4 (2.4) 92.8% 6.1 (2.4) 91.7% 6.5 (2.4) 93.5%
Heart
pounding 3.5 (2.3) 32.6% 3.6 (2.4) 29.8% 3.4 (2.2) 34.8%
Vomiting 5.2 (3.1) 21.4% 4 (3.1) 15.7% 5.8 (3.0) 25.8%
Tired 6.7 (2.3) 96.4% 6.6 (2.2) 95% 6.8 (2.4) 97.4%
Shivering 4.2 (2.7) 42% 3.5 (2.5) 35.5% 4.6 (2.7) 47.1%
Clumsy 4.5 (2.3) 69.1% 4.6 (2.4) 68.6% 4.3 (2.3) 69.5%
Weakness 5.2 (2.3) 86.2% 4.9 (2.3) 84.3% 5.3 (2.3) 87.7%
Dizziness 4.3 (2.6) 58% 4.3 (2.3) 55.4% 4.2 (2.7) 60%
Apathy 5.5 (2.5) 77.5% 5.5 (2.3) 71.1% 5.5 (2.6) 82.5%
Sweating 3.9 (2.3) 48.6% 3.6 (2.2) 49.6% 4.2 (2.4) 47.7%
Stomach
Pain 4.4 (2.6) 52.6% 4.1 (2.3) 53.3% 4.7 (2.8) 51.9%
Confusion 3.8 (2.2) 37.1% 3.7 (2.1) 40.5% 3.9 (2.4) 34.4%
Light
sensitivity 4.1 (2.4) 50% 3.9 (2.3) 50.4% 4.2 (2.6) 49.7%
Thirst 6.4 (2.5) 93.1% 6.5 (2.5) 94.2% 6.3 (2.5) 92.3%
Heart racing 3.4 (2.2) 38.9% 3.4 (2.1) 43% 3.4 (2.3) 35.7%
Anxiety 2.9 (2.3) 16.4% 2.7 (1.9) 15.8% 3 (2.7) 16.9%
Depression 3.7 (2.5) 30.4% 3.4 (2.4) 25.6% 3.9 (2.5) 34.2%
Reduced
appetite 5.6 (2.5) 62% 5.4 (2.6) 61.2% 5.8 (2.5) 62.6%
Significant differences (p < 0.002, after Bonferroni correction) between men and women are indicated with *.
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Table 5. Presence and severity of individual hangover symptoms after alcohol consumption and











Headache 5.8 (2.4) 91.1% 5.6 (2.5) 90.5% 5.9 (2.4) 91.7%
Nausea 5.7 (2.7) 86.4% 5.3 (2.7) 84.4% 6 (2.6) * 88.1%
Concentration
problems 6.0 (2.4) 92.3% 6.1 (2.3) 94.6% 6 (2.4) 90.5%
Regret 4.5 (2.7) 61.1% 4.2 (2.6) 58.8% 4.7 (2.7) 62.9%
Sleepiness 6.6 (2.3) 95.7% 6.4 (2.3) 96.3% 6.8 (2.2) 95.2%
Heart
pounding 3.9 (2.4) 36.3% 4 (2.4) 36.2% 3.9 (2.4) 36.3%
Vomiting 5.4 (3.1) 26% 5 (3.1) 23.5% 5.6 (3.1) 28.1%
Tired 7 (2.2) 97.3% 6.8 (2.2) 96.3% 7.2 (2.1) * 98.1%
Shivering 4.2 (2.6) 47.6% 4.3 (2.5) 42% 4.2 (2.7) 51.9%*
Clumsy 4.9 (2.4) 72.2% 5 (2.4) 73.7% 4.9 (2.5) 71.1%
Weakness 5.4 (2.4) 86.3% 5.1 (2.4) 83.7% 5.7 (2.4) * 88.4%
Dizziness 4.4 (2.5) 62.9% 4.0 (2.4) 62.4% 4.8 (2.6) * 63.4%
Apathy 5.8 (2.5) 81.3% 5.6 (2.5) 79% 6 (2.5) 83.1%
Sweating 4.2 (2.4) 55.4% 4.3 (2.4) 59.7% 4.2 (2.4) 52.1%
Stomach
Pain 4.5 (2.5) 57.6% 4.3 (2.5) 54.8% 4.6 (2.5) 59.8%
Confusion 4 (2.4) 47.5% 3.9 (2.4) 53% 4.2 (2.4) 43.2%*
Light
sensitivity 4.1 (2.5) 53.6% 3.8 (2.4) 55% 4.4 (2.5) 52.6%
Thirst 6.7 (2.3) 95.3% 6.8 (2.3) 95.9% 6.7 (2.3) 94.9%
Heart racing 4.2 (2.5) 41.2% 4.3 (2.5) 45.4% 4.2 (2.5) 37.9%
Anxiety 3.4 (2.4) 20% 3.3 (2.4) 19% 3.4 (2.4) 20.9%
Depression 3.8 (2.5) 31.5% 3.9 (2.5) 31.6% 3.8 (2.5) 31.5%
Reduced
appetite 5.5 (2.6) 72.5% 5.5 (2.6) 73.1% 5.6 (2.6) 72.1%
Significant differences (p < 0.002, after Bonferroni correction) between men and women are indicated with *.
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Table 6. Presence and severity of individual hangover symptoms after alcohol consumption and











Headache 5.7 (2.6) 92.2% 5.8 (2.5) 92.8% 5.6 (2.6) 91.7%
Nausea 5.6 (2.6) 88.8% 5.2 (2.4) 86% 6 (2.7) * 91.1%
Concentration
problems 6.1 (2.4) 93.1% 6.3 (2.4) 93.8% 6 (2.4) 92.5%
Regret 4.6 (2.7) 60.8% 4.5 (2.6) 59.9% 4.7 (2.8) 61.5%
Sleepiness 6.8 (2.1) 95.1% 6.7 (2.1) 93.4% 6.9 (2.1) 96.4%
Heart
pounding 4.3 (2.5) 37.4% 4.4 (2.4) 35.4% 4.3 (2.5) 39%
Vomiting 5.5 (3.4) 27% 4.8 (3.1) 24% 6 (3.5) 29.5%
Tired 7 (2.1) 98.6% 6.7 (2.1) 98.3% 7.2 (2.1) * 98.9%
Shivering 4.4 (2.4) 48.6% 4.3 (2.5) 44.2% 4.4 (2.3) 52.2%
Clumsy 5.1 (2.4) 79% 4.9 (2.5) 78.9% 5.2 (2.4) 79.1%
Weakness 5.5 (2.4) 87.7% 5.3 (2.3) 86.9% 5.7 (2.4) 88.3%
Dizziness 4.4 (2.7) 66.7% 4.2 (2.5) 62.7% 4.6 (2.8) 69.9%
Apathy 5.7 (2.5) 81.9% 5.7 (2.4) 83.2% 5.8 (2.6) 80.8%
Sweating 4.5 (2.5) 58.4% 4.5 (2.4) 62.3% 4.5 (2.6) 55.2%
Stomach
Pain 4.5 (2.5) 59.5% 4.4 (2.4) 54.6% 4.5 (2.6) 63.5%
Confusion 4.6 (2.5) 51.4% 4.5 (2.5) 52.6% 4.6 (2.6) 50.4%
Light
sensitivity 4.2 (2.3) 55.2% 4.2 (2.2) 53.4% 4.3 (2.4) 56.7%
Thirst 6.8 (2.4) 95.5% 6.9 (2.3) 96.9% 6.8 (2.4) 94.4%
Heart racing 4.5 (2.5) 47.0% 4.6 (2.5) 49.5% 4.4 (2.6) 45%
Anxiety 3 (2.3) 19.3% 2.9 (2.3) 17.8% 3.1 (2.2) 20.6%
Depression 3.9 (2.4) 29.6% 4 (2.4) 29.8% 3.8 (2.5) 29.5%
Reduced
appetite 5.5 (2.5) 73.3% 5.7 (2.4) 73.6% 5.4 (2.6) 73.1%
Significant differences (p < 0.002, after Bonferroni correction) between men and women are indicated with *.
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Table 7. Presence and severity of individual hangover symptoms after alcohol consumption and











Headache 5.9 (2.5) 90.6% 5.5 (2.5) 89.2% 6.3 (2.4) 91.8%
Nausea 6 (2.6) 84.3% 5.6 (2.5) 84% 6.4 (2.6) 84.5%
Concentration
problems 6.4 (2.4) 89.8% 6.6 (2.4) 90% 6.3 (2.5) 89.7%
Regret 5.2 (2.8) 51.7% 5.4 (2.8) 45.1% 5.1 (2.8) 57.3%
Sleepiness 6.8 (2.4) 96.1% 6.4 (2.5) 95.2% 7 (2.3) 96.9%
Heart
pounding 4.5 (2.6) 37.4% 4.1 (2.5) 40.2% 5 (2.6) 35.1%
Vomiting 5.3 (3.3) 38.5% 5.2 (3.2) 35.4% 5.5 (3.3) 41.2%
Tired 7 (2.4) 98.9% 6.7 (2.4) 98.8% 7.3 (2.3) 99%
Shivering 4.4 (2.7) 47.8% 4.3 (2.9) 46.3% 4.4 (2.6) 49%
Clumsy 5 (2.6) 77.7% 4.7 (2.7) 73.2% 5.2 (2.5) 81.4%
Weakness 5.8 (2.4) 85.4% 5.4 (2.3) 85.2% 6.2 (2.4) 85.6%
Dizziness 4.6 (2.5) 64.2% 4.3 (2.4) 64.6% 4.9 (2.6) 63.9%
Apathy 6.3 (2.5) 79.9% 6.3 (2.5) 78% 6.3 (2.5) 81.4%
Sweating 4.6 (2.4) 63.7% 4.7 (2.5) 68.3% 4.6 (2.3) 59.8%
Stomach
Pain 4.7 (2.5) 58.2% 4.7 (2.5) 53.8% 4.7 (2.5) 61.9%
Confusion 4.6 (2.4) 50.3% 4.7 (2.3) 51.2% 4.6 (2.5) 49.5%
Light
sensitivity 4.2 (2.3) 52.2% 3.6 (2.1) 50.6% 4.6 (2.3) 53.6%
Thirst 7 (2.3) 93.9% 7 (2.2) 94% 7 (2.4) 93.8%
Heart racing 4.4 (2.5) 46.9% 4 (2.4) 53.7% 4.9 (2.6) 41.2%
Anxiety 3.6 (2.5) 16.3% 3.3 (2.6) 13.6% 3.8 (2.5) 18.6%
Depression 4.1 (2.7) 28.5% 4.3 (3) 20.7% 4.1 (2.6) 35.1%
Reduced
appetite 6.2 (2.5) 72.6% 6.2 (2.4) 73.2% 6.1 (2.5) 72.2%
No significant differences (p < 0.002, after Bonferroni correction) were found between men and women.
In the lowest eBAC group (0% ≤ eBAC < 0.08%, see Table 3) no significant differences were found
between men (n = 91) and women (n = 68). In the subsequent eBAC group (0.08% ≤ eBAC < 0.11%,
see Table 4), nausea was significantly more severe in women (n = 95) compared to men (n = 93). No
other significant sex differences were found. Below an eBAC of 0.11%, the presence and severity of
hangover symptoms were relatively low. This was expected given the relative low alcohol intake, and
in line with the previous consensus paper of the Alcohol Hangover Research Group which stated that
an eBAC < 0.11% is insufficient to produce a hangover per se. A minority of the total sample had an
eBAC below 0.11%, which had an approximate equal sex distribution (18.7% of all women and 20.6%
of all men).
Table 5 summarizes the results of the largest group of drinkers (n = 403 men and n = 383 women).
Their eBAC ranged from 0.11% ≤ eBAC < 0.2%. In women, severity scores on nausea, tiredness,
weakness, and dizziness were significantly higher than in men. In addition, confusion was significantly
more often reported by men and shivering was significantly more often reported by women. All other
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sex comparisons did not reach statistical significance. Figure 1 gives an overview of the presence and
severity of individual hangover symptoms for the eBAC range 0.11% ≤ eBAC < 0.2%. It is evident from
Figure 1, that the observed significant sex differences are of modest magnitude. Except for dizziness,
sex differences in symptom severity were seen only among symptoms that had high presence ratings.
Figure 1 also reveals that some symptoms had a low severity and a low presence (e.g., anxiety and
depression), whereas other symptoms had a high severity and high presence (e.g., sleepiness, headache,
concentration problems, apathy). In this regard, vomiting was an interesting hangover symptom:
vomiting had a low presence, but when it occurred its severity was relatively high.
 
Figure 1. Presence and severity of individual hangover symptoms after alcohol consumption and
reaching an eBAC of 0.11% ≤ eBAC < 0.2%. Sex differences are significant if p < 0.002. Abbreviation:
eBAC = estimated blood alcohol concentration.
Table 6 summarizes data from subjects within the eBAC range 0.2% ≤ eBAC < 0.3% (n = 244 men
and n = 264 women). In women, severity scores on nausea and tiredness were significantly higher
than among men. All other sex comparisons did not reach statistical significance.
Finally, Table 7 summarizes data from subjects within the eBAC range 0.3% ≤ eBAC < 0.4%
(n = 62 men and n = 62 women). For this eBAC range, no significant sex differences were observed.
4. Discussion
The current analyses showed that some sex differences in the presence and severity of
hangover symptoms were observed. These were especially evident at the eBAC levels ranging
from 0.11% ≤ eBAC < 0.2%. In the lowest eBAC group (0% ≤ eBAC < 0.08%), no significant sex
differences were found. In the subsequent eBAC group (0.08% ≤ eBAC < 0.11%), severity of nausea
was significantly higher in women than in men. In the third eBAC group (0.11% ≤ eBAC < 0.2%),
women reported higher severity scores on nausea, tiredness, weakness, and dizziness than men. Men
reported the presence of confusion significantly more often than women, and women reported the
presence of shivering significantly more often than men. In the fourth eBAC group (0.2% ≤ eBAC
< 0.3%), women reported higher severity scores on nausea and tiredness than men. The fifth eBAC
156
J. Clin. Med. 2019, 8, 867
group (0.3% ≤ eBAC < 0.4%), no significant sex differences were found. However, the observed sex
differences were of modest magnitude and have little clinical relevance. This is illustrated in Figure 2
for the most frequently reported sex differences in hangover symptom severity, i.e., nausea and being
tired. The magnitude of the differences in symptom severity scores for nausea and being tired, albeit
statistically significant, across eBAC ranges were always below 1 on a scale ranging from 0 (absent)
to 10 (extreme). Figure 2 further shows that symptom severity scores did somewhat increase when
eBAC became higher. For example, the difference between the lowest eBAC group (<0.08%) and the
highest eBAC group (0.3%–<0.4%) for nausea were +0.7 in men and +1.4 in women, and for being tired
+0.8 in men and +0.7 in women. Thus, the present analyses suggest that men and women experience
hangovers in comparable ways.
 
Figure 2. Severity scores for nausea and being tired for men and women across eBAC ranges. Significant
differences (p < 0.002) are indicated by *. Abbreviation: eBAC = estimated blood alcohol concentration.
4.1. Alcohol Sensitivity during Intoxication and during the Hangover State
The absence of relevant sex differences in the presence and severity of hangover symptoms
contrasts with the various sex differences that are commonly observed in pharmacokinetics and
pharmacodynamics during the alcohol intoxication phase. Thus, there seems to be a discrepancy
between sex differences observed during alcohol intoxication (in previous research) and the absence
of relevant sex effects during the hangover state (found in the current study). Previous research has
addressed this issue. For example, Piasecki and colleagues [74] reported that subjects with lower
alcohol sensitivity appear to be more resistant to experiencing hangovers at a given number of drinks.
However, as these drinkers often consume more alcohol than those with high alcohol sensitivity, they
on average experience more hangovers during an arbitrary monitoring period. Unfortunately, the
association with alcohol sensitivity and hangover severity was not assessed in this study.
Rohsenow et al. [75] did not administer the SRE but instead used an alcohol intoxication rating
as a proxy measure for the sensitivity to acute alcohol effects. They found that hangover severity, as
assessed with the AHS (Acute Hangover Scale), was positivity correlated with this intoxication rating.
In this study, about one-third of the studied sample reported an absence of hangover after consuming
alcohol to reach a peak BAC of 0.12%. As hangover insensitivity was associated with reports of being
less intoxicated, the authors suggested that hangover sensitivity and intoxication sensitivity may be
related to each other. In an earlier study, Ylikhari et al. [15] also found that, despite consuming the same
amount of alcohol (1.5 g/kg), those who reported higher subjective intoxication levels also experienced
more severe hangovers.
In a naturalistic study comprising of an alcohol and alcohol-free test day, Hogewoning et al. [69]
administered the SRE and compared drinking behavior and hangover effects in both hangover-sensitive
drinkers and hangover-resistant drinkers. Although both groups consumed a comparable amount of
alcohol, achieving a peak BAC around 0.17%, the hangover resistant group reported not experiencing a
hangover while the sensitive group did. Hogewoning et al. [69] found that the early life SRE score and
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total SRE score were significantly lower in women compared to men. However, in contrast to Piasecki
et al. [74], SRE scores did not significantly differ between hangover-sensitive and hangover-resistant
drinkers, and the SRE scores did not significantly correlate with hangover severity. Taken together,
these findings suggest that sex differences in alcohol sensitivity seen during the intoxication phase
may be unrelated to the sensitivity for alcohol effects expected during the hangover state. There may
be several explanations for this observation.
Firstly, there is a time lag between the intoxication phase and the hangover phase. After stopping
drinking, usually a period of sleep follows of which the quality and duration has shown to be associated
with hangover severity [76,77]. Secondly, the acute alcohol effects are mainly caused by a direct presence
of alcohol in the blood. Subsequently, alcohol can exert its effects virtually everywhere in the body,
including the brain as it easily crosses the blood–brain barrier. In contrast, the hangover state starts
when blood alcohol concentrations approach zero, and in many cases BAC readings are zero. Finally,
although there is some overlap between the presence and severity of symptoms that are experienced
during the intoxication and hangover phase, there are also several clear differences. Van Schrojenstein
Lantman et al. [1] reported that the most common reported combination of symptoms describing
the alcohol hangover comprised of the following: nausea, headache, tiredness, and apathy. These
symptoms showed the highest associations between each other. Except for nausea, these are symptoms
that are usually not reported to be present or have high severity ratings during the intoxication phase
of drinking. Taken together during the intoxication phase, sex differences in the presence and severity
of intoxication effects are common. However, in contrast, sex differences in symptomatology during
the alcohol hangover are of limited relevance.
4.2. Implications
The current findings have several implications. Firstly, our findings do not suggest that results
from studies conducted in men can be directly extrapolated to women, or that an equal sex balance
would not be necessary. Although the presence and severity of hangover symptoms do not seem to
vary much between men and women, their impact on mood and performance may be considerably
different. Therefore, we advocate an equal sex balance in future hangover studies. Secondly, the
current findings may have implications for drug development. In past research, the efficacy and safety
of potential hangover treatments were often not investigated in women (e.g., [33,78–83]). Currently,
most marketed hangover products lack sound scientific support that confirms their efficacy and
safety [84,85], and no effective treatment has been developed yet. The current analyses suggest that in
order to develop an effective and safe hangover treatment, similar symptoms should be targeted for
both sexes, as they usually not differ in presence and severity. Of note, in both sexes, with increasing
BAC levels the presence and severity of hangover symptoms increases to some extent. Therefore,
dose-ranging studies to demonstrate efficacy and safety at various BAC levels (e.g., low, moderate,
high intake) may be worthwhile to investigate. Given the potential negative impact of hangover
symptoms on performance of daily activities such as driving and job performance [2–6], developing an
effective hangover treatment could be useful. Previous research has shown that the vast majority of
drinkers indicate that experiencing hangovers does not affect future drinking behavior [86], and that if
an effective hangover treatment would be available this would not significantly alter their drinking
behavior [87]. However, recent research did associate experiencing hangovers with having significantly
more future drinking days and alcohol problems [88]. Therefore, more research should address the
relationship between experiencing hangovers or their treatment with increased risk of developing
alcohol use disorder.
As for all clinical trials investigating psychopharmacological treatments [89–91], it is also critical
to examine the efficacy and safety of new hangover treatments in both men and women. Although the
targeted hangover symptoms may have the same presence and severity, the safety, adverse effects, and
efficacy of the hangover treatment itself may show significant sex differences. Even in the absence of a
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clear a priori explanation for expecting sex differences it is vital to examine possible dissociations in
pharmacokinetics and pharmacodynamics of a hangover treatment.
From Figure 1, it is clear that some symptoms are high in both presence and severity. These can be
regarded as core symptoms of the hangover state, and it is suggested that further research focuses
on these symptoms. In this context, there are currently three hangover symptom scales in use that
all comprise ratings of different hangover symptoms to sum up to an overall hangover score [70–72].
A new analysis, taking into account both the presence and severity of symptoms, and perhaps their
impact on cognitive and physical functioning and mood [67], can be useful for the development of a
new hangover scale. Finally, some symptoms such as anxiety and depression have both low presence
and severity scores. This is a consistent finding in scientific literature, and although these symptoms
are included in the Hangover Symptoms Scale (HSS) [71], it can be questioned if they are true hangover
symptoms or should be considered as individual subject characteristics that are unrelated to alcohol
consumption and its aftereffects.
4.3. Strengths and Limitations
Strengths of the current analysis include its large sample size, and the fact that subjects were
stratified according to their estimated peak BAC level. The latter was critical to obtain a fair comparison
between effects observed in men and women.
A limitation of the survey data consisted of retrospective ratings of hangover symptoms,
experienced during their latest past month alcohol hangover. Therefore, in theory, impairments
in accurate recall may have biased these results. However, there is also no reason to assume why
possible recall bias would be different in men and women, or more pronounced for one hangover
symptom over the others.
Second, the participants in the surveys consisted of students, aged 18 to 30 years old. This may
limit the generalizability to other age groups or non-student samples. Hangover data on subjects
aged 40 and beyond are virtually absent in the scientific literature. One study did report a shift in
the presence and severity of hangover symptoms with progressing age [92]. This population-based
Danish Health Examination Study (DANHES) gathered data from over 50,000 adults and showed
that with increasing age, the presence of hangovers significantly decreased, and in a comparable rate
for men and women. Both men and women reported fewer hangover symptoms (thirst, exhaustion,
headache, dizziness, no appetite, stomach pain, nausea, heart racing, and vomiting) with increasing
age. Although several reasons for this observation can be hypothesized (e.g., tolerance, changes
in sensitivity, and alcohol metabolism), the most likely reason for the age-progressing decline in
hangover frequency is the accompanying age-related reduction in the amount of (alcohol consumed
on) heavy drinking sessions [93]. Although no formal testing was presented by Tolstrup et al. [92],
inspection of the odds ratios for “(almost) always experiencing a hangover symptom” suggests that
there are no clinically relevant sex differences across age groups (Tolstrup et al. [92], Table 3, page 469).
Future research should further examine possible sex differences in hangover symptomatology in other
age groups.
Third, we investigated the 22 hangover symptoms that are included in the three commonly
used hangover scales [70–72]. Research has shown that there are several other hangover symptoms
that we could have considered in the current study. For example, Penning et al. [66] identified
47 hangover symptoms in the literature. However, most of the symptoms that were omitted from the
three hangover scales (e.g., nystagmus or tinnitus) are very infrequently reported and their severity
scores are usually low. Hence, for the population as a whole these symptoms must not be regarded
important contributors to the hangover state, and it is unlikely that important sex differences will be
observed among these symptoms.
Fourth, there are several factors that contribute to hangover severity that were not included in the
current analysis. These are discussed in various review articles on alcohol hangover [93–95], although
no possible relationship with sex differences was suggested. Examples of factors that may impact
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the presence and severity of hangover symptoms are sleep duration and quality, physical activity
while drinking, psychological state, congener content and type of drink, and having a family history of
alcoholism. In the current analysis, these factors were not taken into account. Future research should
examine the impact of factors that may aggravate hangover severity on possible sex differences. It
may, for example, be possible that men may consume more congener rich drinks than women, or vice
versa, which may explain observed gender differences. Alternatively, women may be more engaged
in dancing during a drinking session than men or may consume more non-alcoholic drinks during a
night out. Currently, this information is lacking from the scientific literature.
Finally, future research should investigate possible sex differences in memory, cognitive, and
psychomotor functioning. The latter is important as the relative absence of important sex differences in
the presence and severity of hangover symptoms does not imply that no sex differences may exist in
performance outcomes and the conductance of daily life activities.
5. Conclusions
In conclusion, at the same BAC level, young adult male and female social drinkers experience
hangover symptoms in comparable ways. No relevant sex differences were observed in the presence
and severity of hangover symptoms across all eBAC levels. Future research should extend this
investigation to other age groups.
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Abstract: The aim of this study was to investigate whether baseline mood and/or mood while
drinking have an impact on alcohol hangover severity. A survey was held among N = 331 young
adults (mean age = 23.6 years, range = 18–35 years). Demographics, alcohol consumption, subjective
intoxication, and hangover severity were assessed for the past three days. In addition, mood (baseline,
while drinking, and during hangover) was also assessed. N = 143 participants reported to be hungover
on the day of assessment, N = 122 participants reported to have been hungover the previous day
(‘yesterday’), and N = 87 participants reported to have been hungover two days before the assessment
(‘2 days ago’). The analyses revealed that baseline mood and mood while drinking had no relevant
effect on the amount of consumed alcohol and did not significantly contribute to hangover severity.
However, hangover severity was associated with significantly increased negative affect, particularly
with higher levels of subjective stress on the day of the hangover.
Keywords: alcohol; hangover; mood; subjective intoxication; stress; neuroticism
1. Introduction
Negative baseline mood and mood while drinking have been reported to influence alcohol
consumption. This is reflected by reports that situational factors (experiencing negative life events and
stress) and intrinsic factors (e.g., neuroticism) can be associated with negative mood [1,2]. Subsequently,
certain individuals are more likely to develop negative coping styles, including increased alcohol use [3].
Despite their conjoint effect on mood, it is important to note that trait-like, rather stable, baseline mood
may be different from the current affective state while drinking (i.e., state mood) [4], so both should
be considered when investigating associations between mood and drinking behavior. Additionally,
sex may play a role as women are usually more likely than men to increase their drinking behavior
in response to negative affect and stress and to report greater stress relief by drinking [5], but they
also suffer more negative affective (long-term) consequences of excessive alcohol consumption [6,7].
Finally, it should be kept in mind that while alcohol intake may be motivated by the wish for relief of
negative affect, it may also enhance trait or state mood and emotions, thus constituting a bidirectional
association [8].
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The functional link between stress and alcohol consumption has repeatedly been demonstrated
via changes in the hypothalamic–pituitary-adrenal (HPA) axis, especially with respect to the
corticotropin-releasing factor (CRF) [6,9]. Specifically, it has been found that higher levels of stress as
well as reduced sensitivity of the HPA axis escalate alcohol consumption and increase the likelihood
of binge drinking [10]. Lastly, a genetic study conducted in Drosophila has suggested that alcohol
hangover/tolerance development and the response to stress may be partly mediated by the same
molecular pathway [11].
Due to the phenomenological (affective) and functional (neurobiochemical/neuroendocrinological)
overlap between mood, stress, and hangover, mood and subjective stress may be predictors of hangover
severity. Despite the close link between mood and alcohol consumption, only very few studies have
investigated the effects of baseline and/or current mood on experiencing hangovers.
Hangover is the most commonly reported negative consequence of alcohol consumption [12]
and has been defined as the combination of negative mental and physical symptoms which may be
experienced after a single episode of alcohol consumption, starting when blood alcohol concentration
(BAC) approaches zero [13,14]. In a sample of male alcohol use disorder patients and social drinkers,
Gunn [15] reported that negative attitudes towards drinking alcohol and feeling guilty about drinking
were associated with experiencing more severe hangovers, but this association does not allow for
any conclusions on causality. More recently, a regression analysis by Piasecki et al. [16] revealed that
experiencing depressive symptoms was associated with both current and future hangover susceptibility,
and Royle et al. [17] found that drinkers who had higher levels of pain catastrophizing reported
experiencing more severe hangovers. However, research in the area of alcohol hangover is still severely
limited. Hence, more studies need to be conducted to elucidate to what extent personality aspects and
baseline mood have an impact on the susceptibility to the occurrence and severity of hangovers.
While it is commonly reported that mood and emotions are negatively affected during the
hangover state [18–20], the extent to which mood while drinking impacts hangover severity has largely
been neglected in hangover literature. In fact, only two studies investigated the direct impact of mood
during drinking on next-day hangover in the same sample [21,22]. The first article [21], which included
N = 1266 subjects (randomly selected from the Tecumseh Community Health Study), reported positive
correlations between hangover symptom frequency and psychosocial factors, including negative life
events, neuroticism, guilt about drinking, feeling depressed while drinking, and being angry while
drinking. In the second paper, Harburg et al. [22] excluded all sober subjects from their dataset,
i.e., subjects who reported ‘never’ being ‘tipsy, high, or drunk’. When these were removed and the data
of the remaining N = 1104 subjects were re-analyzed, the correlations between hangover symptom
frequency and mood while drinking were less pronounced. Significant correlations were reported for
neuroticism, guilt about drinking, drinking to escape, negative life events, and feelings of depression
and anger while drinking. A stepwise linear regression analysis including all of the assessed variables
was performed separately for men and women. Both analyses yielded a model with only modest
predictive validity (19% in men and 21% in women) for the variance in the reported frequency of
hangover symptoms. The analyses showed that with regard to the contribution of individual variables
to the explained variance, guilt about drinking was the strongest predictor of hangover severity (9% in
men and 11% in women), followed by neuroticism (4% in both men and women), being angry when
high/drunk (3% in men and 2% in women), and negative life events (2% in men and 1% in women).
In men, being depressed when high/drunk (1%) and the amount of consumed ethanol (<1%) further
contributed to the model. In women, additional significant predictors were being younger (2%) and
having experienced being drunk for the first time at a younger age (1%). Together, these findings
suggest that mood during drinking has relatively little impact on experiencing hangover symptoms.
However, there are several issues that complicate the interpretation of the results presented by
Harburg et al. [21,22]. For example, while they excluded subjects who reported not being drunk
(but could still have had a hangover), 23% of the subjects who reported experiencing no hangover
remained in the sample that underwent statistical analyses. As a consequence, the Pearson’s correlations
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and forward stepwise multiple regression used to examine the data may have produced less pronounced
associations in this zero-inflated sample [23]. Moreover, the authors assumed that they measured
hangover severity, but the Hangover Sign Index (HSI) actually assesses the frequency with which eight
different hangover symptoms (‘headache or hangover’, ‘loss of appetite’, ‘diarrhea’, ‘stomach pains’,
‘anxiety’, ‘blackout or loss of memory’, ‘tremors or hand shaking’, and ‘thoughts of suicide’) occur after
drinking, rather than their severity. In the study by Harburg et al. [21,22], subjects indicated whether
or not they experienced these symptoms on the day following the latest occasion when they were
drunk. The specific combination of experienced hangover symptoms was used to estimate hangover
severity. The six levels of hangover severity distinguished by Harburg et al. included (1) ‘no signs’
(gets drunk, but reports no hangover signs), (2) weak (any or all of these three symptoms: headache,
diarrhea, and loss of appetite), (3) ‘mild’ (anxiety and/or stomach pains), (4) strong (any one of blackout,
tremor, and thoughts of suicide), (5) ‘very strong’ (anxiety plus any one of blackout, tremor, and
thoughts of suicide), and (6) ‘severe hangover’ (two or more of blackout, tremor, and suicidal thoughts).
The validity of the HSI to reliably measure hangover severity can be questioned in several ways. First,
the frequency of symptom occurrence does not tell us anything about their severity. Second, the HSI
contains items that are not hangover signs, but signs of intoxication (e.g., blackouts). Third, it omits
several core symptoms of the hangover state (e.g., fatigue or nausea), while including other signs
such as ‘thoughts of suicide’, which are seldom regarded as hangover symptoms in the scientific
literature [19,20]. There is great variability with regard to the presence and severity of hangover
symptoms [19,24] and a recent study suggested that composite hangover scales are less accurate as they
may over- or under-represent core symptoms and/or hangover-irrelevant symptoms [24]. In addition,
the HSI score does not account for the impact of the experienced symptoms.
Taken together, it is important to replicate and improve the study by Harburg et al. by including a
valid assessment of hangover severity to infer whether mood while drinking has an impact on the
presence and severity of next-day alcohol hangover. Therefore, the current study aimed to verify and
extend the observations by Harburg et al. in an international sample of young adults by applying
a 1-item overall hangover severity scale, which is regarded to be superior to composite symptom
scores [24]. Specifically, we investigated whether baseline mood, mood while drinking, and mood
during hangover were associated with and/or predicting current and retrospective hangover severity.
2. Methods
In August 2018, a survey was conducted among an international sample of young adults who
came to Fiji either for work or holidays. Both men and women within the age range of 18–35 years
were included. The young adults were approached at Wailoaloa Beach and asked to complete a survey.
Subjects who were willing to participate and sufficiently understood the English language
completed the survey on location. The location was chosen because a relatively large number of young
adults congregated here to spend a holiday or relax after work.
The survey was anonymous and subjects did not receive an incentive for completing the survey.
The investigator was present to clarify any issues arising from English not being the participants’
mother tongue. The study was conducted by Utrecht University, informed consent was obtained from
all subjects, and the Ethics Committee of the Faculty of Social and Behavioral Sciences of Utrecht
University granted ethical approval (approval code FETC17-061).
The survey collected demographic information, including age, gender, height, and weight to
compute body mass index (BMI), and usual weekly alcohol intake. The survey contained guidance
about standard drinking sizes, and how to convert, for example, a bottle of wine into standardized
alcohol units, which contain 10 g of alcohol each.
To assess the past year’s immune status, the Immune Status Questionnaire (ISQ) was completed [25].
Current perceived immune fitness was assessed using a 1-item scale ranging from 0 (very poor) to 10
(excellent) [25,26]. The scale has a Cronbach’s alpha of 0.80 [25] and was included as previous research
found an association between having hangovers and immune status [27,28]. Additionally, a short scale
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was used to assess baseline mood. The six items reflected the subscales of the short version of the
Profiles of Mood States (POMS-SF) [29], and included tension/stress, anxiety, depression, being active,
fatigue, and anger/hostility. The items were scored on a scale ranging from 0 (absent) to 10 (extreme).
The 11-point scale has successfully been used in previous research [30,31], which showed that single
item visual analog scales are just as sensitive and reliable as full-scale construct assessments of mood
states like depression [32], fatigue [33], or quality of life [34].
Neuroticism was assessed with the neuroticism scale of the Eysenck Personality Questionnaire-
Revised Short Scale (EPQ-RSS) [35,36]. The neuroticism scale consists of 12 items that can be answered
with ‘yes’ or ‘no’, which correspond to the values of 1 and 0, respectively. The sum score of items ranges
from 0 to 12, with higher scores implying more neuroticism. Cronbach’s alpha of the neuroticism scale
is 0.82 [36].
In addition to demographics and baseline mood, various other assessments regarding alcohol
consumption and mood were made for the past three days (referred to as ‘today’, ‘yesterday’, and ‘2 days
ago’). For each of these days, subjects reported their alcohol consumption. Both the number of alcoholic
drinks and the time frame of consumption were assessed. The estimated BAC was computed with a
modified Widmark equation [37]. Subjective intoxication was rated on a scale ranging from 0 (sober)
to 10 (very drunk) [38]. To assess the current mood while drinking, participants rated their mood state
while drinking, including being ‘angry/hostile/irritable’ and being ‘depressed/sad’ on scales ranging
from 0 (absent) to 10 (extreme). Total sleep time was assessed and subjects rated their sleep quality
on a scale ranging from 0 to 10 [39,40]. Regarding next-day effects, hangover severity was scored
with a 1-item severity score, ranging from 0 (absent) to 10 (extreme) [24]. Using the same 0–10 scale,
‘fatigue, sleepiness’, ‘stress’, and ‘guilt about drinking’ were also assessed as measures of current
(hangover) mood.
Statistical analyses were conducted with SPSS (IBM SPSS Statistics for Windows, version 25.0,
released in 2013; IBM Corp., Armonk, NY, USA). Mean and standard deviation (SD) were computed
for each variable. Outlier data (alcohol intake on evening > +3SD of group average) were omitted
from the analyses.
For each test day, participants were independently allocated to the ‘no hangover’ or ‘hangover’
group. This was based on the reported absence (score 0) or presence (score 1–10) of a hangover for that
particular day. Thus, group sizes differed between the three days, and individual subjects could be
allocated to the hangover group on one day, but to the no hangover group on another day, depending
on the reported presence and absence of hangover for that particular day.
All statistical analyses were conducted separately for each of the three days. Most study outcome
variables did not follow a normal distribution. Therefore, nonparametric statistics were used to analyze
the data. To compare demographics and baseline mood between the hangover and the no hangover
group, independent-samples Mann–Whitney U tests were used.
Spearman’s rho correlations were computed between drinking variables and mood outcomes.
Results were considered significant if p < 0.05. Linear stepwise regression analyses (for which
independent variables do not need to be normally distributed or continuous) were conducted to
determine which variables (i.e., demographics, mood, and drinking variables) were significant
predictors of (a) having a hangover (yes/no) and of (b) hangover severity (1–10 score on the single-item
hangover severity assessment). Further, linear stepwise regression analyses were conducted to
determine which of the assessed variables were significant predictors of (c) the amount of consumed
alcohol and of (d) subjective intoxication on the evenings preceding the next-day alcohol hangover.
Analyses were conducted for the whole sample, and for men and women separately.
3. Results
The survey was completed by N = 331 subjects. Their demographics and baseline mood are
summarized in Table 1. A total of N = 143 subjects (43.2% of the sample) reported having a hangover
on the day of the assessment (referred to as ‘today’ throughout the article). Table 1 contrasts their
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demographics and past day drinking behaviors with the N = 188 subjects who did not report having
a hangover. The comparisons revealed that subjects with a hangover scored significantly higher on
some of the baseline mood scales and perceived immune fitness compared to subjects who reported no
hangover. However, it should be noted that the magnitudes of the observed differences were small
(<1 on 11-point scales).
Table 1. Demographics and baseline mood.
Total Sample Hangover No Hangover
Demographics
N (%) 331 (100.0%) 143 (43.2%) 188 (56.8%)
Age (years) 23.6 (4.2) 23.5 (4.3) 23.6 (4.1)
Sex (m/f) 143/188 81/62 63/125
BMI (kg/m2) 23.5 (3.9) 23.8 (4.4) 23.2 (3.5)
Usual weekly alcohol consumption (units) 11.5 (11.0) 13.3 (12.1) * 10.2 (9.8)
Past year’s immune fitness (ISQ) 7.0 (2.3) 6.9 (2.2) 7.1 (2.3)
Perceived immune fitness 8.0 (1.6) 7.8 (1.6) * 8.1 (1.5)
Baseline Mood Ratings
Tension, stress 1.8 (1.8) 1.9 (1.8) 1.7 (1.7)
Anxiety 1.5 (1.9) 1.5 (1.9) 1.5 (1.9)
Depression 0.7 (1.5) 0.8 (1.7) * 0.6 (1.3)
Being active 5.4 (2.8) 5.8 (2.6) * 5.1 (2.9)
Fatigue 3.5 (2.6) 4.1 (2.6) * 3.1 (2.6)
Anger, hostility 0.9 (1.6) 1.1 (1.8) * 0.7 (1.4)
Neuroticism 2.1 (2.2) 2.2 (2.2) 2.0 (2.2)
Mean and standard deviation (between brackets) are shown. Significant differences (p < 0.05) between the hangover
and the no hangover group are indicated by *. No significant partial correlations with hangover severity were
found (p < 0.05), controlling for estimated BAC. Abbreviations: BMI = body mass index, ISQ = Immune Status
Questionnaire, BAC = blood alcohol concentration.
Variables related to alcohol consumption and mood (rated separately for mood during drinking
and mood while hungover) are summarized in Table 2. For subjects with a hangover, the partial
correlation with hangover severity (controlled for estimated BAC) is also indicated.
Table 2. Study outcomes and their association with hangover severity.










n (%) 143 188 122 208 87 243
Drinking variables
Alcohol consumed (units) 12.3 (7.3) * 4.0 (5.3) 11.4 (7.3) * † 3.2 (4.6) 9.9 (7.4) * † 1.9 (3.6)
Time spent drinking (h) 6.9 (3.5) * 3.0 (3.8) 6.6 (4.1) * † 4.3 (4.5) 6.5 (4.6) * † 3.9 (4.1)
Estimated BAC (%) 0.16 (0.1) * † 0.08 (0.1) 0.17 (0.2) * † 0.06 (0.1) 0.14 (0.1) *† 0.05 (0.1)
Subjective intoxication 6.2 (2.5) * † 1.7 (2.4) 6.1 (2.7) * † 1.7 (2.3) 5.6 (3.1) * † 1.0 (2.1)
Cigarettes smoked 3.7 (6.4) * 1.4 (3.8) 2.8 (5.4) * 1.2 (3.1) 2.8 (5.3) * 1.1 (3.0)
Mood during drinking
Angry, hostile, irritable 0.7 (1.6) * 0.4 (1.2) 0.9 (2.0) * † 0.4 (1.3) 0.6 (1.2) * 0.3 (1.1)
Depressed, sad 0.6 (1.5) * 0.3 (1.2) 0.9 (2.0) * 0.4 (1.3) 0.9 (1.7) * 0.5 (1.7)
Sleep
Total sleep time (h) 6.2 (2.0) † 7.3 (2.1) 6.5 (1.8) * † 7.2 (1.9) 6.6 (1.9) * † 6.9 (2.5)
Sleep quality 6.0 (2.5) * † 6.7 (2.3) 6.7 (2.3) † 6.7 (2.3) 6.4 (2.5) † 6.2 (2.7)
Next-day mood
Hangover severity 3.5 (2.5) * 0.0 (0.0) 3.7 (2.7) * 0.0 (0.0) 3.2 (2.3) * 0.0 (0.0)
Fatigue, sleepiness 4.7 (2.9) * † 1.7 (2.4) 5.1 (2.6) * † 1.5 (2.3) 4.5 (3.0) * † 1.7 (2.6)
Stress 1.3 (2.1) * † 0.4 (1.3) 1.7 (2.5) * † 0.4 (1.2) 1.8 (2.6) * † 0.3 (1.0)
Guilt about drinking 1.4 (2.3) * † 0.2 (0.9) 1.4 (2.3) * † 0.1 (0.6) 1.5 (2.4) * † 0.1 (0.7)
Significant differences (p < 0.05) between the hangover and the no hangover group are indicated by *. Significant
partial correlations (p < 0.05), controlling for estimated BAC, with hangover severity are indicated by †. Abbreviation:
BAC = blood alcohol concentration.
169
J. Clin. Med. 2020, 9, 2462
As can be seen in Table 2, the hangover group significantly differed from the no hangover group in
almost all of the drinking-, sleep-, and current mood-associated variables. Significant partial correlations
(controlling for estimated BAC) were found between hangover severity and subjective intoxication
(being drunk) (r = 0.453, p < 0.0001), between hangover severity and total sleep time (r = −0.226,
p = 0.009), and between hangover severity and sleep quality (r = −0.183, p = 0.036). There were no
significant correlations between hangover severity and baseline mood or neuroticism. Ratings of
mood while drinking did not significantly correlate with hangover severity. However, significant
correlations were found between hangover severity and ‘fatigue, sleepiness’ experienced during
hangover (r = 0.514, p < 0.0001), between hangover severity and ‘stress’ experienced during hangover
(r = 0.423, p < 0.0001), and between hangover severity and ‘guilt about drinking’ experienced during
hangover (r = 0.361, p < 0.0001). A similar pattern of outcomes was seen for the other two days that
were assessed (Table 2).
Tables 3 and 4 present the results of stepwise linear regression analyses including all the variables
summarized in Tables 1 and 2. Tables 3 and 4 list those predictors that significantly contributed
to each regression model (once while excluding and once while including “next-day” variables).
The percentage that each particular variable contributed to the model (R2) and the beta coefficient (β)
are also included.
Table 3. Significant predictors of hangover severity (excluding next-day variables).
Full Sample Today (n = 313) Yesterday (n = 243) Two days ago (n = 175)




(β = 0.644, p < 0.0001)
Subjective intoxication
(R2 = 38.9%)
(β = 0.524, p < 0.0001)
Subjective intoxication
(R2 = 37.0%)
(β = 0.561, p < 0.0001)
Baseline fatigue
(R2 = 1.5%)
(β = 0.117, p = 0.006)
ISQ (R2 = 2.1%)
(β = −0.165, p = 0.001)
Estimated BAC
(R2 = 3.9%)
(β = 0.420, p < 0.0001)
Sleep quality (R2 = 0.7%)
(β = −0.096, p = 0.024)
Estimated BAC
(R2 = 1.8%)
(β = 0.167, p = 0.004)
Alcohol intake evening
(R2 = 1.2%)
(β = −0.288, p = 0.022)
Sleep quality (R2 = 1.0%)
(β = −0.115, p = 0.049)
Men only Today (n = 120) Yesterday (n = 110) Two days ago (n = 91)




(β = 0.570, p < 0.0001)
Subjective intoxication
(R2 = 38.9%)
(β = 0.485, p < 0.0001)
Subjective intoxication
(R2 = 41.0%)
(β = 0.818, p < 0.0001)
Baseline anger, hostility
(R2 = 2.7%)
(β = 0.181, p = 0.015)
Stress while hungover
(R2 = 12.3%)
(β = 0.293, p < 0.0001)
Drinking time
(R2 = 3.3%)
(β = −0.263, p = 0.013)
Fatigue while hungover
(R2 = 3.6%)
(β = 0.179, p = 0.019)
Estimated BAC
(R2 = 3.1%)
(β = 0.495, p = 0.002)
Weekly alcohol intake
(R2 = 1.2%)
(β = 0.159, p = 0.019)
Alcohol intake evening
(R2 = 1.4%)
(β = −0.404, p = 0.030)
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Table 3. Cont.
Women only Today (n = 133) Yesterday (n = 132) Two days ago (n = 83)




(β = 0.580, p < 0.0001)
Subjective intoxication
(R2 = 38.9%)
(β = 0.560, p < 0.0001)
Subjective intoxication
(R2 = 32.5%)
(β = 0.392, p = 0.001)
Total sleep time
(R2 = 2.8%)
(β = −0.183, p = 0.009)
Weekly alcohol intake
(R2 = 3.2%)
(β = −0.221, p = 0.001)
Current immune fitness
(R2 = 9.1%)
(β = −0.279, p = 0.001)
ISQ (R2 = 2.4%)
(β = −0.172, p = 0.010)
Estimated BAC
(R2 = 2.1%)
(β = 0.235, p = 0.036)
Estimated BAC
(R2 = 1.7%)
(β = 0.207, p = 0.008)
Linear stepwise regression analyses were conducted on the data of participants who reported having a hangover.
The included variables were demographics, baseline mood, neuroticism, alcohol consumption variables, and sleep
outcomes. The percentage of variance explained (adjusted R2), the unadjusted beta coefficient (β), and standard error
(SE) are provided. Abbreviation: BAC = estimated blood alcohol concentration, ISQ = Immune Status Questionnaire.
The analysis of the current day revealed that three variables accounted for 45.2% of the variance
in overall hangover severity. With regard to the variance explained by individual variables, subjective
intoxication was the strongest predictor of hangover severity (43.0%), followed by baseline fatigue (1.5%)
and sleep quality (0.7%). The addition of the ‘next day’ variables mood and guilt experienced while
hungover yielded a model where four variables accounted for 56.1% of the variance in overall hangover
severity. Subjective intoxication was again the strongest predictor of hangover severity (43.0%),
followed by fatigue while hungover (8.7%), guilt about drinking while hungover (4.0%), and stress
while hungover (0.4%). Regression analyses for the other two days of assessments yielded comparable
results, as subjective intoxication was always the best predictor (Tables 3 and 4). Tables 3 and 4 also
show the outcomes of separate regression analyses for men only and women only. These analyses again
yielded comparable results as subjective intoxication was the most important predictor of hangover
severity. In contrast to subjective intoxication, the amount of consumed alcohol and estimated BAC
only had a marginal impact on hangover severity across all models. The demographic and mood
variables that affected alcohol consumption are summarized in Table 5. For the ‘today’ data, a stepwise
regression analysis revealed that three variables accounted for 25.0% of the variance in the amount
of alcohol consumed (Table 5). The analysis showed that the number of smoked cigarettes was the
strongest predictor and explained the most variance in the amount of consumed alcohol (16.4%).
This was followed by sex (6.2%) and weekly alcohol consumption (2.4%). The data for the other two
days yielded similar results, as the number of smoked cigarettes was always a relevant predictor of the
amount of consumed alcohol.
The demographic and mood variables that affected alcohol consumption are summarized in
Table 6. Three variables accounted for 41.0% of the variance in subjective intoxication (drunkenness)
(Table 6). The analysis showed that the amount of consumed alcohol was the strongest predictor
of subjective intoxication (37.9%), followed by feeling angry while drinking (2.1%) and age (1.0%).
The data for the other two days (Table 6) yielded similar results: alcohol intake on the respective
evening was always the most important predictor of drunkenness. Taken together, baseline mood and
feeling more ‘angry/hostile’ or ‘depressed’ while drinking had only marginal effects on the amount of
consumed alcohol (<5%). The overall variance of alcohol consumption explained across the models
was low, with the number of cigarettes smoked being the most important predictor. This suggests that,
instead of mood, other (not assessed) variables are more important predictors of the amount of alcohol
consumption. The models for subjective intoxication were more robust, with the amount of consumed
alcohol being the best predictor of subjective intoxication. Baseline mood and feeling angry/hostile or
depressed while drinking had only small effects on subjective intoxication.
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Table 4. Significant predictors of hangover severity (including next-day variables).
Full sample Today (n = 313) Yesterday (n = 243) Two days ago (n = 175)




(β = 0.472, p < 0.0001)
Subjective intoxication
(R2 = 38.9%)
(β = 0.331, p < 0.0001)
Subjective intoxication
(R2 = 37.0%)
(β = 0.319, p < 0.0001)
Fatigue while hungover
(R2 = 8.7%)
(β = 0.237, p < 0.0001)
Stress while hungover
(R2 = 13.0%)
(β = 0.220, p < 0.0001)
Stress while hungover
(R2 = 11.8%)
(β = 0.351, p = 0.0001)
Guilt about drinking
(R2 = 4%)
(β = 0.186, p < 0.0001)
Fatigue while hungover
(R2 = 3.9%)
(β = 0.227, p < 0.0001)
Estimated BAC
(R2 = 4.5%)
(β = 0.227, p < 0.0001)
Stress while hungover
(R2 = 0.4%)
(β = 0.093, p = 0.048)
Guilt about drinking
(R2 = 2.0%)
(β = 0.171, p = 0.001)
Fatigue while hungover
(R2 = 2.2%)
(β = 0.188, p = 0.001)
Estimated BAC
(R2 = 0.6%)
(β = 0.107, p = 0.028)
Angry while drinking
(R2 = 1.6%)
(β = −0.142, p = 0.006)
Men only Today (n = 120) Yesterday (n = 110) Two days ago (n = 91)




(β = 0.423, p < 0.0001)
Subjective intoxication
(R2 = 38.9%)
(β = 0.578, p < 0.0001)
Subjective intoxication
(R2 = 41.0%)
(β = 0.618, p < 0.0001)
Fatigue while hungover
(R2 = 12.5%)
(β = 0.306, p < 0.0001)
Estimated BAC
(R2 = 4.8%)
(β = 0.657, p < 0.0001)
Stress while hungover
(R2 = 17.1%)
(β = 0.426, p < 0.0001)
Guilt about drinking
(R2 = 4.3%)
(β = 0.234, p = 0.001)
Baseline anger, hostility
(R2 = 3.2%)
(β = 0.226, p = 0.001)
Estimated BAC
(R2 = 4.1%)
(β = 0.522, p < 0.0001)
Alcohol intake evening
(R2 = 2.1%)
(β = −0.551, p = 0.008)
Alcohol intake evening
(R2 = 2.1%)
(β = −0.437, p = 0.009)
Weekly alcohol intake
(R2 = 1.8%)
(β = 0.155, p = 0.033)
Angry while drinking
(R2 = 1.7%)
(β = −0.143, p = 0.024)
Women only Today (n = 133) Yesterday (n = 132) Two days ago (n = 83)




(β = 0.419, p < 0.0001)
Fatigue while drinking
(R2 = 39.6%)
(β = 0.226, p = 0.002)
Subjective intoxication
(R2 = 32.5%)
(β = 0.358, p < 0.0001)
Fatigue while hungover
(R2 = 9.8%)
(β = 0.322, p < 0.0001)
Guilt about drinking
(R2 = 12.4%)
(β = 0.250, p < 0.0001)
Fatigue while hungover
(R2 = 9.1%)
(β = 0.325, p < 0.0001)
Guilt about drinking
(R2 = 4.1%)
(β = 0.239, p < 0.0001)
Subjective intoxication
(R2 = 5.5%)
(β = 0.343, p < 0.0001)
Stress while hungover
(R2 = 5.9%)
(β = 0.224, p = 0.012)
Baseline anxiety
(R2 = 1.6%)
(β = −0.139, p = 0.021)
Stress while drinking
(R2 = 2.3%)
(β = 0.196, p = 0.005)
Baseline fatigue
(R2 = 3.3%)
(β = −0.220, p = 0.006)
Weekly alcohol intake
(R2 = 1.8%)
(β = −0.147, p = 0.010)
Current immune fitness
(R2 = 2.3%)
(β = −0.189, p = 0.031)
Linear stepwise regression analyses were conducted on the data of participants who reported having a hangover.
The included variables were demographics, baseline mood, neuroticism, alcohol consumption variables, sleep
outcomes, and next-day variables on mood while hungover, as well as guilt about drinking. The percentage of
variance explained (adjusted R2), the standardized beta coefficient (β), and p-value are given.
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Table 5. Significant predictors of alcohol consumption.
Full sample Today (n = 318) Yesterday (n = 315) Two days ago (n = 317)




(β = 0.320, p < 0.0001)
Cigarettes smoked
(R2 = 14.0%)
(β = 0.293, p < 0.0001)
Cigarettes smoked
(R2 = 16.6%)
(β = 0.353, p < 0.0001)
Sex (R2 = 6.2%)
(β = −0.237, p < 0.0001)
Weekly alcohol intake
(R2 = 6.7%)
(β = 0.275, p < 0.0001)
Weekly alcohol intake
(R2 = 3.6%)
(β = 0.165, p = 0.001)
Weekly alcohol intake
(R2 = 2.4%)
(β = 0.167, p = 0.001)
Angry while drinking
(R2 = 3.1%)
(β = 0.194, p < 0.0001)
Baseline anger, hostility
(R2 = 1.6%)
(β = −0.148, p = 0.003)
Sex (R2 = 1.4%)
(β = −0.132, p = 0.009)
Men only Today (n = 140) Yesterday (n = 139) Two days ago (n = 140)




(β = 0.361, p < 0.0001)
Cigarettes smoked
(R2 = 17.1%)
(β = 0.318, p < 0.0001)
Cigarettes smoked
(R2 = 12.9%)
(β = 0.384, p < 0.0001)
Baseline anxiety
(R2 = 3.3%)
(β = −0.204, p = 0.014)
Weekly alcohol intake
(R2 = 6.2%)
(β = 0.279, p = 0.001)
Angry while drinking
(R2 = 6.9%)
(β = 0.304, p < 0.0001)
Baseline anger, hostility
(R2 = 2.4%)
(β = −0.175, p = 0.025)
Women only Today (n = 177) Yesterday (n = 175) Two days ago (n = 176)




(β = 0.442, p < 0.0001)
Weekly alcohol intake
(R2 = 8.0%)
(β = 0.261, p < 0.0001)
Cigarettes smoked
(R2 = 16.6%)
(β = 0.369, p < 0.0001)
Weekly alcohol intake
(R2 = 2.5%)
(β = 0.174, p = 0.010)
Cigarettes smoked
(R2 = 4.3%)
(β = 0.219, p = 0.003)
Weekly alcohol intake
(R2 = 5.8%)
(β = 0.253, p < 0.0001)
Linear stepwise regression analyses were conducted on the data of participants who reported having a hangover.
The included variables were demographics, baseline mood, neuroticism, and mood while drinking. The percentage
of variance explained (adjusted R2), the standardized beta coefficient (β), and p-value are given.
A summary of all findings is presented in Figure 1.
Figure 1. Associations between drinking variables, mood, and hangover severity. Lines represent
significantly contributing variables to the regression analyses. Dashed lines connect variables that
contributed less than 5% to the associations. The actual percentages are listed in Tables 3–6.
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Table 6. Significant predictors of subjective intoxication.
Full sample Today (n = 254) Yesterday (n = 244) Two days ago (n = 175)




(β = 0.617, p < 0.0001)
Alcohol intake evening
(R2 = 39.8%)
(β = 0.623, p < 0.0001)
Alcohol intake evening
(R2 = 52.2%)
(β = 0.735, p < 0.0001)
Angry while drinking
(R2 = 2.1%)
(β = 0.144, p = 0.003)
Angry while drinking
(R2 = 3.8%)
(β = 0.196, p < 0.0001)
Baseline fatigue
(R2 = 2.3%)
(β = 0.160, p = 0.002)
Age (R2 = 1.0%)
(β = −0.112, p = 0.021)
Age (R2 = 1.9%)
(β = −0.145, p = 0.002)
Men only Today (n = 120) Yesterday (n = 110) Two days ago (n = 91)




(β = 1.060, p < 0.0001)
Alcohol intake evening
(R2 = 48.4%)
(β = 1.033, p < 0.0001)
Alcohol intake evening
(R2 = 55.1%)
(β = 1.113, p < 0.0001)
Estimated BAC
(R2 = 3.1%)
(β = −0.438, p = 0.006)
Angry while drinking
(R2 = 8.0%)
(β = 0.252, p < 0.0001)
Estimated BAC
(R2 = 5.7%)
(β = −0.467, p < 0.0001)
Baseline being active
(R2 = 1.9%)
(β = 0.151, p = 0.022)
Estimated BAC
(R2 = 1.8%)
(β = −0.372, p = 0.018)
Baseline being active
(R2 = 3.6%)
(β = 0.148, p = 0.019)
Baseline neuroticism
(R2 = 1.9%)
(β = 0.177, p = 0.006)
Age (R2 = 1.5%)
(β = −0.133, p = 0.031)
Women only Today (n = 133) Yesterday (n = 133) Two days ago (n = 83)




(β = 0.522, p < 0.0001)
Alcohol intake evening
(R2 = 34.7%)
(β = 0.908, p < 0.0001)
Alcohol intake evening
(R2 = 49.5%)
(β = 0.708, p < 0.0001)
Angry while drinking
(R2 = 3.5%)
(β = 0.197, p = 0.006)
Age (R2 = 4.7%)
(β = −0.222, p = 0.001)
Age (R2 = 1.7%)
(β = −0.147, p = 0.040)
Estimated BAC
(R2 = 2.7%)
(β = −0.386, p = 0.006)
Depressed while
drinking (R2 = 2.2%)
(β = 0.160, p = 0.016)
Linear stepwise regression analyses were conducted on the data of participants who reported having a hangover.
The included variables were demographics, baseline mood, neuroticism, mood while drinking, and amount of alcohol
consumed (alcohol intake during the evening). The percentage variance explained (adjusted R2), the standardized
beta coefficient (β), and p-value are given.
4. Discussion
The current study aimed to verify and extend the observations by Harburg et al. in an international
sample of young adults by applying a 1-item overall hangover severity scale to investigate whether
baseline mood, mood while drinking, as well as mood during hangover, were associated with and/or
predicted current and retrospective hangover severity. In contrast to previous reports [15,21,22],
the findings of our study suggest that even though mood while drinking seemed to differ between
hungover and non-hungover populations, this factor has a rather negligible impact on hangover
severity. Instead, variables related to alcohol intake (in particular, subjective intoxication and estimated
BAC) and sleep (in particular, sleep quality) were much more strongly related to hangover severity.
Feeling stressed and fatigued during hangover were also significantly associated with hangover
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severity, confirming that mood changes accompany alcohol hangover. Finally, guilt was experienced
most frequently by drinkers in the hangover group. Guilt about drinking significantly correlated with
both the amount of alcohol consumed and with hangover severity.
The confirmatory regression analyses further supported our conclusions. The obtained models
revealed that subjective intoxication (drunkenness) was the most important contributor to hangover
severity. In comparison to that, mood while drinking had no relevant impact on hangover severity.
Mood while hungover and guilt about drinking while hungover significantly contributed to the model
predicting hangover severity, but it should also be noted that stress, fatigue, and guilt during hangover
are most likely the consequences, rather than the cause of hangover severity.
Regression models predicting subjective intoxication revealed that the most important contributing
factor was the amount of consumed alcohol. For both subjective intoxication and the amount of alcohol
consumed, the regression models revealed that baseline mood and mood during drinking only had
a small contribution to the models, if any (usually < 5%). At first sight, this might be regarded as
comparable to the findings reported by Harburg et al. [22], who reported that being angry when
high/drunk accounted for 3% (2%) of the observed hangover severity variance in men (women) and
that being depressed when high/drunk accounted for another 1% of the variance in hangover severity
observed for men when using composite HSI scores. Yet, our findings need to be interpreted within
the context that out of all the assessed factors, the mood variables tended to explain the least variance,
thus being the least suitable predictors of hangover severity.
The observation that subjective intoxication was the most important predictor of hangover severity
is in line with results of previous studies [41–43]. One of these studies suggested that ‘consuming more
alcohol than usual’ was an even better predictor of hangover severity than subjective intoxication [43].
Unfortunately, this variable was not included in the current study. We therefore recommend assessing
how much alcohol is typically consumed at an average drinking occasion. This might be done either
with individualized questions or with the help of (semi)structured clinical interview tools. Furthermore,
it might also be beneficial to include measures of overall alcohol sensitivity, such as the Self-Rating of the
Effects of Alcohol (SRE) form [44] or the Alcohol Sensitivity Questionnaire (ASQ) [45]. Another potential
limitation of the current study was the relatively young sample, which makes it unclear to what extent
the results can be generalized to other age groups. We therefore recommend assessing samples that cover
wide age ranges, whenever possible. The data also relied on retrospective self-reports, which might
have suffered from recall bias in some participants and which might potentially have led to the
smaller number of hangovers reported with increasing recall period. Therefore, retrospective hangover
assessments should ideally not be averaged over days that differ in recall period. Retrospective
assessments also mean that BAC was not assessed while drinking, but instead calculated using the
Widmark formula [37]. Given the possibility of recall bias and individual differences, the BAC was
therefore reported as an estimate throughout this article. If possible, the BAC should ideally be
determined on the night of drinking, but it should also be kept in mind that the measurement itself and
the presence of investigators might induce bias, thus making drinking behavior less naturalistic [46].
Research on the relationship between smoking and the presence and severity of hangover is
limited, and this is an important topic for future research. Tables 3 and 4 show that both cigarette
smoking and drug use were not significant predictors of hangover severity or subjective intoxication.
However, this observation is in contrast to previous research that found smoking to significantly
increase the odds of hangover incidence and hangover severity [47]. Our analysis did reveal that
the number of cigarettes smoked was the strongest predictor of the amount of alcohol consumed.
This observation is in line with other research showing that drinking and smoking often go hand in
hand [48].
Finally, we examined possible sex differences in variables contributing to hangover severity.
Previous research showed that the presence and severity of hangover symptoms did not relevantly
differ between men and women at comparable BAC levels [49,50]. In the current study, conducting the
statistical analysis separately for men and women revealed that men consumed significantly more
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alcohol than women, but we found no important sex differences in which variables significantly
contributed to hangover severity. Across all analyses, subjective intoxication was the most important
predictor of hangover severity. While mood during drinking had no relevant impact, mood during
hangover was clearly associated with hangover severity.
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Abstract: The current study evaluated the next day consequences of a social night of drinking
compared to a no alcohol night, with standardised mood and portable screen-based performance
measures assessed in the morning at participants’ homes, and a breathalyser screen for zero alcohol.
A mixed sex group (n = 20) took part in the study. Participants reported consuming on average
16.9 units (135 g) alcohol, resulting in a hangover rating of 60 (out of 100) compared to 0.3 following
the no alcohol night. Statistical significance comparisons contrasting the hangover with the no alcohol
condition revealed an increase in negative mood and irritability during hangover and an (unexpected)
increase in risk and thrill seeking. Performance scores showed an overall slowing of responses across
measures, but with less impact on errors. The results support the description of hangover as a general
state of cognitive impairment, reflected in slower responses and reduced accuracy across a variety of
measures of cognitive function. This suggests a general level of impairment due to hangover, as well
as increased negative mood. The use of a naturalistic design enabled the impact of more typical
levels of alcohol associated with real life social consumption to be assessed, revealing wide ranging
neurocognitive impairment with these higher doses. This study has successfully demonstrated the
sensitivity of home-based assessment of the impact of alcohol hangover on a range of subjective
and objective measures. The observed impairments, which may significantly impair daily activities
such as driving a car or job performance, should be further investigated and taken into account by
policy makers.
Keywords: alcohol; hangover; mood; performance; assessment at home; mobile testing
1. Introduction
The negative consequences of alcohol consumption on safety and productivity are well known, but
the separate impact of alcohol hangover has historically received less attention. This is changing, and
alcohol hangover is now being recognised as important in its own right. Around 9% of workers in the
USA report having a hangover whilst at work, which can impair performance both through absenteeism
and “presenteeism”—attending but unable to work effectively [1]. There are also wider implications
for health and safety [2–4]. Safety critical daily activities such as driving have shown impairment
with hangover [5,6]. The economic costs of hangover in terms of absenteeism and presenteeism are
estimated at 4 billion GBP annually [7].
The alcohol hangover refers to the combination of negative mental and physical symptoms
which can be experienced after a single episode of alcohol consumption, starting when blood alcohol
concentration (BAC) approaches zero [8,9]. Symptoms reflect a general state of malaise described
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medically as veisalgia. The most common symptoms may be grouped as follows: (1) drowsiness,
including fatigue, sleepiness and weakness; and (2) cognitive problems, including reduced alertness
and difficulties with memory and concentration. Other symptoms, such as disturbed water balance,
contribute less to the overall hangover [10,11].
A simple “culprit” responsible for this range of symptoms has yet to be identified. The toxic
metabolite acetaldehyde has largely gone from the system when hangover remains, although research
suggests that an inflammatory response and cytokine elevation may account for some symptoms [12–15].
Changes in neurotransmitters and mitochondrial dysfunction, as well as the congeners added to
different types of drink may also have a role [16]. The presence and severity of a hangover have
been linked to the level of prior consumption in some studies, with the proportion of hangover
resistant participants reducing to closer to zero as consumption levels achieve 0.3–0.4% estimated
BAC [17,18]. However, individual differences affecting metabolism, such as genetic variation in alcohol
dehydrogenase, as well as personality and health status, reflect a wide range of reported symptoms
and overall severity [13,16]. Sex differences in alcohol metabolism are well known and may also reflect
variability of the presence and severity of hangover symptoms in men and women, and their impact
on cognitive and psychomotor functioning and mood [19,20]. Surveys generally indicate higher social
consumption levels by males, although gender differences in consequential hangover severity have
not been consistently reported, and may be more apparent in women at intermediate BAC levels
(0.1–0.3%) [21,22].
Acute alcohol consumption tends to lead to an increase in errors, with less effect on speed of
performance, possibly reflecting a “risky shift” [23,24]. In contrast, slowed responses seems a more
general consequence of alcohol hangover and may reflect the distinct neurocognitive effects when
contrasted with alcohol intoxication [25,26]. A key problem facing alcohol hangover research is the need
for participants to achieve sufficient levels of alcohol consumption, in order to produce a measurable
hangover for impairment studies to be effective. Due to ethics constraints, sufficient alcohol dosing
required to achieve higher real-life BACs cannot always be administered in experimental settings; or
requires stringent assessment and prolonged post dose participant support. For example, supervised
overnight stays at the research facility are required to monitor participants’ wellbeing. This makes
these studies resource intensive and demanding for participants [27]. In addition, social drinking
frequently includes a mixture of alcoholic beverages being consumed in a single drinking occasion
which cannot easily be reproduced in a laboratory. This has led to a number of naturalistic studies
where typically residual effects next day are assessed, contrasting a regular drinking night as part of
normal social life with a no alcohol consumption night [27]. The resulting hangover assessment can
then still include the same validated measures as used in RCTs [27,28]. However, the hangover state in
naturalistic studies reflects a real-life hangover experience significantly better than studies that involve
lab-based alcohol administration [26,27,29].
The following investigation was based on a naturalistic study design with participants assessed
within their own homes in order to maximise their safety and comfort after a potentially heavy social
drinking session. The aim of using the naturalistic study design was to mimic real-life as closely as
possible and as such is characterised by a minimum of lifestyle rules for participants. The investigators
did not (actively) interfere with their activities, and behaviours and activities of the participants
were neither standardised nor regulated by the study protocol. All assessments were undertaken
whilst participants remained in their usual environment (i.e., at home), which was less demanding for
participants and the results may more accurately reflect real life. Balanced gender groups were included
to see if there were any marked differences. The principal research questions were to determine
whether subjective state and objective performance measures differed when assessed at home the
morning after a night of social drinking compared to a night without alcohol. Based on previous
research, it was hypothesised that both performance and mood are impaired during alcohol hangover.
The secondary exploratory research question was to evaluate possible relationships between measures
including reported alcohol consumption and subsequent subjective state and performance.
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2. Methods
2.1. Design
The study was a two-period comparison of performance and subjective state between days
following an evening of drinking or an evening with no alcohol. One day in each condition was
assessed for each subject. The study was unblinded, and the order of conditions was not specified in
advance. The study was approved by the University of the West of England Faculty Ethics Committee
(Approval number: HLS130235, 1 March 2013), informed consent was obtained from all participants
and the study was undertaken in accordance with the British Psychological Society Code of Ethics and
Conduct (2009).
2.2. Participants
Participants were social drinkers, with no specific criterion of hangover frequency. They were
recruited using the snowball technique from acquaintances of people known personally to the principal
experimenter, rather than the direct friends of the experimenter. This approach was used to minimise
the impact of personal relationships, whilst optimising researcher safety as well as participant comfort
for home-based assessment. Exclusion criteria were frequent illicit drug use, or use prior to testing,
any health issues, including those adversely affected by alcohol, breast feeding, pregnancy and those
who may be pregnant. No financial payment was made for participation.
Most participants were (friends of) students from the University of the West of England, providing
an age range of 18–33 years old. The sample consisted of twenty healthy Caucasian participants, ten
female (mean ages of 28.8 years old). Thirty-five per cent were smokers (mean 4–5 cigarettes per day),
with 65% in full employment and 5% students. They reported having a mean (SD) of 2.8 (1.3) (range
1–6) hangovers per month.
2.3. Procedure
Participants were given information sheets describing the study as well as inclusion and exclusion
criteria. Those eligible to be enrolled then provided signed informed consent and were advised of their
rights to withdraw. Enrolled participants completed a demographic questionnaire and assigned their
unique participant code facilitating anonymity, and reminded that participation and all information
was confidential. Participants were reminded not to consume any stimulants, e.g., coffee, tea and
chocolate, or smoke an hour before assessment, as well as to make a note of the number and type of
drinks they consumed the previous evening for their residual alcohol assessment days.
Participants contacted the investigator to arrange a suitable time for an assessment visit and were
tested at their homes in the morning (08:00–12:00) with the experimenter accompanied by a research
buddy who remained in the car outside during the visit. Assessment day and treatment order selected
by participants resulting in 65% undertaking the hangover condition first. An initial positive breath
alcohol test resulted in the schedule start being moved back enabling a zero reading to be obtained, or
testing rearranged, so that all assessments were completed with zero BAC% following drinking, as
well as in the control condition. Subjective assessments were followed by performance tests with the
total assessment period completed within a 45 min period. There was an average of 5 weeks between
treatments and minimum washout period of a week following the hangover assessment. Participants
were given a debrief sheet including contacts for support and advice about excessive drinking after
completing both assessments, and being reminded of their rights to withdraw their data.
2.4. Assessments
Breath Alcohol Concentration (BAC%) was assessed with a Lion Alcolmeter 400 (Lion Laboratories,
Barry, South Glamorgan, UK) by the experimenter who kept their hand over the visual display so that
participants were blind to readings.
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Subjective Assessments comprised paper questionnaires including general mood assessment
dimensions, namely “alert”, “calm” and “content”, assessed with 100 mm Visual Analog Scales
(VAS) [30]; an Irritability Questionnaire based on a 4-point Likert scale [31]; risk taking comprising a
100 mm VAS [32]; the Alcohol Hangover Severity Scale (AHSS) with an 11-point scale, 0–10 [28,33]; and
a 1-item overall hangover severity score (a single item, rated on a 100 mm VAS, ranging from “not at all”
to “worst ever hangover”) [28]. Participants were also required to record their alcohol consumption on
their social nights out with the aid of a retrospective diary when assessed in their homes.
Performance Tests were selected from the Penscreen Test Battery (www.MobileCognition.com)
presented on ARNOVA 7 G2 android 7 Inch/17.8 cm Screens. The five a priori selected tests (Arrow
Flankers, Continuous Performance, Four Choice Reaction Time, Serial Sevens and Stop Signal Task)
each included a single measure of response time and a single error measure for each test to enable
a speed–accuracy trade-off evaluation to be undertaken, and with a view to limiting type I errors
in the subsequent statistical analyses. Each test was explained to the participant and performed
by the researcher where necessary, before the participants had an initial practice, as well as being
provided with a printed sheet describing each test including the stimulus display and the required
responses. Participants were asked to respond as quickly and accurately as possible, with a practice
block preceding each test which took around 5 min to complete with derived test variables including
response speed (reaction time) and number of errors, and the total assessment period taking up to
45 min.
Arrow Flankers [34,35] measures divided attention and inhibition. Sets of five symbols appear
on the screen one set at a time. The central symbol (target) is always an arrow, pointing either to the
right or the left. The other four symbols (flankers) are either congruent (arrows pointing in the same
direction as the target); incongruent (arrows pointing in the opposite direction to the target); neutral
(squares); or suppressors (crosses). The task is to press a left or right button, corresponding to the
central arrow, unless the flankers are crosses, in which case no response should be made. Outcome
measures are the mean overall reaction time and the total number of errors.
Continuous Performance [36,37] measures sustained attention. The A–X version of the test was
used. Letters appear on the screen one at a time. The task is to respond when X appears immediately
following A. Outcome measures are the mean reaction time for correct responses and the number of
missed targets.
Four Choice Reaction Time [38,39] is a measure of psychomotor performance. An array of four
“lights” on the screen corresponds to four buttons below. Each of the lights is highlighted in turn,
and the participant responds by tapping the corresponding button as quickly as possible. Outcome
measures are the mean reaction time for correct responses and the number of incorrect responses.
Serial Sevens [39,40] assesses arithmetic and working memory. A starter number in the range
800–899 is presented on the screen followed by a series of descending 3-digit numbers. The task is to
tap a Yes key if the number is seven less than the previous number shown. In other cases, participants
press “No”. Outcome measures are the mean reaction time for correct responses and the number of
incorrect responses.
Stop Signal Task [41,42] is a measure of impulsivity and inhibition. A letter stimulus which is
either an O or an X is displayed, together with two on-screen buttons. The task is to tap the left button
for an X, the right button for an O, as quickly as possible. In one trial in four, a stop-signal is presented
after the onset of the letter, consisting of two horizontal red lines superimposed on the letter display.
When a stop-signal appears, the user should not respond to the letter stimulus. Outcome measures are
the mean reaction time for correct responses and the number of missed stop signal items (i.e., response
not withheld).
2.5. Statistical Analyses
Statistical analyses were undertaken using IBM SPSS Version 25 (IBM SPSS Statistics 2015, IBM
Corp, Armonk, NY, USA). In line with the research questions, statistical analyses were based on
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contrasting data from the residual alcohol (alcohol hangover) with the no alcohol condition, as well
investigating possible relationships among subjective hangover, the amount of alcohol consumed
the previous night, and performance and other subjective measures. Separate MANOVAS were first
performed to limit type I errors for the subjective and performance data, including independent
variables within groups: measure (performance tests or questionnaires) and alcohol (post-alcohol or no
alcohol); and between groups factors: assessment order (post-alcohol or no alcohol first) and gender
(male or female). They were rerun as a reduced model (questionnaires) with nonsignificant factors
removed (assessment order and gender). Where MANOVA indicated an interaction between alcohol
and gender (performance tests), ANOVAS were run including alcohol and gender as factors. Overall
significant effects for alcohol enabled subsequent paired comparisons to be run for individual variables
(each performance test, or each questionnaire) contrasting no alcohol with the post-alcohol condition.
Nonparametric paired comparisons were run as confirmatory tests as a control for departures from
normality amongst test variable data and identified the same significant paired contrasts as the
parametric analyses. Exact p values are reported. Tests of association were run as partial correlations
with hangover frequency (monthly) as a control for possible tolerance effects [43] as well as smoking as
a control, which may impact hangover [44]. Two-tailed significance levels (p < 0.05) were used for
all analyses.
3. Results
Twenty participants successfully completed the experimental protocol undertaking assessments in
their own homes after a night of social drinking (alcohol night) and a night without alcohol consumption
(no alcohol). All participants had zero BAC confirmed with the breathalyser prior to their assessments.
3.1. Alcohol Consumption
All participants reported zero alcohol consumption on their no alcohol nights before testing,
and they reported consuming a mean (SD) of 16.9 (4.2) units (range 8–26), calculated using the UK
National Health Service (NHS) website tool (available at: www.nhs.uk) to convert recorded drinks
into standard UK units (1 unit = 10 mL, 8 g pure alcohol). This level of consumption is similar to those
reported elsewhere including 13.5 standard drinks (10 g pure alcohol) reported in a recent Australian
study [26] averaging 135 g pure alcohol, whilst for this study 16.9 units of 8 g/10 mL is also equivalent
to averaging 135 g pure alcohol based on the UK definition. Most participants mixed their drinks, with
two participants having only one type of drink, most 2–3, and two of the 20 participants mixing four
different drinks, typical of a naturalistic study.
3.2. Subjective Assessments
Multivariate analysis failed to reveal significant effects for treatment order (η2p = 0.00) or gender
(η2p = 0.08), including interactions; thus, these factors were removed and data reanalysed with the
reduced model where alcohol remained significant (F(1,19) = 17.98, p < 0.0001, η2p = 0.49), reflecting an
overall difference in subjective ratings between the alcohol and no alcohol conditions and enabling
paired comparisons to be undertaken for the individual measures. The subjective assessments and
results of the pairwise statistical analyses are summarised in Table 1.
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Table 1. Subjective assessments of mood and hangover.
Measure Control Alcohol
Alert VAS (0–100) 51.2 (4.9) 44.1 (6.8) *,†
Content VAS (0–100) 54.0 (6.7) 50.0 (9.1)
Calm VAS (0–100) 70.0 (17.7) 53.4 (12.2) *,†
Irritability (0–3) 0.98 (0.29) 1.56 (0.52) *,†
Overall risk taking VAS (0–100) 53.1 (4.4) 53.3 (4.2)
Risk and thrill seeking VAS (0–100) 50.6 (6.9) 54.1 (6.0) *,†
Self-confidence EVAR (0–100) 54.2 (6.2) 51.0 (8.6)
Need for control EVAR (0–100) 54.5 (9.6) 54.9 (10.1)
Alcohol Hangover Severity Scale (0–10) 0.6 (0.4) 3.8 (1.0) *,†
One-item hangover severity (0–100) 0.3 (1.1) 60.3 (20.0) *,†
Mean and standard deviation (SD) are shown. Abbreviations: VAS, visual analogue scale; EVAR, Evaluation of
Risks Scale. Significant differences (p < 0.05) are indicated by * (parametric) and † (nonparametric).
The parametric analyses provided the same significant contrasts as the nonparametric confirmatory
analysis. Significant increases (p < 0.0001) were seen following alcohol for both the AHSS and the
one-item hangover severity VAS, with both showing close to zero symptom ratings after no alcohol but
notable increases after alcohol (see Table 1). For example, a mean (SD) one-item hangover severity VAS
scores of 0.3 (1.1) (range 0–100) was reported following no alcohol rising to 60.3 (20.0) (range 15–90) the
day after alcohol consumption, confirming overall hangover status amongst participants.
The VAS mood scale revealed a significant reduction in measures of alertness (p = 0.002) and
calmness (p = 0.005) in the hangover condition and a trend for a reduction in contentedness (p = 0.075).
A significant increase was also recorded with the irritability scale (p < 0.0001), reflecting an overall
reduction in positive mood and increased negative state with alcohol hangover compared to the no
hangover condition. Although no overall change in subjective risk taking was recorded with EVAR, a
modest increase was seen in risk and thrill seeking (p = 0.032), although no change in need for control.
3.3. Performance Tests
Multivariate analysis again failed to find overall significant effects for either treatment order
(η2p = 0.00) or gender (η2p = 0.10), but did find a significant alcohol × gender interaction (F(1,16) = 8.1,
p = 0.012, η2p = 0.34), which was explored with ANOVAs run for each variable and including alcohol
and gender as factors. Alcohol × gender interaction was found for serial sevens response time
(F(1,18) = 7.1, p = 0.016, η2p = 0.28) and errors (F(1,18) = 8.1, p = 0.011, η2p = 0.31) where males had
significantly slower responses (1712.0 (699.9) versus 1005.3 (332.9), p < 0.0001) and more errors (6.2 (5.9)
versus 3.1 (4.6), p = 0.011) after alcohol compared to no alcohol, although no significant effects were
found for females. There were no other significant interactions or gender differences. An overall
effect for alcohol was seen with response times for arrow flankers (F(1,18) = 5.1, p = 0.036, η2p = 0.22),
continuous performance (F(1,18) = 8.1, p = 0.011, η2p = 0.31) and choice reaction time (F(1,18) = 11.5,
p = 0.003, η2p = 0.39), and for errors with arrow flankers alone (F(1,18) = 10.1, p = 0.005, η2p = 0.36).
These differences were further examined with paired comparisons. Results for the cognitive tests and
the pairwise comparisons are summarised in Table 2.
The parametric paired contrasts reflected the nonparametric analyses (see Table 2). Responses
were significantly slower with arrow flankers (p = 0.036), continuous performance (p = 0.011) and
choice reaction time (p = 0.005). Errors were significantly increased in the hangover condition for arrow
flankers (p = 0.004).
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Table 2. Performance outcomes.
Test Measure Control Alcohol
Arrow Flankers RT (ms) 625.8 (127.8) 693.9 (143.5) *,†
Errors (n) 3.4 (6.6) 13.9 (16.5) *,†
Serial Sevens RT (ms) 1948.9 (1938.2) 2055.6 (1339.3)
Errors (n) 3.3 (3.7) 4.4 (4.6)
Continuous Performance RT (ms) 468.5 (67.5) 506.0 (69.0) *,†
Errors (n) 2.4 (3.0) 2.6 (2.5)
Choice Reaction Time RT (ms) 597.9 (263.0) 705.0 (245.2) *,†
Errors (n) 2.8 (2.1) 4.5 (10.6)
Stop Signal Task RT (ms) 797.3 (115.1) 828.3 (120.6)
Errors (n) 4.2 (1.5) 3.7 (1.3)
Mean and standard deviation (SD) are shown. Abbreviations: RT, reaction time; ms, milliseconds; n, number.
Significant differences (p < 0.05) are indicated by * (parametric) and † (nonparametric).
3.4. Associations between Measures
The secondary research question was concerned with possible associations between subjective
state including perceived hangover, performance and other variables. Statistical analysis employed
partial correlations with monthly hangover frequency to take into account possible tolerance effects [43]
and smoking habit (categorised as yes, occasional, no) [44], included as control variables which may
impact scores in the assessed hangover condition).
The one-item overall hangover severity score was selected as an overall measure of subjective
hangover and was found to be more sensitive than the AHSS [28], with a relatively weak association
between the two scales (r = 0.439, p = 0.068). Overall hangover severity (one-item) correlated
significantly with the recalled amount of alcohol consumed the night before (r = 0.548, p = 0.019), with
the more alcohol consumed the previous evening the greater the subjective hangover the following day.
The amount of alcohol consumed the previous evening failed to show any significant associations with
performance or other subjective variables. However, overall hangover severity was also correlated
with other performance and subjective data collected in the hangover condition.
With the VAS, increased one-item overall hangover severity was associated with participants
feeling less content (r=−0.524, p= 0.026). Risk taking (EVAR) indicated a reduction in the self-confidence
subscale with increased hangover (r = −0.493, p = 0.037), but an unexpected increase in the risk and
thrill seeking subscale (r = 0.479, p = 0.044).
There was a significant association between the 1-item overall hangover severity score and cognitive
performance. With serial sevens (continuous subtraction), increased hangover was unexpectedly
associated with faster responses (r = −0.623, p = 0.006) and fewer errors (r = −0.541, p = 0.020), although
there were no other significant associations. In contrast to the one-item overall hangover severity score,
none of the associations among mood, performance and AHSS scores were significant.
4. Discussion
The main aim of the study was to investigate differences in both subjective state and performance
following a night of social drinking that may result in a hangover next day when assessed at home
and contrasted with a night without alcohol consumption using a naturalistic design. A relatively
high mean (SD) alcohol consumption was reported of 17 (4.2) units (range 8–26) based on primed
recall next day, and with most participants consuming two or more types of drinks. Mixing drinks, or
the order in which they are consumed, has not in itself shown an impact on hangover [45], although
congeners may have a role in determining hangover severity [46]. The mean (SD) hangover severity
score of 60.3 (20.0) on a one-item scale ranging from “not at all” (0) to “worst ever” (100) reflects
a clearly demonstrable hangover for this group overall, although BAC was not directly measured.
Significant differences in the present study were associated with overall effect sizes (η2p) of around of
0.5 for subjective measures and 0.2–0.4 for performance measures. These are comparable with those
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reported in compatible repeated measures studies [47], and supported by impairments reported in
other measures such as driving [5], suggesting the real life consequences of alcohol hangover after
social drinking occasions in everyday life.
4.1. Subjective Measures
Six of the 10 subjective measures returned significant differences between the alcohol hangover
and no hangover conditions (see Table 1) showing that participants were clearly experiencing different
subjective states, and the reduction in alertness is consistent with the study of 1400 participants
identifying key factors of the subjective hangover state [11]. The reduction in positive mood measured
with the VAS and increase in irritability supports the descriptions of hangover as a state of malaise and
supported by significant increases in both specific hangover symptoms measured with the AHSS as
well as the overall one-item hangover severity score.
The finding of a significant positive association between recalled consumption the previous night
and one-item hangover severity assessed next day (r = 0.548, p = 019) has been found in some other
studies but not all, and thus the relatively small sample size included here provides limited support
for this [26]. Given the wide range of hangover symptoms including CNS, gastrointestinal and more
general physiological effects [11,48], as well as individual differences in alcohol metabolism that may
impact hangover including reported immunity, larger samples are required to establish this association,
possibly with selected cohorts where distinct groups of phenotypes are found. The average change in
subjective hangover (one-item severity score) ratings from less than 1 on the control day to 60 (out of
100) on the hangover day indicates a notable hangover for the majority of participants. The AHSS
also increased significantly, but a relative lack of sensitivity for the AHSS when correlated with other
measures may reflect its component nature, where a restricted number of individual symptoms may
not reflect the complete hangover experience and its impact accurately [28]. The decrease in positive
mood with the VAS supports the hangover ratings, with significant reductions in feeling alert and
calm, and a trend for a reduction in feeling content in the hangover condition compared to no alcohol,
and supports the reliability of the subjective data.
The EVAR scale has been widely used in assessing risk taking and found to be a sensitive and
reliable measure [32]. The component scores showed a differential effect when contrasting hangover
with no alcohol conditions. Overall risk taking, need for control and self-confidence were relatively
unchanged. Interestingly, risk and thrill seeking were increased which would not be predicted
for participants in a hangover state that may be associated with increased feelings of fragility and
vulnerability. However, reduced executive function [25] may result in disinhibition during hangover
that may then be reflected in increased risk and thrill seeking ratings. This has been seen alongside
increased impulsivity with alcohol and driving [49], although the stop signal task failed to show
significant changes in the present study, suggesting a different impact profile for neurocognitive
domains linked to risk taking and impulsivity behaviour with hangover.
Although recalled alcohol consumption was associated with one-item overall hangover severity,
other measures were not, suggesting a lack of direct changes in mood states with quantitative changes
in alcohol consumption and resulting hangover status. However, hangover severity did correlate
significantly with decreases in self-confidence and contentedness, as well as increased risk and thrill
seeking, suggesting the sensitivity of subjective awareness of a hangover state. These results contrast
with the more limited associations found between subjective hangover and performance measures.
4.2. Performance Tests
The five performance tests assessed a range of cognitive functions including psychomotor
performance (choice reaction time), sustained attention (continuous performance) and executive
functions. All tests included a response time measure as well as errors enabling a potential
speed—accuracy trade-off to be evaluated. Executive function measures included working memory
(serial sevens) as well as inhibition (arrow flankers and stop signal task). In contrasting the no
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alcohol and hangover conditions, four of the five tests indicated a significant contrast (arrow flankers,
choice reaction time, continuous performance and (for males only) serial sevens), reflecting impaired
performance with slower responses with hangover. Significantly increased errors were only seen with
arrow flankers and (for males only) serial sevens, although more errors were generally seen in the
hangover condition. The stop signal task alone failed to show differences (see Table 2).
Slower response speeds were evident for all but the stop signal task, resulting in significant slowing
with hangover across test averages, although for serial sevens the difference was only significant for
male participants. Increased errors only achieved significance with arrow flankers and (for males only)
serial sevens, but all except the stop signal task showed an increased number of errors with hangover.
These results are in opposition to the speed–accuracy trade-off that has been reported for alcohol,
where response speeds are maintained but with an increase in errors [23]. This may be associated with
a “risky shift” after acute alcohol administration and observed in the field [50] and characteristic of
disinhibition. The speed—accuracy trade-off has not always been observed and error rates can also
increase with alcohol induced impairment [51]. However, based on the overall profile of significant
results observed in this study, response slowing is a more consistent feature of alcohol hangover
induced impairment than increased errors and this has been observed in other studies [26,52,53]. The
greater impact on response slowing is therefore an emerging important factor in profiling alcohol
hangover induced impairment in contrast to the effects of acute alcohol intoxication.
The overall results of slower response and more errors for all except for the stop signal task,
supports alcohol hangover being associated with impairment and slowing of cognitive functions.
The apparently contradictory finding of a significant association with serial sevens (assessing mental
arithmetic, working memory) and increased hangover severity with faster and more accurate responses,
albeit within a general slowing of responses of 100 ms between the no alcohol and hangover conditions,
was unexpected. This might reflect an increased situational awareness [54] of being in a sensitive state
with increased perception of hangover and possibly increased effort as a result, but was found for this
performance measure alone and requires replication.
4.3. Limitations and Strengths
Study limitations included the limited number of participants (n = 20) and, although this was
sufficient to show both differences between the no alcohol and alcohol hangover conditions, which
has been supported by a partial replication, as well as some associations between measures, it was
underpowered for gender comparisons and a more reliable investigation of associations between
measures. The age range of participants was 18–33 years old. Although high level drinking and
hangovers are frequently reported by this age range, future studies should examine to what extent the
current findings can be generalised to other age groups. Especially, hangover data of elderly are lacking.
Whereas declines are observed in overall drinking in the last 15 years [55] and a growing number
of British young adults routinely do not drink alcohol [56], reported alcohol use and corresponding
problems in older age groups are reported to be on the increase [57,58].
The naturalistic design did enable the impact of higher alcohol consumption levels (17 units) to be
assessed reflecting real life. This enabled a number of differences in both subjective and performance
measures to be found between the hangover and no alcohol conditions, suggesting an overall successful
investigation in relation to the primary research question. The partial replication also supports these
general findings. Assessment at home provided a more natural environment to record actual subjective
state and functionality, as well as improving participant safety if travelling in a potentially vulnerable
condition. In addition, where participants initially showed a small positive BAC with breathalyser the
morning after drinking, assessments could be comfortably delayed until a zero BAC was recorded.
These attributes of home-based assessment enabled all participants to complete the study protocol
without dropping out, suggesting that this approach places less demands on participants and is
therefore a further benefit of naturalistic designs in alcohol hangover research [27]. These differences
may account for some of the observed differences in alcohol hangover studies when comparing lab
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with naturalistic studies. However, one study which directly compared the effects of acute alcohol
consumption in the laboratory and in a naturalistic setting showed similar patterns of impairment by
alcohol in both settings [59].
5. Conclusions
This study employed a naturalistic design so that participants were able to reflect a typical hangover
state after a night out of social drinking with higher consumption, unrestrained from laboratory protocol
and ethical limitations on alcohol administration. The use of home-based assessment was successful,
demonstrating significant effects on both mood and performance. The pattern of impairment found
here supports other findings of alcohol hangover as inducing a state of malaise or veisalgia which
negatively impacts a range of cognitive abilities including executive functions, and in addition to more
negative mood and experience of hangover symptoms. The findings support others showing both
mood and performance impairment with alcohol hangover, and a pattern of general impairment is
emerging that is distinct to that found in acute alcohol administration studies. Future studies should
determine how the observed impairments may have negative consequences in everyday life, work
performance and daily activities such as driving.
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Abstract: Results from studies into the cognitive effects of alcohol hangover have been mixed.
They also present methodological challenges, often relying on self-reports of alcohol consumption
leading to hangover. The current study measured Breath Alcohol Concentration (BAC, which was
obtained via breathalyzer) and self-reported drinking behavior during a night out. These were
then related to hangover severity and cognitive function, measured over the internet in the same
subjects, the following morning. Volunteers were breathalyzed and interviewed as they left the
central entertainment district of an Australian state capital. They were provided with a unique
identifier and, the following morning, logged on to a website. They completed a number of measures
including an online version of the Alcohol Hangover Severity Scale (AHSS), questions regarding
number and type of drinks consumed the previous night, and the eTMT-B-a validated, online
analogue of the Trail Making Test B (TMT-B) of executive function and working memory. Hangover
severity was significantly correlated with one measure only, namely the previous night’s Breath
Alcohol Concentration (r = 0.228, p = 0.019). Completion time on the eTMT-B was significantly
correlated with hangover severity (r = 0.245, p = 0.012), previous night’s BAC (r = 0.197, p = 0.041),
and time spent dinking (r = 0.376, p < 0.001). These findings confirm that alcohol hangover negatively
affects cognitive functioning and that poorer working memory and executive performance correlate
with hangover severity. The results also support the utility and certain advantages of using online
measures in hangover research.
Keywords: hangover; alcohol; internet; attention; executive function; working memory
1. Introduction
The alcohol hangover (AH) is defined as “the combination of mental and physical symptoms,
experienced the day after a single episode of heavy drinking, starting when blood alcohol concentration
approaches zero” [1]. It describes a feeling of malaise that follows a bout of drinking when
blood alcohol levels are at or returning to zero [2–7]. The AH is variously characterized by
somatic and behavioral symptoms including headache, thirst, stomach upsets, negative mood,
and cognitive problems.
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There can be considerable inter-individual variability in the pattern, severity, and temporal
characteristics of hangover symptoms [8], with no clear relationship between AH severity and any
single physiological process (although cytokine response to alcohol is emerging as a possible key
factor [9,10]). Other mechanisms that may contribute to AH include, but are not limited to, gut dysbiosis
(including ghrelin-mediated), decreased blood glucose concentrations, poor sleep architecture, dehydration
(and concomitant electrolyte imbalances), oxidative stress, and inflammatory responses [2,11,12]. These last
two may in part be elevated in response to circulating ethanol metabolites.
The majority of previous research exploring the cognitive effects of alcohol has focused on acute
intoxication, and the long-term neurocognitive consequences of alcohol dependence [7,13,14]. Acute
intoxication impairs aspects of memory, attention, and psychomotor performance [15–20]. Alcohol also
produces a characteristic shift in the speed/accuracy trade-off. Unlike other impairing drugs which tend to
slow responding, alcohol typically increases error rates with little effect on response speed [16,17,21].
Compared with alcohol intoxication, relatively little research has been directed at the specific
cognitive effects of AH [22,23]. A recent meta-analysis of next-day cognitive effects of heavy alcohol
consumption included 19 studies published in 11 articles since 1970 [24]. It concluded that sustained
attention, short- and long-term memory, and psychomotor speed are the cognitive domains most
susceptible to hangover.
Any hangover-related cognitive impairment could have major implications for everyday activities.
For example, hangover impairments to driving ability were similar to those observed at Breath Alcohol
Concentrations (BAC) of 0.05–0.08% [25], that is similar to those. Such impairments have clear
ramifications for safety-sensitive occupations, but also negatively impact on those that continue
to engage in everyday activities while in a hangover state. In the context of absenteeism and
presenteeism, it has been estimated that alcohol hangover costs the US economy 179 billion annually
in lost productivity [26].
There are a number of methodological approaches to the study of hangover effects on cognition
(see Stephens et al., 2014 for a critical review) [2]. These include laboratory studies where controlled
doses of alcohol are administered, usually in a relatively pure form (typically vodka), and cognitive
outcomes are measured once BACs have returned to zero. Alcohol is either administered at fixed doses
or titrated to reach a target BAC. This approach has the advantage of providing relatively high levels of
control, particularly regarding the timing of alcohol administration and measurement of physiological
and functional endpoints. On the other hand, it may not have high ecological validity. For example,
in real-life drinking situations individuals may consume a variety of beverages over different lengths
of time. Secondly, because Ethics Boards tend to err on the side of caution, laboratory studies typically
use lower levels of alcohol than those observed in the field. Even when bar-like settings are simulated
in the laboratory there tends to be a limit on target alcohol levels.
An alternative methodology in AH research is to use a so-called ‘naturalistic’ design.
Here participants visit the laboratory on two mornings, one after a night’s drinking and another after
a sober night (with order counterbalanced across participants) [27]. This method has the advantage of
ecological validity by not limiting participants’ drinking. On the other hand, the approach relies on
recollection of levels of alcohol consumed to generate an estimated Blood Alcohol Level (eBAC). Given
that alcohol intoxication is associated with memory problems (as may be hangover), this is problematic
when trying to explore the relationship between alcohol consumed and functional consequences of AH.
The relative utility of these approaches is illustrated by disparate findings regarding cognitive
impairments associated with hangover [28]. For example, psychomotor deficits associated with AH
were observed in naturalistic studies [23,29,30] but not in laboratory settings [31–33].
The current study took a somewhat different approach. Over the past decade or so, internet
studies have been increasingly used in psychological research, including to evaluate the impact
of substance use and complement field and laboratory studies on the effects of recreational drugs
and alcohol [14,16,17,34–42]. Here, we employed a mixed methodology involving a subgroup of
individuals who were taking part in ongoing field studies, SmartStart [43] and Last Drinks [44],
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into patterns and consequences of alcohol consumption. These studies included a cohort of patrons
who were breathalyzed while leaving the entertainment area of an Australian capital city and agreed
to be contacted the following morning to complete an internet study of hangover. This included a
version of the Alcohol Hangover Severity Scale (AHSS [28]) and an online analogue of the Trail Making
Test B (TMT-B), named the eTMT-B-a test of psychomotor function, working memory, and executive
function. This task was chosen as it is relatively brief, the task demands are easily understood, and it
captures elements of the major cognitive domains (psychomotor function, attention, and executive
function) affected by AH [24,45].
This approach has several advantages. Next-day symptomatology and performance can be linked
to measured alcohol levels and drinking characteristics, collecting data via the internet is relatively
convenient in that it does not require travelling to a testing location, and the method can address
certain methodological questions—for example what factors contribute to attrition in hangover studies.
We hypothesized that previous night BAC would be related to both worse hangover severity
and cognitive performance as measured using the eTMT-B. Further analyses explored the influence of
beverage types and patterns of drinking on hangover severity and cognitive performance.
2. Experimental Section
2.1. Pilot Study
A pilot study was conducted to evaluate the validity of the online eTMT-B. Twenty-four young
adult volunteers (17 female, mean age 30.29 years, SD 5.03) completed both the pencil-and-paper and
online versions of the test (with order counterbalanced across participants).
The traditional TMT-B requires participants to draw lines connecting 25 circles distributed on
a page containing single digits and letters. Correct completion involves joining the stimuli alternating
between ascending numbers and letters (e.g., 1-A-2-B-3-C . . . , etc.), with completion time as the
main outcome [29]. The TMT-B was administered according to the published protocol [46], with the
exception that errors were not corrected (as this would not be possible in the online version).
The eTMT-B was designed as an online analogue of the Pencil-and-Paper TMT-B. It consisted of
a 5 × 5 grid of rectangular panels each labeled with a digit or number. Similar to the paper version,
the task involved clicking on alternating ascending numbers and digits starting with 1-A and so on
(see Figure 1). Once a panel was pressed it changed color from white to grey, after which clicking on it
had no effect. If a participant attempted to press an incorrect button, no response could be made and
an incorrect response was recorded. Both versions were scored for errors and completion time.
Figure 1. Layout of the online analogue of the Trail Making Test B, eTMT-B. The task requires




This study formed part of a larger series of studies aimed at determining patterns and drivers
for drinking in and around an Australian state capital. This part of the study employed a mixed
methodology approach, whereby individuals were approached as they left the Central Entertainment
District (CED) and then contacted the following morning to conduct an internet study.
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The study was approved by the ethics committees of both Griffith University (2015/704) and
Swinburne University (2016/167).
When first engaged during the CED phase, participants were presented verbally with a summary
of the nature of the study and what their involvement would entail. Survey and breathalyzer measures
were completed only if the participant provided verbal consent for both the concurrent and next morning
measures (as approved by the ethics committee) as is usual for this kind of research. Each participant
was given a unique identifier card with a link to the study information sheet (www.last-drinks.com.au).
They were informed that they would be allowed to withdraw their data (using the anonymous ID number
given on the card) and obtain further information regarding the study if they so wished.
2.2.2. Participants
One hundred and five participants provided usable datasets. They were recruited at and
around exit points (taxi ranks and train station) in the central entertainment area of Brisbane,
Queensland, Australia.
2.2.3. Breath Alcohol
Breath alcohol levels were measured using an Alcolizer LE5 (Alcolizer Pty Ltd, Australia).
This device is used by law enforcement agencies throughout Australia and South East Asia, is Australia
Standard 3547 certified, and has an accuracy of greater than 0.005 at 0.100 BAC g/100 mL. It has been
demonstrated to have high reliability and validity for measuring intoxication in a sample of people
attending nighttime entertainment districts [47].
2.2.4. Online Measures
A website survey was constructed which included questions collecting demographic and
morphometric information (birth year, gender, weight, and height). Participants were asked specifically
about the number of beers/ciders, glasses of wine, shots (unmixed), and alcohol mixed with either
energy drinks or other beverages they had consumed the previous night and on a typical night
out. This was followed by an 11-item version of the Alcohol Hangover Severity Scale (AHSS [28]),
comprising of 11-point scales with endpoints (0 and 10) labelled as ‘absent’ and ‘extreme’. Individual
items were ‘sweating’, ‘confusion’, ‘thirst’, ‘nausea’, ‘fatigue (being tired)’, ‘heart pounding’, ‘dizziness’,
‘shivering’, ‘clumsiness’, ‘apathy (lack of interest/concern)’, and ‘stomach pain’. Note that the ‘difficulty
concentrating’ item was omitted to reduce expectancy effects while engaging in a task requiring
an element of focused attention.
The next sections asked questions regarding the previous night’s alcohol consumption (specifically
numbers and types of beverages), sleep, and qualitative hangover data (these will be reported
elsewhere). Alcohol intake data were collected according to the number of standard drinks consumed
for each drink type (an Australian standard drink contains 10 grams of alcohol). Participants were
provided with a link to the Better Health Channel online drink calculator where they were shown
images of glasses containing an Australian standard drink. Participants were able to compute
the number of standard drinks they had consumed by moving a slider to add or remove alcohol
from the glass. Calculations were based on the average alcohol content for each drink type.
For example, red wine was calculated at 13% alcohol, white wine at 11.5% alcohol, and full-strength
beer at 4.8% alcohol. The full list of average alcohol contents by drink type can be found at
http://mapi.betterhealth.vic.gov.au/saywhen/my-drinking/calculator.
Participants were then directed to a website with the eTMT-B. Following completion of the online
test, a debriefing page was displayed, and participants were given details for entry to an online
competition to win an iPad. They were also compensated with a $15 AUD iTunes voucher if they
provided an email address.
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2.2.5. Procedure
Individuals were recruited by being approached as they left the central entertainment area of
Brisbane, Queensland. If willing to be interviewed, they provided consent, were breathalyzed, and gave
details regarding their consumption of alcohol (including time drinking and number of drinks) that
night. Those with BACs around 0.05% or above were asked if they agreed to be contacted the following
morning. Those consenting (N = 346) provided their contact details and estimated bedtime for that
night. Participants were given a card with a unique identifier which allowed anonymous linking of
their BAC and drinking data to the data collected over the internet.
The following morning individuals were contacted by text message 8 h following their estimated
bedtime and again 6 h later if they had not completed the survey. If participating, they entered their
unique identifier and then completed the webpages as described above.
2.2.6. Statistics and Analysis
Number of drinks recorded were converted to standard drinks (one Australian standard drink is
equivalent to 10 g alcohol). Initial analyses involved exploring the relationship between BAC, hangover
severity, and cognitive performance with various drinking factors. These included number of standard
drinks, time drinking, and number of specific types of drink. The relationships between these factors
were analyzed using Pearson’s correlations. To determine whether BAC affected participation in the
hangover part of the study, t-tests compared BACs of those who did and did not participate in the
next-day online phase of the study.
3. Results
3.1. Pilot Study
Response times were similar between the paper-and pencil and internet platforms. With a mean
completion time of 40.27 s (range 14.71–71.59) for the paper version of the TMT-B and 41.49 s (23.02–75.10)
for the eTMT-B (t(23) = 0.116, p = 0.909). These were significantly correlated between individuals completing
the two platforms (r = 0.499, p = 0.013).
Published norms for completion of the paper version of the task are typically around 50 s [44,48].
Considering our sample were predominantly students and the paper version involves error correction,
our figures are in line with normative data. Errors were rare on both platforms with 4 people making
errors on the paper version and 10 people on the eTMT-B. The vast majority of these were single errors.
3.2. Main Study
Of 346 participants who were breathalyzed and indicated that they may be prepared to participate
in the next-day phase of the study, 105 provided complete online datasets. Sample characteristics of
this cohort are presented in Table 1.




Age 24.7 (17–49) years
Weight 74.0 (43–115) kg
BMI 24.15 (16.58–40.28)
Drinking characteristics of the cohort are presented in Table 2. The sample had a mean BAC of
0.11% (SD ± 0.40). They reported drinking for an average of 7.45 hours and had consumed a mean
number of 13.5 standard drinks. Analyses of next-day reports revealed that the most consumed drink
was alcohol mixed with non-energy drink mixers (N = 83 drinkers, consuming a mean of 7.27 drinks)
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followed by beer/cider (N = 59, mean = 7.16), shots (N = 43, mean = 3.51), wine (N = 31, mean = 5.68),
with alcohol mixed with energy drinks being the least consumed beverage both in terms of number of
drinkers and average number of beverages (N = 30, mean = 2.87).
Table 2. Reported drinking characteristics, including types of drinks consumed on the night of data
collection, Breath Alcohol Concentration (BAC), and hours drinking.
N Mean SD Max
Drinks consumed
Beer/cider 59 7.16 5.86 30
Wine 31 5.68 4.56 20
Shots (unmixed) 43 3.51 3.21 16
Alcohol mixed with Energy Drink 30 2.87 1.98 8
Alcohol mixed with Other Beverage 83 7.27 5.80 40
Total 105 13.48 5.94 35
Drinking measures
BAC (%) - 0.110 0.040 0.25
Hours drinking - 7.45 4.09 17
The main focus of the study was to examine factors associated with hangover severity and
cognitive performance (see Figure 2).
Figure 2. Graphs depicting significant associations between (a). previous night’s breath alcohol
content (BAC) and hangover severity (Hangover Severity Scale (HSS) score), (b). hangover severity
and cognitive performance (eTMT-B), (c). BAC and cognitive performance (d). drinking time and
cognitive performance.
Hangover severity was significantly related to one measure only, namely BAC (r = 0.228, p = 0.019).
The correlation between total number of standard drinks and HSS gave a value of r = 0.184, p = 0.064.
Speed of completion of eTMT-B correlated with self-rated hangover severity (r = 0.245, p = 0.0120,
previous night’s BAC (r = 0.197, p = 0.04), and drinking time (r = 0.376, p < 0.001).
Further analyses revealed that BAC correlated significantly with number of standard drinks
consumed (r = 0.486, p < 0.001) and time drinking (r = 0.376, p < 0.001). Examination of the relationship
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between individual drinks and alcohol levels revealed significant correlations between BAC and
amount of alcohol consumed as beer/cider (r = 0.361, p = 0.005), wine (r = 0.398, p = 0.026), and alcohol
mixed with other beverages (r = 0.228, p = 0.038) but not between BAC and shots alone or alcohol
mixed with energy drink (Table 3).



















N 105 105 105 102 59 31 43 30 83
BAC (%) - 0.376 *** 0.228 * 0.486 *** 0.361 ** 0.398 * −0.028 −0.099 0.228 *
Time
drinking (h)
- - 0.148 0.633 *** 0.503 *** 0.223 0.166 0.068 0.257 *
HSS score - - - 0.184 0.171 0.293 −0.010 0.019 0.018
Standard
drinks (N) - - - - 0.623 *** 0.437 * 0.249 0.360 0.369 **
Beer/cider (N) - - - - - −0.388 −0.047 0.033 −0.255
Wine (N) - - - - - - −0.131 0.162 −0.284
Shots (N) - - - - - - - 0.102 −0.067
AMED (N) - - - - - - - - −0.023
BAC = Blood Alcohol Content, HSS = Hangover Severity Scale, AMED = alcohol mixed with energy drinks,
AMOB = alcohol mixed with other beverage. Significant correlations are indicated in bold (*, p < 0.05; **, p < 0.01;
***, p < 0.0001). Drinking characteristics including types of drinks consumed reported on the night of data collection,
BAC, and hours drinking.
Time drinking significantly correlated with standard drinks consumed in total (r = 0.633, p < 0.001),
and as beer/cider (r = 0.503, p < 0.001) and alcohol mixed with other beverage (AMOB, r = 0.257,
p = 0.019). Standard drinks significantly correlated with drinks consumed as beer/cider (r = 0.623,
p < 0.001), wine (r = 0.437, p = 0.014), and AMOB (r = 0.369, p = 0.001). There were no other
significant correlations.
There was no difference in the BACs of those who did (x = 0.11% ± SD 0.0408) and did not
(x = 0.11% ± SD 0.0405) complete the online hangover phase of the study (t(345) = 0.240, p = 0.81).
4. Discussion
Using mixed field and internet methodology, we found that hangover severity is significantly
related to BAC and both are associated with worse performance on the eTMT-B test of attention and
executive function. Drinking time was also associated with BAC and with worse performance on the
task (though not with hangover score).
The current methodology allowed the measurement of BACs and next morning collection of data
regarding types of alcohol consumed, evaluation of severity of alcohol hangover, and cognitive
functioning. The study confirmed that previous night’s BAC was significantly associated with
hangover severity. No other measure was significantly correlated with hangover scores despite
some intercorrelations with other measures and BAC including type of beverage consumed.
It has been suggested that different types of alcoholic beverage may influence hangover severity.
In particular it has been suggested that non-alcohol constituents of drinks, known as congeners,
may differentially affect AH [49]. In particular, it has been suggested that congener-rich drinks such as
whiskey produce worse hangover symptoms than beverages with essentially no congeners, such as
vodka, although there is little systematic research in this area. Our (albeit limited) data do not suggest
that different alcohol types contribute differentially to AH symptomatology. Similarly, different types
of mixers had no differential effect on hangover (symptom) severity.
Conversely there was some evidence that certain drink types were more closely associated with
BAC. As well as correlating with amount of time drinking, BAC was related to the amount of beer/cider,
wine, and AMOBs reportedly consumed (but not shots, or alcohol mixed with energy drinks—AMED).
It seems unlikely that the nature of beverage consumed could differentially contribute to BAC. AMOBs
were the most commonly consumed drinks (by N = 83 people, consuming x = 7.27 standard drinks),
followed by beer/cider (N = 59, x = 7.16), and shots (N = 43, x = 3.51). AMEDs were the least consumed
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beverages (N = 30, x = 2.87), and although wine was consumed by a similar number of people (N = 31),
on average it was consumed at a higher level (x = 7.16 drinks). Thus, our data confirm other findings
using other methodology [50] showing that irrespective of the type of alcoholic drink or mixer, the most
meaningful association was between the number of drinks consumed and BAC.
The error rate on the eTMT-B was generally low, with more than half of the sample (54%)
making no errors, and around one quarter (26%) making one or two errors only. This suggests
that participants engaged with the eTMT-B and understood task demands of the online version.
This confirms the results of the pilot study where there was high correspondence between the paper
and online versions of the task. Thus AH-related impairment was largely manifest by slowed function.
A pattern of slower reaction times with increasing hangover severity would differentiate alcohol
hangover from alcohol intoxication. The latter is typified by a characteristic shift in the speed/accuracy
trade-off (SATO) with intoxication leading to more errors while having relatively little effect on reaction
times [16,17,21,51]. Since few errors were made on either version of the TMT-B however, we cannot
draw strong conclusions from this limited dataset. Nevertheless, the literature does suggest that
slowing of response times during AH is more robust than increased errors [24,52]. One focus of
this study was to implement a cognitive task that was sensitive to impairment and could be used
online (and thus be relatively brief with clear task demands). Clearly, future studies would benefit
from a more comprehensive assessment of working memory and executive functions as well as other
cognitive domains.
The current study had certain advantages over previous studies applying naturalistic
methodology. For example, rather than relying on next-day recall of previous night’s drinks, we had an
objective measure of BACs. Additionally, the number of alcoholic beverages consumed and length of
time drinking were recorded on the night, making these data less susceptible (though not invulnerable)
to recall bias.
While we can be confident that measured BACs were accurate [47], we do not know which phase
of drinking participants were in when breathalyzed. Specifically, we do not know if BACs were
measured at peak alcohol levels or during the rising or falling limb of the blood alcohol curve. Further,
although the BAC measurement occurred at Central Entertainment District exit points (taxi ranks and
train stations), we cannot preclude the possibility that some participants continued to consume alcohol,
which would affect hangover and related functional consequences.
Another issue is that approximately one third of the sample did not attempt the next-day measures.
Drop-out rates in hangover studies are typically high (e.g., 70 % attrition in Grange et al. [53]),
suggesting that the current methodology is as viable as others in this respect. One possibility is
that those subjects who consume the most alcohol and/or have the worse hangover symptoms are
less likely to complete the next-day measures. The current methodology allowed us to address this
directly by comparing the BACs of those who did and did not complete the hangover part of the study.
This showed that the BACs were more-or-less identical. Furthermore, the sample who completed the
next-day measures had a large range of BACs (up to 0.245%), suggesting that reaching a relatively high
BAC did not affect the ability to complete the next-day measures. This may be an advantage of the
current methodology, as next-day measures were completed online and so were relatively convenient.
The similarity of BACs between the next-day completers and non-completers also partially
addresses a potential ethical issue in this type of research, specifically pertaining to consent from
intoxicated individuals. It is reasonable to assume that any individual who consented in error would
simply not enter into the next-day data collection phase. The fact that previous night’s BACs were
statistically similar between those who did and did not complete next-day measures strongly suggests
that level of intoxication did not affect consent to the extent that the sample were ‘self-selecting’ in
this context.
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5. Conclusions
In conclusion, using novel methodology, this study has confirmed that higher BACs and associated
measures result in worse hangover symptoms and poorer performance on a newly-validated online
measure of working memory and executive function—the eTMT-B. Such hangover-related impairments
are likely to have clear, real-life ramifications. For example, they would impact on the ability to
engage in complex behaviors and may explain some of the hangover-associated impairment of
driving [25]. They are also likely to impinge on fundamental aspects of cognitive functioning. Moreover,
our findings suggest that a mixed field/internet approach provides a novel and viable methodology
for hangover research.
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Abstract: Driving is increasing across the world and road traffic accidents are a major cause of
serious injuries and fatalities. The link between alcohol consumption and impaired driving has
long been established and has led to legislation in many countries, with enforcement of legal limits
based on blood alcohol concentration levels. Alcohol hangover research is an emerging field with
a range of laboratory and naturalistic studies now clearly demonstrating the significant impairments
that can result from hangover, even when alcohol levels are measured at or close to zero the day
following a social drinking occasion. Driving is a commonplace activity but requires competency
with a range of complex and potentially demanding tasks. Driving impaired can have serious
consequences, including death and serious injury. There have been only limited alcohol hangover
driving studies. The studies presented examined the consequences of alcohol hangover with a driving
simulator contrasting a group with zero residual alcohol (N = 26) next day and another with residual
alcohol (N = 26) assessed with breathalyzer in the morning before undertaking a 20 min commute to
work. All participants completed a morning drive after a night without alcohol consumption and
another after a night of social drinking. The driving scenarios were relatively demanding including
traffic and pedestrians, traffic lights and other potential hazards in a mixed rural and urban journey.
Subjective hangover and workload were assessed in addition to a range of driving performance
variables, including divided attention, steering control and driving violations. Analyses contrasted
driving in the no alcohol condition with the residual alcohol condition. The combined groups data
(N = 52) was contrasted with the zero and residual alcohol groups. Significant contrasts were found
for a range of driving measures, including divided attention, vehicle control, and driving violations
as well as perceived workload. The pattern of impairment was broadly similar across both groups,
indicating that whether or not residual alcohol was present, consistent driving impairment was
seen. The relatively high number of significant variables may reflect the increased cognitive demand
of the 20 min commute drive including busy and complex urban environments. This was also
reflected in the significant increase in perceived workload recorded across the 6 dimensions of the
National Aeronautics and Space Administration Task Load Index (NASA-TLX). Associations between
subjective measures and driving performance with hangover suggested a potential lack of awareness
of impairment, though were limited in number. The overall findings indicate that the levels of
impairment seen reflect those seen with alcohol impaired driving, even when breath alcohol is zero.
Keywords: alcohol; awareness of impairment; hangover; driving; residual alcohol
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1. Introduction
Road traffic accidents are a leading cause of mortality, with around 1.35 million deaths recorded
worldwide in 2016, ranked in the top 10 causes of mortality, the leading cause of death for 5–29 year olds,
and with up to 35% of road accident deaths estimated as being alcohol related [1]. Whilst there has been
much research into the impairing effects of alcohol intoxication on driving performance [2–5], there has
been only limited research into the effects of alcohol hangover on driving [6–11]. Alcohol hangover
is the most commonly experienced consequence of alcohol consumption [12] and is defined as the
combination of negative mental and physical symptoms which can be experienced after a single episode
of alcohol consumption, starting when blood alcohol concentration (BAC) approaches zero [13,14].
The annual costs of alcohol hangover to the economy in terms of absenteeism and presenteeism have
been estimated at 169 billion dollars for the US and 4 billion pounds for the UK [15,16], corresponding
with a significant loss of productivity [17]. The neurocognitive and psychomotor effects of alcohol
hangover have been demonstrated in both laboratory and field studies [18,19], showing significant
levels of impaired function on a range of tasks and impacting mood and subjective state in some but
not all studies.
The one hour (100 km) on-road highway driving test is considered the ‘gold standard’ of driving
assessments and has been the basis of a large body of research in the Netherlands examining the impact
of acute dosing as well as residual effects of a range of psychoactive compounds including alcohol [20].
The test has also been successfully implemented in driving research demonstrating the acute and
after effects of alcohol [9,21]. The principal measure is the standard deviation of lateral position
(SDLP) that captures the weaving behavior of the car as it travels along the highway or motorway
environment. The more impaired a driver is then the greater the weaving and increased measure of
SDLP. The highway driving test was developed to measure monotonous driving performance with
low external stimuli, in order to capture basic driving performance. However, other driving situations
such as city driving comprise more skills than primarily steering control and vigilance performance.
Different driving environments impose different levels of cognitive demand on the driver. The one
hour driving test is undertaken in a relatively undemanding driving environment for a competent
driver, such as a highway or motorway setting with an identified and clearly marked driving lane
and without oncoming traffic. Driving assessments made under more challenging conditions have
found significant impairment in driving control at blood alcohol concentration as low as 0.02%–0.03%
BAC [3,22], and it has been shown that driving distractions can produce a two-fold increase in alcohol
induced driving impairment [4].
A wide range of cognitive and psychomotor functions including planning, working memory,
attention and perceptual motor tasks become more important in more cognitively demanding tasks
such as a ‘commute to work’. Modern simulators include a range of measures which complement SDLP
and may provide a more comprehensive assessment of driving abilities needed in these circumstances.
Whilst the one hour test has a significant bibliography to support it and provides comparators for
assessing any new psychoactive compounds and medications, this does not represent the typical
morning ‘commute to work’, which can include a range of rural as well as busy urban environments
and is of shorter duration [23]. There is a need to assess shorter driving durations as the UK 2018
National Travel Survey [24] found that the average car journey was found to be just over 20 min.
Typical commutes to work have been reported as averaging around 20–30 min in the UK in 2018 [23].
Given that a significant number of the working population will use a car for their morning commute,
then the impact of alcohol hangover on a typical commute to work requires further investigation.
To date, there have been relatively few hangover driving studies [6–11]. Verster et al. [10] surveyed
343 Dutch truck drivers who reported impaired driving after drinking the previous night. Of concern,
the drivers that participated in this study acknowledged continued driving, both professional and
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private, despite being aware that being hungover impaired their driving. Early driving studies reported
impairment during hangover when performing swerve maneuvers around cones on a closed road,
and performance on a high speed driving test in a simple driving simulator [7,8]. More recently,
Verster et al. [9] reported significant driving impairment (increased SDLP) on a standardized 100-km
highway driving test in the STISIM driving simulator. Significant increases in SDLP occurred mostly in
the last half of the simulated drive. Robbins et al. [11] examined driving during hangover employing
a 15 min test of simulated motorway driving, including hazards. They found that in the hangover
condition participants, who mostly had residual alcohol though below the legal limit, drove at higher
speeds and for longer periods over the speed limit, with greater speed variation interpreted as increased
likelihood of traffic violations, although attention was not impaired. Together, these studies suggest
that driving ability during hangover is impaired at various performance levels, which may also be
present during a ‘commute to work’ drive.
Awareness of impairment plays an important role in determining if someone drives as well
as affecting their driving behavior. Self estimates of acute alcohol intoxication vary with the level
of consumption such that lower levels below the UK driving limit 0.08% BAC may be accurate or
overestimates, transitioning to underestimates for higher levels [25,26]). There has been relatively
little published research into the effects of alcohol hangover on self estimates of induced impairment,
and yet this is an important aspect given that alcohol hangover cannot easily be quantified in the same
way as a breathalyzer might assess alcohol induced impairment.
The current study was set out to assess the next-day consequences of a social drinking session on
driving simulator performance on a representative commute to work drive. The study employed the
commonly accepted naturalistic design [27]. The primary research question was to examine whether
‘commute to work’ driving is impaired during alcohol hangover. Previous driving studies investigating
both acute alcohol intake and alcohol hangover have found significant decrements in performance
despite increased mental effort [9]. This is therefore an important measure, particularly where cognitive
demand is increased, and was therefore included in the current study. Awareness of impairment is also
an important driving safety related factor and so the association between subjective state and driving
performance was assessed.
Finally, the current definition of alcohol hangover states that the alcohol hangover starts when
BAC approaches zero [13,14]. The few currently published driving studies did not differentiate between
subjects that have a BAC of zero and subjects with residual alcohol still present [9,11] and included
all subjects in the statistical analysis where they were treated as a single sample. However, given the
established driving impairments found with acute alcohol administration at low dosages [3,22], it may
be important to distinguish residual alcohol effects from hangover effects. Therefore, the current study
directly contrasted hungover subjects with residual BAC with those with a BAC of zero.
2. Methods
2.1. Design and Participants
A within-subjects naturalistic design was used to investigate driving performance and subjective
state contrasting two conditions: alcohol hangover (the morning after a social drinking occasion) and an
alcohol-free control day (the morning after no alcohol consumption). Participants were free to arrange
or postpone assessment days as they chose, depending on whether they had consumed alcohol on
their social drinking occasion. The order of conditions was counterbalanced across participants, as was
the order for the driving scenarios used to assess driving. The data represents the combination of three
studies which were approved by the University of the West of England Faculty Ethics Committee
(Approval numbers: ASP12-276, HAS.14.12.74, HAS.16.12.069). Informed consent was obtained from
all participants, and the studies were undertaken in accordance with the British Psychological Society
Code of Ethics and Conduct (2009). No financial payments were made for participation.
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Participants included both students as well as others recruited through contacts of the
experimenters. A total of N = 52 participants (21 men and 31 women) age range of 18–25 years,
with a mean age of 20.9 were included. They were driving license holders with 1–6 years driving
experience who self-reported as being in good health, not pregnant or using illicit drugs at the time
of the investigation, non-smokers, with a daily consumption of less than 5 cups of coffee or other
caffeinated drinks. Subjects were social drinkers and self-reported to experience hangovers regularly.
There were 26 participants in each of the BAC zero and residual alcohol groups.
2.2. Procedure
Prospective participants completed screening questionnaires collecting demographic information
and assessing health and pregnancy status, alcohol, caffeine, drug use and alcohol hangover experience.
Screening also included a short 5 min simulated drive in the STISIM to check for simulator sickness
propensity, promote adaptation, and familiarize participants with the driving simulator test [28,29].
During the study, participants attended the driving simulator twice in the morning for full
driving assessment, once after an evening without alcohol consumption (no alcohol) and once after
an alcohol consumption occasion (alcohol/hangover). They did not ride or drive to the university on
post alcohol assessment days and their health status was checked verbally and by observation on
attendance, followed by breathalyzer assessment. They were asked to follow their regular procedures on
assessment days, although excluding caffeine consumption on the test days until after participation was
completed. They completed subjective assessments rating hangover severity and subjective workload
after completing the driving simulator test. Following completion of assessments participants health
status was again checked before they were permitted to leave the University. On study completion
they were provided with a debrief sheet including contacts for the experimenters, as well as advice on
support for excessive alcohol use.
2.3. Breathalyzer Assessments
Breath alcohol concentration was measured with a Lion Alcometer 400/500 (Lion Laboratories,
UK) by the experimenters who kept their hand over the visual display so that participants were blind
to readings. Assessments were conducted directly before the driving simulator test.
2.4. Driving Simulator Test
A STISIM DriveTM driving fixed base simulator was used to measure driving performance
(Systems Technology Inc, Hawthorne, CA, USA). The simulator comprises a driving frame housing
the adjustable seat, standard foot controls (clutch, brake, accelerator), and the gear lever. The Driving
scenario (see Figure 1) is displayed on a 40” LG monitor. The speed of the vehicle and current gear
selection are displayed within the virtual dashboard at the bottom of the screen. The balanced scenarios
comprised 60,000 feet of mixed rural and urban driving environments with speed limit set to 50 mph.
This provided a driving assessment period of around 20 min in a virtual driving environment with UK
signage and driving on the left hand carriageway. Potential hazards included crossings, stop signs,
traffic lights, parked vehicles in the road, other vehicles as well as pedestrians and dogs crossing the
road. A divided attention task was included with symbols displayed in the top left and right of the
screen. The default symbol is a diamond and when either symbol changes to a triangle the participant
is required to press the corresponding response button on the steering wheel. A range of buildings
dominated the urban landscape, whilst trees and fields were prominent in the rural sections of the
driving environment.
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Figure 1. Examples from the STISIM driving test scenario. The STISIM driving test scenario included
both city driving scenes (A) with a relatively high number of external stimuli (e.g., traffic lights,
pedestrians crossing the road and rural roads (B) with less external stimuli (e.g., no traffic lights, lower
traffic density). On the top left and right of the screen, symbols for the divided attention task are
depicted to which subjects had to respond by pressing a button on the steering wheel.
The STISIM driving simulator records a range of parameters, including variables related to
divided attention (mean response time, and the number of correct, incorrect and missed responses),
basic vehicle control (mean speed and deviation, mean lane position and standard deviation of lateral
position (SDLP)), driving errors (percentage of center line crossings (offside), percentage off road
(nearside), excursions from lane) and driving violations (number of accidents and collisions, speed limit
exceedances and tickets (e.g., failure to stop at stop sign or jumping red lights)).
2.5. Subjective Assessments
The Alcohol Hangover Severity Scale (AHSS) with an 11 point scale of 0–10 for a variety of
symptoms, including fatigue, nausea and thirst with a total of 12 descriptors was used to assess
subjective hangover [30]. Fatigue was selected as a single dimension to provide a measure of
fatigue and sleepiness which are important consequences of hangover and associated with driving
impairment [31,32]. Participants were also required to recall their alcohol consumption on their social
nights out with the aid of a retrospective diary. The National Aeronautics and Space Administration
Task Load Index (NASA-TLX) was used to assess perceived workload with an 101 point scale 0–100
with 5 unit divisions, for 6 workload dimensions including effort and performance, which are both
important for assessing subjective impairment as well as the overall average or Raw TLX [33,34].
2.6. Statistical Analyses
Statistical analyses were undertaken using IBM SPSS Version 26 (IBM SPSS Statistics 2019 Armonk,
NY, USA). In line with the research questions statistical analyses were based on contrasting driving
performance data from the post alcohol/alcohol hangover with the no alcohol (control) condition,
for both the residual and zero alcohol groups as A Priori factors, and gender and study as exploratory
factors. Possible relationships between driving performance and subjective measures were also
investigated. Separate MANOVAs were first performed for the driving performance and subjective
data to limit type I errors, including independent variables within groups: measure (e.g., STISIM
driving variable, subjective variable); alcohol (post-alcohol/hangover, no alcohol). The between
groups factors were: residual alcohol (zero alcohol, residual alcohol); study (1,2,3); gender (female,
male). Separate ANOVAS were run for each performance variable, and each subjective variable
including alcohol and residual alcohol as factors. Significant findings with ANOVA allowed paired
comparisons aligned with the research questions to be run for performance and subjective workload
variables. These contrasted no alcohol (control) with the hangover condition for the zero alcohol
(N = 26), and the residual alcohol (N = 26) groups. Nonparametric paired comparisons were run as
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distribution free confirmatory analyses. p-Values, two-tailed, were considered significant if p < 0.05.
Effect size calculations for paired comparisons were undertaken using pooled variance estimates [35].
Measures of association (Pearson’s r) were included where P-values were at least significant at p < 0.01
and supported by nonparametric equivalents, in order to limit type 1 errors given the number of
variables included.
3. Results
All N = 52 participants had zero BAC on the morning after their no alcohol consumption night.
Following a night of social drinking some participants were unable to recall their exact previous
night’s amount of alcohol consumption, though all participants did report they had a night of alcohol
consumption. This was reflected in the results for the AHSS where group symptom means (4.7, SD 1.8)
indicated they had a substantial hangover comparable with other studies. Breath analysis identified
N = 26 participants who recorded 0% BAC, providing the zero alcohol group. A further N = 26
participants recorded residual alcohol with the breathalyzer, averaging 0.047% BAC (range 0.01–0.08%
BAC) and made up the residual alcohol group. The AHSS hangover score was 5.1 for the zero BAC
group and 4.3 for the residual alcohol group.
Multivariate analyses failed to reveal a significant effect for the exploratory factors gender and
study for both the driving performance data and subjective data, and so these factors were removed
whilst A Priori factors were retained, and data reanalyzed with the reduced model. MANOVA indicated
a significant effect for alcohol for driving performance, as well as a significant effect for alcohol and
an interaction between alcohol and residual alcohol for the subjective data.
3.1. Driving Performance
Multivariate analysis revealed an overall significant effect for alcohol (F(1,50) = 19.4, p < 0.0001,
η2p = 0.30). A Priori factors were included in the separate ANOVAs for the driving measures.
Driving test results are presented in Table 1. Effect sizes fall within the small (0.2–0.4) to large (0.8–1+)
effect size range [35].
Analysis of separate variables revealed significant differences between the alcohol hangover
and no alcohol (control) conditions for components of the divided attention task including mean
response time (F(1,50) = 15.6, p < 0.0001, η2p = 0.24), incorrect responses (F(1,50) = 4.85, p = 0.03,
η2p = 0.09) and missed responses (F(1,50) = 4.48, p = 0.04, η2p = 0.08) reflecting impairment with
hangover. Driving control measures produced significant contrasts for mean speed (F(1,50) = 9.00,
p = 0.004, η2p = 0.15), center line crossing (F(1,50) = 6.49, p = 0.01, η2p = 0.12), time off road (F(1,50) = 19.9,
p < 0.0001, η2p = 0.29) and excursions from lane (F(1,50) = 14.8, p < 0.0001, η2p = 0.23), again reflecting
poorer driving with hangover. Driving violations provided significant contrasts for accidents and
collisions (F(1,50) = 4.59, p = 0.04, η2p = 0.08), and tickets (F(1,50) = 5.99, p = 0.02, η2p = 0.11). All these
measures revealed impaired performance including slower responses, poorer steering control and
more errors as well as increased traffic violations in the hangover condition compared to driving after
no alcohol. Significant contrasts between the zero alcohol and residual alcohol group included mean
speed (F(1,50) = 4.28, p = 0.04, η2p = 0.08), speed limit exceedances (F(1,50) = 4.59, p = 0.04, η2p = 0.10)
and tickets (F(1,50) = 4.17, p = 0.046, η2p = 0.08). Residual alcohol resulted in a greater mean speed,
more speed limit exceedances and more tickets than the zero residual alcohol group.
A single interaction between alcohol and residual alcohol was found with accidents and collisions
where the residual alcohol group experienced a greater number on hangover days compared to the
zero alcohol group who showed a decrease, although with paired comparisons hangover driving
failed to contrast with the no alcohol control for either the combined or zero alcohol groups, whilst the
residual alcohol group had shown an increase with hangover.
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Table 1. Driving Performance and Subjective Measures: Means (SDs).
Combined Groups Zero BAC Group Residual Alcohol Group











Deviation 1.9 (1.1) 2.3 (1.0) 1.9 (1.1) 2.4 (1.2) 1.8 (1.2) 2.2 (0.8)




[0.21] 0.0 (0.0) 0.1 (0.3) 0.0 (0.0) 0.2 (0.6)
Missed Responses 1.1 (1.9) 2.1 (2.9) *[0.30] 0.9 (1.3) 2.0 (2.5) 1.3 (2.4) 2.2 (3.3)
Driving Control





Speed Deviation 10.5 (3.3) 10.6 (3.1) 10.3 (3.7) 10.5 (3.0) 10.7 (3.0) 10.7 (3.2)
Mean Lane
Position −6.4 (3.1) −5.9 (3.2) −7.0 (3.6) −5.7 (3.2) −5.8 (2.3) −6.2 (3.2)
Lane Deviation 2.6 (1.8) 2.9 (1.7) 2.9 (2.0) 2.8 (1.6) 2.3 (1.5) 3.0 (1.8)
Center Line




[0.48] 4.1 (3.4) 9.6 (14.2)



















Exceedances 8.7 (5.8) 9.8 (6.0) 7.0 (5.6) 9.2 (5.3) 10.4 (5.5) 10.5 (6.7)
+
















Performance 47.4 (22.8) 60.9 (24.7) *[0.39] 47.1 (23.1) 51.0 (20.6) 47.7 (22.9)
70.8 (24.8) *+
[0.66]
Key: p < 0.05 * Control versus Hangover, + Zero BAC versus Residual Alcohol. Effect size [Cohen’s d] Control
versus Hangover.
For the combined groups, the results revealed significant impairments for three of the divided
attention measures, indicating slower responses with more errors comprising missed responses and
incorrect responses (false positives) in the hangover condition. Driving measures indicated faster
driving (mean speed) with more center line crossing (going out of lane to the right), and time off road
(going out of lane to the left) and more lane excursions (to left and right) in the hangover condition
compared to after no alcohol. There were also a higher number of tickets (reflecting failure to stop
at stop signs, jumping red lights). The paired comparisons for the zero alcohol group paralleled the
combined groups except for divided attention task incorrect and missed responses, and tickets where
differences were not significant. Contrasts between no alcohol and alcohol hangover for the residual
alcohol group were similar to the zero alcohol group for the divided attention task, with both missed
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and incorrect responses failing to achieve significance, as did center line crossings in the driving
control category. In contrast, there were a significantly higher number of accidents and collisions,
reflecting the number of vehicles, pedestrians or animals hit, for the residual alcohol group but not for
the zero alcohol group. Significant contrasts comparing hangover driving in the zero alcohol group
with the residual alcohol group revealed faster driving, a greater number of speed exceedances and
more tickets for the residual alcohol group.
Nonparametric paired comparisons were run as distribution free confirmatory analyses for the
combined, zero and residual alcohol groups contrasting the no alcohol with the alcohol hangover
condition. All statistically significant results with parametric tests were reflected in significant results
with nonparametric analyses (Wilcoxon), except for missed responses for the zero alcohol group where
a trend (p < 0.07) was observed.
3.2. Subjective Measures
Multivariate analysis combining the six NASA-TLX dimensions revealed an overall significant
effect for alcohol (F(1,50) = 54.8, p < 0.0001, η2p = 0.52) and alcohol x residual alcohol (F(1,50) = 5.19,
p = 0.03, η2p = 0.09) with the combined measures. Based on the literature, the focus for subjective
assessment was on perceived effort and performance. These are presented in Table 1 along with the
overall mean (Raw TLX) for the 6 workload dimensions. The parametric analyses provided the same
significant contrasts as the nonparametric confirmatory analyses.
Analysis of the six component dimensions for the NASA-TLX with ANOVA revealed significant
differences between the no alcohol (control) and alcohol hangover conditions for mental demand
(F(1,50) = 18.8, p < 0.0001, η2p = 0.27 η2p), physical demand (F(1,50) = 17.5, p < 0.0001, η2p = 0.26),
temporal demand (F(1,50) = 37.8, p < 0.0001, η2p = 0.43), effort (F(1,50) = 33.3, p < 0.0001, η2p = 0.40),
performance (F(1,50) = 8.2, p = 0.006, η2p = 0.14), frustration (F(1,50) = 16.3, p < 0.0001, η2p = 0.25) and
the overall means for the 6 component dimensions (F(1,50) = 54.8, p < 0.0001, η2p = 0.52). All these
measures showed an increase in perceived workload in the hangover condition compared to no alcohol.
A significant alcohol x residual alcohol interaction was recorded for the overall means (F(1,50) = 5.19,
p = 0.027, η2p = 0.09), and performance (F(1,50) = 4.17, p = 0.046, η2p = 0.08). For performance there was
also a significant contrast between the zero alcohol and residual alcohol groups (F(1,50) = 5.69, p = 0.02,
η2p = 0.10) reflecting the greater increase in scores for the residual alcohol group with hangover (see
Table 1.). The comparison between the zero alcohol and the residual alcohol groups indicates that the
increase in performance score, reflecting poorer perceived performance, showed a significant increase
with hangover in the residual alcohol group that was not seen in the zero alcohol group.
3.3. Associations Between Measures
The association between subjective measures and driving performance, reflecting awareness of
subjective impairment, was a secondary research question. The selected subjective variables were
the overall hangover rating as well as the fatigue component of the AHSS, and the NASA-TLX
overall means together with the effort and performance components. The AHSS and NASA-TLX
were correlated with each other as well as the driving performance measures. Variables achieving
a minimum significance level of p < 0.01 with Pearson’s r, and supported by significant nonparametric
equivalents for at least one group are included in Table 2. Significant results included subjective ratings
of hangover symptoms (AHSS), including fatigue, as well as overall subjective workload (NASA-TLX),
and both effort and performance component ratings. Effect sizes were close to or in the large effect size
range (≥ 0.37) [35]. The AHSS and NASA-TLX were not associated at the required significance level
(p < 0.01).
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AHSS −0.359 ** 0.173 −0.573 **
Fatigue −0.460 ** −0.232 −0.561 **
Performance −0.247 −0.706 ** −0.104
Speed Deviation AHSS 0.051 −0.553 ** 0.317
NASA-TLX −0.254 −0.542 ** 0.003
Mean Lane
Position Residual BAC 0.154 - 0.555 **
Lane Deviation Performance −0.466 −0.542 ** −0.544
Driving Violations
Speed Exceedances Effort −0.357 ** −0.348 −0.367
Residual BAC Assessments
Residual BAC Performance 0.467 ** - 0.336
Key: ** p < 0.01 (minimum significance level), and nonparametric correlation also significant.
For residual BAC, positive correlation with subjective performance indicated higher residual
alcohol levels were associated with higher performance scores which reflect poorer perceptions of
performance with this component of the NASA-TLX. Higher residual BAC was also associated with
greater (less negative) mean lane position scores for the residual alcohol group, possibly reflecting
poorer driving by being closer to the center of the road (scored at ‘0′).
For the driving performance measures, higher scores generally indicate poorer driving.
Increased mean speed and speed deviation were associated with lower hangover (AHSS, Fatigue)
and workload ratings (Performance, NASA-TLX). Increased lane deviation was associated with
lower performance ratings, reflecting better perceived performance, and lower subjective effort was
associated with an increase in speed exceedances. However, significant associations with driving
measures differed between the combined, zero and residual alcohol groups.
4. Discussion
This is the first study to demonstrate significant driving impairment with hangover during
a typical commute to work. For the combined groups a total of 8 of the 15 driving variables including
those associated with the divided attention task, as well as driving control, and driving violations
which included attentional measures (e.g., tickets) showed significant impairment in the hangover
condition. The means for the combined groups showed slower responses, more errors including poorer
driving control and loss of attention for all the variables, even though they did not all individually
achieve statistical significance. The levels of impairment during alcohol hangover seen here suggest
that these are equivalent to the magnitude of driving impairment seen under conditions of alcohol
intoxication at or above the 0.05–0.08% BAC level [21]. The range of neurocognitive impairments
are supported by those reviewed by Kruisselbrink [19] as sensitive to alcohol hangover including
perceptual motor function, complex attention and executive functioning. These results support earlier
simulator studies, including the one hour highway driving test [9] and shorter motorway driving
assessment [11]. The observed significant impairments indicate the need to address this issue, and also
substantiate the use of our driving model for assessing hangover.
The likely explanation for the range of significant performance decrements observed on our
driving test of relatively short duration is the increased cognitive demand imposed by the driving
scenarios. Data from the NASA-TLX revealed that significantly increased effort was needed by the
participants in both the zero and residual alcohol groups to perform (well on) the driving test, but this
increased effort could not counteract driving performance impairments due to a hangover. This was
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also observed in the simulated highway driving study by Verster et al. [9]. Under more demanding
cognitive load such as the complex driving environment used here, cognitive demand can more easily
exceed capacity resulting in driving errors and decrements in performance. The impairments were
therefore also recorded across a shorter driving period, rather than reflecting vigilance decrements
seen in longer duration drives including the one hour driving test, in which the effects on driving were
most pronounced in the second half of the test [9].
An important further aim of the study was to compare hangover driving performance for
participants who had zero BAC with those who had residual levels of alcohol when driving next
day in a mixed urban and rural environment during a 20 min commute to work. Although there
was a residual BAC group, it is important to note that none of these participants was over the UK
alcohol limit for driving (BAC 0.08%), and the mean BAC in the residual alcohol group (BAC 0.047%)
was also below the 0.05% BAC limit common to several countries and recommended by the World
Health Organization [1]. This observation is important as with current UK legislation all participants
would be considered ‘street legal’, i.e., allowed to drive a car. When contrasting hungover driving
performance of those with zero BAC and those with residual alcohol, the profiles of impairment for
both these groups were similar to each other, suggesting that having residual BAC during hangover
did not have a marked additional impact on driving ability. However, the residual alcohol group
did drive significantly faster, resulting in significantly more speed exceedances, and they received
significantly more tickets for driving violations, possibly indicating poorer attention and awareness.
Increased speed, disinhibition and greater risk taking have been reported previously in studies of both
alcohol intoxication, as well as alcohol hangover [3,4,11].
The impact of alcohol hangover on self awareness is important for driving and may determine
whether or not a driver commutes to work next day, even though their residual alcohol BAC is within
legal limits. Alcohol research has shown limited awareness of impairment in relation to driving
particularly with higher BAC levels [25,26], and currently little is known in relation to alcohol hangover.
Results from the present study yielded strong effects with hangover indicating that poorer driving
(increased mean speed and speed deviation) was associated with reduced perceptions of hangover
and fatigue (AHSS) as well as overall workload (NASA-TLX), even though workload was increased
with hangover compared to no alcohol. In the hangover condition, reduced effort was associated
with more speed exceedances (driving violations). Lower subjective performance ratings from the
NASA-TLX, indicating perceptions of better performance, were similarly associated with poorer driving
performance (increased mean speed and lane deviation). However, the finding that increased residual
BAC was associated with higher ratings of poorer performance suggests some awareness, but includes
the impact of the remaining alcohol. Overall, there were relatively few significant correlations between
subjective measures and driving performance, this could reflect a limitation of the AHSS, which is
based on individual symptoms that may not capture the complete hangover experience [36].
Taken together, these results suggest a potential lack of awareness of subjective impairment due to
hangover. This was apparent in terms of lower hangover symptom scores including fatigue, and lower
perceived workload including effort and better performance, being linked to more impaired driving.
This is a concerning factor given that we do not currently have a direct objective measure of hangover
that is equivalent to the alcohol breathalyzer and the driving performance scores show consistent
impairment in the hangover condition. However, significant correlations with individual driving
performance measures were limited and varied between the hangover groups, and therefore requires
replication with larger samples, although the significant positive correlation with higher residual BAC
associated with perceptions of poorer performance adds validity. Previous alcohol hangover studies
have not shown a consistent relationship between estimated BAC for consumption the previous night,
or hangover severity and objective performance on the next day [37,38]. Similarly, for this study,
subjective hangover ratings (AHSS) were not significantly associated with overall subjective workload
or effort and performance components.
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The current study had a naturalistic design, so that participants were not monitored during the
drinking session. As a result, participants consumed the type and amount of alcohol of choice, which
varied between participants. Although this variability may be viewed as a limitation, it can also be
regarded as a strength, because the naturalistic study design much more closely mimics a real-life
drinking session, which includes non-standardized alcohol consumption and various behaviors (e.g.,
dancing, changing pubs) that cannot be replicated in randomized controlled trials [27]. In this context,
it should be noted that the actual amount of alcohol consumed was of little relevance to the current
study. More important, and irrespective of the alcohol consumed, was the premise that this would
result in a next-day hangover. These criteria was met by all participants with overall hangover ratings
broadly in line with earlier findings [37]. Recent research confirmed that hangovers can be experienced
at any BAC level [38].
Participants were allocated to either the BAC zero or residual alcohol group after the data was
collected. This was done for practical reasons, as the presence and severity of hangovers vary both
within and between drinkers. Even in case of standardized alcohol administration in controlled
trials, significant variability was observed in the presence and severity of hangover symptoms [38,39].
Given this, it was not possible to randomize participants and allocate them to a group before data
collection took place. A related issue is how BAC was established. It has been demonstrated that
breathalyzer assessments do not always correspond well with blood alcohol assessments [40]. Taking
this into account, the allocation of participants to the BAC zero or residual alcohol group based on
breath alcohol assessments only may not have been accurate. Future studies for which it is essential to
accurately determine the presence of residual alcohol, should confirm BAC readings of zero obtained
with a breathalyzer with assessments of ethanol in blood. The BAC zero group made up half of the
sample, limiting the validity of the residual BAC correlations as half the 52 participants therefore had a
zero score, but noting the correlations were strong with both parametric and nonparametric analyses.
Sleep disruption is a common component of alcohol hangover and naturalistic studies show
reduced sleep with alcohol hangover compared to control no alcohol nights, so that overall sleep loss
may be a significant component of hangover effects on waking performance next day [32]. In the
current study, sleep was not recorded. Future studies should incorporate these assessments.
In the current study, participants were relatively young and inexperienced drivers. Their inclusion
is warranted given that road traffic collisions are the leading cause of death for this age group [1],
contributed to by a lack of observation and anticipation skills [41], increased recklessness and thrill
seeking, and feelings of invincibility and over-confidence [42,43]. These combine to create ‘skill-risk
optimism’ [44] whereby young drivers believe they possess high level driving skills and are unlikely to
have an accident in risky-driving scenarios such as driving following a night of alcohol consumption.
The research evidence, supported by the results presented here, demonstrates the opposite and may
in part explain the lack of awareness of impairment amongst this population. However, what is
unclear is whether the observed results in this study translate to older and more experienced drivers.
Therefore, future research should also investigate the effects of alcohol hangover on driving across
other age groups.
Finally, no significant sex differences were observed in the current study. This is in line with
previous driving studies [9] and corresponds with the general absence in sex differences in the presence
and severity of hangover symptoms at various BAC levels [45,46].
Positive aspects of the study included the sensitivity of the driving model, which included finding
significant decrements in a range of driving variables including divided attention, driving control and
driving violations reflecting impaired attention or risk taking, where other studies have failed to find
such a wide range of effects.
5. Conclusions
Overall, this evaluation of driving hangover performance has been successful in demonstrating
the marked impact of alcohol hangover in impairing driving performance, even though participants
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overall were below the legal alcohol limit for driving in several countries. The key findings are that
significant impairments were seen in a range of driving measures, including complex attention and
driving control for those with residual alcohol as well as those with zero alcohol, with only limited
differences between the groups. The level of impairment seen here, which was comparable to driving
while intoxicated at or above a BAC of 0.05%, indicates the dangers of driving whilst hungover,
even when breath alcohol is at zero.
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Abstract: The aim of this study was to examine the effects of hangover on mood, multitasking
ability, and psychological stress reactivity to cognitive demand. Using a crossover design and
semi-naturalistic methodology, 25 participants attended the laboratory in the morning following
a night of (i) alcohol abstinence and (ii) alcohol self-administration during a typical night out (with
order counterbalanced across participants). They completed a four-module multitasking framework
(MTF, a widely used laboratory stressor) and a battery of questionnaires assessing mood, hangover
symptom severity, and previous night’s sleep. The effects of the MTF on mood and perceived
workload were also assessed. Participants in the hangover condition reported significantly lower
alertness and contentment coupled with a higher mental fatigue and anxiety. Multitasking ability
was also significantly impaired in the hangover condition. Completion of the cognitive stressor
increased reported levels of mental demand, effort, and frustration, and decreased perceived level
of performance. MTF completion did not differentially affect mood. Lastly, participants rated
their sleep as significantly worse during the night prior to the hangover compared with the control
condition. These findings confirm the negative cognitive and mood effects of hangover on mood. They
also demonstrate that hangover is associated with greater perceived effort during task performance.
Keywords: hangover; alcohol; internet; attention; executive function; working memory
1. Introduction
The effects of binge drinking on cognitive functioning beyond intoxication, to the subsequent
alcohol hangover, has received increasing attention over the past few years. The alcohol hangover is
generally obtained following alcohol intake equivalent to a blood alcohol concentration (BAC) of at
least 0.10%–0.12% [1], although it can occur following lower BACs [2], and commences once BAC
approaches 0.00% [3]. It is characterized by a cluster of physical symptoms, negative mood, and
impaired cognitive functioning. Commonly reported symptoms include headache [1,4], nausea [1,5],
anxiety [5–7], fatigue [1,6,8], reduced alertness [1,6,9,10], and concentration difficulties [1,11,12].
Hangover-induced cognitive impairment has been described across several domains including
spatial and visual abilities [13], attention [14–17], memory, information processing [18], and reaction
time [18–20]. Conversely, some studies have failed to find convincing evidence for hangover-induced
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cognitive impairment [10,11,16]. A recent meta-analysis of 11 articles reported hangover-induced
impairment to short and long-term memory, psychomotor performance, and sustained attention, but
not divided attention [21]. As suggested by the authors, accumulating mental fatigue caused by
prolonged attentional demand is more evident in sustained as opposed to divided attention tasks that
may drive the differential attention effects [22].
Importantly, each of the studies [15,17,23,24] included in the meta-analysis [21] assessing the effects
of hangover on divided attention used tasks with relatively few stimuli and limited task-switching.
Furthermore, three of the four studies were published decades ago and appear under-powered [15,23,24].
More recent studies have utilized assessments of compound behaviors requiring more complex divided
attention across several stimuli, such as simulated driving [25,26] and flying [27,28] ability. These have
consistently demonstrated hangover-induced performance impairment. Indeed, driving and flying are
complex skills which require several cognitive processes and as such, are not strict measures of divided
attention per se. Nevertheless, complex tasks are a realistic representation of real-world activities
where attention is often divided across several stimuli streams, causing cognitive demand [29] and
a stress reactivity response [30], characterized by increased negative mood, cortisol, and self-reported
stress [30,31].
Stress reactivity is increased in certain populations such as recreational drug users [32]. Given that
the alcohol hangover is characterized by worsened cognition and mood, individuals with a hangover
may display an exaggerated response to stress. The effects of hangover on stress reactivity have not
been previously assessed but warrant investigation. Particularly in the context of potential negative
implications of performing everyday multitasking and potentially stress-inducing activities, such as
driving, studying, or working, with a hangover.
Real-life stressors typically involve simultaneous exposure to multiple stressors. The Purple
multitasking framework (MTF) requires simultaneous attention and response to several stimuli and,
therefore, may have better ecological validity than previously used divided attention tasks [33]. The
MTF has previously been shown to elicit a response typical of workload stress (where mental resources
cannot meet ongoing demands). That is reduced self-rated calmness, elevated stress, and state anxiety
coupled with increased perceived demand, effort, and frustration [32–34].
The aim of this investigation was to examine the effects of hangover on mood, stress reactivity,
multitasking performance, and perceived effort of performing the tasks. Specifically, we hypothesized
that compared with no hangover, hangover would be associated with more negative mood, higher
stress reactivity, poorer performance, and greater perceived effort during multitasking.
2. Experimental Section
2.1. Method
The present study was approved by the Swinburne University Human Research Ethics Committee
(SUHREC, approval number 2016/061) and was conducted in accordance with the Declaration
of Helsinki.
2.2. Design
This study utilized a semi-naturalistic, crossover design whereby, in the hangover condition,
participants consumed alcohol during a ‘typical’ night out and attended the laboratory the following
morning. The testing visit of the no-hangover condition was held following a night of alcohol abstinence.
2.3. Participants
Thirty-six participants enrolled in the study. However, seven participants failed to complete the
two testing visits and one participant reported alcohol intake the evening prior to the hangover-free
visit and thus, was excluded. The final sample consisted of 25 participants (76% female) with a mean
age of 25.32 years (range = 18–35 years).
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All participants were healthy, not taking any medications that could potentially interact with
alcohol and experienced an alcohol hangover frequently. Exclusion criteria were current or past alcohol
abuse and current or past psychiatric disorders.
2.4. Measures
2.4.1. Blood Alcohol Concentration (BAC)
To ensure a BAC of 0.00% prior to the commencement of each testing visit, BAC readings were
recorded using a regularly calibrated Lion Alcolmeter SD400PA.
2.4.2. Consensus Sleep Diary (CSD)
All sleep parameters were collected using the 9-item CSD [35].
2.4.3. Alcohol Consumption Questions
Participants were questioned on their alcohol intake on the evening prior to the testing visits.
Specifically, participants were asked the number of standard drinks of various drink types (i.e., beer,
cider, wine, spirits, and alcohol mixed with energy drink) that were consumed and the number of hours
that they had spent drinking.
2.4.4. Estimated BAC (eBAC)
Responses to the alcohol consumption questions were used to calculate eBAC. eBAC obtained on
the night of drinking was calculated by averaging the total body water (TBW) estimates of Forrest [36],
Watson [37], Seidl [38], Widmark [39], and Ulrich [40] (males only) calculations. The mean TBW was
then used in the following eBAC formula:
BAC = (G/(TBW) − β × t (1)
where G is the amount of alcohol consumed in grams; β is the metabolic rate in gram per hour; and t is
time in hours.
2.4.5. Multitasking Framework
The Purple multitasking framework (Purple MTF: Purple Research Solutions, UK) has been
shown to induce cognitive demand, stress, negative mood, and anxiety [32,33,41–43]. The task requires
attention to be given to four tasks that are presented simultaneously, each on one of four quadrants on
a computer screen (see Figure 1).
 
Figure 1. Layout of the Purple multitasking framework (MTF). The task requires participants to
simultaneously perform four cognitive tasks. These were (clockwise from top left) Mental Arithmetic,
Stroop, Letter Search, and Visual Tracking.
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In the centre of the screen, a counter displaying the overall performance score, based on accuracy
and reaction time, is presented. The tasks used in the current study were Mental Arithmetic, Stroop,
Letter Search, and Visual Tracking. Each task was set to the ‘difficult’ level and the battery was
completed over 20 min (for a detailed description of the tasks and scoring, please see [44]). As well as
an overall score, each task was scored separately.
2.4.6. NASA-Task Load Index (NASA-TLX)
Participants were asked to provide their subjective assessment of the workload presented by the
Purple MTF using the NASA-TLX [45]. Workload was assessed on six dimensions: Mental Demand,
Physical Demand, Temporal Demand, Own Performance, Effort, and Frustration.
2.4.7. Single Item Hangover Symptom Severity Score
Overall hangover severity was measured using a single visual analogue scale (VAS) asking
participants to rate ‘how severe is your hangover’ on a scale from 0, being ‘no hangover symptoms,
to 10, being ‘very severe hangover symptoms’.
2.4.8. Alcohol Hangover Severity Scale (AHSS)
The AHSS [46] measures hangover severity according to 12-items measured on a 10-point Likert
scale. The AHSS is found to be reliable (Cronbach’s α = 0.85) and valid (r = 0.92 correlation with the
Acute Hangover Scale (AHS; [4])) [46].
2.4.9. Stress and Fatigue Visual Analogue Mood Scale (Stress and Fatigue VAMS)
Self-reported levels of stress and fatigue were each measured using a single-item visual analogue
scale labeled stress and fatigue with the endpoints labeled ‘not at all’ and ‘extremely’.
2.4.10. Spielberger State-Trait Anxiety Inventory, State Portion (STAI-S)
The STAI consists of two parts evaluating trait and state anxiety, respectively. This study used the
state (STAI-S; [47]) portion only. Participants responded to 20 statements (e.g., “I feel calm”, “I am
relaxed”) on a 4-point scale ranging from ‘not at all’ to ‘very much so’. Scores are combined to give a
measure of current anxiety.
2.4.11. Bond-Lader Visual Analogue Mood Scales (Bond-Lader VAMS)
The Bond-Lader VAMS [48] have been utilized in numerous pharmacological,
psychopharmacological, and medical trials. These scales comprise a total of 16 lines measuring 100
mm long and anchored at either end by antonyms (e.g., alert-drowsy, calm-excited). Participants
indicate their current subjective position between the antonyms on the line. Individual item scores
were calculated as the distance along the line. Outcomes are three factor analysis-derived scores:
Alertness, calmness, and contentment.
2.5. Procedure
Participants were required to attend a screening visit and two testing visits; one while experiencing
a hangover and one following at least 24-h of alcohol abstinence. During the screening visit, participants
provided a written informed consent before being assessed for eligibility. Participants then underwent
training and practice in completing the Bond-Lader VAMS and Stress and Fatigue VAMS, a cognitive
dual attention task (to be reported elsewhere), the Purple MTF, and the NASA-TLX.
Participants were instructed not to consume any caffeine the morning of their testing visits or any
alcohol within 24-h prior to the no-hangover visits. Participants were also asked for the food consumed
prior to the testing visits to be held consistent. Lastly, participants booked in their first testing visit,
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which could be either the hangover or no-hangover condition, depending on the participants planned
drinking activities.
At the commencement of each testing visit, participants were breathalyzed to ensure a BAC of
0.00%. Participants then completed the pre-stressor Bond-Lader VAMS, the individual Stress and
Fatigue VAMS, and the STAI-S. They then underwent the Purple MTF, followed by the post-stressor
Bond-Lader VAMS, Stress and Fatigue VAMS, and STAI-S. Finally, they completed the NASA-TLX,
alcohol consumption questions, the single-item measure of overall hangover severity, the AHSS, and
lastly, the CSD.
2.6. Statistical Analysis
All analyses were performed using SPSS version 25 (IBM Corp, Armonk, NY, USA). The effects of
the Purple MTF on the three mood dimensions from the Bond-Lader VAMS (‘alert’, ‘calm’, ‘content),
anxiety measured using the STAI-S, and the individual VAMS items (‘stress’, ‘mental fatigue’) were
assessed using two-way (Hangover; present, absent × Time; pre, post) repeated measures ANOVA. All
other variables were analyzed using paired sample t-tests comparing hangover with control conditions.
Effect sizes (Cohen’s d) were calculated for all significant t-test findings using ‘Equation 8’ [49] to
account for dependence in the data. All testing was two-tailed, and comparisons were planned prior
to testing.
3. Results
3.1. Consensus Sleep Diary (CSD)
In the hangover condition, participants rated their sleep quality as significantly worse (t(24) =
2.70, p = 0.012, d = 0.54) and reported significantly more awakenings (t(24) = 2.47, p = 0.021, d = 1.80)
than in the control condition. However, the length of awakenings and time taken to fall asleep did not
differ between the conditions.
3.2. eBAC
The mean eBAC level on the night prior to the hangover visit was 0.135% (±0.001%).
3.3. Hangover Symptom Severity
As shown in Table 1, at the hangover visit, participants were significantly negatively affected on
each hangover symptom included in the AHSS apart from ‘sweating’.
3.4. Multitasking Performance
The total MTF score was significantly lower in the hangover compared with the no-hangover
condition (t(24) = 2.26, p = 0.033, d = 0.46). Performance on the four individual tasks did not differ
with condition.
3.5. Mood
As displayed in Figure 2, completion of the Purple MTF did not differentially affect mood ratings
in either hangover condition. However, there were significant main effects of hangover on alertness
(F(1,24) = 54.63, p < 0.001), contentedness (F(1,24) = 16.34, p < 0.001), anxiety (F(1,24) = 10.97, p = 0.003),
and mental fatigue (F(1,24) = 40.70, p < 0.001). There were also significant main effects of time (pre-post)
on calmness (F(1,24) = 8.42, p = 0.008, stress (F(1,24) = 5.86, p = 0.023), and mental fatigue (F(1,24) = 5.90,
p = 0.023). Prior to completing the Purple MTF, participants reported significantly worse levels of
alertness (t(24) = 7.33, p <.001, d = 1.47), contentedness (t(24) = 3.34, p = 0.002, d = 0.68), mental fatigue
(t(24) = 4.90, p < 0.001, d = 0.99), and anxiety (t(24) = 2.58, p = 0.016, d = 0.21) in the hangover, compared
to the no-hangover condition.
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Table 1. Effects of alcohol hangover on the single item severity score and items from the Alcohol
Hangover Severity Scale (AHSS). Means and standard deviations are presented with t-statistic,
associated p-value, and Cohen’s d effect size.
Item
Condition
t-Value p-Value Cohen’s d
Control Hangover
Single-Item Severity Scale
‘How severe is your hangover?’ 0.05(0.16) 4.67(2.36) 10.07 <0.001 3.07
Alcohol Hangover Severity
Scale
Fatigue 2.40(2.36) 7.36(2.18) 9.08 <0.001 1.82
Apathy 0.56(0.96) 3.64(2.80) 5.69 <0.001 1.35
Concentration problems 1.00(1.41) 5.88(2.22) 10.54 <0.001 2.20
Clumsiness 0.68(0.90) 4.72(3.14) 6.46 <0.001 1.54
Confusion 0.48(1.12) 3.48(3.20) 5.30 <0.001 1.38
Thirst 1.44(2.20) 6.24(2.51) 8.86 <0.001 1.78
Sweating 0.40(1.04) 1.20(1.94) 2.02 0.055 -
Shivering 0.16(0.62) 1.84(3.00) 2.80 0.010 0.69
Stomach pain 0.08(0.28) 2.36(2.84) 4.04 <0.001 1.10
Nausea 0.40(1.00) 3.12(2.76) 4.95 <0.001 1.14
Dizziness 0.36(0.91) 4.28(2.64) 7.50 <0.001 1.75
Heart pounding 0.40(1.23) 2.24(2.52) 3.71 0.001 0.82
Total score 0.70(0.74) 3.86(1.83) 8.90 <0.001 2.03
Figure 2. Effects of hangover and completing the Purple MTF on dimensions of mood measured pre-
and post-Purple MTF. (a) Alert, (b) calm, and (c) content are derived from the Bond-Lader scales;
(d) anxiety is derived from the Spielberger State-Trait Anxiety Inventory (STAI state portion); (e) stress
and (f) mental fatigue are single visual analogue scales. Graphs depict means with standard errors
of the mean (SEM). Vertical and horizontal arrows indicate a significant main effect of hangover and
time, respectively (*, p < 0.05; **, p < 0.01; ***, p < 0.005; ***, p < 0.001). † Scales range from 0–100 except
(d) anxiety which ranges from 20–80.
3.6. NASA-TLX
Participants rated the workload demand of completing the Purple MTF as more mentally
demanding (t(24) = 2.19, p = 0.039, d = 0.46) and effortful (t(24) = 2.29, p = 0.031, d = 0.47) during the
hangover condition. Additionally, participants rated their performance as worse (t(24) = 2.75, p = 0.011,
d = 0.55) and the task as more frustrating (t(24) = 2.26, p = 0.033, d = 0.46) in the hangover condition,
see Figure 3.
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Figure 3. Mean (standard error) perceived levels of workload demand in the hangover (AH) and
control (CON) conditions. * p < 0.05 between conditions.
4. Discussion
The current study assessed the effects of alcohol hangover on mood, multitasking performance
and stress reactivity, and perceived demand. Several of our hypotheses were supported. Compared
with no hangover, hangover was associated with significantly more negative mood (lower alertness
and contentment, higher anxiety, and mental fatigue). Additionally, hangover was associated with
poorer multitasking performance and greater perceived effort during multitasking. Counter to our
hypothesis, stress reactivity was not differentially affected by hangover.
Hangover was reliably induced by using a semi-naturalistic study design and allowing participants
to self-administer alcohol, according to the estimated BAC calculations, participants obtained a mean
eBAC of 0.135%, a level beyond that deemed required to cause a hangover [1,50]. Self-reports also
provided support for the link between hangover and poor sleep quality [16,51,52]. However, our
findings were inconsistent with previous sleep studies that show a faster sleep onset after alcohol [53–55].
The negative mood associated with hangover was manifested as significantly lower alertness and
contentment, and higher anxiety and mental fatigue. These findings are consistent with symptoms
commonly reported in the hangover literature [1,5–10]. They are also supported by significant effects,
here and elsewhere, on individual items on the AHSS which gauge elements of mood—namely fatigue,
apathy, concentration problems, and confusion.
Participant self-reports also confirmed the presence of a hangover and hangover symptoms,
demonstrating that the manipulation was successful. Every item of the AHSS differed significantly
between visits with the exception of ‘sweating’ (p-value for ‘sweating’ = 0.055 two-tailed). Inspection
of the effect sizes shows that the largest effect by far is for the single hangover item (Cohen’s d = 3.07).
This adds further support to the recent argument that the single item measure can capture hangover
better than more granular items [56].
The second most prominent effect (d = 2.20) was for ‘concentration problems’. This supports the
documented cognitive impairment seen with hangover. In the current study, this was manifested as
significantly poorer overall performance on the MTF but not on any individual task thereof. These
results, along with previous evidence for hangover-induced impairment to more complex [25–28] but
not simple divided attention [15,17,23,24] suggest that hangover differentially impairs tasks which
draw on multiple domains. This result may help explain certain inconsistencies in the literature
on hangover and cognitive performance (as outlined in the introduction). Unlike previous studies that
have utilized assessments of divided attention across relatively few stimuli with limited task-switching,
the current study used a cognitive stressor with multitasking across four tasks. Unlike many other
laboratory stressors, this model has better correspondence with the more usual day-to-day stress that
typically requires attention and response to several tasks concurrently [57]. Additionally, it may be that
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behavioral outcomes which are aggregates of several cognitive domains may be most sensitive to the
negative effects of hangover. This has clear implications for behaviors such as driving which draw on
several cognitive domains simultaneously. Further research is needed utilizing cognitive measures
which mirror the processes involved in driving.
There are additional layers of cognitive control and function that are required for complex
multitasking. For example, multitasking places a considerable load on working memory and executive
processes, in addition to the resources needed for task performance, thus, likely taxing cognitive
capacities [58,59]. These data suggest that hangover depletes cognitive resources making the effects
of cognitive demand more profound than in a no hangover state.
Contrary to our hypothesis, completion of the cognitive stressor failed to elicit further changes
in mood. The fact that two of the mood measures (calmness and stress) were significantly worse
due to completing the MTF (independent of hangover condition) strongly suggests that the measure
is sensitive to change in this cohort. Inspection of the pattern of results suggests that, for the other
measures, the mood state of participants prior to completion of the MTF was already low and unlikely
to change further.
Supporting our hypothesis, NASA-TLX scores revealed that being exposed to the cognitive
stressor resulted in greater subjective demand in the hangover group. Compared with the control
condition, hangover significantly increased ratings of perceived effort, mental demand, and frustration.
Additionally, participants were aware of their poorer performance in the hangover condition. This
is unlike alcohol intoxication, where individuals become ‘uncalibrated’ and, thus, overestimate their
performance [60]. Despite awareness of poorer performance, it appears that in the hangover state
individuals are unable to draw on additional cognitive resources to compensate and meet ongoing task
demands. This has clear implications for behaviors requiring complex multitasking—including driving.
The physiological mechanisms of hangover are not well understood, but likely involve multiple
processes [61], including actual and perceived immune status [62,63].
Limitations of this study included relying on self-reported alcohol intake and eBAC calculations
to estimate BAC obtained to induce the hangover, and the lack of objective stress (i.e., cortisol)
and sleep (i.e., actigraphy) measurement. Since excessive drinking commonly results in memory
impairment [64–66], participants’ accuracy of recalling their drinking behaviors may be questioned,
a limitation inherent in hangover semi-naturalistic and naturalistic study designs (see [2]). Given the
lack of empirical investigation into the effects of hangover on “real-life” multitasking ability and stress
reactivity, this study fills an important research gap.
5. Conclusions
The findings presented here show that hangover negatively affects performance on an ecologically
valid, complex multitasking tasks and mood. This is the first report of the effects of hangover
on psychological stress reactivity and results indicated that, despite a greater perceived workload in the
hangover condition, mood, and/or stress were not differentially affected following the completion
of the cognitively demanding task. Future research should include a variety of complex ‘real-life’
measures of cognition and be directed towards determining the physiological changes that occur with
a hangover.
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Abstract: Recent research has suggested that processes reliant on executive functions are impaired
by an alcohol hangover, yet few studies have investigated the effect of hangovers on core executive
function processes. Therefore, the current study investigated the effect of hangovers on the three core
components of the unity/diversity model of executive functions: the ability to switch attention, update
information in working memory, and maintain goals. Thirty-five 18-to-30-year-old non-smoking
individuals who reported experiencing a hangover at least once in the previous month participated
in this study. They completed tasks measuring switching (number-switching task), updating (n-back
task), and goal maintenance (AX Continuous Performance Test, AX-CPT) whilst experiencing a
hangover and without a hangover in a ‘naturalistic’ within-subjects crossover design. Participants
made more errors in the switching task (p = 0.019), more errors in both the 1- (p < 0.001) and 2-back
(p < 0.001) versions of the n-back, and more errors in the AX-CPT (p = 0.007) tasks when experiencing
a hangover, compared to the no-hangover condition. These results suggest that an alcohol hangover
impairs core executive function processes that are important for everyday behaviours, such as
decision-making, planning, and mental flexibility.
Keywords: alcohol; hangover; executive functions; working memory; cognition
1. Introduction
An alcohol hangover is a combination of mental and physical symptoms, experienced the day
after a single episode of heavy drinking, when blood alcohol concentration (BAC) approaches zero [1].
It is the most common negative consequence of heavy drinking and can impair cognitive processes,
such as sustained attention, memory, and psychomotor skills [2,3]. However, relatively few studies
have investigated the effect of alcohol hangovers on core components of executive functions.
Executive functions are higher-order cognitive processes used in everyday behaviours, such as
decision-making, mental flexibility, and planning. Recent studies have indicated that executive functions
may be negatively influenced by alcohol hangovers. Studies have suggested that performance on tasks
of interference control [4,5] and response inhibition [6] is impaired when subjects are experiencing
a hangover, suggesting poorer inhibitory control, which may negatively influence decisions around
subsequent alcohol use [7] and emotion regulation [8]. Furthermore, findings showing poorer spatial
working memory [4], reward learning [9], prospective memory [10,11], semantic verbal fluency [10],
and performance on backward visual span tasks [12] indicate that executive functions are impaired
whilst experiencing a hangover. A recent report by the Institute of Alcohol Studies suggested that the
cost of hangover-related reductions in work productivity could be as high as £1.4 billion per annum in
the UK [13]. As effective workplace performance relies on an individual’s ability to make decisions,
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organise tasks, and plan, detrimental effects of hangovers on executive functions may contribute
toward these costs. Therefore, it is important to understand how these processes may be influenced
the morning after a night of heavy alcohol consumption, i.e., during a hangover.
Executive functions are utilised when behaviours need to be controlled (rather than when they
are ‘automatic’), when cognitive processes are combined, or when individuals need to switch attention
between tasks [14]. The unity/diversity model conceptualises executive functions as being composed
of two core components, alongside a single common factor that is utilised in all executive function
tasks [15]. The two components represent the ability to switch attention from one task/mental set
to another (switching) and the ability to update information within working memory (updating).
The common factor of the unity/diversity model represents the ability to maintain and manage goals,
in order to effectively complete tasks (goal maintenance). All executive function tasks utilise aspects
of these core components. As hangover-related impairments have been observed in higher-order
cognitive processes, such as prospective memory [10], it is possible that hangovers influence these core
components of executive function.
Attentional switching requires allocation of attentional resources to effectively switch from one
task or mental set to another [16]. Recent studies have indicated that a hangover may be a state in
which individuals experience high cognitive load [17] and thus have fewer available resources to
switch attention [18,19]. When available cognitive resources are low, completion of executive function
tasks becomes ineffective or inefficient [20–22]. Factors associated with heavy alcohol consumption,
such as a reduction in glutamatergic and an increase in GABAergic, dopaminergic, and serotonergic
neurotransmission, may also influence attentional switching [23,24]. During hangover, dopaminergic
neurotransmission may be reduced, and noradrenaline may be elevated [9,25], suggesting that switching
could become impaired. Furthermore, studies have highlighted that fatigue (which is one of the most
commonly reported symptoms of a hangover [26]) can lead to impairments in switching [27].
Thus far, studies investigating attentional switching in individuals experiencing a hangover have
yielded mixed results. One study induced hangovers experimentally [19] and reported no effect on
switch costs, reflecting the additional time needed to switch attention to the new rule set. However,
experimental hangover manipulations involve administering lower doses of alcohol than are typically
consumed when drinking in everyday life [28], and this practice could influence the effects of a
hangover [29]. Two naturalistic studies, which involve assessing the impact of hangovers experienced
following real-life drinking, investigated the effects of a hangover on perseveration errors, which are
erroneous responses made according to the previously correct rule or set, reflecting a switching failure.
One reported that a hangover did not influence switching performance in a non-student sample [4],
whereas another study using a student sample indicated poorer switching accuracy when experiencing
a hangover, as compared to a control condition [30]. It is possible that hungover individuals attempt to
maintain performance on switching tasks by either sacrificing accuracy to maintain the speed of their
responses or by sacrificing speed to maintain accuracy (i.e., a ‘speed–accuracy trade-off’).
To our knowledge, no studies have investigated the effects of an alcohol hangover on updating
or goal maintenance; however, there are indications that both processes could be negatively affected
by a hangover. Goal maintenance is an important process utilised to complete all executive function
tasks [15]. For example, an individual completing a task at work (e.g., writing a report) would need
to keep his or her overall goal in mind whilst planning, organising, and making decisions about the
individual task subcomponents. If goal maintenance is impaired, individuals may be less effective or
efficient at completing complex tasks with multiple subcomponents. As previously mentioned, studies
have indicated impairments in working memory performance, prospective memory, and semantic
verbal fluency—all tasks requiring executive functions—during a hangover [4,10–12]. Therefore,
it is possible that a common factor underlying hangover-related impairments in each of these tasks
is a deficit in the ability to maintain goals. Inhibitory control is also impaired when experiencing
a hangover [4–6] and is a key part of goal maintenance [15], further suggesting goal maintenance
could be influenced by a hangover. In addition, reduced cognitive resources during a hangover may
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influence goal maintenance by biasing individuals toward reacting to external events (i.e., bottom-up
stimulus-driven processing) rather than proactive control of one’s actions (i.e., actively sustaining
goal representations through top-down processing) [18,31]. The AX Continuous Performance Task
(AX-CPT) can be used to assess goal maintenance and can differentiate between proactive and reactive
control [32].
The process of updating information in working memory can become impaired by high cognitive
load and when there is a reduction in available cognitive resources [33]. As previously mentioned,
cognitive resources may be reduced during a hangover [18,19], negatively affecting the ability to
update information in working memory. Furthermore, a study of the cognitive effects of pain
indicate that a headache can impair performances on tasks measuring updating [34]. By using an
n-back task with conditions that vary in difficulty, studies have also demonstrated that cognitive
load selectively influenced the disrupting effect of pain on updating [35]. In addition, studies have
indicated that updating can be impaired following sleep deprivation [36]. As a headache is a ‘core’
hangover symptom [1], and individuals experience sleep disruptions after heavy alcohol consumption
(e.g., decreased efficiency and REM sleep, increased night-time awakenings [37], and decreased sleep
duration [38]), updating ability may also be compromised by a hangover. To assess this possibility, we
used an n-back working memory task with two conditions that vary in difficulty (1-back and 2-back).
In summary, the current study aimed to investigate the effects of an alcohol hangover on all three
core components of the unity/diversity model of executive functions: switching, updating, and goal
maintenance. Specifically, we hypothesised that participants experiencing a hangover would show
impairments in: (1) switching, (2) updating, and (3) goal maintenance, as compared to the no-hangover
control condition. We also hypothesised that participants would adopt a more reactive control style on
the AX-CPT task in the hangover condition, as compared to the no-hangover condition, and that the
magnitude of impairments in goal maintenance, updating, and switching abilities would be positively
associated with hangover severity. As performance on executive function tasks may be related to an
individual’s confidence in his or her ability to complete tasks (self-efficacy: the belief we have in our
ability to execute the actions required for specifically designated performances, usually assessed as our
degree of confidence that we can perform specific tasks [39]), and self-efficacy to complete tasks is
lower when individuals are experiencing a hangover [12,40], we also explored the relationship between
self-efficacy and task performance. We hypothesised that performance in goal maintenance, updating,
and switching tasks would be positively associated with self-efficacy to complete these tasks.
2. Materials and Methods
2.1. Participants
Thirty-eight participants were recruited from a student population by poster/flyer and digital
advertisements, the University of Bath’s research participation scheme, word of mouth, and direct
approach by the researcher. Inclusion criteria required participants to consume at least 6 (female) or
8 (male) units of alcohol in a typical heavy drinking session, to be aged between 18 and 30 years old,
to be non-smokers, and to be in general good mental and physical health. To exclude the potential
confound of hangover-resistance, only participants who reported experiencing a hangover in the
past month were recruited. Participants who were pregnant/breast-feeding, taking medication or
recreational drugs, consuming > 400 mg of caffeine per day, had a current or past personal or family
history of drug dependency, or had a diagnosed sleep disorder were excluded. Three participants
withdrew before completing both conditions; thus, 35 participants (14 males; 21 females) completed
the study. The University of Bath Psychology research ethics committee approved this research, ethics
code: 18-328.
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2.2. Design
An experimental ‘naturalistic’ design, with one within-subjects factor of condition (hangover and
no-hangover) was used. The naturalistic design is a valid method when one is interested in examining
the real-life cognitive effects of alcohol hangover, and it has been successfully implemented in many
hangover studies [41]. The hangover condition took place on a morning following an evening of heavy
alcohol consumption, and the no-hangover condition on a morning following no alcohol consumption
for at least 24 h prior to testing. Order of testing was counterbalanced across subjects, whereby 53% of
participants completed the hangover condition first.
2.3. Measures
Participants completed three cognitive tasks assessing different components of executive function:
switching, updating, and goal maintenance.
2.3.1. Number-Switching Task
A cued-switching task was used to measure switching [42]. In this task, participants were
presented with a string of numbers (1, 2, 3, 4, 6, 7, 8, and 9) appearing within a shape (square or
diamond). A cue (square/diamond without number) appeared for 650 ms before the number stimulus.
Participants were instructed to respond depending on the ‘rule’, which was indicated by the colour
of the shape. Participants responded with ‘z’ if the number was odd or ‘x’ if the number was even,
when presented within a blue shape, and responded with ‘n’ if the number was lower than 5 or ‘m’
if the number was higher than 5, when presented within an orange shape. The rule was switched
every 4 trials, in a sequential manner. The primary outcome measures were switch costs, which
were calculated by subtracting RT for the second trial following a rule change (P2) from the first trial
following a rule change (P1) and perseveration errors, i.e., erroneous responses made according to the
prior rule set. Schematic representations of each task are presented in Figure 1.
2.3.2. The N-Back Task
The letter version of the n-back task was used to measure updating [43]. In this task, participants
viewed a string of letters (random presentation) and were asked to indicate whether the letter was the
same as the letter presented in a previous trial (i.e., n-back). Letters were presented for 500 ms, with
an inter-trial interval (blank screen) for 1500 ms. Participants were asked to respond with ‘m’ when
the letter was the same as n-back (target trials), and ‘z’ when it was not the same (non-target trials).
The task consisted of two 1-back (letter same as the previous trial) and two 2-back (letter same as the
one presented before the last trial) blocks presented in alternating blocks (i.e., 1-back, 2-back, 1-back,
and 2-back). There were 45 trials in each block, with target stimuli (those that are valid n-back trials)
presented 33% of the time. The primary outcome measure for this task was errors to target stimuli.
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Figure 1. Schematic representations of each cognitive task. (a) In the switching task, participants are
presented with a cue (empty blue/orange shape), followed by a number stimulus. Participants respond
according to the rule (determine odd/even or higher/lower than 5), indicated by the colour of the shape
(blue or orange). (b) In the AX Continuous Performance Task (AX-CPT) task, participants are presented
with a cue-probe pair separated by a long delay (+). When **** appeared on the screen, participants
respond by pressing the ‘m’ key when the cue is ‘A’ and probe is ‘X’; otherwise, participants respond
with the ‘z’ key. The first trial is an example of a target trial (AX) and the second trial is an example
of a BX non-target trial type (the cue “T” is incorrect in this case). (c) In the n-back task, participants
respond with the ‘m’ key when the target is the same as the stimulus presented either 1 or 2 trials
earlier (e.g., if the target is the same as the previous letter in the 1-back version); otherwise, participants
respond with the ‘z’ key.
2.3.3. The AX Continuous Performance Task
The AX Continuous Performance Task (AX-CPT) can be used to assess goal maintenance and
can differentiate between proactive and reactive aspects of cognitive control [32,44,45]. Participants
respond to a probe on the basis of a preceding cue. A letter cue was presented on screen for 500 ms,
followed by a long delay of 4000 ms (displayed as ‘+’) [32]. Participants were then presented with a
letter probe for 500 ms, followed by an inter-trial interval of 1000 ms (displayed as ‘****’). Participants
responded to probes by pressing ‘m’ on the keyboard for cue-probe targets or ‘z’ for non-targets. Target
responses are when an ‘A’ cue is followed by an ‘X’ probe (AX-type trial), and non-target trials are
responses to all other letter sequences. ‘AY-type’ trials are when an ‘A’ cue is followed by any probe
other than ‘X’; ‘BX-type’ trials are those when any cue other than ‘A’ are followed by an ‘X’ probe;
and ‘BY-type’ trials occur when any cue other than ‘A’ is followed by any probe other than ‘X’. Target
trials (AX) were presented with 70% frequency, and non-targets with 30% frequency; non-target trial
frequency was equally distributed so that non-cue–probe (e.g., BX-type), cue–non-probe (e.g., AY-type),
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and non-cue–non-probe (e.g., BY-type) trials each occurred 10% of the time. A total of 120 trials were
presented in a single block, and the primary outcome measure was the number of errors for each trial
type. Participants utilising reactive control selectively retrieve contextual information when stimuli
are presented, and they are less likely to actively maintain contextual information. In the AX-CPT task,
reactive control can be observed with increased errors in ‘BX-type’ trials as participants react to a valid
stimulus (the ‘X’), but without actively maintaining the preceding invalid cue (not an ‘A’). Thus, if
individuals with a hangover are biased toward reactive control processes, we would expect to observe
an increase in erroneous responses to ‘BX-type’ trials relative to the no-hangover control condition.
2.3.4. Subjective Measures
Self-reported alcohol consumption on the previous night was used to calculate estimated peak
BAC (eBAC), using the Widmark formula [46]. Hangover severity was measured by using a 1-item
hangover severity scale and modified Alcohol Hangover Severity Scale (mAHSS; [47]). Participants
were also asked to rate how confident they felt about completing the tasks effectively (self-efficacy) on
an 11-point scale (0 = cannot do at all; 10 = certainly can do; [39]), following practice trials on each
cognitive task. Following each task, participants were asked to complete the Rating Scale of Mental
Effort (RSME) which assessed the degree of effort involved in performing the respective task [48].
2.4. Procedure
Participants were given information about the study and were booked in for two sessions
(hangover and no-hangover), according to when they next expected to experience a hangover or have
a no-hangover day. Time of day of testing was as similar as possible for both sessions. Participants
were screened to ensure they met inclusion criteria and gave written informed consent before the
study started. Participants self-reported their previous night’s alcohol consumption by using pictorial
prompts labelled with alcohol unit content and caffeine consumption on the day of testing. Participants
were breathalysed and completed the 1-item hangover severity scale and mAHSS, to verify their
condition (hangover and no-hangover) before completing the three cognitive tasks in a randomised
counterbalanced order. Following practice trials, participants rated their self-efficacy before completing
each task. Following completion of each task, participants completed the RSME. Participants then
arranged the second testing session at least 36 h later, to prevent crossover effects. Upon completion of
both conditions, participants were paid £10 and received a full debrief.
2.5. Statistical Analysis
Statistical analysis was conducted in accordance with our preregistered protocol [49]. Outliers
were removed if they were > 1.5 * Inter-Quartile Range and > 2 SD from the mean. Analysis was also
conducted by winsorizing the outliers, which did not impact the results presented below. For the
switching task, trials following an error and trials with RT > 2500 ms were omitted from analysis.
Participants for whom < 50% trials were available were removed from analysis (n = 5). Error trials
were omitted from RT analysis [50]. Repeated measures ANOVAs were conducted with order and sex
as between-subject factors, using SPSS (version 25). Effect sizes are reported as Cohen’s d. Due to the
possible effects of acute intoxication at BAC > 0.02% [51], a sensitivity analysis was conducted to see if
residual alcohol concentrations during a hangover influenced cognitive performance. A sensitivity
analysis, excluding one participant with a BAC > 0.02%, yielded similar results; therefore, this
participant is included in the analyses presented below.
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3. Results
3.1. Participant Characteristics
The average age of participants was 20.23 years (SD = 2.81; range = 18–30), and they consumed an
average of 13.28 alcohol units the evening before the hangover condition (SD = 5.13; range = 5–28.5).
The mean eBAC calculated for the evening before the hangover condition was 0.16% (SD = 0.08;
range = 0.01%–0.37%). None of the participants consumed alcohol before the no-hangover control
condition or reported experiencing a hangover (i.e., all participants scored zero on the hangover-severity
scale). Although eBAC calculations for some participants were low (e.g., 0.01%), all participants in
the hangover condition reported having a hangover (severity scale score > 0). A sensitivity analysis
indicated that excluding participants with an eBAC < 0.05% the night before the hangover condition
did not alter results, and these participants were therefore included in the analyses reported below.
A visual representation of the range of eBAC values in the sample is provided in Figure 2. There was
no difference in caffeine consumption between the hangover and no-hangover conditions (p = 0.781).
Figure 2. A visual representation of the range of eBAC values during the drinking episode preceding
the hangover condition and number of participants experiencing each eBAC value.
3.2. Effects of Hangover on Switching
For reaction times, the analysis of switch costs indicated a trend-level main effect for condition
(F (1, 26) = 3.359, p = 0.078, d = 0.72), whereby switch costs were marginally greater in the hangover
relative to the no-hangover condition. There was also a condition *order interaction (F (1, 26) = 9.850,
p = 0.004, d = 1.23) indicating performance improved (lower switch costs) across testing days when
the first testing session was the hangover condition (F (1, 26) = 13.748, p = 0.001, d = 1.45). However,
there were no significant differences between testing days for those who completed the task for the
second, time when hungover (p = 0.387). There were no other significant effects or interactions. Results
for main effects on each task are presented graphically in Figure 3, condition * order interactions are
presented in Figure 4, and means and SDs are presented in Table 1.
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Figure 3. Graphical representations of the main effects from the three cognitive tasks. (a) Relative to the
no-hangover condition, mean switch costs on the switching task tended to be greater when individuals
were experiencing a hangover. (b) Relative to the no-hangover condition, mean errors on the switching
task were higher when individuals were experiencing a hangover. (c) Relative to the no-hangover
condition, errors for non-target and target stimuli in the 1-back version of the n-back task were greater
in the hangover condition. (d) Relative to the no-hangover condition, errors in the 2-back task were
greater overall in the hangover condition. (e) Relative to the no-hangover condition, errors on AX trials
of the AX-CPT task were greater in the hangover condition. The error bars represent ±1 standard error
of the mean.
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Figure 4. Graphical representations of the condition * order interactions. (a) Switching speed decreased
(lower switch costs) across testing days when the first testing session was the hangover condition, but
not when the first testing session was the no-hangover condition. (b) Switching accuracy declined
(greater number of non-perseveration errors) across testing days when the first testing session was the
no-hangover condition, but not when the first testing session was the hangover condition. (c) Updating
performance improved (fewer errors) across the testing days for those completing the hangover
condition first, but not for those completing the no-hangover condition first. The error bars represent
±1 standard error of the mean.




M SD M SD
Switching Task
Switch Cost (ms) 247.83 87.09 208.95 82.27 0.078 d = 0.72
Switch Errors 6.01 2.97 4.92 2.68 0.019 * d = 1.08
n-back Working Memory Task
1-back errors 3.92 1.78 2.47 1.31 <0.001 * d = 1.64
2-back errors 6.89 3.12 4.78 1.66 <0.001 * d = 1.63
AX-CPT Task
Target Errors (AX-type trials) 4.48 4.33 1.79 163 <0.001 * d = 1.52
Non-Target Errors 1.39 1.24 1.00 1.23 0.081 d = 0.69
Hangover Severity
1-Item Hangover Severity 3.83 1.84 0 0 <0.001 * d = 2.08
mAHSS 2.40 1.31 0.24 0.26 <0.001 * d = 1.72
Alcohol Consumption
Alcohol Units (night before testing) 13.28 5.13 0 0 <0.001 * d = 5.27
eBAC 0.16% 0.08 0 0 <0.001 * d = 4.04
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M SD M SD
Subjective Measures
RSME Switching 77.27 23.7 58.72 22.78 0.001 * d = 0.72
RSME n-back 76.41 24.22 58.79 20.81 0.001 * d = 0.65
RSME AX-CPT 59.69 23.70 47.41 28.67 0.008 * d = 0.55
Self-efficacy Switching 6.88 2.14 8.76 1.28 < 0.001 * d = 1.00
Self-efficacy n-back 6.31 2.18 6.74 2.5 0.384 d = 0.14
Self-efficacy AX-CPT 8.53 1.38 9.06 1.41 0.051 d = 0.35
Notes: M, mean; SD, standard deviation; mAHSS, modified Alcohol Hangover Severity Scale; RSME, Rating
Scale of Mental Effort; eBAC, estimated Blood Alcohol Concentration; AX-CPT, AX-Continuous Performance Task.
The asterisk indicates that the difference between the hangover and no-hangover conditions was significant.
For errors, analysis indicated a main effect of condition (F (1, 22) = 6.392, p = 0.019, d = 1.08),
whereby errors were greater overall in the hangover relative to no-hangover condition. There was
also a main effect of error type (F (1, 26) = 77.544, p < 0.001, d = 3.75), whereby there was a greater
number of non-perseveration than perseveration errors. An order * error-type interaction indicated
non-perseveration errors were greater for those who completed the no-hangover condition first than
those who completed the hangover condition first (F (1, 22) = 8.301, p = 0.009, d = 1.23). There
was also a greater number of non-perseveration errors than perseveration errors in both orders of
condition (ps < 0.001). A condition * order interaction (F (1, 26) = 7.483, p = 0.012, d = 1.17) indicated
that performance significantly declined across testing days when the first testing session was the
no-hangover condition (F (1, 22) = 11.650, p = 0.002, d = 1.45), whereas there were no significant
differences between testing days for those who completed the task for the second time, when sober
(p = 0.872). The analysis also indicated that participants who were hungover during their second
session made greater errors in the hangover condition than those who were hungover during their first
session (F (1, 22) = 12.958, p = 0.002, d = 1.54). A condition * order * error-type interaction indicated
that order effects were restricted to non-perseveration errors (F (1, 26) = 6.428, p = 0.019, d = 1.08)
(see Figure 4b). There were no other significant effects or interactions.
3.3. Effects of Hangover on Updating
To investigate the effect of a hangover on updating, each version of the n-back task was analysed
separately. For the 1-back version, there was a main effect of condition (F (1, 31) = 20.734, p < 0.001,
d = 1.64), whereby errors were greater in the hangover than the no-hangover condition. There was
also a main effect of trial type (F (1, 31) = 25.399, p < 0.001, d = 1.81), whereby there as a greater
number of errors for target than non-target trials. Furthermore, there was a condition*trial type
interaction (F (1, 31) = 7.444, p = 0.01, d = 0.98). Pairwise comparisons indicated errors were greater in
the hangover condition than the no-hangover condition for both target (F (1, 33) = 21.700, p < 0.001,
d = 1.62) and non-target trials (F (1, 33) = 4.454, p = 0.042, d = 0.74). Furthermore, errors for target trials
were greater than errors for non-target trials within both the hangover (F (1, 33) = 24.087, p < 0.001,
d = 1.71) and no-hangover conditions (F (1, 33) = 19.080, p < 0.001, d = 1.52). There were no other
significant effects or interactions.
For the more difficult 2-back version of the task, there was a main effect of condition
(F (1, 31) = 20.708, p < 0.01, d = 1.63), whereby errors were greater in the hangover than the no-hangover
condition. There was also a condition*order interaction (F (1, 31) = 6.732, p = 0.014, d = 0.93) that
indicated performance significantly improved across testing days for those completing the hangover
condition first (F (1, 31) = 28.528, p < 0.001, d = 1.92), whereas there were no significant differences
between testing days for those who completed the task for a second time, whilst hungover (p = 0.198)
(see Figure 4c). Our analysis also indicated that participants who were sober during their first session
made a greater number of errors in the no-hangover condition than those who were sober during
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their second session (F (1, 22) = 12.958, p = 0.002, d = 1.54). There were no other significant effects
or interactions.
3.4. Effects of Hangover on Goal Maintenance
Target and non-target trials were analysed separately, to avoid comparing stimuli presented 70%
of the time to non-target stimuli, which were presented 10% of the time each [45]. A 2 (condition) * 2
(order) repeated measures ANOVA indicated a main effect of condition only (F (1, 29)= 16.643, p< 0.001,
d = 1.52), whereby AX-type trial errors were greater in the hangover than the no-hangover condition.
Errors for non-target trials (BX-, BY-, and AY-type trials) were analysed separately. Increased
errors on BX-type trials in the hangover relative to the no-hangover condition are indicative of a shift
toward a reactive control style. There was a trend-level main effect of condition (F (1, 28) = 3.279,
p = 0.081, d = 0.69) whereby non-target errors tended to be greater in the hangover relative to the
no-hangover condition. In addition, there was a main effect of trial type (F (1, 31) = 28.829, p < 0.001,
d = 2.84), whereby there were more errors on AY-type relative to BY-type and BX-type trials and more
errors on BX-type relative to BY-type trials. There were no other significant effects or interactions.
3.5. Subjective Measures
A series of paired-samples t-tests was used to analyse RSME scores for each task. For the
switching task, perceived mental effort was greater (t (28) = 3.899, p = 0.001, d = 0.72) in the hangover
condition than the no-hangover condition. For the n-back task, perceived mental effort was also
greater (t (33) = 3.767, p = 0.001, d = 0.65) in the hangover condition than the no-hangover condition.
Furthermore, perceived mental effort for the AX-CPT task was greater (t (31) = 2.818, p = 0.008, d = 0.50)
in the hangover condition than the no-hangover condition. There were lower self-efficacy scores in
the hangover relative to the no-hangover condition for the switching task (t (33) = 5.816, p < 0.001,
d = 1.00). This difference was marginally significant for the AX-CPT task (p = 051), but not the n-back
task (p = 0.384). There were no sex differences in hangover severity (p = 0.790) or eBAC (p = 0.195).
3.6. Correlational Analysis
Bivariate correlational analysis provided no evidence that hangover-severity scores (as measured
by the mAHSS; ps > 0.178) and self-efficacy scores (ps > 0.098) were associated with performance on
the switching, n-back, or AX-CPT tasks. Bivariate correlational analysis also provided no evidence that
eBAC was related to hangover severity (p = 0.229) or task performance (ps ≥ 0.161).
4. Discussion
This study demonstrated that switching, updating, and goal maintenance are all impaired during
an alcohol hangover. Thus, in terms of the unity/diversity model of executive functions [15], all of the
core components of executive function appear to be negatively influenced by a hangover. Errors for
non-target trial types on the AX-CPT task (i.e., AY-type, BX-type, or BY-type trials) showed a trend
toward being greater in the hangover than the no-hangover condition. Moreover, contrary to our
hypothesis, there was no evidence that performance on switching, updating, and goal-maintenance
tasks was related to hangover severity. There was also no evidence that hangover-related impairments
in task performance were related to self-efficacy during switching, updating, and goal-maintenance
task performance. However, the participants felt that they needed to expend greater mental effort to
complete each task when experiencing a hangover than when not hungover. Furthermore, there was
no influence of sex on cognitive performance when hungover for any of the tasks.
In line with a previous naturalistic study of hangovers [30], our results from the switching task
indicate that individuals make a greater number of errors, reflective of deficits in task switching, when
they are experiencing a hangover, as opposed to when they are not hungover. This suggests that a
hangover impairs an individual’s ability to switch attention from one task or mental set to another
effectively. Although studies that experimentally induce hangovers often administer lower doses of
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alcohol than observed in real-life drinking [2], our null results for an effect of a hangover on switch costs
are in line with previous experimental research [19]. Therefore, it appears as though individuals may
maintain speed of switching, but become less accurate, when experiencing a hangover, as compared to
not being hungover. For switching, our results also tentatively indicated an interaction of condition
with order, further suggesting a speed-accuracy trade-off. Those completing the hangover condition
first appear to sacrifice time (switch costs) to maintain accuracy during the hangover condition, whereas
those completing the hangover condition second appear to sacrifice accuracy to maintain speed.
Our results indicate poorer performance on both the 1-back and 2-back versions of the n-back
task in the hangover compared to no-hangover condition. This suggests that an individual’s ability
to update information in working memory is impaired during a hangover. As the 1-back version
of the task is relatively easy and places a comparatively low load on working memory, the current
results suggest that participants with a hangover experienced an increased cognitive load, relative to
during a non-hungover state. This is in line with previous research suggesting that a hangover reduces
the amount of cognitive resources available [18,19], and it is consistent with our results indicating
greater mental effort to complete tasks. Although hangover symptoms, such as headache and fatigue,
are known to impair an individual’s ability to update information via increased cognitive load [34],
our results indicate no evidence of an association between performance on any task and overall
hangover-severity scores. This suggests that hangover-related impairments in executive functions are
likely due to factors other than simple cognitive interference due to the presence of negative symptoms.
For example, it is possible that physical alterations in hangovers, such as dopaminergic or noradrenergic
transmission [9,25], or immune effects (indexed via cytokine levels) [52,53], influence cognition [54].
The observed interaction of condition and order tentatively suggests that those completing the hangover
condition first appear to have greater improvement in their second session than those completing
the no-hangover condition first. This could indicate an expectancy effect, whereby, when the first
condition is during a hangover, participants expect their second performance on the task (i.e., when
sober) to be greatly improved.
Results from the current study indicate poorer goal maintenance during hangovers, as reflected
by a greater number of errors on the core AX trials of the AX-CPT task in the hangover compared to
the no-hangover condition. This suggests that an individual’s ability to maintain and manage goals is
impaired whilst experiencing a hangover. Goal maintenance is thought to represent the ‘common factor’
of the unity/diversity model, and an important aspect of maintaining goals is inhibitory control [15].
Therefore, impaired goal maintenance during a hangover may contribute toward findings of previous
studies of executive functions that have reported impaired prospective memory, semantic verbal
fluency [10], working memory, [12], and inhibitory control [5,6,30] during a hangover relative to a
no-hangover condition. Contrary to our hypothesis, there was no evidence that participants were
biased toward reactive control during a hangover, suggesting participants engaged in proactive control
during this task, but were ineffective in doing so (as evidenced by increased errors on the core AX-type
trials). However, it is possible that the current study did not have sufficient power to observe effects
on reactive control, due to the low number of non-target trials on this task. As goal maintenance is
important for many everyday behaviours that rely on executive functions, such as planning, decision
making, organising, and other ‘higher-order’ skills, future studies should investigate the influence of
hangovers on these processes.
The current results should be viewed in light of the following strengths and limitations.
The crossover, within-subjects design could be considered a strength of the current study, because each
subject serves as his or her own control. Furthermore, the naturalistic design, although the naturalistic
design is limited in its control over alcohol consumption, it can be considered a strength as it involves
investigating the impact of real-life drinking, rather than an experimentally induced hangover, which
might involve consuming lower levels of alcohol [41]. However, the study is limited in its ability
to generalise beyond the narrow demographics of this student population (i.e., to other age groups,
education levels, etc.). Another limitation is the use of the Widmark formula, which should be viewed
242
J. Clin. Med. 2020, 9, 1148
as a rough estimate of alcohol consumption. Future studies should explore directly measuring BAC
during the heavy drinking occasion, possibly via wearable technology. Although each task used in
this study was chosen to reflect switching, updating, or goal maintenance, these tasks are cognitively
complex (i.e., they measure multiple executive and non-executive functions). One technique that
could be utilised in future studies, to overcome variability attributable to task stimuli, rather than the
respective executive function component, is the adoption of a latent variable approach, which is a
statistical technique that can capture common variance across multiple measures (e.g., [55]).
5. Conclusions
Results from the current study indicate that all domains of the unity/diversity model of executive
functions are negatively affected by alcohol hangover. Executive functions are important cognitive
processes which are utilised in everyday behaviours, such as planning, decision-making, and emotion
regulation. Thus, impairments in a range of executive functions could have broad implications for
a wide variety of everyday activities, including in the workplace. For example, employees who
go to work when experiencing a hangover may negatively influence the productivity and working
environment of others [13]. Future studies should aim to investigate the impact of hangover-induced
executive dysfunction on the performance of everyday tasks.
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Abstract: Elevated distractibility is one of the major contributors to alcohol hangover-induced
behavioral deficits. Yet, the basic mechanisms driving increased distractibility during hangovers are
still not very well understood. Aside from impairments in attention and psychomotor functions,
changes in stimulus-response bindings may also increase responding to distracting information,
as suggested by the theory of event coding (TEC). Yet, this has never been investigated in the context
of alcohol hangover. Therefore, we investigated whether alcohol hangover has different effects on
target-response bindings and distractor-response bindings using a task that allows to differentiate
these two phenomena. A total of n = 35 healthy males aged 19 to 28 were tested once sober and
once hungover after being intoxicated in a standardized experimental drinking setting the night
before (2.64 gr of alcohol per estimated liter of body water). We found that alcohol hangover reduced
distractor-response bindings, while no such impairment was found for target-response bindings,
which appeared to be unaffected. Our findings imply that the processing of distracting information is
most likely not increased, but in fact decreased by hangover. This suggests that increased distractibility
during alcohol hangover is most likely not caused by modulations in distractor-response bindings.
Keywords: alcohol; hangover; distraction; stimulus-response binding; distractor-response binding;
theory of event coding
1. Introduction
Driving under the influence of alcohol is prohibited and legally sanctioned in most countries,
as alcohol drastically impairs the required cognitive and motor skills, thus putting the driving individual
as well as co-drivers and bystanders at substantial risk of accidents and injury [1–5]. Even after the
acute intoxication has worn off and blood alcohol levels (BAC) have returned to 0.00‰, cognitive,
attentional, and psychomotor functions likely remain impaired to a certain degree [6–11]. While there
is currently no neurobiochemical marker that could help to reliably detect the presence of alcohol
hangover [12], being hungover may not only be disastrous for driving a vehicle, but also for various
daily activities including safety-sensitive tasks at work and at home. Surprisingly, the mechanisms
underlying such hangover-associated behavioral deficits are still not very well understood, as compared
to the effects of acute intoxication.
Alcohol hangover is commonly defined as a “combination of mental and physical symptoms,
experienced the day after a single episode of heavy drinking, starting when BAC approaches
zero” [13]. The findings on cognitive and behavioral effects of alcohol-induced hangover in different
functional domains are not always consistent (for review, please see Mackus et al. [11]), but there
is consensus that attentional deficits are one of the factors that likely underlie hangover-associated
driving impairments [7,11,14]. Another important factor for impaired driving skills are slowing
and impairments of motor responses and coordination during hangover [6,7,11,14,15]. Even though
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distraction is recognized as a major risk factor for impaired driving [16], we still know rather little
about whether and how alcohol hangover changes the way we process and respond to distracting
information, other than that hangover may influence response selection and conflict monitoring,
thus impairing goal-directed behavior [17–19]. Specifically, only very little is known about whether
alcohol hangover differently modulates the integration and processing of irrelevant vs. relevant
information, even though this may give rise to conflicts and distraction at later information processing
stages. Against this background, obtaining a better understanding of hangover-induced changes
in distractor processing is important. From a mechanistic point of view, driving performance, as
well as some forms of occupational performance (for review, please see Mackus et al. [11]), may not
only be compromised by hangover-induced impairments in attention and psychomotor functions,
but also by the phenomenon of stimulus-response (S-R) binding. In this context, the theory of event
coding (TEC) [20] has provided compelling evidence for why and how we respond to distracting
information (Figure 1). While it has not been developed to explain alcohol effects per se, it is a widely
known theory which may be used to elucidate mechanisms potentially underlying hangover-induced
changes. In short, it states that sensory information on all kinds of different stimuli will be “bound”
(i.e., associated) in a so-called object file, while all response-related information is bound/associated in
the so-called “response file”. Additionally, stimulus and response features become associated with
each other in the “event file”, thus constituting the S-R link [21]. Importantly, the event file binds
stimulus and response features irrespective of whether a given stimulus feature/sensory information
is functionally relevant for the response we intend or need to carry out [21]. Instead, temporal
co-occurrence is the main determinant of whether sensory input becomes associated with a given
response [21]. As a result, any distractor that will occur at the same time as a response-relevant
(target) stimulus feature, will also find entry into the event file. Following a pattern-completion logic,
the entire event file, including the previously associated response, will become activated once any
part of a pre-existing event file is re-encountered [20]. Importantly, this also holds true for distractor
information so that task-irrelevant information may lead to a similar reactivation of an event file as
task-relevant information [20]. This way, a distractor, especially if previously encountered, may prime
certain responses - even when they are no longer needed or correct.
Figure 1. Schematic illustrations of the bindings postulated by the theory of event coding (TEC).
Abbreviations: D-R = distractor-response; T-R = target-response.
While previous studies have suggested that acute alcohol intoxication does not seem to strongly
impair S-R binding [22], this has never been investigated in the hungover state, which may functionally
differ from the intoxicated state [17,18]. Of note, there are several mechanisms which could drive
such differences, including differential modulation of gamma-aminobutyric acid (GABAergic) signaling
by ethanol and its metabolite acetaldehyde, which is likely responsible for feeling hungover [23–25],
and immunological parameters, including those related to inflammation [26,27]. To the best of our
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knowledge, it has furthermore never been investigated whether potential alcohol effects on this
phenomenon could be different for the S-R binding of response-relevant target information vs. that
of response-irrelevant distractor information. Stock et al. [22] investigated acute intoxication effects
using a paradigm, which does not separately account for target- and distractor-response binding.
We therefore chose a paradigm that allows to make this dissociation in order to investigate our research
question in detail. Since the sensory processing of stimulus information might be altered during
hangover due to increased sensory information processing speed [17], it could be conceivable that
S-R binding, including distractor-response binding, is in fact enhanced during alcohol hangover.
Such an enhancement could constitute a risk factor for distractibility and resulting safety issues for
activities like driving (via the automatic reactivation of previously associated and thus potentially
incorrect responses [28]).
To investigate this research question, we subjected n = 35 healthy young males to an experimental
within-subject study design that was comparable to the procedure used in previously published
hangover studies from our group [18,19]. Each participant was once tested sober and once after having
consumed 2.64 gr of alcohol per estimated liter of body water on the night before testing. A paradigm
introduced by Moeller et al. [29] was used to separately investigate the effects of target-response
and distractor-response binding. In short, the paradigm combines target and distractor stimuli in
a shared visual array that requires different manual responses (button presses) from the participants.
By systematically and independently varying the repetition vs. change of target information, distractor
information, and required response, the task allows to dissociate the different binding effects: The
effect of distractor-response (D-R) binding should become evident in the statistical main effects
of the distractor (i.e., be reflected by the effect size of distractor repetition vs. distractor change).
Likewise, the effects of target-response (T-R) binding should become evident in statistical main effects
of the target (i.e., be reflected by the effect size of whether the target and/or required response
changed). Lastly, distractor-response binding may also show in the statistical interaction of distractor
and response effects, as the automatic response tendency induced by the distractor should vary across
response repetition vs. response change [30]: Distractor repetition should be beneficial whenever the
repetition of a given response is required because the repetition of the distractor then reactivates the
correct response. Opposing this, distractor repetition should be detrimental whenever a given response
needs to be changed because the repetition of the distractor then reactivates an incorrect response.
In summary, we investigated whether S-R binding is altered during alcohol hangover against
the background of potentially different sensory processing of distracting stimulus information [17,18].
We further investigated whether there are potentially different hangover effects on the binding of
task-/response-relevant vs. irrelevant information, as this might explain why and how distractibility
may be increased during alcohol hangover.
2. Experimental Section
2.1. Participants
The original study sample comprised n= 37 healthy males aged between 19 and 28 years, who were
recruited from the local university (TU Dresden) and local nightlife district. Inclusion criteria were
right-handedness, normal or corrected-to-normal vision, absence of color blindness, no acute or chronic
somatic psychological, or neurological illnesses, and no intake of medication affecting kidney or liver
function, or the central nervous system. Participants’ drinking habits were assessed during a telephone
screening using the alcohol use disorders identification test (AUDIT) [31,32]. An AUDIT score below 16
specifies low-to-moderate risk of alcohol use disorder (AUD) [31]. Almost all participants scored below
this cut off and therefore reported no drinking habits at high-risk. In total, n = 4 participants scored
between 16 and 19 indicating harmful use of alcohol [31] but did not meet the criteria for the diagnosis
of an AUD according to the International Classification of Diseases (ICD-10). None of the participants
scored above 19, which would have indicated a high risk/presence of an AUD [31]. Although harmful
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drinking may potentially have detrimental effects on cognitive functions [33], previous findings
from our lab suggested that young frequent binge drinkers (who engaged in equal, and/or more
binge-drinking than our current sample) seem to have no significant behavioral impairments in
executive functioning [34].
Exclusion criteria used to minimize the number of individuals who might not cope well with
the amount of experimentally administered alcohol were an overall AUDIT score below 2 points,
less than 13 self-reported binge-drinking nights over the past 12 months, and not being markedly
drunk at least once in the past 12 months. Exclusion criteria used to minimize the number of
individuals with high alcohol tolerance and/or high risk of AUD were an overall AUDIT score
above 19 points [31], and self-reported (nearly) daily occurrences of either binge drinking behavior,
and/or alcohol-induced memory problems, and/or failure to fulfill daily routine tasks due to alcohol
consumption. All participants provided written informed consent and received a reimbursement
of 80€. The study was conducted according to the Declaration of Helsinki. Ethical approval was
given by the ethics committee of the Faculty of Medicine of the TU Dresden, Germany (EK293082014).
Eventually, n = 35 participants (23.1 ± 2.7 years old) were included in the statistical analyses because
one participant was excluded due to performance accuracy close to chance level (i.e., below 55%) in
at least one experimental task condition and another participant was excluded because of his high
residual breath alcohol concentration (BrAC = 0.45‰) at the hangover session, which would have
taken a waiting time of 4 to 5 additional hours until sobriety and he was not able to invest the required
time on that day. Please also note that the sample in this publication largely overlapped with that of
a previous publication investigating the influence of alcohol hangover on meta-control/the interplay
between controlled and automated processes [19].
2.2. Experimental Design
The experimental design was identical to that described in previous publications by our
group [18,19], and is illustrated in Figure 2.
Each participant was tested twice (once sober and once hungover) with a delay of a minimum of
48 h to a maximum of 7 days between the sober and hangover sessions. The order of both sessions
was counterbalanced across the sample. Participants were asked to neither use nicotine, nor caffeine
or guarana within four hours before the start of each session. At the start of each session, BrAC was
measured using the breathalyzer “Alcotest 3000” following the instructions by the manufacturer
(Drägerwerk, Lübeck, Germany). The experimental procedure in the sober and hangover sessions
only proceeded in case of a BrAC of 0.00‰. On the night before the hangover session, participants
were experimentally intoxicated at our laboratory in order to induce hangover symptoms. For this,
we asked groups of 4 to 8 participants to join a drinking session on a Friday or Saturday evening
(starting at 20:00 and ending at approximately 01:30/02:00). The subsequent hangover session was
planned for the following morning (that is either on Saturday or on Sunday, starting between 09:00 and
11:00) to slightly reduce sleep duration, as the amount of sleep time is negatively related to hangover
severity [35].
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Figure 2. Outline of the intoxication, hangover, and sober sessions. Each participant was tested twice,
once sober and once hungover, with a delay of a min. 48 h to max. 7 days between both sessions.
The order of both sessions was counterbalanced across all participants. Written informed consent
and a brief evaluation of the current health status was provided at the start of each session. Rating of
hangover symptoms and recording of task performance was only started in case of a breath alcohol
concentration (BrAC) of zero on both sessions. To induce alcohol hangover symptoms, participants were
experimentally intoxicated at our laboratory on a Friday or Saturday evening starting from 20:00 (8 pm).
Participants provided their written consent and completed questionnaires on sociodemographic data,
height, weight, alcohol sensitivity, and depression. BrAC was measured before they started drinking
to ensure sobriety. An individually-measured alcohol amount was consumed from approximately
20:15 to 23:00. BrAC was measured 30, 60, 90, and 120 min after the last alcoholic drink was finished.
At around 01:30, participants were brought home via cab, given that their BrAC values were already
declining, they had no impairments of consciousness, and no major walking/coordination impairments.
Participants came back to the laboratory in the next morning between 09:00 and 11:00 to complete their
hangover session.
2.3. Experimental Intoxication Procedure
The experimental intoxication procedure applied to cause hangover symptoms followed the same
protocol as described in previous publications [18,19] and is briefly outlined in Figure 2. By using
a version of the equation by Widmark [36] and Watson et al. [37], an individual amount of alcohol was
calculated for each participant at the beginning of the intoxication session. It estimates the total body
water (TBW) in liters based on an individual’s sex, age, weight, and height and specifies the alcohol
amount in grams which is required to be dissolved in the body water to attain a given intoxication
level (2.64 gr of alcohol per estimated liter of body water). This limited the provided alcohol amount
so that it was physiologically impossible to reach a BrAC of more than 2.0‰ (which would only
have been possible to reach if all of the alcohol had been dissolved in TBW at once). Realistically, the
amount of provided alcohol translates to a mean BrAC of 1.6‰ in case it is consumed at once and on
an empty stomach (i.e., with an expected resorption deficit of about 20%). However, participants were
encouraged to eat a full dinner before the intoxication session, as a full stomach typically increases
the resorption deficit (approx. 30%–40%). Additionally, the experimenters ensured a minimum
consumption duration of 2 h in order to prevent the participants from drinking the entire amount at
once and potentially experiencing “overshooting” (i.e., a very rapid increase in blood alcohol levels
that might initially lead to otherwise unexpectedly high blood alcohol concentrations and associated
complications like vomiting). As a consequence of these precautions, the participants were expected to
achieve a mean BrAC of approximately 1.2‰ with only a small chance of reaching BrAC values beyond
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1.6‰. The equation used to calculate the individual amount of alcohol and the protocol used to record
the alcohol consumption of each participant is available online at https://osf.io/ktgyr/. As alcoholic
beverages with high congener content are more likely to induce a (more severe) hangover [7], we only
offered cheap red wine (9.5 vol %) and/or cheap brandy (36 vol %). To keep the quantity and speed
of alcohol consumption similar across beverages, the experimenters served standardized portions
of 50 mL brandy (14 g alcohol) or 200 mL red wine (15 g alcohol). For each standardized portion
of alcoholic beverage, participants could choose whether they wanted to drink it pure, chilled on
ice, or mixed with orange lemonade, caffeine-free coke, or ginger ale. Participants were supplied
with tap water and snacks (wine gums and chips), the use of which was not recorded. Participants
were additionally allowed to smoke cigarettes while drinking, as this has been suggested to enhance
hangover severity [38,39]. In total, n = 9 participants appreciated this offer, n = 8 of whom reported
to smoke regularly. BrAC was assessed 30, 60, 90, and 120 min after the last alcoholic beverage
was consumed.
2.4. Questionnaires
At both the sober and hangover session, participants rated the severity of their hangover symptoms.
For this purpose, we used the 11-point Likert-scale by van Schrojenstein Lantman and colleagues [13].
This rating scale enlists 23 hangover symptoms, and rating options range from 0 points (no symptoms)
to 10 points (extreme symptoms). We additionally asked participants to rate their sleep quality/sleep
problems of the previous night in the same way. Furthermore, participants indicated the number of
sleeping hours they had received the night prior to each testing session. Of note, they were explicitly
asked to rate each symptom irrespective of whether or not they had been drinking the night before and
of whether or not they attributed their symptoms to alcohol.
At the intoxication session, participants provided sociodemographic information and filled
in Beck’s depression inventory (BDI) [40] to identify depressive symptoms, as depression could
have potentially affected cognitive performance. Finally, the alcohol sensitivity questionnaire (ASQ)
was used to assess susceptibility to known alcohol effects, like experiencing a hangover or feeling
relaxed [41]. The ASQ further distinguishes between alcohol-related experiences associated with
lower doses (ASQlight) and with heavier doses (ASQheavy). While we ran detailed analyses on the role
of alcohol sensitivity in a previous publication [19], we refrained from detailed alcohol sensitivity
analyses in the current study, as this did not seem to contribute to hangover-associated behavioral
changes in the previous study [19].
2.5. Task
In order to be able to dissociate the effects of alcohol hangover on the processing and binding
of response-relevant (target) information and response-irrelevant (distractor) information, we used
a paradigm introduced by Moeller et al. [29]. Figure 3 illustrates the paradigm.
The stimuli were presented on a 17′’ high quality flat screen monitor and keyboard responses
were recorded using Presentation® software (Version 16.5, Neurobehavioral Systems, Inc., Berkeley,
CA, USA). The time course of a single trial was as follows: A white fixation cross was centrally
presented on a black screen for 500 ms. This was followed by a centrally presented prime stimulus
consisting of five horizontally aligned letters. The presentation of the prime array was either ended
by a button press, or after 1500 ms had elapsed (in case of a missing response). Next, a central white
fixation cross was presented for 500 ms. In case of an incorrect or missed response to the prime,
a 500 ms error feedback was additionally displayed on the screen (i.e., the word “Fehler”, translating
to “error”). Then, another five letters were centrally displayed as the probe array. Like for the prime
array, the presentation of the probe array was either terminated by a button press, or after 1500 ms
had elapsed (in case of a missing response). The probe array was also followed by the presentation of
a central white fixation cross. In the case of an incorrect or missed response to the probe, an additional
500 ms error feedback was presented on the screen (i.e., the word “Fehler”, translating to “error”).
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The inter-trial interval (ITI) randomly varied between 700 and 1100 ms. The paradigm comprised a
total of 576 trials, which were divided into six equally-sized blocks. Participants were offered to take
breaks in-between these blocks.
Figure 3. Illustration of the time course in milliseconds (ms) of a single trial in the distractor-response
paradigm [29]. In each trial, a white fixation cross was centrally shown on a black screen for 500 ms.
This was followed by a centrally presented prime array consisting of five letters. The prime array
presentation was terminated either by a button press in response to the red target letters, or after
1500 ms (in case of a missing response). After another presentation of a central white fixation cross for
500 ms, a probe array was centrally presented. The probe array also consisted of five letters and its
presentation was again terminated by a button press in response to the red target letters or ended after
1500 ms. The inter-trial interval (ITI) was jittered between 700 and 1100 ms. The upper half of the figure
illustrates exemplary probe arrays for each combination of conditions in relation to the prime array used
for illustration in this figure (“G L G L G”). Depending on whether the target and/or distractor stimulus
were repeated or changed between prime and probe array, six different combinations of conditions were
distinguished. In terms of the distractor stimuli, distractor repetition (DR) and distractor change (DC)
were distinguished. In terms of the required response, response repetition when the target stimulus
was identical (RRi), response repetition when the target stimulus differed (RR), and response change
(RC) were distinguished.
With respect to S-R mapping, two out of eight letter stimuli (S, D, F, G, H, J, K, L) each formed
a group. This resulted in four stimulus groups, each associated with a different response button on
a standard QWERTZ keyboard. In detail, S and D required pressing the left Ctrl button with the left
middle finger; F and G required pressing the left Alt button with the left index finger; H and J required
pressing the right Win button with the right index finger; and K and L required pressing the right
Ctrl button with the right middle finger. In each array, there were always two target letter stimuli
which were shown in red font color. They were horizontally flanked by three distractor letter stimuli,
which were shown in green font color. Please note that the target and distractor stimuli were never
identical and always associated with different response buttons, even though only the targets required
a single button press response. Participants were asked to respond to the red target letters while
ignoring the green distractor letters. They were instructed to respond by pressing the appropriate
button as quickly and as accurately as possible. Each trial asked for a first response to the prime array
and a second response to the subsequent probe array.
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The task allows to distinguish six combinations of conditions resulting from the modification of
the distractor stimulus and/or response between prime and probe. All conditions are exemplarily
illustrated in Figure 3. Regarding the distractor stimuli, there could be a distractor repetition (DR) or
a distractor change (DC) between the prime and probe. Regarding the required response, there could
be a repetition of the correct response button when the target stimulus was identical for both prime and
probe (RRi), a repetition of the correct response button when the target stimulus differed between prime
and probe (RR), and a change of the correct response button (RC). Each combination of conditions was
presented equally often. In each of the conditions, all possible combinations of probe target and probe
distractor were equally likely (considering that target and distractor stimuli could never require the
same response). Prime and probe distractors were identical in all DR trials, while the prime distractor
was randomly picked from one of the other response groups in all DC trials (e.g., when the probe
distractor was the letter “G”, the prime distractor could not be the letter “G” or “F”). Additionally, the
prime target was randomly picked from one of the other response groups in the RC condition. A total
of 30 practice trials was performed before the experiment started. The task itself took around 40 min
to finish.
2.6. Statistical Analyses
Statistical analyses included only trials in which participants responded correctly to both the prime
and probe arrays. For each participant, trials with prime and/or probe response times (RTs) beyond
±2 standard deviations from the individual’s mean RT in the respective task condition were rejected
in order to reduce outlier effects. The obtained correct probe RTs and probe accuracy were analyzed
with SPSS Statistics 25 (IBM Corp. Released 2017. IBM SPSS Statistics for Windows, Version 25.0.
Armonk, NY, USA: IBM Corp.) using separate repeated-measures ANOVAs. Status (hangover vs.
sober), response (response repetition to identical target (RRi) vs. response repetition to other target
(RR) vs. response change (RC)), and distractor (distractor repetition (DR) vs. distractor change (DC))
were used as within-subject factors. Greenhouse–Geisser correction was applied whenever necessary.
Post hoc multiple comparisons were Bonferroni-corrected. All behavioral variables were analyzed for
normal distribution indicated by Kolmogorov–Smirnov tests. As this assumption was not met for RTs
in a few conditions and for most accuracy conditions, all significant main effects and post hoc tests were
additionally tested for significance using non-parametric Wilcoxon signed-rank tests. All descriptive
statistics provide the mean value and the standard error of the mean (SEM) as a measurement of




Out of n = 35 participants, n = 17 had their hangover session before their sober session and n = 18
had their sober session before their hangover session. Sociodemographic characteristics, questionnaire
scores, and alcohol-related data are detailed in Table 1. Subjective sleep and hangover ratings on both
sessions are provided in Table 2. A total of n = 2 participants reported to have never experienced
a hangover over their entire lifetime as assessed by the first ASQ item. Only one of them belonged
to a total of n = 2 participants who indicated to not have experienced any overall hangover at the
hangover session, meaning they rated the first item of the hangover severity rating by van Schrojenstein
Lantman et al. [13] with 0 points. Nevertheless, both of these participants reported light hangover
complaints for some of the symptoms in this rating, suggesting that none of them were entirely free of
any hangover symptoms (please note that add-on analyses on hangover severity and symptoms can
be found in the Supplementary Materials). Furthermore, a paired t-test showed that the number of
standard drinks consumed at the intoxication session (16.74 drinks ± 0.25) was significantly larger
than the maximal number of drinks participants indicated to be able to drink before experiencing
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a hangover (8.94 drinks ± 0.69; t(32) = |10.696|; p < 0.001). Thus, the amount of alcohol administered in
this study exceeded the self-reported hangover threshold.
Table 1. Sociodemographic, questionnaire, and alcohol-related data of the included sample. All values
are reported as means ± standard error of the mean and (range). Please note that all relevant items
were averaged for the ASQlight score (alcohol-related experiences associated with lower doses). For the
ASQheavy score (alcohol-related experiences associated with heavier doses), all relevant items except
for “passing out” were averaged, as only a single participant had indicated to have ever passed out
due to alcohol drinking.
Characteristic Included Sample (n = 35)
Age in years 23.14 ± 0.47 (19–28)
Height in cm 181.89 ± 0.98 (170–195)
Weight in kg 76.87 ± 1.69 (63–105)
Cigarettes smoked per day 0.78 ± 0.37 (0–10)
Hours of sport per week 4.63 ± 0.56 (0–16)
BDI score 3.37 ± 0.69 (0–19)
AUDIT score 10.26 ± 0.58 (5–19)
ASQ total score 8.23 ± 0.40 (3.25–13.29)
ASQlight score 5.16 ± 0.30 (1.63–9.25)
ASQheavy score 13.17 ± 0.78 (5.20–24.0)
Individual alcohol amount indicated in mL of brandy (36 vol %) 418.00 ± 5.81 (369–516)
Alcohol consumption duration in minutes 181.43 ± 4.29 (111–243)
BrAC 30 min after end of consumption 1.32 ± 0.03 (1.05–1.69)
BrAC 60 min after end of consumption 1.24 ± 0.02 (1.01–1.56)
BrAC 90 min after end of consumption 1.15 ± 0.02 (0.91–1.40)
BrAC 120 min after end of consumption 1.08 ± 0.03 (0.83–1.43)
BDI = Beck depression inventory; AUDIT = alcohol use disorders identification test; ASQ = alcohol sensitivity
questionnaire; BrAC = breath alcohol concentration.
Table 2. Subjective ratings of sleep and hangover symptoms on both sessions. Hangover symptoms
were rated on an 11-point Likert scale ranging from 0 points (no symptoms) to 10 points (extreme
symptoms). Of note, participants were asked to truthfully rate the severity of each symptom on both
sessions, irrespective of whether they had been drinking the night before the sober session. The mild
symptom severity for the sober session and the resulting minimal variance of this rating may have
contributed to the fact that nearly all hangover symptoms differed significantly between the sober
and the hangover session (as was intended by the study). These comparisons were performed with
uncorrected paired t-tests. p-Values are reported in the column “Difference.” All values are given as





Hours of sleep in
previous night 7.40 ± 0.15 (5.5–9) 5.54 ± 0.19 (4–8) - p < 0.001 **
Overall hangover
severity 0 ± 0 (0–0) 3.63 ± 0.39 (0–10) 94.3% p < 0.001 **
Thirst 0.91 ± 0.28 (0–7) 3.46 ± 0.37 (0–8) 91.4% p < 0.001 **
Concentration
problems 0.61 ± 0.18 (0–4) 3.11 ± 0.37 (0–8) 88.6% p < 0.001 **
Tired 1.12 ± 0.21 (0–4) 4.57 ± 0.39 (1–10) 88.6% p < 0.001 **
Sleepiness 1.00 ± 0.23 (0–4) 3.71 ± 0.42 (0–9) 85.7% p < 0.001 **
Weakness 0.30 ± 0.11 (0–2) 2.31 ± 0.34 (0–10) 85.7% p < 0.001 **
Headache 0.06 ± 0.04 (0–1) 2.69 ± 0.38 (0–8) 82.9% p < 0.001 **
Clumsy 0.39 ± 0.15 (0–3) 1.97 ± 0.32 (0–6) 71.4% p < 0.001 **
Dizziness 0.03 ± 0.03 (0–1) 1.69 ± 0.27 (0–6) 71.4% p < 0.001 **
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Sensitivity to light 0.24 ± 0.12 (0–3) 1.57 ± 0.32 (0–8) 60% p < 0.001 **
Reduced appetite 0.21 ± 0.16 (0–5) 1.97 ± 0.41 (0–9) 57.1% p = 0.001 **
Sweating 1.18 ± 0.33 (0–7) 1.09 ± 0.21 (0–4) 51.4% p = 0.784
Nausea 0.03 ± 0.03 (0–1) 1.46 ± 0.35 (0–7) 48.6% p < 0.001 **
Apathy 0 ± 0 (0–0) 0.89 ± 0.20 (0–4) 48.6% p < 0.001 **
Shivering 0.36 ± 0.13 (0–3) 1.20 ± 0.29 (0–6) 45.7% p = 0.010 *
Confusion 0.15 ± 0.08 (0–2) 0.91 ± 0.22 (0–5) 45.7% p < 0.001 **
Heart pounding 0.30 ± 0.10 (0–2) 0.94 ± 0.23 (0–5) 42.9% p = 0.012 *
Stomach pain 0.24 ± 0.16 (0–5) 1.06 ± 0.32 (0–7) 40% p = 0.012 *
Anxiety 0.39 ± 0.14 (0–3) 0.94 ± 0.25 (0–5) 40% p = 0.028 *
Regret 0.12 ± 0.12 (0–4) 0.83 ± 0.31 (0–10) 37.1% p = 0.003 **
Sleeping problems 0.21 ± 0.14 (0–4) 0.91 ± 0.32 (0–8) 31.4% p = 0.027 *
Depression 0.21 ± 0.16 (0–5) 0.66 ± 0.28 (0–9) 28.6% p = 0.021 *
Vomiting 0.03 ± 0.03 (0–1) 0.60 ± 0.28 (0–9) 22.9% p = 0.055
Heart racing 0.15 ± 0.08 (0–2) 0.57 ± 0.25 (0–6) 22.9% p = 0.138
* p < 0.05, ** p < 0.01.
3.2. Behavioral Data
The correct probe RTs and probe accuracy are illustrated in Figure 4.
The repeated-measures ANOVA for correct probe RTs (in case of correct prime response) revealed
task-specific effects: There was a main effect of response (F(2,68) = 374.42; p < 0.001; η2p = 0.917). Post hoc
comparisons revealed significant differences between all conditions, with the fastest responses in RRi
trials (493 ms ± 9), followed by RR trials (613 ms ± 14), and RC trials (770 ms ± 13) (all p < 0.001).
The main effect of distractor (F(1,34) = 54.56; p < 0.001; η2p = 0.616) showed faster responses in DR trials
(617 ms ± 11) than in DC trials (634 ms ± 11). Furthermore, there was an interaction of response
and distractor (F(2,68) = 9.21; p = 0.001; η2p = 0.213). Post hoc comparisons revealed that participants
responded significantly faster in DR than in DC trials on RRi condition (p < 0.001; RRi-DR: 479 ms ±
9; RRi-DC: 508 ms ± 9), and on RR condition (p = 0.006; RR-DR: 605 ms ± 14; RR-DC: 621 ms ± 14),
but not on RC condition (p = 0.254). We additionally computed the size of the distractor effect (DC
minus DR) for each response condition. Post hoc comparisons revealed that the distractor effect in RRi
trials (29 ms ± 3) was significantly greater than in RR trials (16 ms ± 5) (p = 0.023) and in RC trials
(7 ms ± 4) (p ≤ 0.001). RR and RC trials did not significantly differ in the size of their distractor effect
(p = 0.471). All main and interaction effects of status were non-significant (all F ≤ 1.16; all p ≥ 0.295).
Regarding probe accuracy, the repeated-measures ANOVA showed a main effect of response
(F(2,68) = 79.07; p < 0.001; η2p = 0.699). Post hoc comparisons revealed significant differences between all
conditions, with the highest accuracy in RRi trials (93.5 % ± 0.7), followed by RR trials (89.4 % ± 1.0)
and then by RC trials (83.5 % ± 1.2) (all p < 0.001). Importantly, an interaction of status and distractor
was obtained (F(1,34) = 5.02; p = 0.032; η2p = 0.129), which is illustrated in Figure 5. Post hoc comparisons
showed differences between distractor repetition and distractor change in the sober and hangover
assessment. In the sober assessment, accuracy was significantly higher for DR trials (89.8 % ± 1.1)
than for DC trials (88.4 % ± 1.1) (p = 0.027), while there was no significant distractor difference during
the hangover assessment (p = 0.487). We additionally computed the size of the distractor effect (DC
minus DR) for each status. A post hoc paired t-test showed that the size of the distractor effect was
significantly smaller in the hangover assessment (|1.0|% ± 0.8) than in the sober assessment (|1.4|% ±
0.5) (t(34) = |2.24|; p = 0.032). To investigate whether alcohol sensitivity or hangover severity modulated
this effect, we correlated the overall ASQ score, the ASQ heavy score, and the overall hangover severity
item by van Schrojenstein Lantman [13] with an average of all hungover DR trials, an average of all
hungover DC trials, and the distractor effect size at hangover assessment as well as with the difference
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in distractor effect sizes between the sober and hangover assessment, and with the size of the hangover
effect (SOB minus HANG) in DR and DC trials. None of these uncorrected correlations between ASQ
scores, hangover severity, and performance parameters was significant (all p ≥ 0.064). All other main
and interaction effects of the ANOVA were non-significant (all F ≤ 2.26; all p ≥ 0.118).
To summarize, we found that alcohol hangover affects the processing of response-irrelevant
(distractor) information, but not the processing of response-relevant (target) information. The former
is reflected by the interaction of status and distractor in probe accuracy, while the latter is reflected by
non-significant hangover effects on response conditions in both correct probe RTs and probe accuracy.
Figure 4. Box plots of the obtained mean correct probe response times (RTs in milliseconds, upper left
graph) and mean probe accuracy (in percent, lower graph) for each combination of conditions. We
observed significantly faster and more accurate responses in RRi than in RR and RC. We further
observed significantly faster responses in DR than in DC. For probe response times, the size of the
distractor effect (i.e., the difference between DC and DR, upper right graph) was significantly greater in
RRi than in RR and RC, while it was not significantly different between RR and RC. While we found no
significant main effects/overall differences between the sober and hangover session (i.e., irrespective
of all other conditions), we found a significant interaction between status and distractor, which is
depicted in Figure 5. Abbreviations: DR = distractor repetition; DC = distractor change; RRi = response
repetition when the target stimulus was identical; RR = response repetition when the target stimulus
differed; RC = response change; ms =milliseconds; * = p < 0.05; n.s. = non-significant.
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Figure 5. Box plots of the obtained mean probe accuracy (in percent) for the significant interaction
of status and distractor are illustrated in the left graph. While the accuracy was significantly higher
in DR trials (89.8 % ± 1.1) than in DC trials (88.4 % ± 1.1) when being sober, there was no such
significant difference when being hungover. Consequently, the size of the distractor effect (the difference
between DC and DR) was significantly smaller in the hangover assessment than in the sober assessment
(right graph). Abbreviations: DR = distractor repetition; DC = distractor change; * = p < 0.05;
n.s. = non-significant.
4. Discussion
Distractibility is one of the major contributors of hangover-induced behavioral deficits in daily
activities, like when driving a car [6–11,16]. As the basic mechanisms causing hangover-induced
distractibility are still not very well understood, our study aimed to investigate the underlying
mechanisms of distraction, as proposed by the TEC [20]. This theory postulates that stimulus-response
(S-R) bindings are established in so-called event files. Given previous findings that sensory information
seems to be accumulated more quickly when hungover [17], we hypothesized that S-R bindings should
consequently be enhanced in the hungover state. We further hypothesized that alcohol hangover
has different effects on the binding of response-relevant (target) information and the binding of
response-irrelevant (distracting) information. To test these hypotheses, we used a paradigm by Moeller
et al. [29] that allows to differentiate the effects of target-response binding and distractor-response
binding. Each participant was tested once sober and once hungover after being intoxicated in
a standardized experimental drinking setting the night before. Behavioral testing did not start until
a BrAC of 0.00‰ was measured on both appointments.
Interestingly, alcohol hangover modulated distractor-response binding in the accuracy data,
while target-response binding was not similarly affected: During the sober assessment, distractor
repetition was advantageous in responding to the relevant target stimuli, and this effect was found
regardless of target and response alterations (repetition vs. change). During the hungover assessment,
this advantage of distractor repetition was no longer evident, as the distractor effect was significantly
smaller. Of note, the sober distractor repetition effect can be explained by the TEC [20]: Whenever
response-irrelevant distracting information is presented at the same time as response-relevant target
information, both irrelevant and relevant stimulus features, as well as the response, are bound in event
files [20,42]. Once the distracting information of the pre-existing event file reappears, the entire event
file becomes (re)activated following a pattern-completion logic [20]. Changes in the configuration of
presented stimuli and required response do however require readjustments of the current event file.
As compared to distractor changes, distractor repetition should therefore require less extensive changes
or adaptations in the reactivated event file. Hence, less cognitive resources should be needed in case of
distractor repetition. This ultimately results in faster and more accurate responses. Even though the
TEC may explain why and how distracting information modulates behavior in a sober state, this theory
does not provide a straightforward explanation for the resulting pattern observed during alcohol
hangover. Given that target-response binding was seemingly unaffected by hangover (as substantiated
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by the lack of interactions between response and status), it can be assumed that event files were still
established during the hungover state. Within the framework of the TEC, the fact that the distractor
effect became substantially smaller during hangover may be explained by reduced distractor processing
and/or by enhanced target processing: Alcohol hangover may have affected the reactivation of the
event file by recurrent distractor features. This would imply that the sensory processing of distracting
information may be altered during hangover. Given that the accumulation of sensory information is
likely more efficient in hangover state [17], we had initially expected distractor-response bindings to be
strengthened. Based on Stock et al. [17], it was however not clear, whether all or only selected sensory
information could be processed in a more efficient way. It is therefore also possible that relevant
and irrelevant sensory information may be better discriminated during hangover. As a consequence,
response-irrelevant distracting information might be processed to a lesser degree than during the
sober state. By comparison, target information would then be processed more efficiently. In line
with this, the typically higher activation of target information is assumed to have a greater impact
on S-R bindings than the typically lower distractor information [43]. It could hence be speculated
that the activation of the more dominant target information might be even higher during hangover
due to its more efficient information accumulation [17]. Given that response and target repetition
effects were however not enhanced during hangover, it seems more likely that the observed changes
were primarily driven by decreased distractor processing, rather than by absolute increases in target
processing. Interestingly, this may theoretically help to neutralize some of the cognitive side effects of
alcohol hangover, rather than aggravate them. Further adding to this, the lack of target-associated
effects matches the findings of a previous publication demonstrating that target-based S-R associations
were not systematically modulated by acute alcohol intoxication [22].
Irrespective of hangover state, we found task-specific distractor-response binding effects in
response times, which are in line with previous findings on the paradigm used in this study [30,44]:
The event file-associated automatic response tendency induced by the distractor was advantageous in
case of response repetition while the benefit of distractor repetition was no longer evident in case of
response change. Additionally, the size of the distractor repetition effect was most pronounced in case
of response and target repetition, while the effect was smaller in case of target change, regardless of the
required response (repeated vs. changed). This result pattern may again be explained by the TEC:
Whenever distractor repetition and response repetition coincide, the distractor reactivates an event
file containing a response that is still correct in the current setting, thus resulting in faster responding.
Whenever there is a response change in the presence of distractor repetition, the reactivated response
no longer holds true for the current task requirement, resulting in a time-taking “unbinding” process
of the event file [42,45]. Additionally, the reactivation of the event file is suggested to be stronger,
the more stimulus and response features are repeated/activated [42,45]. That is, target and distractor
repetition lead to a stronger reactivation and thus faster responding than distractor repetition alone,
even when the response is the same in both cases (i.e., target change and target repetition). These sober
findings are thus well in line with various studies investigating S-R binding [22,29,30,46].
Putting our results in a broader context, it should be noted that previous studies investigating
distractor-induced cognitive and behavioral conflicts reported hangover-related impairments of
selective attention when applying classical Stroop and Erikson flanker tasks [47,48]. Further detailing
this, a previous study of our group showed that hangover enhanced the flanker effect only in case of
(subliminally) increased conflict load, suggesting that the overall strain on cognitive control resources
may play an important role for hangover effects on distractibility [18]. Yet, all these studies have
in common that the applied tasks did not allow differentiation between response-relevant target
and response-irrelevant distractor processing to the same degree as the current study. Furthermore,
they put a stronger focus on conflict processing than on binding phenomena. While we only found
selective impairments in distractor-response bindings, this does not exclude the possibility that
other cognitive and attentional mechanisms, which were not assessed by our paradigm, may also
be impaired and thus contribute to the hangover-related enhanced distractibility reported in other
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studies [14,47,48]. Therefore, further research is needed on other attentional mechanisms that could
help explain increased distractibility in the hangover state. Furthermore, it would be conceivable to
investigate these mechanisms in a naturalistic environment [49] and to investigate performance in
real-life challenges like an actual exam or quantifiable work performance. This would help to gain
insights into whether the consequences of alcohol hangover could be more severe in these situations
and could help to derive better preventive measures.
Limitations
The study sample was limited to males, as the ethics committee did not approve inducing such
an intoxication in females. This is rather unfortunate, as other studies have reported females to
experience more severe hangover symptoms than males [24,50], potentially because females tend to
metabolite ethanol more slowly than males. In this light, females might experience greater hangover
effects, which could translate to more severely impaired behavioral performance. Additionally, it has
been suggested that the quality and incidences of experiencing alcohol hangover might change with
age [51,52]. Based on these aspects, further studies including both sexes and adults of different age
groups would provide a more complete picture. Furthermore, we did not collect data on drinking
and detailed hangover history beyond the scope of the ASQ and AUDIT (which only covers the last
12 months). In doing so, we might have missed details on hangover and binge-drinking history,
which could potentially have explained additional variance. In this context, it should however also be
noted that as a result of the recruitment process, our study sample was quite homogenous with respect
to drinking patterns. As our sample was likely to have shown comparatively minor differences in their
hangover and/or binge-drinking history, we did not systematically investigate this. Studies that do
not apply such inclusion criteria might however benefit from assessing more details on their sample’s
drinking and hangover history.
5. Conclusions
In summary, we investigated whether and how alcohol hangover modulates S-R bindings,
as this may explain why distractibility might be increased during hangover, resulting in various
behavioral and performance difficulties. Specifically, we investigated whether hangover has different
effects on target-response bindings vs. distractor-response bindings. While hangover did not affect
target-response bindings, it decreased distractor-response bindings, resulting in the absence of distractor
effects. These findings implicate that heightened distractibility during hangover is likely not due
to increased distractor-response binding. Hence, other cognitive mechanisms relating to selective
attention are more likely to underlie the adverse effects of hangover on driving skills and other daily
activities. Therefore, more studies investigating the different aspects of distractibility and distractor
processing are needed to conclusively understand how alcohol hangover may increase distractibility.
Supplementary Materials: The following is available online at http://www.mdpi.com/2077-0383/9/3/778/s1.
Author Contributions: Conceptualization, methodology, validation, all authors; formal analysis, A.O., and A.-K.S.;
investigation, A.O. and A.-K.S.; resources, C.B. and A.-K.S.; data curation, A.O. and A.-K.S.; writing—original
draft preparation, A.O. and A.-K.S.; writing—review and editing, all authors; visualization, A.O.; supervision,
C.B. and A.-K.S.; project administration, A.-K.S.; funding acquisition, C.B. and A.-K.S. All authors have read and
agreed to the published version of the manuscript.
Funding: This research was funded by the Deutsche Forschungsgemeinschaft (DFG), grant numbers TRR 265 B07
and FOR 2698.
Acknowledgments: The authors thank all individuals who took part in this study. Open Access Funding by the
Publication Funds of the TU Dresden.
Conflicts of Interest: The authors declare no conflict of interest. The funders had no role in the design of the
study; in the collection, analyses or interpretation of data; in the writing of the manuscript or in the decision to
publish the results.
260
J. Clin. Med. 2020, 9, 778
References
1. Fell, J.C. Approaches for reducing alcohol-impaired driving: Evidence-based legislation, law enforcement
strategies, sanctions, and alcohol-control policies. Forensic Sci. Rev. 2019, 31, 161–184. [PubMed]
2. Ogden, E.J.D.; Moskowitz, H. Effects of alcohol and other drugs on driver performance. Traffic Inj. Prev.
2004, 5, 185–198. [CrossRef] [PubMed]
3. Lefio, Á.; Bachelet, V.C.; Jiménez-Paneque, R.; Gomolán, P.; Rivas, K. A systematic review of the effectiveness
of interventions to reduce motor vehicle crashes and their injuries among the general and working populations.
Rev. Panam. Salud Publica Pan Am. J. Public Health 2018, 42, e60. [CrossRef]
4. Rezaee-Zavareh, M.S.; Salamati, P.; Ramezani-Binabaj, M.; Saeidnejad, M.; Rousta, M.; Shokraneh, F.;
Rahimi-Movaghar, V. Alcohol consumption for simulated driving performance: A systematic review. Chin. J.
Traumatol. Zhonghua Chuang Shang Za Zhi 2017, 20, 166–172. [CrossRef] [PubMed]
5. Verster, J.C.; van de Loo, A.J.A.E.; Downey, L.A. Driving while hungover: The necessity of biomarkers of the
alcohol hangover state. Curr. Drug Abuse Rev. 2014, 7, 1–2. [CrossRef]
6. Seppälä, T.; Leino, T.; Linnoila, M.; Huttunen, M.; Ylikahri, R. Effects of hangover on psychomotor skills
related to driving: Modification by fructose and glucose. Acta Pharmacol. Toxicol. (Copenh.) 1976, 38, 209–218.
[CrossRef]
7. Rohsenow, D.J.; Howland, J.; Arnedt, J.T.; Almeida, A.B.; Greece, J.; Minsky, S.; Kempler, C.S.; Sales, S.
Intoxication with Bourbon Versus Vodka: Effects on Hangover, Sleep, and Next-Day Neurocognitive
Performance in Young Adults. Alcohol. Clin. Exp. Res. 2010, 34, 509–518. [CrossRef]
8. Verster, J.C.; Maarel, M.A.V.D.; McKinney, A.; Olivier, B.; Haan, L.D. Driving During Alcohol Hangover
Among Dutch Professional Truck Drivers. Traffic Inj. Prev. 2014, 15, 434–438. [CrossRef]
9. Verster, J.C.; Bervoets, A.C.; de Klerk, S.; Vreman, R.A.; Olivier, B.; Roth, T.; Brookhuis, K.A. Effects of alcohol
hangover on simulated highway driving performance. Psychopharmacology (Berl.) 2014, 231, 2999–3008.
[CrossRef]
10. Høiseth, G.; Fosen, J.T.; Liane, V.; Bogstrand, S.T.; Mørland, J. Alcohol hangover as a cause of impairment in
apprehended drivers. Traffic Inj. Prev. 2015, 16, 323–328. [CrossRef]
11. Mackus, M.; Griffin, C.; Munafò, M.R.; Adams, S. A systematic review of the next-day effects of heavy alcohol
consumption on cognitive performance. Addiction 2018, 113, 2182–2193.
12. Mackus, M.; van de Loo, A.J.A.E.; Raasveld, S.J.; Hogewoning, A.; Sastre Toraño, J.; Flesch, F.M.;
Korte-Bouws, G.A.H.; van Neer, R.H.P.; Wang, X.; Nguyen, T.T.; et al. Biomarkers of the alcohol hangover
state: Ethyl glucuronide (EtG) and ethyl sulfate (EtS). Hum. Psychopharmacol. Clin. Exp. 2017, 32, e2624.
[CrossRef]
13. van Schrojenstein Lantman, M.; van de Loo, A.; Mackus, M.; Verster, J. Development of a Definition for the
Alcohol Hangover: Consumer Descriptions and Expert Consensus. Curr. Drug Abuse Rev. 2017, 9, 148–154.
[CrossRef]
14. McKinney, A.; Coyle, K.; Verster, J. Direct comparison of the cognitive effects of acute alcohol with the
morning after a normal night’s drinking. Hum. Psychopharmacol. 2012, 27, 295–304. [CrossRef] [PubMed]
15. Karadayian, A.G.; Cutrera, R.A. Alcohol hangover: Type and time-extension of motor function impairments.
Behav. Brain Res. 2013, 247, 165–173. [CrossRef]
16. Shiferaw, B.; Stough, C.; Downey, L. Drivers’ visual scanning impairment under the influences of alcohol
and distraction: A literature review. Curr. Drug Abuse Rev. 2014, 7, 174–182. [CrossRef]
17. Stock, A.-K.; Hoffmann, S.; Beste, C. Effects of binge drinking and hangover on response selection
sub-processes-a study using EEG and drift diffusion modeling: Binge-drinking and hangover. Addict.
Biol. 2017, 22, 1355–1365. [CrossRef]
18. Zink, N.; Bensmann, W.; Beste, C.; Stock, A.-K. Alcohol Hangover Increases Conflict Load via Faster
Processing of Subliminal Information. Front. Hum. Neurosci. 2018, 12, 316. [CrossRef]
19. Opitz, A.; Hubert, J.; Beste, C.; Stock, A.-K. Alcohol Hangover Slightly Impairs Response Selection but not
Response Inhibition. J. Clin. Med. 2019, 8, 1317. [CrossRef]
20. Hommel, B. Action control according to TEC (theory of event coding). Psychol. Res. Psychol. Forsch. 2009, 73,
512–526. [CrossRef]
21. Hommel, B. How Much Attention Does an Event File Need? J. Exp. Psychol. Hum. Percept. Perform. 2005, 31,
1067–1082. [CrossRef]
261
J. Clin. Med. 2020, 9, 778
22. Stock, A.-K.; Bensmann, W.; Zink, N.; Münchau, A.; Beste, C. Automatic aspects of response selection remain
unchanged during high-dose alcohol intoxication. Addict. Biol. 2019, e12852. [CrossRef]
23. Martí-Prats, L.; Sánchez-Catalán, M.J.; Orrico, A.; Zornoza, T.; Polache, A.; Granero, L. Opposite motor
responses elicited by ethanol in the posterior VTA: The role of acetaldehyde and the non-metabolized fraction
of ethanol. Neuropharmacology 2013, 72, 204–214. [CrossRef] [PubMed]
24. Prat, G.; Adan, A.; Sánchez-Turet, M. Alcohol hangover: A critical review of explanatory factors. Hum.
Psychopharmacol. Clin. Exp. 2009, 24, 259–267. [CrossRef]
25. Wiese, J.G.; Shlipak, M.G.; Browner, W.S. The alcohol hangover. Ann. Intern. Med. 2000, 132, 897–902.
[CrossRef]
26. Le Daré, B.; Lagente, V.; Gicquel, T. Ethanol and its metabolites: Update on toxicity, benefits, and focus on
immunomodulatory effects. Drug Metab. Rev. 2019, 51, 545–561. [CrossRef]
27. Tipple, C.T.; Benson, S.; Scholey, A. A Review of the Physiological Factors Associated with Alcohol Hangover.
Curr. Drug Abuse Rev. 2017, 9, 93–98. [CrossRef]
28. Klapp, S.T. One version of direct response priming requires automatization of the relevant associations but
not awareness of the prime. Conscious. Cogn. 2015, 34, 163–175. [CrossRef]
29. Moeller, B.; Schächinger, H.; Frings, C. Irrelevant Stimuli and Action Control: Analyzing the Influence of
Ignored Stimuli via the Distractor-Response Binding Paradigm. J. Vis. Exp. 2014, 51571. [CrossRef]
30. Opitz, A.; Beste, C.; Stock, A.-K. Using temporal EEG signal decomposition to identify specific
neurophysiological correlates of distractor-response bindings proposed by the theory of event coding.
NeuroImage 2020, 209, 116524. [CrossRef]
31. World Health Organization. AUDIT: The Alcohol Use Disorders Identification Test: Guidelines for use in
primary care/Thomas F. Babor... [et al.], 2nd ed. Available online: https://apps.who.int/iris/handle/10665/67205
(accessed on 5 March 2020).
32. Dybek, I.; Bischof, G.; Grothues, J.; Reinhardt, S.; Meyer, C.; Hapke, U.; John, U.; Broocks, A.; Hohagen, F.;
Rumpf, H.-J. The Reliability and Validity of the Alcohol Use Disorders Identification Test (AUDIT) in
a German General Practice Population Sample. J. Stud. Alcohol 2006, 67, 473–481. [CrossRef]
33. Montgomery, C.; Fisk, J.E.; Murphy, P.N.; Ryland, I.; Hilton, J. The effects of heavy social drinking on
executive function: A systematic review and meta-analytic study of existing literature and new empirical
findings: EXECUTIVE FUNCTION AND ALCOHOL USE. Hum. Psychopharmacol. Clin. Exp. 2012, 27,
187–199. [CrossRef] [PubMed]
34. Bensmann, W.; Kayali, Ö.F.; Beste, C.; Stock, A.-K. Young frequent binge drinkers show no behavioral deficits
in inhibitory control and cognitive flexibility. Prog. Neuropsychopharmacol. Biol. Psychiatry 2019, 93, 93–101.
[CrossRef]
35. van Schrojenstein Lantman, M.; Mackus, M.; Roth, T.; Verster, J. Total sleep time, alcohol consumption,
and the duration and severity of alcohol hangover. Nat. Sci. Sleep 2017, 9, 181–186. [CrossRef]
36. Widmark, E.M.P. Die Theoretischen Grundlagen Und Die Praktische Verwendbarkeit Der Gerichtlich-Medizinischen
Alkoholbestimmung; Urban und Schwarzenberg: Berlin, Germany, 1932.
37. Watson, P.E.; Watson, I.D.; Batt, R.D. Total body water volumes for adult males and females estimated from
simple anthropometric measurements. Am. J. Clin. Nutr. 1980, 33, 27–39. [CrossRef] [PubMed]
38. Epler, A.J.; Tomko, R.L.; Piasecki, T.M.; Wood, P.K.; Sher, K.J.; Shiffman, S.; Heath, A.C. Does Hangover
Influence the Time to Next Drink? An Investigation Using Ecological Momentary Assessment. Alcohol. Clin.
Exp. Res. 2014, 38, 1461–1469. [CrossRef] [PubMed]
39. Jackson, K.M.; Rohsenow, D.J.; Piasecki, T.M.; Howland, J.; Richardson, A.E. Role of Tobacco Smoking in
Hangover Symptoms Among University Students. J. Stud. Alcohol Drugs 2013, 74, 41–49. [CrossRef]
40. Beck, A.T. An Inventory for Measuring Depression. Arch. Gen. Psychiatry 1961, 4, 561. [CrossRef]
41. Fleming, K.A.; Bartholow, B.D.; Hilgard, J.; McCarthy, D.M.; O’Neill, S.E.; Steinley, D.; Sher, K.J. The Alcohol
Sensitivity Questionnaire: Evidence for Construct Validity. Alcohol. Clin. Exp. Res. 2016, 40, 880–888.
[CrossRef]
42. Colzato, L.S.; Warrens, M.J.; Hommel, B. Priming and binding in and across perception and action:
A correlational analysis of the internal structure of event files. Q. J. Exp. Psychol. 2006, 59, 1785–1804.
[CrossRef]
43. Hommel, B.; Müsseler, J.; Aschersleben, G.; Prinz, W. The Theory of Event Coding (TEC): A framework for
perception and action planning. Behav. Brain Sci. 2001, 24, 849–937. [CrossRef] [PubMed]
262
J. Clin. Med. 2020, 9, 778
44. Frings, C.; Rothermund, K.; Wentura, D. Distractor repetitions retrieve previous responses to targets. Q. J.
Exp. Psychol. 2007, 60, 1367–1377. [CrossRef] [PubMed]
45. Hommel, B.; Colzato, L. Visual attention and the temporal dynamics of feature integration. Vis. Cogn. 2004,
11, 483–521. [CrossRef]
46. Petruo, V.A.; Stock, A.-K.; Münchau, A.; Beste, C. A systems neurophysiology approach to voluntary event
coding. NeuroImage 2016, 135, 324–332. [CrossRef]
47. Devenney, L.E.; Coyle, K.B.; Verster, J.C. Memory and attention during an alcohol hangover. Hum.
Psychopharmacol. Clin. Exp. 2019, 34, e2701. [CrossRef]
48. McKinney, A.; Coyle, K.; Penning, R.; Verster, J.C. Next day effects of naturalistic alcohol consumption on
tasks of attention. Hum. Psychopharmacol. Clin. Exp. 2012, 27, 587–594. [CrossRef]
49. Verster, J.C.; van de Loo, A.J.A.E.; Adams, S.; Stock, A.-K.; Benson, S.; Scholey, A.; Alford, C.; Bruce, G.
Advantages and Limitations of Naturalistic Study Designs and Their Implementation in Alcohol Hangover
Research. J. Clin. Med. 2019, 8, 2160. [CrossRef]
50. van Lawick van Pabst, A.E.; Devenney, L.E.; Verster, J.C. Sex Differences in the Presence and Severity of
Alcohol Hangover Symptoms. J. Clin. Med. 2019, 8, 867. [CrossRef]
51. Tolstrup, J.S.; Stephens, R.; Grønbaek, M. Does the Severity of Hangovers Decline with Age? Survey of the
Incidence of Hangover in Different Age Groups. Alcohol. Clin. Exp. Res. 2014, 38, 466–470. [CrossRef]
52. Thumin, F.; Wims, E. The Perception of the Common Cold, and other Ailments and Discomforts, as Related
to Age. Int. J. Aging Hum. Dev. 1975, 6, 43–49. [CrossRef]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution






Alcohol Hangover Slightly Impairs Response
Selection but not Response Inhibition
Antje Opitz, Jan Hubert, Christian Beste and Ann-Kathrin Stock *
Cognitive Neurophysiology, Department of Child and Adolescent Psychiatry, Faculty of Medicine, TU Dresden,
Fetscherstr. 74, 01307 Dresden, Germany
* Correspondence: ann-kathrin.stock@ukdd.de
Received: 31 July 2019; Accepted: 23 August 2019; Published: 27 August 2019
Abstract: Alcohol hangover commonly occurs after an episode of heavy drinking. It has previously
been demonstrated that acute high-dose alcohol intoxication reduces cognitive control, while automatic
processes remain comparatively unaffected. However, it has remained unclear whether alcohol
hangover, as a consequence of binge drinking, modulates the interplay between cognitive control
and automaticity in a comparable way. Therefore, the purpose of this study was to investigate
the effects of alcohol hangover on controlled versus automatic response selection and inhibition.
N = 34 healthy young men completed a Simon Nogo task, once sober and once hungover. Hangover
symptoms were experimentally induced by a standardized administration of alcoholic drinks (with
high congener content) on the night before the hangover appointment. We found no significant
hangover effects, which suggests that alcohol hangover did not produce the same functional deficits
as an acute high-dose intoxication. Yet still, add-on Bayesian analyses revealed that hangover slightly
impaired response selection, but not response inhibition. This pattern of effects cannot be explained
with the current knowledge on how ethanol and its metabolite acetaldehyde may modulate response
selection and inhibition via the dopaminergic or GABAergic system.
Keywords: alcohol; hangover; cognitive control; automatism; Simon Nogo task; response selection;
response inhibition
1. Introduction
Alcohol hangover is an unpleasant state that may occur after an episode of heavy drinking, that
is, once the breath/blood alcohol concentration (BAC) returns to 0.0‰. It subsumes several aversive
mental and physical symptoms like headaches, vomiting, tiredness, sweating, circulatory problems or
depressed mood [1]. It has furthermore been shown to slow psychomotor speed as well as information
processing and has been suggested to impair several cognitive functions, including attention, memory,
and executive functioning [2–7]. As a consequence, alcohol hangover is associated with impaired
workplace productivity and safety [8], as well as reduced driving abilities [4,9]. Given that binge
drinking is quite prevalent [10–12], alcohol hangover has been estimated to also be very prevalent and
result in huge economic and societal costs due to its debilitating effects [2].
Importantly, regular binge-drinking does not only increase the likelihood and frequency of
hangover, it also strongly increases the risk of developing alcohol use disorder (AUD) [13–15]. While it
is still unclear whether or how these two consequences are functionally linked, it has been shown that
the acute cognitive effects of a high-dose alcohol intoxication resemble the pattern of cognitive deficits
observed in AUD patients—both produce pronounced impairments in cognitive control/executive
functioning, while behavioural automaticity is comparatively preserved [16–20]. This imbalance
between behavioural control and automaticity has repeatedly been shown to play an important role
in the development and maintenance of AUD [21] but it has never been investigated whether such
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specific effects can also be found during alcohol hangover (which should be a regular occurrence in
frequent binge drinkers). Demonstrating the persistence of such detrimental effects during hangover
(i.e., beyond acute intoxication) would provide an important functional link, which may help to explain
why and how regular binge drinking increases the risk of developing AUD [13–15]: If impairments of
cognitive control functions persisted beyond acute intoxication, the poor cognitive functioning on the
day following alcohol use might promote continued aberrant drinking as well as other decisions that
may be detrimental to the overall health of affected individuals. This is especially relevant as acute
alcohol intoxication, alcohol hangover and AUD are all characterized by changes in the dopaminergic
and GABAergic neurotransmitter systems [22–27]. Specifically, ethanol and its major metabolite
acetaldehyde, which has been suggested to strongly contribute to hangover symptoms [28,29], show
similar effects on dopaminergic neural transmission by increasing dopaminergic signalling [23,26].
In contrast, ethanol enhances GABAergic signalling [24,25], while acetaldehyde has been suggested to
decrease GABAergic signalling [27,30], even though this effect is still debated [31,32]. Overall, both the
dopaminergic and GABAergic neurotransmitter systems play a strong modulatory role for cognitive
control including response selection [33–37] and might therefore provide a functional link between all
three phenomena.
We therefore set out to investigate the effects of alcohol hangover on controlled versus automatic
behavior in young healthy males. They were subjected to a previously established, counter-balanced
within-subject study design where hangover symptoms are experimentally induced via standardized
administration of alcoholic beverages with high congener content [38]. In order to assess differences
in controlled versus automatic response selection, we used the Simon Nogo task [39], which is an
extended Simon task [40,41], where 30% of the trials require to inhibit all motor responses. The typical
Simon effect reflects a stimulus-response (S-R) conflict [41,42]. This conflict is thought to arise between
automatic “direct route” processes that promote “unconditionally automatic” responding on the
task-irrelevant stimulus side and controlled “indirect route” processing of the correct response based
on the “conditional” processing of task-relevant stimulus features [43]. When stimulus and responding
hand have the same laterality (S-R congruency), these two kinds of processing indicate the same
response. This overlap allows to rely on automatic response selection so that very little control is needed.
When stimulus and responding hand have an incongruent laterality, the two processes interfere with
each other. As a consequence, increased control is required to overcome the incorrect automatic
response tendencies, which ultimately impairs response selection [40,41,43–45]. Aside from this typical
Simon effect, opposing effects are observed in case of response inhibition which is typically better in
case of S-R incongruence, than in case of S-R congruency [18,39,46]. The reason for this inversion of
effects is that, other than response selection, response inhibition is typically worse in case of fast and
automatic response tendencies (as compared to slower, more controlled responding) [18,39,47,48]. As a
consequence, correct responding requires more top-down control/is more error-prone in incongruent
Go trials and congruent Nogo trials (as compared to congruent Go trials and incongruent Nogo trials).
Importantly, the detrimental effects of an acute high-dose alcohol intoxication have recently been found
to be most pronounced in these conditions, suggesting that top-down control is more severely impaired
by alcohol intoxication than automatic processing [18]. As we wanted to test whether the same
effects can be found during alcohol hangover, we hypothesized that hangover induces a comparable
pattern (i.e., stronger impairments in incongruent Go trials and congruent Nogo trials, as compared to
congruent Go trials and incongruent Nogo trials). Given that alcohol hangover might however not
necessarily replicate the same data pattern as acute intoxication [38], we decided to conduct Bayesian
analyses on non-significant hangover effects in order to substantiate whether the null or alternative
hypothesis is more likely, given the obtained data.
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2. Experimental Section
2.1. Participants and Sample Size Estimation
In a previous within-subject hangover study conducted by our group [38], the detected hangover
effects yielded effect sizes between η2p = 0.26/f = 0.59 and η2p = 0.39/f = 0.80. When using those, as
well as the correlation of r = 0.356 among repeated (sober accuracy) measures obtained in a previous
study using the same paradigm [18], for an a priori estimation of required sample size with G*power
software [49], we obtained a sample size between n = 7 and n = 4, when yielding for an alpha error
probability of 5% and a power of 95%. The effect sizes for acute high-dose intoxication on this task
were between η2p = 0.09/f = 0.31 and η2p = 0.16/f = 0.44 [18], which yields samples sizes between n =
19 and n = 11 in the same a priori estimation. When being a little more conservative and assuming
medium effect sizes of f = 0.25 [50], the a priori power analysis yielded a required sample size of n
= 30. In order to compensate for drop-outs and minor issues, we therefore initially recruited n = 37
healthy male participants. These were aged 19–28 years and recruited via online advertising, flyers
and postings at the local University (TU Dresden) and in the local nightlife district (Dresden Neustadt).
All participants were right-handed and had normal or corrected to normal vision. Inclusion criteria
and eligibility was assessed during a telephone screening. All included participants reported to have
no chronic, somatic, neurological or psychiatric diseases and to not take any medication affecting
normal central nervous system (CNS), liver or kidney function. We further assessed the alcohol use
disorders identification test (AUDIT) [51]. In order to exclude individuals with a high likelihood of
AUD and/or high alcohol tolerance, we excluded all applicants with an overall AUDIT score above
19 [51]. We further excluded all individuals reporting to binge-drink (i.e., consume 8 or more units of
alcohol on a single occasion), or have alcohol-induced memory issues, or fail to do things that were
normally expected from them “daily or almost daily.” In order to exclude light drinkers (who might
not be able to cope well with the alcohol amounts administered in this study), we excluded individuals
who indicated to binge-drink only once a month or less in the last 12 months. As a consequence, the
minimum AUDIT cutoff for inclusion was 2 points. Lastly, individuals who stated to not having been
noticeably drunk on at least one occasion in the last 12 months were also excluded. All participants
provided written informed consent and were reimbursed with 80 €. The study was approved by the
Ethics Committee of the Faculty of Medicine of the TU Dresden and was conducted in accordance of
the Declaration of Helsinki.
2.2. Experimental Design and Hangover Provoking Procedure
The study design and experimental intoxication to provoke hangover symptoms followed the
protocol used in a previous study of our lab [38], which is illustrated in Figure 1.
In short, each participant was tested twice (once sober and once hungover) with a delay of no
less than 48 h and no more than 7 days between sober and hangover appointment. The order of both
appointments was counterbalanced between all participants (that is, half of the participants had their
sober appointment before their hangover appointment; the other half had their hangover appointment
before their sober appointment). Breath alcohol concentration (BAC) was assessed at the start of each
appointment. The experiment was not started until participants reached a BAC of 0.00‰. We used
the breathalyser “Alcotest 3000“ to measure BAC as instructed by the manufacturer (Drägerwerk,
Lübeck, Germany). In order to provoke hangover symptoms, we invited 4 to 8 participants to our
laboratory on the night before their hangover appointment. These drinking appointments were always
scheduled for Friday or Saturday evening (20:00 starting time; ending usually 01:30 to 02:00), while the
subsequent hangover appointment was always scheduled for the morning of the following day (i.e.,
either Saturday or Sunday, starting time between 09:00 and 11:00). This resulted in a slight reduction
of sleeping time, which seems to be inversely associated with hangover severity [52].
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Figure 1. Illustration of sober, intoxication and hangover appointments, as adapted from Zink et al. [38].
Each participant was tested on a sober and a hangover appointment, which were at least 48 h and
no more than 7 days apart. The order of both appointments was counterbalanced across the sample.
Each session started with providing written consent and a brief assessment of the current health. Data
collection (assessment of hangover symptoms and paradigm performance) was not started before
participants had reached a blood alcohol concentration (BAC) of 0.00‰ on both appointments. In order
to provoke alcohol hangover symptoms, participants were invited to the laboratory on a Friday or
Saturday evening at 20:00. After providing their written consent, participants filled out questionnaires
assessing sociodemographic data, depression, anxiety, alcohol sensitivity, height and weight. To assure
sobriety at the start of drinking, BAC was assessed before alcohol consumption. An individually
calculated amount of alcohol was consumed from around 20:15 to 23:00. Participants were asked to
stay in the laboratory until 01:30. BAC readings were taken every 30 min starting half an hour after the
last sip of alcohol. Eventually, participants were taken home by taxi and returned the next morning
between 09:00 and 11:00 for their hangover appointment.
In the night of experimental intoxication, an individual amount of alcohol was determined for
each participant using a version of the equation by Widmark [53] and Watson [54]. We aimed to reach
BAC values of no more than 1.6‰, by assessing how much alcohol needed to be added to the total
body water in order to reach a concentration of 2.0‰. Given that the expected resorption deficit is
about 20% on an empty stomach in case all alcohol is consumed at once, this ensures that a BAC of
1.6‰ is very unlikely to be exceeded. Furthermore, the consumption duration was stretched over at
least 2 h by the experimenters and all participants were instructed to partake on a full stomach, where
the resorptions deficit is usually higher (about 30–40%). Hence, participants were expected to reach a
mean BAC of approximately 1.2‰ with a small probability of achieving a BAC beyond 1.6‰. The tool
used to determine individual amounts of alcohol and to document alcohol consumption can be found
online at https://osf.io/9ykpg/.
Due to the greater likelihood of causing a severe hangover, only alcoholic drinks with a high
congener content were offered [55,56]. Therefore, each participant could choose between drinking cheap
brandy (36 Vol %) and/or cheap red wine (9.5 Vol %). Both drinks were served by the experimenters in
standardized portions of 200 mL red wine (15 g alcohol) or 50 mL brandy (14 g alcohol), so that the
speed and amount of alcohol consumption were similar across drinks. Participants could furthermore
choose whether they wanted to consume each drink pure, chilled on ice or mixed with caffeine-free coke,
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ginger ale, or orange lemonade. Tap water and snacks (chips, wine gums) were available at all times
and their intake was not controlled or documented. Moreover, participants were permitted to smoke
while drinking, because this is assumed to increase hangover symptoms [57,58]. This opportunity was
taken by n = 8 participants, of which n = 7 claimed to be regular smokers. BAC was measured 30, 60,
90 and 120 min after the end of alcohol consumption. Lastly, participants were encouraged to neither
use caffeine, guarana nor nicotine within four hours before the start of each appointment.
2.3. Questionnaires
At the beginning of the intoxication appointment (before alcohol administration), participants
provided sociodemographic details and filled in the anxiety sensitivity index (ASI) [59] to assess fears
of physical symptoms of anxiety itself. As hangover symptoms like nausea, heart racing, shivering or
concentration problems are similar to the anxiety symptoms assessed by the ASI, this allowed us to
obtain an estimation of how unpleasant physical symptoms of hangover might be for the participant
(please note that we did so as there is currently no reliable questionnaire to assess the affective rating
of hangover symptoms). Moreover, Beck’s depression inventory (BDI) [60] was used to determine
depressive symptoms, as these may have a potential influence on cognitive (task) performance. To
evaluate sensitivity to common alcohol effects, participants were asked to fill in the alcohol sensitivity
questionnaire (ASQ) [61]. The ASQ enables to distinguish between alcohol related experiences referring
to lighter drinking (like being more talkative) and alcohol related experiences referring to heavier
drinking (like experiencing a hangover). High ASQ scores point to low alcohol sensitivity. At the
beginning of each sober and hangover appointment, participants were asked to rate their hangover
symptom severity on a Likert-scale ranging from 0 (no symptoms) to 10 (extreme symptoms) consisting
of 23 items as used by van Schrojenstein Lantman and colleagues [1]. Of note, we added another item
to assess sleeping problems/sleep quality. Finally, participants stated how many hours of sleep they
obtained the previous nights, respectively.
2.4. Task
We used a so-called Simon Nogo paradigm in order to assess the effects of alcohol hangover
on automatic versus top-down response selection and inhibition [39]. Importantly, we previously
employed this paradigm in a study demonstrating that an acute alcohol intoxication of ~1.1‰ had
stronger detrimental effects when high levels of top-down control were required for correct responding,
as compared to less controlled/more automatic response processing [18]. The paradigm is schematically
illustrated in Figure 2.
The task was presented on a 17” CRT monitor, which displayed a central white fixation cross and
two lateralized white frame boxes on black background throughout the entire duration of the task.
Every trial started with the synchronous 200 ms presentation of a target stimulus (single yellow letter;
either “A” or “B”) in one of the two boxes and a distractor stimulus (three white horizontal lines) in the
respective other box. Participants were instructed to press the left Ctrl button on a regular QWERTZ
keyboard with the left index finger in response to the target letter “A” and to press the right Ctrl button
with the right index finger in response to the target letter “B.” Importantly, participants were further
instructed to only respond when the target letters were printed in a regular font (i.e., “A”/“B”; Go
condition) but to refrain from all responses whenever the target letters were printed italic and bold
(i.e., “A”/“B”; Nogo condition). The first given response ended the trial. In Nogo trials, any response
was coded as a false alarm, while it was either coded as “correct” or “incorrect” in Go trials. If no
response was given, the trial was terminated after 1700 ms and either coded as a “miss” (Go condition)
or as a “correct omission” (Nogo condition). The inter-trial interval (ITI) was jittered between 1300 and
1700 ms. Overall, the experiment comprised 360 trials, which were subdivided into three equally large
blocks. The participants were offered breaks in between the blocks and took approximately 15 min to
complete the task.
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Figure 2. Illustration of the experimental paradigm showing all possible stimulus combinations. On the
upper half, the Go condition (70% of all trials) is illustrated. It was indicated by regular letter stimuli.
Regardless of stimulus location, stimulus “A” always required a left button press while stimulus “B”
always required a right button press. Whenever stimulus location and required response button were
located on the same side, the trial was labelled as congruent. Whenever stimulus location and required
response button were located on opposite sides, the trial was labelled as incongruent. On the lower
half, the Nogo condition (30% of all trials) is illustrated. It was indicated by bold and italic letter stimuli
(“A” and “B”), which required to withhold all motor responses and thus display no response at all.
Of note, each of the two target stimuli occurred equally often on each side and in each condition.
Whenever the target stimulus appeared on the side of the correct response (i.e., left “A” and right “B”),
we coded the trial as congruent (50% of Go and Nogo trials). When the target stimulus appeared on
the opposing side (i.e., right “A” and left “B”), we coded the trial as incongruent (50% of Go and Nogo
trials). In summary, each experimental block contained 70% Go trials and 30% Nogo trials and in each
of those two conditions, each target letter and congruency rating occurred equally often. The order of
trials was separately randomized in each block.
2.5. Statistical Analyses
The behavioural data (accuracy) was analysed using a repeated-measures ANOVA. Hangover
status (hangover vs. sober), condition (Go vs. Nogo), and congruency (congruent vs. incongruent)
were used as within-subject factors. Reported values of the ANOVA underwent Greenhouse-Geisser
correction and parametric post hoc tests were Bonferroni-corrected, whenever necessary. All descriptive
statistics were reported using the mean value and the standard error of the mean (SEM) as a measurement
of variability. All variables were tested for normal distribution using Kolmogorov-Smirnov tests.
As this prerequisite was not given for most accuracy variables, all significant main effects and post
hoc tests were additionally tested for significance using non-parametric Wilcoxon signed-rank tests.
Lastly, in order to investigate whether the null or alternative hypothesis was more likely in case of
non-significant main or interaction effects of hangover status, Bayesian analyses were computed as
suggested by Masson [62]. In short, this method returns the likelihood of the H0 and H1, given the
obtained data. According to Raftery [63], P(Hi|D) values of 50–75% can be regarded as weak evidence
for a given hypothesis, values of 75–95% can be regarded as positive evidence for a given hypothesis,
values of 95–99% can be regarded as strong evidence for a given hypothesis, and values above 99%
can be regarded as very strong evidence for a given hypothesis. Behavioural data and all statistical
analyses can be found online at https://osf.io/9ykpg/.
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3. Results
3.1. Sample Characteristics
Out of the initially recruited n = 37 participants, one participant was excluded from the sample
due to a high residual BAC at the start of his hangover appointment (0.45‰), as this would have
required 4 to 5 h of waiting time which he could not afford to spend on that day. Another participant
was excluded due to technical problems on the sober appointment. A last participant was excluded due
to performance accuracy below 60% in Nogo trials on both appointments (his performance deviated
from the mean performance of the respective conditions by ≥ 3.57 standard deviations). As a result, n
= 34 participants entered statistical analyses. Of those, n = 17 had their sober appointment before their
hangover appointment and n = 17 had their hangover appointment before their sober appointment.
Sociodemographic characteristics as well as hangover-related data are provided in Table 1. Subjective
ratings of sleep and hangover symptoms on both appointments are given in Table 2.
Table 1. Sociodemographic and alcohol-related data of all included participants. All values are given
as means ± standard error of the mean (range). Of note, missing alcohol sensitivity questionnaire
(ASQ) values (in case a participant indicated never having experienced a given alcohol-associated
phenomenon) were not interpolated. All ASQ lighter drinking items as well as almost all ASQ heavier
drinking items except for the item “passing out” were averaged, as only one participant reported ever
having passed out after heavy drinking.
Characteristic Included Sample (n = 34)
Age in years 23.21 ± 0.48 (19–28)
Height in cm 181.59 ± 0.99 (170–195)
Weight in kg 77.37 ± 1.73 (63–105)
Cigarettes smoked per day 0.80 ± 0.38 (0–10)
Hours of sport per week 4.65 ± 0.58 (0–16)
BDI Score 3.32 ± 0.70 (0–19)
ASI Score 13.34 ± 1.45 (1–33)
AUDIT Score 9.94 ± 0.54 (5–18)
ASQ Score total 8.40 ± 0.41 (3.25–13.29)
ASQ Score of light-drinking 5.27 ± 0.31 (1.63–9.25)
ASQ Score of heavy-drinking 13.43 ± 0.79 (5.20–24.00)
Individual measured alcohol amount of brandy (36 Vol %) in mL 419.71 ± 5.95 (369–516)
Alcohol consumption duration in minutes 182.50 ± 4.33 (111–243)
BAC 30 min after end of consumption 1.31 ± 0.03 (1.05–1.69)
BAC 60 min after end of consumption 1.24 ± 0.02 (1.01–1.56)
BAC 90 min after end of consumption 1.15 ± 0.02 (0.91–1.40)
BAC 120 min after end of consumption 1.07 ± 0.03 (0.83–1.43)
BDI = Beck Depression Inventory, ASI = Anxiety Sensitivity Index, AUDIT = Alcohol Use Disorders Identification
Test, ASQ = Alcohol Sensitivity Questionnaire, BAC = Breath Alcohol Concentration.
Table 2. Subjective sleep and hangover symptoms on both appointments. Hangover symptoms were
rated on an 11-point Likert scale ranging from 0 (no symptoms) to 10 (extreme symptoms). Of note,
participants were asked to truthfully rate the severity of each symptom on both testing days, irrespective
of whether they had been drinking the night before the sober appointment. The mild symptom severity
for the sober appointment and the resulting minimal variance of this rating may have contributed to
the fact that nearly all hangover symptoms differed significantly between the sober and the hangover
testing (as was intended by the study). These comparisons were run with uncorrected paired t-tests.
p-values are given in the column “Difference.” All values are reported as means ± standard error of the
mean (range).
Symptom Sober Hangover Difference
Hours of sleep in previous night 7.35 ± 0.15 (5.50–9) 5.58 ± 0.19 (4–8) p < 0.001 **
Overall hangover severity 0 ± 0 (0–0) 3.82 ± 0.42 (0–10) p < 0.001 **
Headache 0.06 ± 0.04 (0–1) 2.68 ± 0.40 (0–8) p < 0.001 **
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Table 2. Cont.
Symptom Sober Hangover Difference
Nausea 0.03 ± 0.03 (0–1) 1.71 ± 0.39 (0–7) p < 0.001 **
Concentration problems 0.61 ± 0.18 (0–4) 3.21 ± 0.40 (0–8) p < 0.001 **
Regret 0.12 ± 0.12 (0–4) 1.00 ± 0.36 (0–10) p = 0.003 **
Sleepiness 0.97 ± 0.22 (0–4) 3.91 ± 0.44 (0–9) p < 0.001 **
Heart pounding 0.30 ± 0.10 (0–2) 0.94 ± 0.24 (0–5) p = 0.010 *
Vomiting 0.03 ± 0.03 (0–1) 0.82 ± 0.34 (0–9) p < 0.030 *
Tired 1.09 ± 0.21 (0–4) 4.71 ± 0.40 (1–10) p < 0.001 **
Shivering 0.36 ± 0.13 (0–3) 1.24 ± 0.29 (0–6) p = 0.006 **
Clumsy 0.42 ± 0.15 (0–3) 2.12 ± 0.33 (0–6) p < 0.001 **
Weakness 0.30 ± 0.11 (0–2) 2.50 ± 0.37 (0–10) p < 0.001 **
Dizziness 0.03 ± 0.03 (0–1) 1.88 ± 0.33 (0–8) p < 0.001 **
Apathy 0 ± 0 (0–0) 1.03 ± 0.23 (0–5) p < 0.001 **
Sweating 1.06 ± 0.28 (0–6) 1.24 ± 0.32 (0–9) p = 0.555
Stomach pain 0.24 ± 0.16 (0–5) 1.29 ± 0.38 (0–8) p < 0.001 **
Confusion 0.15 ± 0.08 (0–2) 1.15 ± 0.28 (0–7) p = 0.001 **
Sensitivity to light 0.30 ± 0.13 (0–3) 1.68 ± 0.33 (0–8) p < 0.001 **
Thirst 0.79 ± 0.22 (0–4) 3.44 ± 0.37 (0–8) p < 0.001 **
Heart racing 0.15 ± 0.08 (0–2) 0.65 ± 0.26 (0–6) p = 0.084
Anxiety 0.48 ± 0.16 (0–3) 1.24 ± 0.35 (0–9) p = 0.016 *
Depression 0.21 ± 0.16 (0–5) 0.76 ± 0.29 (0–9) p = 0.011 *
Reduced appetite 0.21 ± 0.16 (0–5) 2.12 ± 0.44 (0–9) p < 0.001 **
Sleeping problems 0.21 ± 0.14 (0–4) 1.00 ± 0.35 (0–8) p = 0.018 *
* p < 0.05, ** p < 0.01.
3.2. Test-Retest Reliability of the Experimental Paradigm
As we tested the participants on two consecutive appointments, we decided to assess the test-retest
reliability of the Simon Nogo paradigm. For this, we compared the first and second appointment of
the entire group, while disregarding the experimental manipulation. As appointment order had been
balanced across the group, half of the performance data in the first appointment was “sober,” while the
other half was “hungover.” The same was true for the second appointment. We separately determined
the test-retest reliability of Go and Nogo trials, as they assess different cognitive domains. Doing so,
we found that the test-retest reliability was good in both measures, as all r ≥ 0.803 and all p < 0.001.
3.3. Behavioral Data
The accuracy data are shown in Figure 3. The repeated-measures ANOVA for accuracy revealed a
main effect of condition (F(1,33) = 12.284; p = 0.001; η2p = 0.271), with higher accuracy in Go (97.0% ± 0.40)
than in Nogo trials (93.3% ± 1.03). There was also a main effect of congruency (F(1,33) = 6.944; p = 0.013;
η2p = 0.174), showing higher accuracy in incongruent (95.7% ± 0.54) than in congruent trials (94.7% ±
0.68). Yet, it should be noted that this effect does not contradict the Simon effect, as these numbers
average Go trials (where congruent trials are typically performed better than incongruent trials) and
Nogo trials (where congruent trials are typically performed worse than incongruent trials). In addition,
there was an interaction of condition x congruency (F(1,33) = 16.03; p < 0.001; η2p = 0.327). In line with
previous studies of this task [18,39], we found opposing effects of stimulus congruency on Go versus
Nogo trials. Specifically, there was a typical Simon effect (congruent > incongruent) in Go trials (t(33)
= 2.134; p = 0.040; cong = 97.4% ± 0.33; incong = 96.6% ± 0.54), which was inverted (congruent <
incongruent) in Nogo trials (t(33) = −3.851; p = 0.001; cong = 91.9% ± 1.30; incong = 94.7% ± 0.84).
In line with this, a post-hoc paired t-test showed a positive Simon effect (congruent minus incongruent)
in Go trials (0.9% ± 0.40) and negative Simon effect in Nogo trials (−2.8% ± 0.74), which significantly
differed from each other (t(33) = 4.004; p < 0.001). The interaction of hangover status x condition was
non-significant (F(1,33) = 3.478; p = 0.071; η2p = 0.095) but add-on Bayesian analysis provided positive
evidence for the alternative hypothesis, given the obtained data (PBIC(H1|D) = 94.3%) (please see
Table 3 for details) [63]. We therefore decided to conduct post-hoc analyses. Post-hoc paired t-tests
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showed significantly higher accuracy in sober Go trials (97.4% ± 0.39) than in hangover Go trials (96.6%
± 0.51) (t(33) = 2.053; p = 0.048). No such effect was obtained for Nogo trials (t(33) = −1.125; p = 0.269).
Additional correlation analyses showed that hangover Go accuracy was significantly correlated with
the hangover effect (sober minus hangover) (r = −0.664, p < 0.001), while sober Go accuracy was not
(p= 0.291). This suggests that the size of the hangover effect was mainly determined by changes induced
by the hangover status. In order to explore whether these measures showed a performance difference
between participants who reported light versus heavy hangover symptoms, we performed a median
split of the group. All participants with an overall hangover severity rating of 0–3 on the 11-point
Likert scale were classified as “low hangover severity” (n = 19), while all participants with an overall
hangover severity rating of 4–10 were classified as “high hangover severity” (n = 15). Mann-Whitney-U
tests for independent samples showed that Go accuracy on the hangover day was lower in individuals
with high hangover severity (95.50% ± 0.89) than in individuals with low hangover severity (97.43%
± 0.51) (p = 0.040). No such effect was found for the Go accuracy performance difference between
sober and hangover day (p = 0.891). All other main and interaction effects of the hangover status were
non-significant in the repeated-measures ANOVA (all F ≤ 0.364; p ≥ 0.550).
 
Figure 3. Both graphs visualize the obtained sober vs. hungover accuracy (percentage of correct trials)
with error bars depicting the standard error of the mean. Left graph: While we obtained no significant
difference between the sober and hangover appointments, Bayesian statistics strongly suggested that
there was an interaction between hangover status and condition. As depicted, post hoc paired t-tests
detailing this effect showed significantly decreased accuracy in the Go condition, but not in the Nogo
condition. Right graph: All factor combinations are depicted. There was a significant interaction
between condition and congruency, as Go accuracy was higher in the congruent condition than in
the incongruent condition, while Nogo accuracy was higher in the incongruent condition than in the
congruent condition. This effect did, however, not vary between sober and hangover appointments.
In order to assess whether there was truly no other effect of hangover status (i.e., whether the
null hypothesis H0 was more likely than the alternative hypothesis H1), we furthermore ran add-on
Bayesian analyses [62] for all main and interaction effects of the hangover status. With the exception of
hangover status x condition (on which we already elaborated above), all Bayesian analyses provided
positive evidence for the null hypothesis, that is the assumption that hangover status did indeed not
modulate the data (please see Table 3 for details).
Table 3. Bayesian analyses for each effect of hangover status.
Effect BF PBIC(H0|D) PBIC(H1|D)
Main effect hangover status 5.56 0.848 0.152
Interaction hangover status x condition 0.06 0.057 0.943
Interaction hangover status x congruency 5.77 0.852 0.148
Interaction hangover status x condition x congruency 5.92 0.855 0.145
BF = Bayes factor, PBIC(H0|D) = posterior probability for the null hypothesis (i.e., the probability of the null
hypothesis, given the obtained data); PBIC(H1|D) = posterior probability for the alternative hypothesis.
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In summary, we found no significant hangover effects on task performance. Yet, Bayesian
analyses suggested a slight detrimental effect of hangover status on response selection, as Go accuracy
was slightly worse at the hangover appointment than at the sober appointment. This effect was
slightly larger for individuals with high hangover severity on the day of hangover testing. Given
that no such effect was observed for the Nogo condition, there was no such corresponding effect on
response inhibition.
3.4. Add-On Analyses—Alcohol Sensitivity
Previous studies suggested that individuals with lower sensitivity to the effects of alcohol are
more hangover-resistant [64] and might show altered cognitive control processes in alcohol-related
contexts [65,66]. It could hence be possible that alcohol sensitivity modulated hangover effects in our
study. Based on this, we had a closer look at alcohol sensitivity in add-on analyses, as described below.
In total, n = 2 participants stated in the ASQ that they had never experienced a hangover before
(first item). Yet, only one of these two participants reported not having overall hangover symptoms on
the day of the hangover appointment (rating of “0” on the hangover severity scale by van Schrojenstein
Lantman et al. [1]). Despite this, he still indicated mild complaints in some of the symptoms that
were separately assessed in the list by van Schrojenstein Lantman et al. [1]. Further given that none
of the participants rated all of the assessed hangover symptoms as “0” on the hangover day, we
concluded that none of them were truly hangover-resistant, as defined by never experiencing any kind
of hangover symptoms on the day after heavy drinking. Lastly, we correlated the total ASQ score, the
ASQ heavy score and the ASQ hangover item (maximal number of drinks which could be consumed
before experiencing hangover) with the overall hangover severity Likert scale rating on the hangover
test day. This showed no significant correlations (all uncorrected p ≥ 0.150).
In order to compare the self-reported number of drinks in the ASQ hangover item with the
individually calculated amount of brandy (36 Vol %) administered during the intoxication appointment,
we converted the latter into standard drink units (25 mL brandy or 100 mL red wine, which equal
7–7.5 gr of alcohol, were defined as one standard drink). A paired t-test revealed that the administered
amount of alcohol exceeded the self-reported hangover threshold, as the number of experimentally
administered standard drinks (16.81 drinks ± 0.25) was significantly larger than the maximal number
of drinks which could be consumed before developing a hangover (9.09 drinks ± 0.69) (t(31) = −10.388;
p < 0.001).
In order to investigate whether alcohol sensitivity or hangover sensitivity correlated with the
achieved intoxication, we correlated the overall ASQ score, the ASQ heavy score and ASQ hangover
item with the BAC measured 30/60/90/120 min after the end of consumption on the evening of
experimental drinking. None of the uncorrected correlations between ASQ and BAC were significant
(all p ≥ 0.192).
Lastly, we investigated whether alcohol sensitivity or hangover sensitivity correlated with the
relevant behavioural parameters. For this, we correlated the overall ASQ score, the ASQ heavy score
and ASQ hangover item with the Go accuracy at the sober appointment, the Go accuracy at the
hangover appointment and the Go accuracy difference between both appointments. None of the
uncorrected correlations between ASQ and performance were significant (all p ≥ 0.068).
In summary, we found that none of the included participants were entirely resistant to hangover
symptoms after high-dose alcohol administration. We further found that alcohol and hangover
sensitivity did not significantly correlate with intoxication levels, subjective hangover ratings or
performance in hangover-affected cognitive domains. Yet, it should be noted that the lack of such
effects could potentially have been caused by the standardized alcohol administration (i.e., participants
were not allowed to drink ad libidum) and/or the extremely homogenous study sample.
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4. Discussion
Alcohol hangover is an unpleasant state that is reached after an episode of heavy drinking and starts
once breath and blood alcohol levels have returned to zero [1]. Aside from symptoms like headaches and
gastrointestinal problems [1], a wide range of mild cognitive impairments have been reported, including
attention, memory, task-switching, and psychomotor performance deficits [2–5,7,67,68]. Importantly,
these domains are also known to be impaired during acute alcohol intoxication [11,17,38,69,70]. It has
furthermore been shown that both intoxication and hangover are at least partly characterized by similar
neurobiochemical changes, like increased dopaminergic signalling [23,26]. Against this background,
cognitive functions that are impaired by acute intoxication might also be impaired during alcohol
hangover. Yet, the reports on this are still somewhat inconsistent, with some studies finding comparable
effects, while others fail to do so [6,11,20,38,67,71,72]. Given that alcohol has repeatedly been reported
to impair controlled behaviour to a larger degree than automatic behaviour [21], we decided to focus
on how alcohol hangover impairs controlled versus automatic response selection processes. We
experimentally induced a standardized intoxication and investigated whether the subsequent alcohol
hangover impaired controlled response selection more severely than automatic response selection, as
previously reported for acute alcohol intoxication using a Simon Nogo task [18]. Participants were
tested once sober and once hungover (always at a BAC of 0.00‰).
Replicating the typical task effect of the Simon Nogo paradigm and thus further underpinning its
validity, we found inverse effects of S-R congruency on response selection and response inhibition
during both appointments [18,39,73]: Whenever automatic S-R mapping yielded the correct response,
it was beneficial for response selection, but detrimental for response inhibition. Whenever automatic
S-R mapping yielded the wrong response, the compensatory controlled S-R mapping was detrimental
for response selection, but beneficial for response inhibition. These findings are in line with the
assumptions of the dual-process theory [43]—In the context of lateralized stimuli, it distinguishes
between “direct route” processes and “indirect route” processes. The theory postulates that the
task-irrelevant stimulus lateralization gives rise to direct route processes that result in rather automatic
response tendencies on the side of the stimulus. In contrast to that, indirect route processing refers
to the controlled selection of the correct response based on task-relevant stimulus features (in our
case letter identification) [43]. As direct route processing is faster and more expedient than indirect
route processing, it improves response selection whenever there is an overlap between the two
processes (i.e., in congruent trials, where both indicate the same response). Hence, response selection
is improved by mostly relying on direct route processes in case of congruent stimuli. In case of
incongruent stimuli, responses are typically slower and more error-prone as indirect route processing
is required to overcome the wrong automatic response tendency. In contrast to response selection (Go
trials), response inhibition (Nogo trials) is typically most impaired by fast and automatic response
tendencies [18,39,47,48]. As a consequence, inhibition worsens whenever response selection is mainly
driven by direct route processing (i.e., in case of congruent trials). In case of stimulus incongruence,
the more controlled indirect route processing reduces automatic response tendencies, which supports
response inhibition and ultimately improves performance.
In this context, the adverse effects of acute high-dose alcohol intoxication on response selection
and inhibition have recently been shown to be most pronounced when high levels of control and
effort were needed for correct task performance (i.e., in incongruent Go trials and in congruent Nogo
trials) [18]. This suggests that top-down control is more strongly impaired by alcohol intoxication
than automatic response selection processing. In terms of our main research question, we expected
alcohol hangover to induce a comparable pattern of adverse effects. However, our data showed that
the interaction between condition and congruency was not significantly modulated by hangover status.
Furthermore, add-on Bayesian analysis provided positive evidence for rejecting the assumption that
alcohol hangover alters the interplay between controlled and automatic processes in a similar fashion
as intoxication. As both acute alcohol intoxication and AUD show similar impairment patterns (i.e.,
strongly impaired control functions and relatively preserved behavioural automaticity) [16–20], we
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had initially hypothesized that alcohol hangover might be characterized by similar changes, thus
providing a functional link that helps to explain why and how regular binge drinking increases the risk
of developing AUD [13–15]. Specifically, we had reasoned that cognitive control impairments which
persist beyond intoxication, might contribute to poor behavioural choices, thus (partly) explaining the
increased AUD risk of regular binge-drinkers. Given that we obtained positive evidence for the absence
of such effects for congruency on its own, as well as the interaction of congruency and condition, the
hypothesis of comparable effects between intoxication and hangover needs to be rejected. With respect
to our initial hypothesis, this suggests that premorbid deficits in cognitive control, especially in the
domain of inhibition, might contribute more to the observed link between binge-drinking and AUD,
than the effects of repeated alcohol hangover. While our data does not provide concise information on
why we did not find this effect, it seems conceivable that our participants were either not impaired, or
healthy enough to compensate detrimental effects of hangover onto cognition (e.g., by increasing their
effort during task performance).
Even though top-down cognitive control does hence not seem to be impaired by alcohol hangover,
we found evidence suggesting that response selection might be slightly impaired. While we only
observed a non-significant trend for this effect, Bayesian analyses strongly suggested that alcohol
hangover seems to impair response selection in Go trials, but not response inhibition in Nogo trials.
Importantly, this was observed regardless of S-R mapping. While these findings are not in line with our
initial hypotheses, they match previous reports that alcohol hangover reduces information processing
efficiency during response selection and increases the threshold for response execution in a number
categorization task [5]. Importantly, the observed detrimental effect of hangover on response selection
was slightly larger in individuals with high hangover severity, as compared to individuals with low
hangover severity. Taken together, these findings might indicate a compensatory strategy for perceived
deficits during hangover, where participants are more cautious and hesitant to respond. This also
matches our descriptive data (please see Figure 3): Although we did not find significant hangover
effects in the Nogo condition, alcohol hangover appears to have slightly improved response inhibition,
rather than impairing it. The neurobiological basis of this, however, remains rather unclear, as we did
not directly measure correlates of neurotransmission or neurotransmitter levels. It has been suggested
that acetaldehyde, which is likely present during alcohol hangover, increases dopaminergic signalling
but decreases GABAergic signalling [27]. But as dopamine and GABA have beneficial effects on both
response selection and response inhibition [35–37,74,75], this does however not help to explain the
finding of slightly impaired selection and relatively preserved inhibition.
There are two limitations pertaining to sex and age. We refrained from recruiting females as the
ethical approval for this was denied. On average, females tend to have a slower metabolism of alcohol,
which might lead to greater overall impairments [11]. Furthermore, heavy drinking has been shown to
impair response inhibition more strongly in females than in males [76]. For these reasons, females
could be likely to show greater deficits in cognitive performance during alcohol hangover. We also
did not recruit adults over the age of 30 in order to have a homogeneous young and healthy study
sample. Alcohol hangover frequency and the quality of hangover symptoms seem to change with
age [77,78]. Hence, further studies considering both sexes as well as middle-aged to older adults are
needed to investigate whether the hangover effects we observed may be generalized. Furthermore,
we did not explicitly record participants’ history of binge drinking beyond the last 12 months, which
were assessed with the AUDIT. We also did not assess details on hangover history beyond the ASQ.
Assessing this data in more detail might have helped to explain differences in hangover severity and
cognitive performance during hangover. As we pre-selected individuals according to their drinking
habits, we however had a very homogenous sample, which likely showed only minimal variation with
respect to this factor. Lastly, we omitted placebo administration, as it would have been rather easy to
distinguish between placebo and alcoholic drinks, given the large amounts we served. In line with this,
a recent study demonstrated no expectancy effects on cognitive performance during alcohol hangover
by briefing one group of participants with the correct study purpose [79].
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5. Conclusions
In summary, we investigated whether and how alcohol hangover modulates controlled versus
automatic response selection and behaviour. For this, we used a Simon Nogo task that has previously
been used to demonstrate stronger intoxication-related impairments in controlled behaviour than in
automatic behaviour. The lack of significant hangover effects shows that alcohol hangover did not
produce the same functional impairments as an acute high-dose intoxication. Yet, add-on Bayesian
analyses suggested that alcohol hangover slightly impairs response selection but not response inhibition.
These analyses also showed that alcohol hangover does most likely not alter controlled versus automatic
response selection processes. As the pattern of effects is thus not comparable with intoxication or AUD,
cognitive alcohol hangover symptoms cannot help to explain why or how regular binge drinking
increases the risk of developing AUD.
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Abstract: Frequent alcohol binges shift behavior from goal-directed to habitual processing modes.
This shift in reward-associated learning strategies plays a key role in the development and maintenance
of alcohol use disorders and seems to persist during (early stages of) sobriety in at-risk drinkers.
Yet still, it has remained unclear whether this phenomenon might be associated with alcohol hangover
and thus also be found in social drinkers. In an experimental crossover design, n = 25 healthy young
male participants performed a two-step decision-making task once sober and once hungover (i.e., when
reaching sobriety after consuming 2.6 g of alcohol per estimated liter of total body water). This task
allows the separation of effortful model-based and computationally less demanding model-free
learning strategies. The experimental induction of alcohol hangover was successful, but we found no
significant hangover effects on model-based and model-free learning scores, the balance between
model-free and model-based valuation (ω), or perseveration tendencies (π). Bayesian analyses
provided positive evidence for the null hypothesis for all measures except π (anecdotal evidence for
the null hypothesis). Taken together, alcohol hangover, which results from a single binge drinking
episode, does not impair the application of effortful and computationally costly model-based learning
strategies and/or increase model-free learning strategies. This supports the notion that the behavioral
deficits observed in at-risk drinkers are most likely not caused by the immediate aftereffects of
individual binge drinking events.
Keywords: alcohol; cognitive effort; decision making; hangover; model-based; model-free
1. Introduction
Alcohol is a widely used, and often abused, substance that may cause a number of different
adverse effects during acute intoxication, but also thereafter [1]. Especially after the consumption of
larger-than-usual doses, there is a high risk of developing alcohol hangover [2], which is defined as the
“the combination of negative mental and physical symptoms which can be experienced after a single
episode of alcohol consumption, starting when blood alcohol concentration (BAC) approaches zero” [3].
Symptoms that are commonly reported during hangover include nausea and vomiting, headaches and
stomach pains, clumsiness and weakness, tiredness and sleepiness, depressive symptoms and apathy,
dizziness and confusion, as well as concentration problems [4]. Based on such recurring subjective
reports and in line with studies postulating reduced workplace productivity and safety during alcohol
hangover [5], it is often readily assumed that various physiological and cognitive functions are impaired
during hangover. Yet, this seemingly apparent conclusion has become challenged by several studies
J. Clin. Med. 2020, 9, 1453; doi:10.3390/jcm9051453 www.mdpi.com/journal/jcm281
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showing that not all functional domains appear to be (equally) impaired [6]. On the physiological
level, for example, it has been reported that hangover reduces performance in athletics [7] and in
military contexts [8], but there are also contradictory findings suggesting that holiday activities like
hiking performance do not seem to be objectively impaired in hungover individuals (even though
study participants reported greater subjective exhaustion) [9]. Likewise, there are repeated reports
of impaired cognition in the domains of attention and memory [6,10], which can however not be
found in all studies and tasks investigating these phenomena [6,11,12]. Despite such heterogeneous
findings and despite the fact that most of the tested functional domains require investing voluntary
effort, which is considered to be (potentially) straining, it has never been systematically investigated
whether alcohol hangover might actually reduce the ability and/or willingness to invest cognitive effort,
rather than the general ability to perform a given task. Yet, this could help to explain the observed
heterogeneity of effects, like why physical impairments have been reported in working contexts [7,8],
but not necessarily in recreational activities [9]. Beyond this, improved knowledge about alcohol effects
on engagement of effortful cognitive processes could also help to better understand phenomena like
hangover-related increases in workplace absenteeism [13], or under which circumstances hungover
individuals might still be able to compensate deficits by means of increased effort [14,15].
When investigating alcohol effects on the investment of cognitive effort, one can make use of
the fact that behavior may be generated by relying on different strategies that vary in how much
voluntary effort and control they require. This is all the more important, as both acute and chronic
effects of aberrant alcohol consumption seem to strongly impair performance in tasks that require
effortful cognitive top-down control, while performance is rather unaltered in tasks that require
substantially less effortful automatic processes [16–20]. However, many of these studies typically make
the participants perform both hard and easy tasks, thus confounding the findings with the factor of task
difficulty (which should not be confused with effort). More importantly, the tasks used in these studies
did typically not provide the participants with the possibility to choose a strategy for themselves, or to
arbitrate between more and less straining strategies. Investigating the arbitration between effortful
top-down controlled “model-based” behavior and less demanding “model-free” behavior is not only of
scientific interest, but also of clinical relevance: A better understanding of the mechanisms underlying
intra- and inter-individual differences can elucidate the behavioral and psychological changes that
have been associated with problematic drinking patterns like binge drinking [21,22] and shown to
drive and maintain alcohol use disorders (AUDs) [16,23–25].
In the framework of reinforcement learning, model-based and model-free learning can be
distinguished from each other as two classes of methods. Model-based learning uses an internal model
of the environment and enables us to take appropriate actions through planning, which is based on
that model and on the expected outcomes of the available choice options. While this is computationally
demanding, model-based learning can quickly incorporate and adjust to changes in environmental
structures or in outcomes and is thus associated with adaptive and flexible (goal-directed) behavior [26].
In contrast to this, a model-free strategy does not use a model of the world. Instead, model-free behavior
uses prediction errors to learn the (outcome) values of the available choice options. Those values are
stored in scalar quantities and can be easily accessed so that model-free learning is computationally
cheap. The downside of this strategy is that changes in the environment or in outcomes can only
slowly be incorporated in the values of the choice options through trial-end-error learning, which
makes model-free learning less adaptive [26,27].
The arbitration between more or less demanding cognitive-behavioral strategies can be assessed
with the Markov decision task (also called two-step task), which was specifically designed to disentangle
model-based and model-free learning strategies [28]. This task requires participants to make two
successive decisions, which lead to an outcome (differently sized gains or losses) in the end of each
trial. The outcomes change throughout the course of the task, which necessitates constant updating
(learning). Crucially, the first-level decision leads to one of two second-level states, and therefore to
different associated choice options, with certain probabilities. This transition structure of the task can
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be used for the model-based learning strategy or can be neglected in case of model-free learning, which
allows to computationally distinguish the two strategies [27,28].
We applied the two-step task and subsequent parameter modeling to n = 25 healthy young
men, who participated in a within-subject experimental design [11] where they were tested once
sober and once hungover (i.e., after a night of experimentally induced drinking). Our hypotheses
were based on the findings that AUD patients and heavy binge drinkers (BD) have previously been
shown to demonstrate significant reductions in effortful controlled model-based cognitive strategies,
thus inducing an imbalance between model-free and model-based behavior (as compared to healthy
controls) [21,25]. While there is broad consensus that AUD patients shift from model-based to
model-free behavior [23], it should however be noted that this pattern could not be completely
observed in all studies investigating the phenomenon. For example, Voon et al. did not find differences
between abstinent AUD patients and healthy matched controls [29], while Sebold et al. could not
reproduce their initial findings of selectively impaired goal-directed functions [25] in a larger AUD
sample [30]. Furthermore supporting our hypotheses that alcohol might shift the balance between
model-based and model-free behavior, it has been demonstrated that the BD-associated imbalance in
favor of rather effortless model-free behavior seems to normalize as the time since the last binging event
increases [21]. Lastly, increased perseveration tendencies (i.e., reduced cognitive flexibility) have been
observed in BD, but not in case of abstinent AUD patients [21,29,31]. Thus, increased perseveration
tendencies might also potentially be found during alcohol hangover. Therefore, we hypothesized
that alcohol hangover could induce qualitatively similar effects, albeit probably to a lesser degree.
The investigation of AUD patients and BDs alone does not allow for any conclusions about whether
the shift from model-based to model-free behavior observed in these groups reflects premorbid deficits.
Yet, the lack of such “premorbid” changes in control participants with a positive family history of
AUD [32] as well as in otherwise healthy, young BDs [33] suggests that this might not be the case
and that this behavioral shift is rather a consequence of excessive alcohol consumption. Against the
background that habitual binge drinking might induce a shift from model-based to model-free behavior
that can still be observed after the end of an acute binge-like intoxication [21], we hence hypothesized
that this was also the case during the hangover following a single binge drinking episode.
2. Materials and Methods
2.1. Participants
Healthy young men aged 18–30 were recruited via flyers and online ads at the local university
(TU Dresden). In order to be included in the sample, all participants underwent an extended telephone
screening, during which their somatic, neurological, and psychiatric well-being, as well as their
alcohol consumption were assessed with the help of a semi-structured interview by experienced
neuropsychologists. They had to report to have normal or corrected-to-normal vision, be free of
psychiatric and neurologic disorders, as well as somatic diseases (especially those affecting the
gastrointestinal tract, liver, and kidneys). Likewise, they had to report not taking any medication or
illicit drugs either regularly, or during their participation in the study (including a sufficient number
of preceding days in case the metabolism of a given substance took more than 18 h). With respect to
alcohol consumption habits, we required all included participants to have scores between 2 and 19
points in the Alcohol Use Disorder Identification Test (AUDIT) [34]. Additionally, they were required
to have voluntarily engaged in binge drinking (defined as consuming 8 or more standard units of
alcohol on a single evening) between 13 and 150 times in the past year and to recall at least one
event within the past year when they were markedly drunk (defined as experiencing alcohol-induced
gait, motor, or speech impediments). Individuals who had less than 2 points in the AUDIT or drank
less than these lower limits were excluded in order to minimize the risk of including participants
who might become unwell after drinking the alcohol dose we experimentally administered to induce
intoxication and subsequent hangover. We further excluded individuals who had more than 19 points
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in the AUDIT (as scores of 20 points or more “clearly warrant further diagnostic evaluation for alcohol
dependence” [34]), drank more than our pre-defined upper limits (as binge drinking on 3 or more
days a week shows that binge-like alcohol consumption is no longer limited to social drinking on
weekends), and/or reported having at least weekly alcohol-induced memory problems and/or at least
near-daily failures to fulfill routine tasks that were expected of them (as this would have indicated a
high and likely clinically relevant degree of alcohol-related cognitive dysfunction). In sum, these upper
thresholds were implemented to minimize the likelihood of including individuals with strong alcohol
tolerance and a high risk for AUD. The study was approved for males only by the ethics committee
of the Faculty of Medicine of the TU Dresden, Germany (EK293082014). All participants provided
written informed consent at the start of each study appointment while (still) sober. They received a
compensation of 80€ for study participation.
There were no previous studies investigating the size of hangover effects in Markov decision tasks,
but studies on other cognitive control domains reported effect sizes between f = 0.32 and f = 0.6 for
their reported hangover effects in comparable within-subject study designs [11,17,35]. Based on this,
we estimated the required sample size for two repeated measures sessions (sober vs. hungover) and
five relevant measures (MF-score, MB-score, final score, ω, π) at an alpha error probability of 5% and
a power of 95% for an estimated medium effect size of f = 0.30 (assuming a default inter-correlation
of 0.5). This yielded a required sample size of n = 23. Based on this initial sample size estimation,
n = 25 subjects matching all of the criteria detailed above were eventually included in the sample and
underwent experimental testing as well as statistical analyses. Please note that the sample used in this
publication strongly overlaps with that of a previous publication, which investigated alcohol hangover
effects on attentional processes during varying conflict loads in a prime and flanker context [11].
2.2. Experimental Design
Importantly, we used the same study design as already reported in our previous publication [11].
In short, each participant was invited to the lab for three different appointments the order of which was
balanced across the sample so that half of the participants first performed the paradigm sober and then
hungover, while the other half first performed the paradigm hungover and then sober. Participants
could not start with any of their appointments unless they were entirely sober at the start of each
appointment. The required breath alcohol concentration (BrAC) of 0.00‰ was controlled using the
breathalyzer “Alcotest 3000” following the instructions by the manufacturer (Drägerwerk, Lübeck,
Germany). Participants were further required to refrain from using legal stimulants like coffee, taurine,
or guarana in the three hours preceding each appointment and to eat a full dinner before participating
in the intoxication appointment.
On both the sober and the hangover appointment, the participants rated their subjective hangover
symptoms on a Likert scale (see Section 2.3 for details) and then performed a total of four conceptually
unrelated behavioral tasks. The results of two of these tasks have been previously been published [11],
and the results of the third task, which assessed mental rotation and response inhibition, have not been
published or submitted anywhere, as of yet. The task reported in this study was always conducted
last (i.e., approximately 60–75 min after the start of the appointment). The sober appointments were
conducted on weekdays and between 2 and 7 days apart from the hungover appointments, which were
always conducted on Saturday or Sunday (starting time between 09:00 and 11:00) after a previous night of
experimentally induced alcohol intoxication. These intoxication appointments took place on Friday or
Saturday, starting at 20:00. For each intoxication appointment, we invited between 2 and 6 subjects to
the lab. They were asked to fill in a sociodemographic questionnaire and then consume an individually
determined amount of 2.6375 g of alcohol per estimated liter of total body water (TBW), which was
determined with an equation by Widmark [36] and Watson et al. [37]. The details of equation as well as the
protocols used to document drinking can be found in our previous publication [11] and in the data sheet
provided in the Supplementary Materials. In line with recommendations from previous experimental
studies [2,38–41], the administered amount of alcohol was expected to result in a mean peak intoxication
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of ~1.2 ‰ on the full stomach we asked participants to have (i.e., at a resorption deficit of ~40%), and
no more than 1.6‰ on an empty stomach, which we asked participants to avoid (i.e., at a resorption
deficit of ~20%). Due to the ratio of TBW and administered alcohol, it was physically impossible to
exceed a peak intoxication of 2.0‰ (i.e., at a hypothetical resorption deficit of 0%). Additionally, the
experimenters did not issue more than half of a participant’s drinks within the first hour of drinking so
that participants were kept from consuming the entire amount at once (consumption typically took 2–3 h).
Participants got their drinks from the experimenters and could choose whether they wanted 200 mL red
wine (9.5 Vol % equaling 15 g of alcohol) or 50 mL brandy (36 Vol % equaling 14 g of alcohol) with each
refill. These two drinks were chosen for their comparatively high congener content, which is thought to
increase hangover severity (as compared to beverages with lower congener content, like vodka or white
wine) [42–44]. Drinks could be mixed with caffeine-free softdrinks (coke, orange lemonade, ginger ale)
and ice cubes. Participants were further provided with unlimited access to snacks (chips and wine gum)
and tap water, the consumption of which were not monitored. They were furthermore allowed to smoke.
Participants were free to socially interact, listen to music, play board and card games, or table soccer
during the intoxication appointment. 30, 60, 90, and 120 min after the individual end of their consumption,
participants were asked to provide BrAC measurements. They were then sent home via taxi around
1:30 to 02:00 in the morning (given decreasing BrAC values and no clouded awareness and/or major
motor impairments). They were invited to come back the following day at either 09:00 or 10:30 for their
hangover appointment. This was done for two reasons: Firstly, we wanted to test the participants as soon
as possible after reaching the sobriety criterion of 0.00‰ because hangover-associated cognitive deficits of
social drinkers might be most pronounced at this time point [45] (if they failed to reach this criterion at
the originally scheduled time, they were asked to wait until BrAC had returned to 0.00‰). Secondly, it
has been recommended to standardize sleep time in experimental hangover induction [41,46] as reduced
sleeping time could be associated with more severe hangover symptoms (although reduced sleep time and
quality are of course also directly associated with alcohol intoxication itself) [42,44,47–49]. Yet still, alcohol
effects on sleep do not seem to necessarily mediate hangover effects on cognitive performance [40,44].
Lastly, it should be noted that while we experimentally standardized sleeping times across the sample for
optimal comparability across participants, both the time at which participants could go to bed and the
estimated average sleeping time were oriented towards normal behavior in young healthy social drinkers,
as previously reported in a study with a naturalistic study design (in that study, average drinking started
between 20:06 and 21:06, average bedtimes were between 02:49 and 03:18 am, and the average sleep
duration was between 05:36 and 05:58 h) [47].
2.3. Questionnaires
At the start of the intoxication session and before alcohol administration, subjects provided
sociodemographic information. At the beginning of both the sober and hangover session, participants
were asked to rate the subjective severity of 22 hangover symptoms suggested by van Schrojenstein
Lantman et al. [4,50] on an 11-point Likert-scale ranging from 0 (no symptoms) to 10 (extreme
symptoms). Importantly, participants were asked to truthfully rate the severity of each symptom
irrespective of whether they had consumed alcohol the night before or attributed their symptoms to
alcohol consumption. Furthermore, subjects reported the hours of sleep during the previous night.
2.4. Two-Step Decision-Making Task
In order to investigate whether alcohol hangover reduced cognitively effortful model-based behavior
and/or increased the less costly model-free behavior, we used a modified two-step decision-making task
based on Daw et al. [28] and Kool et al. [27], which was embedded in a space game. Each trial consisted of
two sequential decisions that led to a final outcome. As can be seen in Figure 1, two different spaceships
were presented in the beginning of each trial to represent the choice options at first stage. The spaceships
were associated with a transition probability of 80% (common transition) to reach one of two planets,
and a transition probability of 20% (rare transition) to reach the other planet. These planets indicated
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the second stage options. At the second stage, two new choice options were presented in the form of
different aliens. The subjects were told that the aliens mine in “space mines” where they could find either
treasures (representing positive outcomes), or antimatter (negative outcomes), or nothing. The outcomes
for each of the four second-level choice options slowly changed throughout the task. Therefore, the value
of each option had to be constantly updated. The outcomes ranged from −4 to +5 points and magnitudes
were slowly drifting according to a Gaussian random walk: The outcomes for each of the four options at
second stage were calculated independently so that they ranged from 0 to 1 and slowly changed with
a drift rate of 0.2. The resulting scores were then transformed into points. The transition distribution
and reward distribution were the same for all subjects. Those distributions were simulated beforehand
in order to ensure that model-based engagement would lead to higher final scores (for details, please
see section “Simulation of Transition and Reward Distribution” in the Supplementary Materials). In
other words, this made sure that the more costly model-based strategy always paid off more than the
model-free strategy. At the end of each trial, a bar was presented to indicate the current total score. We
modified the original two-step task by Daw et al. [28] in several ways based on simulation results of Kool
et al. [27] in order to allow for a stronger relationship between model-based learning strategy and reward
payoff: Firstly, we used a simpler, more distinguishable transition probability of 80:20 (instead of the
original 70:30) to reduce rare transition trials, which was intended to reduce the trade-off between pay-off
and cognitive costs. Secondly, we increased the drift rates of second stage outcomes and used a broader
range of reward probabilities (Gaussian random walk: M = 0, SD = 0.20, reflecting boundaries = [0 1]
vs. originally: Gaussian random walk: M = 0, SD = 0.025, reflecting boundaries = [0.25 0.75]) to induce
faster changes of rewards, which was intended to reduce the possibility of easy adaptations of model-free
learning and thereby increase the relative advantage of model-based learning. Thirdly, we used points
instead of binary probabilistic outcomes to increase the information gain of each trial and thus reduce
the necessity to integrate information over several outcomes per choice option. Taken together, these
modifications should have resulted in a higher pay-off for the more cognitive costly model-based strategy.
The task consisted of 250 trials, which were divided into two equally sized blocks. The main goal of the
subjects was to collect as much treasure (points) as possible. The screen position (left or right) of the two
choice options was randomized across trials for stimuli at both stages. If no response was made via button
press on a standard keyboard within the 2 s response limit, participants received a penalty loss of 5 points
and the trial was repeated. Prior to the main task, subjects received detailed instructions and tutorials,
including 25 practice trials to familiarize them with the task. The task was presented with Presentation
software (Neurobehavioral Systems Inc., Berkeley, CA, USA). Trial timing is illustrated in Figure 1a. We
used different planet and alien stimulus sets at the two appointments in order to minimize carry-over
effects between the sober and the hungover appointment.
Importantly, the task allows the detection and dissociation of model-free vs. model-based
decision-making behavior. This becomes especially apparent after rare transitions that ultimately lead
to high rewards: In those cases, an entirely model-free agent would repeat the choices that resulted in
this reward (i.e., the agent would choose the same action/spaceship again) in accordance with basic
reinforcement principles, which state that the probability to choose an option again is higher when
this option was previously rewarded. In contrast, a model-based agent would take into account the
model of the task, i.e., the knowledge of the transition probabilities between stages. In that case,
the probability to choose the same action again would be much lower, because the valuation system
would take into account that the other option has a much higher probability to lead to the promising
second stage option. Therefore, a model-based agent would likely switch the first stage choice under
circumstances of high rewards after rare transitions.
Following this logic, first stage choice behavior can be utilized to determine and distinguish
signatures of model-based and model-free learning. For that purpose, stay probabilities can be
computed, i.e., the probability to choose the same first stage option again, as a function of previous
outcome (win or loss) and transition type (common or rare). Those probabilities can be used to calculate
a model-free score (MF-score) and a model-based score (MB-score) for each subject in order to analyze
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the reliance on the respective learning systems [25]. The MF-score indicates the pure influence of
previous reward on the first stage choice pattern:
MF-score = (Staywin common + Staywin rare) − (Stayloss common + Stayloss rare).
In contrast, the MB-score reflects the interaction effect of previous reward and transition type on
stay probability, and thus the consideration of the model of the task for first stage choices:
MB-score = (Staywin common + Stayloss rare) − (Staywin rare + Stayloss common).
Both scores consider choice behavior with regard to the previous trial, but ignore performance
throughout the whole task, which can be provided by computational modeling accounts.
 
Figure 1. Two-step decision-making task. (a) An exemplary trial sequence as well as the trial timing are
depicted: At the first stage, two spaceships were presented. Participants indicated their response choice
via a button press, followed by a transition two the second stage. Two aliens represented second-stage
choice options and participants made their second response choice via another button press. Response
choices were indicated by boxes around the respective spaceship/alien and trial outcomes are indicated
by blue spheres (space treasure) representing the number of gained points (+5 shown) or pink spheres
(antimatter) representing the number of lost points (not shown). The response time limit was 2 s for
each of the two choices. According to the transition structure (b), a transition could either be common
(80% probability) or rare (20% probability). After the second stage response, the outcome was presented.
(c) The outcomes (+5 to−4 points) of the four choice options are presented for the first 50 trials. Each line
represents a second-stage choice option (alien) for the yellow and red planet, respectively.
The dual-system reinforcement-learning model is an established computational model for the task
we used. It assumes a mixture of model-based and model-free learning strategies [27,28]: During the
course of the task, expected values (Q-values) will be learned for each choice option (a) in each
state (s) at the two stages (i). The model-free value (QMF) is updated at each trial (t) according
to a state-action-reward-state-action, or SARSA(λ) temporal difference learning algorithm [27,51].
After each action, an update takes place to calculate a new estimate of the value of the chosen option
based on the agent’s experience. The general updating rule is:
287
J. Clin. Med. 2020, 9, 1453
QMF(s, a) = QMF(s, a) + αδi,t (1)
where α denotes the learning rate and δ is the reward prediction error:
δi,t = ri,t + QMF(si+1,t, ai+1,t) −QMF(si,t, ai,t) (2)
with r denoting the received reward. The learning rate determines to which extent the new information
provided by the reward prediction error is incorporated in the value estimate. At first stage, the reward
prediction error is solely driven by the Q-value of the option that is chosen at second stage, since no
reward is delivered at the first stage:
δ1,t = QMF(s2,t, a2,t) −QMF(s1,t, a1,t). (3)
At the second stage, the reward prediction error is driven by the received reward, since no third
stage is available:
δ2,t = r2,t −QMF(s2,t, a2,t). (4)
The Q-values for both stages are updated at the end of each trial. For the update of the first
stage model-free Q-value, a decay-rate parameter for eligibility traces (λ) is used to additionally
down-weight the second stage prediction error:
QMF(s1,t, a1,t) = QMF(s1,t, a1,t) + αλδ2,t. (5)
In contrast to this, the model-based strategy for the first stage update considers the transition
probability P (model of the environment) between stages and combines this knowledge with the values











max QMF(s2B,t, a) (6)
where j denotes the index of the first stage choice options and s2A and s2B the two different states at the
second stage. At the second stage, the updating rule for values is the same as for the model-free strategy.
To select an action at the first stage, the model-free and model-based Q-values are combined and














A low weighting parameter (ω < 0.5) indicates a stronger reliance on the model-free strategy,
whereas high values (ω > 0.5) indicate a stronger influence of the model-based strategy. At second
stage, both learning strategies use the model-free Q-value for action selection.
The probability to choose an action at each stage is computed according to a sofmax rule:
P(ai,t = a
∣∣∣si,t) =
exp(β[Qnet(si,t, a) + π·rep(a)])∑
a′ exp(β[Qnet(si,t, a′) + π·rep(a′)])
(8)
where the inverse temperature β determines the stochasticity of the choices. Higher β values indicate
that the agent is more likely to choose the action with the highest Q-value (i.e., high expected outcome)
and lower β values indicate a tendency towards random choice (i.e., that the agent’s decisions are less
determined by this learning strategy). Additionally, a choice “stickiness” parameter πwas included,
which was multiplied with an indicator variable rep(a) that indicates whether the same action was
chosen again, or not. This parameter indicates perseveration (π > 0) or switching (π < 0) tendency.
Lastly, optimal choice rates were separately calculated for each stage [52]. These rates reflect whether
decisions were made in favor of the option with the higher Q-value or not, and thus reflect the
probability of choosing the optimal option. The model fitting was conducted with Matlab 2018b
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(The MathWorks, Inc., Natick, MA, USA), with empirical priors using Sam Gershman’s mfit toolbox to
find the maximum a posteriori parameter estimates [27,53].
In summary, the MF- and MB-scores represent different influences of simple reinforcement learning
vs. effortful goal-directed computation for action selection which is based on the experience of the previous
trial. Whereas the computational model considers choice behavior over the course of the whole task,
the weighting parameter omega (ω) indicates the relative contribution of model-free and model-based
strategies to decision-making and thus the extent of cognitive investment. The choice stickiness parameter
π indicates the arbitration between behavioral perseveration and switching. Lastly, β values indicate to
what degree the participant is likely to choose the response that is associated with the highest expected
outcome. Together with the optimal choice rate, these variables reflect whether decisions were made in
favor of the option with the higher Q-value. Finally, the sum of all collected outcomes (final score) and
reaction times for choices at first and second stage may be used to compare the overall performance.
2.5. Statistical Analyses
To compare task performance between the sober and hangover session, we used the Bayesian
procedure for related samples provided by SPSS Statistics 25 (IBM Corp., Armonk, NY, USA), which
computes a traditional (paired samples) t-test and the Bayes Factor (BF). For this, we used default settings
(Adaptive Gauss-Lobatto Quadrature approach, Tolerance = 0.000001, maximum iterations = 2000)
with a noninformative prior (diffuse prior distribution). To check the normality assumption, we used
the Shapiro-Wilk-Tests and conducted additional non-parametric tests, whenever necessary.
The BF indicates the ratio of the data likelihood given the null hypothesis versus the data likelihood
given the alternative hypothesis: A value above one indicates (more) relative evidence for the null
hypothesis whereas values below one indicate (more) relative evidence for the alternative hypothesis.
Values above three are considered as positive evidence for the null hypothesis, i.e., no difference
between the sober and hangover session [54].
Since we were mainly interested in hangover-associated differences in model-based and model-free
learning, we analyzed MB-scores and MF-scores, which were calculated for each subject and session,
as well as the weighting parameter ω. To analyze perseveration tendencies, we focused on the choice
stickiness parameter π. All other parameters provided by the computation model were analyzed in an
exploratory fashion. The Bayesian information criterion (BIC) was used to verify comparable model fit
between sessions. To further examine whether the participants had based their decisions on hybrid
Q-value estimation to a similar degree in both of their sessions, we analyzed their optimal choice rates
for each stage [52]. Finally, we used the sum of all collected outcomes (final score) and reaction times
for choosing at first and second stage to compare the overall performance.
Given that we balanced the order of the two appointments across participants, used two different
task versions/stimuli on the first and second appointment, and further randomized stimulus positions
on the screen for each trial, we did not anticipate any confounding effects of appointment order. For this
reason, appointment order was not included as a factor in any of the analyses presented in the results
section but add-on analyses of this factor can be found in the section “Investigation of Hypothetical
Task Order Effects” of the Supplementary Materials.
The raw behavioral data as well as the analyzed data (including the syntax) can be accessed at
https://osf.io/vzpn3/.
3. Results
3.1. Sample Characteristics and Intoxication Procedure
The included participants were on average 21.5 years old (SD = 2.3; range 18–27), 183.4 cm tall
(SD = 7.0; range 167–198), and weighed 80.5 kg (SD = 11.6; range 56.5–96.5). This resulted in an average
individual alcohol amount of 432.0 mL brandy (SD = 39.01; range 349–497) at 36 Vol. %. Participants
took on average 174.4 min (SD = 28.3; range 115–230) to consume the alcohol. The mean BrAC was
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1.17 ‰ (SD = 0.23; range 0.75–1.63) 30 min after the end of consumption, 1.09‰ (SD = 0.22; range
0.65–1.51) 60 min after the end of consumption, 1.04 ‰ (SD = 0.17; range 0.65–1.41) 90 min after the
end of consumption, and 0.94 ‰ (SD = 0.14; range 0.67–1.16) 120 min after the end of consumption.
As would have been expected from the study design, participants reported a shorter average
sleep duration in hangover session (mean = 6.05 h; SD = 0.83; range 4.50–8.00) than in the sober session
(mean = 8.10 h; SD = 1.39; range 5.50–10.00). Hence, our participants slept approximately two hours
less before the hungover appointment than before the sober appointment. Of note, this is very similar
to the hangover-associated 1 h and 50 min sleep reduction reported in a previous, naturalistic study by
Hogewoning et al. (where hungover participants had slept 7 h and 26 min on sober nights and 5 h
and 36 min on hungover nights) [47]. Given that none of the task-relevant behavioral and estimated
measures worsened during hangover (for details, please refer to the following text sections), there was
however no need to control for the shorter sleeping time before the hungover session.
Based on the recruitment criterion that all participants had to have some degree of binge drinking
experience in order to minimize the risk of severe adverse effects during alcohol administration,
the mean AUDIT score of the sample was 10.1 points (SD = 2.8; range 4–16). Out of the n = 25
participants, n = 19 had scores between 8 and 15 points, which has been linked to hazardous alcohol
use that does however not require clinical intervention [34]. Only n = 1 participant had a score of
16, which is the lower boundary for “brief counseling and continued monitoring” recommended by
WHO guidelines [34]. Yet, none of the participants obtained a score of 20 or higher and none of the
participants met the criteria for the diagnosis of an AUD according to the International Classification of
Diseases (ICD-10). The subjective ratings for overall hangover severity and the severity of individual
hangover symptoms are presented in Table 1.
Table 1. Symptom severity ratings on both appointments.
Item Sober Hungover p
Overall hangover severity 0.167 ± 0.637 3.640 ± 2.119 <0.001
Regret 0.000 ± 0.000 0.440 ± 1.261 0.039
Headache 0.240 ± 0.831 2.600 ± 2.769 0.001
Sensitivity to light 0.040 ± 0.200 1.680 ± 2.076 0.001
Concentration problems 0.440 ± 0.961 3.640 ± 2.464 <0.001
Clumsy 0.080 ± 0.400 2.120 ± 1.716 <0.001
Confusion 0.000 ± 0.000 1.120 ± 1.166 0.001
Dizziness 0.040 ± 0.200 2.400 ± 2.380 <0.001
Anxiety 0.080 ± 0.277 0.560 ± 0.961 0.020
Depression 0.000 ± 0.000 0.640 ± 1.497 0.008
Apathy 0.120 ± 0.440 1.400 ± 1.780 0.004
Stomach pain 0.120 ± 0.440 0.480 ± 1.229 0.129
Nausea 0.160 ± 0.800 1.520 ± 1.828 0.001
Vomiting 0.040 ± 0.200 0.800 ± 1.384 0.011
Reduced appetite 0.240 ± 1012 1.440 ± 2.022 0.021
Thirst 0.440 ± 1083 3.840 ± 2.267 <0.001
Heart pounding 0.160 ± 0.554 1.280 ± 1.768 0.003
Heart racing 0.000 ± 0.000 0.400 ± 0.707 0.015
Shivering 0.080 ± 0.400 1.083 ± 1.176 0.001
Weakness 0.040 ± 0.200 2.480 ± 2.084 <0.001
Sweating 0.080 ± 0.277 0.920 ± 1.552 0.004
Tired 0.560 ± 1083 4.080 ± 2.448 <0.001
Sleepiness 0.440 ± 0.961 3.680 ± 2.410 <0.001
Sleeping problems 0.120 ± 0.332 0.720 ± 1.242 0.036
Average ± SD rating of each symptom on a Likert-scale ranging from 0 (no symptoms) to 10 (extreme symptoms),
as suggested by van Schrojenstein Lantman et al. [4,50]. Participants had been asked to rate each item on both
appointments, irrespective of whether or not they had consumed alcohol the night before the sober appointment and
also irrespective of whether they attributed a given complaint to alcohol hangover. Whenever the average rating was
greater than zero on both appointments, the appointments were compared using paired Wilcoxon signed-rank tests.
Whenever all of the ratings in the sober session were zero, the hungover appointment was compared to zero using
one sample Wilcoxon signed-rank tests. Uncorrected p-values of the conducted tests are given in the right column.
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3.2. Two-Step Decision-Making Task
Descriptive statistics are shown in Table 2 and Figure 2 shows the first stage choice behavior for
the sober and hangover session.
Table 2. Descriptive task statistics for the two-step decision-making task for the sober and hangover session.
Mean SEM SD Min Max
sober
MF-score 0.08 0.04 0.18 −0.25 0.39
MB-score 0.50 0.07 0.33 −0.10 1.10
Final score 357.12 24.90 124.50 66 564
First stage RT 491 28 141 136 728
Second stage RT 585 27 136 198 886
hangover
MF-score 0.06 0.04 0.18 −0.28 0.35
MB-score 0.49 0.05 0.25 <−0.01 * 0.98
Final score 361.48 19.34 96.71 180 521
First stage RT 489 24 121 204 617
Second stage RT 597 12 62 505 762
MF-score: model-free score; MB-score: model-based score; final score: accumulated outcomes at the end of the task
(in points); RT: reaction time in msec. * The true value lies between −0.01 and 0.00.
Figure 2. First stage choice behavior. Dots indicate values of individual participants and bars indicate
group means with error bars depicting the standard error of the mean. (a) Stay probability (choosing
the same options as in the previous trial) for win and loss trials as a function of transition (common vs.
rare). The sober session is depicted in dark grey and the hangover session is depicted in light grey.
(b) Model-based score (MB-score), reflecting the interaction between outcome and transition type, and
model-free score (MF-score), reflecting the main effect of outcome, for the sober session (dark grey) and
the hangover session (light grey).
There was no significant difference between the sober and hangover session with respect to either
MB-score (t(24) = 0.38, p = 0.80) or MF-score (t(24) = 0.38, p = 0.71). Bayesian analyses indicated positive
evidence in favor of the null hypothesis, i.e., the assumption that the MB-score (BF = 6.30) and the
MF-score (BF = 6.05) did not differ between the sober and hangover session. This suggests that the
degree of model-based and model-free learning was not changed by alcohol hangover.
With respect to the overall task performance, we observed that participants earned comparable
cumulative points at the end of the task (final score). These outcomes did not significantly differ
between sessions (t(24) = −0.11, p = 0.91) and Bayesian analysis provided positive evidence in favor of
the null hypothesis (BF = 6.46). The reaction times at the first stage and at the second stage did also not
significantly differ between the sober and hangover session (first stage: t(24) = 0.11, p = 0.91; Z = −0.23,
p = 0.82; second stage: t(24) = −0.53, p = 0.60). Again, Bayesian analyses provided positive evidence in
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favor of the null hypothesis, i.e., no difference between the sober and hangover session in response
latency (first stage: BF = 6.46; second stage: BF = 5.69). These findings suggest that neither overall task
performance, nor response speed are modulated by alcohol hangover.
Table 3 shows all estimated parameters based on the hybrid dual-system reinforcement-learning
model. The model fit by means of BIC did not statistically differ between sessions (t(24) = −0.28, p = 0.79,
BF = 6.27). In the sober session, the average BIC was 504.07 (SEM = 21.48) and in the hangover session,
the average BIC was 508.72 (SEM = 18.12). At the first stage, subjects reached optimal choice rates with
an average choice rate of 0.66 (SEM = 0.03) in the sober session and with an average choice rate of
0.70 (SEM = 0.03) in the hangover session. Choice rates did not significantly differ between sessions
(t(24) = −0.83, p = 0.42; Z = −0.72, p = 0.48). At the second stage, the average optimal choice rate was
0.77 (SEM = 0.02) in the sober session and 0.76 (SEM = 0.03) in the hangover session. Like for the first
stage, the second stage choice rates did not significantly differ between sessions (t(24) = 0.33, p = 0.75;
Z = −0.69, p = 0.50). Bayesian analyses provided positive evidence in favor of the null hypothesis
(no difference between the sober and hangover session) for optimal choice rates at the first stage
(BF = 4.68) and at the second stage (BF = 6.17). Therefore, both BIC and optimal choice rates indicate
that participants similarly applied the hybrid Q-learning model in both sessions. In this context, please
note that the decision process is assumed to include some randomness. With regard to the dynamic task
environment (slowly changing rewards), it is reasonable that subject explored the other choice option
from time to time, which is also reflected in the optimal choice rates. In such a dynamic environment,
even perfectly adjusted behavior could not yield choice rates of (or close to) 1.
Table 3. Distribution of estimated parameters based on the hybrid dual-system reinforcement-learning
model for the sober and hangover session.
Percentile ω α β λ π
sober
25 0.70 0.81 3.39 0.00 0.11
50 0.83 0.89 4.70 0.48 0.16
75 0.90 1.00 5.48 0.84 0.19
hangover
25 0.68 0.75 3.16 0.28 0.09
50 0.88 0.86 4.04 0.51 0.20
75 0.95 0.98 5.52 0.79 0.23
The weighting parameter ω represents the balance between model-based (ω > 0.5) and model-free learning (ω < 0.5).
The learning rate α indicates to what extent new information is incorporated in the Q-value update. The inverse
temperature β determines the randomness of decision-making. The decay-rate parameter λ represents the degree to
which experience in later stages influences first stage Q-value update. The choice stickiness parameter π indicates
perseveration tendencies (π > 0).
Most importantly, we found no significant difference between the sober and hangover session
in the weighting parameter ω (t(24) = −0.48, p = 0.63; Z = −1.39, p = 0.17). Further supporting this,
Bayesian analyses yielded positive evidence for the null hypothesis (no difference between sessions;
BF = 5.81), indicating that the balance between model-based and model-free learning was not affected
by hangover status. This null finding is in accordance with the results of the MB-score (no session
effect) and provides evidence for unaffected goal-directed learning in the context of this task.
The choice “stickiness” parameter π, which indicates a perseveration tendency in case of values
above zero, did also not differ between the sober and hangover session (t(24) = −1.43, p = 0.17), but the
obtained BF of 2.52 provided only weak evidence in favor of the null hypothesis.
An exploratory analysis of the learning rate α revealed no significant differences between the
sober and hangover session (t(24) = 0.73, p = 0.47; Z = −1.39, p = 0.17). We also found no significant
difference between sessions with respect to the inverse temperature β (t(24) = 0.64, p = 0.53), which
represents the randomness of decisions, i.e., the reliance on Q-values in decision-making. Likewise, the
decay-rate parameter λ did not statistically differ between the sober and hangover session (t(24) = −0.48,
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p = 0.64; Z = −0.55, p = 0.58). Bayesian analyses provided positive evidence for the null hypothesis
(i.e., no difference between the sober and hangover session), for learning rate α (BF = 5.03), inverse
temperature β (BF = 5.33), and decay-rate parameter λ (BF = 5.82). Thus, our exploratory analyses
suggest that none of these parameters seems to be modulated by alcohol hangover.
3.3. Add-On Analyses of Alcohol Consumption Habits
Given that a recent study found acute alcohol intoxication effects on model-based behavior to be
modulated by drinking problems (as assessed with the AUDIT) [55], we ran exploratory add-on analyses
to investigate whether AUDIT scores correlated with any of the functionally relevant descriptive or
estimated parameters in the sober and/or hungover session. As can be seen in Table 4, we did not
find any significant correlation in either the sober or the hungover session. Bayesian analyses (default
settings for Bayesian Pearson Correlation: Tolerance = 0.0001, maximum iterations = 2000; uniform
prior; Jeffreys–Zellner–Siow Bayes Factor) provided positive evidence in favor of the null hypothesis
(no relationship between AUDIT and task performance) for MF-score, MB-score, weighting parameter
ω, and choice stickiness parameter π; and weak evidence in favor of the null hypothesis for the final
score (earned cumulative points at the end of the task). We therefore refrained from using the AUDIT
as a control variable/covariate in any of the main analyses.
Table 4. Correlation between AUDIT and two-step task performance in the sober and hangover session.
r (p) BF τ (p)
sober
MF-score 0.24 (0.24) 3.26 0.15 (0.32)
MB-score 0.21 (0.32) 3.94 0.16 (0.28)
Final score 0.30 (0.15) 2.35 0.21 (0.17)
ω 0.21 (0.31) 3.88 0.16 (0.28)
π 0.06 (0.76) 6.21 −0.05 (0.74)
hangover
MF-score <−0.01 * (0.98) 6.50 0.03 (0.85)
MB-score 0.16 (0.45) 4.90 0.13 (0.37)
Final score −0.11 (0.60) 5.67 −0.14 (0.34)
ω 0.08 (0.72) 6.10 0.11 (0.45)
π −0.01 (0.95) 6.49 0.03 (0.85)
BF: Bayes Factor; MF-score: model-free score; MB-score: model-based score; final score: accumulated outcomes at
the end of the task (in points); weighting parameter ω: balance between model-based (ω > 0.5) and model-free
learning (ω < 0.5); Choice stickiness parameter π: indicates perseveration tendencies (π > 0). * The true value lies
between −0.01 and 0.00.
4. Discussion
Aberrant alcohol consumption has repeatedly been demonstrated to be associated with negative
cognitive, affective, and behavioral consequences [1]. While the effects of acute intoxication and
long-term abuse are comparatively well-researched, much less is known about the cognitive and
behavioral effects of alcohol hangover. In this study, we used an experimental cross-over design to
test the hypothesis that alcohol hangover decreases model-based and increases model-free behavior.
A total of n = 25 healthy young men were tested with a two-step task. Each participant was tested
once sober and once hungover, i.e., after having consumed a standardized amount of alcohol in an
experimental setting. Several behavioral and computational modeling parameters were then compared
across the two sessions. Our study motivation and hypotheses had been based on several studies
showing that alcohol seems to have much stronger detrimental effects on goal-directed/model-based
processes that require high levels of cognitive effort, than on model-free processes which typically
require substantially lower levels of effort. This observation has repeatedly been made in the context of
acute, binge-like intoxication levels [18,19,56–58], and in the context of AUD [16,20,23]. In social BDs,
who do not fulfil enough criteria for an AUD diagnosis, results are generally more mixed, but there are
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also repeated reports of impairments in the domain of goal-directed (executive) functions [21,22]. With
respect to the arbitration between goal-directed and habitual behavior, both AUD and BD have been
linked to reductions in effortful controlled model-based cognitive strategies [21,25]. At least in BD, this
imbalance seems to normalize as the time that has passed since the last binging episode increases [21].
Moreover, perseveration tendencies seem to be altered in BD [21,31]. Based on these findings, we had
hypothesized that alcohol hangover might induce qualitatively similar effects, albeit probably to a
lesser degree.
The employed two-step decision making task based on Daw et al. [28] and Kool et al. [27]
allows for the quantification of model-based and model free behavior by contrasting first stage stay
probabilities in case of all combinations of gain/loss and common/rare transitions on the one hand and
by estimating individual parameters of task performance with a computational model on the other
hand. The underlying logic is that model-free behavior is solely based on previous rewards/losses
and does not consider transition probability, which makes it computationally cheap, but also rather
inflexible. Following this strategy, first stage choices are repeated whenever that choice has been
rewarded, and switched when that choice has been not rewarded or has been punished. In contrast
to this, model-based choices should additionally account for transition probabilities, which makes it
computationally more demanding and effortful, but also more flexible and adaptive. Following this
strategy, first stage choices tend to be repeated whenever a choice has been rewarded on a common
transition or punished on a rare transition, and switched when a choice has been rewarded on a rare
transition or punished on a common transition.
Even though the experimental induction of hangover was effective (as demonstrated by significant
increases in 21 out of 22 assessed hangover symptoms, as well as overall hangover severity [59]), we did
not find evidence for any hangover effects in the MF- and MB-score, as well as in the computationally
deduced weighting parameter ω (which represents the balance between the two strategies), or in the
overall outcome (obtained score). Instead, Bayesian analyses provided positive evidence that there
was likely no difference between the sober and the hungover session. The lack of response time effects
further suggests that the application of goal-directed strategies was not maintained at the cost of a
speed-accuracy tradeoff. The BIC parameter, which allows to compare the model fit across sessions,
further suggested that the observed comparability across sessions was not caused by differences in the
goodness of the model fit. Likewise, we found no evidence for increased perseveration tendencies
(π) during hangover. Subsequent Bayesian analysis failed to provide conclusive evidence for either
hypothesis, but still favored the null hypothesis over the alternative hypothesis at an anecdotal
level. Hence, all of our findings are in favor of the assumption that alcohol hangover does not
alter the balance between model-based and model-free learning strategies, or increase perseveration
tendencies. Still, it would be commendable to also investigate other potential facets of alcohol hangover
effects on automatic and/or habitual behavior with other promising new paradigms [60,61]. Add-on
exploratory analyses further showed that there were also no hangover effects on the learning rate (α),
the randomness of decision-making (β), or the down-weighing of previous experience (λ).
It should however be noted that the weighting parameter omega was numerically higher than
in other studies with healthy young samples [32,62,63], which indicates a stronger preference for
the model-based learning strategy in the investigated sample/applied task. This could be due to
the manipulations in task administration (e.g., more prominent transition probabilities as well as
usage of simulated distributions for outcomes and transitions), which facilitates the application of
model-based, computationally demanding strategies [27]. A higher reliance on a model-based system
is typically found when high incentives shift the cost-benefit-arbitration in favor of a computationally
costly strategy [64,65]. Given this strong preference for model-based over model-free strategies in
both sessions, we can assume a general willingness to exert cognitive effort and thereby exclude the
possibility that the lack of hangover effects could be due to a lack of overall motivation to perform
the task as instructed. It however remains an open question whether high intrinsic motivation or
changes in task settings have led to the more pronounced dominance of the model-based learning
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system, as compared to other studies in the field. In addition, the task and its parameters do not allow
to distinguish between the ability and the willingness/motivation to exert cognitive control: While
we found no decline in the application of effortful model-based strategies, our data does not allow
to exclude the theoretical possibility the participants’ awareness of their hangover symptoms and/or
associated expectations of decreased performance motivated them to exert more effort than during
the sober session, thus masking small to medium detrimental effects of alcohol hangover on effortful
model-based strategies.
To the best of our knowledge, this is the first publication that explicitly investigates the arbitration
between effortful model-based and computationally less demanding model-free learning in alcohol
hangover. Yet still, the finding that hangover does not reduce the ability and/or willingness to invest
cognitive effort (despite the experimentally applied sleep restriction and the fact that binge drinking is
known to decrease sleep quality [42,44,47–49]) adds to the general literature on cognitive hangover
effects, where cognitive effects that can be reliably observed during alcohol intoxication or AUD cannot
always be reproduced during alcohol hangover [6,10–12,17], and are not necessarily modulated or
worsened by light hangover-associated sleep impediments [40,44]. Given that there is an ongoing
debate on whether or not habitual binge drinking impairs cognitive control functions that require high
levels of effort [22,66] and all of our participants had been recruited to engage in binge drinking at
least one a month (in order to minimize the risk of severe adverse side effects during experimental
intoxication), we ran add-on analyses to investigate the potential effects of alcohol use severity on
the investigated measures at both sessions. Of note, none of these analyses provided evidence for
an association between alcohol use severity (indicated by AUDIT scores) and changes in any of the
measures relevant to the arbitration between model-based and model-free behavior. Of note, this
finding is in line with a study by Doñamayor et al. [21], who compared both female and male binge
drinkers (mean AUDIT score of 16) to healthy controls (mean AUDIT score of 5) of similar age as our
sample. While they reported a shift from goal-directed behavior to habitual behavior in binge drinkers,
they found no statistical relationship between AUDIT scores, the weighting parameter, model-free
scores, or model-based scores across the entire sample, even though they had a similar overall mean
and greater variance in AUDIT scores across the entire sample [21]. It also matches reports by Patzelt et
al. [67], who found no correlation between alcohol use (as assessed with the AUDIT) and model-based
scores in over 900 adult Amazon Mechanical Turk participants.
Given that we only investigated young healthy males, it should be critically discussed whether the
null finding reported in this study would also have been found females, or in other age groups. Females
tend to metabolize alcohol more slowly than males [68] and have been suggested to report greater
subjective hangover symptoms than males [69–71]. Lastly, women have been suggested to show greater
cognitive impairments than males in case of regular binge drinking [22] and alcohol abuse [72]. Given
that women might hence be more vulnerable to the negative cognitive effects of alcohol, our results
might unfortunately not be readily generalizable to female populations, thus necessitating further
studies. Furthermore, it has been shown that general cognitive and executive functions (e.g., processing
speed or working memory) interact with model-based learning [62,73]. It could hence be possible
that the typically high functioning levels found in young healthy samples protected our participants
from detrimental effects of intoxication. Given that old age has repeatedly been associated with
decreased cognitive functions in various domains, including model-based decision making [74,75],
and further given that hangover severity might also differ with age [76,77], it could be conceivable that
the combination of reduced cognitive resources and altered alcohol hangover might render elderly
individuals more vulnerable towards the potential detrimental effects of alcohol on model-based
processing. It should therefore be investigated whether our null finding can be reproduced in older
samples as well. Lastly, we did not control for factors such as reward sensitivity or the subjective
cost of control, which may depend on both internal and external factors. Correcting for the expected
value of control as suggested by Shenhav et al. [78] (e.g., controlling for aspects like reward sensitivity,
task difficulty, or anterior cingulate cortex activation) might potentially provide new insights and/or
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help identify functional subgroups. In line with this, it would also have been interesting to assess
whether subjective ratings of motivation and invested effort differed between the sober and hungover
appointment and/or whether they correlated with any of the assessed parameters.
5. Conclusions
In summary, we investigated whether alcohol hangover shifts decision making strategies from a
more model-based to a more model-free approach. We asked n = 25 young healthy male social drinkers
to perform a two-step decision-making task once while sober and once while hungover. Behavioral
and modeling parameters were compared across appointments. The lack of significant hangover effects
and the positive Bayesian evidence for the null hypothesis in all but one investigated parameters
suggest that alcohol hangover, which results from a single binge drinking episode, does not impair the
application of effortful and computationally costly model-based learning strategies and/or increase
model-free learning strategies. While this finding still awaits confirmation in females and other age
groups, it adds to a growing body of literature suggesting that behavioral deficits observed in at-risk
drinkers [20,21,25] might not be a mere consequence of alcohol consumption alone [20,23,24,30,55,67].
When applying this finding to a clinical context, it suggests that the behavioral and psychological
changes that have been associated with problematic drinking patterns like binge drinking [21,22]
and shown to drive and maintain alcohol use disorders (AUD) [16,23–25], are not likely to arise as a
consequence of hangover (alone).
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Abstract: Alcohol consumption can negatively affect sleep quality. The current study examined
the impact of an evening of alcohol consumption on sleep, and next day activity levels and alcohol
hangover. n = 25 healthy social drinkers participated in a naturalistic study, consisting of an
alcohol and alcohol-free test day. On both days, a GENEactiv watch recorded sleep and wake,
and corresponding activity levels. In addition, subjective assessments of sleep duration and
quality were made, and hangover severity, and the amount of consumed alcoholic beverages were
assessed. Alcohol consumption was also assessed in real-time during the drinking session, using
smartphone technology. The results confirmed, by using both objective and subjective assessments,
that consuming a large amount of alcohol has a negative impact on sleep, including a significant
reduction in objective sleep efficiency and significantly lower self-reported sleep quality. Activity
levels during the hangover day were significantly reduced compared to the alcohol-free control day.
Of note, next-morning retrospective alcohol consumption assessments underestimated real-time
beverage recordings. In conclusion, heavy alcohol consumption impairs sleep quality, which is
associated with increased next day hangover severity and reduced activity levels. The outcome of this
study underlines that, in addition to retrospectively reported data, real-time objective assessments
are needed to fully understand the effects of heavy drinking.
Keywords: sleep; daytime activity; alcohol; hangover
1. Introduction
Alcohol hangover refers to the combination of mental and physical symptoms, experienced the
day after a night of heavy drinking, starting when blood alcohol concentration (BAC) approaches
zero [1]. Several factors may aggravate hangover severity and corresponding performance impairment,
and one of them is the quality and duration of sleep after a heavy drinking session. Both hangover and
sleep disturbances have shown to significantly impair potentially dangerous daily activities such as
driving a car [2,3]. While people often report falling asleep immediately after alcohol consumption [4],
the quality of sleep is often disturbed by the over production of glutamine [5]. Glutamine is a natural
stimulant and alcohol produces both stimulant and sedative effects [6]. The stimulating effects of
alcohol are thought to be associated with rising BACs (while drinking), whereas the sedative effects
are associated with already high BAC levels [7]. The stimulating effects are linked to the activation
of dopamine release in the brain’s ‘reward circuitry’ [6]. During alcohol consumption glutamine
production is suppressed, and when alcohol leaves the body, the body then attempts to recover lost
levels of glutamine. The increased glutamine levels after consumption has ceased and is referred to as
glutamine rebound [8]. Roehrs et al. [9] found that when glutamine rebound occurs, increased waking
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and light sleeping was observed during the second half of the sleep period. On a normal night rapid
eye movement (REM) and non-REM sleep periods alternate throughout the night with an average of
six to seven cycles, however, after an evening of drinking this is reduced to two to three cycles [10].
It is therefore vital to further examine the relationship between alcohol consumption, sleep, and the
alcohol hangover. Up to now, several studies have addressed this issue, and the collected evidence
comes from either retrospective self-report or real-time assessments such as polysomnography.
1.1. Self-Report
Most evidence on the association between alcohol hangover and sleep comes from self-report,
either gathered in clinical studies or via (retrospective) surveys. These revealed that drinking time
often goes at the expense of total sleep time, and that alcohol has a detrimental effect on sleep
quality. For example, in a controlled study, Finnigan et al. [11] observed that subjects fell asleep
faster after alcohol consumption and reported reduced next-day alertness. McKinney and Coyle [12]
examined alcohol hangover effects and sleep in 48 social drinkers. Applying a naturalistic study design,
the researchers did not interfere with drinking behavior and no restrictions were placed on the subjects
sleep behavior. Similar to Finnigan et al., McKinney and Coyle found that sleep was disrupted after
alcohol consumption and next-day fatigue was significantly increased. After alcohol consumption,
sleep was qualified as less satisfying, refreshing, and restful. Further, subjects went to bed significantly
later when compared to the alcohol-free day, resulting in a significantly reduced total sleep time (TST).
Moreover, with higher amounts of alcohol intake, sleep onset latency (time of falling asleep—time to
bed; SOL) further reduced. Similar findings were reported by Hogewoning et al. [13] who’s naturalistic
study revealed that drinking time goes at the expense of TST and that time-to-bed is significantly
delayed by more than 1.5 h after alcohol consumption compared to an alcohol-free evening.
Rohsenow et al. [14] examined powerplant performance in n = 61 merchant marine cadets the day
following an evening of alcohol administration to achieve a BAC of 0.11%. Results were compared to
an alcohol-free control test day. After an 8h period of supervised sleep, subjects reported significantly
improved sleep quality in the alcohol condition. This unexpected finding may be explained by the fact
that after alcohol consumption subjects reported significantly reduced sleep latency until sleep onset.
Powerplant performance was not impaired in the hangover state.
Van Schrojenstein Lantman et al. [15] conducted a survey among 578 Dutch University students
examining the impact of TST on the presence and severity of their past months latest alcohol hangover.
Subjects who consumed more alcohol slept significantly longer. A positive correlation was found
between TST and the duration of the alcohol hangover state. However, at the same time, prolonged TST
was associated with significantly reduced overall hangover severity. Thus, reduced TST was associated
with more severe hangover complaints. In a second survey by van Schrojenstein Lantman et al. [16],
335 adults reported that sleep quality was significantly worse after their latest alcohol consumption
session that resulted in a hangover, and that daytime sleepiness was significantly increased compared
to a regular alcohol-free day.
With regard to daytime activity, several studies revealed self-reports of increased apathy and
hangover symptoms suggesting reduced activity during alcohol hangover [17,18].
1.2. Real-Time Assessments
In 2010, Rohsenow et al. applied polysomnography to examine sleep in relation to alcohol
hangover in n = 95 social drinkers [19]. In a double-blind study, sleep was assessed after alcohol
administration to achieve a BAC of 0.11% and an alcohol-free control day. Alcohol significantly
decreased sleep efficiency and rapid eye movement sleep, and next-day self-reported sleepiness was
significantly increased during hangover. Significantly worse hangovers were reported by subjects with
reduced sleep efficiency and shorter TST. When hangover severity increased, less time was spent in
rapid eye movement sleep.
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Earlier polysomnography studies with lower alcohol dosages revealed similar effects on
sleep [9,20,21]. Alcohol significantly reduced sleep latency and the time spent in REM sleep. In the
first half of the night, alcohol significantly increased the time spent in deep sleep (stage 3 and 4),
while in the second half of the night, time spent in stage 1 sleep (drowsy light sleep) was significantly
increased. The observations confirmed previous findings that after alcohol consumption people fall
asleep quicker, spent less time in REM sleep in the first 4 h of sleeping [9]. The next 4 h, i.e., the second
half of the night, sleep is more disturbed and fragmented, often characterized by multiple awakenings
and increased time spent in Stage 1 sleep. Roehrs et al. [9] conducted a Multiple Sleep Latency Test
(MSLT) the day following alcohol consumption (peak BAC 0.08%) or placebo. The assessments showed
that throughout the post-alcohol day subjects were sleepier, as evidenced by the fact that they fell
asleep significantly faster when compared to the alcohol-free day.
More recently, Wilkinson et al. [22] applied actigraphy to a study with ten healthy subjects without
sleep disturbances. Subjects continuously wore an actigraph, starting three nights before a day of
alcohol consumption until 4 days thereafter. In the two days before the alcohol challenge, TST was
on average 8.0 h and no naps were recorded. On the test day, at 9AM, alcohol was administered in a
controlled laboratory setting to achieve a peak BAC of approximately 0.14%. Sleep behavior on the
day and subsequent night were examined and next day (24 h after the start of alcohol consumption),
subjects completed the Acute Hangover Scale [23]. Seven out of 10 subjects took an unscheduled
afternoon nap, on average 8.7h after drinking, which lasted 0.6h. The authors further analyzed the
data separately for those who napped (n = 7) and those who did not have a nap (n = 3) after alcohol
consumption. The analysis revealed that the groups did not significantly differ on TST or hangover
severity. Limitations of the study include its small sample size, and that alcohol was administered at
9AM in the morning. Therefore, it is unclear to what extend this study mimics real-life drinking and
the ‘normal’ hangover experience.
To our knowledge, physical activity levels during the hangover state have not been investigated
previously. Additionally, real-time assessments of sleep and alcohol consumption are usually not
conducted in hangover research. However, emerging research [24,25], provides a foundation in
Ecological Momentary Assessment (EMA), which can be used to collect real time data. Here, EMAs
were used to collect alcohol consumption measures every morning for 4–14 days [24] and one week [25].
Analysis of EMA data showed that subjects exceeded the threshold for binge drinking on drinking
occasions [24]. The analysis also revealed more severe hangovers in adolescents (15–19 years) than
adult heavy drinkers (21 or over) [24]. Moreover, severe hangover symptoms predicted less alcohol
consumption on that particular day [24]. Using EMA messaging, Riordan et al. [25] showed that
messages relating to short-term and long-term health and social consequences reduced alcohol
consumption in female subjects but not males during orientation (freshers) week and semester 1. These
studies [24,25] demonstrate the potential use of EMAs in both research and clinical interventions.
Building on this, smartphone technology has been implemented to collect hourly intoxication
ratings, and alcohol and water consumption. In addition the current study was conducted to examine
sleep after an evening of heavy alcohol consumption and its relationship to next day hangover severity
and physical activity. In order to closely mimic a real life drinking experience, the study had a
naturalistic design in which the researchers monitored but did not intervene with alcohol consumption
or other activities and behaviors, nor did the researchers control time-to-bed or wake up time. Thus, it
provides a unique amalgamation of both the laboratory and naturalistic approach through the use of
objective real time measures in a natural environment.
Considering the literature presented above, it is predicted that alcohol consumption may not be
accurately reported following a night of heavy drinking. It is also anticipated that sleep time will occur
later in the evenings where alcohol is consumed. Finally, it is predicted that sleep efficiency and TST
will be reduced during a hangover and participants will engage in less demanding physical activities
during a hangover.
303
J. Clin. Med. 2019, 8, 752
2. Methods
Twenty-eight healthy social drinkers (students of Ulster University) were recruited to participate
in this naturalistic study. Participants were excluded for head injury, pharmaceutical treatment,
pregnancy, and previous treatment for alcohol or drug abuse. Social drinking status, i.e., not being
alcohol dependent was verified by self-report, and by completion of the Short Michigan Alcohol
Screening Test (SMAST) [26]. Participants with a SMAST score greater than three were excluded from
participation in the study. Ethical approval for this study was obtained from the ethics committee at
Ulster University. All subjects provided written informed consent, and the study was conducted in
accordance with the “Code of Ethics and Conduct” of the British Psychological Society (2009).
2.1. Design
The study comprised an evening of alcohol consumption and an alcohol-free (control) test day.
Both experimental testing days occurred in free-living conditions whereby subjects did not have study
or work commitments, or mandatory training to attend. Using a naturalistic study design, subjects
consumed alcohol at a venue of their own choice, and the type and quantity of alcohol and activities
during the evening were not controlled by the researchers in order to closely mimic real-life drinking
occasions [6]. The investigators did not interfere with the participant’s activities and behavior.
2.2. GENEactiv Accelerometer Assessments of Sleep and Activity
On each test day, participants were asked to wear, on their non-dominant hand, a GENEActiv
accelerometer [27,28] to objectively assess activity levels and sleep. The GENEActiv accelerometer
continuously records activity, environmental temperature and light exposure. The watch could not be
operated by the participants, nor did they have access to the data collected. The device allows for raw
data to be transferred wirelessly in real time and saved as an open source or csv. The data then can
be analyzed in statistical packages such as SPSS and R [27,28]. Esliger et al. [29] has validated and
calibrated the GENEActiv accelerometer using Metabolic Equivalent of Tasks (METs) and Signal Vector
Magnitudes (SVM, magnitude of watch movement). METs represent the energy costs of physical
activity [30]. One MET refers to an individual’s resting metabolic rate and can be calculated by dividing
the volume of oxygen (VO2) used during the activity by 3.5 (1 MET = 3.5 mL O2/kg/min) [21,22].
The outcome intensity levels, categorized by Esliger et al. [29], and included in this study were:
Sedentary (<1.5, METs), light (1.5–3.99 METs), moderate (4.00–6.99 METs), and vigorous (7+METs)
activity. The corresponding cut off points were set at 386 SVM (sedentary to light), 542 SVM (light
to moderate), and 1811 SVM (moderate to vigorous). Outcome measures included the percentage of
time spent in sedentary, light, moderate and vigorous activity from waking up to midnight, and total
METs spent on the hangover and control day were calculated. Continuous measurements of activity
level allowed calculation of time to bed, time of falling asleep, wake up time, TST, sleep efficiency
(i.e., the ratio of total sleep time and the time spent in bed), and number and the median duration of
nightly awakenings/activity. Using this data, sleep onset latency (time of falling asleep—time to bed)
was computed.
2.3. Self-Reported Sleep (Next Morning)
Self-reported assessments of sleep comprised questions on time to bed, time of falling asleep, wake
up time, sleep onset latency, and total sleep time. Using this information sleep efficiency was computed.
To evaluate last night’s sleep, subjects rated several aspects of their sleep quality on a 7-point bi-polar
scale ranging from extremely, quite, and slightly, around a midpoint of four (neither). Sleep quality
was assessments by six bipolar ratings including good-bad, satisfying-not satisfying, restful-not restful,
refreshing-not refreshing, and light-deep. This scale has previously been implemented successfully in
hangover research [12] and was completed each test day in the morning.
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2.4. Assessments of Alcohol Consumption (Real-Time and Retrospective)
On the day before the drinking session, a Droidsurvey/iSurvey app was installed on subjects’
smartphones, and they registered with the program (Harvest Your Data). Participants were identified
through coded usernames and responses were recorded and synced to the researcher’s account online.
When offline, the application stored data until the device went online. On the drinking occasion,
real-time smartphone assessments of alcohol consumption were made. The app required touch screen
responses to four short questions and took approximately 1 min to complete. Participants were asked
to set reminders on their alarm to complete the app once hourly throughout their drinking episode.
One of the questions assessed the amount of alcoholic beverages consumed during the past hour.
The number of units of alcoholic beverages that was consumed last night was also assessed the
following morning. To help recall and calculate the amount of beverages consumed pictures were
shown with the drinks and corresponding standardized UK units that included wine, beer, alcopops,
and shots of spirits (mixers).
2.5. Assessments of Hangover Severity (Next Morning)
In the morning on each test day, the Acute Hangover Scale [23] was completed to measure the
severity of 9 symptoms, including hangover, thirsty, tired, headache, dizziness/faintness, loss of appetite,
stomach ache, nausea, and heart racing. Each item could be scored on a Likert scale ranging from 0 to
7, with the anchors none (0), mild (1), moderate (4), and incapacitating (7). The mean of the item scores
represents overall hangover severity, with higher scores representing more severe hangovers.
2.6. Statistical Analysis
Statistical analysis was conducted with SPSS, version 24. Mean (SD) were computed for each
variable. Results from the hangover day and control day were compared using paired sample t-tests,
and in case the data was not normally distributed the nonparametric Mann-Whitney U test was applied.
Differences were considered significant if p < 0.05. The relationship between objective and subjective
sleep assessments, and other variables was investigated by computing Spearman’s Rank correlation
coefficients, using difference scores (alcohol—control day). Correlations were considered significant if
p < 0.05.
3. Results
Three participants did not attend the testing sessions, and as a result, 25 participants completed
both testing sessions. On the experimental day, participants’ retrospectively reported a mean (SD) of
8.0 beverages (SD = 2.7), and their mean (SD) hangover severity was 2.2 (0.9). Descriptive statistics of
the study sample are summarized in Table 1.
Results from the real time data collection of alcoholic drinks consumption revealed that a mean
(SD) of 11.4 (3.8) beverages were consumed. However, participants reported a mean (SD) of 8.0
beverages (SD = 2.7) the following day. While the Pearson’s product-moment correlation revealed a
significant association between alcohol consumption reported next day and in real time (r = 0.57, p
< 0.01), a paired samples T-test revealed a significant difference in real time and next day reports of
alcohol consumption (t(22) = −5.133, p = 0.0001).
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Age (years) 26.0 (7.1)
Age of first drink (years) 14.9 (1.7)
Usual Total sleep time (TST) (h:min) 6:33 (1:55)
Alcohol consumption on study night
Reported units of alcohol consumed (real-time) 11.4 (3.8)
Reported units of alcohol consumed (retrospective) 8.0 (2.7)
Start time drinking (h:min) 20:48 (3:47)
Stop time drinking (h:min) 01:17 (1:12)
Duration of alcohol consumption (min) 269 (149.2)
Consumed more alcohol than planned (Yes/No) 10/15
Mean (SD) hangover severity 2.2 (0.9)
3.1. GENEActiv Sleep Assessments
A summary of all GENEactiv sleep assessments in the hangover and control condition is given in
Table 2.
Table 2. GENEactiv sleep assessments.
Sleep Outcomes
Alcohol Day Control Day
Mean (SD) Mean (SD) p-Value
Sleep start time 02:41 (1:17) 00.41 (1.16) 0.00 *
Wake-up time 9:46 (1:37) 8.56 (1:53) 0.07
Time in bed (h:min) 9:27 (2:46) 9:22 (2:14) 0.85
Total sleep time (TST) (h:min) 6:34 (3:45) 7:59 (4:42) 0.16
Sleep efficiency (%) 69.0 (16.7) 80.0 (15.2) 0.04 *
Number of nightly activity periods 8.4 (5.5) 8.0 (6.1) 0.81
Median duration nightly activity (min) 27.5 (59.9) 33.5 (79.0) 0.46
Significant differences (p < 0.05) between the alcohol and control test day are indicated by *.
The GENEactiv assessments further revealed that sleep efficiency was significantly worse after
alcohol consumption (p = 0.04). Time to bed was significantly later on the alcohol and the control day.
Wake up time did not significantly differ between the alcohol and control day. Interestingly, TST after
alcohol consumption did not significantly differ from the alcohol-free control day.
An example of the visual output and summary data is presented in Figure 1. It can be seen in
Figure 1 that there is a delay in sleep time after alcohol consumption. Of note, drinking occurred on
Friday evening.
The subject in this example went to bed 1 h and 17 min later after alcohol consumption when
compared to the alcohol-free control night. In the control condition, 64% of participants went to bed at
or after midnight and this was the case for 100% of participants on the alcohol test day. In line with this,
TST was about 1.5 h shorter on the alcohol test day, confirming that usually drinking time goes at the
expense of sleeping time. However, given the large variability in TST between subjects, the difference
in TST between the alcohol and control test days did not reach statistical significance (p = 0.16).
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Figure 1. Visual output and summary data provided by the GENEActiv.
3.2. Self-Reported Sleep
Self-reported sleep outcomes are summarized in Table 3. Ratings of sleep quality revealed that
subjective quality of sleep was significantly worse after consuming alcohol than on the control day
(p = 0.046), as well as significantly less restful (p = 0.001) and less refreshing (p = 0.01). Sleep was also
rated more satisfying when participants did not consume alcohol, although the difference with the
alcohol test day did not reach significance (p = 0.07).
Table 3. Self-reported sleep outcomes.
Alcohol Day Control Day
Mean (SD) Mean (SD) p-Value
Start time sleeping 02:28 (1:14) 00:23 (1:11) 0.00 *
Sleep onset latency (min) 29 (41) 49 (62) 0.22
Total sleep time (TST) 06:40 (1:53) 7:01 (1:50) 0.44
Wake-up time 09:00 (2:25) 8:25 (1:14) 0.00 *
Sleep efficiency (%) 94.5% (17.0%) 91.6% (8.6%) 0.55
Sleep quality 1
Good-Bad 3.7 (1.6) 2.8 (1.3) 0.046 *
Satisfying-Not Satisfying 4.0 (1.6) 3.4 (1.3) 0.07
Refreshing-Not Refreshing 4.2 (1.4) 3.1 (1.2) 0.01 *
Restful-Not Restful 4.6 (1.3) 3.4 (1.4) 0.01 *
Light-Deep Sleep 5.0 (1.7) 5.0 (1.2) 0.92
Significant differences (p < 0.05) between the alcohol and control day are indicated by *. 1 Higher scores represent
poorer sleep quality.
3.3. Correspondence between Objective and Subjective Sleep Assessments
A Spearman’s R correlation analysis (using alcohol—control difference scores) comparing objective
and subjective sleep measures revealed a significant negative relationship for TST (r = −0.41, p = 0.04).
In addition, positive correlations were found between objective and subjective time of sleep onset
(r = 0.71, p < 0.001) and wake-up time (r = 0.46, p = 0.02). There was no significant correlation between
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objective and subjective sleep efficiency, and paired t-tests revealed that this outcome significantly
differed between the assessment methods (p = 0.03). Other sleep outcomes did not significantly differ
between subjective and objective assessments.
3.4. Correspondence between Sleep Assessments, Alcohol Consumption, and Hangover Severity
Spearman’s R correlation revealed that the total number of units of alcohol consumed and mean
hangover severity did not significantly correlate with any of the sleep outcomes.
3.5. Physical Activity
An example of physical activity assessment on the hangover day and the control day is given
in Figure 2. It is evident from Figure 2 that activity levels were reduced on the hangover day. Most
time was spent in the sedentary activity mode. In this example, moderate activity levels were seen on
the control day, which were absent on the hangover day. It can be hypothesized that the absence of
moderate activity levels are associated with the large reduction in total sleep time (i.e., more than 2 h
in this subject) the night before the hangover day.
Figure 2. Physical activity levels on the alcohol and control day.
The overall results on physical activity for the hangover and control day are summarized in
Figure 3. First, the percentage of time spent on vigorous activity was significantly less (p = 0.03)
on the hangover day (2.8%) compared to the control day (10.0%). Second, a significantly (p = 0.01)
higher percentage of time was spent in a sedentary manner on the hangover day (63.6%) compared to
the control day (50.8%). Third, no significant difference between the hangover and control day was
observed for percentage of time spent on light activity (p = 0.86) and moderate activity (p = 0.09).
Figure 4 summarizes the amount of MET.minutes for different physical activity levels on the
hangover day and control day. Total energy spent on the hangover day (1870 METs) was lower
compared to the control day (2279 METs). However, the difference did not reach statistical significance
(p = 0.37), presumably due to the large standard deviations observed on both the hangover and control
day (SD = 1487 and SD = 1549, respectively). Wilcoxon Signed-Ranks analyses revealed no significant
differences between hangover and control day for sedentary (p = 0.43), light (p = 0.62) or moderate
(p = 0.06) MET.minutes. Thus, although a significantly less percentages of time was spent on sedentary
activity on the hangover day compared to the control day, the level of energy spent at this level did not
significantly differ between the test days. On the control day, the mean vigorous MET.minutes was
significantly higher compared to the hangover day (p = 0.02).
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Figure 3. Percentage spent engaging in sedentary, light, moderate and vigorous activity on the alcohol
day and control day.
Figure 4. MET.minutes for different physical activity levels on the alcohol day and control day.
3.6. Sleep and Drinking Variables Associated with Percentual Changes in Activity
A Spearman’s R correlation analysis was computed to compare the differences scores of percentages
spent at the 4 activity levels (hangover-control day) with the total units of alcohol consumed, hangover
severity, and sleep outcomes. Significant positive correlations were found between total units of
alcohol consumed and differences in the percentage of light activity (r=0.45, p = 0.02). No significant
association was found between percentual changes of activity levels and mean hangover severity.
With regards to objective sleep measures, differences in percentages of sedentary activity positively
correlated with wake-up time (r = 0.40, p = 0.049) as well as TST (r = 0.53, p = 0.01). Moreover
MET.minutes of moderate activity negatively correlated with wake-up time (r = −0.44, p = 0.03).
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However, no other objective sleep measures correlated with MET.minute measurements. In terms of
subjective sleep, the percentage of sedentary activity positively correlated with sleep onset latency
(r = 0.52, p = 0.01) and moderate activity level MET.Minutes negatively correlated with sleep onset
latency (r = −0.53, p = 0.01). Subjective measures of sleep quality revealed no significant differences
relating to the percentage of activity levels or MET.minutes.
4. Discussion
Using both objective and subjective assessments, this study confirmed that consuming a large
amount of alcohol has a negative impact on sleep, including a significantly reduced objective sleep
efficiency and significantly lower subjective sleep quality. The study further revealed that next-day
activity levels are significantly reduced during the alcohol hangover.
In relation to previous research, these results are in line with previous investigations of sleep and
hangover [5,6]. Also in the current study, time to bed was significantly delayed by more than 1 h.
However, in contrast to previous research [12,13,15], the difference in TST between the alcohol and
control day in our study did not reach statistical significance, and in contrast to previous research [8,12]
no significant association was found between objective TST and hangover severity. An explanation for
the absence of significant effects may be the fact that there was great variability in TST between the
subjects in this sample. Second, similar to previous findings by Rohsenow et al. [19], in the current study,
sleep efficiency was significantly reduced after alcohol consumption. Whereas Rohsenow et al. [12]
found a significant negative correlation between sleep efficiency and alcohol hangover, this correlation
was not significant in the current study. In line with previous research [12,16], but not all [13],
sleep quality was significantly poorer after alcohol consumption. Finally, several studies reported a
reduced SOL after alcohol consumption [9,11,12,14]. While in the current study, subjective SOL was
20 min shorter after alcohol, the difference with the control day did not reach statistical significance.
A correlation between alcohol consumption and hangover severity was not found. This observation
supports recent findings [15] but contrasts with others [16]. It should be noted that the current study
had less power than other studies that had a larger numbers of participants, so non-significant results
can also be a result of low power for those particular analyses.
4.1. Objective Versus Subjective Assessments
The objective and subjective sleep assessments were generally in agreement with each other.
However, some discrepancies were also noted. Most notably, while after consuming alcohol objective
TST was reduced by more than 1 h, the difference in subjective TST was much smaller (<30 min).
A similar discrepancy was found for objective and subjective assessments of sleep efficiency. The reason
for these differences in subjective and objective assessments are unclear, but it may be related that
subjects are unaware of the number and duration of nightly awakenings.
One could argue that these differences in outcomes underline the need for including real-time
assessments to complement subjective sleep reports in clinical studies. Objective sleep may differ from
perceived sleep and this discrepancy is not captured by relying solely on self-report. In this context,
previous research in other areas has shown that subjects are sometimes unaware of performance or
mood changes. For example, subjects were unaware of impairment in on-road driving tests after
administering pharmacological treatment, while in contrast to this perception the objective assessments
demonstrated that their actual driving performance showed clinically relevant impairment [31]. Thus,
relying solely on patient perceptions of mood and impairment may therefore be dangerous in real life
(e.g., they may decide to drive a car while they are not fit to drive) and bias clinical trial outcomes. For
future research it is therefore recommended that, when possible, subjective ratings are complemented
by objective assessments.
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4.2. Recall Bias
When using a naturalistic study design, accurate capturing of alcohol consumption data is critical,
as researchers are not present during the drinking session. It is therefore important to discuss the
possible limitations of the methodologies used in this study.
While it should be taken into account that both being intoxicated and being hungover can
result in inaccurate answering, this study revealed that retrospective reporting resulted in significant
under-reporting of actual alcohol consumption. Retrospective self-report measures have long since been
implemented in data collection. In the case of alcohol consumption this involves using retrospective
memory to recall the type and number of alcoholic beverages consumed [32], as well as applying one’s
ability to comprehend the question being asked, make decisions about the accuracy of the information
recalled, and format an answer [33]. It is however unlikely that these factors may have played a role
in the current student sample. Further, participants may be reluctant to disclose information about
the number of drinks consumed the previous night. Additionally, this is unlikely to be an issue, as
both research data and study participation was treated anonymously. The timing and place of data
collection can however have had a significant impact on what is reported by study participants [34].
For example, diminished retrospective ability to recall the amounts of drinks consumed may be an
issue, especially the morning after a night’s drinking when subjects suffer from an alcohol hangover.
Research has shown that under these circumstances memory may be impaired [35,36]. Given this,
accurately reporting alcohol consumption the day following a night’s drinking remains challenging,
and is an issue inherent to conducting alcohol research. Furthermore, periods of memory loss while
a person is intoxicated (e.g., blackouts or lapses of attention) can hinder both accurate retrospective
recall [37] and real-time reporting.
The use of smart phone and wearable technologies has garnered increasing attention in the fields
of addiction research, as they offer the possibility of real time data collection at times people use alcohol
and/or drugs in a natural setting and they also offer a more accurate assessment of alcohol consumption
over time [38–41]. While real time data may be inaccurate because subjects are intoxicated, this data
collection technique is not affected by recall bias.
The integration of mobile phone technology to real time alcohol consumption data has been
considered for some time [38]. While mobile phones were not as robust at the time, research concluded
that it was a feasible alternative to paper and pencil self-monitoring [38]. Nonetheless, since then, few
other studies have implemented smartphone technology to capture real-time alcohol consumption data
and compare this to retrospective assessments [41–43]. Monk, Heim, and Price [41] applied smartphone
technologies to investigate real-time alcohol consumption. Their application was designed to give
hourly prompts to participants to select the context and number of drinks consumed. In line with our
findings, their study confirmed that participants significantly under-report alcohol consumption when
assessed by retrospective self-report measures. A difference of almost four drinks was reported on
daily alcohol consumption (8.5 in real-time versus 4.2 retrospective). Taken together, these findings
underline the importance of using real-time assessments when accurate real word evidence is needed.
4.3. Daytime Activity Levels
To our knowledge, this is the first study that directly compared objective assessments of levels of
daytime activity during the hangover state and an alcohol-free control day. The assessments revealed
that daytime activity levels were significantly reduced during alcohol hangover. These findings confirm
previous self-reports of increased apathy and reduced alertness during the hangover state [16,17],
which can be regarded as indications of reduced activity during alcohol hangover. While the GENEactiv
watch objectively assessed the levels and duration of daytime activity, in the current study it was not
assessed in what type of activity the subjects were actually engaged. Future research should address
which specific activities are affected, delayed or fully skipped, and which other activities are conducted
in the same manner as on an alcohol-free day. Also, motives for possible behavioral and activity level
changes are largely unknown. Previous research has shown that potentially dangerous activities such
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as driving a car are significantly impaired during the hangover state [2]. It would be interesting to
examine whether or not these types of behaviors are avoided or delayed during the hangover state,
and how these behavioral changes and corresponding decision making are motivated by drinkers.
4.4. Limitations and Objectives for Future Research
The study has several limitations that should be addressed. First of all, there were great
inter-individual differences in the data, which prevented several differences to reach statistical
significance. While the study was adequately powered to demonstrate relevant differences between the
hang over and control day, one should take into account that the hangover is a very personal experience
that may vary from occasion to occasion. Hence, after consuming the same amount of alcohol, within
a subject mood and cognitive effects and the impact on sleep may differ from drinking to drinking
occasion. Therefore, future research should capture data from more than one drinking night to get
a better overall view of the impact of alcohol consumption on sleep and subsequent hangover state.
Second, not all assessments made by the GENEactiv watch were equally informative. For example,
the standard output for nightly awakenings was the median duration of these awakenings. It would
be more useful to have data on the frequency and duration of each individual nightly awakening.
Unfortunately, with the current GENEactiv set-up, we could not recover this data. Third, while the
assessments capture physical activity it would also be interested to collect objective data on mental
activity during the alcohol hangover state. Electroencephalogram (EEG) and functional magnetic
resonance imaging (fMRI) studies should be conducted to provide more insight on this topic. Up to
now, only one small pilot study used fMRI to examine brain activity during alcohol hangover [44].
The authors reported that, in the hangover condition, subjects’ task performance was not significantly
affected. However, maintenance of accurate performance level required compensatory increased
activity of prefrontal and temporal brain structures. The authors concluded that correctly performing
tasks in the hangover state requires significantly more mental effort compared to performing them on
a normal non-drinking day. The interaction between physical and mental activity, and the mediating
role of motivation and effort to accomplish tasks during hangover is a largely unexplored, an important
topic for future research.
5. Conclusions
The current study showed that sleep duration and quality is significantly negatively affected after
alcohol consumption. Furthermore, during the hangover state, activity levels are significantly reduced.
Our study advocates for implementing both objective and subjective assessments, and combine both
real-time and retrospective measures to provide a more accurate view of a heavy drinking session, and
its aftereffects.
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Abstract: Alcohol hangover is a potentially debilitating state. Several studies have demonstrated that
it does not seem to impair strength or short-term endurance, but its effects on continuous exercise
performance/long-term endurance have never been investigated. Therefore, the aim of the current
study was to assess hiking performance of participants who walked the 15.8 km Samaria Gorge
in Crete, Greece. Participants completed a survey in the morning before walking the Gorge, and
in the afternoon after completion of the walk. Demographics, data on previous evening alcohol
consumption, sleep, hangover symptoms, and walking performance were assessed. Data from N =
299 participants with a mean (SD) age of 38.9 (11.0) years were analyzed. N = 223 participants (74.6%)
consumed alcohol the evening before walking the Samaria Gorge, and N = 176 (78.9%) of those
reported a hangover. They consumed a mean (SD) of 3.0 (1.8) alcoholic drinks (10 g alcohol each)
with a corresponding next-morning hangover severity of 4.6 (2.4) on a 0–10 scale. Participants with a
hangover reported feeling significantly more exhausted after the walk compared to participants with
no hangover. The groups did not significantly differ in duration of the walk, and the number and
duration of breaks. Overall hangover severity, assessed either before, during, or after walking the
Samaria Gorge was not significantly correlated with any walking outcome. In conclusion, hungover
participants experienced significantly more exhaustion when performing physical activity at the same
level as non-hungover participants.
Keywords: physical performance; hiking; walking; water consumption; alcohol; hangover; sleep;
Samaria Gorge
1. Introduction
The alcohol hangover is defined as the combination of mental and physical symptoms experienced
the day after a single episode of heavy drinking, starting when the blood alcohol concentration (BAC)
approaches zero [1]. A growing body of evidence shows that cognitive functioning and mood are
negatively affected in the hangover state [2,3], which may result in impaired daily activities such as job
performance [4,5], riding a bicycle [6], or driving a car [7–9].
Much less research has been devoted to the possible impact of the alcohol hangover on physical
performance. Van Schrojenstein Lantman et al. [10] investigated the impact of individual hangover
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symptoms on physical performance. Participants reported that being tired, sleepiness, headache,
nausea, and weakness had the greatest impact on their physical performance in the hangover state.
However, the few studies that have investigated physical performance in the hangover state to date
have failed to find significant effects. In 30 male students, Nelson et al. [11] examined various physical
performance activities, including grip strength, a 45-s bicycle ergometer test assessing the maximum
number of revolutions against 10 Lb resistance, softball throwing, a vertical jump, and push-ups.
Performance in the hangover state did not differ significantly from performance on the control day for
any of the tests. Karvinen et al. [12] examined physical performance in 30 firemen and policemen on
grip strength, back lift, vertical jump test and a 5-min bicycle ergometer test on a hangover and control
day. In this study, also, no significant performance differences were found between the hangover and
control day. In a more recent study, Kruisselbrink et al. [13] examined physical activity in the hangover
state in 12 females. They performed a 6-min submaximal treadmill run at 6 miles per hour, followed
by a run to exhaustion once the treadmill had been raised to a 7% grade. In addition, a grip strength
test was conducted. Again, no significant performance difference was observed during the hangover
state vs. control.
Devenney et al. [14] assessed physical activity levels during the hangover state. Compared
to an alcohol-free control day, activity levels were significantly reduced in the hangover state. In
particular, the percentage of time spent on vigorous activity was significantly reduced and a significantly
higher percentage of time was spent in a sedentary manner on the hangover day. No significant
differences between the hangover and control day were found for time spent on light and moderate
activity. Unfortunately, the type of activities participants engaged in was not recorded in this study.
Nevertheless, the data show that the activity level is reduced to less demanding levels during the
hangover state. Based on this observation, it is tempting to hypothesize that participants may be less
capable of performing physical activity at vigorous levels during the hangover state, but more research
is needed to verify this.
It should be noted that physical performance in these studies was assessed with tests of relatively
short duration and can often be categorized as assessing strength (e.g., grip strength) or balance (e.g.,
standing on one foot) or short-term endurance (e.g., a bicycle test). As of now, there are however no
studies that have examined long-term endurance, i.e., physical performance effects over a longer time,
such as a 10 km walk, long-distance running, playing a football match, or skiing. Furthermore, the
sample sizes of these studies (12–30 subjects) were relatively small, which may have contributed to
observing nonsignificant findings. Therefore, the aim of the current study was to investigate the effects
of alcohol hangover on endurance performance within a naturalistic setting. To this extent, walking
performance was examined in participants walking the 15.8 km Samaria Gorge, in Crete, Greece.
2. Materials and Methods
The study was conducted in the summer of 2019, at Crete, Greece. Participants who booked a
tour to walk the Samaria Gorge were invited to participate in the study. They were recruited on the
bus drive towards the entrance of the Samaria Gorge. Participants met the inclusion criteria if they
were 18–65 years old and could understand and write English. A researcher was present to help clarify
any questions that arose while completing the surveys. The study was conducted by researchers
from Utrecht University. The survey was anonymous and participants did not receive an incentive
for completing the surveys. The Ethics Committee of the Faculty of Social and Behavioral Sciences
of Utrecht University granted ethical approval (approval code FETC17-061). N = 307 participants
provided informed consent to take part in the study.
2.1. The Walk
Data were collected on 9 different day-excursions to the Samaria Gorge between 23 July and
11 August 2019. Weather data for these days at the Samaria Gorge were obtained from www.
worldweatheronline.com. On all days except one (partly cloudy), the weather was described as ‘sunny’.
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No rainfall was recorded on any of the excursions, the average humidity was 56% with a pressure
of 1009 mb. The average temperature rose from 27.7 ◦C at 21:00 to 29.2 ◦C at 12:00, 28.9 ◦C at 15:00
and 27.2 ◦C at 18:00. A paired samples t-test revealed no significant temperature difference between
individual test days and the mean 9-day temperature (p = 0.988).
Figure 1A schematizes the day tour of the participants. They were picked up at their
accommodation between 06:15 and 06:45 in the morning. Participants had booked their day-excursion
to the Samaria Gorge either from Chania (n= 2 excursions), Rethymnon (n= 4 excursions) or Herakleion
(n = 3 excursions). Depending on their city of residence, they arrived at the Samaria Gorge after a bus
drive of approximately 2 to 3 h: Chania (08:35), Rethymnon (09:00) or Herakleion (09:15). From Hora
Sfakia, all busses returned to the participants’ accommodations in the afternoon at 18:00. Figure 1B
shows the several resting locations where participants could drink water during the walk. These are
simple tap points, as there are no inhabited villages or stores from which to buy refreshments in the
Samaria Gorge.
 
Figure 1. Schematic representation of the day tour and Samaria Gorge walk. (A) is adapted and used
with permission from www.depositphotos.com. (B) is adapted and used with permission from Psarakis
Travel Agency (www.psarakistravel.gr).
The Samaria Gorge walk is 15.8 km long. It starts in Xiloskalo at an altitude of 1230 m and ends in
Agia Roumeli, a small village at the Libyan Sea. Agia Roumeli can only be reached by walking the
Samaria Gorge or by boat. The actual walk through the Samaria Gorge is about 12.8 km long, and after
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the end of the gorge, it takes another 3 km of walking to reach Agia Roumeli. Hence, participants walk
15.8 km in total, starting at an altitude of 1230 m, slowly descending to sea level in Agia Roumeli. The
first part of the walk is 3.8 km long with a 580 m descent, followed by 3.7 km with a 310 m descent.
Thereafter, the decent is less steep (3.6 km with a decent of 170 m). The last 4.7 km has a decent of 170
m towards sea level. An impression of the Samaria Gorge walk is given in Figure 2.
Figure 2. Impressions of the Samaria Gorge walk. (A,B) Over the first kilometers, participants descend
a narrow switchback path, which is partly bordered by a wooden handrail. A large part of the walk is
trough rough terrain, i.e., the slippery stones of a dried-up riverbed. In winter, the riverbed is filled
with water, but in summer the river has mostly dried up. Participants cross the riverbed several times,
sometimes aided by wooden improvised bridges. (C,D) there is no paved road but participants have to
follow a trail through a rocky valley. Samaria is the main resting place for most participants, as this
uninhabited tiny village contains benches in the shade, a water tap point and a medical post. Through
the last part of the walk, the cliffs become higher and narrower. (E) At its narrowest point, called
the “Gates”, the Samaria Gorge is approximately 4 m wide, while the cliffs rise over 300 m high. (F)
Thereafter, the final fairly flat part of the walk ends in Agia Roumeli at the seaside. Participants can
relax, eat and drink in the taverns, and recover from the walk. From Agia Roumeli, a ferry brings the
participants to Hora Sfakia in about 1 h. From there, coaches leave at 18:00 to bring the participants back
to their accommodation. Figures adapted and used with permission from www.depositphotos.com.
2.2. Data Collection
Two surveys were conducted. The first survey was completed in the bus, before walking the
Samaria Gorge. Demographic information was collected. Participants provided information on
the past evening’s alcohol consumption. They reported the number of alcoholic drinks consumed
(European sizes were provided as examples, which contain 10 g alcohol each) as well as the start and
stop time of drinking. Together with information on sex and weight, this allowed for the calculation of
their estimated blood alcohol concentration (BAC) using a modified Widmark formula [15]. Being
drunk/intoxicated was rated on an 11-point scale ranging from 0 (absent) to 10 (extreme) [16,17]. The
number of smoked cigarettes was recorded as well, as previous research has shown an interaction
between smoking and hangover [18]. To capture possible effects of sleep [14,19,20], total sleep time
was recorded as well as the (consciously perceived) number of nightly awakenings. Sleep quality was
rated on an 11-point scale ranging from 0 (very poor) to 10 (excellent) [21,22].
Physical activity levels were assessed with the IPAQ (International Physical Activity
Questionnaire)—short form [23]. This measure assesses the intensity and duration of physical
318
J. Clin. Med. 2020, 9, 114
activity and sitting time that people do as part of their daily lives. The outcomes are presented in
Metabolic Equivalent Task (MET)-minutes. MET minutes represent the amount of energy spent when
engaged in a physical activity. One MET is what you expend when you are at rest. When calculating
the MET-minutes per week for the different activity levels, the duration of activity is multiplied with
3.3 (walking), 4 (moderate physical activity) or 8 (vigorous physical activity). The assessments were
made for usual physical activity at home, and for physical activity during their holiday in Crete.
Overall hangover severity before starting the walk was rated on a single item 11-point scale
ranging from 0 (absent) to 10 (extreme) [24]. Using the same 11-point scale, the severity of a number of
individual symptoms that are often related to hangover was also assessed. These included fatigue
(being tired), sleepiness, thirst, headache, nausea, loss of appetite, dizziness, stomach pain, heart racing,
weakness, anxiety, depression, tension/stress, and anger/hostility. The past year’s immune fitness was
assessed with the Immune Status Questionnaire (ISQ) [25]. The ISQ consists of 7 items, including
‘common cold’, ‘diarrhea’, ‘sudden high fever’, ‘headache’, ‘muscle and joint pain’, ‘skin problems (e.g.,
acne and eczema)’ and ‘coughing’. The items are scored on a 5-point Likert scale stating how often
the participants experienced these complaints during the past year, including ‘never’, ‘sometimes’,
‘regularly’, ‘often’, and ‘(almost) always’. The overall ISQ score ranges from 0 (poor) to 10 (excellent),
with higher scores indicating a better immune fitness. Current immune fitness (in Crete) was assessed
using the 1-item perceived immune functioning scale [26,27]. In a similar way, current ‘physical fitness’
and ‘mental fitness’ were assessed. The scores on these scales ranged from 0 (very bad) to 10 (very
good). Finally, participants estimated the amount of effort it would take them to walk the Samaria
Gorge on an 11-point scale ranging from 0 (absolutely no effort) to 10 (extreme effort).
The surveys were collected by the researcher once completed. When the participants arrived at
the entrance of the Samaria Gorge and started their walk, the bus returned by road and drove towards
Hora Sfakia, a small seaside city where the participants were picked up at 18:00 to return by bus to
their accommodation. The second survey was completed at the end of the day (between 18:00 and
19:00), during the bus drive to their accommodation. In the second survey, participants reported how
they experienced walking the Samaria Gorge. Data were collected on the total duration of the walk,
the number and duration of breaks, and the amount of water consumed while walking. Participants
rated the amount of effort it took them to walk the Samaria Gorge on an 11-point scale ranging from
0 (absolutely no effort) to 10 (extreme effort). Their level of exhaustion was assessed on an 11-point
scale ranging from 0 (absolutely not) to 10 (extremely exhausted). Using the scale described above,
overall hangover severity was assessed for two additional time frames: (1) retrospectively for how
they were during the walk, and (2) in real-time after the walk (when travelling on the bus to their
accommodation). Of note, anxiety, depression, tension/stress, and anger/hostility were omitted from
the ‘during the walk’ assessment. Finally, the number of alcoholic drinks consumed and cigarettes
smoked after walking the Samaria Gorge were recorded, and subjective intoxication was rated as
described above [16,17].
2.3. Statistical Analysis
All surveys were anonymous. However, because date of birth and sex were entered on both the
morning and afternoon survey, they could be matched with each other. Data from participants who
used drugs, or who did not the complete the questions on previous evening alcohol consumption
were omitted from the statistical analysis. Statistical analyses were conducted with SPSS (IBM Corp.
Released 2013. IBM SPSS Statistics for Windows, Version 25.0. Armonk, NY, USA: IBM Corp.).
Mean and standard deviation (SD) were computed for each variable. Most data in the study did not
follow a normal distribution. Therefore, nonparametric statistics were used to analyze the data. As a
nonparametric analog of analysis of variance (ANOVA), the Kruskal–Wallis test was used to compare
outcomes of the ‘no alcohol’, ‘no hangover’, and hangover’ groups. If significant, Independent Samples
Mann–Whitney U tests (the nonparametric analog of independent t-tests) were used to make paired
comparisons between two individual groups (e.g., compare the ‘hangover’ versus ‘no hangover’ group).
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To compare assessments made within subjects (e.g., before versus after walking), Related Samples
Wilcoxon Signed Rank tests were conducted (the nonparametric analog of paired t-tests). Spearman’s
rho correlations were used to compute correlations. Results were considered statistically significant if
p < 0.05. In case of multiple related comparison (i.e., hangover symptoms), a Bonferroni’s correction
was applied to account for multiplicity. Linear stepwise regression analyses (for which independent
variables do not need to be normally distributed or continuous) were conducted to determine which of
the individual variables assessed in this study were significant predictors of walking outcomes.
3. Results
3.1. Demographics and Physical Activity Levels
N = 307 participants provided consent to participate in the study. One subject used illicit drugs
and her data was excluded from the analysis. N = 7 other participants did not report on previous
evening alcohol consumption, and these incomplete datasets and were also excluded from the analyses.
Data for the remaining N = 299 participants were included in the analyses. Except for N = 6 participants
from Canada (2%), all participants originated from 17 European countries. Most participants came
from Germany (14.0%), the UK (12.5%), The Netherlands (11.4%), Poland (7.0%), Belgium (6.7%), and
Greece (6.1%). N = 223 participants (74.6%) consumed alcohol the evening before walking the Samaria
Gorge, and N = 176 (78.9%) of those reported a hangover score greater than zero in the morning. Their
demographics are summarized in Table 1.
Table 1. Demographics and physical activity levels of participants with and without a hangover.






N 299 76 47 176
Age (years) 38.9 (11.0) 39.4 (12.1) 37.5 (11.4) 39.0 (10.3) 0.506
BMI (kg/m2) 23.9 (2.4) 23.5 (2.4) 24.4 (2.7) 24.0 (2.4) 0.061
ISQ 8.6 (1.9) 8.8 (1.9) 7.6 (2.5) ‡ 8.7 (1.5) 0.006
General health 7.4 (1.1) 7.5 (1.0) 7.9 (1.2) 7.3 (1.0) 0.005
Weekly alcohol consumption at home 4.8 (3.6) 2.0 (1.7) 4.5 (4.0) ‡ 5.9 (3.3) *X 0.000
Physical activity at home
Vigorous (MET-min/w) 961 (1728) 879 (1937) 1351 (1757) ‡ 883 (1617) * 0.035
Moderate (MET-min/w) 1869 (2470) 1928 (3048) 2004 (3868) 1806 (1551) 0.100
Walking (MET-min/w) 3298 (2240) 3511 (1913) 2937 (3725) ‡ 3305 (1810) * 0.004
Total (MET-min/w) 5972 (4231) 6124 (4130) 6201 (6008) 5843 (3666) 0.637
Time spent sitting (min) 385 (119) 404 (121) 382 (150) 377 (108) 0.490
On holiday in Crete
Vigorous (MET-min/w) 708 (1432) 823 (1722) 892 (1406) 611 (1299) 0.258
Moderate (MET-min/w) 1588 (1531) 1665 (1766) 1319 (1981) 1627 (1273) * 0.019
Walking (MET-min/w) 3409 (2361) 4099 (2964) 3319 (2953) ‡ 3141 (1788) X 0.028
Total (MET-min/w) 5588 (3937) 6498 (4569) 5536 (4979) 5219 (4274) 0.155
Time spent sitting (min) 353 (111) 355 (114) 291 (117) ‡ 369 (102) 0.000
Evening before
Number of cigarettes smoked 3.7 (5.9) 0.8 (2.8) 1.3 (3.1) ‡ 5.6 (6.6) * X 0.000
Total sleep time (h) 6.1 (0.8) 6.3 (0.8) 6.2 (1.2) 5.9 (0.6) * X 0.000
Number of nightly awakenings 1.1 (1.0) 0.9 (1.0) 1.1 (1.2) 1.3 (0.9) X 0.006
Sleep quality 6.1 (1.9) 7.2 (1.9) 7.1 (1.6) 5.4 (1.6) * X 0.000
p-value from the Kruskal–Wallis test is shown, comparing the outcomes of the three groups. If the group effect
was significant (p < 0.05), Independent Samples Mann–Whitney U tests were conducted to investigate paired
comparisons between the individual groups. Significant differences (p < 0.0001) between the ‘hangover’ group and
‘no hangover’ group are indicated by *. Significant differences (p < 0.0001) between the ‘no hangover’ group and
‘no alcohol’ group are indicated by ‡. Significant differences (p < 0.0001) between the ‘hangover’ group and ‘no
alcohol’ group are indicated by X. Abbreviations: BMI = body mass index, ISQ = immune status questionnaire,
MET =metabolic equivalent of task, min =minutes, /w = per week.
Table 1 shows that at home, participants in the ‘hangover’ group consumed significantly more
alcohol (p < 0.0001) compared to the ‘no hangover’ group and ‘no alcohol’ group. The evening before
the walk, participants with a hangover smoked significantly more cigarettes (p < 0.0001), and reported
a significantly reduced sleep quality (p < 0.0001) and sleep duration (p = 0.022) than the ‘no hangover’
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group. Although some differences between the intensity levels were observed, total physical activity at
home and in Greece did not significantly differ between the groups.
3.2. Drinking Characteristics and Hangover Symptom Severity
Alcohol consumption characteristics the evening before their Samaria Gorge excursion for drinkers
with and without a hangover on the day of their walk are summarized in Table 2.
Table 2. Drinking characteristics.
No Alcohol No Hangover Hangover p-Value
Evening before walking
Number of alcoholic drinks 0.0 (0.0) 0.9 (1.6) 3.0 (1.8) 0.000 *
Subjective intoxication — 1.3 (1.9) 4.6 (2.4) 0.000 *
Start time drinking (h.min) — 19.10 (2.4) 17.40 (1.8) 0.000 *
Stop time drinking (h.min) — 21.45 (1.9) 20.13 (1.9) 0.000 *
Duration of drinking (h) — 2.6 (2.4) 2.5 (1.5) 0.157
Estimated BAC (%) — 0.02 (0.03) 0.03 (0.03) 0.001 *
Test day
Overall hangover severity before walking — 0.0 (0.0) 4.6 (2.1) 0.000 *
Overall hangover severity during walking — 1.1 (1.8) 3.4 (2.3) 0.000 *
Overall hangover severity after walking — 1.1 (2.1) 3.5 (2.4) 0.000 *
Afternoon after walking
Number of alcoholic drinks 0.4 (0.9) 1.0 (1.7) 1.0 (1.3) 0.112
Subjective intoxication 0.6 (1.6) 0.9 (2.1) 1.5 (2.0) 0.010 *
Number of cigarettes smoked 0.4 (1.5) 1.0 (2.3) 3.4 (4.5) 0.000 *
An Independent Samples Mann–Whitney U test was conducted to compare the ‘no hangover’ and ‘hangover’ group.
Significant differences between the ‘hangover’ and ‘no hangover’ group (p < 0.05) are indicated by *.
Table 2 shows that, the evening before their excursion, participants in the ‘hangover’ group
consumed on average 3.0 alcoholic drinks (European size, 10 g alcohol each). Although this seems a
low amount of alcohol in comparison to, for example, student samples [24], it equates to half their
usual weekly alcohol consumption (see Table 1). Overall hangover severity declined during the day.
Participants were allocated to the ‘no hangover’ group when overall hangover severity was rated zero
in the morning. However, some of these participants did report positive hangover scores during or
after the walk. Hence, the mean hangover severity is not zero in the ‘no hangover’ group for these
assessments. Severity scores for individual hangover symptoms, rated before, during (retrospectively),
and after walking the Samaria Gorge are summarized in Table 3.
In the morning, hangover symptom severity scores were usually significantly higher in the
‘hangover’ group compared to the ‘no hangover’ group. During and after the walk, no significant
differences were found between the ‘hangover’ group and ‘no hangover’ group.
The hangover group experienced a significant reduction in severity scores during the walk for
sleepiness, headache, nausea, dizziness, and stomach pain. No significant differences were observed
between individual symptom severity assessment ‘during’ or ‘after’ the walk, indicating that the
experience of symptom severity had plateaued during the walk.
Although often not considered in hangover research, various symptoms experienced during the
hangover state are also experienced by participants who reported having no hangover or consumed no
alcohol at all, thus reporting overall hangover severity scores of zero. Although their severity scores are
usually low and fairly constant, ratings for fatigue, thirst, and weakness significantly increased during
the walk in both the ‘no alcohol’ and ‘no hangover’ group (p < 0.0001). Compared to the morning
assessments, there was also a significant increase in heart racing severity during the walk in the ‘no
hangover’ group. Again, no significant differences between ‘during’ and ‘after’ walking assessments
were observed in these groups.
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No Hangover (in the Morning)
N = 47
Hangover (in the Morning)
N = 176
Symptom Before During After Before During After Before During After
Fatigue 3.6 (2.0) 5.0 (2.4) bd 5.3 (2.3) 2.6 (1.9) 5.9 (2.7) bd 6.1 (2.5) ba 6.1 (1.7) *, X 6.3 (1.6) X 6.3 (1.7) X
Sleepiness 4.0 (2.5) 3.6 (2.5) 4.1 (2.4) 2.5 (2.3) 3.7 (3.1) 4.2 (3.0) 6.5 (2.0) *, X 4.8 (2.6) bd 5.3 (2.3) X, ba
Thirst 2.1 (2.3) 3.8 (2.8) bd 4.1 (2.9) 2.3 (2.2) 5.1 (2.8) bd 5.1 (2.5) ba 5.6 (2.8) *, X 5.1 (2.6) 5.2 (2.6)
Headache 0.7 (1.7) 0.6 (1.4) 1.0 (2.1) 0.4 (0.9) 1.6 (2.6) 0.8 (1.4) 2.2 (3.0) X 0.9 (1.7) bd 1.1 (2.0) ba
Nausea 0.3 (0.7) 0.3 (0.9) 0.3 (1.1) 0.1 (0.3) 0.5 (1.2) 0.3 (0.9) 0.8 (1.6) 0.4 (0.9) bd 0.4 (1.3)
Dizziness 0.4 (1.2) 0.4 (1.0) 0.7 (1.5) 1.0 (1.8) 0.6 (1.2) 0.9 (1.7) 1.3 (1.7) *, X 0.6 (1.2) bd 0.9 (1.6)
Stomach pain 0.6 (1.4) 0.4 (1.1) 0.7 (1.5) 0.3 (0.8) 0.6 (1.1) 0.8 (1.5) 2.1 (2.2) *, X 0.9 (1.5) bd 1.0 (1.4) ba
Heart racing 0.7 (1.6) 1.5 (2.0) 1.2 (2.0) 0.3 (0.7) 2.8 (2.7) bd 2.6 (2.3) ba, ‡ 2.3 (2.1) *, X 2.1 (2.0) 1.9 (1.7) X
Weakness 0.6 (1.2) 2.2 (2.2) bd 2.0 (2.1) 0.5 (0.8) 2.8 (2.1) bd 2.6 (2.5) 2.3 (1.9) X 2.9 (1.9) 2.4 (1.9)
Loss of appetite 1.0 (1.9) NA 0.6 (1.6) 1.4 (1.8) NA 1.1 (1.6) 1.0 (1.7) NA 0.5 (1.2)
Anxiety 0.6 (1.1) NA 0.5 (1.3) 0.7 (1.6) NA 0.2 (0.6) 1.2 (1.6) NA 0.8 (1.2)
Depression 0.1 (0.5) NA 0.2 (0.8) 0.3 (1.0) NA 0.0 (0.3) 0.3 (1.0) NA 0.1 (0.5)
Tension, stress 0.6 (1.5) NA 0.6 (1.7) 0.7 (1.5) NA 0.5 (1.6) 0.4 (1.0) NA 0.4 (0.9)
Anger, hostility 0.2 (0.7) NA 0.3 (0.7) 0.6 (1.5) NA 0.4 (1.0) 0.3 (0.9) NA 0.3 (0.7)
Mean (SD) severity scores are shown. A Bonferroni’s correction (p < 0.0001) was applied to account for multiple
comparisons. Related Samples Wilcoxon Signed Rank tests were conducted to investigate pairwise comparisons
between the timepoints of assessment within each group. Significant differences between ‘before walking’ and
‘after walking’ assessments (p < 0.0001) are indicated with ‘ba’. Significant differences between ‘before walking’
and ‘during walking’ assessments (p < 0.0001) are indicated with ‘bd’. No significant differences between ‘during
walking’ and ‘after walking’ assessments (p < 0.0001) were observed. Between-group comparisons were made
with a Kruskal–Wallis test. If the group effect was significant (p < 0.001), Independent Samples Mann–Whitney U
tests were conducted to investigate paired comparisons between the individual groups. Significant differences (p
< 0.0001) between the ‘hangover’ group and ‘no hangover’ group are indicated by *. Significant differences (p <
0.0001) between the ‘no hangover’ group and ‘no alcohol’ group are indicated by ‡. Significant differences (p <
0.0001) between the ‘hangover’ group and ‘no alcohol’ group are indicated by X. Abbreviation: NA = not assessed.
Table 3 further summarizes alcohol consumption and smoking data that occurred after the
completion of walking the Samaria Gorge. Across all groups, alcohol consumption, smoking, and
subjective intoxication levels were relatively low.
As this alcohol consumption and smoking occurred after the walk while waiting for the bus to
return to their apartments/hotel, they have no impact on the dependent variables in this study (i.e.,
the walking outcomes). Their effects on hangover severity assessed after the walk are described in
Section 3.7.
3.3. Walking Performance
Table 4 summarizes the walking outcomes and fitness measures of the three groups.
Participants in the ‘hangover’ group felt significantly more exhausted after walking the Samaria
Gorge compared to participants in the ‘no hangover’ group (p = 0.004). The latter was anticipated
by participants of the ‘hangover’ group, as they rated the expected effort to complete the walk as
significantly higher than the ‘no hangover’ group (p < 0.0001). However, actual effort scores did
not significantly differ between the ‘hangover’ group and ‘no hangover’ group (p = 0.136). Also,
participants with a hangover consumed significantly more water compared to participants with no
hangover (300 mL more on average, p = 0.043) and those who consumed no alcohol (400 mL more on
average).
Interestingly, the immune fitness rating before walking was significantly better in the ‘no hangover’
group (p < 0.0001) compared to the ‘hangover’ group and the ‘no alcohol’ group (p < 0.0001). In the
‘hangover’ group, the immune fitness rating did not significantly correlate with overall hangover
severity (r = 0.101, p = 0.184).
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Immune fitness 7.5 (1.3) 8.3 (1.5) ‡ 7.3 (1.2) * 0.000
Mental fitness 8.6 (1.3) 8.6 (1.2) 8.5 (1.2) 0.628
Physical fitness 6.9 (1.5) 7.4 (1.8) 6.8 (1.4) 0.057
Expected effort to walk the Gorge 8.0 (1.9) 6.6 (1.9) ‡ 8.4 (1.4) 0.000
Assessed after walking
Immune fitness 6.9 (1.2) 6.8 (1.7) 6.3 (1.4) X 0.003
Mental fitness 7.9 (1.4) 7.8 (1.7) 7.7 (1.5) 0.636
Physical fitness 6.8 (1.3) 6.4 (1.8) 6.1 (1.4) X 0.004
Effort to walk the Gorge 8.1 (1.4) 7.9 (1.7) 8.3 (1.5) 0.135
Exhaustion 8.3 (1.4) 7.8 (2.2) 8.8 (1.4) * X 0.002
Walking time (hours) 6.1 (0.7) 6.1 (0.9) 6.0 (0.6) 0.734
Number of breaks 4.3 (1.7) 4.4 (1.9) 4.0 (1.1) 0.666
Total duration of breaks (minutes) 24.3 (12.5) 26.7 (19.0) 25.6 (8.7) 0.227
Water consumed during the walk (liters) 2.3 (0.9) 2.4 (0.8) 2.7 (0.7) * X 0.001
p-value from the Kruskal–Wallis test is shown, comparing the outcomes of the three groups. If the group effect
was significant (p < 0.05), Independent Samples Mann–Whitney U tests were conducted to investigate paired
comparisons between the individual groups. Significant differences (p < 0.0001) between the ‘hangover’ group and
‘no hangover’ group are indicated by *. Significant differences (p < 0.0001) between the ‘no hangover’ group and ‘no
alcohol’ group are indicated by ‡. Significant differences (p < 0.0001) between the ‘hangover’ group and ‘no alcohol’
group are indicated by X.
3.4. Correlates of Walking Performance
Overall hangover severity, assessed either before, during (in retrospect), or after walking the
Samaria Gorge was not significantly correlated with any walking outcome.
Linear stepwise regression models were computed, including sex, age, BMI, weekly alcohol
consumption, Total MET/week home and Crete, time spent sitting home and Crete, ISQ, general health
rating, immune/menta/physical fitness in morning, number of cigarettes smoked, overall hangover
severity (but NOT all individual hangover symptoms) in the morning, total sleep time, nightly
awakenings, sleep quality, all drinking outcomes, and group (‘no alcohol’, ‘no hangover’, ‘hangover’).
The models are summarized in Table 5.
3.5. Sex Differences
Of the participants with a hangover, N = 105 were men and N = 71 were women. Only a few
sex differences were observed. With regards to demographics, women had a significantly lower BMI
than men (22.8 ± 1.9 vs. 24.9 ± 2.3 kg/m2, p < 0.0001), spent less time on walking at home (2918 ±
1585 vs. 3566 ± 1911 MET-minutes, p = 0.035), reported less physical activity (total METs per week) at
home (5014 ± 2974 vs. 6390 ± 3981 MET-minutes, p = 0.037), and reported a significantly lower weekly
alcohol consumption at home (3.9 ± 1.8 vs. 7.4 ± 3.4 alcoholic drinks, p < 0.0001). Women’s reported
past year immune fitness was significantly higher than men’s (9.1 ± 1.4 vs. 8.5 ± 1.6, p = 0.004).
The evening before the walk, women smoked significantly fewer cigarettes (4.3 ± 5.8 vs. 6.6 ± 6.9
cigarettes, p = 0.026), and consumed significantly less alcohol (2.3 ± 1.3 vs. 3.5 ± 1.9 alcoholic drinks,
p < 0.0001), but over a significantly shorter time (2.1 ± 1.5 vs. 2.8 ± 1.3 h, p < 0.0001), resulting in a
significantly higher estimated BAC in women (0.036%± 0.03% vs. 0.028%± 0.03%, p= 0.006). Subjective
intoxication during drinking (4.2 ± 2.3 vs. 4.9 ± 2.5, p = 0.051) and next morning hangover severity
(4.2 ± 2.2 vs. 4.8 ± 2.1, p = 0.063) did not significantly differ between men and women. Nonetheless,
hangover severity was significantly lower in women than in men, as assessed retrospectively when
thinking back on their experience during the walk (2.7 ± 2.1 vs. 3.8 ± 2.4, p = 0.001) and after the
walk (2.7 ± 2.1 vs. 4.0 ± 2.4, p < 0.0001). During the walk, women consumed significantly less water
than men (2.3 ± 0.6 vs. 2.9 ± 0.5 L, p < 0.0001), but no significant sex differences were found on any
walking outcome.
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Table 5. Correlates of walking performance.
Predictive Validity of
the Model
Contribution of Individual Variables
Exhaustion 11.0%
Physical fitness rate before walking (6.3%)
Group (2.6%)
Physical activity (total METs) in Crete (2.1%)
Effort 29.6%
Physical activity (total METs) in Crete (14.5%)
Physical fitness rate before walking (6.7%)
Number of cigarettes smoked (3.4%)
Group (1.9%)
Number of alcoholic drinks consumed (1.6%)
BMI (1.5%)
Duration of the walk 29.2%
Physical fitness rate before walking (11.0%)
Physical activity (total METs) in Crete (5.1%)
BMI (3.7%)
Past year’s immune status (ISQ) (3.7%)
Usual weekly alcohol consumption (3.0%)
Time spent sitting on a week day in Crete (2.7%)
Number of breaks 19.9%
Time spent sitting on a week day at home (7.9%)
BMI (3.7%)
Physical activity (total METs) in Crete (3.5%)
Sex (2.9%)
Group (1.9%)
Total duration of breaks 17.5%
Usual weekly alcohol consumption (6.5%)
BMI (6.2%)




Physical activity (total METs) in Crete (7.2%)
Past year’s immune status (ISQ) (5.2%)
BMI (3.2%)
Physical fitness rate before walking (1.4%)
The regression models show that physical activity (total METs) in Crete, the physical fitness rate before walking,
and BMI are important factors that predict walking outcomes. Albeit modest, ‘group’ membership (‘no alcohol’, ‘no
hangover’, ‘hangover’) significantly predicted exhaustion after the walk, effort to perform the walk, and the number
of breaks. Sex had the largest impact on water consumption.
3.6. The Association of Water Consumption and Hangover Severity
In the ‘hangover’ group, the amount of consumed water was significantly correlated with the
duration of the walk (r = 0.160, p = 0.033), the number of breaks (r = 0.234, p = 0.002), the total duration
of the breaks (r = 0.173, p = 0.022), and the level of reported exhaustion after the walk (r = 0.161, p =
0.034). Water consumption was not significantly correlated with the amount of effort to complete the
walk (r = 0.016, p = 0.831). No significant correlations were found between the amount of consumed
water and overall hangover severity, or other individual hangover symptom scores that were assessed
either before, during or after walking the Samaria Gorge. It was further investigated whether the
changes in severity scores were associated with the amount of water consumed during the walk. A
difference score (Δ, afternoon assessment −morning assessment) was calculated for overall hangover
severity and correlated with water intake while walking the Samaria Gorge. The amount of water
consumed did not significantly correlate with Δ overall hangover severity (r = 0.066, p = 0.388) (see
Figure 3). The hangover severity difference score between the assessment during walking and the
assessment before walking also did not significantly correlate with the amount of water consumed (r =
0.103, p = 0.174).
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Figure 3. Relationship between water consumption and change in overall hangover severity. A
difference score (Δ) was calculated for overall hangover severity, by deducting the morning severity
rating from the afternoon severity rating. Red dotted line represents the Spearman’s rho correlation,
which was not significant.
3.7. The Association of Alcohol Consumption and Smoking after Walking and Hangover Severity
Alcohol consumption after the walk was low across all groups, averaging about one alcoholic
drink. However, a consumption range of zero to eight drinks was observed. Similarly, the reported
number of cigarettes smoked after the walk varied between zero and 17 cigarettes. For the subgroup
that had a hangover in the morning, a difference score (Δ, afternoon assessment − during walking
assessment) was calculated for overall hangover severity and correlated with the amount of alcohol
consumed and number of cigarettes smoked after walking the Samaria Gorge. A significant correlation
was found with the amount of alcohol consumed (r = 0.329, p < 0.0001), suggesting that alcohol
consumption in the afternoon was associated with increased hangover severity (See Figure 4A). The
correlation with number of cigarettes smoked after the walk was not significant (r = 0.119, p = 0.125).
Those who consumed alcohol (N = 99) had a significant increase in hangover severity (Δ, afternoon
assessment − during walking assessment), mean (SD) + 0.4 (1.9), while subjects that did not consume
alcohol (N = 75) showed a further decrease in hangover severity after the walk, mean (SD) − 0.3 (1.6)
(See Figure 4B). The difference observed change scores of the groups was statistically significant (p =
0.005).
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Figure 4. The relationship of alcohol consumption and hangover severity. (A) shows the Spearman’s
correlation between alcohol consumption and the change in hangover severity (Δ, afternoon assessment
− during walking assessment). A positive correlation was found suggesting that higher levels of
alcohol consumption during hangover (after the walk) were associated with experiencing more severe
hangovers. (B) shows the change in hangover severity scores (Δ, afternoon assessment − during
walking assessment) for subjects that consumed alcohol after the walk versus subjects that did not
consume alcohol after walking the Samaria Gorge. An increase in hangover severity was observed in
those who consumed alcohol after the walk, whereas a decrease in hangover severity was observed in
subjects who did not consume alcohol after walking the Samaria Gorge. Error bars represent standard
errors. The significant difference (p = 0.005) between drinkers and those who did not consume alcohol
after the walk is indicated by *.
When interpreting the data in Figure 4, it should be taken into account that the observed absolute
differences are small on a hangover scale ranging from 0 to 10. For the two groups individually, the
difference in change scores (hangover severity assessed after walking minus before walking) did not
reach statistical significance (p = 0.056 and p = 0.082 for those who did and did not consume alcohol,
respectively). The two groups did not differ in the amount of water consumed during the walk (p =
0.199), nor on any of the demographic variables assessed in this study.
4. Discussion
The data showed that walking the Samaria Gorge while having a hangover was associated
with significantly higher exhaustion scores when compared to participants with no hangover or
who consumed no alcohol. However, no significant differences between the groups were found in
the duration of the walk, or number and duration of breaks. The amount of water consumed was
significantly correlated with the duration of the walk, the number of breaks, the total duration of the
breaks, and the level of reported exhaustion after the walk. Further, participants with a hangover
consumed significantly more water during the walk. However, neither hangover severity, nor its
reduction during the day, were significantly correlated with the amount of water consumed (see
Figure 3). The regression analyses revealed that the observed differences in walking outcomes between
participants with and without a hangover are related to differences in levels of physical activity in
Crete, reported physical fitness, and BMI. The regression analyses revealed that in this sample, sleep
outcomes had no relevant impact on walking performance. Furthermore, overall hangover severity
did not significantly correlate with any walking outcome and was not a significant predictor in the
regression analyses, even though group membership was. The latter suggests that the relative severity
of a hangover is not important with regard to endurance performance, but the fact whether or not you
experience a hangover per se is a significant determinant.
As walking the Samaria Gorge is an activity that most people do together with others (e.g., in
the current study, several families and groups of friends participated), it is understandable that these
individuals all have the same total walking time, number and duration of breaks. Indeed, all three
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groups completed the walk in approximately the same time, with the same total duration of breaks,
providing a useful between groups control. It is therefore understandable that participants with a
hangover reported that more effort was needed to perform at this same physical exercise level and
reported to be significantly more exhausted than participants who reported no hangover or who had
consumed no alcohol.
Several factors may have influenced our findings. First, this was a naturalistic study, in which
the researchers did not intervene with the activities of the participants, nor did they receive any
instructions [28]. Participants received no instructions on how to walk the Gorge. The results could
have been different if, for example, participants were instructed to walk the Gorge as quickly as
possible, or when water intake was restricted to a pre-set volume. Participants were also not aware
that they would need to retrospectively rate their hangover symptoms experienced during the walk.
Had they known, they might have monitored their subjective experience more closely which might
have produced more accurate ratings.
Second, this was a non-student sample of middle-aged adults. As a consequence, this sample
consumed much less alcohol in the evening before the walk, as compared to the amounts of alcohol
usually seen in hangover studies conducted in student populations [24]. Despite their lower estimated
BAC levels, a considerable number of participants reported having a hangover in the morning. Since
their weekly alcohol consumption was relatively low, the increase in alcohol consumption seen on
holiday in Crete (i.e., about half their usual weekly alcohol intake at home consumed at a single drinking
occasion in Crete) may have been sufficient to elicit a hangover, despite the fact that the estimated BAC
(0.03%) was well below the levels commonly reported in student samples. This observation supports
observations in other studies that lower estimated BAC levels can also elicit a hangover, and that the
previously suggested lower limit of 0.11% [29] should be abandoned [30].
Third, participants may have anticipated the fact that they had to complete the Samaria Gorge
and, as a result, adjusted their drinking and sleep behavior. Perhaps they also practiced for the walk.
Although we did not directly assess this with our surveys, the data suggests that overall weekly
physical activity levels did not significantly differ between the groups. In contrast, sleep quality was
rated as significantly poorer among participants with a hangover. Moreover, a substantial number of
participants (8.4%) consumed more alcohol in the evening before the walk than they normally did in a
full regular week at home, and on average drinkers consumed about half their usual weekly alcohol
intake on this single study occasion in Crete. The latter suggests that the knowledge of having to walk
the Samaria Gorge was not a motivation for participants to moderate their alcohol consumption on the
evening before the walk. However, the ‘no hangover’ group consumed less alcohol than the ‘hangover’
group. This may suggest that this group did moderate their alcohol consumption in anticipation that
they had to walk the Samaria Gorge.
Interestingly, the ‘no hangover’ group happened to give significantly higher ratings of their
immune fitness and physical fitness, as compared to the two other groups. Previous studies have
reported a relationship between perceived immune fitness and hangover susceptibility [31], but not with
hangover severity [32]. In the current study, hangover severity scores also did not significantly correlate
with the immune fitness rating in the ‘hangover’ group. There is anecdotal evidence suggesting that
water consumption brings hangover relief. Indeed, the ‘hangover’ group consumed significantly more
water than participants from the ‘no hangover’ group, and more than those who consumed ‘no alcohol’.
However, the observed reduction in hangover severity during the day was not significantly correlated
with the amount of water consumed during the walk. Previous research showed that consumption
of water before going to bed did not affect next-day hangover severity [33]. It is important to note
that causality cannot be concluded from these correlational analyses. The absence of a significant
correlation can either imply that consumption of water is not effective in the relief of hangovers, or
that having a hangover does not stimulate individuals to consume more water. We also did not found
evidence for the ‘hair of the dog’ effect, i.e., the hypothesis that hangover severity will attenuate by
consuming alcohol [34,35]. Instead, the results suggest the opposite, as hangover severity scores
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increased in those who consumed alcohol in the afternoon and reduced in those who did not consume
alcohol. However, these results must be interpreted with caution as, although not very likely, we did
not record possible alcohol consumption during the walk. Furthermore, we did not record water and
soft drink consumption after the walk. Therefore, future controlled trials are necessary to determine
the impact of water and alcohol consumption on the presence and severity of alcohol hangover.
Finally, hangover symptoms were also reported by participants with no hangover, and participants
who did not consume any alcohol the evening before walking the Samaria Gorge. The reported
symptoms are common complaints, such as sleepiness and thirst, that can be experienced by anyone,
including without any specific intervention or event that could explain their occurrence (e.g., alcohol
consumption). Some symptoms may be related to sleep loss, whereas other symptoms may be related
to the temperature in the Gorge (e.g., the rise in severity scores of thirst while walking), or the physical
demands to perform the walk (e.g., increases in scores of weakness during the walk). This points to
the importance of using overall hangover severity ratings instead of composite ratings of individual
hangover symptoms, as it appears that participants in the ‘no hangover’ group and ‘no alcohol’ group
did not attribute their experience of individual symptoms such as sleepiness and thirst to alcohol
hangover since their overall hangover severity rating was zero. This finding underlines the importance
of including an overall hangover severity score in research design instead of relying on composite
symptom scores to calculate an overall hangover score, which is done when using the three most
frequently used hangover scales [36–38].
5. Conclusions
In conclusion, this study suggests that a significant hangover may be experienced after relatively
low levels of alcohol consumption for this older non-student group. In addition, physical endurance
performance was associated with experiencing significantly more exhaustion during the hangover
state. Future research should investigate possible hangover effects on other physical activities, such as
short-term anaerobic performance (e.g., a 100 m sprint or power lifting) or other forms of long term
aerobic exercise (e.g., swimming laps or running long distance).
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Abstract: Background. Despite a clear market need and many hangover products available,
currently there is no hangover treatment that is supported by substantial scientific evidence
demonstrating its efficacy and safety. A pilot study was conducted to investigate the effects of
a potential new hangover treatment, SJP-001, and its constituents (220 mg naproxen and 60 mg
fexofenadine) on hangover severity. Methods. N = 13 healthy social drinkers (36.3 ± 8.9 years old)
participated in a double-blind, factorial design, cross-over study. On each test day, they consumed their
own choice of alcohol up to a self-reported level sufficient to elicit a next-day hangover. Treatments
were administered prior to onset of drinking. Next morning, hangover severity was assessed with
the Acute Hangover Scale (AHS). Subjects were included in the efficacy analysis only if they reported
a hangover after placebo. Results. N = 5 subjects (60% male, 35.2 ± 9.0 years old) were included
in the analysis. They consumed a mean (SD) of 4.6 ± 1.1 units of alcohol and had an average peak
breath alcohol concentration (BrAC) of 0.065% across conditions. Compared to placebo, SJP-001
significantly improved the AHS overall hangover severity score (0.8 ± 0.3 versus 1.5 ± 0.9, p = 0.042).
Compared to placebo, SJP-001 also reduced scores on the individual item ‘hangover’, although the
observed improvement (−1.6) did not reach statistical significance (p = 0.102). The differences from
placebo after naproxen alone and fexofenadine alone were not statistically significant. SJP-001 also
improved scores for the individual hangover symptoms tired, thirsty, headache, dizziness, nausea,
and loss of appetite, but these effects did not reach statistical significance. Discussion. Compared to
placebo, SJP-001 significantly reduced overall hangover severity. The effects of SJP-001 should be
further examined in a double-blind, placebo-controlled trial with a larger sample size and controlled
administration of sufficient amounts of alcohol to provoke a more substantial alcohol hangover.
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1. Introduction
The alcohol hangover is defined as “the combination of negative mental and physical symptoms
which can be experienced after a single episode of alcohol consumption, starting when blood alcohol
concentration (BAC) approaches zero” [1,2]. Recent research suggests that there is no BAC threshold
for producing hangover, but that hangovers may occur at all BAC levels, and are most likely elicited
following consumption of more alcohol than usual on a drinking occasion [3,4].
Alcohol hangovers are typically characterized by a combination of symptoms, affecting mood,
cognition, and physical functioning [5–8]. These negatively impact daily activities including, but not
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restricted to, job performance [9] and driving [10–12]. In the USA, the annual economic costs of
alcohol hangover in terms of absenteeism and presenteeism have been estimated at $173 billion
annually [13]. A recent UK study rated the annual economic costs of hangover at 4 billion GBP [14].
Unsurprisingly, consumers have expressed a clear need for an effective hangover treatment [15].
However, to date, little research has been devoted to the development of effective and safe hangover
treatments, and currently there is no evidence-based hangover treatment [16–18]. The pathology of
alcohol hangover is not yet elucidated [19–21], although alcohol metabolism and the immune response
to alcohol consumption are current research foci [22–25].
The immune system likely plays a role in the development of alcohol hangover, with significant
immune reactions (e.g., changes in blood cytokine levels and C-reactive protein) being associated
with heavy alcohol consumption and subsequent hangovers [23,26–30]. In addition, alcohol and
acetaldehyde liberate histamine from mast cells and depress histamine elimination by inhibiting
diamine oxidase [31]. Independently of alcohol consumption, prostaglandin and histamine release
contributes to inflammation, pain (including headache), and fatigue [32–34]. These are all symptoms
of alcohol hangover [5,6]. Thus, it is hypothesized that an intervention that prevents the release of
prostaglandin and histamine may serve as an effective treatment to prevent alcohol hangover.
SJP-001 has been developed as such a potential new treatment for prevention of alcohol hangover.
SJP-001 is a combination of two over-the-counter (OTC) oral generic drugs (i.e., a nonsteroidal
anti-inflammatory drug (220 mg naproxen) and an H1-antagonist (60 mg fexofenadine)). Both naproxen
and fexofenadine are individually marketed in USA as over-the-counter (OTC) drugs [35,36].
The anti-inflammatory properties of naproxen are well documented [37]. Although prescribed
primarily for its H1 antagonist activity [38], fexofenadine also exhibits some anti-inflammatory
properties by modulating the release of a variety of proinflammatory mediators. For example, in a
study to evaluate the immunomodulatory properties of antihistamines, it was found that fexofenadine
downregulated IL 4–induced production of IL 5 and suppressed IL 12–induced secretion of IFN γ [39].
Given this background, a pilot study was conducted to determine if SJP-001 can reduce hangover
severity when taken prior to drinking in a sample of healthy social drinkers.
2. Methods
The study followed a randomized, double-blind, placebo-controlled, factorial, cross-over design.
In addition to a screening day, there were four study visits, separated by a washout period of
three to nine days. The study was sponsored by Sen-Jam Pharmaceutical (JMI Capital Group) and
conducted by Clinilabs, Inc. in accordance with the guidelines of the Declaration of Helsinki and its
latest amendments. Ethics approval was obtained from the Chesapeake Institutional Review Board
(Study number: Pro00016219) and written informed consent was obtained from all subjects. Data from
the study are on file (Sen-Jam Pharmaceutical) and available upon reasonable request.
2.1. Subjects
N = 16 self-reported moderate drinkers that previously experienced alcohol hangovers were
recruited via online advertisement. Screening procedures included a brief physical examination
including height and weight, collection of demographic information, medical history and vital signs,
review of prior and concomitant medications, and a urine drug and pregnancy screen, and a breathalyzer
alcohol test. To be included, subjects had to be nonsmoking men or women between 25 and 65 years old,
have a body mass index (BMI) between 19 and 32 kg/m2, have a regular, habitual bedtime between 21:30
and 24:00 h, and have a good general health as determined by a thorough medical history and physical
examination including vital signs, conducted by the study physician. Subjects had to be self-reported
moderate drinkers of alcohol, which was approximated with a breath alcohol concentration (BrAC) of
0.04%–0.11% on usual drinking occasions (corresponding to 2 to 5 or 3 to 7 alcoholic drinks for a 70 kg
female and male, respectively, over a 2 to 3 h period). Subjects were included if they reported that this
amount of alcohol usually resulted in a next-day hangover. Subjects were excluded if they reported
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acute illness within 14 days prior to screening visit, experienced an allergic reaction or upper respiratory
tract infection within 7 days of screening visit, had been vaccinated within 7 days of screening visit,
had a history of clinically significant allergies (except for untreated, asymptomatic, seasonal allergies at
time of dosing), hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic,
or neurological disease, cancer or diabetes, or psychiatric illness, previous or current Substance-Related
Disorder as defined by DSM-5, self-reported usual consumption of more than 14 units of alcohol
per week, recent (within one month) or current use of tobacco or nicotine products. In addition,
subjects were excluded if medical examination revealed a clinically significant, unstable medical
illness, a positive alcohol breathalyzer or urine drug screen test (including cocaine, THC-marijuana,
opiates, amphetamines, methamphetamine, phencyclidine, benzodiazepines, barbiturates, methadone,
MDMA-ecstasy, oxycodone, and propoxyphene) which was provided at screening, when subjects had
a blood pressure >140/90 mm/Hg or heart rate >100 bpm. Women who were pregnant or breastfeeding,
or had a positive urine pregnancy test at screening were also excluded. Subjects taking any prescription
or OTC oral pain medication(s) or antihistamine drug, or who previously experienced an allergic
reaction or adverse event associated with aspirin, nonsteroidal anti-inflammatory drugs (NSAID),
or antihistamine usage were excluded. Finally, subjects were excluded if they were unwilling to forgo
caffeine consumption with or following dinner on each treatment night or who were unwilling to
comply with study restrictions for prohibited medications/foods throughout study participation.
2.2. Procedures
During the four test days, each participant arrived at the clinical unit at approximately 5 pm. On the
first test day, subjects were randomized to one of four treatment sequences according to Latin Square
assignment. On test days, after general health assessments, including a urine drug and pregnancy
test and a breathalyzer test to ensure a BrAC of zero, subjects were served a standardized dinner.
Alcohol was available with dinner. Subjects received an oral dose of either SJP-001 (220 mg naproxen
and 60 mg fexofenadine), naproxen alone (220 mg), fexofenadine alone (60 mg), or placebo. Treatments
consisted of two oral capsules administered 30 min (first capsule) and 15 min (second capsule) before
the start of alcohol consumption, taken with approximately 240 mL of water. Treatments were
self-administered by subjects under the supervision of study personnel.
Subjects remained together in a lounge room during dinner and thereafter for the evening.
They were permitted to socialize, read, and watch television. Study staff were present to monitor
alcohol and food consumption and general behavior. Foods high in histamine such as red meat, lamb,
and aged cheese were not served. Subjects were provided a variety of alcoholic beverages from which
to choose including red and white wine, various types of beer, champagne, and liquors. Water was
provided, along with other nonalcoholic beverages as mixers. They were instructed to consume the
amount of alcohol (and nonalcoholic drinks including water) that had in the past resulted in a hangover,
and consume the same type and amount of alcohol on each test day. For example, if a subject reported at
screening that consuming four glasses of red wine in a 3 h period had previously resulted in a hangover,
the target for that subject was to consume four glasses of red wine at each visit. Subjects could mix
different types of alcohol and were allowed to drink at their own pace; all alcohol consumption was
completed within a maximum 3 h period. Light snacks (e.g., pretzels, potato chips, nuts) were provided
during the alcohol consumption period. At the end of alcohol consumption, a breathalyzer test was
conducted to assess BAC. Subjects stayed overnight in the study center. They were required to go to bed
at their usual habitual bedtime. Subjects slept in a private room with a bed, night table, writing table,
and chair, and were instructed to remain in bed for 8 h with the lights turned off. Subjects were allowed
to deviate from these instructions to use the restroom during the night. Study staffmade rounds during
the night to monitor subjects’ safety. Next morning, if necessary, subjects were awakened 8 h after
their bedtime. Within 10–20 min after awakening, and prior to breakfast or the consumption of any
coffee or other caffeine-containing beverages, a breathalyzer test and brief neurological assessments
(tests examining walking and heel-to-toe walking, and the Romberg test to evaluate balance) were
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conducted. A postsleep questionnaire was completed, including questions regarding total sleep time,
sleep onset latency, number of nightly awakenings, time awake while in bed, and a rating of sleep
quality on a scale from 1 (poor) to 10 (excellent). Next-morning hangover severity was assessed with
the Acute Hangover Scale [40]. Thereafter, subjects received breakfast and the test day was ended.
2.3. Assessment of Hangover Severity
The Acute Hangover Scale [40] consists of nine items including ‘hangover’, ‘thirsty’, ‘tired’,
‘headache’, ‘dizziness/faintness’, ‘loss of appetite’, ‘stomachache’, ‘nausea’, and ‘heart racing’,
which could be rated on a scale ranging from 0 to 7. The anchors of the Likert-type scale were
‘none’ (score of 0), ‘mild’ (score of 1), ‘moderate’ (score of 4), and ‘incapacitating’ (score of 7).
Overall hangover severity was computed by calculating the average score across the AHS nine items.
In the interest of safety, subjects with hangover symptoms were confined to the study center at the
discretion of the clinician until symptoms had improved.
2.4. Statistical Analysis
Subjects were included in the statistical analysis only if they reported a hangover on the placebo
test day. The reasons for this were twofold. Firstly, the absence of a hangover in the placebo condition
implies that the subject had not complied with the instructions to drink to levels which would typically
produce hangover. Secondly, we wished to evaluate if the combination of naproxen and fexofenadine
in SJP-001 was superior to either compound alone. This required us to compare effects on a hangover in
the placebo group (note that the absence of a hangover in any of the nonplacebo arms could theoretically
be attributable to efficacy of the treatment so such cases could not be excluded). Statistical analyses
were conducted with SPSS (IBM Corp. Released 2013. IBM SPSS Statistics for Windows, Version 25.0,
IBM Corp. Armonk, NY, USA). Mean and standard deviation (SD) were computed for all variables.
The primary outcome measure of the study was the average AHS score. Secondary outcomes were the
individual AHS items. Overall hangover severity and individual symptom ratings after SJP-001 and
placebo were compared applying a nonparametric Related-Samples Wilcoxon Signed Rank test.
3. Results
Of the N = 16 subjects that were screened, N = 13 met all inclusion and exclusion criteria and
participated in the study. Seven subjects who reported no hangover on the placebo test day were
excluded from the statistical analysis (see previous section). Another subject was excluded due to
significant sleep difficulties in the clinical setting. N = 5 subjects were included in the final dataset.
For one of these subjects, the last test day (naproxen) was discontinued due to noncompliance with
study procedures during the drinking session. The demographic data of the included subjects are
summarized in Table 1.
Table 1. Demographics, morphometrics, and drinking characteristics of the sample.
Overall Subject 7 Subject 8 Subject 9 Subject 12 Subject 16
Sex (male/female) 3/2 Male Male Male Female Female
Age (years) 35.2 (9.0) 27 47 33 27 42
Weight (lb) 170.8 (13.7) 169.4 192.6 172.8 162.4 156.6
Height (in) 67.4 (2.6) 67.5 68.9 70.7 65.5 64.2
BMI (kg/m2) 26.4 (1.5) 26.1 28.5 24.3 26.6 26.7
Habitual bedtime 1 (h:min) 23:12 (0:34) 00:00 23:30 23:00 22:30 23:00
Preferred alcohol type 2 - Rum Mixed 3 Mixed 4 Rum Vodka
Units alcohol for hangover 5 4.6 (1.1) 3 6 5 4 5
Mean and standard deviation (SD) are shown for the overall sample and five individual subjects. 1: the individual
habitual bedtime was used for each test day. 2: these drinks were also consumed on each test day. 3: subject
consumed white wine (Chardonnay), red wine (Pinot Noir), and tequila on a usual drinking occasion. 4: subject
consumed Scotch whiskey, beer, and red wine on a usual drinking occasion. 5: this amount of alcohol units was also
consumed on each test day. Abbreviation: BMI = body mass index.
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In the study, subjects consumed on average 4.6 alcoholic drinks and had an average BrAC of
0.065% at the end of the drinking session. BrACs did not statistically differ between conditions
(see Table 2). After the drinking session, subjects slept in the clinical research unit. Table 2 summarizes
the sleep outcomes for each treatment condition. No significant differences were found between
SJP-001 and placebo.
Table 2. Alcohol consumption and sleep outcomes.
SJP-001 Fexofenadine Naproxen Placebo
Units of alcohol consumed 4.6 (1.1) 4.6 (1.1) 4.6 (1.1) 4.6 (1.1)
BrAC (3h) (%) 0.064 (0.034) 0.068 (0.026) 0.053 (0.030) 0.072 (0.038)
Total sleep time (min) 412.0 (45.9) 377.0 (66.3) 406.0 (59.3) 421.0 (44.2)
Number of nightly awakenings 1.6 (1.1) 2.0 (1.4) 1.5 (1.9) 1.6 (1.1)
Sleep onset latency (min) 34.0 (18.5) 52.0 (30.9) * 45.0 (17.3) 12.2 (11.3)
Time awake while in bed (min) 29.4 (30.7) 34.2 (38.8) 13.0 (12.9) 36.0 (38.7)
Sleep quality 7.2 (1.5) 4.8 (3.6) 8.3 (1.0) 7.8 (1.6)
Mean and standard deviation (SD) are shown for alcohol consumption and sleep outcomes in the four treatment
conditions. Significant differences (p < 0.05) between the treatments and placebo are indicated by *. Abbreviation:
BrAC = breath alcohol concentration.
Mean ± SD AHS scores were mild and equaled 1.5 ± 0.9 after placebo, 0.8 ± 0.3 after SJP-001,
1.0 ± 0.7 after fexofenadine, and 0.7 ± 0.7 after naproxen. Scores on individual hangover symptoms
are listed in Table 3. Compared to placebo, SJP-001 significantly improved overall hangover severity
(p = 0.042), whereas the differences from placebo after naproxen (p = 0.066) and fexofenadine (p = 0.345)
were not statistically significant (See Figure 1A).
Table 3. Mean Acute Hangover Scale and individual hangover symptom scores.
Symptoms SJP-001 Fexofenadine Naproxen Placebo
Hangover 0.8 (0.8) 1.6 (1.5) 0.8 (0.5) 2.4 (1.3)
Thirsty 2.4 (1.8) 1.6 (1.1) 1.5 (2.4) 2.8 (2.4)
Tired 2.2 (1.9) 2.4 (2.1) 1.8 (2.1) 2.8 (1.6)
Headache 0.4 (0.5) 1.6 (1.5) 0.3 (0.5) 1.6 (2.5)
Dizziness/faintness 0.0 (0.0) 0.2 (0.4) 1.0 (2.0) 1.0 (1.2)
Loss of appetite 0.4 (0.5) 1.0 (1.7) 0.3 (0.5) 1.0 (0.7)
Stomachache 0.8 (1.3) 0.4 (0.9) 0.3 (0.5) 0.6 (0.5)
Nausea 0.4 (0.9) 0.2 (0.4) 0.3 (0.5) 1.0 (1.7)
Heart racing 0.4 (0.5) 0.2 (0.4) 0.0 (0.0) 0.2 (0.4)
Mean AHS score 0.8 (0.3) * 1.0 (0.7) 0.7 (0.7) 1.5 (0.9)
Mean (SD) are shown for the AHS and its individual items for the four treatment conditions. Abbreviation: AHS =
Acute Hangover Scale. Significant differences (p < 0.05) between the treatments and placebo are indicated by *.
Also, compared to placebo, SJP-001 reduced scores on the individual item ‘hangover’, although the
difference of −1.6 did not reach statistical significance in this small sample (p = 0.102) (see Figure 1B).
SJP-001 also improved scores for other individual hangover symptoms including tired, thirsty, headache,
dizziness/faintness, nausea, and loss of appetite (none of the differences between SJP-001 and placebo
reached statistical significance). After fexofenadine alone and naproxen alone, none of the individual
item scores differed significantly from placebo.
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A 
B 
Figure 1. Overall hangover severity by group. (A) shows the average AHS scores; (B) shows the scores
on the individual AHS item ‘hangover’. Mean scores with standard errors are shown. Abbreviation:
AHS = Acute Hangover Scale. Significant differences (p < 0.05) between the treatments and placebo are
indicated by *.
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4. Discussion
The findings of the current pilot study suggest that SJP-001 may be effective in the prevention of
alcohol hangover. However, the observations should be interpreted with caution, as this pilot study
had a small sample size (albeit using a cross-over design). The observed significant reduction in overall
hangover severity, assessed both via the average AHS score and the individual item “hangover”,
justifies further investigation of the properties of SJP-001 in future randomized controlled trials (RCTs)
with an adequate sample size and improved methodology.
It has been argued that when conducting pilot studies with a small sample size, one should focus
on descriptive statistics and estimation rather than formal hypothesis testing to infer whether findings
are clinically relevant or not [41–43]. To further evaluate descriptive data of the current study, difference
scores in hangover severity between SJP-001 and placebo were calculated. These mean (SD) difference
scores equal −0.64 (0.62) for the AHS overall hangover severity score and −1.6 (1.67) for the one-item
hangover severity score. Applying the anchor-based approach [44], both the average AHS and one-item
hangover score are between the anchors ‘mild’ and ’moderate’ after placebo which were relevantly
improved towards scores between the anchors ‘none’ and ‘mild’ after SJP-001. When applying the
one-half SD criterion as a benchmark [45], the minimal clinically important difference (MCID) should
be greater than −0.31 on the AHS and greater than −0.84 for the one-item hangover severity score. Thus,
both the AHS (−0.64 > −0.31) and the one-item hangover severity difference score (−1.6 > 0.84) can be
considered as clinically relevant reductions in hangover severity. However, to infer clinical relevance,
the single-item hangover severity score is likely to be more accurate with regard to clinical relevance
than the AHS aggregate symptoms score [46]. Taken together, evaluating descriptive data further
supports the decision to conduct adequately powered RCTs to enable more definitive conclusions
regarding the efficacy of SJP-001.
Turning to individual symptoms, it may be argued that the effects of SJP-001 are relatively similar
to those observed when naproxen alone is administered. Importantly, for the AHS scores, the difference
between SJP-001 and placebo (but not naproxen and placebo) is statistically significant. This is likely
due to the fact that, although the mean AHS scores of SJP-001 and naproxen are similar, there is a
considerable difference in the corresponding standard deviation of SJP-001 and naproxen (0.3 versus
0.7, respectively). One could argue that the lower variance after SJP-001 in contrast to naproxen alone
is a result of the naproxen–fexofenadine combination resulting in a more stable, less variable treatment
effect due to the anti-inflammatory properties of fexofenadine. Also, the achieved BrAC after SJP-001
was higher than after naproxen (0.064% versus 0.053% BrAC, respectively), which may have resulted
in an enhanced treatment effect after naproxen compared to that of SJP-001. Had equal BrACs been
achieved, the effect of SJP-001 may have been superior to naproxen alone. Alternatively, it may be that
the observed difference in standard deviation reflects the small sample size of this pilot study, and will
not be replicated in a larger, well-powered RCT. Future research should investigate these hypotheses.
In addition to assessing initial evidence regarding the effectiveness of SJP-001 in preventing
hangover, an important goal of this pilot study was to verify whether the current study design is
suitable for large sample, double-blind RCTs. From the current pilot study, several important lessons
were learned regarding limitations to the study design.
Firstly, the sample size of this pilot study was small. Future RCTs should be adequately powered.
An important reason for this small study size was that of the N = 13 subjects that completed the
study, only N = 5 were suitable to be included in the data analysis. Although subjects consumed the
self-reported amount of alcohol that was sufficient to induce hangover, seven subjects reported to have
no hangover in the placebo condition. In future RCTs, the amount of alcohol to provoke a hangover
should be determined in more detail to prevent such a large dropout. Currently, a hangover sensitivity
scale is in development to aid this process. This approach will increase the likelihood that a hangover
will be present on each test day.
The exclusion of subjects who had no hangover following placebo only was necessary to allow
meaningful statistical comparison across the groups. It is possible that excluding individuals not
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experiencing hangover in the placebo condition may have somehow increased the probability of a
significant outcome favoring SJP-001. If this were the case, however, one might also expect significant
effects when comparing the naproxen-only and fexofenadine-only arms with placebo. To verify this,
we conducted two additional analyses, in which we compared naproxen-only versus placebo and
fexofenadine-only versus placebo, including only subjects with a placebo score greater than zero.
Again, no significant differences between the treatments were found for the AHS and one-item overall
hangover severity score. Therefore, we believe that excluding subjects without a hangover in the
placebo condition did not affect the probability of obtaining a significant outcome favoring SJP-001.
A second issue in this pilot study is that subjects could consume their preferred types of alcohol.
Although the type(s) of drink(s) were the same on each test day, eliminating intraindividual differences,
this does introduce interindividual variability. Additionally, alcoholic drinks have variable amounts
of congeners and histamines, which may impact study outcomes. A high congener content has been
shown to negatively impact hangover severity [47]. One obvious solution to this is to administer
one standard type of alcoholic drink to all subjects. On the other hand, this may not adequately
reflect participants’ usual drinking behavior. Achieving a balance between experimental control and
ecological validity is a challenge for hangover research [48].
One subject was excluded because of experiencing significant sleep difficulties in the clinical
research unit. Sleeping in a new (and especially clinical) environment may require adaptation.
The current study did not include a sleep rehearsal night during screening to identify possible
‘first-night effects’ or other sleep disturbances [49,50]. It is advisable to include a sleep rehearsal night
in future RCTs to screen for subjects with possible sleep disturbances. Further, the current study used
subjective measures of sleep. Subjective assessments of sleep do not always correspond to objective
sleep measures [51], such as polysomnography or actigraphy. Future RCTs could usefully include
objective sleep measures, for example, by using mobile technology such as the GENEactiv device [51].
Finally, the assessment of alcohol hangover depends solely on self-report. The most direct
method to assess hangover severity is a single question allowing subjects to rate their hangover
severity, for example, a 0 to 7 score as used for the AHS [40], or a 0 to 10 rating scale ranging
from absent to extreme [52]. Since hangover may differ qualitatively from person to person,
a single question is more likely to accurately reflect overall hangover severity than an aggregate
score of variable hangover symptoms, such as that utilized with current hangover scales [40,53,54].
Aggregate symptom scores may be lower than one-item overall hangover severity scores as the
scales may include low-frequency/low-severity symptoms and omit high-frequency/high-severity
symptoms [46]. Notably in this pilot study, the single-item hangover score was higher, and better
differentiated SJP-001 from placebo than the AHS aggregate symptom score. Relying on self-report
to investigate hangovers is necessary, as there is currently no known objective criteria or biomarker
for hangover severity. It is, however, important to include biomarkers of immune function in future
RCTs, to assess the immune response to alcohol consumption in the placebo condition, and to infer
whether SJP-001 is capable of reducing this effect. Such data will be important to provide insight into
the mechanism(s) of action of SJP-001.
In conclusion, the data from this pilot study suggest that SJP-001 is effective in preventing alcohol
hangover. However, the sample size of this study was very small. Therefore, the effects of SJP-001
should be further evaluated in RCTs with a larger sample size.
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Abstract: The aim of this study was to evaluate the efficacy of putative hangover treatment, Rapid
Recovery, in mitigating alcohol hangover (AH) symptom severity. Using a double-blind, randomized,
placebo-controlled, balanced crossover design, 20 participants attended the laboratory for two
evenings of alcohol consumption, each followed by morning assessments of AH severity. Participants
were administered Rapid Recovery and placebo on separate visits. In the first testing visit, participants
self-administered alcoholic beverages of their choice, to a maximum of 1.3 g/kg alcohol. Drinking
patterns were recorded and replicated in the second evening testing visit. In the morning visits,
AH severity was assessed using questionnaires measuring AH symptom severity and sleep quality,
computerized assessments of cognitive functioning as well as levels of blood biomarkers of liver
function (gamma-glutamyl transferase (GGT)) and inflammation (high-sensitive C-reactive protein
(hs-CRP)). There were no differences in the blood alcohol concentrations (BAC) obtained in the
Rapid Recovery (mean = 0.096%) and placebo (mean = 0.097%) conditions. Participants reported
significantly greater sleep problems in the Rapid Recovery compared to placebo condition, although
this difference was no longer significant following Bonferroni’s correction. There were no other
significant differences between Rapid Recovery and placebo. These data suggest that Rapid Recovery
has no significant effect on alcohol hangover nor on associated biomarkers.
Keywords: hangover; alcohol; hangover treatment; inflammation; liver function
1. Introduction
Alcohol hangover (AH) is defined as the combination of negative mental and physical symptoms
which can be experienced after a single episode of alcohol consumption, starting when blood alcohol
concentration (BAC) approaches zero [1,2]. It is characterized by a general state of malaise and a range
of physical and psychological symptoms including headache [3,4], fatigue [5], nausea [4] and reduced
cognitive functioning [6–8]. These symptoms negatively impact daily activities such as driving [9,10],
job performance [11,12] and studying [4].
AH is pervasive, affecting 75% of all social drinkers [13]. As well as subjective effects it contributes
to significant economic costs. It is estimated that, due to associated absenteeism and presenteeism,
AH costs the UK economy between £1.2 billion and £1.4 billion per year [14] (i.e., approximately US $1.5
to $1.7 billion) and the Australian economy over AUS $3 billion annually [15] (i.e., approximately
US $1.8 billion). Assessing the full cost, beyond absenteeism and presenteeism, it has been estimated
that AH costs the American economy some US $179 billion per year [16].
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The physiological causes of AH are largely unknown. Analyses of blood, saliva and urine
samples indicate that concentrations of various hormones, electrolytes, free fatty acids, triglycerides,
lactate, ketone bodies, cortisol, glucose and biomarkers of dehydration do not appear to correlate
with hangover symptom severity [17,18]. In a recent review of biological factors that contribute to
AH, Palmer et al. [19] concluded that alcohol metabolites, inflammatory factors, neurotransmitter
alterations and mitochondrial dysfunction are the most likely contributors to AH severity.
Alcohol is predominately broken down in the liver, where it is metabolized by alcohol
dehydrogenase (ADH) to acetaldehyde, which is then itself metabolized by aldehyde dehydrogenase
(ALDH) to acetate. Acetate is then broken down into water and carbon dioxide for elimination.
Acetaldehyde is rapidly metabolized by most individuals so that blood acetaldehyde levels typically
remain low and it is unlikely to be present during AH. Nevertheless, acetaldehyde is highly toxic.
It can cause tissue damage [20,21] and its presence in the body has been associated with hangover-like
symptoms, including nausea, sweating, rapid pulse and headache [22,23]. It has been argued that
increased acetaldehyde concentration and its long-lasting effects contribute to the presence of hangover
symptoms [24,25]. However, the one human study to assess the effects of blood acetaldehyde levels on
AH severity failed to find any evidence for a correlation between peak acetaldehyde concentration and
hangover severity [26]. However, this one study does not provide sufficient evidence to exclude the
possibility of an association between acetaldehyde and AH severity.
Evidence collected in several animal [27–30], human [31] and in vitro studies [32,33] indicate
severe effects of ethanol on inflammatory processes. Inflammatory responses can also result in a
variety of hangover-related symptoms, including nausea, vomiting, headache, negative mood and
cognitive impairment [34,35]. Several studies have demonstrated evidence for elevated cytokine levels
during hangover [31,36–38]. Another marker of inflammation, C-reactive protein (CRP), has been
reported in two studies to correlate with AH severity [25,39], while another study has failed to find
an association between CRP levels and AH [40]. However, the reliability of one of the studies that
reported an association [25] is questionable as the assays that were used to measure CRP had limited
detection sensitivity. This resulted in almost one-quarter of the data being outside the detection limit.
Since this study, the development of highly sensitive assays to measure CRP levels have enabled more
accurate measurement of CRP.
The current lack of understanding of the pathology of AH has hindered the development of an
effective hangover treatment. Despite this there remains a high consumer demand [41] and many
currently available products are advertised as mitigating AH severity. Yet there is no hangover
treatment on the market with robust evidence for efficacy. Proposed treatments that have been
investigated in human research showed either no effect, or minimal and differential reduction in the
presence or severity of some but not other hangover symptoms [42].
The treatment of AH is further complicated by individual variation in hangover symptom frequency
and severity [43,44], of which, genetic variations contribute about 40%–45% [45]. The influence of
genetic variations on AH is evident when considering the efficacy of Korean pear juice, which has
been shown to effectively reduce certain AH symptoms according to aldehyde dehydrogenase (ALDH)
genotype. Specifically, it is effective in carriers of the ALDH2*1/*1 and ALDH2*1/*2 alleles, while being
ineffective in the ALDH2*2/*2 genotype [46]. Variations in aldehyde dehydrogenase genes are also
responsible for alcohol-induced flush reactions that are evident in 36% of people descended from East
Asia [47]. Symptoms include flushing of the face, neck and shoulders, along with symptoms commonly
associated with hangover, including headache and nausea, which are caused by elevated circulating
levels of acetaldehyde [48]. Individuals who experience alcohol-induced flush reactions also display
greater susceptibility to AH [49] and sensitivity to AH symptom severity [50], adding further support
for the important role of acetaldehyde in AH. However, it should also be noted that Lee et al. [44]
investigated the effects of Korean pear in a sample of 14 healthy male-only Asian subjects. Therefore,
more research is needed to confirm these findings in groups of non-Asian descent men and women.
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The aim of this investigation was to examine the effects of Rapid Recovery on AH symptom
severity, inflammation, sleep quality and cognitive functioning. Rapid Recovery is an oral capsule that
contains the amino acid L-cysteine and B and C group vitamins. It is proposed by the manufacturers that
these ingredients will improve acetaldehyde metabolism and reduce oxidative stress. L-cysteine plays
a role in reversing oxidization in the liver, with animal research showing that L-cysteine accelerates
the breakdown and reduces the accumulation of acetaldehyde [51]. Another rodent study found
that the administration of L-cysteine combined with vitamins B-1 and C reduced mortality caused
by acetaldehyde poisoning [52]. In the current study, we tested the hypothesis that Rapid Recovery
would reduce AH severity in social drinkers. A number of relevant biomarkers were co-monitored.
2. Experimental Section
2.1. Method
This study was conducted in accordance with the Declaration of Helsinki and was
approved by the Swinburne University Human Research Ethics Committee (SUHREC, 2018/275).
This study was registered with the Australian New Zealand Clinical Trials Registry (ANZCTR,
ACTRN12618001996257).
2.2. Design
This study was a semi-naturalistic, randomized, double-blind, placebo-controlled, crossover
clinical trial. The laboratory was set-up to simulate a bar-like environment and participants consumed
alcoholic drinks of their choice and at their own pace, to a maximum of 1.3 g/kg alcohol. Participants
were administered either placebo or active treatment over two testing visits.
2.3. Participants
Twenty-three participants who were healthy, aged 21–50 years old and regularly experienced
hangovers were enrolled in the study. Three participants withdrew at the first morning visit,
two withdrew due to illness and one failed to meet the eligibility requirement of a (BAC of 0.00% at the
morning visit. The final sample consisted of 20 participants (65% female) with a mean age of 30.30
years (range 25–43 years old).
All participants were free of any current or history of drug or alcohol abuse, medically treated
liver or renal impairment, pregnancy or breast feeding in females, and current use of any medication
that could potentially affect the outcome of the study.
2.4. Measures
2.4.1. Breath Alcohol Concentration (BAC)
BAC was measured at the beginning of each testing visit to ensure a reading of 0.00%. In the
evening testing visits, BAC was measured approximately 20-min after the final alcoholic drink.
BAC was collected using a regularly calibrated Lion Alcolmeter SD400PA.
2.4.2. Assessment of Hangover Severity
Overall hangover severity was measured using a single one-item rating and severity of 23
hangover symptoms were rated on an 11-point Likert scale ranging from 0 to 10, with higher scores
indicating a more severe hangover. The 23 items were derived from the Alcohol Hangover Severity
Scale, the Hangover Symptoms Scale and the Acute Hangover Scale [53,54]. This composite scale has
been successfully implemented in previous hangover research [55].
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2.4.3. Sleep Quality Assessments
Self-reported assessments of sleep quality comprised of the Groningen Sleep Quality Scale
(GSQS) [56] and the Karolinska Sleepiness Scale (KSS) [57], which measured sleep quality during
the previous night and current sleepiness, respectively. The GSQS comprises of 15 sleep complaints
requiring a “yes” or “no” response indicating whether they had been experienced during the previous
night’s sleep. Scores range from 0 to 14, (the first item is not scored) with higher scores indicating
poorer sleep quality. The KSS requires participants to indicate their level of fatigue in the last five
minutes on a single-item using a nine-point Likert scale. Higher scores indicate greater levels of
sleepiness. These scales have been implemented successfully in previous hangover research [9,55].
2.4.4. Assessment of Biomarkers for Inflammation and Liver Function
High-sensitivity C-reactive protein (hs-CRP) tests were used to measure inflammation and
gamma-glutamyl transferase (GGT) tests were used to measure liver function.
2.4.5. Assessment of Cognitive Performance
Cognitive performance was measured using the following tests available on the Vienna Test
System (Schuhfried GmbH, Moedling, Austria). This test system assesses cognitive functioning that
influence driving ability. The entire battery required approximately 15–20 min to complete.
Reaction Test (RT)
This test measures reaction time and motor time in response to optical and acoustic signals [58].
Participants were asked to place and leave their index finger on a pressure-sensitive key (i.e., rest key).
Using the same index finger, participants were required to react as quickly as possible to the signals by
pressing a target key before retiring their finger to the rest key. Performance was measured according
to mean reaction time, mean motor time and number of correct reactions.
Determination Test (DT)
This test assesses reactive stress tolerance, divided attention and mental flexibility [59]. Participants
are presented with various visual and auditory stimuli and are required to respond the stimuli by
pressing corresponding response buttons with either their hands or feet, using the response panel and
foot pedals of the Vienna Test System. Performance was assessed according to reaction time, number
of correct responses, number of errors and number of missed responses.
Adaptive Tachistoscopic Traffic Perception Test (ATAVT)
This test assesses visual observation skills, visual orientation ability, speed of perception and skills
in obtaining a traffic overview [60]. Images of traffic situations appeared briefly on a computer screen
and the participant was asked to state what was in each image, by choosing from five answer options;
motor vehicle, road sign, traffic light, pedestrian and bicycle. Performance was measured according to
reaction time and the number of errors made.
2.4.6. Perceived Treatment Order
Awareness of the allocated condition order (active-placebo or placebo-active) was measured at
the end of the trial. Participants were asked which treatment (active or placebo) they believed they had
received on the first and second testing visit.
2.5. Procedure
Prior to undergoing any testing procedures, participants provided written informed consent and
were assessed for eligibility. Participants then underwent training and practice in completing the RT,
DT and ATAVT tasks, and provided a baseline blood sample for hs-CRP and GGT analyses.
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All testing visits were held in the laboratory, with intoxication visits held between 17:00 and 00:30,
and hangover visits held the following morning between 7:00 and 11:00. The two evening visits were
held within 7–14 days of one another. During the evening visits, the laboratory was set-up to mimic a
bar and background music was played while participants socialized with one another.
Participants were advised to avoid alcohol for 24-h prior to the intoxication visits, food and drink
(other than water) for 2-h prior to all testing visits and alcohol, drugs, food and caffeine between
the evening and morning visits. At the beginning of each evening visit, participants were provided
with a meal, the type and quantity of food consumed in the first visit was recorded and replicated
in the second evening visit. Participants were then instructed to freely consume the drink type(s)
of their choice (of wine, cider, beer, spirits), to a maximum of 1.3 g/kg alcohol. The time that each
drink was started and finished was recorded and drinking behavior was replicated in the second
evening visit. Participants were administered the first dose of the study treatment with their final
drink and were provided the second dose to self-administer upon their first awakening the following
morning. The study treatment was either placebo (corn flour) or Rapid Recovery (L-cysteine, thiamine,
pyridoxine and ascorbic acid). The contents of the study treatments were controlled by a laboratory
independent of the manufacturer.
Participants returned to the laboratory the following morning where they were initially
breathalyzed to ensure a BAC reading of 0.00%. Once deemed eligible, participants were able
to commence the testing procedures.
2.6. Statistics and Analyses
Statistical analyses were conducted using SPSS, Version 25 (IBM Corp, Armonk, NY, USA).
All variables were analyzed using paired sample t-tests comparing Rapid Recovery with placebo.
The sleep quality assessments and Hs-CRP and GGT levels were correlated with overall hangover
severity. Lastly, a chi-square test was used to determine whether there was a significant difference
between correct and incorrect perceived treatment order.
In order to further investigate whether the obtained data was more in favor of the null hypothesis
(H0, i.e., the assumption of no differences between the active and placebo condition) or more in favor
of the alternative hypothesis (H1, i.e., the assumption of differences between the active and placebo
condition), add-on Bayesian statistics were conducted using the standard settings of SPSS for the
respective tests. Based on the cutoffs suggested by Wagenmakers, et al. [61] the Bayes factor (BF) of 1
does not provide evidence for either hypothesis. Larger BF values provide stronger evidence for the
H0 (compared to the H1), while smaller BF values provide stronger evidence for the H1 (compared to
the H0), given the obtained data. Specifically, values 1–3 (1/3–1) are seen as anecdotal evidence for the
H0, values 3–10 (1/10–1/3) are seen as substantial evidence for the H0, values of 10–30 (1/30–1/10) are
seen as strong evidence for the H0, values of 30–100 (1/100–1/30) are seen as very strong evidence for
the H0, and values of >100 (<1/100) are seen as extreme evidence for the H0.
3. Results
3.1. BAC Levels
BAC levels obtained in the active (mean = 0.096%, sd = 0.023) and placebo (mean = 0.097%,
sd = 0.028) conditions did not significantly differ (t(19) = 0.507, p = 0.618). Add-on Bayesian analyses
provided substantial evidence for the null hypothesis (BF = 5.183), showing that BAC concentrations
did indeed not differ between conditions.
3.2. Hangover Symptom Severity
The only hangover symptom to significantly differ according to testing condition was “sleep
problems” t(19) = 2.10, p = 0.049, with more severe sleep problems in the active (mean = 2.59,
sd = 2.86) compared to placebo (mean = 1.63, sd = 1.75) condition. Following Bonferroni’s correction,
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this difference was no longer significant. Add-on Bayesian analyses for the non-significant effects
revealed that in most cases, the obtained BF provided substantial evidence for the H0, as indicated by
BF values between 3 and 10. For the other factors (“reduced appetite”, “sweating”, “heart beating” and
“vomiting”), the Bayesian analyses still provided anecdotal evidence in favor of the H0, as indicated by
BF values between 1 and 3. Taken together, all of these findings support the assumption that none of
the investigated measures improved during the active condition. Hangover symptom severity scores
can be found in Table 1, below.
Table 1. Hangover symptom severity scores (means and standard deviations) in the Rapid Recovery
and placebo conditions. Descriptive data is given in the left columns, while the p value obtained from
paired samples t-tests and the Bayes factor (BF) value obtained in case of non-significant differences






p Value BF Value
Single-Item Severity Scale
‘How severe is your hangover?’ 3.18 (2.69) 3.22 (2.07) 0.962 5.856
Hangover Symptom Composite Scale
Concentration problems 5.65 (2.40) 5.43 (1.92) 0.748 5.570
Thirst 4.94 (2.51) 5.12 (1.35) 0.775 5.630
Tiredness 4.78 (2.35) 4.83 (2.43) 0.957 5.854
Sleepiness 4.53 (2.340 4.66 (2.50) 0.874 5.790
Headache 3.31 (3.07) 3.31 (2.51) 0.996 5.862
Apathy 2.90 (2.64) 2.79 (2.22) 0.856 5.768
Clumsiness 2.65 (2.01) 2.66 (2.11) 0.994 5.862
Weakness 2.54 (2.63) 2.71 (2.07) 0.835 5.737
Sensitivity to light 2.26 (2.54) 2.38 (2.06) 0.811 5.698
Nausea 1.77 (1.72) 2.37 (2.47) 0.365 3.904
Sleep problems 1.63 (1.75) 2.59 (2.86) 0.049 * /
Reduced appetite 1.61 (1.80) 2.57 (2.75) 0.219 2.774
Dizziness 1.53 (1.54) 2.05 (1.97) 0.360 3.870
Stomach pain 1.37 (2.38) 1.35 (2.08) 0.977 5.860
Shaking, shivering 1.23 (1.66) 0.95 (1.31) 0.407 4.169
Anxiety 1.18 (1.54) 1.07 (1.20) 0.668 5.350
Confusion 1.17 (1.54) 0.98 (0.95) 0.569 4.991
Regret 1.05 (1.68) 0.77 (1.00) 0.429 4.298
Sweating 0.93 (1.08) 1.40 (1.68) 0.238 2.940
Heart beating 0.90 (1.31) 1.41 (1.76) 0.234 2.903
Depression 0.73 (0.88) 0.75 (0.97) 0.935 5.843
Heart racing 0.67 (0.95) 0.84 (0.93) 0.247 3.016
Vomiting 0.39 (0.53) 0.89 (1.70) 0.193 2.529
Note: M: Mean; SD: Standard deviation; *: p < 0.05.
3.3. Sleep Quality and Cognitive Performance
There were no significant differences between the Rapid Recovery and placebo conditions
on the Groningen Sleep Quality Scale (GSQ), Karolinska Sleepiness Scale (KSS), reaction test (RT),
determination test (DT) and adaptive tachistoscopic traffic perception test (ATAVT). The mean
scores and standard deviations are displayed in Table 2, below. Self-rated overall hangover severity
significantly correlated with GSQ (r= 0.552, p= 0.012) and KSS (r= 0.764, p≤ 0.001) scores in the placebo
condition. The same result was found in the treatment condition, with overall hangover severity scores
significantly correlating with GSQ (r = 0.638, p = 0.002) and KSS (r = 0.762, p < 0.001) scores.
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Table 2. Sleep quality and cognitive performance scores (means and standard deviations) in the Rapid
Recovery and placebo conditions. Descriptive data is given in the left columns, including Groningen
Sleep Quality Scale (GSQS), Karolinska Sleepiness Scale (KSS), reaction test (RT), determination test
(DT) and adaptive tachistoscopic traffic perception test (ATAVT) while the p value obtained from paired
samples t-tests and the BF value obtained in case of non-significant differences (i.e., p values < 0.05) are








GSQ 4.10 (3.54) 3.35 (3.01) 0.429 4.300
KSS 5.00 (2.15) 4.85 (2.06) 0.845 5.753
RT
Reaction time (milliseconds) 426.79 (57.23) 415.37 (79.40) 0.297 3.341
Motor time (milliseconds) 152.84 (37.55) 156.89 (34.64) 0.584 4.788
Number of correct reactions 15.95 (0.23) 16.00 (0.00) 0.331 3.580
DT
Reaction time (milliseconds) 676.80 (61.20) 668.90 (62.35) 0.544 4.770
Number of correct responses 283.05 (33.58) 289.32 (27.03) 0.367 3.826
Number of errors 21.42 (11.76) 22.21 (11.54) 0.681 5.265
Number of missed responses 14.21 (8.34) 13.95 (6.93) 0.823 5.586
ATAVT
Reaction time (seconds) 8.98 (1.50) 9.03 (1.47) 0.893 5.675
Number of errors 5.95 (2.37) 6.00 (3.79) 0.956 5.718
Note: M: Mean; SD: Standard deviation.
3.4. Levels of Biomarkers for Inflammation and Liver Function
There were no significant differences in hs-CRP and GGT levels in the Rapid Recovery compared
to placebo condition (all p ≥ 0.376). Bayesian add-on analyses further provided substantial evidence
for the H0 (all BF ≥ 3.587), thus demonstrating that both measures did not differ across conditions.
Furthermore, hs-CRP and GGT levels did not significantly correlate with self-rated overall hangover
severity in either of the testing conditions (all p ≥ 0.286). For both conditions, add-on Bayesian analyses
provided substantial evidence for the lack of correlation between hs-CRP and overall hangover ratings
(all BF ≥ 3.000) and for the lack of correlation between GGT and overall hangover (all BF ≥ 3.008).
The hs-CRP and GGT levels can be found in Table 3, below.
Table 3. High sensitivity C-reactive protein (hs-CRP) and gamma-glutamyl transpeptidase (GGT)
levels (means and standard deviations) at baseline and in the Rapid Recovery and placebo conditions.
Descriptive data is given in the left columns, while the p value obtained from paired samples t-tests
comparing the placebo and active condition, as well as the BF value obtained in case of non-significant








Hs-CRP (mg/L) 1.78 (2.86) 1.49 (2.28) 1.43 (2.37) 0.813 5.150
GGT (U/L) 27.56 (14.39) 28.31 (15.17) 27.13 (13.85) 0.376 3.587
Note: M: Mean; SD: Standard deviation.
3.5. Percieved Treatment Order and Adverse Events
A total of 60% of the participants guessed the correct condition order, indicating adequate blinding,
χ2 = 0.80, p = 0.371.
There were no reported adverse events associated with Rapid Recovery.
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4. Discussion
The current study assessed the effects of Rapid Recovery on hangover symptom severity.
The hypothesis that Rapid Recovery would reduce AH severity was not supported. There were
no significant differences between placebo and Rapid Recovery on self-rated overall hangover severity,
sleep quality, CRP and GGT levels and cognitive performance. Furthermore, Bayesian add-on analyses
provided credible evidence that the assumption of a null effect was more likely (than the assumption
of non-significant/residual differences), given the obtained data. Of the 23 hangover symptoms
that were assessed, the only significant difference between Rapid Recovery and placebo was found
on the symptom of “sleep problems”, which was worse following Rapid Recovery administration.
The ineffectiveness of Rapid Recovery to reduce AH severity may indicate that administration of
l-cysteine combined with B and C vitamins does not improve acetaldehyde metabolism, or that
acetaldehyde is not responsible for AH severity.
The results of this study further support the relationship between poor sleep quality and hangover
severity [8,62–64], with significant and positive correlations between AH severity, and poor previous
night’s sleep quality and current sleepiness. The current study failed to provide any evidence for
a correlation between AH severity and CRP or GGT levels, which remained within normal ranges
at each testing timepoint. Currently, the evidence for an association between AH severity and
CRP is mixed, with some studies [25,39] demonstrating support for an association, while one other
study [40], consistent with the findings of the current study, failed to find significant correlation
between AH severity and CRP. While GGT is a reliable biomarker of liver damage caused by chronic
heavy drinking [65–67], previous research has indicated that GGT levels are not associated with AH
susceptibility [49] and, consistent with the findings of this study, are not necessarily elevated during
AH [39]. Although it was not demonstrated in the current study, compelling evidence indicates an
impairing effect of AH on immune functioning, and more reliable markers of this may include, but are
not limited to, interleukin (IL)-6, IL-10, IL-12 and tumor necrosis factor (TNF)-α [37,68,69].
This investigation utilized a novel, controlled and ecologically valid methodology, which was
found to successfully induce AH. Participants obtained mean BACs of 0.096% and 0.097% in the Rapid
Recovery and placebo conditions, respectively, levels beyond that required to induce a hangover [70].
By enabling participants to self-administer alcohol within a controlled laboratory setting, we were
able to overcome several commonly occurring methodological issues within the area of AH research.
While methods of alcohol dosing used in previous laboratory studies assessing AH have been criticized
for not mimicking real-life drinking behaviors, naturalistic studies have been criticized for lacking
experimental control, and relying on self-reported alcohol intake to calculate estimated BAC [4,71–73].
The current study used methodology which combined the advantages of naturalistic approaches
(i.e., participants drinking alcohol of their choice in a social setting) with those of laboratory studies
(i.e., a controlled environment, objective measures of BAC and other biomarkers, veracity of treatment
administration).
There were several limitations in this study. Firstly, we allowed participants to consume their
preferred type of alcohol to ensure drinking behaviors replicated real-life drinking. Although
drinking behaviors were consistent across the two testing visits, which eliminated intraindividual
differences, this introduced interindividual variability. Alcoholic drinks contain various concentrations
of congeners, which have been found to increase AH severity [17,74]. On the other hand, the fact
that each individual’s session was matched, somewhat, mitigates against this influencing our results.
Furthermore, it is possible that the effectiveness of Rapid Recovery is dependent on individual factors,
for example, genetic variations or tolerance to alcohol. This was evident in literature on the effectiveness
of Korean pear juice in treating certain AH symptoms in particular genetic subgroups but not others [46].
The sample size of this study was too small to allow meaningful subgroup analysis. Lastly, we did not
assess hangover symptoms following alcohol abstinence because, although interesting, this was not
necessary for the aim of this study, i.e., comparing Rapid Recovery and placebo. As such, we are unable
to determine the severity of AH obtained in this study. While mean BAC levels are beyond those
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deemed required to induce a hangover [70], the mean overall hangover severity score is relatively low.
Recent evidence indicates that BAC may not be the most appropriate predictor of AH severity, which is
better predicted by levels of subjective intoxication and increased alcohol consumption compared to
usual [70]. While these factors were not assessed in the current study, future AH research should aim
to include measures of subjective intoxication and typical alcohol intake.
In conclusion, the findings from this study suggest that the administration of Rapid Recovery does
not mitigate AH severity, and Hs-CRP and GGT levels are not associated with AH. Further research is
required to assess the impact of an effective hangover treatment on alcohol consumption and determine
whether it would encourage excessive drinking. Importantly, an effective hangover treatment would
not mitigate all adverse factors associated with heavy drinking, such as chronic disease and injury.
The development of an effective hangover treatment is currently hindered by a lack of understanding
of the pathology of AH. As such, future research should continue to assess the pathology of AH to
enable the development of treatments that target key mechanisms involved in the AH.
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